MPEP 1400: Difference between revisions

From wikilawschool.net. Wiki Law School does not provide legal advice. For educational purposes only.
No edit summary
m (Text replacement - "__TOC__" to "<div class="noautonum">__TOC__</div>")
 
(5 intermediate revisions by the same user not shown)
Line 3: Line 3:
'''<big>Chapter 1400 Correction of Patents</big>'''
'''<big>Chapter 1400 Correction of Patents</big>'''


__TOC__
<div class="noautonum">__TOC__</div>


==1400 [No Text]==
==1400 [No Text]==
Line 26: Line 26:
MPEP Chapter 2600 for inter partes reexamination.
MPEP Chapter 2600 for inter partes reexamination.


==1401 Reissue==


 
{{Statute|35 U.S.C. 251. Reissue of defective patents.}}
 
 
1401Reissue [R-3]
 
35 U.S.C. 251. Reissue of defective patents.
 
Whenever any patent is, through error without any deceptive  
Whenever any patent is, through error without any deceptive  
intention, deemed wholly or partly inoperative or invalid, by reason  
intention, deemed wholly or partly inoperative or invalid, by reason  
Line 60: Line 54:
claims of the original patent unless applied for within two years  
claims of the original patent unless applied for within two years  
from the grant of the original patent.
from the grant of the original patent.
|}


The provisions of 35 U.S.C. 251 permit the reissue  
The provisions of 35 U.S.C. 251 permit the reissue  
Line 68: Line 64:
directed to reissue.  
directed to reissue.  


1402Grounds for Filing [R-5]
==1402 Grounds for Filing==


A reissue application is filed to correct an error in  
A reissue application is filed to correct an error in  
Line 102: Line 98:
present).
present).


These corrections may be made via a certificate of  
These corrections may be made via a certificate of  
correction; see MPEP § 1481.
correction; see MPEP § 1481.


Line 108: Line 104:
are:
are:


(A)the claims are too narrow or too broad;  
{{Tab1}}(A)the claims are too narrow or too broad; </p>


(B)the disclosure contains inaccuracies;  
{{Tab1}}(B)the disclosure contains inaccuracies; </p>


(C)applicant failed to or incorrectly claimed foreign  
{{Tab1}}(C)applicant failed to or incorrectly claimed foreign priority; and</p>
priority; and


(D)applicant failed to make reference to or incorrectly  
{{Tab1}}(D)applicant failed to make reference to or incorrectly made reference to prior copending applications.</p>
made reference to prior copending applications.


An attorney’s failure to appreciate the full scope of  
An attorney’s failure to appreciate the full scope of  
the invention was held to be an error correctable  
the invention was held to be an error correctable  
through reissue in the decision of In re Wilder,  
through reissue in the decision of In re Wilder,  
736  
736 F.2d 1516, 222 USPQ 369 (Fed. Cir. 1984). The  
F.2d 1516, 222 USPQ 369 (Fed. Cir. 1984). The  
correction of misjoinder of inventors in divisional  
correction of misjoinder of inventors in divisional  
reissues has been held to be a ground for reissue. See  
reissues has been held to be a ground for reissue. See  
Line 144: Line 137:
by filing a request for a certificate of correction under  
by filing a request for a certificate of correction under  
the provisions of 35 U.S.C. 256 and 37 CFR 1.324.  
the provisions of 35 U.S.C. 256 and 37 CFR 1.324.  
See MPEP §
See MPEP § 1412.04 and § 1481. A Certificate of  
1412.04 and § 1481. A Certificate of  
Correction will be issued if all parties are in agreement  
Correction will be issued if all parties are in agreement  
and the inventorship issue is not contested.
and the inventorship issue is not contested.
Line 152: Line 143:
A reissue was granted in Brenner v. State of Israel,  
A reissue was granted in Brenner v. State of Israel,  
400 F.2d 789, 158 USPQ 584 (D.C. Cir. 1968), where  
400 F.2d 789, 158 USPQ 584 (D.C. Cir. 1968), where  
the only ground urged was failure to file a certified  
the only ground urged was failure to file a certified  
copy of the original foreign application to obtain the  
copy of the original foreign application to obtain the  
Line 203: Line 188:
delayed claim under 35 U.S.C. 119(e) would  
delayed claim under 35 U.S.C. 119(e) would  
not be required in addition to filing a reissue application..
not be required in addition to filing a reissue application..


Section 4503 of the American Inventors Protection  
Section 4503 of the American Inventors Protection  
Line 260: Line 244:
within the time period set forth in 37 CFR 1.78(a)(2),  
within the time period set forth in 37 CFR 1.78(a)(2),  
then a petition for an unintentionally delayed benefit  
then a petition for an unintentionally delayed benefit  
claim under 37 CFR 1.78(a)(3) along with the surcharge  
claim under 37 CFR 1.78(a)(3) along with the surcharge  
set forth in 37 CFR 1.17(t) would be required  
set forth in 37 CFR 1.17(t) would be required  
Line 300: Line 278:
one substantive “error ” under 35 U.S.C. 251.
one substantive “error ” under 35 U.S.C. 251.


1403Diligence in Filing [R-3]
==1403 Diligence in Filing==


When a reissue application is filed within 2 years  
When a reissue application is filed within 2 years  
Line 345: Line 323:
1410.01.
1410.01.


1404Submission of Papers Where Reissue  
==1404 Submission of Papers Where Reissue Patent Is in Litigation==
Patent Is in Litigation [R-2]


Marking of envelope: Applicants and protestors  
Marking of envelope: Applicants and protestors  
Line 366: Line 343:
marked “REISSUE LITIGATION” will be given special  
marked “REISSUE LITIGATION” will be given special  
attention and expedited handling. (For IFW processing,  
attention and expedited handling. (For IFW processing,  
see IFW Manual.) See MPEP §
see IFW Manual.) See MPEP § 1442.01through § 1442.04 for examination of litigation-
1442.01through § 1442.04 for examination of litigation-
related reissue applications. Protestor’s participation,  
related reissue applications. Protestor’s participation,  
including the submission of papers, is limited in  
including the submission of papers, is limited in  
accordance with 37 CFR 1.291(c).
accordance with 37 CFR 1.291(c).


 
==1405 Reissue and Patent Term==
 
 
 
 
 
1405Reissue and Patent Term [R-2]


35 U.S.C. 251 prescribes the effect of reissue on the  
35 U.S.C. 251 prescribes the effect of reissue on the  
Line 458: Line 426:
original patent.”
original patent.”


1406Citation and Consideration of  
==1406 Citation and Consideration of References Cited in Original Patent==
References Cited in Original Patent[R-3]


In a reissue application, the examiner should consider  
In a reissue application, the examiner should consider  
Line 468: Line 435:
patent may no longer be relevant, e.g., in view of a  
patent may no longer be relevant, e.g., in view of a  
narrowing of the claim scope in the reissue application.
narrowing of the claim scope in the reissue application.


Should applicants wish to ensure that all of the references  
Should applicants wish to ensure that all of the references  
Line 481: Line 447:
1.98(a)(2) requires
1.98(a)(2) requires


(A)a legible copy of each foreign patent,
(A) a legible copy of each foreign patent,
 
 
 
 


(B)each publication or that portion which caused  
(B) each publication or that portion which caused  
it to be listed,
it to be listed,


(C)each pending unpublished U.S. application  
(C) each pending unpublished U.S. application  
unless the cited pending U.S. application is stored in  
unless the cited pending U.S. application is stored in  
the Image File Wrapper (IFW) system. The requirement  
the Image File Wrapper (IFW) system. The requirement  
Line 504: Line 465:
(Oct. 19, 2004),
(Oct. 19, 2004),


(D)all other information or that portion which  
(D) all other information or that portion which  
caused it to be listed.
caused it to be listed.


See MPEP § 609.04(a). The Office imposes no  
See MPEP § 609.04(a). The Office imposes no  
responsibility on a reissue applicant to resubmit, in a  
responsibility on a reissue applicant to resubmit, in a  
reissue application, all the “References Cited” in the  
reissue application, all the “References Cited” in the  
Line 524: Line 485:
reference has been considered.
reference has been considered.


1410Content of Reissue Application[R-3]
==1410 Content of Reissue Application==
 
37 CFR 1.171. Application for reissue.


{{Statute|37 CFR 1.171. Application for reissue.}}
An application for reissue must contain the same parts required  
An application for reissue must contain the same parts required  
for an application for an original patent, complying with all the  
for an application for an original patent, complying with all the  
Line 533: Line 493:
must comply with the requirements of the rules relating to  
must comply with the requirements of the rules relating to  
reissue applications.
reissue applications.
|}


37 CFR 1.173. Reissue specification, drawings, and
amendments.


(a)Contents of a reissue application. An application for  
{{Statute|37 CFR 1.173. Reissue specification, drawings, and amendments.}}
(a) Contents of a reissue application. An application for  
reissue must contain the entire specification, including the claims,  
reissue must contain the entire specification, including the claims,  
and the drawings of the patent. No new matter shall be introduced  
and the drawings of the patent. No new matter shall be introduced  
Line 545: Line 505:
35 U.S.C. 251.
35 U.S.C. 251.


(1)Specification, including claims. The entire specification,  
<p style="padding-left: +20px;">(1) Specification, including claims. The entire specification,  
including the claims, of the patent for which reissue is  
including the claims, of the patent for which reissue is  
requested must be furnished in the form of a copy of the printed  
requested must be furnished in the form of a copy of the printed  
Line 556: Line 516:
of correction (§§ 1.322 through 1.324), or reexamination certificate  
of correction (§§ 1.322 through 1.324), or reexamination certificate  
(§ 1.570) issued in the patent must be included. (See also §  
(§ 1.570) issued in the patent must be included. (See also §  
1.178).
1.178).</p>


(2)Drawings. Applicant must submit a clean copy of  
<p style="padding-left: +20px;">(2) Drawings. Applicant must submit a clean copy of  
each drawing sheet of the printed patent at the time the reissue  
each drawing sheet of the printed patent at the time the reissue  
application is filed. If such copy complies with § 1.84, no further  
application is filed. If such copy complies with § 1.84, no further  
Line 565: Line 525:
the changes to the drawing must be made in accordance with  
the changes to the drawing must be made in accordance with  
paragraph (b)(3) of this section. The Office will not transfer the  
paragraph (b)(3) of this section. The Office will not transfer the  
drawings from the patent file to the reissue application.
drawings from the patent file to the reissue application.</p>
 
{{Ellipsis}}
|}




Line 594: Line 555:
made either by:
made either by:


(A)physically incorporating the changes within  
(A) physically incorporating the changes within  
the specification by cutting the column of the printed  
the specification by cutting the column of the printed  
patent and inserting the added material and rejoining  
patent and inserting the added material and rejoining  
Line 601: Line 562:
printed patent. Markings pursuant to 37 CFR 1.173(d)  
printed patent. Markings pursuant to 37 CFR 1.173(d)  
must be used to show the changes. The columnar  
must be used to show the changes. The columnar  
structure of the printed patent must be preserved, and  
structure of the printed patent must be preserved, and  
the physically modified page must comply with  
the physically modified page must comply with  
37  
37 CFR 1.52(a)(1). As to compliance with 37 CFR  
CFR 1.52(a)(1). As to compliance with 37 CFR  
1.52(a)(1)(iv), the “written either by a typewriter or  
1.52(a)(1)(iv), the “written either by a typewriter or  
machine printer in permanent dark ink or its equivalent”  
machine printer in permanent dark ink or its equivalent”  
Line 618: Line 572:
typed legibly in the margin; or
typed legibly in the margin; or


(B)providing a separate amendment paper with  
(B) providing a separate amendment paper with  
the reissue application.
the reissue application.


In either case, the amendment must be made pursuant  
In either case, the amendment must be made pursuant  
to 37 CFR 1.173(b) and must comply with all the  
to 37 CFR 1.173(b) and must comply with all the  
provisions of 37 CFR 1.173(b)– (e) and (g).  
provisions of 37 CFR 1.173(b)– (e) and (g).  
Line 663: Line 617:
The initial contents of a  
The initial contents of a  
reissue application are discussed  
reissue application are discussed  
in detail in MPEP §
in detail in MPEP § 1410.01 through § 1418.
1410.01 through § 1418.


For expedited processing, new and continuing reissue  
For expedited processing, new and continuing reissue  
application filings under 37 CFR 1.53(b) may be  
application filings under 37 CFR 1.53(b) may be  
addressed to: Mail Stop REISSUE, Commissioner for  
addressed to: Mail Stop REISSUE, Commissioner for  
Line 695: Line 647:
MPEP § 1410.01.
MPEP § 1410.01.


Form PTO/SB/50, Reissue Patent Application
===1410.01 Reissue Applicant, Oath or Declaration, and Consent of all Assignees===
Transmittal, may be used for filing reissue applications.


{{Statute|37 CFR 1.172. Applicants, assignees.}}
(a) A reissue oath must be signed and sworn to or declaration
made by the inventor or inventors except as otherwise provided
(see §§ 1.42, 1.43, 1.47), and must be accompanied by the
written consent of all assignees, if any, owning an undivided interest
in the patent, but a reissue oath may be made and sworn to or
declaration made by the assignee of the entire interest if the application
does not seek to enlarge the scope of the claims of the original
patent. All assignees consenting to the reissue must establish
their ownership interest in the patent by filing in the reissue application
a submission in accordance with the provisions of § 3.73(b)
of this chapter.


(b) A reissue will be granted to the original patentee, his
legal representatives or assigns as the interest may appear.
|}




{{Statute|37 CFR 3.73. Establishing right of assignee to take action.}}
{{Ellipsis}}
(b)


<p style="padding-left: +20px;">(1) In order to request or take action in a patent or trademark
 
matter, the assignee must establish its ownership of the
patent or trademark property of paragraph (a) of this section to the
satisfaction of the Director. The establishment of ownership by
the assignee may be combined with the paper that requests or
takes the action. Ownership is established by submitting to the
Office a signed statement identifying the assignee, accompanied
by either:</p>
 
<p style="padding-left: +40px;">(i) Documentary evidence of a chain of title from the
original owner to the assignee (e.g., copy of an executed assignment).
For trademark matters only, the documents submitted to
establish ownership may be required to be recorded pursuant to §
3.11 in the assignment records of the Office as a condition to permitting
the assignee to take action in a matter pending before the
Office. For patent matters only, the submission of the documentary
evidence must be accompanied by a statement affirming that
the documentary evidence of the chain of title from the original
owner to the assignee was or concurrently is being submitted for
recordation pursuant to § 3.11; or</p>


<p style="padding-left: +40px;">(ii) A statement specifying where documentary evidence
of a chain of title from the original owner to the assignee is
recorded in the assignment records of the Office (e.g., reel and
frame number).</p>


Reissue Patent Application Transmittal
<p style="padding-left: +20px;">(2) The submission establishing ownership must show
PTO/SB/50 (04-05)  
that the person signing the submission is a person authorized to  
Approved for use through 04/30/2007. OMB 0651-0033
act on behalf of the assignee by:</p>
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
 
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
<p style="padding-left: +40px;">(i) Including a statement that the person signing the  
REISSUE PATENT APPLICATION TRANSMITTAL
submission is authorized to act on behalf of the assignee; or</p>
Attorney Docket No.
First Named Inventor
Original Patent Number
Original Patent Issue Date
(Month/Day/Year)
Address to:
Mail Stop Reissue
Commissioner for Patents
P.O. Box 1450
Alexandria, VA 22313-1450Express Mail Label No.
APPLICATION FOR REISSUE OF:
(Check applicable box)
Utility Patent Design Patent Plant Patent
APPLICATION ELEMENTS (37 CFR 1.173) ACCOMPANYING APPLICATION PARTS
Statement of status and support for all
10. changes to the claims. See 37 CFR 1.173(c).
11. Foreign Priority Claim (35 U.S.C. 119)
(if applicable)
12. Information Disclosure Statement (IDS)
PTO/SB/08 or PTO-1449
Copies of foreign patent documents,
publications & other information
13. English Translation of Reissue Oath/Declaration
(if applicable)
14. Preliminary Amendment
Return Receipt Postcard (MPEP 503)
15. (Should be specifically itemized)
16. Other:  
1. Fee Transmittal Form (PTO/SB/56)(Submit a duplicate copy)
2. Applicant claims small entity status. See 37 CFR 1.27.
3. Specification and Claims in double column copy of patent format
(amended, if appropriate)
4. Drawing(s) (proposed amendments, if appropriate)
5. Reissue Oath/Declaration (original or copy)
(37 C.F.R. 1.175) (PTO/SB/51 or 52)
6. Power of Attorney7. Original U.S. Patent currently assigned? Yes No
(If Yes, check applicable box(es))
Written Consent of all Assignees (PTO/SB/53)
37 CFR 3.73(b) Statement (PTO/SB/96)
8. CD-ROM or CD-R in duplicate, Computer Program (Appendix)
or large table
Landscape Table on CD
9. Nucleotide and/or Amino Acid Sequence Submission
(if applicable, items a. – c. are required))
a. Computer Readable Form (CRF)
b. Specification Sequence Listing on:  
i CD-ROM (2 copies) or CD-R (2 copies); or
ii paper
c. Statements verifying identity of above copies17. CORRESPONDENCE ADDRESS
The address associated withCustomer Number: OR Correspondence address below
Name
Address
City State Zip Code
Country Telephone Email
Signature Date
Name (Print/Type) Registration No. (Attorney/Agent)
This collection of information is required by 37 CFR 1.173. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO
to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 12 minutes to complete,
including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on  
the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
ADDRESS. SEND TO: Mail Stop Reissue,Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
Doc Code:


<p style="padding-left: +40px;">(ii) Being signed by a person having apparent authority
to sign on behalf of the assignee, e.g., an officer of the
assignee.</p>


(c) For patent matters only:


<p style="padding-left: +20px;">(1) Establishment of ownership by the assignee must be
submitted prior to, or at the same time as, the paper requesting or
taking action is submitted.</p>


<p style="padding-left: +20px;">(2) If the submission under this section is by an assignee
of less than the entire right, title and interest, such assignee must
indicate the extent (by percentage) of its ownership interest, or the
Office may refuse to accept the submission as an establishment of
ownership.</p>
|}




Privacy Act Statment
The reissue oath must be signed and sworn to by all
Privacy Act Statement
the inventors, or declaration made by all the inventors,  
ThePrivacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
except as otherwise provided in 37 CFR 1.42,
with your submission of the attached form related to a patent application or patent. Accordingly,
1.43, and 1.47 (see MPEP § 409). Pursuant to 37 CFR
pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
1.172, where the reissue application does not seek to  
collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
enlarge the scope of any of the claims of the original
and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
patent, the reissue oath may be made and sworn to, or
Office is to process and/or examine your submission related to a patent application or patent. If you do
declaration made, by the assignee of the entire interest.  
not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
Depending on the circumstances, either Form
process and/or examine your submission, which may result in termination of proceedings or
PTO/SB/51, Reissue Application Declaration by the  
abandonment of the application or expiration of the patent.
Inventor, or Form PTO/SB/52, Reissue Application
The information provided by you in this form will be subject to the following routine uses:
Declaration by the Assignee, may be used to prepare a  
1. The information on this form will be treated confidentially to the extent allowed under the
declaration in a reissue application. These forms are
Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
reproduced in MPEP § 1414.
this system of records may be disclosed to the Department of Justice to determine whether
disclosure of these records is required by the Freedom of Information Act.
2. A record from this system of records may be disclosed, as a routine use, in the course of
presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to  
opposing counsel in the course of settlement negotiations.
3. A record in this system of records may be disclosed, as a routine use, to a Member of  
Congress submitting a request involving an individual, to whom the record pertains, when the  
individual has requested assistance from the Member with respect to the subject matter of the  
record.
4. A record in this system of records may be disclosed, as a routine use, to a contractor of the  
Agency having need for the information in order to perform a contract. Recipients of
information shall be required to comply with the requirements of the Privacy Act of 1974, as
amended, pursuant to 5 U.S.C. 552a(m).
5. A record related to an International Application filed under the Patent Cooperation Treaty in
this system of records may be disclosed, as a routine use, to the International Bureau of the
World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.  
6. A record in this system of records may be disclosed, as a routine use, to another federal
agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
the Atomic Energy Act (42 U.S.C. 218(c)).
7. A record from this system of records may be disclosed, as a routine use, to the Administrator,  
General Services, or his/her designee, during an inspection of records conducted by GSA as
part of that agency’s responsibility to recommend improvements in records management
practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
be made in accordance with the GSA regulations governing inspection of records for this
purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
be used to make determinations about individuals.
8. A record from this system of records may be disclosed, as a routine use, to the public after
either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
CFR 1.14, as a routine use, to the public if the record was filed in an application which
became abandoned or in which the proceedings were terminated and which application is
referenced by either a published application, an application open to public inspection or an
issued patent.  
9. A record from this system of records may be disclosed, as a routine use, to a Federal, State,
or local law enforcement agency, if the USPTO becomes aware of a violation or potential
violation of law or regulation.  


If an inventor is to be added in a reissue application,
a proper reissue oath or declaration including the
signatures of all of the inventors is required. If one or
more inventors are being deleted in a reissue application,
an oath or declaration must be supplied over the
signatures of the remaining inventors. Note that
although an inventor being deleted in a reissue application
need not sign the oath or declaration, if that
inventor to be deleted has any ownership interest in
the patent (e.g., that inventor did not assign away his/
her rights to the patent), the signature of that inventor
must be supplied in the consent to filing the reissue
application. See MPEP § 1412.04 as to correction of
inventorship via reissue.


I.CONSENT TO THE REISSUE


Where no assignee exists, applicant should affirmatively
state that fact. This can be done by simply
checking the “NO” box of item 7 of Form PTO/SB/50
(which form may be signed by the inventors, or by a
registered practitioner). If the file record is silent as to
the existence of an assignee, it will be presumed that
an assignee does exist. This presumption should be
set forth by the examiner in the first Office action
alerting applicant to the requirement. It should be
noted that the mere filing of a written assertion of
small entity status in no way relieves applicant of the
requirement to affirmatively state that no assignee
exists.


Where a written assertion of small entity status, or
other paper in file indicates that the application/patent
is assigned, and there is no consent by the assignee
named in the written assertion of small entity, the
examiner should make inquiry into the matter in an
Office action, even if the record otherwise indicates
that the application/patent is not assigned.


The reissue oath or declaration must be accompanied
by the written consent of all assignees. 35 U.S.C.
111(a) and 37 CFR 1.53(b) provide, however, for
according an application a filing date if filed with a
specification, including claim(s), and any required
drawings. Thus, where an application is filed without
an oath or declaration, or without the consent of all
assignees, if the application otherwise complies with
37 CFR 1.53(b) and the reissue rules, the Office of
Initial Patent Examination (OIPE) will accord a filing
date and send out a notice of missing parts setting a
period of time for filing the missing part and for payment
of any surcharge required under 37 CFR 1.53(f)
and 1.16(f). If the reissue oath or declaration is filed
but the assignee consent is lacking, the surcharge is
required because, until the consent is filed, the reissue
oath or declaration is defective, since it is not apparent
that the signatures thereon are proper absent an indication
that the assignees have consented to the filing.


The consent of assignee must be signed by a party
authorized to act on behalf of the assignee. See MPEP
§ 324 for a discussion of parties authorized to act on
behalf of the assignee.


Where the written consent of all the assignees to the
filing of the reissue application cannot be obtained,
applicant may under appropriate circumstances petition
to the Office of Petitions (MPEP § 1002.02(b))
for a waiver under 37 CFR 1.183 of the requirement
of 37 CFR 1.172, to permit the acceptance of the filing
of the reissue application. The petition fee under
37 CFR 1.17(f) must be included with the petition.


1410.01Reissue Applicant, Oath or
The reissue application can then be examined, but
Declaration, and Consent of all
will not be allowed or issued without the consent of
Assignees [R-5]
all the assignees as required by 37 CFR 1.172. See
Baker Hughes Inc. v. Kirk, 921 F.Supp. 801, 809,
38 USPQ2d 1885, 1892 (D.D.C. 1995), N. B. Fassett,
1877 C.D. 32, 11 O.G. 420 (Comm’r Pat. 1877);
James D. Wright, 1876 C.D. 217, 10 O.G. 587
(Comm’r Pat. 1876).


37 CFR 1.172. Applicants, assignees.
Where a continuation reissue application is filed
 
with a copy of the assignee consent from the parent
(a)A reissue oath must be signed and sworn to or declaration
reissue application, and the parent reissue application
made by the inventor or inventors except as otherwise provided
is not to be abandoned, the copy of the consent should
(see
not be accepted. Where a divisional reissue application
§§
is filed with a copy of the assignee consent from
the parent reissue application, regardless of whether
1.42, 1.43, 1.47), and must be accompanied by the  
or not the parent reissue application is to be abandoned,
written consent of all assignees, if any, owning an undivided interest
the copy of the consent should not be
in the patent, but a reissue oath may be made and sworn to or
accepted. The copy of the consent from the parent
declaration made by the assignee of the entire interest if the application
does not indicate that the assignee has consented to  
does not seek to enlarge the scope of the claims of the original  
the addition of the new invention of the divisional
patent. All assignees consenting to the reissue must establish
reissue application to the original patent, or to the  
their ownership interest in the patent by filing in the reissue application  
addition of the new error correction of the continuation
a submission in accordance with the provisions of §
reissue application. (Presumably, a new correction
has been added via the continuation, since the
3.73(b)  
parent is still pending.) As noted above, OIPE will
of this chapter.
accord a filing date and send out a notice of missing
parts stating that there is no proper consent and setting
a period of time for filing the missing part and for
payment of any surcharge required under 37 CFR
1.53(f) and 1.16(f)


(b)A reissue will be granted to the original patentee, his
Where a continuation reissue application is filed
legal representatives or assigns as the interest may appear.
with a copy of the assignee consent from the parent
reissue application, and the parent reissue application
is, or will be abandoned, the copy of the consent
should be accepted by the Office.


37 CFR 3.73. Establishing right of assignee to take action.
II.PROOF OF OWNERSHIP OF ASSIGNEE


The assignee that consents to the filing of the reissue
application (as discussed above) must also establish
that it is the assignee, i.e., the owner, of the
patent. See 37 CFR 1.172. Accordingly, a 37 CFR
3.73(b) paper establishing the ownership of the
assignee should be submitted at the time of filing the
reissue application, in order to support the consent of
the assignee. The assignee must establish its ownership
in accordance with 37 CFR 3.73(b) by:


(A) filing in the reissue application documentary
evidence of a chain of title from the original owner to
the assignee; or


(b)(1) In order to request or take action in a patent or trademark
(B) specifying in the record of the reissue application
matter, the assignee must establish its ownership of the  
where such evidence is recorded in the Office
patent or trademark property of paragraph (a) of this section to the  
(e.g., reel and frame number, etc.).
satisfaction of the Director. The establishment of ownership by
the assignee may be combined with the paper that requests or
takes the action. Ownership is established by submitting to the
Office a signed statement identifying the assignee, accompanied
by either:


Compliance with 37
CFR 3.73(b) may be provided
as part of the same paper in which the consent by
assignee is provided.


In connection with option (A) above, the submission
of the documentary evidence to establish ownership
must be accompanied by a statement affirming
that the documentary evidence of the chain of title
from the original owners to the assignee was, or concurrently
is, submitted for recordation pursuant to 37
CFR 3.11. Thus, when filing a 37 CFR
3.73(b) statement
to establish ownership, an applicant or patent
owner must also submit the relied-upon assignment
document(s) to the Office for recordation, unless such
a submission has already been previously made. If the
37 CFR 3.73(b) statement is not accompanied by a
statement affirming that the documentary evidence
was, or concurrently is, submitted for recordation pursuant
to 37 CFR 3.11, then the 37 CFR
3.73(b) statement will not be accepted, and the assignee(s) will not
have established the right to take action in the patent
application or the patent for which the 37
CFR 3.73(b) statement was submitted. This could
result, for example, in an incomplete response, where
a party stated to be the “assignee” signs a consent to
the reissue to obviate a requirement for submission of
assignee consent made in an Office action.


(i) Documentary evidence of a chain of title from the
Upon initial receipt of a reissue application, the  
original owner to the assignee (e.g., copy of an executed assignment).
examiner should inspect the application to determine
For trademark matters only, the documents submitted to
whether the submission under 37 CFR 1.172 and
establish ownership may be required to be recorded pursuant to §
37 CFR 3.73(b) establishing the ownership of the  
3.11 in the assignment records of the Office as a condition to permitting
assignee is present and sufficient.  
the assignee to take action in a matter pending before the
Office. For patent matters only, the submission of the documentary
evidence must be accompanied by a statement affirming that
the documentary evidence of the chain of title from the original
owner to the assignee was or concurrently is being submitted for
recordation pursuant to § 3.11; or
 
(ii) A statement specifying where documentary evidence
of a chain of title from the original owner to the assignee is  
recorded in the assignment records of the Office (e.g., reel and  
frame number).


(2)The submission establishing ownership must show
If an assignment document is attached with the
that the person signing the submission is a person authorized to  
37 CFR 3.73(b) submission, the assignment should be
act on behalf of the assignee by:
reviewed to ensure that the named assignee is the
same for the assignment document and the 37 CFR
3.73(b) statement, and that the assignment document
is an assignment of the patent to be reissued to the
assignee. If an assignment document is not attached
with the 37 CFR 3.73(b) statement, but rather the reel
and frame number where the assignment document is
recorded in the USPTO is referenced in the 37 CFR
3.73(b) statement, it will be presumed that the assignment
recorded in the USPTO supports the statement
identifying the assignee. It will not be necessary
for the examiner to obtain a copy of the recorded
assignment document.


(i)Including a statement that the person signing the  
Just as the consent of assignee must be signed by a
submission is authorized to act on behalf of the assignee; or
party authorized to act on behalf of the assignee, the
submission with respect to 37 CFR 3.73(b) to establish
ownership must be signed by a party authorized
to act on behalf of the assignee. The signature of an
attorney or agent registered to practice before the  
Office is not sufficient, unless that attorney or agent is  
authorized to act on behalf of the assignee.


(ii)Being signed by a person having apparent authority
Where the submission establishes the assignee’s
to sign on behalf of the assignee, e.g., an officer of the  
ownership as to the patent, ownership as to the reissue
assignee.
application will be presumed. Accordingly, a submission
as to the ownership of the patent will be construed
to satisfy the 37
CFR1.172 (and 37 CFR
3.73(b)) requirements for establishing ownership of
the application. Thus, a terminal disclaimer can be
filed in a reissue application where ownership of the  
patent has been established, without the need for a
separate submission under 37 CFR 3.73(b) showing
ownership of the reissue application.


(c)For patent matters only:
Even if the submission states that it is establishing
ownership of the reissue application (rather than the
patent), the submission should be accepted by the
examiner as also establishing ownership in the patent.
The documentation in the submission establishing
ownership of the reissue application must, of necessity,
include chain of title as to the patent.


(1)Establishment of ownership by the assignee must be
III.COMPARISON OF ASSIGNEE THAT
submitted prior to, or at the same time as, the paper requesting or
CONSENTS TO ASSIGNEE SET FORTH
taking action is submitted.
IN SUBMISSION ESTABLISHING OWNERSHIP
INTEREST


(2)If the submission under this section is by an assignee
The examiner must inspect both the consent and
of less than the entire right, title and interest, such assignee must  
documentary evidence of ownership to determine
indicate the extent (by percentage) of its ownership interest, or the  
whether the requirements of 37 CFR 1.172 have been
Office may refuse to accept the submission as an establishment of
met. The assignee identified by the documentary evidence
ownership.
must be the same assignee which signed the
consent. Also, the person who signs the consent for
the assignee and the person who signs the submission
of evidence of ownership for the assignee must both
be persons having authority to do so. See also MPEP
§ 324.


The reissue oath must be signed and sworn to by all
The reissue patent will be granted to the original  
the inventors, or declaration made by all the inventors,
patentee, his or her legal representatives or assigns as
except as otherwise provided in 37 CFR 1.42,
the interest may appear.  
1.43, and 1.47 (see MPEP § 409). Pursuant to 37 CFR
1.172, where the reissue application does not seek to  
enlarge the scope of any of the claims of the original  
patent, the reissue oath may be made and sworn to, or  
declaration made, by the assignee of the entire interest.
Depending on the circumstances, either Form
PTO/SB/51, Reissue Application Declaration by the
Inventor, or Form PTO/SB/52, Reissue Application
Declaration by the Assignee, may be used to prepare a
declaration in a reissue application. These forms are
reproduced in MPEP § 1414.


If an inventor is to be added in a reissue application,
==1411 Form of Specification==
a proper reissue oath or declaration including the
signatures of all of the inventors is required. If one or
more inventors are being deleted in a reissue application,
an oath or declaration must be supplied over the
signatures of the remaining inventors. Note that
although an inventor being deleted in a reissue application
need not sign the oath or declaration, if that
inventor to be deleted has any ownership interest in
the patent (e.g., that inventor did not assign away his/
her rights to the patent), the signature of that inventor
must be supplied in the consent to filing the reissue
application. See MPEP § 1412.04 as to correction of
inventorship via reissue.


I.CONSENT TO THE REISSUE
{{Statute|37 CFR 1.173. Reissue specification, drawings, and amendments.}}
(a) Contents of a reissue application. An application for
reissue must contain the entire specification, including the claims,
and the drawings of the patent. No new matter shall be introduced
into the application. No reissue patent shall be granted enlarging
the scope of the claims of the original patent unless applied for
within two years from the grant of the original patent, pursuant to
35 U.S.C. 251.


Where no assignee exists, applicant should affirmatively
<p style="padding-left: +20px;">(1) Specification, including claims. The entire specification,
state that fact. This can be done by simply
including the claims, of the patent for which reissue is
checking the “NO” box of item 7 of Form PTO/SB/50
requested must be furnished in the form of a copy of the printed
(which form may be signed by the inventors, or by a  
patent, in double column format, each page on only one side of a  
registered practitioner). If the file record is silent as to  
single sheet of paper. If an amendment of the reissue application is  
the existence of an assignee, it will be presumed that
to be included, it must be made pursuant to paragraph (b) of this
section. The formal requirements for papers making up the reissue
application other than those set forth in this section are set out in §
1.52. Additionally, a copy of any disclaimer (§ 1.321), certificate
of correction (§§ 1.322 through 1.324), or reexamination certificate
(§ 1.570) issued in the patent must be included. (See also
§ 1.178).</p>


<p style="padding-left: +20px;">(2) Drawings. Applicant must submit a clean copy of
each drawing sheet of the printed patent at the time the reissue
application is filed. If such copy complies with § 1.84, no further
drawings will be required. Where a drawing of the reissue application
is to include any changes relative to the patent being reissued,
the changes to the drawing must be made in accordance with
paragraph (b)(3) of this section. The Office will not transfer the
drawings from the patent file to the reissue application.</p>
|}




The file wrappers of all /08 and earlier series reissue
applications are stamped “REISSUE” above the
application number on the front of the file. “Reissue”
also appears below the application number on the
printed label on the file wrapper of the application
with 08/ and earlier series.


Reissue applications filed after July of 1998 (09/
series and later) are placed in an orange and white
striped file wrapper and can be easily identified as
reissue applications. (For IFW Processing, see IFW
Manual.)


an assignee does exist. This presumption should be  
Reissue applications filed prior to November 7,
set forth by the examiner in the first Office action
2000 should be furnished in the form of cut-up soft
alerting applicant to the requirement. It should be
copies of the original patent, with only a single column
noted that the mere filing of a written assertion of
of the printed patent securely mounted on a separate
small entity status in no way relieves applicant of the
sheet of paper.  
requirement to affirmatively state that no assignee
exists.


Where a written assertion of small entity status, or  
For reissue applications filed on or after November
other paper in file indicates that the application/patent
7, 2000, 37 CFR 1.173(a)(1) requires that the application  
is assigned, and there is no consent by the assignee
specification, including the claims, must be furnished
named in the written assertion of small entity, the  
in the form of a copy of the printed patent in  
examiner should make inquiry into the matter in an
double column format (so that the patent can be simply
Office action, even if the record otherwise indicates
copied without cutting). Applicants are required to
that the application/patent is not assigned.
submit a clean copy of each drawing sheet of the
 
printed patent at the time the reissue application is
The reissue oath or declaration must be accompanied
filed (37 CFR 1.173(a)(2)). Any changes to the drawings must be made in accordance with 37 CFR  
by the written consent of all assignees. 35 U.S.C.
1.173(b)(3). Thus, a full copy of the printed patent
111(a) and 37 CFR 1.53(b) provide, however, for
(including the front page) is used to provide the
according an application a filing date if filed with a
abstract, drawings, specification, and claims of the
specification, including claim(s), and any required
patent for the reissue application. Each page of the  
drawings. Thus, where an application is filed without
patent must appear on only one side of each individual
an oath or declaration, or without the consent of all
page of the specification of the reissue application;
assignees, if the application otherwise complies with  
a two-sided copy of the patent is not proper. It
37 CFR 1.53(b) and the reissue rules, the Office of
should be noted that a re-typed specification is not
Initial Patent Examination (OIPE) will accord a filing
acceptable in a reissue application; the full copy of the  
date and send out a notice of missing parts setting a
printed patent must be used. If, however, the changes
period of time for filing the missing part and for payment
to be made to the patent are so extensive/numerous
of any surcharge required under 37 CFR 1.53(f)
that reading and understanding the specification is
and 1.16(f). If the reissue oath or declaration is filed
extremely difficult and error-prone, a clean copy of
but the assignee consent is lacking, the surcharge is  
the specification may be submitted if accompanied by
required because, until the consent is filed, the reissue
a grantable petition under 37 CFR 1.183 for waiver of
oath or declaration is defective, since it is not apparent
37 CFR 1.125(d) and 37 CFR 1.173(a)(1).  
that the signatures thereon are proper absent an indication
that the assignees have consented to the filing.  


The consent of assignee must be signed by a party
Pursuant to 37 CFR 1.173(b), amendments may be  
authorized to act on behalf of the assignee. See MPEP
made at the time of filing of a reissue application.  
§ 324 for a discussion of parties authorized to act on
The amendment may be made either by:
behalf of the assignee. The consent to the reissue
application may use language such as:


The XYZ Corporation, assignee of U.S. Patent No.  
(A) physically incorporating the changes within
9,999,999, consents to the filing of reissue application No.  
the specification by cutting the column of the printed
09/999,999 (or the present application, if filed with the
patent and inserting the added material and rejoining
initial application papers) for the reissue of U.S. Patent
the remainder of the column and then joining the
No. 9,999,999.
resulting modified column to the other column of the
printed patent. Markings pursuant to 37 CFR 1.173(d)
must be used to show the changes. The columnar
structure of the printed patent must be preserved, and
the physically modified page must comply with 37
CFR 1.52(a)(1). As to compliance with 37 CFR
1.52(a)(1)(iv), the “written either by a typewriter or
machine printer in permanent dark ink or its equivalent”
requirement is deemed to be satisfied where a
caret and line are drawn from a position within the
text to a newly added phrase, clause, sentence, etc.  
typed legibly in the margin; or


(B) providing a preliminary amendment (a separate
amendment paper) directing that specified
changes be made to the copy of the printed patent.


_______________
The presentation of the insertions or deletions as
 
part of the original reissue specification is an amendment
under 37 CFR 1.173(b). An amendment of the
 
reissue application made at the time of filing of the
Lilly M. Schor
reissue application must be made in accordance with
 
37 CFR 1.173(b)-(e) and (g); see MPEP § 1453. Thus,
as required by 37 CFR 1.173(c), an amendment of the
claims made at the time of filing of a reissue application
must include a separate paper setting forth the
status of all claims (i.e., pending or canceled), and an
explanation of the support in the disclosure of the
patent for the changes made to the claims.


Vice President,
If a chart, table, or chemical formula is amended
and it spans two columns of the patent, it should not
be split. Rather, the chart, table, or chemical formula
should be provided in its entirety as part of the column
of the patent to which it pertains, in order to provide
a continuity of the description. When doing so,
the chart, table, or chemical formula may extend
beyond the width of the column. Change in only a part
of a word or chemical formula is not permitted. Entire
words or chemical formulas must be shown as being
changed. Deletion of a chemical formula should be
shown by brackets which are substantially larger and
darker than any in the formula.


Where a terminal disclaimer was filed in the application
for the patent to be reissued, a copy of that terminal
disclaimer is not needed in the reissue
application file. For a reissue application that is
maintained in a paper file, the face of the file wrapper
should be marked to indicate that a terminal disclaimer
has been filed for the patent. For a reissue
application that is maintained in IFW, the “Final
SPRE Review” form will be filled in.


XYZ Corporation
Twice reissued patent:


Where the written consent of all the assignees to the  
Examples of the form for a twice-reissued patent
filing of the reissue application cannot be obtained,  
are found in Re. 23,558 and Re. 28,488. Double
applicant may under appropriate circumstances petition
underlining and double bracketing are used in the second
to the Office of Petitions (MPEP § 1002.02(b))
reissue application, while bold-faced type and
for a waiver under 37 CFR 1.183 of the requirement
double bracketing appear in the printed patent (the  
of 37 CFR 1.172, to permit the acceptance of the filing
second reissue patent) to indicate further insertions
of the reissue application. The petition fee under
and deletions, respectively, in the second reissue  
37 CFR 1.17(f) must be included with the petition.
patent.


The reissue application can then be examined, but
When a copy of a first reissue patent is used as the
will not be allowed or issued without the consent of  
specification of a second reissue application (filed as
all the assignees as required by 37 CFR 1.172. See
a reissue of a reissue), additions made by the first reissue  
Baker Hughes Inc. v. Kirk, 921 F.Supp. 801, 809,
will already be printed in italics, and should  
38
remain in such format. Thus, applicants need only
USPQ2d 1885, 1892 (D.D.C. 1995), N. B. Fassett,
present additions to the specification/claims in the  
1877 C.D. 32, 11 O.G. 420 (Comm’r Pat. 1877);
second reissue application as double underlined text.
James D. Wright, 1876 C.D. 217, 10 O.G. 587
Subject matter to be deleted from the first reissue
(Comm’r Pat. 1876).
patent should be presented in the second reissue application  
 
within sets of double brackets.  
Where a continuation reissue application is filed  
with a copy of the assignee consent from the parent
reissue application, and the parent reissue application
is not to be abandoned, the copy of the consent should  
not be accepted. Where a divisional reissue application
is filed with a copy of the assignee consent from
the parent reissue application, regardless of whether
or not the parent reissue application is to be abandoned,
the copy of the consent should not be
accepted. The copy of the consent from the parent
does not indicate that the assignee has consented to
the addition of the new invention of the divisional
reissue application to the original patent, or to the
addition of the new error correction of the continuation
reissue application. (Presumably, a new correction
has been added via the continuation, since the
parent is still pending.) As noted above, OIPE will
accord a filing date and send out a notice of missing
parts stating that there is no proper consent and setting
a period of time for filing the missing part and for
payment of any surcharge required under 37 CFR
1.53(f) and 1.16(f)


Where a continuation reissue application is filed
===1411.01 Certificate of Correction or Disclaimer in Original Patent===
with a copy of the assignee consent from the parent
reissue application, and the parent reissue application
is, or will be abandoned, the copy of the consent
should be accepted by the Office.


The applicant should include any changes, additions,
or deletions that were made by a Certificate of
Correction to the original patent grant in the reissue
application without underlining or bracketing. The
examiner should  make certain that all Certificate of
Correction changes in the patent have been properly
incorporated into the reissue application.


Certificate of Correction changes and disclaimer of
claim(s) under 37 CFR 1.321(a) should be made without
using underlining or brackets. Since these are part
of the original patent and were made before the reissue
was filed, they should show up in the printed reissue
patent document as part of the original patent,
i.e., not in italics or bracketed. If the changes are
extensive and/or applicant has submitted them
improperly with underlining and brackets, a clean
copy of the specification with the Certificate of Correction
changes in it may be requested by the examiner.
In order for the clean copy to be entered as a
substitute specification, the reissue applicant must file
a grantable petition under 37 CFR 1.183 for waiver of
37 CFR 1.125(d) and 37 CFR 1.173(a)(1). The examiner’
s request for the clean copy will generally serve
as sufficient basis for granting the petition.


===1411.02 New Matter===


New matter, that is, matter not present in the patent
sought to be reissued, is excluded from a reissue
application in accordance with 35 U.S.C. 251.


Form paragraph 14.15 may be used to indicate that
The claims in the reissue application must be for
the consent of the assignee is lacking.
subject matter which the applicant had the right to
 
claim in the original patent. Any change in the patent
¶ 14.15 Consent of Assignee to Reissue Lacking
made via the reissue application should be checked to  
 
ensure that it does not introduce new matter. Note that
This application is objected to under 37 CFR 1.172(a) as lacking
new matter may exist by virtue of the omission of a
the written consent of all assignees owning an undivided interest
feature or of a step in a method. See United States
in the patent. The consent of the assignee must be in
Industrial Chemicals, Inc. v. Carbide & Carbon
compliance with 37 CFR 1.172. See MPEP § 1410.01.
Chemicals Corp., 315 U.S. 668, 53 USPQ 6 (1942).  


A proper assent of the assignee in compliance with 37 CFR
==1412 Content of Claims==
1.172 and 3.73 is required in reply to this Office action.


Examiner Note:
The content of claims in a reissue application is
somewhat limited, as is indicated in MPEP § 1412.01through MPEP § 1412.03.


1.This form paragraph may be used in an Office action which
1412.01Reissue Claims Must Be for
rejects any of the claims on other grounds.
Same General Invention [R-2]


2.If a consent document/statement has been submitted but is  
The reissue claims must be for the same invention
insufficient (e.g., not by all the assignees) or is otherwise ineffective
as that disclosed as being the invention in the
(e.g., a conditional consent, or a copy of the consent from the
original patent, as required by 35 U.S.C. 251. This
parent reissue application was filed in this continuation reissue
does not mean that the invention claimed in the reissue
application and the parent reissue application is not being abandoned),
must have been claimed in the original patent,
an explanation of such is to be included following this
although this is evidence that applicants considered it
form paragraph.
their invention. The entire disclosure, not just the  
claim(s), is considered in determining what the patentee
objectively intended as his or her invention. The
proper test as to whether reissue claims are for the
same invention as that disclosed as being the invention
in the original patent is “an essentially factual
inquiry confined to the objective intent manifested by
the original patent.” In re Amos, 953 F.2d 613, 618,
21 USPQ2d 1271, 1274 (Fed. Cir. 1991) (quoting In
re Rowand, 526 F.2d 558, 560, 187 USPQ 487, 489
(CCPA 1975)) (emphasis added). See also In re Mead,
581 F.2d 257, 198 USPQ 412 (CCPA 1978). The
“original patent” requirement of 35 U.S.C. 251 must
be understood in light of In re Amos, supra, where the
Court of Appeals for the Federal Circuit stated:


3.If the case is otherwise ready for allowance, this form paragraph
We conclude that, under both Mead and Rowand, a claim
should be followed by form paragraph 7.51 (insert the  
submitted in reissue may be rejected under the “original
phrase --See above-- in bracket 1 of form paragraph 7.51).
patent” clause if the original specification demonstrates,
to one skilled in the art, an absence of disclosure sufficient
to indicate that a patentee could have claimed the subject
matter. Merely finding that the subject matter was “not
originally claimed, not an object of the original patent,
and not depicted in the drawing,” does not answer the
essential inquiry under the “original patent” clause of §
251, which is whether one skilled in the art, reading the


II.PROOF OF OWNERSHIP OF ASSIGNEE


The assignee that consents to the filing of the reissue
application (as discussed above) must also establish
that it is the assignee, i.e., the owner, of the
patent. See 37 CFR 1.172. Accordingly, a 37 CFR
3.73(b) paper establishing the ownership of the
assignee should be submitted at the time of filing the
reissue application, in order to support the consent of
the assignee. The assignee must establish its ownership
in accordance with 37 CFR 3.73(b) by:


(A)filing in the reissue application documentary
evidence of a chain of title from the original owner to
the assignee; or


(B)specifying in the record of the reissue application
where such evidence is recorded in the Office
(e.g., reel and frame number, etc.).


Compliance with 37
specification, would identify the subject matter of the new
CFR 3.73(b) may be provided
claims as invented and disclosed by the patentees. In
as part of the same paper in which the consent by
short, the absence of an “intent,” even if objectively evident
assignee is provided.  
from the earlier claims, the drawings, or the original
objects of the invention is simply not enough to establish
that the new claims are not drawn to the invention disclosed
in the original patent.


In connection with option (A) above, the submission
953 F.2d at 618-19, 21 USPQ2d at 1275. Claims presented
of the documentary evidence to establish ownership
in a reissue application are considered to satisfy
must be accompanied by a statement affirming
the requirement of 35 U.S.C. 251 that the claims
that the documentary evidence of the chain of title
be “for the invention disclosed in the original patent”
from the original owners to the assignee was, or concurrently
where:
is, submitted for recordation pursuant to 37
CFR
3.11. Thus, when filing a 37 CFR
3.73(b) statement
to establish ownership, an applicant or patent
owner must also submit the relied-upon assignment
document(s) to the Office for recordation, unless such
a submission has already been previously made. If the
37 CFR
3.73(b) statement is not accompanied by a
statement affirming that the documentary evidence
was, or concurrently is, submitted for recordation pursuant
to 37 CFR
3.11, then the 37 CFR
3.73(b) statement
will not be accepted, and the assignee(s) will not
have established the right to take action in the patent
application or the patent for which the 37
CFR
3.73(b) statement was submitted. This could
result, for example, in an incomplete response, where  
a party stated to be the “assignee” signs a consent to
the reissue to obviate a requirement for submission of
assignee consent made in an Office action.


Upon initial receipt of a reissue application, the  
(A)the claims presented in the reissue application  
examiner should inspect the application to determine
are described in the original patent specification and  
whether the submission under 37 CFR 1.172 and  
enabled by the original patent specification such that
37
35 U.S.C. 112 first paragraph is satisfied; and
CFR 3.73(b) establishing the ownership of the
assignee is present and sufficient.


If an assignment document is attached with the
(B)nothing in the original patent specification
37
indicates an intent not to claim the subject matter of
CFR 3.73(b) submission, the assignment should be
the claims presented in the reissue application.
reviewed to ensure that the named assignee is the
same for the assignment document and the 37 CFR
3.73(b) statement, and that the assignment document
is an assignment of the patent to be reissued to the
assignee. If an assignment document is not attached
with the 37 CFR 3.73(b) statement, but rather the reel
and frame number where the assignment document is
recorded in the USPTO is referenced in the 37 CFR
3.73(b) statement, it will be presumed that the assignment
recorded in the USPTO supports the statement
identifying the assignee. It will not be necessary
for
the examiner to obtain a copy of the recorded
assignment document. If the submission under
37
CFR 1.172 and 37 CFR 3.73(b) is not present,
form paragraph 14.16 may be used to indicate that the
assignee has not provided evidence of ownership.


¶ 14.16 Failure of Assignee To Establish Ownership
The presence of some disclosure (description
 
and enablement) in the original patent should evidence
This application is objected to under 37 CFR 1.172(a) as the
that applicant intended to claim or that applicant
assignee has not established its ownership interest in the patent for
considered the material now claimed to be his or
which reissue is being requested. An assignee must establish its
her invention.  
ownership interest in order to support the consent to a reissue
application required by 37 CFR 1.172(a). The assignee’s ownership
interest is established by:


The original patent specification would indicate an
intent not to claim the subject matter of the claims
presented in the reissue application in a situation analogous
to the following:


The original patent specification discloses that
composition X is not suitable (or not satisfactory) for
molding an item because composition X fails to provide
quick drying. After the patent issues, it is found
that composition X would be desirable for the molding
in spite of the failure to provide quick drying,
because of some other newly recognized benefit from
composition X. A claim to composition X or a method
of use thereof would not be permitted in a reissue
application, because the original patent specification
contained an explicit statement of intent not to claim
composition X or a method of use thereof.


In most instances, however, the mere failure to
claim a disclosed embodiment in the original patent
(absent an explicit statement in the original patent
specification of unsuitability of the embodiment)
would not be grounds for prohibiting a claim to that
embodiment in the reissue.


FAILURE TO TIMELY FILE A DIVISIONAL
APPLICATION PRIOR TO ISSUANCE OF
ORIGINAL PATENT


(a) filing in the reissue application evidence of a chain of title
Where a restriction requirement was made in an
from the original owner to the assignee, or  
application and applicant permitted the elected invention
to issue as a patent without the filing of a divisional
application on the non-elected invention(s), the
non-elected invention(s) cannot be recovered by filing
a reissue application. A reissue applicant’ s failure to
timely file a divisional application covering the non-
elected invention(s) in response to a restriction
requirement is not considered to be error causing a
patent granted on the elected claims to be partially
inoperative by reason of claiming less than the applicant
had a right to claim. Accordingly, such error is
not correctable by reissue of the original patent under
35 U.S.C. 251. In re Watkinson, 900 F.2d 230, 14
USPQ2d 1407 (Fed. Cir. 1990); In re Orita, 550 F.2d
1277, 1280, 193 USPQ 145, 148 (CCPA 1977). See
also In re Mead, 581 F.2d 251, 198 USPQ 412 (CCPA
1978). In this situation, the reissue claims should be
rejected under 35 U.S.C. 251 for lack of defect in the
original patent and lack of error in obtaining the original  
patent. Compare with In re Doyle, 293 F.3d 1355,
63 USPQ2d 1161 (Fed. Cir. 2002) where the court
permitted the patentee to file a reissue application to  
present a so-called linking claim, a claim broad
enough to read on or link the invention elected (and
patented) together with the invention not elected. The
non-elected invention(s) were inadvertently not filed
as a divisional application.


(b) specifying in the record of the reissue application where
1412.02Recapture of Canceled SubjectMatter [R-5]
such evidence is recorded in the Office (e.g., reel and frame number,
etc.).


The submission with respect to (a) and (b) to establish ownership
A reissue will not be granted to “recapture” claimed
must be signed by a party authorized to act on behalf of the
subject matter which was surrendered in an application
assignee. See MPEP § 1410.01.
to obtain the original patent. North American
 
Container, Inc. v. Plastipak Packaging, Inc., 415 F.3d
An appropriate paper satisfying the requirements of 37 CFR
1335, 75 USPQ2d 1545 (Fed. Cir. 2005, Pannu v.
3.73 must be submitted in reply to this Office action.
Storz Instruments Inc., 258 F.3d 1366, 59 USPQ2d
 
1597 (Fed. Cir. 2001); Hester Industries, Inc. v. Stein,
Examiner Note:
Inc., 142 F.3d 1472, 46 USPQ2d 1641 (Fed. Cir.  
1998); In re Clement, 131 F.3d 1464, 45 USPQ2d
1161 (Fed. Cir. 1997); Ball Corp. v. United States, 729
F.2d 1429, 1436, 221 USPQ 289, 295 (Fed. Cir.  
1984); In re Wadlinger, 496 F.2d 1200, 181 USPQ
826 (CCPA 1974); In re Richman, 409 F.2d 269, 276,


1.This form paragraph may be used in an Office action which
rejects any of the claims on other grounds.


2.If otherwise ready for allowance, this form paragraph should
be followed by form paragraph 7.51 (insert the phrase --See
above-- in bracket 1 of form paragraph 7.51).


Just as the consent of assignee must be signed by a
party authorized to act on behalf of the assignee, the
submission with respect to 37 CFR 3.73(b) to establish
ownership must be signed by a party authorized
to act on behalf of the assignee. The signature of an
attorney or agent registered to practice before the
Office is not sufficient, unless that attorney or agent is
authorized to act on behalf of the assignee.


If the submission under 37 CFR 3.73(b) to establish
ownership is not signed by a party authorized to act
on behalf of the assignee, the appropriate paragraphs
of form paragraphs 14.16.01 through 14.16.06 may be
used.


161 USPQ 359, 363-364 (CCPA 1969); In re Willingham,
282
F.2d 353, 127 USPQ 211 (CCPA 1960).


I.THREE STEP TEST FOR RECAPTURE:


¶ 14.16.01 Establishment of Ownership Not Signed by
In Clement, 131 F.3d at 1468-70, 45 USPQ2d at
Appropriate Party
1164-65, the Court of Appeals for the Federal Circuit
set forth a three step test for recapture analysis. In
Pannu, 258 F.3d at 1371, 59 USPQ2d at 1600, the
court restated this test as follows:


This application is objected to under 37 CFR 1.172(a) as the  
Application of the recapture rule is a three-step process.
assignee has not established its ownership interest in the patent for
which reissue is being requested. An assignee must establish its
ownership interest in order to support the consent to a reissue
application required by 37 CFR 1.172(a). The submission establishing
the ownership interest of the assignee is informal. There is
no indication of record that the party who signed the submission is
an appropriate party to sign on behalf of the assignee. 37 CFR
3.73(b)


A proper submission establishing ownership interest in the
patent, pursuant to 37 CFR 1.172(a), is required in response to this
action.


Examiner Note:
The first step is to ‘determine whether and in what aspect
the reissue claims are broader than the patent claims.’....


1.This form paragraph should be followed: by one of form
‘The second step is to determine whether the broader
paragraphs 14.16.02 through 14.16.04, and then optionally by
aspects of the reissued claim related to surrendered subject
form paragraph 14.16.06.  
matter’ ....


2.See MPEP § 1410.01.
Finally, the court must determine whether the reissued
claims were materially narrowed in other respects to avoid
the recapture rule. [Emphasis added]


A.The First Step - Was There Broadening?


In every reissue application, the examiner must first
review each claim for the presence of broadening, as
compared with the scope of the claims of the patent to
be reissued. A reissue claim is broadened where some
limitation of the patent claims is no longer required in
the reissue claim; see MPEP § 1412.03 for guidance
as to the nature of a “broadening claim.” If the reissue
claim is not broadened in any respect as compared to
the patent claims, the analysis ends; there is no recapture.


¶ 14.16.02 Failure To State Capacity To Sign


The person who signed the submission establishing ownership
B.The Second Step - Does Any Broadening
interest has failed to state his/her capacity to sign for the corporation
Aspect of the Reissued Claim Relate to  
or other business entity, and he/she has not been established
Surrendered Subject Matter?
as being authorized to act on behalf of the assignee. See MPEP §
324.


Examiner Note:
Where a claim in a reissue application is broadened
 
in some respect as compared to the patent claims, the
1.This form paragraph is to be used when the person signing
examiner must next determine whether the broadening
the submission establishing ownership interest does not state his/
aspect(s) of that reissue claim relate(s) to subject
her capacity (e.g., as a recognized officer) to sign for the assignee,
matter that applicant previously surrendered during
and is not established as being authorized to act on behalf of the  
the prosecution of the original application (which
assignee.
became the patent to be reissued). Each limitation of
 
the patent claims, which is omitted or broadened in
2.Use form paragraph 14.16.06 to explain how an official,  
the reissue claim, must be reviewed for this determination.
other than a recognized officer, may properly sign a submission
This involves two sub-steps:
establishing ownership interest.


¶ 14.16.03 Lack of Capacity To Sign
1.The Two Sub-Steps:


The person who signed the submission establishing ownership
(A)It must first be determined whether there was
interest is not recognized as an officer of the assignee, and he/she
any surrender of subject matter made in the prosecution
has not been established as being authorized to act on behalf of the  
of the original application which became the  
assignee. See MPEP § 324.
patent to be reissued.


¶ 14.16.04 Attorney/Agent of Record Signs
If an original patent claim limitation now being
omitted or broadened in the present reissue application
was originally relied upon by applicant in the
original application to make the claims allowable over
the art, the omitted limitation relates to subject matter
previously surrendered by applicant. The reliance by
applicant to define the original patent claims over the
art can be by way of presentation of new/amended
claims to define over the art, or an argument/statement
by applicant that a limitation of the claim(s)
defines over the art. To determine whether such reliance
occurred, the examiner must review the prosecution
history of the original application file (of the
patent to be reissued) for recapture. The prosecution
history includes the rejections and applicant’s arguments
made therein.


The submission establishing ownership interest was signed by
If there was no surrender of subject matter made
applicant’s [1]. An attorney or agent of record is not authorized to
in the prosecution of the original application, again
sign a submission establishing ownership interest, unless he/she
the analysis ends and there is no recapture.
has been established as being authorized to act on behalf of the  
assignee. See MPEP § 324.


Examiner Note:
(B)If there was a surrender of subject matter in
the original application prosecution, it must then be
determined whether any of the broadening of the reissue
claims is in the area of the surrendered subject
matter. All of the broadening aspects of reissue claims
must be analyzed to determine if any of the omitted/
broadened limitation(s) are directed to limitations
relied upon by applicant in the original application to
make the claims allowable over the art.


1.This form paragraph is to be used when the person signing
2.Examples of the Pannu Second Step Analysis:
the submission establishing ownership interest is an attorney or
agent of record who is not an authorized officer as defined in
MPEP § 324 and has not been established as being authorized to
act on behalf of the assignee.


2.Use form paragraph 14.16.06 to explain how an official,
other than a recognized officer, may properly sign a submission
establishing ownership interest.


3.In bracket 1, insert either --attorney-- or --agent--.
(A)Example (1) - Argument without amendment:


¶ 14.16.06 Criteria To Accept When Signed by a Non-
In Hester, supra, the Federal Circuit held that the
Recognized Officer
surrender which forms the basis for impermissible
 
recapture “can occur through arguments alone”.
It would be acceptable for a person, other than a recognized
142
officer, to sign a submission establishing ownership interest, provided
F.3d at 1482, 46 USPQ2d at 1649. For example,  
the record for the application includes a duly signed statement
assume that limitation A of the patent claims is omitted
that the person is empowered to sign a submission
in the reissue claims. This omission provides a  
establishing ownership interest and/or act on behalf of the  
broadening aspect in the reissue claims, as compared
assignee.
to the claims of the patent. If the omitted limitation A
was argued in the original application to make the  
application claims allowable over the art in the appli


Accordingly, a new submission establishing ownership interest
which includes such a statement above, will be considered to be
signed by an appropriate official of the assignee. A separately
filed paper referencing the previously filed submission establishing
ownership interest and containing a proper empowerment
statement would also be acceptable.
Examiner Note:
1.This form paragraph MUST be preceded by form paragraphs
14.16.02, 14.16.03 or 14.16.04.




Line 1,355: Line 1,447:
   
   


2.When one of form paragraphs 14.16.02, 14.16.03 or 14.16.04is used to indicate that a submission establishing ownership interest
cation, then the omitted limitation relates to subject
is not proper because it was not signed by a recognized officer,  
matter previously surrendered in the original application,  
this form paragraph should be used to point out one way to correct
and recapture will exist. Accordingly, where
the problem.
claims are broadened in a reissue application, the
 
examiner should review the prosecution history of the  
3.While an indication of the person’s title is desirable, its inclusion
original patent file for recapture, even where the
is not mandatory when this option is employed.
claims were never amended during the prosecution of  
 
the application which resulted in the patent.
Where the submission establishes the assignee’s
ownership as to the patent, ownership as to the reissue  
application will be presumed. Accordingly, a submission
as to the ownership of the patent will be construed
to satisfy the 37
CFR1.172 (and 37 CFR
3.73(b)) requirements for establishing ownership of  
the application. Thus, a terminal disclaimer can be
filed in a reissue application where ownership of the  
patent has been established, without the need for a
separate submission under 37 CFR 3.73(b) showing
ownership of the reissue application.


Even if the submission states that it is establishing
Note: The argument that the claim limitation
ownership of the reissue application (rather than the
defined over the rejection must have been specific as
patent), the submission should be accepted by the
to the limitation relied upon, rather than a general
examiner as also establishing ownership in the patent.  
statement regarding the claims as a whole. A general
The documentation in the submission establishing
'boiler plate' sentence in the original application will
ownership of the reissue application must, of necessity,  
not, by itself, be sufficient to establish surrender and
include chain of title as to the patent.
recapture.


III.COMPARISON OF ASSIGNEE THAT
An example of a general “boiler plate” sentence of
CONSENTS TO ASSIGNEE SET FORTH
argument is:
IN SUBMISSION ESTABLISHING OWNERSHIP
INTEREST


The examiner must inspect both the consent and
“In closing, it is argued that the limitations of claims 1-7
documentary evidence of ownership to determine
distinguish the claims from the teachings of the prior art,  
whether the requirements of 37 CFR 1.172 have been
and claims 1-7 are thus patentable.
met. The assignee identified by the documentary evidence
must be the same assignee which signed the  
consent. Also, the person who signs the consent for
the assignee and the person who signs the submission
of evidence of ownership for the assignee must both
be persons having authority to do so. See also MPEP
§ 324.


The reissue patent will be granted to the original
An argument that merely states that all the limitations
patentee, his or her legal representatives or assigns as
of the claims define over the prior art will also
the interest may appear.  
not, by itself, be sufficient to establish surrender and
recapture. An example is:


1411Form of Specification [R-3]
“Claims 1-5 set forth a power-train apparatus which comprises
 
the combination of A+B+C+D+E. The prior art of
37 CFR 1.173. Reissue specification, drawings, and  
record does not disclose or render obvious a motivation to
amendments.
provide for a material-transfer apparatus as defined by the
limitations of claim 1, including an A member and a B
member, both connected to a C member, with all three
being aligned with the D and E members.


(a)Contents of a reissue application. An application for
This statement is simply a restatement of the  
reissue must contain the entire specification, including the claims,
entirety of claim 1 as allowed. No measure of surrender
and the drawings of the patent. No new matter shall be introduced
could be gleaned from such a statement of reasons
into the application. No reissue patent shall be granted enlarging
for allowance. See Ex parte Yamaguchi, 61 USPQ2d
the scope of the claims of the original patent unless applied for  
1043 (Bd. Pat. App. & Inter. 2001)(reported but
within two years from the grant of the original patent, pursuant to
unpublished, precedential).
35 U.S.C. 251.


(1)Specification, including claims. The entire specification,
In both of the above examples, the argument does
including the claims, of the patent for which reissue is
not provide an indication of what specific limitations,  
requested must be furnished in the form of a copy of the printed
e.g., specific element or step of the claims, cooperative
patent, in double column format, each page on only one side of a
effect, or other aspect of the claims, are being
single sheet of paper. If an amendment of the reissue application is
relied upon for patentability. Thus, applicant has not
to be included, it must be made pursuant to paragraph (b) of this
surrendered anything.
section. The formal requirements for papers making up the reissue
application other than those set forth in this section are set out in §
1.52. Additionally, a copy of any disclaimer (§ 1.321), certificate
of correction (§§ 1.322 through 1.324), or reexamination certificate
(§ 1.570) issued in the patent must be included. (See also
§
1.178).


(2)Drawings. Applicant must submit a clean copy of
(B)Example (2) - Amendment of the claims without
each drawing sheet of the printed patent at the time the reissue
argument:
application is filed. If such copy complies with § 1.84, no further
drawings will be required. Where a drawing of the reissue application
is to include any changes relative to the patent being reissued,
the changes to the drawing must be made in accordance with
paragraph (b)(3) of this section. The Office will not transfer the  
drawings from the patent file to the reissue application.


The limitation omitted in the reissue claim(s) was
added in the original application claims for the purpose
of making the application claims allowable over
a rejection or objection made in the application. Even
though applicant made no argument on the record that
the limitation was added to obviate the rejection, the
nature of the addition to the claim can show that the
limitation was added in direct reply to the rejection.
This too will establish the omitted limitation as relating
to subject matter previously surrendered. To illustrate
this, note the following example:


The original application claims recite limitations A+B+C,
and the Office action rejection combines two references to
show A+B+C. In the amendment replying to the Office
action, applicant adds limitation D to A+B+C in the
claims, but makes no argument as to that addition. The
examiner then allows the claims. Even though there is no
argument as to the addition of limitation D, it must be presumed
that the D limitation was added to obviate the
rejection. The subsequent deletion of (omission of) limitation
D in the reissue claims would be presumed to be a
broadening in an aspect of the reissue claims related to
surrendered subject matter. Accordingly, the reissued
claims would be barred by the recapture doctrine.
The above result would be the same whether the
addition of limitation D in the original application
was by way of applicant’s amendment or by way of an
examiner’s amendment with authorization by applicant.


The file wrappers of all /08 and earlier series reissue
applications are stamped “REISSUE” above the
application number on the front of the file. “Reissue”
also appears below the application number on the
printed label on the file wrapper of the application
with 08/ and earlier series.
Reissue applications filed after July of 1998 (09/
series and later) are placed in an orange and white
striped file wrapper and can be easily identified as
reissue applications. (For IFW Processing, see IFW
Manual.)


Reissue applications filed prior to November 7,
(C)Example (3) - Who can make the surrendering
2000 should be furnished in the form of cut-up soft
argument?
copies of the original patent, with only a single column
of the printed patent securely mounted on a separate
sheet of paper.


For reissue applications filed on or after November
Assume that the limitation A omitted in the reissue
7, 2000, 37 CFR 1.173(a)(1) requires that the application
claims was present in the claims of the original application.
specification, including the claims, must be furnished
The examiner’s reasons for allowance in the
in the form of a copy of the printed patent in  
original application stated that it was that limitation A
double column format (so that the patent can be simply
which distinguished over a potential combination of
copied without cutting). Applicants are required to
references X and Y. Applicant did not present on the
submit a clean copy of each drawing sheet of the  
record a counter statement or comment as to the  
printed patent at the time the reissue application is
examiner’s reasons for allowance, and permitted the  
filed (37 CFR 1.173(a)(2)). Any changes to the draw
claims to issue.  


Ex parte Yamaguchi, supra, held that a surrender of
claimed subject matter cannot be based solely upon an
applicant’s failure to respond to, or failure to challenge,
an examiner’s statement made during the prosecution
of an application. Applicant is bound only by
applicant’s revision of the application claims or a positive
argument/statement by applicant. An applicant’s
failure to present on the record a counter statement or




Line 1,478: Line 1,560:
   
   


ings must be made in accordance with 37 CFR
comment as to an examiner’s reasons for allowance
1.173(b)(3). Thus, a full copy of the printed patent
does not give rise to any implication that applicant
(including the front page) is used to provide the  
agreed with or acquiesced in the examiner’s reasoning
abstract, drawings, specification, and claims of the
for allowance. Thus, the failure to present a counter
patent for the reissue application. Each page of the
statement or comment as to the examiner’s statement
patent must appear on only one side of each individual
of reasons for allowance does not give rise to any
page of the specification of the reissue application;
finding of surrender. The examiner’s statement of  
a two-sided copy of the patent is not proper. It
reasons for allowance in the original application  
should be noted that a re-typed specification is not
cannot, by itself, provide the basis for establishing
acceptable in a reissue application; the full copy of the
surrender and recapture.  
printed patent must be used. If, however, the changes
to be made to the patent are so extensive/numerous
that reading and understanding the specification is
extremely difficult and error-prone, a clean copy of
the specification may be submitted if accompanied by
a grantable petition under 37 CFR 1.183 for waiver of
37 CFR 1.125(d) and 37 CFR 1.173(a)(1).  


Pursuant to 37 CFR 1.173(b), amendments may be
It is only in the situation where applicant does file
made at the time of filing of a reissue application.  
comments on the statement of reasons for allowance,
The amendment may be made either by:
that surrender may have occurred. Note the following
two scenarios in which an applicant files comments:


(A)physically incorporating the changes within
Scenario 1- There is Surrender: The examiner’s statement
the specification by cutting the column of the printed
of reasons for allowance in the original application stated
patent and inserting the added material and rejoining
that it was limitation C (of the combination of ABC)
the remainder of the column and then joining the
which distinguished over a potential combining of references
resulting modified column to the other column of the
X and Y, in that limitation C provided increased
printed patent. Markings pursuant to 37 CFR 1.173(d)
speed to the process. Applicant filed comments on the  
must be used to show the changes. The columnar
examiner’s statement of reasons for allowance essentially
structure of the printed patent must be preserved, and
supporting the examiner’ s reasons. The limitation C is
the physically modified page must comply with 37
thus established as relating to subject matter previously
CFR 1.52(a)(1). As to compliance with 37 CFR
surrendered.
1.52(a)(1)(iv), the “written either by a typewriter or
machine printer in permanent dark ink or its equivalent”
requirement is deemed to be satisfied where a
caret and line are drawn from a position within the
text to a newly added phrase, clause, sentence, etc.  
typed legibly in the margin; or


(B)providing a preliminary amendment (a separate
Scenario 2- There is No Surrender: On the other hand, if
amendment paper) directing that specified
applicant’s comments on the examiner’s statement of reasons
changes be made to the copy of the printed patent.
for allowance contain a counter statement that it is limitation
B (of the combination of ABC), rather than C, which
distinguishes the claims over the art, then limitation B
would constitute surrendered subject matter, and limitation
C has not been surrendered.


The presentation of the insertions or deletions as
C.The Third Step - Were the reissued claims
part of the original reissue specification is an amendment
materially narrowed in other respects to
under 37 CFR 1.173(b). An amendment of the
compensate for the broadening in the area of  
reissue application made at the time of filing of the  
surrender, and thus avoid the recapture rule?
reissue application must be made in accordance with
37 CFR 1.173(b)-(e) and (g); see MPEP § 1453. Thus,
as required by 37 CFR 1.173(c), an amendment of the  
claims made at the time of filing of a reissue application
must include a separate paper setting forth the
status of all claims (i.e., pending or canceled), and an
explanation of the support in the disclosure of the
patent for the changes made to the claims.


If a chart, table, or chemical formula is amended
As pointed out above, the third prong of the recapture
and it spans two columns of the patent, it should not
determination set forth in Pannu is directed to
be split. Rather, the chart, table, or chemical formula
analysis of the broadening and narrowing effected via
should be provided in its entirety as part of the column
the reissue claims, and of the significance of the claim
of the patent to which it pertains, in order to provide
limitations added and deleted, using the prosecution
a continuity of the description. When doing so,  
history of the patent (to be reissued), to determine
the chart, table, or chemical formula may extend
whether the reissue claims should be barred as recapture.
beyond the width of the column. Change in only a part
of a word or chemical formula is not permitted. Entire
words or chemical formulas must be shown as being
changed. Deletion of a chemical formula should be  
shown by brackets which are substantially larger and
darker than any in the formula.


Where a terminal disclaimer was filed in the application
for the patent to be reissued, a copy of that terminal
disclaimer is not needed in the reissue
application file. For a reissue application that is
maintained in a paper file, the face of the file wrapper
should be marked to indicate that a terminal disclaimer
has been filed for the patent. For a reissue
application that is maintained in IFW, the “Final
SPRE Review” form will be filled in.


Twice reissued patent:
The following discussion addresses analyzing the
reissue claims, and which claims are to be compared
to the reissue claims in determining the issue of surrender
(for reissue recapture).


Examples of the form for a twice-reissued patent
When analyzing a reissue claim for the possibility
are found in Re. 23,558 and Re. 28,488. Double
of impermissible recapture, there are two different
underlining and double bracketing are used in the second
types of analysis that must be performed. If the reissue  
reissue application, while bold-faced type and
claim “fails” either analysis, recapture exists.
double bracketing appear in the printed patent (the  
second reissue patent) to indicate further insertions
and deletions, respectively, in the second reissue
patent.


When a copy of a first reissue patent is used as the  
First, the reissue claim must be compared to any
specification of a second reissue application (filed as
claims canceled or amended during prosecution of the
a reissue of a reissue), additions made by the first reissue  
original application. It is impermissible recapture for
will already be printed in italics, and should
a reissue claim to be as broad or broader in scope than
remain in such format. Thus, applicants need only
any claim that was canceled or amended in the original
present additions to the specification/claims in the  
prosecution to define over the art. Claim scope
second reissue application as double underlined text.  
that was canceled or amended is deemed surrendered
Subject matter to be deleted from the first reissue
and therefore barred from reissue. In re Clement,
patent should be presented in the second reissue application
supra.
within sets of double brackets.  
 
Second, it must be determined whether the reissue  
claim entirely omits any limitation that was added/
argued during the original prosecution to overcome an
art rejection. Such an omission in a reissue claim,  
even if it includes other limitations making the reissue  
claim narrower than the patent claim in other aspects,
is impermissible recapture. Pannu v. Storz Instruments
Inc., supra. However, if the reissue claim
recites a broader form of the key limitation added/
argued during original prosecution to overcome an art
rejection (and therefore not entirely removing that key
limitation), then the reissue claim may not be rejected
under the recapture doctrine. Ex Parte Eggert,  
67
USPQ2d 1716 (Bd. Pat. App. & Inter. 2003) (precedential).
For example, if the key limitation added to  
overcome an art rejection was “an orange peel,” and
the reissue claim instead recites “a citrus fruit peel”,
the reissue claim may not be rejected on recapture
grounds.
 
The following discussion is provided for analyzing
the reissue claims.
 
1.Comparison of Reissue Claims Narrowed/
Broadened Vis-à-vis the Canceled Claims
 
DEFINITION: “Canceled claims,” in the context of
recapture case law, are claims canceled from the original
application to obtain the patent for which reissue  
is now being sought. The claims
 
(A)can simply be canceled and not replaced by
others, or
 
(B)can be canceled and replaced by other claims
which are more specific than the canceled claims in at
least one aspect (to thereby define over the art of
record). The “replacement claims” can be new claims
which are narrower than the canceled claims, or can




Line 1,585: Line 1,675:
   
   


1411.01Certificate of Correction or Disclaimer
be the same claims amended to be narrower than the
in Original Patent [R-2]
canceled version of the claims.


The applicant should include any changes, additions,
(a)Reissue Claims are Same or Broader in  
or deletions that were made by a Certificate of
Scope Than Canceled Claims in All Aspects:
Correction to the original patent grant in the reissue
application without underlining or bracketing. The
examiner should  make certain that all Certificate of
Correction changes in the patent have been properly
incorporated into the reissue application.


Certificate of Correction changes and disclaimer of
The recapture rule bars the patentee from acquiring,
claim(s) under 37 CFR 1.321(a) should be made without
through reissue, claims that are in all aspects (A) of  
using underlining or brackets. Since these are part
the same scope as, or (B) broader in scope than, those
of the original patent and were made before the reissue
claims canceled from the original application to  
was filed, they should show up in the printed reissue
obtain a patent. In re Ball Corp. v. United States,
patent document as part of the original patent,  
729
i.e., not in italics or bracketed. If the changes are
F.2d at 1436, 221 USPQ at 295.  
extensive and/or applicant has submitted them
improperly with underlining and brackets, a clean
copy of the specification with the Certificate of Correction
changes in it may be requested by the examiner.
In order for the clean copy to be entered as a
substitute specification, the reissue applicant must file
a grantable petition under 37 CFR 1.183 for waiver of
37 CFR 1.125(d) and 37 CFR 1.173(a)(1). The examiner’
s request for the clean copy will generally serve
as sufficient basis for granting the petition.


1411.02New Matter
(b)Reissue Claims are Narrower in Scope Than
Canceled Claims in at Least One Aspect:


New matter, that is, matter not present in the patent  
If the reissue claims are equal in scope to, or narrower
sought to be reissued, is excluded from a reissue  
than, the claims of the original patent (as
application in accordance with 35 U.S.C. 251.
opposed to the claims “canceled from the application”)
in all aspects, then there can never be recapture.
The discussion that follows is not directed to that situation.
It is rather directed to the situation where the
reissue claims are narrower than the claims 'canceled'
from the application in some aspect, but are broader
than the claims of the original patent in some other
aspect.


The claims in the reissue application must be for
If the reissue claims are narrower in scope than the  
subject matter which the applicant had the right to  
claims canceled from the original application by
claim in the original patent. Any change in the patent
inclusion of the limitation added to define the original  
made via the reissue application should be checked to
application claims over the art, there will be no recapture,
ensure that it does not introduce new matter. Note that
even if the reissue claims are broader than the  
new matter may exist by virtue of the omission of a
canceled claims in some other aspect (i.e., an aspect
feature or of a step in a method. See United States
not related to the surrender made in the original application).
Industrial Chemicals, Inc. v. Carbide & Carbon
Chemicals Corp., 315 U.S. 668, 53 USPQ 6 (1942).  


Form paragraph 14.22.01 may be used where new
matter has been added anywhere in “the application
for reissue” as prohibited by 35 U.S.C. 251.


¶ 14.22.01 Rejection, 35 U.S.C. 251, New Matter
Assume combination AB was originally presented
 
in the application, and was amended in response to an
Claim [1] rejected under 35 U.S.C. 251 as being based upon
art rejection to add element C and thus provide ABC
new matter added to the patent for which reissue is sought. The
(after which the patent issued). The reissue claims are
added material which is not supported by the prior patent is as follows:
then directed to combination ABbroadenedC. The
[2]
ABbroadenedC claims are narrower in scope when
compared with the canceled claim subject matter AB
in respect to the addition of C (which was added in the
application to overcome the art), and there is no
recapture.
 
As another example, assume combination ABZ was
originally presented in the application, and was
amended in response to an art rejection to add element
C and thus provide ABZC (after which the patent
issued). The reissue claims are then directed to combination
ABC (i.e., element Z is deleted from the canceled
claims, while element C remains present). The
ABC claims of the reissue are narrower in scope as  
compared to the canceled-from-the-original-application
claim subject matter ABZ in respect to the addition
of C (which was added in the application to
overcome the art), and there is thus no recapture.


Examiner Note:
2.Comparison of Reissue Claims Narrowed/
Broadened Via-à-vis the Patent Claims


1.In bracket 2, fill in the applicable page and line numbers and  
The “patent claims,” in the context of recapture
provide an explanation of your position, as appropriate.
case law, are claims which issued in the original
patent for which reissue is now being sought. As
pointed out above, where the reissue claims are narrower
than the claims of the original patent in all
aspects, then there can never be recapture. If reissue
claims are equal in scope to the patent claims, there is
no recapture as to those reissue claims. Where, however,
reissue claims are both broadened and narrowedas compared with the original patent claims, the
nature of the broadening and narrowing must be
examined to determine whether the reissue claims are
barred as being recapture of surrendered subject matter.
If the claims are 'broader than they are narrower in
a manner directly pertinent to the subject matter... surrendered
during prosecution' (Clement, 131 F.3d at
1471, 45 USPQ2d at 1166), then recapture will bar the
claims. This narrowing/broadening vis-à-vis the
patent is broken down into four possibilities that will
now be addressed.


2.A rejection under 35 U.S.C. 112, first paragraph, should also
The “limitation” presented, argued, or stated to
be made if the new matter is added to the claims or is added to the  
make the claims patentable over the art (in the application)
specification and affects the claims. If new matter is added to the  
“generates” the surrender of claimed subject
specification and does not affect the claims, an objection should
matter. For the sake of simplification, this limitation
be made based upon 35  
will be referred to throughout this section as the surrender-
U.S.C. 132 using form paragraph 7.28.
generating limitation. If a claim is presented in
a reissue application that omits, in its entirety, the surrender-
generating limitation, that claim impermissibly
recaptures what was previously surrendered, and that
claim is barred under 35 U.S.C. 251. This terminology
will be used in the discussion of the four categories
of narrowing/broadening vis-à-vis the patent that
follows.


1412Content of Claims


The content of claims in a reissue application is
somewhat limited, as is indicated in MPEP § 1412.01through MPEP § 1412.03.


1412.01Reissue Claims Must Be for
Same General Invention [R-2]


The reissue claims must be for the same invention
as that disclosed as being the invention in the
original patent, as required by 35 U.S.C. 251. This
does not mean that the invention claimed in the reissue
must have been claimed in the original patent,
although this is evidence that applicants considered it
their invention. The entire disclosure, not just the
claim(s), is considered in determining what the patentee
objectively intended as his or her invention. The
proper test as to whether reissue claims are for the
same invention as that disclosed as being the invention
in the original patent is “an essentially factual
inquiry confined to the objective intent manifested by
the original patent.” In re Amos, 953 F.2d 613, 618,
21 USPQ2d 1271, 1274 (Fed. Cir. 1991) (quoting In
re Rowand, 526 F.2d 558, 560, 187 USPQ 487, 489
(CCPA 1975)) (emphasis added). See also In re Mead,
581 F.2d 257, 198 USPQ 412 (CCPA 1978). The
“original patent” requirement of 35 U.S.C. 251 must
be understood in light of In re Amos, supra, where the
Court of Appeals for the Federal Circuit stated:


We conclude that, under both Mead and Rowand, a claim
(a)Reissue Claims are Narrower in Scope Than
submitted in reissue may be rejected under the “original
Patent Claims, in Area Not Directed to  
patent” clause if the original specification demonstrates,  
Amendment/Argument Made to Overcome
to one skilled in the art, an absence of disclosure sufficient
Art Rejection in Original Prosecution; are
to indicate that a patentee could have claimed the subject
Broader in Scope by Omitting Limitation(s)
matter. Merely finding that the subject matter was “not
Added/Argued To Overcome Art Rejection
originally claimed, not an object of the original patent,
in Original Prosecution:
and not depicted in the drawing,” does not answer the
essential inquiry under the “original patent” clause of §
251, which is whether one skilled in the art, reading the


In this case, there is recapture.


This situation is where the patent claims are
directed to combination ABC and the reissue claims
are directed to ABD. Element C was either a limitation
added to AB to obtain allowance of the original
patent, or was argued by applicant to define over the
art (or both). Thus, addition of C (and/or argument as
to C) has resulted in the surrender of any combination
of A & B that does not include C; this is the surrendered
subject matter. Element D, on the other hand, is
not related to the surrendered subject matter. Thus, the
reissue claim, which no longer contains C, is broadened
in an area related to the surrender, and the narrowing
via the addition of D does not save the claim
from recapture since D is not related to the surrendered
subject matter.


Reissue claims that are broader than the original
patent claims by not including the surrender-generating
limitation (element C, in the example given) will
be barred by the recapture rule even though there is
narrowing of the claims not related to the surrender-
generating limitation. As stated in the decision of In re
Clement, 131 F.3d at 1470, 45 USPQ2d at 1165, if the
reissue claim is broader in an aspect germane to a
prior art rejection, but narrower in another aspect
completely unrelated to the rejection, the recapture
rule bars the claim. Pannu v. Storz Instruments Inc.,
supra, then brings home the point by providing an
actual fact situation in which this scenario was held to
be recapture.


(b)Reissue Claims are Narrower or Equal in
 
Scope, in Area Directed to Amendment/
specification, would identify the subject matter of the new
Argument Made to Overcome Art Rejection
claims as invented and disclosed by the patentees. In
in Original Prosecution; are Broader in  
short, the absence of an “intent,” even if objectively evident
Scope in Area Not Directed to Amendment/
from the earlier claims, the drawings, or the original
Argument:
objects of the invention is simply not enough to establish
that the new claims are not drawn to the invention disclosed
in the original patent.
 
953 F.2d at 618-19, 21 USPQ2d at 1275. Claims presented
in a reissue application are considered to satisfy
the requirement of 35 U.S.C. 251 that the claims
be “for the invention disclosed in the original patent”
where:


(A)the claims presented in the reissue application
In this case, there is no recapture.
are described in the original patent specification and
enabled by the original patent specification such that
35 U.S.C. 112 first paragraph is satisfied; and


(B)nothing in the original patent specification
This situation is where the patent claims are
indicates an intent not to claim the subject matter of
directed to combination ABCDE and the reissue
the claims presented in the reissue application.
claims are directed to ABDE (element C is omitted).
Assume that the combination of ABCD was present in  
the original application as it was filed, and element E
was later added to define over that art. No argument
was ever presented as to elements A-C defining over
the art.  


The presence of some disclosure (description
In this situation, the ABCDE combination of the
and enablement) in the original patent should evidence
patent can be broadened (in the reissue application) to
that applicant intended to claim or that applicant
omit element C, and thereby claim the combination of  
considered the material now claimed to be his or  
ABDE, where element E (the surrender generating
her invention.  
limitation) is not omitted. There would be no recapture
in this instance. (If an argument had been presented
as to element C defining over the art, in
addition to the addition of element E, then the
ABCDE combination could not be broadened to omit
element C and thereby claim combination of ABDE.
This would be recapture; see the above discussion as
to surrender and recapture based upon argument.)
 
Additionally, the reissue claims are certainly permitted
to recite combination ABDEspecific (where surrender-
generating element E is narrowed). The patent
claims have been broadened in an area not directed to
the surrender (by omitting element C) and narrowed
in the area of surrender (by narrowing element E to
Especific). This is clearly permitted.
 
As another example, assume limitation C was
added to application claims AB to obtain the patent to
ABC, and now the reissue application presents claims
to AC or ABbroadC. Such reissue claims avoid the
effect of the recapture rule because they are broader in
a way that does not attempt to reclaim what was surrendered
earlier. Mentor Corp. v. Coloplast, Inc., 998
F.2d 992, 994, 27 USPQ2d 1521, 1525 (Fed. Cir.
1993). Such claims are considered to be broader in an
aspect not 'germane to a prior art rejection,' and thus
are not barred by recapture. Note In re Clement,
131
F.3d at 1470, 45 USPQ2d at 1165.
 
Reissue claims that are broader than the original
patent claims by deletion of a limitation or claim
requirement other than the “surrender-generating limitation”
will avoid the effect of the recapture rule,
regardless of the nature of the narrowing in the
claims, and even if the claims are not narrowed at all
from the scope of the patent claims.


The original patent specification would indicate an
intent not to claim the subject matter of the claims
presented in the reissue application in a situation analogous
to the following:


The original patent specification discloses that
composition X is not suitable (or not satisfactory) for
molding an item because composition X fails to provide
quick drying. After the patent issues, it is found
that composition X would be desirable for the molding
in spite of the failure to provide quick drying,
because of some other newly recognized benefit from
composition X. A claim to composition X or a method
of use thereof would not be permitted in a reissue
application, because the original patent specification
contained an explicit statement of intent not to claim
composition X or a method of use thereof.


In most instances, however, the mere failure to
claim a disclosed embodiment in the original patent
(absent an explicit statement in the original patent
specification of unsuitability of the embodiment)
would not be grounds for prohibiting a claim to that
embodiment in the reissue.


FAILURE TO TIMELY FILE A DIVISIONAL
APPLICATION PRIOR TO ISSUANCE OF
ORIGINAL PATENT


Where a restriction requirement was made in an
(c)Reissue Claims are Narrower in Scope in  
application and applicant permitted the elected invention
Area Not Directed to Amendment/Argument
to issue as a patent without the filing of a divisional
Made to Overcome Art Rejection in Original
application on the non-elected invention(s), the
Prosecution; are Broader in Scope in Area
non-elected invention(s) cannot be recovered by filing
Not Directed to the Amendment/Argument:
a reissue application. A reissue applicant’ s failure to
timely file a divisional application covering the non-
elected invention(s) in response to a restriction
requirement is not considered to be error causing a
patent granted on the elected claims to be partially
inoperative by reason of claiming less than the applicant
had a right to claim. Accordingly, such error is
not correctable by reissue of the original patent under
35 U.S.C. 251. In re Watkinson, 900 F.2d 230, 14
USPQ2d 1407 (Fed. Cir. 1990); In re Orita, 550 F.2d
1277, 1280, 193 USPQ 145, 148 (CCPA 1977). See
also In re Mead, 581 F.2d 251, 198 USPQ 412 (CCPA
1978). In this situation, the reissue claims should be
rejected under 35 U.S.C. 251 for lack of defect in the
original patent and lack of error in obtaining the original
patent. Compare with In re Doyle, 293 F.3d 1355,
63 USPQ2d 1161 (Fed. Cir. 2002) where the court
permitted the patentee to file a reissue application to
present a so-called linking claim, a claim broad
enough to read on or link the invention elected (and
patented) together with the invention not elected. The
non-elected invention(s) were inadvertently not filed
as a divisional application.


1412.02Recapture of Canceled SubjectMatter [R-5]
In this instance, there is clearly no recapture. In the
reissue application, there has been no change in the
claims related to the matter surrendered in the original
application for the patent.


A reissue will not be granted to “recapture” claimed
In this instance, element C was added to the AB
subject matter which was surrendered in an application
combination to provide ABC and define over the art,
to obtain the original patent. North American
and the patent was issued. The reissue omits element
Container, Inc. v. Plastipak Packaging, Inc., 415 F.3d
B and adds element Z, to thus claim ACZ. There is no
1335, 75 USPQ2d 1545 (Fed. Cir. 2005, Pannu v.
recapture since the surrender generating element C
Storz Instruments Inc., 258 F.3d 1366, 59 USPQ2d
has not been modified in any way. (Note, however,  
1597 (Fed. Cir. 2001); Hester Industries, Inc. v. Stein,  
that if, when element C was added to AB, applicant
Inc., 142 F.3d 1472, 46 USPQ2d 1641 (Fed. Cir.
argued that the association of newly added C with B
1998); In re Clement, 131 F.3d 1464, 45 USPQ2d
provides a synergistic (unexpected) result to thus
1161 (Fed. Cir. 1997); Ball Corp. v. United States, 729
define over the art, then neither B nor C could be
F.2d 1429, 1436, 221 USPQ 289, 295 (Fed. Cir.
omitted in the reissue application.)
1984); In re Wadlinger, 496 F.2d 1200, 181 USPQ
826 (CCPA 1974); In re Richman, 409 F.2d 269, 276,


(d)Reissue Claims Broader in Scope in Area
Directed to Amendment/Argument Made to
Overcome Art Rejection in Original
Prosecution; but Reissue Claims Retain, in
Broadened Form, the Limitation(s) Argued/
Added to Overcome Art Rejection in
Original Prosecution:


Assume the combination AB was originally
claimed in the application, and was amended in reply
to an art rejection to add element C and thus provide
the combination ABC (after which the patent issued).
A reissue application is then filed, and the reissue
application claims are directed to the combination
ABCbroadened. The ABCbroadened claims are narrowed
in scope when compared with the canceled claim subject
matter AB, because of the addition of Cbroadened.
Thus, the claims retain, in broadened form, the limitation
argued/added to overcome art rejection in original
prosecution. There is no recapture, since
ABCbroadened is narrower than canceled claim subject
matter AB in an area related to the surrender. This is
so, because it was element C that was added in the
application to overcome the art. See Ex Parte Eggert,
supra.


II.REISSUE TO TAKE ADVANTAGE OF
35
U.S.C. 103(b):


A patentee may file a reissue application to permit
consideration of process claims which qualify for
35
U.S.C. 103(b) treatment if a patent is granted on an
application entitled to the benefit of 35 U.S.C. 103(b),
without an election having been made as a result of..
error without deceptive intent. See MPEP
§
   
   
706.02(n). This is not to be considered a recapture.
The addition of process claims, however, will
generally be considered to be a broadening of the
invention (Ex parte Wikdahl, 10 USPQ2d 1546 (Bd.
Pat. App. & Inter. 1989)), and such addition must be
applied for within two years of the grant of the original
patent. See also MPEP § 1412.03 as to broadened
claims.
III.REISSUE FOR ARTICLE CLAIMS
WHICH ARE FUNCTIONAL DESCRIPTIVE
MATERIAL STORED ON A COMPUTER-
READABLE MEDIUM:


161 USPQ 359, 363-364 (CCPA 1969); In re Willingham,
A patentee may file a reissue application to permit
282
consideration of article of manufacture claims which
F.2d 353, 127 USPQ 211 (CCPA 1960).
are functional descriptive material stored on a computer-
readable medium, where these article claims
correspond to the process or machine claims which
have been patented. The error in not presenting claims
to this statutory category of invention (the “article”
claims) must have been made as a result of error without
deceptive intent. The addition of these “article”
claims will generally be considered to be a broadening
of the invention (Ex parte Wikdahl, 10 USPQ2d
1546 (Bd. Pat. App. & Inter. 1989)), and such addition
must be applied for within two years of the grant of
the original patent. See also MPEP § 1412.03 as to
broadened claims.


I.THREE STEP TEST FOR RECAPTURE:
IV.REJECTION BASED UPON RECAPTURE:


In Clement, 131 F.3d at 1468-70, 45 USPQ2d at
1164-65, the Court of Appeals for the Federal Circuit
set forth a three step test for recapture analysis. In
Pannu, 258 F.3d at 1371, 59 USPQ2d at 1600, the
court restated this test as follows:


Application of the recapture rule is a three-step process.
Reissue claims which recapture surrendered subject
matter should be rejected using form paragraph 14.17.


¶ 14.17 Rejection, 35 U.S.C. 251, Recapture


The first step is to ‘determine whether and in what aspect
Claim[1] rejected under 35 U.S.C. 251 as being an improper
the reissue claims are broader than the patent claims.....
recapture of broadened claimed subject matter surrendered in the
application for the patent upon which the present reissue is based.
See Pannu v. Storz Instruments Inc., 258 F.3d 1366, 59 USPQ2d
1597 (Fed. Cir. 2001); Hester Industries, Inc. v. Stein, Inc., 142
F.3d 1472, 46 USPQ2d 1641 (Fed. Cir. 1998); In re Clement, 131


‘The second step is to determine whether the broader
aspects of the reissued claim related to surrendered subject
matter’ ....


Finally, the court must determine whether the reissued
claims were materially narrowed in other respects to avoid
the recapture rule. [Emphasis added]


A.The First Step - Was There Broadening?


In every reissue application, the examiner must first
review each claim for the presence of broadening, as
compared with the scope of the claims of the patent to
be reissued. A reissue claim is broadened where some
limitation of the patent claims is no longer required in
the reissue claim; see MPEP § 1412.03 for guidance
as to the nature of a “broadening claim.” If the reissue
claim is not broadened in any respect as compared to
the patent claims, the analysis ends; there is no recapture.


F.3d 1464, 45 USPQ2d 1161 (Fed. Cir. 1997); Ball Corp. v.
United States, 729 F.2d 1429, 1436, 221 USPQ 289, 295 (Fed. Cir.
1984). A broadening aspect is present in the reissue which was not
present in the application for patent. The record of the application
for the patent shows that the broadening aspect (in the reissue)
relates to claim subject matter that applicant previously surrendered
during the prosecution of the application. Accordingly, the
narrow scope of the claims in the patent was not an error within
the meaning of 35 U.S.C. 251, and the broader scope of claim subject
matter surrendered in the application for the patent cannot be
recaptured by the filing of the present reissue application.


B.The Second Step - Does Any Broadening
[2]
Aspect of the Reissued Claim Relate to
Surrendered Subject Matter?


Where a claim in a reissue application is broadened
Examiner Note:
in some respect as compared to the patent claims, the
examiner must next determine whether the broadening
aspect(s) of that reissue claim relate(s) to subject
matter that applicant previously surrendered during
the prosecution of the original application (which
became the patent to be reissued). Each limitation of
the patent claims, which is omitted or broadened in
the reissue claim, must be reviewed for this determination.
This involves two sub-steps:


1.The Two Sub-Steps:
In bracket 2, the examiner should explain the specifics of why
 
recapture exists, including an identification of the omitted/broadened
(A)It must first be determined whether there was
claim limitations in the reissue which provide the “broadening
any surrender of subject matter made in the prosecution
aspect” to the claim(s), and where in the original application  
of the original application which became the  
the narrowed claim scope was presented/argued to obviate a rejection/
patent to be reissued.
objection. See MPEP §
1412.02.  


If an original patent claim limitation now being
See the recapture-analysis flow chart which follows
omitted or broadened in the present reissue application
for assistance in determining whether recapture is
was originally relied upon by applicant in the
present, consistent with the case law discussed above.
original application to make the claims allowable over
the art, the omitted limitation relates to subject matter
previously surrendered by applicant. The reliance by
applicant to define the original patent claims over the
art can be by way of presentation of new/amended
claims to define over the art, or an argument/statement
by applicant that a limitation of the claim(s)
defines over the art. To determine whether such reliance
occurred, the examiner must review the prosecution
history of the original application file (of the
patent to be reissued) for recapture. The prosecution
history includes the rejections and applicant’s arguments
made therein.
 
If there was no surrender of subject matter made
in the prosecution of the original application, again
the analysis ends and there is no recapture.


(B)If there was a surrender of subject matter in
the original application prosecution, it must then be
determined whether any of the broadening of the reissue
claims is in the area of the surrendered subject
matter. All of the broadening aspects of reissue claims
must be analyzed to determine if any of the omitted/
broadened limitation(s) are directed to limitations
relied upon by applicant in the original application to
make the claims allowable over the art.


2.Examples of the Pannu Second Step Analysis:




(A)Example (1) - Argument without amendment:


In Hester, supra, the Federal Circuit held that the
Flowchart - Reissue Recapture - Determining its presence or absence
surrender which forms the basis for impermissible
recapture “can occur through arguments alone”.
142
F.3d at 1482, 46 USPQ2d at 1649. For example,
assume that limitation A of the patent claims is omitted
in the reissue claims. This omission provides a
broadening aspect in the reissue claims, as compared
to the claims of the patent. If the omitted limitation A
was argued in the original application to make the
application claims allowable over the art in the appli




Line 1,922: Line 2,039:
   
   


cation, then the omitted limitation relates to subject
1412.03Broadening Reissue Claims
matter previously surrendered in the original application,
[R-3]
and recapture will exist. Accordingly, where
 
claims are broadened in a reissue application, the
35 U.S.C. 251 prescribes a 2-year limit for filing
examiner should review the prosecution history of the
applications for broadening reissues:
original patent file for recapture, even where the
claims were never amended during the prosecution of
the application which resulted in the patent.


Note: The argument that the claim limitation
No reissue patent shall be granted enlarging the scope of
defined over the rejection must have been specific as
the original patent unless applied for within two years
to the limitation relied upon, rather than a general
from the grant of the original patent.  
statement regarding the claims as a whole. A general
'boiler plate' sentence in the original application will
not, by itself, be sufficient to establish surrender and
recapture.


An example of a general “boiler plate” sentence of
argument is:


“In closing, it is argued that the limitations of claims 1-7
distinguish the claims from the teachings of the prior art,
and claims 1-7 are thus patentable.”


An argument that merely states that all the limitations
I. MEANING OF “BROADENED REISSUE
of the claims define over the prior art will also
CLAIM”
not, by itself, be sufficient to establish surrender and
recapture. An example is:


“Claims 1-5 set forth a power-train apparatus which comprises
A broadened reissue claim is a claim which  
the combination of A+B+C+D+E. The prior art of  
enlarges the scope of the claims of the patent, i.e., a
record does not disclose or render obvious a motivation to  
claim which is greater in scope than each and every
provide for a material-transfer apparatus as defined by the  
claim of the original patent. If a disclaimer is filed in
limitations of claim 1, including an A member and a B
the patent prior to the filing of a reissue application,
member, both connected to a C member, with all three
the disclaimed claims are not part of the “original
being aligned with the D and E members.
patent” under 35 U.S.C. 251. The Court in Vectra Fitness
Inc. v. TNWK Corp., 49 USPQ2d 1144, 1147,
162 F.3d 1379, 1383 (Fed. Cir. 1998) held that a reissue
application violated the statutory prohibition
under 35 U.S.C. 251 against broadening the scope of
the patent more than 2 years after its grant because the
reissue claims are broader than the claims that remain
after the disclaimer, even though the reissue claims
are narrower than the claims that were disclaimed by
the patentee before reissue. The reissue application
was bounded by the claims remaining in the patent
after a disclaimer is filed.A claim of a reissue application
enlarges the scope of the claims of the patent if it
is broader in at least one respect, even though it may
be narrower in other respects.
 
A claim in the reissue which includes subject matter
not covered by the patent claims enlarges the scope
of the patent claims. For example, if any amended or
newly added claim in the reissue contains within its
scope any conceivable product or process which
would not have infringed the patent, then that reissue
claim would be broader than the patent claims. Tillotson,
Ltd. v. Walbro Corp., 831 F.2d 1033, 1037 n.2,
4
USPQ2d 1450, 1453 n.2 (Fed. Cir. 1987); In re
Ruth, 278 F.2d 729, 730, 126 USPQ 155, 156 (CCPA
1960); In re Rogoff, 261 F.2d 601, 603, 120 USPQ
185, 186 (CCPA 1958). A claim which reads on
something which the original claims do not is a broadened
claim. A claim would be considered a broadening
claim if the patent owner would be able to sue any
party for infringement who previously could not have
been sued for infringement. Thus, where the original
patent claims only the process, and the reissue application
adds (for the first time) product claims, the
scope of the claims has been broadened since a party
could not be sued for infringement of the product
based on the claims of the original patent.
 
The addition of combination claims in a reissue
application where only subcombination claims were
present in the original patent could be a broadening of
the invention. The question which must be resolved in
this case is whether the combination claims added in
the reissue would be for “the invention as claimed” in
the original patent. See Ex parte Wikdahl, 10 USPQ2d
at 1549. The newly added combination claims should
be analyzed to determine whether they contain every
limitation of the subcombination of any claim of the
original patent. If the combination claims (added in
the reissue) contain every limitation of the subcombination
(which was claimed in the original application),
then infringement of the combination must also
result in infringement of the subcombination. Accordingly,
the patent owner could not, if a reissue patent
issues with the combination claims, sue any new
party for infringement who could not have been sued
for infringement of the original patent. Therefore,  
broadening does not exist, in spite of the addition of
the combination.


This statement is simply a restatement of the
entirety of claim 1 as allowed. No measure of surrender
could be gleaned from such a statement of reasons
for allowance. See Ex parte Yamaguchi, 61 USPQ2d
1043 (Bd. Pat. App. & Inter. 2001)(reported but
unpublished, precedential).


In both of the above examples, the argument does
not provide an indication of what specific limitations,
e.g., specific element or step of the claims, cooperative
effect, or other aspect of the claims, are being
relied upon for patentability. Thus, applicant has not
surrendered anything.


(B)Example (2) - Amendment of the claims without
II. SCOPE OF DEPENDENT CLAIM
argument:
ENLARGED-NOT BROADENING


The limitation omitted in the reissue claim(s) was
As pointed out above, a claim will be considered a
added in the original application claims for the purpose
broadened reissue claim when it is greater in scope
of making the application claims allowable over
than each and every claim of the patent to be reissued.  
a rejection or objection made in the application. Even
A corollary of this is that a claim which has
though applicant made no argument on the record that  
been broadened in a reissue as compared to its scope
the limitation was added to obviate the rejection, the
in the patent is not a broadened reissue claim if it is
nature of the addition to the claim can show that the
narrower than, or equal in scope to, any other claim
limitation was added in direct reply to the rejection.
which appears in the patent. A common example of
This too will establish the omitted limitation as relating
this is where dependent claim 2 is broadened via the  
to subject matter previously surrendered. To illustrate
reissue (other than the addition of a process step to  
this, note the following example:
convert an intermediate to a final product as discussed
 
in the preceding subsection), but independent claim 1
The original application claims recite limitations A+B+C,
on which it is based is not broadened. Since a dependent
and the Office action rejection combines two references to  
claim is construed to contain all the limitations of  
show A+B+C. In the amendment replying to the Office
the claim upon which it depends, claim 2 must be at
action, applicant adds limitation D to A+B+C in the  
claims, but makes no argument as to that addition. The
examiner then allows the claims. Even though there is no
argument as to the addition of limitation D, it must be presumed
that the D limitation was added to obviate the
rejection. The subsequent deletion of (omission of) limitation
D in the reissue claims would be presumed to be a
broadening in an aspect of the reissue claims related to
surrendered subject matter. Accordingly, the reissued
claims would be barred by the recapture doctrine.


The above result would be the same whether the
addition of limitation D in the original application
was by way of applicant’s amendment or by way of an
examiner’s amendment with authorization by applicant.




(C)Example (3) - Who can make the surrendering
argument?


Assume that the limitation A omitted in the reissue
claims was present in the claims of the original application.
The examiner’s reasons for allowance in the
original application stated that it was that limitation A
which distinguished over a potential combination of
references X and Y. Applicant did not present on the
record a counter statement or comment as to the
examiner’s reasons for allowance, and permitted the
claims to issue.


Ex parte Yamaguchi, supra, held that a surrender of
least as narrow as claim 1 and is thus not a broadened
claimed subject matter cannot be based solely upon an
reissue claim.
applicant’s failure to respond to, or failure to challenge,
an examiner’s statement made during the prosecution
of an application. Applicant is bound only by
applicant’s revision of the application claims or a positive
argument/statement by applicant. An applicant’s
failure to present on the record a counter statement or






III. NEW CATEGORY OF INVENTION
ADDED IN REISSUE - GENERALLY
IS BROADENING


The addition of process claims as a new category of
invention to be claimed in the patent (i.e., where there
were no method claims present in the original patent)
is generally considered as being a broadening of the
invention. See Ex parte Wikdahl, 10 USPQ2d 1546
(Bd. Pat. App. & Inter. 1989). A situation may arise,
however, where the reissue application adds a limitation
(or limitations) to process A of making the product
A claimed in the original patent claims. For
example:


comment as to an examiner’s reasons for allowance
(1)a process of using the product A (made by the  
does not give rise to any implication that applicant
process of the original patent) to make a product B,
agreed with or acquiesced in the examiner’s reasoning
disclosed but not claimed in the original patent; or
for allowance. Thus, the failure to present a counter
statement or comment as to the examiner’s statement
of reasons for allowance does not give rise to any
finding of surrender. The examiner’s statement of
reasons for allowance in the original application
cannot, by itself, provide the basis for establishing
surrender and recapture.


It is only in the situation where applicant does file
(2)a process of using the product A to carry out a
comments on the statement of reasons for allowance,
process B disclosed but not claimed in the original
that surrender may have occurred. Note the following
patent.
two scenarios in which an applicant files comments:


Scenario 1- There is Surrender: The examiner’s statement
Although this amendment of the claims adds a
of reasons for allowance in the original application stated
method of making product B or adds a method of  
that it was limitation C (of the combination of ABC)
using product A, this is not broadening (i.e., this is not
which distinguished over a potential combining of references
an enlargement of the scope of the original patent)
X and Y, in that limitation C provided increased
because the “newly claimed invention” contains all
speed to the process. Applicant filed comments on the  
the limitations of the original patent claim(s).
examiner’s statement of reasons for allowance essentially
supporting the examiner’ s reasons. The limitation C is
thus established as relating to subject matter previously
surrendered.


Scenario 2- There is No Surrender: On the other hand, if
applicant’s comments on the examiner’s statement of reasons
for allowance contain a counter statement that it is limitation
B (of the combination of ABC), rather than C, which
distinguishes the claims over the art, then limitation B
would constitute surrendered subject matter, and limitation
C has not been surrendered.


C.The Third Step - Were the reissued claims
materially narrowed in other respects to
compensate for the broadening in the area of
surrender, and thus avoid the recapture rule?


As pointed out above, the third prong of the recapture
IV. WHEN A BROADENED CLAIM CAN BE
determination set forth in Pannu is directed to
PRESENTED
analysis of the broadening and narrowing effected via
the reissue claims, and of the significance of the claim
limitations added and deleted, using the prosecution
history of the patent (to be reissued), to determine
whether the reissue claims should be barred as recapture.


A broadened claim can be presented within two
years from the grant of the original patent in a reissue
application. In addition, a broadened claim can be
presented after two years from the grant of the original
patent in a broadening reissue application
which was filed within two years from the grant.
Where any intent to broaden is indicated in the reissue
application within the two years from the patent grant,
a broadened claim can subsequently be presented in
the reissue after the two year period. Thus, a broadened
claim may be presented in a reissue application
after the two years, even though the broadened claim
presented after the two years is different than the
broadened claim presented within the two years.
Finally, if intent to broaden is indicated in a parent
reissue application within the two years, a broadened
claim can be presented in a continuing (continuation
or divisional) reissue application after the two year
period. In any other situation, a broadened claim cannot
be presented, and the examiner should check carefully
for the improper presentation of broadened
claims.


The following discussion addresses analyzing the  
A reissue application filed on the 2-year anniversary
reissue claims, and which claims are to be compared
date from the patent grant is considered to be  
to the reissue claims in determining the issue of surrender
filed within 2 years of the patent grant. See Switzer v.
(for reissue recapture).
Sockman, 333 F.2d 935, 142 USPQ 226 (CCPA 1964)
for a similar rule in interferences.


When analyzing a reissue claim for the possibility
See also the following cases which pertain to
of impermissible recapture, there are two different
broadened reissues:
types of analysis that must be performed. If the reissue
claim “fails” either analysis, recapture exists.


First, the reissue claim must be compared to any
In re Graff, 111 F.3d 874, 877, 42 USPQ2d 1471,  
claims canceled or amended during prosecution of the
1473-74 (Fed. Cir. 1997) (Broadened claims in a continuing
original application. It is impermissible recapture for  
reissue application were properly rejected
a reissue claim to be as broad or broader in scope than
under 35 U.S.C. 251 because the proposal for broadened
any claim that was canceled or amended in the original  
claims was not made (in the parent reissue application)
prosecution to define over the art. Claim scope
within two years from the grant of the original  
that was canceled or amended is deemed surrendered
patent and the public was not notified that broadened
and therefore barred from reissue. In re Clement,
claims were being sought until after the two-year
supra.
period elapsed.);


Second, it must be determined whether the reissue
In re Fotland, 779 F.2d 31, 228 USPQ 193 (Fed.  
claim entirely omits any limitation that was added/
Cir. 1985), cert. denied, 476 U.S. 1183 (1986) (The
argued during the original prosecution to overcome an
failure by an applicant to include an oath or declaration
art rejection. Such an omission in a reissue claim,  
indicating a desire to seek broadened claimswithin two years of the patent grant will bar a subsequent
even if it includes other limitations making the reissue
attempt to broaden the claims after the two year
claim narrower than the patent claim in other aspects,
limit. Under the former version of 37 CFR 1.175 (the  
is impermissible recapture. Pannu v. Storz Instruments
former 37 CFR 1.175(a)(4)), applicant timely sought
Inc., supra. However, if the reissue claim
a “no-defect” reissue, but the Court did not permit an  
recites a broader form of the key limitation added/
attempt made beyond the two year limit to convert the  
argued during original prosecution to overcome an art
reissue into a broadening reissue. In this case, applicant
rejection (and therefore not entirely removing that key
did not indicate any intent to broaden within the  
limitation), then the reissue claim may not be rejected
two years.);
under the recapture doctrine. Ex Parte Eggert,
67
USPQ2d 1716 (Bd. Pat. App. & Inter. 2003) (precedential).
For example, if the key limitation added to
overcome an art rejection was “an orange peel,” and
the reissue claim instead recites “a citrus fruit peel”,  
the reissue claim may not be rejected on recapture
grounds.


The following discussion is provided for analyzing
In re Bennett, 766 F.2d 524, 528, 226 USPQ 413,
the reissue claims.
416 (Fed. Cir. 1985) (en banc) (A reissue application
with broadened claims was filed within two years of
the patent grant; however, the declaration was executed
by the assignee rather than the inventor. The  
Federal Circuit permitted correction of the improperly
executed declaration to be made more than two years
after the patent grant.);


1.Comparison of Reissue Claims Narrowed/
In re Doll, 419 F.2d 925, 928, 164 USPQ 218, 220
Broadened Vis-à-vis the Canceled Claims
(CCPA 1970) (If the reissue application is timely filed
 
within two years of the original patent grant and the  
DEFINITION: “Canceled claims,” in the context of
recapture case law, are claims canceled from the original
application to obtain the patent for which reissue
is now being sought. The claims
 
(A)can simply be canceled and not replaced by
others, or
 
(B)can be canceled and replaced by other claims
which are more specific than the canceled claims in at
least one aspect (to thereby define over the art of
record). The “replacement claims” can be new claims
which are narrower than the canceled claims, or can




Line 2,150: Line 2,261:
   
   


be the same claims amended to be narrower than the  
applicant indicates in the oath or declaration that the
canceled version of the claims.
claims will be broadened, then applicant may subsequently
broaden the claims in the pending reissue
prosecution even if the additional broadening occurs
beyond the two year limit.).  


(a)Reissue Claims are Same or Broader in  
Form paragraphs 14.12 and 14.13 may be used in  
Scope Than Canceled Claims in All Aspects:
rejections based on improper broadened reissue
claims.


The recapture rule bars the patentee from acquiring,
¶ 14.12 Rejection, 35 U.S.C. 251, Broadened Claims After
through reissue, claims that are in all aspects (A) of
Two Years
the same scope as, or (B) broader in scope than, those
claims canceled from the original application to
obtain a patent. In re Ball Corp. v. United States,  
729
F.2d at 1436, 221 USPQ at 295.


(b)Reissue Claims are Narrower in Scope Than
Claim [1] rejected under 35 U.S.C. 251 as being broadened in  
Canceled Claims in at Least One Aspect:
a reissue application filed outside the two year statutory period.
[2] A claim is broader in scope than the original claims if it contains
within its scope any conceivable product or process which
would not have infringed the original patent. A claim is broadened
if it is broader in any one respect even though it may be narrower
in other respects.


If the reissue claims are equal in scope to, or narrower
Examiner Note:
than, the claims of the original patent (as
opposed to the claims “canceled from the application”)
in all aspects, then there can never be recapture.
The discussion that follows is not directed to that situation.
It is rather directed to the situation where the
reissue claims are narrower than the claims 'canceled'
from the application in some aspect, but are broader
than the claims of the original patent in some other
aspect.


If the reissue claims are narrower in scope than the
The claim limitations that broaden the scope should be identified
claims canceled from the original application by
and explained in bracket 2. See MPEP §§ 706.03(x) and
inclusion of the limitation added to define the original
1412.03.
application claims over the art, there will be no recapture,
even if the reissue claims are broader than the
canceled claims in some other aspect (i.e., an aspect
not related to the surrender made in the original application).


¶ 14.13 Rejection, 35 U.S.C. 251, Broadened Claims Filed
by Assignee


Assume combination AB was originally presented
Claim [1] rejected under 35 U.S.C. 251 as being improperly
in the application, and was amended in response to an
broadened in a reissue application made and sworn to by the
art rejection to add element C and thus provide ABC
assignee and not the patentee. [2]A claim is broader in scope than
(after which the patent issued). The reissue claims are
the original claims if it contains within its scope any conceivable
then directed to combination ABbroadenedC. The
product or process which would not have infringed the original
ABbroadenedC claims are narrower in scope when
patent. A claim is broadened if it is broader in any one respecteven though it may be narrower in other respects.
compared with the canceled claim subject matter AB
in respect to the addition of C (which was added in the  
application to overcome the art), and there is no
recapture.


As another example, assume combination ABZ was
Examiner Note:
originally presented in the application, and was
amended in response to an art rejection to add element
C and thus provide ABZC (after which the patent
issued). The reissue claims are then directed to combination
ABC (i.e., element Z is deleted from the canceled
claims, while element C remains present). The
ABC claims of the reissue are narrower in scope as
compared to the canceled-from-the-original-application
claim subject matter ABZ in respect to the addition
of C (which was added in the application to
overcome the art), and there is thus no recapture.


2.Comparison of Reissue Claims Narrowed/
The claim limitations that broaden the scope should be identified
Broadened Via-à-vis the Patent Claims
and explained in bracket 2. See MPEP §§ 706.03(x) and
 
1412.03.
The “patent claims,” in the context of recapture
case law, are claims which issued in the original
patent for which reissue is now being sought. As
pointed out above, where the reissue claims are narrower
than the claims of the original patent in all
aspects, then there can never be recapture. If reissue
claims are equal in scope to the patent claims, there is
no recapture as to those reissue claims. Where, however,
reissue claims are both broadened and narrowedas compared with the original patent claims, the
nature of the broadening and narrowing must be
examined to determine whether the reissue claims are
barred as being recapture of surrendered subject matter.
If the claims are 'broader than they are narrower in  
a manner directly pertinent to the subject matter... surrendered
during prosecution' (Clement, 131 F.3d at
1471, 45 USPQ2d at 1166), then recapture will bar the
claims. This narrowing/broadening vis-à-vis the
patent is broken down into four possibilities that will
now be addressed.


The “limitation” presented, argued, or stated to
make the claims patentable over the art (in the application)
“generates” the surrender of claimed subject
matter. For the sake of simplification, this limitation
will be referred to throughout this section as the surrender-
generating limitation. If a claim is presented in
a reissue application that omits, in its entirety, the surrender-
generating limitation, that claim impermissibly
recaptures what was previously surrendered, and that
claim is barred under 35 U.S.C. 251. This terminology
will be used in the discussion of the four categories
of narrowing/broadening vis-à-vis the patent that
follows.




V. BROADENING REISSUE - OATH/
DECLARATION REQUIREMENTS


A broadening reissue application must be applied
for by all of the inventors (patentees), that is, the original
reissue oath or declaration must be signed by all
of the inventors. See also MPEP § 1414. If a supplemental
oath or declaration in a broadening reissue
application is needed in the application in order to fulfill
the requirements of 37 CFR 1.175, the supplemental
reissue oath or declaration must be signed by all of
the inventors. See In re Hayes, 53 USPQ2d 1222
(Comm’r Pat. 1999) and MPEP § 1414.01.
1412.04Correction of Inventorship [R-5]


The correction of misjoinder of inventors has been
 
held to be a ground for reissue. See Ex parte Scudder,
(a)Reissue Claims are Narrower in Scope Than
169 USPQ 814, 815 (Bd. App. 1971) wherein the
Patent Claims, in Area Not Directed to
Board held that 35 U.S.C. 251 authorizes reissue
Amendment/Argument Made to Overcome
applications to correct misjoinder of inventors where35 U.S.C. 256 is inadequate. See also A.F. Stoddard &
Art Rejection in Original Prosecution; are
Co. v. Dann, 564 F.2d 556, 567 n.16, 195 USPQ 97,  
Broader in Scope by Omitting Limitation(s)
106 n.16 (D.C. Cir. 1977) wherein correction of
Added/Argued To Overcome Art Rejection
inventorship from sole inventor A to sole inventor B
in Original Prosecution:
was permitted in a reissue application. The court
noted that reissue by itself is a vehicle for correcting
inventorship in a patent.


In this case, there is recapture.  
I.CERTIFICATE OF CORRECTION AS A
VEHICLE FOR CORRECTING INVEN-
TORSHIP


This situation is where the patent claims are
While reissue is a vehicle for correcting inventorship
directed to combination ABC and the reissue claims
in a patent, correction of inventorship should be
are directed to ABD. Element C was either a limitation
effected under the provisions of 35 U.S.C. 256 and
added to AB to obtain allowance of the original
37
patent, or was argued by applicant to define over the
CFR 1.324 by filing a request for a Certificate of  
art (or both). Thus, addition of C (and/or argument as
Correction if:
to C) has resulted in the surrender of any combination
of A & B that does not include C; this is the surrendered
subject matter. Element D, on the other hand, is
not related to the surrendered subject matter. Thus, the
reissue claim, which no longer contains C, is broadened
in an area related to the surrender, and the narrowing
via the addition of D does not save the claim
from recapture since D is not related to the surrendered
subject matter.


Reissue claims that are broader than the original
(A)the only change being made in the patent is to  
patent claims by not including the surrender-generating
correct the inventorship; and
limitation (element C, in the example given) will
 
be barred by the recapture rule even though there is  
(B)all parties are in agreement and the inventorship
narrowing of the claims not related to the surrender-
issue is not contested.
generating limitation. As stated in the decision of In re
 
Clement, 131 F.3d at 1470, 45 USPQ2d at 1165, if the  
See MPEP § 1481 for the procedure to be followed
reissue claim is broader in an aspect germane to a
to obtain a Certificate of Correction for correction of
prior art rejection, but narrower in another aspect
inventorship.
completely unrelated to the rejection, the recapture
rule bars the claim. Pannu v. Storz Instruments Inc.,
supra, then brings home the point by providing an
actual fact situation in which this scenario was held to  
be recapture.


(b)Reissue Claims are Narrower or Equal in
II.REISSUE AS A VEHICLE FOR CORRECTING
Scope, in Area Directed to Amendment/
INVENTORSHIP
Argument Made to Overcome Art Rejection
in Original Prosecution; are Broader in
Scope in Area Not Directed to Amendment/
Argument:


In this case, there is no recapture.
Where the provisions of 35 U.S.C. 256 and  
 
37
This situation is where the patent claims are
CFR 1.324 do not apply, a reissue application is
directed to combination ABCDE and the reissue
the appropriate vehicle to correct inventorship. The
claims are directed to ABDE (element C is omitted).  
failure to name the correct inventive entity is an error
Assume that the combination of ABCD was present in
in the patent which is correctable under 35 U.S.C.  
the original application as it was filed, and element E
251. The reissue oath or declaration pursuant to
was later added to define over that art. No argument
37
was ever presented as to elements A-C defining over
CFR 1.175 must state that the applicant believes
the art.  
the original patent to be wholly or partly inoperative
 
or invalid through error of a person being incorrectly
In this situation, the ABCDE combination of the
named in an issued patent as the inventor, or through
patent can be broadened (in the reissue application) to
error of an inventor incorrectly not named in an
omit element C, and thereby claim the combination of
issued
ABDE, where element E (the surrender generating
patent, and that such error arose without any
limitation) is not omitted. There would be no recapture
deceptive intention on the part of the applicant. The
in this instance. (If an argument had been presented
as to element C defining over the art, in  
addition to the addition of element E, then the
ABCDE combination could not be broadened to omit
element C and thereby claim combination of ABDE.  
This would be recapture; see the above discussion as
to surrender and recapture based upon argument.)
 
Additionally, the reissue claims are certainly permitted
to recite combination ABDEspecific (where surrender-
generating element E is narrowed). The patent
claims have been broadened in an area not directed to
the surrender (by omitting element C) and narrowed
in the area of surrender (by narrowing element E to
Especific). This is clearly permitted.
 
As another example, assume limitation C was
added to application claims AB to obtain the patent to  
ABC, and now the reissue application presents claims
to AC or ABbroadC. Such reissue claims avoid the
effect of the recapture rule because they are broader in
a way that does not attempt to reclaim what was surrendered
earlier. Mentor Corp. v. Coloplast, Inc., 998
F.2d 992, 994, 27 USPQ2d 1521, 1525 (Fed. Cir.
1993). Such claims are considered to be broader in an  
aspect not 'germane to a prior art rejection,' and thus
are not barred by recapture. Note In re Clement,
131
F.3d at 1470, 45 USPQ2d at 1165.
 
Reissue claims that are broader than the original
patent claims by deletion of a limitation or claim
requirement other than the “surrender-generating limitation”
will avoid the effect of the recapture rule,  
regardless of the nature of the narrowing in the
claims, and even if the claims are not narrowed at all
from the scope of the patent claims.




Line 2,360: Line 2,380:
   
   


(c)Reissue Claims are Narrower in Scope in
reissue oath or declaration must, as stated in 37 CFR
Area Not Directed to Amendment/Argument
1.175, also comply with 37CFR 1.63.
Made to Overcome Art Rejection in Original
Prosecution; are Broader in Scope in Area
Not Directed to the Amendment/Argument:


In this instance, there is clearly no recapture. In the  
The correction of inventorship does not enlarge the  
reissue application, there has been no change in the
scope of the patent claims. Where a reissue application  
claims related to the matter surrendered in the original
does not seek to enlarge the scope of the claims of
application for the patent.
the original patent, the reissue oath may be made and
 
sworn to, or the declaration made, by the assignee of
In this instance, element C was added to the AB
the entire interest under 37 CFR 1.172. An assignee of
combination to provide ABC and define over the art,  
part interest may not file a reissue application to correct
and the patent was issued. The reissue omits element
inventorship where the other co-owner did not
B and adds element Z, to thus claim ACZ. There is no
join in the reissue application and has not consented
recapture since the surrender generating element C  
to the reissue proceeding. See Baker Hughes Inc. v.  
has not been modified in any way. (Note, however,  
Kirk, 921 F. Supp. 801, 809, 38 USPQ2d 1885, 1892
that if, when element C was added to AB, applicant
(D.D.C. 1995). See 35 U.S.C. 251, third paragraph.
argued that the association of newly added C with B
Thus, the signatures of the inventors are not needed
provides a synergistic (unexpected) result to thus
on the reissue oath or declaration where the assignee
define over the art, then neither B nor C could be
of the entire interest signs the reissue oath/declaration.  
omitted in the reissue application.)
Accordingly, an assignee of the entire interest can add
or delete the name of an inventor by reissue (e.g., correct
inventorship from inventor A to inventors A and
B) without the original inventor’s consent. See also 37
CFR 3.71(a) (“One or more assignees as defined in
paragraph (b) of this section may, after becoming of
record pursuant to paragraph (c) of this section, conduct
prosecution of a national patent application or
reexamination proceeding to the exclusion of either
the inventive entity, or the assignee(s) previously
entitled to conduct prosecution.” Emphasis added).
Thus, the assignee of the entire interest can file a reissue
to change the inventorship to one which the
assignee believes to be correct, even though an inventor
might disagree. The protection of the assignee’s
property rights in the application and patent are statutorily
based in 35 U.S.C. 118.


(d)Reissue Claims Broader in Scope in Area
Where the name of an inventor X is to be deleted in  
Directed to Amendment/Argument Made to
a reissue application to correct inventorship in a
Overcome Art Rejection in Original
patent, and inventor X has not assigned his/her rights
Prosecution; but Reissue Claims Retain, in
to the patent, inventor X has an ownership interest in  
Broadened Form, the Limitation(s) Argued/
the patent. Inventor X must consent to the reissue
Added to Overcome Art Rejection in  
(37
Original Prosecution:
CFR 1.172(a)), even though inventor X’s name is
 
being deleted as an inventor and need not sign the  
Assume the combination AB was originally
reissue oath or declaration. If inventor X has assigned
claimed in the application, and was amended in reply
his/her rights to the patent, then inventor X’s assignee
to an art rejection to add element C and thus provide
must consent. In addition to providing the consent,
the combination ABC (after which the patent issued).
even though inventor X does not sign the reissue oath
A reissue application is then filed, and the reissue  
or declaration as an inventor (since the correction of  
application claims are directed to the combination
inventorship does not enlarge the scope of the patent
ABCbroadened. The ABCbroadened claims are narrowed
claims), the assignee of the entire interest must sign
in scope when compared with the canceled claim subject
the reissue oath or declaration as assignee (37 CFR
matter AB, because of the addition of Cbroadened.
1.172(a)). Thus, if inventor X has not assigned his/her
Thus, the claims retain, in broadened form, the limitation
patent rights, inventor X’s signature must be included
argued/added to overcome art rejection in original
in the reissue oath or declaration as the assignee. If
prosecution. There is no recapture, since
inventor X has assigned his/her patent rights, inventor
ABCbroadened is narrower than canceled claim subject
X’s assignee must sign the reissue oath or declaration
matter AB in an area related to the surrender. This is
as the assignee. For example, a patent to inventors X
so, because it was element C that was added in the  
and Y has no assignee. A reissue application is filed
application to overcome the art. See Ex Parte Eggert,  
by inventor Y to delete the name of inventor X as an
supra.
inventor. 37 CFR 1.172(a) provides that a reissue oath
 
or declaration may be made by the assignee/owners of  
II.REISSUE TO TAKE ADVANTAGE OF
the entire interest, rather than by the inventors, where
35
the scope of the claims is not to be enlarged. However,
U.S.C. 103(b):
since inventor X has not assigned his/her patent  
 
rights, inventor X must sign the reissue oath or declaration
A patentee may file a reissue application to permit
as one of the owners, and consent to the filing
consideration of process claims which qualify for
of the reissue application by inventor Y. See MPEP  
35
U.S.C. 103(b) treatment if a patent is granted on an
application entitled to the benefit of 35 U.S.C. 103(b),  
without an election having been made as a result of..
error without deceptive intent. See MPEP  
§
§
   
   
706.02(n). This is not to be considered a recapture.
1410.01.
The addition of process claims, however, will
generally be considered to be a broadening of the
invention (Ex parte Wikdahl, 10 USPQ2d 1546 (Bd.
Pat. App. & Inter. 1989)), and such addition must be
applied for within two years of the grant of the original
patent. See also MPEP § 1412.03 as to broadened
claims.


III.REISSUE FOR ARTICLE CLAIMS
Where a reissue to correct inventorship also
WHICH ARE FUNCTIONAL DESCRIPTIVE
changes the claims to enlarge the scope of the patent
MATERIAL STORED ON A COMPUTER-
claims, the signature of all the inventors is needed.  
READABLE MEDIUM:
However, if an inventor refuses to sign the reissue
 
oath or declaration because he or she believes the
A patentee may file a reissue application to permit
change in inventorship (to be effected) is not correct,
consideration of article of manufacture claims which
the reissue application can still be filed with a petition
are functional descriptive material stored on a computer-
under 37 CFR 1.47 without that inventor’s signature
readable medium, where these article claims
provided the written consent of all owners/assignees
correspond to the process or machine claims which
as required by 37 CFR 1.172(a) is also submitted. In
have been patented. The error in not presenting claims
the situation where a patent to inventors X and Y has
to this statutory category of invention (the “article”
no assignee and a reissue application is filed by inventor
claims) must have been made as a result of error without
Y to delete the name of inventor X as an inventor
deceptive intent. The addition of these “article”
and to broaden the patent. Inventor X refuses to sign
claims will generally be considered to be a broadening
the reissue oath or declaration and refuses to provide
of the invention (Ex parte Wikdahl, 10 USPQ2d
the consent as required by 37 CFR 1.172(a). In this
1546 (Bd. Pat. App. & Inter. 1989)), and such addition
instance, a 37 CFR 1.47 petition would not be appropriate
must be applied for within two years of the grant of  
to permit the filing of the reissue application
the original patent. See also MPEP § 1412.03 as to
since the consent requirement of 37 CFR 1.172(a) for
broadened claims.
each owner/assignee is not met. Resort to the courts
would be required to delete the name of inventor X as
an inventor where X will not consent to the filing of a  
reissue application. As stated in the second paragraph
of 35 U.S.C. 256, “[t]he court before which such matter
is called in question may order correction of the  
patent on notice and hearing of all parties concerned
and the Director shall issue a certificate accordingly.


IV.REJECTION BASED UPON RECAPTURE:
The reissue application with its reissue oath or declaration
 
under 37 CFR 1.175 provides a complete
 
mechanism to correct inventorship. See A.F. Stoddard
Reissue claims which recapture surrendered subject
matter should be rejected using form paragraph 14.17.
 
¶ 14.17 Rejection, 35 U.S.C. 251, Recapture
 
Claim[1] rejected under 35 U.S.C. 251 as being an improper
recapture of broadened claimed subject matter surrendered in the
application for the patent upon which the present reissue is based.  
See Pannu v. Storz Instruments Inc., 258 F.3d 1366, 59 USPQ2d
1597 (Fed. Cir. 2001); Hester Industries, Inc. v. Stein, Inc., 142
F.3d 1472, 46 USPQ2d 1641 (Fed. Cir. 1998); In re Clement, 131




Line 2,472: Line 2,489:
   
   


F.3d 1464, 45 USPQ2d 1161 (Fed. Cir. 1997); Ball Corp. v.  
& Co. v. Dann, 564 F.2d at 567, 195 USPQ at 106. A
United States, 729 F.2d 1429, 1436, 221 USPQ 289, 295 (Fed. Cir.  
request under 37
1984). A broadening aspect is present in the reissue which was not
CFR 1.48 or a petition under 37 CFR
present in the application for patent. The record of the application
1.324 cannot be used to correct the inventorship of a
for the patent shows that the broadening aspect (in the reissue)
reissue application. If a request under 37 CFR 1.48 or
relates to claim subject matter that applicant previously surrendered
a petition under 37 CFR 1.324 is filed in a reissue
during the prosecution of the application. Accordingly, the  
application, the request or petition should be dismissed
narrow scope of the claims in the patent was not an error within
and the processing or petition fee refunded.  
the meaning of 35 U.S.C. 251, and the broader scope of claim subject
The material submitted with the request or petition
matter surrendered in the application for the patent cannot be
should then be considered to determine if it complies
recaptured by the filing of the present reissue application.
with 37 CFR 1.175. If the material submitted with the  
request or petition does comply with the requirements
of 37 CFR 1.175 (and the reissue application is otherwise
in order), the correction of inventorship will be
permitted as a correction of an error in the patent  
under 35 U.S.C. 251.


[2]
Where a reissue application seeks to correct inventorship
in the patent and the inventors are required to
sign the reissue oath or declaration (rather than an
assignee of the entire interest under 37 CFR 1.172)
due to a broadening of any claims of the original
patent, the correct inventive entity must sign the reissue
oath or declaration. Where an inventor is being
added in a reissue application to correct inventorship
in a patent, the inventor being added must sign the
reissue oath or declaration together with the inventors
previously designated on the patent. For example, a
reissue application is filed to correct the inventorship
from inventors A and B (listed as inventors on the
patent) to inventors A, B, and C. Inventor C is the
inventor being added. In such a case, A, B, and C are
the correct inventors, and accordingly, each of A, B,
and C must sign the reissue oath or declaration.
Where an inventor is being deleted in a reissue application
to correct inventorship in a patent and the
inventors are required to sign the oath or declaration
due to a broadening of any claims of the original
patent, the inventor being deleted need not sign the
reissue oath or declaration. The reissue oath or declaration
must be signed by the correct inventive entity.
For example, a reissue application is filed to correct
inventorship from inventors A, B, and C (listed as
inventors on the patent) to inventors A and B. Inventor
C is being deleted as a named inventor. In such a
case, A and B are the correct inventors, and accordingly,
inventors A and B must sign the reissue oath or
declaration but inventor C need not sign the reissue
oath or declaration.


Examiner Note:
==1413 Drawings==


In bracket 2, the examiner should explain the specifics of why
37 CFR 1.173. Reissue specification, drawings, and  
recapture exists, including an identification of the omitted/broadened
amendments.
claim limitations in the reissue which provide the “broadening
aspect” to the claim(s), and where in the original application
the narrowed claim scope was presented/argued to obviate a rejection/
objection. See MPEP §
1412.02.  


See the recapture-analysis flow chart which follows
for assistance in determining whether recapture is
present, consistent with the case law discussed above.




(a)(2) Drawings. Applicant must submit a clean copy of each
drawing sheet of the printed patent at the time the reissue application
is filed. If such copy complies with § 1.84, no further drawings
will be required. Where a drawing of the reissue application
is to include any changes relative to the patent being reissued, the
changes to the drawing must be made in accordance with paragraph
(b)(3) of this section. The Office will not transfer the drawings
from the patent file to the reissue application.






Flowchart - Reissue Recapture - Determining its presence or absence
A clean copy (e.g., good quality photocopies free of
any extraneous markings) of each drawing sheet of
the printed patent must be supplied by the applicant at
the time of filing of the reissue application. If the copies
meet the requirements of 37 CFR 1.84, no further
formal drawings will be required. New drawing sheets
are not to be submitted, unless some change is made
in the original patent drawings. Such changes must be
made in accordance with 37 CFR 1.173(b)(3).
 
The prior reissue practice of transferring drawings
from the patent file has been eliminated, since clean
photocopies of the printed patent drawings are acceptable
for use in the printing of the reissue patent.
 
AMENDMENT OF DRAWINGS
 
37 CFR 1.173. Reissue specification, drawings, and
amendments.
 
 






(b)(3) Drawings. One or more patent drawings shall be
amended in the following manner: Any changes to a patent drawing
must be submitted as a replacement sheet of drawings which
shall be an attachment to the amendment document. Any replacement
sheet of drawings must be in compliance with § 1.84 and
shall include all of the figures appearing on the original version of
the sheet, even if only one figure is amended. Amended figures
must be identified as “Amended,” and any added figure must be
identified as “New.” In the event that a figure is canceled, the figure
must be surrounded by brackets and identified as “Canceled.”
All changes to the drawing(s) shall be explained, in detail, beginning
on a separate sheet accompanying the papers including the
amendment to the drawings.






1412.03Broadening Reissue Claims
The provisions of 37 CFR
[R-3]
1.173(b)(3) govern the
manner of making amendments (changes) to the


35 U.S.C. 251 prescribes a 2-year limit for filing
applications for broadening reissues:


No reissue patent shall be granted enlarging the scope of
the original patent unless applied for within two years
from the grant of the original patent.






I. MEANING OF “BROADENED REISSUE
drawings in a reissue application. The following guidance
CLAIM”
is provided as to the procedure for amending
drawings:


A broadened reissue claim is a claim which
(A)Amending the original or printed patent drawing
enlarges the scope of the claims of the patent, i.e., a
sheets by physically changing or altering them is  
claim which is greater in scope than each and every
not permitted. Any request to do so should be denied.  
claim of the original patent. If a disclaimer is filed in
the patent prior to the filing of a reissue application,
the disclaimed claims are not part of the “original
patent” under 35 U.S.C. 251. The Court in Vectra Fitness
Inc. v. TNWK Corp., 49 USPQ2d 1144, 1147,
162 F.3d 1379, 1383 (Fed. Cir. 1998) held that a reissue
application violated the statutory prohibition
under 35 U.S.C. 251 against broadening the scope of
the patent more than 2 years after its grant because the
reissue claims are broader than the claims that remain
after the disclaimer, even though the reissue claims
are narrower than the claims that were disclaimed by
the patentee before reissue. The reissue application
was bounded by the claims remaining in the patent
after a disclaimer is filed.A claim of a reissue application
enlarges the scope of the claims of the patent if it
is broader in at least one respect, even though it may
be narrower in other respects.  


A claim in the reissue which includes subject matter
(B)Where a change to the drawings is desired,
not covered by the patent claims enlarges the scope
applicant must submit a replacement sheet for each
of the patent claims. For example, if any amended or
sheet of drawings containing a Figure to be revised.  
newly added claim in the reissue contains within its
Any replacement sheet must comply with 37 CFR
scope any conceivable product or process which
1.84 and include all of the figures appearing on the  
would not have infringed the patent, then that reissue
original version of the sheet, even if only one figure is
claim would be broader than the patent claims. Tillotson,  
being amended. Each figure that is amended must be
Ltd. v. Walbro Corp., 831 F.2d 1033, 1037 n.2,
identified by placing the word “Amended” at the bottom
4
of that figure. Any added figure must be identified
USPQ2d 1450, 1453 n.2 (Fed. Cir. 1987); In re
as “New.In the event that a figure is canceled,
Ruth, 278 F.2d 729, 730, 126 USPQ 155, 156 (CCPA
the figure must be identified as “Canceled” and also
1960); In re Rogoff, 261 F.2d 601, 603, 120 USPQ
surrounded by brackets. All changes to the figure(s)
185, 186 (CCPA 1958). A claim which reads on
must be explained, in detail, beginning on a separate
something which the original claims do not is a broadened
sheet which accompanies the papers including the  
claim. A claim would be considered a broadening
amendment to the drawings.
claim if the patent owner would be able to sue any
party for infringement who previously could not have
been sued for infringement. Thus, where the original
patent claims only the process, and the reissue application
adds (for the first time) product claims, the
scope of the claims has been broadened since a party
could not be sued for infringement of the product
based on the claims of the original patent.


The addition of combination claims in a reissue
(C)If desired, applicant may include a marked-up
application where only subcombination claims were
copy of any amended drawing figure, including annotations
present in the original patent could be a broadening of
indicating the changes made. Such a marked-
the invention. The question which must be resolved in
up copy must be clearly labeled as “Annotated
this case is whether the combination claims added in
Marked-up Drawings”, and it must be presented in the  
the reissue would be for “the invention as claimed” in
amendment or remarks section that explains the  
the original patent. See Ex parte Wikdahl, 10 USPQ2d
change to the drawings.  
at 1549. The newly added combination claims should
be analyzed to determine whether they contain every
limitation of the subcombination of any claim of the
original patent. If the combination claims (added in  
the reissue) contain every limitation of the subcombination
(which was claimed in the original application),
then infringement of the combination must also
result in infringement of the subcombination. Accordingly,
the patent owner could not, if a reissue patent
issues with the combination claims, sue any new
party for infringement who could not have been sued
for infringement of the original patent. Therefore,
broadening does not exist, in spite of the addition of
the combination.


In addition, the examiner may desire a marked-up
copy of any amended drawing figure, and so state in
an Office action. A marked-up copy of any amended
drawing figure, including annotations indicating the
changes made, must be provided when required by the
examiner.


(D)For each proper new drawing sheet being
added, the new sheet should be inserted after the
existing drawing sheets. For each proper  drawing
sheet being added which replaces an existing drawing
sheet, the existing sheet should be canceled by
placing the sheet face down in the file and placing a
large “X” on the back of the sheet. The new sheet
should be inserted in place of the turned over existing
sheet.


II. SCOPE OF DEPENDENT CLAIM
(E)If any drawing change  is not  approved,
ENLARGED-NOT BROADENING
or if any submitted sheet of formal drawings is not
entered, the examiner will so inform the reissue applicant
in the next Office action, and the examiner will
set forth the reasons for same.


As pointed out above, a claim will be considered a
==1414 Content of Reissue Oath/Declaration==
broadened reissue claim when it is greater in scope
than each and every claim of the patent to be reissued.
A corollary of this is that a claim which has
been broadened in a reissue as compared to its scope
in the patent is not a broadened reissue claim if it is
narrower than, or equal in scope to, any other claim
which appears in the patent. A common example of
this is where dependent claim 2 is broadened via the
reissue (other than the addition of a process step to
convert an intermediate to a final product as discussed
in the preceding subsection), but independent claim 1
on which it is based is not broadened. Since a dependent
claim is construed to contain all the limitations of
the claim upon which it depends, claim 2 must be at


37 CFR 1.175. Reissue oath or declaration.


(a)The reissue oath or declaration in addition to complying
with the requirements of § 1.63, must also state that:


(1)The applicant believes the original patent to be wholly
or partly inoperative or invalid by reason of a defective specification
or drawing, or by reason of the patentee claiming more or less
than the patentee had the right to claim in the patent, stating at
least one error being relied upon as the basis for reissue; and


(2)All errors being corrected in the reissue application up
 
to the time of filing of the oath or declaration under this paragraph
least as narrow as claim 1 and is thus not a broadened
arose without any deceptive intention on the part of the applicant.
reissue claim.


(b)(1) For any error corrected, which is not covered by the
oath or declaration submitted under paragraph (a) of this section,
applicant must submit a supplemental oath or declaration stating
that every such error arose without any deceptive intention on the
part of the applicant. Any supplemental oath or declaration
required by this paragraph must be submitted before allowance
and may be submitted:


(i) With any amendment prior to allowance; or


III. NEW CATEGORY OF INVENTION
(ii) In order to overcome a rejection under 35
ADDED IN REISSUE - GENERALLY
U.S.C. 251
IS BROADENING
made by the examiner where it is indicated that the submission of
a supplemental oath or declaration as required by this paragraph
will overcome the rejection.


The addition of process claims as a new category of
(2)For any error sought to be corrected after allowance, a
invention to be claimed in the patent (i.e., where there
supplemental oath or declaration must accompany the requested
were no method claims present in the original patent)
correction stating that the error(s) to be corrected arose without
is generally considered as being a broadening of the  
any deceptive intention on the part of the applicant.  
invention. See Ex parte Wikdahl, 10 USPQ2d 1546
(Bd. Pat. App. & Inter. 1989). A situation may arise,
however, where the reissue application adds a limitation
(or limitations) to process A of making the product
A claimed in the original patent claims. For
example:


(1)a process of using the product A (made by the  
(c)Having once stated an error upon which the reissue is
process of the original patent) to make a product B,
based, as set forth in paragraph (a)(1), unless all errors previously
disclosed but not claimed in the original patent; or
stated in the oath or declaration are no longer being corrected, a
subsequent oath or declaration under paragraph (b) of this section
need not specifically identify any other error or errors being corrected.


(2)a process of using the product A to carry out a
process B disclosed but not claimed in the original
patent.


Although this amendment of the claims adds a
(d)The oath or declaration required by paragraph (a) of this  
method of making product B or adds a method of  
section may be submitted under the provisions of § 1.53(f).
using product A, this is not broadening (i.e., this is not
 
an enlargement of the scope of the original patent)  
(e)The filing of any continuing reissue application which
because the “newly claimed invention” contains all
does not replace its parent reissue application must include an
the limitations of the original patent claim(s).
oath or declaration which, pursuant to paragraph (a)(1) of this section,
identifies at least one error in the original patent which has
not been corrected by the parent reissue application or an earlier
reissue application. All other requirements relating to oaths or
declarations must also be met.
 
The reissue oath/declaration is an essential part of a
reissue application and must be filed with the application,
or within the time period set under 37 CFR
1.53(f) along with the required surcharge as set forth
in 37 CFR 1.16(f) in order to avoid abandonment.
 
The question of the sufficiency of the reissue oath/
declaration filed under 37 CFR 1.175 must in each
case be reviewed and decided personally by the primary
examiner.






IV. WHEN A BROADENED CLAIM CAN BE
PRESENTED
A broadened claim can be presented within two
years from the grant of the original patent in a reissue
application. In addition, a broadened claim can be
presented after two years from the grant of the original
patent in a broadening reissue application
which was filed within two years from the grant.
Where any intent to broaden is indicated in the reissue
application within the two years from the patent grant,
a broadened claim can subsequently be presented in
the reissue after the two year period. Thus, a broadened
claim may be presented in a reissue application
after the two years, even though the broadened claim
presented after the two years is different than the
broadened claim presented within the two years.
Finally, if intent to broaden is indicated in a parent
reissue application within the two years, a broadened
claim can be presented in a continuing (continuation
or divisional) reissue application after the two year
period. In any other situation, a broadened claim cannot
be presented, and the examiner should check carefully
for the improper presentation of broadened
claims.
A reissue application filed on the 2-year anniversary
date from the patent grant is considered to be
filed within 2 years of the patent grant. See Switzer v.
Sockman, 333 F.2d 935, 142 USPQ 226 (CCPA 1964)
for a similar rule in interferences.


See also the following cases which pertain to
broadened reissues:


In re Graff, 111 F.3d 874, 877, 42 USPQ2d 1471,
Reissue oaths or declarations must contain the following:
1473-74 (Fed. Cir. 1997) (Broadened claims in a continuing
reissue application were properly rejected
under 35 U.S.C. 251 because the proposal for broadened
claims was not made (in the parent reissue application)
within two years from the grant of the original
patent and the public was not notified that broadened
claims were being sought until after the two-year
period elapsed.);


In re Fotland, 779 F.2d 31, 228 USPQ 193 (Fed.
Cir. 1985), cert. denied, 476 U.S. 1183 (1986) (The
failure by an applicant to include an oath or declaration
indicating a desire to seek broadened claimswithin two years of the patent grant will bar a subsequent
attempt to broaden the claims after the two year
limit. Under the former version of 37 CFR 1.175 (the
former 37 CFR 1.175(a)(4)), applicant timely sought
a “no-defect” reissue, but the Court did not permit an
attempt made beyond the two year limit to convert the
reissue into a broadening reissue. In this case, applicant
did not indicate any intent to broaden within the
two years.);


In re Bennett, 766 F.2d 524, 528, 226 USPQ 413,
(A)A statement that the applicant believes the
416 (Fed. Cir. 1985) (en banc) (A reissue application
original patent to be wholly or partly inoperative or
with broadened claims was filed within two years of  
invalid—
the patent grant; however, the declaration was executed
 
by the assignee rather than the inventor. The
(1)by reason of a defective specification or
Federal Circuit permitted correction of the improperly
drawing, or
executed declaration to be made more than two years
 
after the patent grant.);
(2)by reason of the patentee claiming more or
less than patentee had the right to claim in the patent;  


In re Doll, 419 F.2d 925, 928, 164 USPQ 218, 220
(B)A statement of at least one error which is
(CCPA 1970) (If the reissue application is timely filed
relied upon to support the reissue application, i.e., as
within two years of the original patent grant and the  
the basis for the reissue;


(C)A statement that all errors which are being
corrected in the reissue application up to the time of
filing of the oath/declaration arose without any deceptive
intention on the part of the applicant; and


(D)The information required by 37 CFR 1.63.


These elements will now be discussed:


I.A STATEMENT THAT THE APPLICANT
BELIEVES THE ORIGINAL PATENT TO
BE WHOLLY OR PARTLY INOPERATIVE
OR INVALID BY REASON OF A DEFECTIVE
SPECIFICATION OR DRAWING,
OR BY REASON OF THE PATENTEE
CLAIMING MORE OR LESS THAN PATENTEE
HAD THE RIGHT TO CLAIM IN
THE PATENT.


applicant indicates in the oath or declaration that the
In order to satisfy this requirement, a declaration  
claims will be broadened, then applicant may subsequently
can state as for example:
broaden the claims in the pending reissue
prosecution even if the additional broadening occurs
beyond the two year limit.).


Form paragraphs 14.12 and 14.13 may be used in
rejections based on improper broadened reissue
claims.


¶ 14.12 Rejection, 35 U.S.C. 251, Broadened Claims After
Two Years


Claim [1] rejected under 35 U.S.C. 251 as being broadened in
1. “Applicant believes the original patent to be
a reissue application filed outside the two year statutory period.
partly inoperative or invalid by reason of a defective
[2] A claim is broader in scope than the original claims if it contains
specification or drawing.
within its scope any conceivable product or process which
would not have infringed the original patent. A claim is broadened
if it is broader in any one respect even though it may be narrower
in other respects.


Examiner Note:


The claim limitations that broaden the scope should be identified
and explained in bracket 2. See MPEP §§ 706.03(x) and
1412.03.


¶ 14.13 Rejection, 35 U.S.C. 251, Broadened Claims Filed
2. “Applicant believes the original patent to be
by Assignee
partly inoperative or invalid by reason of the patentee
claiming more than patentee had a right to claim in
the patent.”


Claim [1] rejected under 35 U.S.C. 251 as being improperly
broadened in a reissue application made and sworn to by the
assignee and not the patentee. [2]A claim is broader in scope than
the original claims if it contains within its scope any conceivable
product or process which would not have infringed the original
patent. A claim is broadened if it is broader in any one respecteven though it may be narrower in other respects.


Examiner Note:


The claim limitations that broaden the scope should be identified
3. “Applicant believes the original patent to be  
and explained in bracket 2. See MPEP §§ 706.03(x) and
partly inoperative or invalid by reason of the patentee
1412.03.
claiming less than patentee had a right to claim in the
patent.


Where the specification or drawing is defective andpatentee claimed both more and less than patentee had
the right to claim in the patent, then all three statements
should be included in the reissue oath/declaration.
A statement that the original patent is “wholly
or partly inoperative or invalid” (emphasis added) by
reason of the patentee “claiming more or less than the
patentee had the right to claim in the patent” (emphasis
added) is improper since a claim cannot claim
“more or less” at the same time. Where, however, a
given independent claim is considered to be overly
broad, and another independent claim is considered to
be overly narrow, patentee has claimed both more andless than he or she had a right to claim. In such an
instance, both the second and third above-quoted
statements would be used. See MPEP § 1412.04 for
an exemplary declaration statement when the error
being corrected is an error in inventorship.


The above examples will be sufficient to satisfy this
requirement without any further statement.


V. BROADENING REISSUE - OATH/
It should be noted that the reissue oath/declaration
DECLARATION REQUIREMENTS
must also satisfy the requirement for a statement of at
least one error being relied upon as the basis for reissue,
in the manner set forth in subsection II. below.


A broadening reissue application must be applied
Form paragraph 14.01 may be used where the reissue  
for by all of the inventors (patentees), that is, the original  
oath/declaration does not provide the required
reissue oath or declaration must be signed by all
statement as to applicant’s belief that the original  
of the inventors. See also MPEP § 1414. If a supplemental
patent is wholly or partly inoperative or invalid.  
oath or declaration in a broadening reissue
 
application is needed in the application in order to fulfill
¶ 14.01 Defective Reissue Oath/Declaration, 37 CFR  
the requirements of 37 CFR 1.175, the supplemental
1.175(a)(1) - No Statement of Defect in the Patent
reissue oath or declaration must be signed by all of  
the inventors. See In re Hayes, 53 USPQ2d 1222
(Comm’r Pat. 1999) and MPEP § 1414.01.


1412.04Correction of Inventorship [R-5]
The reissue oath/declaration filed with this application is
defective because it fails to contain the statement required under
37 CFR 1.175(a)(1) as to applicant’s belief that the original patent
is wholly or partly inoperative or invalid. See 37 CFR 1.175(a)(1)
and see MPEP §
1414. [1]


The correction of misjoinder of inventors has been
Examiner Note:
held to be a ground for reissue. See Ex parte Scudder,
169 USPQ 814, 815 (Bd. App. 1971) wherein the
Board held that 35 U.S.C. 251 authorizes reissue
applications to correct misjoinder of inventors where35 U.S.C. 256 is inadequate. See also A.F. Stoddard &
Co. v. Dann, 564 F.2d 556, 567 n.16, 195 USPQ 97,
106 n.16 (D.C. Cir. 1977) wherein correction of
inventorship from sole inventor A to sole inventor B
was permitted in a reissue application. The court
noted that reissue by itself is a vehicle for correcting
inventorship in a patent.


I.CERTIFICATE OF CORRECTION AS A
1.Use this form paragraph when applicant: (a) fails to allege
VEHICLE FOR CORRECTING INVEN-
that the original patent is inoperative or invalid and/or (b) fails to
TORSHIP
state the reason of a defective specification or drawing, or of patentee
claiming more or less than patentee had the right to claim in
the patent . In bracket 1, point out the specific defect to applicant
by using the language of (a) and/or (b), as it is appropriate.


While reissue is a vehicle for correcting inventorship
2.Form paragraph 14.14 must follow this form paragraph.
in a patent, correction of inventorship should be
effected under the provisions of 35 U.S.C. 256 and
37
CFR 1.324 by filing a request for a Certificate of
Correction if:


(A)the only change being made in the patent is to
II.A STATEMENT OF AT LEAST ONE ERROR
correct the inventorship; and
WHICH IS RELIED UPON TO SUPPORT
THE REISSUE APPLICATION (I.E.,
THE BASIS FOR THE REISSUE).


(B)all parties are in agreement and the inventorship
(A)A reissue applicant must acknowledge the
issue is not contested.
existence of an error in the specification, drawings, or
claims, which error causes the original patent to be


See MPEP § 1481 for the procedure to be followed
to obtain a Certificate of Correction for correction of
inventorship.


II.REISSUE AS A VEHICLE FOR CORRECTING
INVENTORSHIP


Where the provisions of 35 U.S.C. 256 and
37
CFR 1.324 do not apply, a reissue application is
the appropriate vehicle to correct inventorship. The
failure to name the correct inventive entity is an error
in the patent which is correctable under 35 U.S.C.
251. The reissue oath or declaration pursuant to
37
CFR 1.175 must state that the applicant believes
the original patent to be wholly or partly inoperative
or invalid through error of a person being incorrectly
named in an issued patent as the inventor, or through
error of an inventor incorrectly not named in an
issued
patent, and that such error arose without any
deceptive intention on the part of the applicant. The




defective. In re Wilder, 736 F.2d 1516, 222 USPQ 369
(Fed. Cir. 1984). A change or departure from the original
specification or claims represents an “error” in
the original patent under 35 U.S.C. 251. See MPEP
§
1402 for a discussion of grounds for filing a reissue
that may constitute the “error” required by 35 U.S.C.
251. Not all changes with respect to the patent constitute
the “error” required by 35 U.S.C. 251.


(B)Applicant need only specify in the reissue
oath/declaration one of the errors upon which reissue
is based. Where applicant specifies one such error,
this requirement of a reissue oath/declaration is satisfied.
Applicant may specify more than one error.


Where more than one error is specified in the
oath/declaration and some of the designated “errors”
are found to not be “errors” under 35 U.S.C. 251, any
remaining error which is an error under 35 U.S.C. 251will still support the reissue.


reissue oath or declaration must, as stated in 37 CFR
The “at least one error” which is relied upon to
1.175, also comply with 37CFR 1.63.
support the reissue application must be set forth in the
oath/declaration. It is not necessary, however, to point
out how (or when) the error arose or occurred. Further,  
it is not necessary to point out how (or when) the
error was discovered. If an applicant chooses to point
out these matters, the statements directed to these
matters will not be reviewed by the examiner, and the
applicant should be so informed in the next Office
action. All that is needed for the oath/declaration
statement as to error is the identification of “at least
one error” relied upon.


The correction of inventorship does not enlarge the  
In identifying the error, it is sufficient that the  
scope of the patent claims. Where a reissue application
reissue oath/declaration identify a single word,
does not seek to enlarge the scope of the claims of
phrase, or expression in the specification or in an original
the original patent, the reissue oath may be made and
claim, and how it renders the original patent
sworn to, or the declaration made, by the assignee of
wholly or partly inoperative or invalid. The corresponding
the entire interest under 37 CFR 1.172. An assignee of
corrective action which has been taken to  
part interest may not file a reissue application to correct  
correct the original patent need not be identified in the  
inventorship where the other co-owner did not  
oath/declaration. If the initial reissue oath/declaration
join in the reissue application and has not consented
“states at least one error” in the original patent, and, in
to the reissue proceeding. See Baker Hughes Inc. v.
addition, recites the specific corrective action taken in
Kirk, 921 F. Supp. 801, 809, 38 USPQ2d 1885, 1892
the reissue application, the oath/declaration would be
(D.D.C. 1995). See 35 U.S.C. 251, third paragraph.
considered acceptable, even though the corrective
Thus, the signatures of the inventors are not needed
action statement is not required.
on the reissue oath or declaration where the assignee
 
of the entire interest signs the reissue oath/declaration.
(C)It is not sufficient for an oath/declaration to
Accordingly, an assignee of the entire interest can add
merely state “this application is being filed to correct
or delete the name of an inventor by reissue (e.g., correct
errors in the patent which may be noted from the  
inventorship from inventor A to inventors A and  
changes made in the disclosure.” Rather, the oath/declaration  
B) without the original inventor’s consent. See also 37
must specifically identify an error. In addition,  
CFR 3.71(a) (“One or more assignees as defined in
it is not sufficient to merely reproduce the claims
paragraph (b) of this section may, after becoming of
with brackets and underlining and state that such will
record pursuant to paragraph (c) of this section, conduct
identify the error. See In re Constant, 827 F.2d 728,
prosecution of a national patent application or
729, 3 USPQ2d 1479 (Fed. Cir.), cert. denied, 484
reexamination proceeding to the exclusion of either
U.S. 894 (1987). Any error in the claims must be
the inventive entity, or the assignee(s) previously
identified by reference to the specific claim(s) and the  
entitled to conduct prosecution.” Emphasis added).  
specific claim language wherein lies the error.
Thus, the assignee of the entire interest can file a reissue
to change the inventorship to one which the  
assignee believes to be correct, even though an inventor
might disagree. The protection of the assignee’s
property rights in the application and patent are statutorily
based in 35 U.S.C. 118.


Where the name of an inventor X is to be deleted in
A statement of “…failure to include a claim
a reissue application to correct inventorship in a  
directed to…” and then presenting a newly added
patent, and inventor X has not assigned his/her rights
claim, would not be considered a sufficient “error”
to the patent, inventor X has an ownership interest in
statement since applicant has not pointed out what the  
the patent. Inventor X must consent to the reissue
other claims lacked that the newly added claim has, or  
(37
vice versa. Such a statement would be no better than
CFR 1.172(a)), even though inventor X’s name is
saying in the reissue oath or declaration that “this
being deleted as an inventor and need not sign the
application is being filed to correct errors in the patent
reissue oath or declaration. If inventor X has assigned
which may be noted from the change made by adding
his/her rights to the patent, then inventor X’s assignee
new claim 10.” In both cases, the error has not been
must consent. In addition to providing the consent,  
identified.
even though inventor X does not sign the reissue oath
or declaration as an inventor (since the correction of
inventorship does not enlarge the scope of the patent
claims), the assignee of the entire interest must sign
the reissue oath or declaration as assignee (37 CFR
1.172(a)). Thus, if inventor X has not assigned his/her
patent rights, inventor X’s signature must be included
in the reissue oath or declaration as the assignee. If
inventor X has assigned his/her patent rights, inventor
X’s assignee must sign the reissue oath or declaration
as the assignee. For example, a patent to inventors X
and Y has no assignee. A reissue application is filed  
by inventor Y to delete the name of inventor X as an
inventor. 37 CFR 1.172(a) provides that a reissue oath
or declaration may be made by the assignee/owners of
the entire interest, rather than by the inventors, where
the scope of the claims is not to be enlarged. However,
since inventor X has not assigned his/her patent
rights, inventor X must sign the reissue oath or declaration
as one of the owners, and consent to the filing
of the reissue application by inventor Y. See MPEP
§
1410.01.


Where a reissue to correct inventorship also
(D)Where a continuation reissue application is
changes the claims to enlarge the scope of the patent
filed with a copy of the reissue oath/declaration from
claims, the signature of all the inventors is needed.
the parent reissue application, and the parent reissue  
However, if an inventor refuses to sign the reissue  
application is not to be abandoned, the reissue oath/
oath or declaration because he or she believes the
declaration should be accepted by the Office of Initial
change in inventorship (to be effected) is not correct,  
Patent Examination without further evaluation, since
the reissue application can still be filed with a petition
it is an oath/declaration, albeit improper under
under 37 CFR 1.47 without that inventor’s signature
35
provided the written consent of all owners/assignees
U.S.C. 251. The examiner should, however, reject
as required by 37 CFR 1.172(a) is also submitted. In
the claims of the continuation reissue application  
the situation where a patent to inventors X and Y has
under 35 U.S.C. 251 as being based on an oath/declaration
no assignee and a reissue application is filed by inventor
that does not identify an error being corrected
Y to delete the name of inventor X as an inventor
by the continuation reissue application, and should
and to broaden the patent. Inventor X refuses to sign
require a new oath/declaration. 37 CFR 1.175(e)  
the reissue oath or declaration and refuses to provide
states that “the filing of any continuing reissue application
the consent as required by 37 CFR 1.172(a). In this
which does not replace its parent reissue application  
instance, a 37 CFR 1.47 petition would not be appropriate
must include an oath or declaration, which
to permit the filing of the reissue application  
pursuant to [37 CFR 1.175(a)(1)], identifies at least
since the consent requirement of 37 CFR 1.172(a) for
one error in the original patent which has not been
each owner/assignee is not met. Resort to the courts
corrected by the parent reissue application or an earlier
would be required to delete the name of inventor X as
reissue application.” One of form paragraphs
an inventor where X will not consent to the filing of a
14.01.01 through 14.01.03 may be used.
reissue application. As stated in the second paragraph
of 35 U.S.C. 256, “[t]he court before which such matter
is called in question may order correction of the
patent on notice and hearing of all parties concerned
and the Director shall issue a certificate accordingly.


The reissue application with its reissue oath or declaration  
Where a continuation reissue application is filed
under 37 CFR 1.175 provides a complete
with a copy of the reissue oath/declaration from the
mechanism to correct inventorship. See A.F. Stoddard
parent reissue application, and the parent reissue
application is, or will be abandoned, the copy of the
reissue oath/declaration should be accepted by OIPE,
and the examiner should check to ensure that the oath/
declaration identifies an error which is still being corrected
in the continuation application. If a preliminary
amendment was filed with the continuation reissue




Line 2,964: Line 2,970:
   
   


& Co. v. Dann, 564 F.2d at 567, 195 USPQ at 106. A
application, the examiner should check for the need of
request under 37
a supplemental reissue oath/declaration. Pursuant to  
CFR 1.48 or a petition under 37 CFR
37 CFR 1.175 (b)(1), for any error corrected via the  
1.324 cannot be used to correct the inventorship of a
preliminary amendment which is not covered by the  
reissue application. If a request under 37 CFR 1.48 or
oath or declaration submitted in the parent reissue
a petition under 37 CFR 1.324 is filed in a reissue
application, applicant must submit a supplemental
application, the request or petition should be dismissed
oath/declaration stating that such error arose without
and the processing or petition fee refunded.
any deceptive intention on the part of the applicant.
The material submitted with the request or petition
See MPEP § 1414.01.
should then be considered to determine if it complies
with 37 CFR 1.175. If the material submitted with the  
request or petition does comply with the requirements
of 37 CFR 1.175 (and the reissue application is otherwise
in order), the correction of inventorship will be
permitted as a correction of an error in the patent
under 35 U.S.C. 251.


Where a reissue application seeks to correct inventorship
Where a divisional reissue application is filed
in the patent and the inventors are required to
with a copy of the reissue oath/declaration from
sign the reissue oath or declaration (rather than an  
the  
assignee of the entire interest under 37 CFR 1.172)
parent reissue application, the reissue oath/declaration  
due to a broadening of any claims of the original
should be accepted by OIPE, since it is an oath/
patent, the correct inventive entity must sign the reissue  
declaration, though it may be improper under  
oath or declaration. Where an inventor is being
35
added in a reissue application to correct inventorship
U.S.C. 251. The examiner should check the copy
in a patent, the inventor being added must sign the  
of the oath/declaration to ensure that it identifies an
reissue oath or declaration together with the inventors
error being corrected by the divisional reissue application.
previously designated on the patent. For example, a
The copy of the oath/declaration from the parent
reissue application is filed to correct the inventorship
reissue application may or may not cover an error
from inventors A and B (listed as inventors on the
being corrected by the divisional reissue application
patent) to inventors A, B, and C. Inventor C is the  
since the divisional reissue application is (by definition)
inventor being added. In such a case, A, B, and C are
directed to a new invention. If it does not, the  
the correct inventors, and accordingly, each of A, B,
examiner should reject the claims of the divisional
and C must sign the reissue oath or declaration.
reissue application under 35 U.S.C. 251 as being
Where an inventor is being deleted in a reissue application  
based on an oath/declaration that does not identify an
to correct inventorship in a patent and the  
error being corrected by the divisional reissue application,
inventors are required to sign the oath or declaration  
and require a new oath/declaration. If the copy of
due to a broadening of any claims of the original
the reissue oath/declaration from the parent reissue
patent, the inventor being deleted need not sign the  
application does in fact cover an error being corrected
reissue oath or declaration. The reissue oath or declaration
in the divisional reissue application, no such rejection
must be signed by the correct inventive entity.  
should be made. However, since a new invention is  
For example, a reissue application is filed to correct
being added by the filing of the divisional reissue  
inventorship from inventors A, B, and C (listed as
application, a supplemental reissue oath/declaration  
inventors on the patent) to inventors A and B. Inventor
pursuant to 37 CFR 1.175 (b)(1) will be required. See
C is being deleted as a named inventor. In such a
MPEP § 1414.01.
case, A and B are the correct inventors, and accordingly,
inventors A and B must sign the reissue oath or
declaration but inventor C need not sign the reissue  
oath or declaration.


1413Drawings [R-2]
Form paragraph 14.01.01 may be used where the
 
reissue oath/declaration does not identify an error.
37 CFR 1.173. Reissue specification, drawings, and
amendments.


¶ 14.01.01 Defective Reissue Oath/Declaration, 37 CFR
1.175(a)(1) - No Statement of a Specific Error


The reissue oath/declaration filed with this application is
defective because it fails to identify at least one error which is
relied upon to support the reissue application. See 37 CFR
1.175(a)(1) and MPEP § 1414.


(a)(2) Drawings. Applicant must submit a clean copy of each
Examiner Note:
drawing sheet of the printed patent at the time the reissue application
is filed. If such copy complies with § 1.84, no further drawings
will be required. Where a drawing of the reissue application
is to include any changes relative to the patent being reissued, the
changes to the drawing must be made in accordance with paragraph
(b)(3) of this section. The Office will not transfer the drawings
from the patent file to the reissue application.


1.Use this form paragraph when the reissue oath or declaration
does not contain any statement of an error which is relied upon to
support the reissue application.


2.This form paragraph can be used where the reissue oath or
declaration does not even mention error. It can also can be used
where the reissue oath or declaration contains some discussion of
the concept of error but never in fact identifies a specific error to
be relied upon. For example, it is not sufficient for an oath or declaration
to merely state “this application is being filed to correct
errors in the patent which may be noted from the changes made in
the disclosure.”


A clean copy (e.g., good quality photocopies free of
3.Form paragraph 14.14 must follow this form paragraph.
any extraneous markings) of each drawing sheet of
the printed patent must be supplied by the applicant at
the time of filing of the reissue application. If the copies
meet the requirements of 37 CFR 1.84, no further
formal drawings will be required. New drawing sheets
are not to be submitted, unless some change is made
in the original patent drawings. Such changes must be
made in accordance with 37 CFR 1.173(b)(3).


The prior reissue practice of transferring drawings
Where the reissue oath/declaration does identify an
from the patent file has been eliminated, since clean
error or errors, the oath/declaration must be checked
photocopies of the printed patent drawings are acceptable
carefully to ensure that at least one of the errors identified
for use in the printing of the reissue patent.
is indeed an “error” which will support the filing
of a reissue, i.e., an “error” that will provide
grounds for reissue of the patent. See MPEP § 1402.
If the error identified in the oath/declaration is not an
appropriate error upon which a reissue can be based,
then the oath/declaration must be indicated to be
defective in the examiner’s Office action.  


AMENDMENT OF DRAWINGS
Form paragraphs 14.01.02 and 14.01.03 may be
used where the reissue oath/declaration fails to provide
at least one error upon which a reissue can be
based.


37 CFR 1.173. Reissue specification, drawings, and
¶ 14.01.02 Defective Reissue Oath/Declaration, 37 CFR
amendments.
1.175(a)(1)-The Identified “Error” Is Not Appropriate
Error


The reissue oath/declaration filed with this application is
defective because the error which is relied upon to support the
reissue application is not an error upon which a reissue can be
based. See 37 CFR 1.175(a)(1) and MPEP § 1414.


Examiner Note:


1.Use this form paragraph when the reissue oath/declaration
identifies only one error which is relied upon to support the reissue
application, and that one error is not an appropriate error upon
which a reissue can be based.
2.Form paragraph 14.14 must follow this form paragraph.


¶ 14.01.03 Defective Reissue Oath/Declaration, 37 CFR
1.175(a)(1) - Multiple Identified “Errors” Not Appropriate
Errors


(b)(3) Drawings. One or more patent drawings shall be
The reissue oath/declaration filed with this application is
amended in the following manner: Any changes to a patent drawing
defective because none of the errors which are relied upon to support
must be submitted as a replacement sheet of drawings which
the reissue application are errors upon which a reissue can be  
shall be an attachment to the amendment document. Any replacement
based. See 37 CFR 1.175(a)(1) and MPEP § 1414.
sheet of drawings must be in compliance with § 1.84 and
shall include all of the figures appearing on the original version of
the sheet, even if only one figure is amended. Amended figures
must be identified as “Amended,” and any added figure must be
identified as “New.” In the event that a figure is canceled, the figure
must be surrounded by brackets and identified as “Canceled.”
All changes to the drawing(s) shall be explained, in detail, beginning
on a separate sheet accompanying the papers including the
amendment to the drawings.


Examiner Note:


1.Use this form paragraph when the reissue oath/declaration
identifies more than one error relied upon to support the reissue
application, and none of the errors are appropriate errors upon
which a reissue can be based.


The provisions of 37 CFR
2.Note that if the reissue oath/declaration identifies more than
1.173(b)(3) govern the  
one error relied upon, and at least one of the errors is an error
manner of making amendments (changes) to the  
upon which reissue can be based, this form paragraph should not
be used, despite the additional reliance by applicant on “errors”




Line 3,081: Line 3,097:
   
   


drawings in a reissue application. The following guidance
which do not support the reissue. Only one appropriate error is
is provided as to the procedure for amending
needed to support a reissue.
drawings:
 
3.Form paragraph 14.14 must follow this form paragraph.


(A)Amending the original or printed patent drawing
III.A STATEMENT THAT ALL ERRORS
sheets by physically changing or altering them is
WHICH ARE BEING CORRECTED IN
not permitted. Any request to do so should be denied.  
THE REISSUE APPLICATION UP TO
THE TIME OF SIGNING OF THE OATH/
DECLARATION AROSE WITHOUT ANY
DECEPTIVE INTENTION ON THE PART
OF THE APPLICANT.


(B)Where a change to the drawings is desired,  
In order to satisfy this requirement, the following
applicant must submit a replacement sheet for each
statement may be included in an oath or declaration:
sheet of drawings containing a Figure to be revised.
Any replacement sheet must comply with 37 CFR
1.84 and include all of the figures appearing on the  
original version of the sheet, even if only one figure is
being amended. Each figure that is amended must be  
identified by placing the word “Amended” at the bottom
of that figure. Any added figure must be identified
as “New.” In the event that a figure is canceled,
the figure must be identified as “Canceled” and also
surrounded by brackets. All changes to the figure(s)
must be explained, in detail, beginning on a separate
sheet which accompanies the papers including the
amendment to the drawings.


(C)If desired, applicant may include a marked-up  
“All errors in the present reissue application up to the time
copy of any amended drawing figure, including annotations
of signing of this oath/declaration, or errors which are
indicating the changes made. Such a marked-
being corrected by a paper filed concurrently with this
up copy must be clearly labeled as “Annotated
oath/declaration which correction of errors I/we have
Marked-up Drawings”, and it must be presented in the  
reviewed, arose without any deceptive intention on the  
amendment or remarks section that explains the  
part of the applicant.
change to the drawings.  


In addition, the examiner may desire a marked-up
Nothing more is required. The examiner will determine
copy of any amended drawing figure, and so state in
only whether the reissue oath/declaration contains
an Office action. A marked-up copy of any amended
the required averment; the examiner will not
drawing figure, including annotations indicating the  
make any comment as to whether it appears that there
changes made, must be provided when required by the  
was in fact deceptive intention (see MPEP § 2022.05).
examiner.
It is noted that a reissue oath/declaration will not be
effective for any errors which are corrected by a filing
made after the execution of the reissue oath/declaration,
unless it is clear from the record that the parties
executing the document were aware of the nature of
the correction when they executed the document. Further,  
a reissue oath/declaration with an early date of  
execution cannot be filed after a correction made later
in time, to cover the correction made after the execution
date. This is so, even if the reissue oath/declaration
states that all errors up to the filing of the oath/
declaration arose without any deceptive intention on
the part of the applicant.  


(D)For each proper new drawing sheet being
Form paragraph 14.01.04 may be used where the  
added, the new sheet should be inserted after the  
reissue oath/declaration does not provide the required
existing drawing sheets. For each proper  drawing
statement as to “without any deceptive intention on
sheet being added which replaces an existing drawing
the part of the applicant.
sheet, the existing sheet should be canceled by
placing the sheet face down in the file and placing a
large “X” on the back of the sheet. The new sheet
should be inserted in place of the turned over existing
sheet.  


(E)If any drawing change  is not  approved,
¶ 14.01.04 Defective Reissue Oath/Declaration, 37 CFR
or if any submitted sheet of formal drawings is not
1.175- Lack of Statement of “Without Any Deceptive
entered, the examiner will so inform the reissue applicant
Intention”
in the next Office action, and the examiner will
set forth the reasons for same.


1414Content of Reissue Oath/Declaration
The reissue oath/declaration filed with this application is
[R-5]
defective because it fails to contain a statement that all errors
which are being corrected in the reissue application up to the time
of filing of the oath/declaration arose without any deceptive intention
on the part of the applicant. See 37 CFR 1.175 and MPEP §
1414.


37 CFR 1.175. Reissue oath or declaration.
Examiner Note:


(a)The reissue oath or declaration in addition to complying
1.Use this form paragraph when the reissue oath/declaration  
with the requirements of § 1.63, must also state that:
does not contain the statement required by 37 CFR 1.175 that all
errors being corrected in the reissue application arose without any
deceptive intention on the part of the applicant.


(1)The applicant believes the original patent to be wholly
2.This form paragraph is appropriate to use for a failure by  
or partly inoperative or invalid by reason of a defective specification
applicant to comply with the requirement, as to any of 37 CFR
or drawing, or by reason of the patentee claiming more or less
1.175(a)(2), 37 CFR 1.175(b)(1), or 37 CFR 1.175(b)(2).
than the patentee had the right to claim in the patent, stating at
least one error being relied upon as the basis for reissue; and


(2)All errors being corrected in the reissue application up
3.Form paragraph 14.14 must follow.  
to the time of filing of the oath or declaration under this paragraph  
arose without any deceptive intention on the part of the applicant.


(b)(1) For any error corrected, which is not covered by the
IV.THE REISSUE OATH/DECLARATION
oath or declaration submitted under paragraph (a) of this section,
MUST COMPLY WITH 37 CFR 1.63.
applicant must submit a supplemental oath or declaration stating
that every such error arose without any deceptive intention on the
part of the applicant. Any supplemental oath or declaration
required by this paragraph must be submitted before allowance
and may be submitted:


(i) With any amendment prior to allowance; or
The reissue oath/declaration must include the averments
required by 37 CFR 1.63(a) and (b), e.g., that
applicants for reissue


(ii) In order to overcome a rejection under 35
(A)have reviewed and understand the contents of
U.S.C. 251
the specification, including the claims, as amended by  
made by the examiner where it is indicated that the submission of
any amendment specifically referred to in the oath/
a supplemental oath or declaration as required by this paragraph
declaration;
will overcome the rejection.


(2)For any error sought to be corrected after allowance, a
(B)believe the named inventor or inventors to be  
supplemental oath or declaration must accompany the requested
the original and the first inventor or inventors of the  
correction stating that the error(s) to be corrected arose without
subject matter which is claimed and for which a
any deceptive intention on the part of the applicant.
patent is sought; and


(c)Having once stated an error upon which the reissue is
(C)acknowledge the duty to disclose to the
based, as set forth in paragraph (a)(1), unless all errors previously
Office all information known to the person to be
stated in the oath or declaration are no longer being corrected, a
material to patentability as defined in 37 CFR 1.56.
subsequent oath or declaration under paragraph (b) of this section
See also the discussion regarding the requirements of
need not specifically identify any other error or errors being corrected.
an oath/declaration beginning at MPEP § 602.
 
The examiner should check carefully to ensure that
all the requirements of 37 CFR 1.63 are met. Form
paragraph 14.01.05 should be used in conjunction
with the content of form paragraphs 6.05 through
6.05.20 as appropriate, where the reissue oath/declaration  
fails to comply with the requirements of 37
CFR 1.63.


¶ 14.01.05 Defective Reissue Oath/Declaration, 37 CFR
1.175 - General


(d)The oath or declaration required by paragraph (a) of this  
The reissue oath/declaration filed with this application is
section may be submitted under the provisions of § 1.53(f).
defective (see 37 CFR 1.175 and MPEP § 1414) because of the
following:


(e)The filing of any continuing reissue application which
Examiner Note:
does not replace its parent reissue application must include an
oath or declaration which, pursuant to paragraph (a)(1) of this section,
identifies at least one error in the original patent which has
not been corrected by the parent reissue application or an earlier
reissue application. All other requirements relating to oaths or
declarations must also be met.


The reissue oath/declaration is an essential part of a
1.Use this form paragraph when the reissue oath/declaration  
reissue application and must be filed with the application,
does not comply with 37 CFR 1.175, and none of form paragraphs
or within the time period set under 37 CFR  
14.01 - 14.01.04 or 14.05.02 apply.
1.53(f) along with the required surcharge as set forth
in 37 CFR 1.16(f) in order to avoid abandonment.  


The question of the sufficiency of the reissue oath/
2.This form paragraph must be followed by an explanation of  
declaration filed under 37 CFR 1.175 must in each
why the reissue oath/declaration is defective.  
case be reviewed and decided personally by the primary
examiner.




Line 3,209: Line 3,220:
   
   


Reissue oaths or declarations must contain the following:
3.Form paragraph 14.14 must follow the explanation of the
defect.
 
See MPEP § 1414.01 for a discussion of the
requirements for a supplemental reissue oath/declaration.




(A)A statement that the applicant believes the  
Depending on the circumstances, either form PTO/
original patent to be wholly or partly inoperative or
SB/51, Reissue Application Declaration By The
invalid—
Inventor, or form PTO/SB/52, Reissue Application
Declaration By The Assignee may be used to prepare
a declaration in a reissue application.
 


(1)by reason of a defective specification or
drawing, or


(2)by reason of the patentee claiming more or
less than patentee had the right to claim in the patent;


(B)A statement of at least one error which is
relied upon to support the reissue application, i.e., as
the basis for the reissue;


(C)A statement that all errors which are being
corrected in the reissue application up to the time of
filing of the oath/declaration arose without any deceptive
intention on the part of the applicant; and


(D)The information required by 37 CFR 1.63.


These elements will now be discussed:
Reissue Application Declaration by the Inventor


I.A STATEMENT THAT THE APPLICANT
BELIEVES THE ORIGINAL PATENT TO
BE WHOLLY OR PARTLY INOPERATIVE
OR INVALID BY REASON OF A DEFECTIVE
SPECIFICATION OR DRAWING,
OR BY REASON OF THE PATENTEE
CLAIMING MORE OR LESS THAN PATENTEE
HAD THE RIGHT TO CLAIM IN
THE PATENT.


In order to satisfy this requirement, a declaration
can state as for example:






1. “Applicant believes the original patent to be
partly inoperative or invalid by reason of a defective
specification or drawing.”


Reissue Application Declaration by the Inventor (page 2)




2. “Applicant believes the original patent to be
partly inoperative or invalid by reason of the patentee
claiming more than patentee had a right to claim in
the patent.”






3. “Applicant believes the original patent to be
partly inoperative or invalid by reason of the patentee
claiming less than patentee had a right to claim in the
patent.”


Where the specification or drawing is defective andpatentee claimed both more and less than patentee had
Privacy Act Statment
the right to claim in the patent, then all three statements
should be included in the reissue oath/declaration.
A statement that the original patent is “wholly
or partly inoperative or invalid” (emphasis added) by
reason of the patentee “claiming more or less than the
patentee had the right to claim in the patent” (emphasis
added) is improper since a claim cannot claim
“more or less” at the same time. Where, however, a
given independent claim is considered to be overly
broad, and another independent claim is considered to
be overly narrow, patentee has claimed both more andless than he or she had a right to claim. In such an
instance, both the second and third above-quoted
statements would be used. See MPEP § 1412.04 for
an exemplary declaration statement when the error
being corrected is an error in inventorship.


The above examples will be sufficient to satisfy this
requirement without any further statement.


It should be noted that the reissue oath/declaration
must also satisfy the requirement for a statement of at
least one error being relied upon as the basis for reissue,
in the manner set forth in subsection II. below.


Form paragraph 14.01 may be used where the reissue
oath/declaration does not provide the required
statement as to applicant’s belief that the original
patent is wholly or partly inoperative or invalid.


¶ 14.01 Defective Reissue Oath/Declaration, 37 CFR
1.175(a)(1) - No Statement of Defect in the Patent


The reissue oath/declaration filed with this application is
defective because it fails to contain the statement required under
37 CFR 1.175(a)(1) as to applicant’s belief that the original patent
is wholly or partly inoperative or invalid. See 37 CFR 1.175(a)(1)
and see MPEP §
   
   
1414. [1]


Examiner Note:
Reissue Application Declaration by the Assognee
 
 
 


1.Use this form paragraph when applicant: (a) fails to allege
that the original patent is inoperative or invalid and/or (b) fails to
state the reason of a defective specification or drawing, or of patentee
claiming more or less than patentee had the right to claim in
the patent . In bracket 1, point out the specific defect to applicant
by using the language of (a) and/or (b), as it is appropriate.


2.Form paragraph 14.14 must follow this form paragraph.


II.A STATEMENT OF AT LEAST ONE ERROR
Reissue Application Declaration by the Assognee (page 2)
WHICH IS RELIED UPON TO SUPPORT
THE REISSUE APPLICATION (I.E.,
THE BASIS FOR THE REISSUE).


(A)A reissue applicant must acknowledge the
existence of an error in the specification, drawings, or
claims, which error causes the original patent to be




Line 3,334: Line 3,280:
   
   


defective. In re Wilder, 736 F.2d 1516, 222 USPQ 369
Privacy Act Statment
(Fed. Cir. 1984). A change or departure from the original
 
specification or claims represents an “error” in
 
the original patent under 35 U.S.C. 251. See MPEP
 
§
 
 
1402 for a discussion of grounds for filing a reissue
that may constitute the “error” required by 35 U.S.C.
251. Not all changes with respect to the patent constitute
the “error” required by 35 U.S.C. 251.


(B)Applicant need only specify in the reissue
oath/declaration one of the errors upon which reissue
is based. Where applicant specifies one such error,
this requirement of a reissue oath/declaration is satisfied.
Applicant may specify more than one error.


Where more than one error is specified in the
oath/declaration and some of the designated “errors”
are found to not be “errors” under 35 U.S.C. 251, any
remaining error which is an error under 35 U.S.C. 251will still support the reissue.


The “at least one error” which is relied upon to
1414.01Supplemental Reissue Oath/
support the reissue application must be set forth in the  
Declaration [R-5]
oath/declaration. It is not necessary, however, to point
 
out how (or when) the error arose or occurred. Further,  
If additional defects or errors are corrected in the  
it is not necessary to point out how (or when) the
reissue after the filing of the application and the original
error was discovered. If an applicant chooses to point
reissue oath or declaration, a supplemental reissue
out these matters, the statements directed to these
oath/declaration must be filed, unless all additional
matters will not be reviewed by the examiner, and the
errors corrected are spelling, grammar, typographical,  
applicant should be so informed in the next Office
editorial or clerical errors which are not errors under
action. All that is needed for the oath/declaration  
35 U.S.C. 251 (see MPEP § 1402). In other words, a
statement as to error is the identification of “at least
supplemental oath/declaration is required where any
one error” relied upon.
“error” under 35 U.S.C. 251 has been corrected and
the error was not identified in the original reissue
oath/declaration.


In identifying the error, it is sufficient that the
The supplemental reissue oath/declaration must
reissue oath/declaration identify a single word,
state that every error which was corrected in the reissue
phrase, or expression in the specification or in an original
application not covered by the prior oath(s)/declaration(
claim, and how it renders the original patent
s) submitted in the application arose without
wholly or partly inoperative or invalid. The corresponding
any deceptive intention on the part of the applicant.  
corrective action which has been taken to
correct the original patent need not be identified in the
oath/declaration. If the initial reissue oath/declaration  
“states at least one error” in the original patent, and, in
addition, recites the specific corrective action taken in
the reissue application, the oath/declaration would be
considered acceptable, even though the corrective
action statement is not required.


(C)It is not sufficient for an oath/declaration to
An example of acceptable language is as follows:
merely state “this application is being filed to correct
errors in the patent which may be noted from the
changes made in the disclosure.” Rather, the oath/declaration
must specifically identify an error. In addition,
it is not sufficient to merely reproduce the claims
with brackets and underlining and state that such will
identify the error. See In re Constant, 827 F.2d 728,
729, 3 USPQ2d 1479 (Fed. Cir.), cert. denied, 484
U.S. 894 (1987). Any error in the claims must be
identified by reference to the specific claim(s) and the
specific claim language wherein lies the error.


A statement of “…failure to include a claim
“Every error in the patent which was corrected in the
directed to…” and then presenting a newly added
present reissue application, and is not covered by the prior
claim, would not be considered a sufficient “error”
declaration submitted in this application, arose without
statement since applicant has not pointed out what the  
any deceptive intention on the part of the applicant.”
other claims lacked that the newly added claim has, or
vice versa. Such a statement would be no better than
saying in the reissue oath or declaration that “this
application is being filed to correct errors in the patent
which may be noted from the change made by adding
new claim 10.” In both cases, the error has not been
identified.


(D)Where a continuation reissue application is
A supplemental reissue oath/declaration will not be
filed with a copy of the reissue oath/declaration from  
effective for any errors which are corrected by a filing
the parent reissue application, and the parent reissue
made after the execution of the supplemental reissue  
application is not to be abandoned, the reissue oath/
oath/declaration, unless it is clear from the record that
declaration should be accepted by the Office of Initial
the parties executing the document were aware of the  
Patent Examination without further evaluation, since
nature of the correction when they executed the document.
it is an oath/declaration, albeit improper under
Further, a supplemental reissue oath/declaration  
35
with an early date of execution cannot be filed after a
U.S.C. 251. The examiner should, however, reject
correction made later in time, to cover the correction
the claims of the continuation reissue application
made after the execution date. This is so, even if the  
under 35 U.S.C. 251 as being based on an oath/declaration  
supplemental reissue oath/declaration states that all
that does not identify an error being corrected
errors up to the filing of the supplemental reissue  
by the continuation reissue application, and should
oath/declaration oath or declaration arose without
require a new oath/declaration. 37 CFR 1.175(e)
any deceptive intention on the part of the applicant.
states that “the filing of any continuing reissue application
which does not replace its parent reissue application
must include an oath or declaration, which
pursuant to [37 CFR 1.175(a)(1)], identifies at least
one error in the original patent which has not been
corrected by the parent reissue application or an earlier
reissue application.” One of form paragraphs
14.01.01 through 14.01.03 may be used.


Where a continuation reissue application is filed
 
with a copy of the reissue oath/declaration from the  
 
parent reissue application, and the parent reissue  
Form PTO/SB/51S, “Supplemental Declaration For
application is, or will be abandoned, the copy of the  
Reissue Patent Application To Correct ‘Errors’ Statement
reissue oath/declaration should be accepted by OIPE,  
(37 CFR 1.175),” may be used to prepare a supplemental
and the examiner should check to ensure that the oath/
reissue declaration. Form PTO/SB/51S
declaration identifies an error which is still being corrected  
serves to indicate that every error in the patent that
in the continuation application. If a preliminary
was corrected in the reissue application, but was not
amendment was filed with the continuation reissue
covered by a prior reissue oath/declaration submitted
in the reissue application, arose without any deceptive
intention on the part of the applicant.
 
In the event that the applicant for a reissue applicant
is required to file a supplemental reissue oath/
declaration that also includes a specific statement of
the error being corrected by reissue in accordance
with 37 CFR 1.175(c), as discussed in subsection I.
below, applicant must also include in the supplemental
declaration language equivalent to the “Every error
…” language in the example of acceptable language
set forth above. Therefore, if either form PTO/SB/51,
“Reissue Application Declaration By The Inventor,”
or form PTO/SB/52, “Declaration By The Assignee”
(see MPEP § 1414) is used for the purpose of filing
such supplemental reissue oath/declaration, the form
must be completed so that it is clear that the supplemental
reissue oath/declaration addresses all errors
corrected subsequent to the date upon which the last
previously reissue oath/declaration (whether original
or supplemental) was filed. For example, the form
could be completed by specifying the date upon
which the reissue application was originally filed, the
reissue application number, and the date(s) of every
amendment filed subsequent to the date upon which
the last reissue oath/declaration (whether original or
supplemental) was filed. Any manner of completing
the form so that affiant/declarant unambiguously
states that every error corrected subsequent to the filing
of the last filed reissue oath/declaration (whether
original or supplemental) arose without deceptive
intent will be acceptable. It will not be acceptable for
the new (“catch-up”) oath/declaration to simply refer
to the reissue application as filed, even though the  
new oath/declaration may be submitted after an
amendment.
 
I.WHEN AN ERROR MUST BE STATED IN
THE SUPPLEMENTAL OATH/
DECLARATION
 
In the supplemental reissue oath/declaration, there
is no need to state an error which is relied upon to
support the reissue application if:
 
(A)an error to support a reissue has been previously
and properly stated in a reissue oath/declaration
in the application; and
 
(B)that error is still being corrected in the reissue
application.  




Line 3,446: Line 3,399:
   
   


application, the examiner should check for the need of
If applicant chooses to state any further error at this
a supplemental reissue oath/declaration. Pursuant to  
point (even though such is not needed), the examiner
37 CFR 1.175 (b)(1), for any error corrected via the  
should not review the statement of the further error.  
preliminary amendment which is not covered by the  
oath or declaration submitted in the parent reissue
application, applicant must submit a supplemental
oath/declaration stating that such error arose without
any deceptive intention on the part of the applicant.
See MPEP § 1414.01.


Where a divisional reissue application is filed
The supplemental reissue oath/declaration muststate an error which is relied upon to support the reissue  
with a copy of the reissue oath/declaration from
application only where one of the following is  
the
true:
parent reissue application, the reissue oath/declaration
should be accepted by OIPE, since it is an oath/
declaration, though it may be improper under
35
U.S.C. 251. The examiner should check the copy
of the oath/declaration to ensure that it identifies an
error being corrected by the divisional reissue application.
The copy of the oath/declaration from the parent
reissue application may or may not cover an error  
being corrected by the divisional reissue application
since the divisional reissue application is (by definition)
directed to a new invention. If it does not, the
examiner should reject the claims of the divisional
reissue application under 35 U.S.C. 251 as being
based on an oath/declaration that does not identify an
error being corrected by the divisional reissue application,
and require a new oath/declaration. If the copy of  
the reissue oath/declaration from the parent reissue
application does in fact cover an error being corrected
in the divisional reissue application, no such rejection
should be made. However, since a new invention is  
being added by the filing of the divisional reissue
application, a supplemental reissue oath/declaration
pursuant to 37 CFR 1.175 (b)(1) will be required. See
MPEP § 1414.01.


Form paragraph 14.01.01 may be used where the  
(A)the prior reissue oath/declaration failed to
reissue oath/declaration does not identify an error.
state an error;


¶ 14.01.01 Defective Reissue Oath/Declaration, 37 CFR
(B)the prior reissue oath/declaration attempted to
1.175(a)(1) - No Statement of a Specific Error
state an error but did not do so properly; or


The reissue oath/declaration filed with this application is
(C)all errors under 35 U.S.C. 251 stated in the
defective because it fails to identify at least one error which is
prior reissue oath(s)/declaration(s) are no longer being
relied upon to support the reissue application. See 37 CFR
corrected in the reissue application.
1.175(a)(1) and MPEP § 1414.


Examiner Note:
II.WHEN A SUPPLEMENTAL OATH/DE-
CLARATION MUST BE SUBMITTED


1.Use this form paragraph when the reissue oath or declaration  
The supplemental oath/declaration in accordance
does not contain any statement of an error which is relied upon to
with 37 CFR 1.175(b)(1) must be submitted before
support the reissue application.  
allowance. See MPEP § 1444 for a discussion of the
action to be taken by the examiner to obtain the supplemental
oath/declaration in accordance with 37
CFR 1.175(b)(1), where such is needed.


2.This form paragraph can be used where the reissue oath or
Where applicant seeks to correct an error after
declaration does not even mention error. It can also can be used
allowance of the reissue application, a supplemental
where the reissue oath or declaration contains some discussion of
reissue oath/declaration must accompany the
the concept of error but never in fact identifies a specific error to  
requested correction stating that the error(s) to be corrected
be relied upon. For example, it is not sufficient for an oath or declaration  
arose without any deceptive intention on the
to merely state “this application is being filed to correct
part of the applicant. The supplemental reissue oath/
errors in the patent which may be noted from the changes made in
declaration submitted after allowance will be directed
the disclosure.
to the error applicant seeks to correct after allowance.
This supplemental oath/declaration need not cover
any earlier errors, since all earlier errors should have
been covered by a reissue oath/declaration submitted
prior to allowance.


3.Form paragraph 14.14 must follow this form paragraph.
III.SUPPLEMENTAL OATH/DECLARA-
TION IN BROADENING REISSUE


Where the reissue oath/declaration does identify an
A broadening reissue application must be applied
error or errors, the oath/declaration must be checked
for by all of the inventors (patentees), that is, the original
carefully to ensure that at least one of the errors identified
reissue oath/declaration must be signed by all of
is indeed an “error” which will support the filing
the inventors. See MPEP § 1414. If a supplemental
of a reissue, i.e., an “error” that will provide
oath/declaration in a broadening reissue application is  
grounds for reissue of the patent. See MPEP § 1402.  
subsequently needed in the application in order to fulfill
If the error identified in the oath/declaration is not an
the requirements of 37 CFR 1.175, the supplemental
appropriate error upon which a reissue can be based,  
reissue oath/declaration must be signed by all of
then the oath/declaration must be indicated to be
the inventors. In re Hayes, 53 USPQ2d 1222, 1224
defective in the examiner’s Office action.  
(Comm’r Pat. 1999) (“37 CFR 1.175(b)(1), taken in
conjunction with Section 1.172, requires a supplemental
declaration be signed by all of the inventors.  
This is because all oaths or declarations necessary to
fulfill the rule requirements in a reissue application
are taken together collectively as a single oath or declaration.
Thus, each oath and declaration must bear
the appropriate signatures of all the inventors.”).


Form paragraphs 14.01.02 and 14.01.03 may be  
If a joint inventor refuses or cannot be found or
used where the reissue oath/declaration fails to provide
reached to sign a supplemental oath/declaration, a
at least one error upon which a reissue can be
supplemental oath/declaration listing all the inventors,
based.  
and signed by all the available inventors may be filed
provided it is accompanied by a petition under 37
CFR 1.183 along with the petition fee, requesting
waiver of the signature requirement of the nonsigning
inventor.


¶ 14.01.02 Defective Reissue Oath/Declaration, 37 CFR
 
1.175(a)(1)-The Identified “Error” Is Not Appropriate
Error
 
The reissue oath/declaration filed with this application is
defective because the error which is relied upon to support the
reissue application is not an error upon which a reissue can be
based. See 37 CFR 1.175(a)(1) and MPEP § 1414.
 
Examiner Note:
 
1.Use this form paragraph when the reissue oath/declaration
identifies only one error which is relied upon to support the reissue
application, and that one error is not an appropriate error upon
which a reissue can be based.
 
2.Form paragraph 14.14 must follow this form paragraph.
 
¶ 14.01.03 Defective Reissue Oath/Declaration, 37 CFR
1.175(a)(1) - Multiple Identified “Errors” Not Appropriate
Errors
 
The reissue oath/declaration filed with this application is
defective because none of the errors which are relied upon to support
the reissue application are errors upon which a reissue can be
based. See 37 CFR 1.175(a)(1) and MPEP § 1414.
 
Examiner Note:
 
1.Use this form paragraph when the reissue oath/declaration
identifies more than one error relied upon to support the reissue
application, and none of the errors are appropriate errors upon
which a reissue can be based.
 
2.Note that if the reissue oath/declaration identifies more than
one error relied upon, and at least one of the errors is an error
upon which reissue can be based, this form paragraph should not
be used, despite the additional reliance by applicant on “errors”




Line 3,573: Line 3,477:
   
   


which do not support the reissue. Only one appropriate error is
needed to support a reissue.


3.Form paragraph 14.14 must follow this form paragraph.


III.A STATEMENT THAT ALL ERRORS
SUPPLEMENTAL DECLARATION FOR REISSUE PATENT APPLICATION TO CORRECT “ERRORS” STATEMENT (37 CFR 1.175)
WHICH ARE BEING CORRECTED IN
PTO/SB/51S (09-04)
THE REISSUE APPLICATION UP TO  
Approved for use through 04/30/2007. OMB 0651-0033
THE TIME OF SIGNING OF THE OATH/
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
DECLARATION AROSE WITHOUT ANY
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
DECEPTIVE INTENTION ON THE PART
Attorney Docket Number
OF THE APPLICANT.
First Named Inventor
 
COMPLETE if known
In order to satisfy this requirement, the following
Application Number
statement may be included in an oath or declaration:  
Filing Date
 
Art Unit
“All errors in the present reissue application up to the time
SUPPLEMENTAL DECLARATION
of signing of this oath/declaration, or errors which are
FOR REISSUE  
being corrected by a paper filed concurrently with this  
PATENT APPLICATION  
oath/declaration which correction of errors I/we have
TO CORRECT “ERRORS” STATEMENT
reviewed, arose without any deceptive intention on the  
(37 CFR 1.175)
part of the applicant.
Examiner Name
I/We hereby declare that:
Every error in the patent which was corrected in the present reissue application, and which is not covered by the
prior oath(s) and/or declaration(s) submitted in this application, arose without any deceptive intention on the part of
the applicant.  
I/We hereby declare that all statements made herein of my/our own knowledge are true and that all statements made
on information and belief are believed to be true; and further that these statements were made with the knowledge
that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C.
1001 and that such willful false statements may jeopardize the validity of the application or any patent issued
thereon.
Name of Sole or First Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or Surname
Inventor’s
SignatureDate
Name of Second Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or Surname
Inventor’s
SignatureDate
Name of Third Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or Surname
Inventor’s
SignatureDate
Name of Fourth Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or SurnameInventor’s
SignatureDate
Additional inventors or legal representatives(s) are being named on the __________ supplemental sheets PTO/SB/02A or 02LR attached hereto.
This collection of information is required by 37 CFR 1.175. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO
to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 1.8 minutes to complete,
including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on
the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
ADDRESS. SEND TO:Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.  
Doc Code:
 


Nothing more is required. The examiner will determine
only whether the reissue oath/declaration contains
the required averment; the examiner will not
make any comment as to whether it appears that there
was in fact deceptive intention (see MPEP § 2022.05).
It is noted that a reissue oath/declaration will not be
effective for any errors which are corrected by a filing
made after the execution of the reissue oath/declaration,
unless it is clear from the record that the parties
executing the document were aware of the nature of
the correction when they executed the document. Further,
a reissue oath/declaration with an early date of
execution cannot be filed after a correction made later
in time, to cover the correction made after the execution
date. This is so, even if the reissue oath/declaration
states that all errors up to the filing of the oath/
declaration arose without any deceptive intention on
the part of the applicant.


Form paragraph 14.01.04 may be used where the
reissue oath/declaration does not provide the required
statement as to “without any deceptive intention on
the part of the applicant.”


¶ 14.01.04 Defective Reissue Oath/Declaration, 37 CFR
1.175- Lack of Statement of “Without Any Deceptive
Intention”


The reissue oath/declaration filed with this application is
defective because it fails to contain a statement that all errors
which are being corrected in the reissue application up to the time
of filing of the oath/declaration arose without any deceptive intention
on the part of the applicant. See 37 CFR 1.175 and MPEP §
1414.


Examiner Note:


1.Use this form paragraph when the reissue oath/declaration
does not contain the statement required by 37 CFR 1.175 that all
errors being corrected in the reissue application arose without any
deceptive intention on the part of the applicant.


2.This form paragraph is appropriate to use for a failure by
==1415 Reissue Application and Issue Fees==
applicant to comply with the requirement, as to any of 37 CFR
1.175(a)(2), 37 CFR 1.175(b)(1), or 37 CFR 1.175(b)(2).


3.Form paragraph 14.14 must follow.  
I.BASIC REISSUE APPLICATION FILING,
SEARCH, AND EXAMINATION FEES


IV.THE REISSUE OATH/DECLARATION
The Consolidated Appropriations Act, 2005 (Consolidated
MUST COMPLY WITH 37 CFR 1.63.
Appropriations Act), effective December 8,
2004, provides for a separate reissue application filing
fee, search fee, and examination fee during fiscal
years 2005 and 2006. For reissue applications filed on
or after December 8, 2004, the following fees are
required: basic filing fee as set forth in 37 CFR  
1.16(e)(1); search fee as set forth in 37 CFR 1.16(n);
examination fee as set forth in 37 CFR 1.16(r); application
size fee, if applicable (see subsection II.
below); and excess claims fees, if applicable (see subsection
III. below).  


The reissue oath/declaration must include the averments
For reissue applications filed prior to December 8,
required by 37 CFR 1.63(a) and (b), e.g., that
2004, the following fees are required: basic filing fee
applicants for reissue  
as set forth in 37 CFR 1.16(e)(2); and excess claims
fees, if applicable (see subsection III below). No
search and examination fees are required for reissue  
applications filed before December 8, 2004.


(A)have reviewed and understand the contents of  
The basic filing, search and examination fees are
the specification, including the claims, as amended by
due on filing of the reissue application. These fees
any amendment specifically referred to in the oath/
may be paid on a date later than the filing date of the
declaration;
reissue application provided they are paid within the  
 
time period set forth in 37 CFR 1.53(f) and include
(B)believe the named inventor or inventors to be
the surcharge set forth in 37 CFR 1.16(f). For reissue
the original and the first inventor or inventors of the  
applications filed on or after December 8, 2004 but
subject matter which is claimed and for which a  
prior to July 1, 2005, which have been accorded a filing
patent is sought; and
date under 37 CFR 1.53(b), if the search and/or
examination fees are paid on a date later than the filing
date of the reissue application, the surcharge
under 37 CFR 1.16(f) is not required. For reissue
applications filed on or after July 1, 2005, which have
been accorded a filing date under 37 CFR 1.53(b), if
any of the basic filing fee, the search fee, or the examination
fee are paid on a date later than the filing date
of the reissue application, the surcharge under 37 CFR
1.16(f) is required.


(C)acknowledge the duty to disclose to the  
For reissue applications filed on or after December
Office all information known to the person to be
8, 2004, in which a petition under 37 CFR
material to patentability as defined in 37 CFR 1.56.  
1.138(d) to expressly abandon the application was
See also the discussion regarding the requirements of
filed on or after March 10, 2006, applicant may file a
an oath/declaration beginning at MPEP § 602.
request for refund of the search fee and excess claims
fee paid in the application. See MPEP § 711.01.


The examiner should check carefully to ensure that
II.APPLICATION SIZE FEE
all the requirements of 37 CFR 1.63 are met. Form
paragraph 14.01.05 should be used in conjunction
with the content of form paragraphs 6.05 through
6.05.20 as appropriate, where the reissue oath/declaration
fails to comply with the requirements of 37
CFR 1.63.


¶ 14.01.05 Defective Reissue Oath/Declaration, 37 CFR  
The Consolidated Appropriations Act also provides
1.175 - General
for an application size fee. 37 CFR 1.16(s) sets forth
the application size fee for reissue applications filed
on or after December 8, 2004, the specification and
drawings of which, excluding a sequence listing or
computer program listing filed in an electronic
medium in compliance with the rules (see 37 CFR
1.52(f)), exceed 100 sheets of paper. The application
size fee does not apply to reissue applications filed
before December 8, 2004. The application size fee
applies for each additional 50 sheets or fraction
thereof over 100 sheets of paper. Any sequence listing
in an electronic medium in compliance with 37 CFR
1.52(e) and 37 CFR 1.821(c) or (e), and any computer
program listing filed in an electronic medium in compliance
with 37 CFR 1.52(e) and 1.96, will be
excluded when determining the application size fee
required by 37 CFR 1.16(s). See also MPEP § 607.


The reissue oath/declaration filed with this application is
III.EXCESS CLAIMS FEES
defective (see 37 CFR 1.175 and MPEP § 1414) because of the
following:


Examiner Note:
37 CFR 1.16(h) sets forth the excess claims fee for
 
each independent claim in excess of three. 37 CFR
1.Use this form paragraph when the reissue oath/declaration
1.16(i) sets forth the excess claims fee for each claim
does not comply with 37 CFR 1.175, and none of form paragraphs
(whether independent or dependent) in excess of
14.01 - 14.01.04 or 14.05.02 apply.
twenty. The access claims fees specified in 37 CFR  
1.16(h) and (i) apply to all reissue applications pending
on or after December 8, 2004. The excess claims
fees specified in 37 CFR 1.16(h) and (i) apply to any
excess claims fee paid on or after December 8, 2004,
regardless of the filing date of the reissue application
and regardless of the date on which the claim necessitating
the excess claims fee payment was added to the
reissue application.  


2.This form paragraph must be followed by an explanation of  
For reissue applications filed on or after December
why the reissue oath/declaration is defective.  
8, 2004, in which a petition under 37 CFR
1.138(d) to expressly abandon the application was
filed on or after March 10, 2006, applicant may file a
request for refund of the search fee and excess claims
fee paid in the application. See MPEP § 711.01.


Under 35 U.S.C. 41(a)(2) as amended by the Consolidated
Appropriations Act, the claims in the original
patent are not taken into account in determining
the excess claims fee for a reissue application.


Example 1:


 
Applicant filed a reissue application before
December 8, 2004, with the same number of
 
3.Form paragraph 14.14 must follow the explanation of the
defect.
 
See MPEP § 1414.01 for a discussion of the
requirements for a supplemental reissue oath/declaration.
 
 
Depending on the circumstances, either form PTO/
SB/51, Reissue Application Declaration By The
Inventor, or form PTO/SB/52, Reissue Application
Declaration By The Assignee may be used to prepare
a declaration in a reissue application.




Line 3,714: Line 3,648:
   
   


claims as in the patent. The patent has more than 3
independent claims and more than 20 total claims.
If applicant added one more independent claim in
the reissue application by filing an amendment
before December 8, 2004, but did not pay for the
excess claims fees prior to December 8, 2004, on
or after December 8, 2004, applicant will have to
pay for one additional independent claim per the
fee set forth in 37 CFR 1.16(h) and one additional
total claim per the fee set forth in 37 CFR 1.16(i).


Example 2:


Reissue Application Declaration by the Inventor
Applicant filed a reissue application on or after
 
December 8, 2004, with the same number of
 
claims as in the patent. The patent has 4 independent
 
claims and 21 total claims. Excess claims fees
for the 4th independent claim (one additional independent
claim per the fee set forth in 37 CFR
1.16(h)) and the 21st claim (one additional total
claim per the fee set forth in 37 CFR 1.16(i)) are
required. Under 35 U.S.C. 41(a)(2) as amended by  
the Consolidated Appropriations Act, the claims in
the original patent are not taken into account in
determining the excess claims fees for a reissue
application.


The excess claims fees, if any, due with an amendment
are required prior to any consideration of the
amendment by the examiner. Upon submission of an
amendment (whether entered or not) affecting the
claims, payment of fees for those claims in excess of
the number previously paid for is required. The additional
fees, if any, due with an amendment are calculated
on the basis of the claims (total and
independent) which would be present, if the amendment
were entered. If an amendment is limited to
revising the existing claims and it does not result in
the addition of any new claim, there is no excess
claim fee. Excess claims fees apply only to the addition
of claims. It is to be noted that where excess
claims fees have been previously paid, a later amendment
affecting the claims cannot serve as the basis for
granting any refund. See 37 CFR 1.26(a).


Amendments filed before a first Office action, or
otherwise not filed in reply to an Office action, presenting
additional claims in excess of the number
already paid for, not accompanied by the full additional
claims fee due, will not be entered in whole or
in part and applicant will be so notified. Such amendments
filed in reply to an Office action will be
regarded as being non-responsive to the Office action
and the practice set forth in MPEP § 714.03 will be
followed.


Reissue Application Declaration by the Inventor (page 2)
An amendment canceling claims accompanying the
papers constituting the reissue application will be
effective to diminish the number of claims to be considered
in calculating the filing fees to be paid. A preliminary
amendment filed concurrently with a reply to
a Notice To File Missing Parts of Application that
required the filing fees, which preliminary amendment
cancels or adds claims, will be taken into
account in determining the appropriate filing fees due
in response to the Notice To File Missing Parts of
Application. However, no refund will be made for
claims being canceled in the reply that have already
been paid for.


After a requirement for restriction, non-elected
claims will be included in determining the fees due in
connection with a subsequent amendment unless such
claims are canceled.


IV.ISSUE FEE


The issue fee for issuing each reissue patent is set
forth in 37 CFR 1.18(a).


V.REISSUE APPLICATION FEE TRANS-
MITTAL FORM


The Office has prepared Form PTO/SB/56, Reissue
 
Application Fee Transmittal Form which is designed
Privacy Act Statment
to assist in the correct calculation of reissue filing
 
fees.




Line 3,740: Line 3,741:
   
   


Reissue Application Declaration by the Assognee
Reissue Application Fee Transmittal Form




Line 3,748: Line 3,749:
   
   


Reissue Application Declaration by the Assognee (page 2)
Privacy Act Statment
Privacy Act Statement
ThePrivacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
with your submission of the attached form related to a patent application or patent. Accordingly,
pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
Office is to process and/or examine your submission related to a patent application or patent. If you do
not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
process and/or examine your submission, which may result in termination of proceedings or
abandonment of the application or expiration of the patent.
The information provided by you in this form will be subject to the following routine uses:
1. The information on this form will be treated confidentially to the extent allowed under the
Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
this system of records may be disclosed to the Department of Justice to determine whether
disclosure of these records is required by the Freedom of Information Act.
2. A record from this system of records may be disclosed, as a routine use, in the course of
presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
opposing counsel in the course of settlement negotiations.
3. A record in this system of records may be disclosed, as a routine use, to a Member of
Congress submitting a request involving an individual, to whom the record pertains, when the
individual has requested assistance from the Member with respect to the subject matter of the
record.
4. A record in this system of records may be disclosed, as a routine use, to a contractor of the
Agency having need for the information in order to perform a contract. Recipients of
information shall be required to comply with the requirements of the Privacy Act of 1974, as
amended, pursuant to 5 U.S.C. 552a(m).
5. A record related to an International Application filed under the Patent Cooperation Treaty in
this system of records may be disclosed, as a routine use, to the International Bureau of the
World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
6. A record in this system of records may be disclosed, as a routine use, to another federal
agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
the Atomic Energy Act (42 U.S.C. 218(c)).
7. A record from this system of records may be disclosed, as a routine use, to the Administrator,
General Services, or his/her designee, during an inspection of records conducted by GSA as
part of that agency’s responsibility to recommend improvements in records management
practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
be made in accordance with the GSA regulations governing inspection of records for this
purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
be used to make determinations about individuals.
8. A record from this system of records may be disclosed, as a routine use, to the public after
either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
CFR 1.14, as a routine use, to the public if the record was filed in an application which
became abandoned or in which the proceedings were terminated and which application is
referenced by either a published application, an application open to public inspection or an
issued patent.
9. A record from this system of records may be disclosed, as a routine use, to a Federal, State,
or local law enforcement agency, if the USPTO becomes aware of a violation or potential
violation of law or regulation.




Line 3,756: Line 3,806:
   
   


Privacy Act Statment
1415.01Maintenance Fees on the Original
Patent [R-5]


The filing of a reissue application does not alter the
schedule of payments of maintenance fees on the
original patent. If maintenance fees have not been
paid on the original patent as required by 35 U.S.C.
41(b) and 37 CFR 1.20, and the patent has expired, no
reissue patent can be granted. 35 U.S.C. 251, first
paragraph, only authorizes the granting of a reissue
patent for the unexpired term of the original patent.
Once a patent has expired, the Director of the USPTO
no longer has the authority under 35 U.S.C. 251 to
reissue the patent. See In re Morgan, 990 F.2d 1230,
26
USPQ2d 1392 (Fed. Cir. 1993).


The examiner should determine whether all
required maintenance fees have been paid prior to
conducting an examination of a reissue application. In
addition, during the process of preparing the reissue
application for issue, the examiner should again determine
whether all required maintenance fees have been
paid up to date.


The history of maintenance fees is determined by
the following, all of which should be used (to provide
a check on the search made):


(A)Go to the USPTO Intranet (http://ptoweb/ptointranet/
index.htm) and select the PALM screen, then
the “General Information” screen, type in the patent
number and then select the “Fees” screen.


(B)Go to the USPTO Intranet and then the “Revenue
Accounting and Management” screen, then the
“File History” screen. Then type in the patent number.
(C)Go to the USPTO Internet Site (http://
www.uspto.gov) and select “eBusiness”, then the
“Patent Electronic Business Center” screen, then the
“Patent Application Information Retrieval (PAIR)”
screen (http://pair.uspto.gov/cgi-bin/final/home.pl),
and type in the patent number and select the “view
Maint. Statement” screen.


If the window for the maintenance fee due has
closed (maintenance fees are due by the day of the
4th, 8th and 12th year anniversary of the grant of the
patent), but the maintenance fee has not been paid,
the Office of Patent Legal Administration (OPLA)
should be contacted by the Technology Center
(TC) Special Program Examiner (SPRE) for instructions
as to what appropriate action to take.


PAYMENT OF MAINTENANCE FEES WHERE
THE PATENT HAS BEEN REISSUED


1414.01Supplemental Reissue Oath/
Pursuant to 37 CFR 1.362(b), maintenance fees are
Declaration [R-5]
not required for a reissue patent if the original patent
that was reissued did not require maintenance fees.


If additional defects or errors are corrected in the  
Where the original patent that was reissued did
reissue after the filing of the application and the original  
require maintenance fees, the schedule of payments of
reissue oath or declaration, a supplemental reissue
maintenance fees on the original patent will continue
oath/declaration must be filed, unless all additional
for the reissue patent. 37 CFR 1.362(h). Once an original
errors corrected are spelling, grammar, typographical,
patent reissues, maintenance fees are no longer
editorial or clerical errors which are not errors under
due in the original patent, but rather the maintenance
35 U.S.C. 251 (see MPEP § 1402). In other words, a
fees are due in the reissue patent. This is because upon
supplemental oath/declaration is required where any
the issuance of the reissue patent, the original patent is
“error” under 35 U.S.C. 251 has been corrected and
surrendered and ceases to exist.
the error was not identified in the original reissue
oath/declaration.


The supplemental reissue oath/declaration must
In some instances, more than one reissue patents
state that every error which was corrected in the reissue  
will be granted to replace a single original patent. The  
application not covered by the prior oath(s)/declaration(
issuance of more than one reissue patent does not alter
s) submitted in the application arose without
the schedule of payments of maintenance fees on the
any deceptive intention on the part of the applicant.  
original patent. The existence of multiple reissue patents
for one original patent can arise where multiple
divisional reissue applications are filed for the same
patent, and the multiple applications issue as reissue  
patents (all to replace the same original patent). In
addition, a divisional application or continuation
application of an existing reissue application may be
filed, and both may then issue as reissue patents. In
such instances, 35 U.S.C. 41 does not provide for the
charging of more than one maintenance fee for the
multiple reissues. Thus, no payment of additional
maintenance fees is required for the second or subsequent
reissue patents, i.e., continuation or divisional
reissues, which are derived from a first reissue patent
which has issued. The maintenance fee must be
directed to the first reissue patent that has issued. This
is unlike the instance where there is a reissue of a reissue
patent, and the maintenance fee must be directed
to the reissue of the reissue patent.


An example of acceptable language is as follows:
See MPEP Chapter 2500 for additional information
pertaining to maintenance fees.


“Every error in the patent which was corrected in the
==1416 No Physical Surrender of Original Patent==
present reissue application, and is not covered by the prior
declaration submitted in this application, arose without
any deceptive intention on the part of the applicant.”


A supplemental reissue oath/declaration will not be
37 CFR 1.178. Original patent; continuing duty of  
effective for any errors which are corrected by a filing
applicant.
made after the execution of the supplemental reissue
oath/declaration, unless it is clear from the record that
the parties executing the document were aware of the
nature of the correction when they executed the document.  
Further, a supplemental reissue oath/declaration
with an early date of execution cannot be filed after a
correction made later in time, to cover the correction
made after the execution date. This is so, even if the
supplemental reissue oath/declaration states that all
errors up to the filing of the supplemental reissue
oath/declaration oath or declaration arose without
any deceptive intention on the part of the applicant.


(a)The application for reissue of a patent shall constitute
an offer to surrender that patent, and the surrender shall take effect




Form PTO/SB/51S, “Supplemental Declaration For
Reissue Patent Application To Correct ‘Errors’ Statement
(37 CFR 1.175),” may be used to prepare a supplemental
reissue declaration. Form PTO/SB/51S
serves to indicate that every error in the patent that
was corrected in the reissue application, but was not
covered by a prior reissue oath/declaration submitted
in the reissue application, arose without any deceptive
intention on the part of the applicant.
In the event that the applicant for a reissue applicant
is required to file a supplemental reissue oath/
declaration that also includes a specific statement of
the error being corrected by reissue in accordance
with 37 CFR 1.175(c), as discussed in subsection I.
below, applicant must also include in the supplemental
declaration language equivalent to the “Every error
…” language in the example of acceptable language
set forth above. Therefore, if either form PTO/SB/51,
“Reissue Application Declaration By The Inventor,”
or form PTO/SB/52, “Declaration By The Assignee”
(see MPEP § 1414) is used for the purpose of filing
such supplemental reissue oath/declaration, the form
must be completed so that it is clear that the supplemental
reissue oath/declaration addresses all errors
corrected subsequent to the date upon which the last
previously reissue oath/declaration (whether original
or supplemental) was filed. For example, the form
could be completed by specifying the date upon
which the reissue application was originally filed, the
reissue application number, and the date(s) of every
amendment filed subsequent to the date upon which
the last reissue oath/declaration (whether original or
supplemental) was filed. Any manner of completing
the form so that affiant/declarant unambiguously
states that every error corrected subsequent to the filing
of the last filed reissue oath/declaration (whether
original or supplemental) arose without deceptive
intent will be acceptable. It will not be acceptable for
the new (“catch-up”) oath/declaration to simply refer
to the reissue application as filed, even though the
new oath/declaration may be submitted after an
amendment.
I.WHEN AN ERROR MUST BE STATED IN
THE SUPPLEMENTAL OATH/
DECLARATION


In the supplemental reissue oath/declaration, there
is no need to state an error which is relied upon to
support the reissue application if:


(A)an error to support a reissue has been previously
and properly stated in a reissue oath/declaration
in the application; and


(B)that error is still being corrected in the reissue  
upon reissue of the patent. Until a reissue application is granted,
application.  
the original patent shall remain in effect.






37 CFR 1.178(a) was amended, effective October
21, 2004, to eliminate the requirement for physical
surrender of the original letters patent (i.e., the
“ribbon copy” of the original patent) in a reissue
application, and to make surrender of the original
patent automatic upon the grant of the reissue patent.


Amended 37 CFR 1.178(a) applies retroactively to
all pending applications. For those applications with
an outstanding requirement for the physical surrender
of the original letters patent, a reissue applicant must
timely reply that the requirement is moot in view of
the implementation of the amended rule. Such a reply
will be considered a complete reply to any requirement
directed toward the surrender of the original letters
patent. It is to be noted that the Office will not
conduct a search to withdraw Office actions where the
only outstanding requirement is compliance with the
physical surrender of the original letters patent.


If applicant chooses to state any further error at this
Example 1:
point (even though such is not needed), the examiner
should not review the statement of the further error.


The supplemental reissue oath/declaration muststate an error which is relied upon to support the reissue  
An Office action issues prior to the effective date
application only where one of the following is
of the amendment to 37 CFR 1.178 with only a
true:
requirement for a return of the original letters
patent to the Office. A two-month period for reply
is set in the Office action. Applicant fails to timely
reply to the Office action, relying on the amendment
to 37 CFR 1.178 as mooting the requirement
for physical surrender of the original letters patent.
The six-month full statutory period for reply
expires. In this instance, the reissue application
would be abandoned (as of the day after the last
day of the two-month period set in the Office
action) for failure to timely reply to the Office
action, because no reply was timely filed.


(A)the prior reissue oath/declaration failed to
Example 2:
state an error;


(B)the prior reissue oath/declaration attempted to  
An Office action issues prior to the effective date
state an error but did not do so properly; or
of the amendment to 37 CFR 1.178 with the only
requirement for a return of the original letters
patent to the Office. Applicant fails to reply to the
Office action within the two-month period set in
the Office action, relying on the amendment to
37
CFR 1.178 as mooting the requirement for
physical surrender of the original letters patent. In
reviewing the reissue application in connection
with a related application, the examiner notes the
omission prior to the expiration of the six-month
full statutory period for reply. In this instance, the
examiner may telephone the applicant, and remind
the applicant of the need to file a timely reply.


(C)all errors under 35 U.S.C. 251 stated in the
Example 3:
prior reissue oath(s)/declaration(s) are no longer being
corrected in the reissue application.


II.WHEN A SUPPLEMENTAL OATH/DE-
An Office action issues prior to the effective date
CLARATION MUST BE SUBMITTED
of the amendment to 37 CFR 1.178 with the only
requirement being a return of the original letters
patent to the Office. Applicant timely replies to the
Office that it should vacate/withdraw the requirement,
or otherwise indicates that return of the original
letters patent is now unnecessary. In this
instance, a complete reply would have been filed,
and the requirement would be withdrawn and the
application passed to issue.


The supplemental oath/declaration in accordance
Example 4:
with 37 CFR 1.175(b)(1) must be submitted before
allowance. See MPEP § 1444 for a discussion of the
action to be taken by the examiner to obtain the supplemental
oath/declaration in accordance with 37
CFR 1.175(b)(1), where such is needed.


Where applicant seeks to correct an error after
An Office action issues prior to the effective date
allowance of the reissue application, a supplemental
of the amendment to 37 CFR 1.178 with both (a) a  
reissue oath/declaration must accompany the  
requirement to return the original letters patent to
requested correction stating that the error(s) to be corrected
the Office, and (b) a rejection of the claims under
arose without any deceptive intention on the  
35 U.S.C. 103. Applicant timely replies to the
part of the applicant. The supplemental reissue oath/
Office action addressing only the rejection under
declaration submitted after allowance will be directed
35 U.S.C. 103 (but not the need for physical surrender
to the error applicant seeks to correct after allowance.  
of the original letters patent). In this
This supplemental oath/declaration need not cover
instance, the reply would be accepted as complete,
any earlier errors, since all earlier errors should have
and the Office would withdraw the requirement for
been covered by a reissue oath/declaration submitted
physical surrender of the original letters patent.  
prior to allowance.
(The requirement was proper when made, so the
Office would not vacate the action in regard to
submission of the original letters patent.).


III.SUPPLEMENTAL OATH/DECLARA-
Where the patentee has submitted the original letters
TION IN BROADENING REISSUE
patent in a reissue application subject to  
 
37  
A broadening reissue application must be applied
CFR 1.178 as it is now amended, the Office
for by all of the inventors (patentees), that is, the original  
may, in response to a timely request, return the  
reissue oath/declaration must be signed by all of
original letters patent, when it can be readily
the inventors. See MPEP § 1414. If a supplemental
retrieved from where it is stored, namely, the paper
oath/declaration in a broadening reissue application is
application file, or the artifact storage area for an
subsequently needed in the application in order to fulfill
Image File Wrapper (IFW) file. Any request for
the requirements of 37 CFR 1.175, the supplemental
return of the letters patent which is submitted after
reissue oath/declaration must be signed by all of
the issue fee has been paid will require a petition
the inventors. In re Hayes, 53 USPQ2d 1222, 1224
pursuant to 37 CFR 1.59(b) to expunge from the
(Comm’r Pat. 1999) (“37 CFR 1.175(b)(1), taken in
file and return the original letters patent. Where
conjunction with Section 1.172, requires a supplemental
the original letters patent cannot be readily
declaration be signed by all of the inventors.
retrieved, or in the rare instance that it has been
This is because all oaths or declarations necessary to
subsequently misplaced, the Office will not be able
fulfill the rule requirements in a reissue application
are taken together collectively as a single oath or declaration.
Thus, each oath and declaration must bear
the appropriate signatures of all the inventors.”).


If a joint inventor refuses or cannot be found or
reached to sign a supplemental oath/declaration, a
supplemental oath/declaration listing all the inventors,
and signed by all the available inventors may be filed
provided it is accompanied by a petition under 37
CFR 1.183 along with the petition fee, requesting
waiver of the signature requirement of the nonsigning
inventor.


 






to return the original letters patent and will not create
a new one.


Example 5:


In an application filed after the effective date of
the amendment to 37 CFR 1.178, applicant has
mistakenly submitted the original letters patent
and later seeks its return. In this instance, provided
applicant timely requests the return of the original
letters patent, the Office would return the patent,
provided it can be readily retrieved.


Example 6:


SUPPLEMENTAL DECLARATION FOR REISSUE PATENT APPLICATION TO CORRECT “ERRORS” STATEMENT (37 CFR 1.175)
A reissue application was pending at the time of
PTO/SB/51S (09-04)
the effective date of the amendment to 37 CFR  
Approved for use through 04/30/2007. OMB 0651-0033
1.178, and an original letters patent was submitted.  
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Applicant requests return of the original letters
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
patent, although the application is abandoned at
Attorney Docket Number
the time the request for return is made. In this
First Named Inventor
instance, the Office would return the original letters
COMPLETE if known
patent if it is readily retrievable. Even where
Application Number
the reissue application was already abandoned at
Filing Date
the time of the effective date of the amendment to  
Art Unit
37 CFR 1.178, the Office would also return the  
SUPPLEMENTAL DECLARATION
original letters patent.
FOR REISSUE
PATENT APPLICATION
TO CORRECT “ERRORS” STATEMENT
(37 CFR 1.175)
Examiner Name
I/We hereby declare that:
Every error in the patent which was corrected in the present reissue application, and which is not covered by the
prior oath(s) and/or declaration(s) submitted in this application, arose without any deceptive intention on the part of
the applicant.  
I/We hereby declare that all statements made herein of my/our own knowledge are true and that all statements made
on information and belief are believed to be true; and further that these statements were made with the knowledge
that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C.  
1001 and that such willful false statements may jeopardize the validity of the application or any patent issued
thereon.  
Name of Sole or First Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or Surname
Inventor’s
SignatureDate
Name of Second Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or Surname
Inventor’s
SignatureDate
Name of Third Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or Surname
Inventor’s
SignatureDate
Name of Fourth Inventor: A petition has been filed for this unsigned inventor
Given Name (first and middle [if any]) Family Name or SurnameInventor’s
SignatureDate
Additional inventors or legal representatives(s) are being named on the __________ supplemental sheets PTO/SB/02A or 02LR attached hereto.
This collection of information is required by 37 CFR 1.175. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO
to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 1.8 minutes to complete,
including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on
the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
ADDRESS. SEND TO:Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
Doc Code:


Example 7:


A reissue application is pending at the time of the
effective date of the amendment to 37 CFR 1.178.
An original letters patent was submitted, and the
issue fee has been paid for the reissue application
at the time the request for return of the original letters
patent is made. In this instance, the Office may
similarly return the original letters patent, but only
if the request is accompanied by a grantable petition
under 37 CFR 1.59(b).


Example 8:


A reissue application was pending at the time of
the effective date of the amendment to 37 CFR
1.178. An original letters patent was submitted,
and the reissue application then issued as a reissue
patent. After the reissue patent issues, the request
for return of the original letters patent is made.
Once again, the Office may return the original letters
patent, but only if the request is accompanied
by a grantable petition under 37 CFR 1.59(b).


Example 9:


A reissue application issued as a reissue patent
prior to the effective date of the amendment to
37
CFR 1.178. The reissue applicant, now the patentee,
requests return of the original letters patent
that was submitted in the reissue application. In
this instance, the Office will not return the original
letters patent. The original letters patent was submitted
in reply to a requirement that was in effect
throughout the pendency of the reissue application.




1415Reissue Application and Issue Fees
[R-5]


I.BASIC REISSUE APPLICATION FILING,
SEARCH, AND EXAMINATION FEES


The Consolidated Appropriations Act, 2005 (Consolidated
==1417 Claim for Benefit Under 35 U.S.C. 119(a)-(d)==
Appropriations Act), effective December 8,
2004, provides for a separate reissue application filing
fee, search fee, and examination fee during fiscal
years 2005 and 2006. For reissue applications filed on
or after December 8, 2004, the following fees are
required: basic filing fee as set forth in 37 CFR
1.16(e)(1); search fee as set forth in 37 CFR 1.16(n);
examination fee as set forth in 37 CFR 1.16(r); application
size fee, if applicable (see subsection II.
below); and excess claims fees, if applicable (see subsection
III. below).


For reissue applications filed prior to December 8,
PRIORITY UNDER 35 U.S.C. 119(a)-(d) WAS
2004, the following fees are required: basic filing fee
PERFECTED IN THE ORIGINAL PATENT
as set forth in 37 CFR 1.16(e)(2); and excess claims
fees, if applicable (see subsection III below). No
search and examination fees are required for reissue
applications filed before December 8, 2004.


The basic filing, search and examination fees are
A “claim” for the benefit of an earlier filing date in
due on filing of the reissue application. These fees
a foreign country under 35 U.S.C. 119(a)-(d) must be
may be paid on a date later than the filing date of the
made in a reissue application, even though such a  
reissue application provided they are paid within the
claim was previously made in the application for the  
time period set forth in 37 CFR 1.53(f) and include
original patent to be reissued. However, no additional
the surcharge set forth in 37 CFR 1.16(f). For reissue
certified copy of the foreign application is necessary.
applications filed on or after December 8, 2004 but
The procedure is similar to that for “Continuing
prior to July 1, 2005, which have been accorded a filing
Applications” in MPEP § 201.14(b).
date under 37 CFR 1.53(b), if the search and/or
examination fees are paid on a date later than the filing
date of the reissue application, the surcharge
under 37 CFR 1.16(f) is not required. For reissue
applications filed on or after July 1, 2005, which have
been accorded a filing date under 37 CFR 1.53(b), if
any of the basic filing fee, the search fee, or the examination
fee are paid on a date later than the filing date
of the reissue application, the surcharge under 37 CFR
1.16(f) is required.  


For reissue applications filed on or after December
In addition, 37 CFR 1.63 requires that in any application
8, 2004, in which a petition under 37 CFR  
in which a claim for foreign priority is made
1.138(d) to expressly abandon the application was
pursuant to 37 CFR 1.55, the oath or declaration must
filed on or after March 10, 2006, applicant may file a  
identify the foreign application for patent or inventors’
request for refund of the search fee and excess claims
certificate on which priority is claimed unless
fee paid in the application. See MPEP § 711.01.
supplied on an application data sheet (37 CFR 1.76),  
and any foreign applications having a filing date
before that of the application on which priority is
claimed, by specifying:


II.APPLICATION SIZE FEE
(A)the application number of the foreign application;


The Consolidated Appropriations Act also provides
for an application size fee. 37 CFR 1.16(s) sets forth
the application size fee for reissue applications filed
on or after December 8, 2004, the specification and
drawings of which, excluding a sequence listing or
computer program listing filed in an electronic
medium in compliance with the rules (see 37 CFR
1.52(f)), exceed 100 sheets of paper. The application
size fee does not apply to reissue applications filed
before December 8, 2004. The application size fee
applies for each additional 50 sheets or fraction
thereof over 100 sheets of paper. Any sequence listing
in an electronic medium in compliance with 37 CFR
1.52(e) and 37 CFR 1.821(c) or (e), and any computer
program listing filed in an electronic medium in compliance
with 37 CFR 1.52(e) and 1.96, will be
excluded when determining the application size fee
required by 37 CFR 1.16(s). See also MPEP § 607.


III.EXCESS CLAIMS FEES
(B)the foreign country or intellectual property
authority; and


37 CFR 1.16(h) sets forth the excess claims fee for
(C)the day, month, and year of the filing of the  
each independent claim in excess of three. 37 CFR
foreign application.
1.16(i) sets forth the excess claims fee for each claim
(whether independent or dependent) in excess of
twenty. The access claims fees specified in 37 CFR
1.16(h) and (i) apply to all reissue applications pending
on or after December 8, 2004. The excess claims
fees specified in 37 CFR 1.16(h) and (i) apply to any
excess claims fee paid on or after December 8, 2004,
regardless of the filing date of the reissue application
and regardless of the date on which the claim necessitating
the excess claims fee payment was added to the  
reissue application.  


For reissue applications filed on or after December
8, 2004, in which a petition under 37 CFR
1.138(d) to expressly abandon the application was
filed on or after March 10, 2006, applicant may file a
request for refund of the search fee and excess claims
fee paid in the application. See MPEP § 711.01.


Under 35 U.S.C. 41(a)(2) as amended by the Consolidated
Appropriations Act, the claims in the original
patent are not taken into account in determining
the excess claims fee for a reissue application.


Example 1:


Applicant filed a reissue application before
December 8, 2004, with the same number of


The examiner should note that the heading on
printed copies of the patent will not be carried forward
to the reissue from the original patent. Therefore,
it is important that the bibliographic data sheet
(or the front face of the reissue file wrapper for series
08/ and earlier paper applications) be endorsed by the
examiner under “FOREIGN APPLICATIONS.” For
an IFW reissue file, a copy of the bibliographic data
sheet should be printed from the IFW file history. The
printed copy should be annotated by the examiner and
then the annotated copy should be scanned into the
IFW.


PRIORITY UNDER 35 U.S.C. 119(a)-(d) IS
NEWLY PERFECTED IN THE REISSUE APPLICATION




A reissue was granted in Brenner v. State of Israel,
400 F.2d 789, 158 USPQ 584 (D.C. Cir. 1968), where
the only ground urged was failure to file a certified
copy of the original foreign application to obtain the
right of foreign priority under 35 U.S.C. 119(a)-(d)
before the patent was granted. In Brenner, the claim
for priority had been made in the prosecution of the
original patent, and it was only necessary to submit a
certified copy of the priority document in the reissue
application to perfect priority (the claim for priority
must be repeated in the reissue application). Reissue
is also available to correct the “error” in failing to take
any steps to obtain the right of foreign priority under
35 U.S.C. 119(a)-(d) before the original patent was
granted. See Fontijn v. Okamoto, 518 F.2d 610, 622,
186 USPQ 97, 106 (CCPA 1975) (“a patent may be
reissued for the purpose of establishing a claim to priority
which was not asserted, or which was not perfected
during the prosecution of the original
application”) In a situation where it is necessary to
submit for the first time both the claim for priority and
the certified copy of the priority document in the reissue
application and the patent to be reissued resulted
from a utility or plant application filed on or after
November 29, 2000, the reissue applicant will have to
file a petition for an unintentionally delayed priority
claim under 37 CFR 1.55(c) in addition to filing a
reissue application. See MPEP §
   
   
201.14(a).
==1418 Notification of Prior/Concurrent Proceedings and Decisions Thereon, and of Information Known to be Material to Patentability==
37 CFR 1.178. Original patent; continuing duty of
applicant.


claims as in the patent. The patent has more than 3
independent claims and more than 20 total claims.
If applicant added one more independent claim in
the reissue application by filing an amendment
before December 8, 2004, but did not pay for the
excess claims fees prior to December 8, 2004, on
or after December 8, 2004, applicant will have to
pay for one additional independent claim per the
fee set forth in 37 CFR 1.16(h) and one additional
total claim per the fee set forth in 37 CFR 1.16(i).


Example 2:


Applicant filed a reissue application on or after
(b)In any reissue application before the Office, the applicant
December 8, 2004, with the same number of  
must call to the attention of the Office any prior or concurrent proceedings
claims as in the patent. The patent has 4 independent
in which the patent (for which reissue is requested) is or
claims and 21 total claims. Excess claims fees
was involved, such as interferences, reissues, reexaminations, or
for the 4th independent claim (one additional independent
litigations and the results of such proceedings (see also
claim per the fee set forth in 37 CFR
§
1.16(h)) and the 21st claim (one additional total
claim per the fee set forth in 37 CFR 1.16(i)) are
1.173(a)(1)).
required. Under 35 U.S.C. 41(a)(2) as amended by
the Consolidated Appropriations Act, the claims in
the original patent are not taken into account in
determining the excess claims fees for a reissue
application.


The excess claims fees, if any, due with an amendment
37 CFR 1.178(b) requires reissue applicants to call
are required prior to any consideration of the  
to the attention of the Office any prior or concurrent
amendment by the examiner. Upon submission of an
proceeding in which the patent (for which reissue is  
amendment (whether entered or not) affecting the
requested) is or was involved and the results of such
claims, payment of fees for those claims in excess of
proceedings. These proceedings would include interferences,  
the number previously paid for is required. The additional
reissues, reexaminations, and litigations.  
fees, if any, due with an amendment are calculated
Litigation would encompass any papers filed in the  
on the basis of the claims (total and
court or issued by the court, which may include, for
independent) which would be present, if the amendment
example, motions, pleadings, and court decisions.  
were entered. If an amendment is limited to
This duty to submit information is continuing, and
revising the existing claims and it does not result in
runs from the time the reissue application is filed until
the addition of any new claim, there is no excess
the reissue application is abandoned or issues as a  
claim fee. Excess claims fees apply only to the addition
reissue patent.
of claims. It is to be noted that where excess
claims fees have been previously paid, a later amendment
affecting the claims cannot serve as the basis for
granting any refund. See 37 CFR 1.26(a).  


Amendments filed before a first Office action, or  
In addition, a reissue application is subject to the
otherwise not filed in reply to an Office action, presenting
same duty of disclosure requirements as is any other
additional claims in excess of the number
nonprovisional application. The provisions of 37 CFR
already paid for, not accompanied by the full additional
1.63 require acknowledgment in the reissue oath or  
claims fee due, will not be entered in whole or
declaration of the “duty to disclose to the Office all
in part and applicant will be so notified. Such amendments
information known to the [applicants] to be material
filed in reply to an Office action will be
to patentability as defined in §
regarded as being non-responsive to the Office action
and the practice set forth in MPEP § 714.03 will be
1.56.” Note that the  
followed.  
Office imposes no responsibility on a reissue applicant
to resubmit, in a reissue application, all the “References
Cited” in the patent for which reissue is
sought. Rather, applicant has a continuing duty under
37 CFR 1.56 to timely apprise the Office of any information
which is material to the patentability of the
claims under consideration in the reissue application.


An amendment canceling claims accompanying the
37 CFR 1.97 and 37 CFR 1.98 provide a mechanism
papers constituting the reissue application will be
to submit information known to applicants to be  
effective to diminish the number of claims to be considered
material to patentability. Information submitted in
in calculating the filing fees to be paid. A preliminary
compliance with 37 CFR 1.97 and 37 CFR 1.98 will
amendment filed concurrently with a reply to
be considered by the Office. See MPEP § 609.  
a Notice To File Missing Parts of Application that
Although a reissue applicant may utilize 37 CFR 1.97and 37 CFR 1.98 to comply with the duty of disclo
required the filing fees, which preliminary amendment
cancels or adds claims, will be taken into
account in determining the appropriate filing fees due
in response to the Notice To File Missing Parts of
Application. However, no refund will be made for
claims being canceled in the reply that have already
been paid for.
 
After a requirement for restriction, non-elected
claims will be included in determining the fees due in
connection with a subsequent amendment unless such
claims are canceled.
 
IV.ISSUE FEE


The issue fee for issuing each reissue patent is set
forth in 37 CFR 1.18(a).
V.REISSUE APPLICATION FEE TRANS-
MITTAL FORM
The Office has prepared Form PTO/SB/56, Reissue
Application Fee Transmittal Form which is designed
to assist in the correct calculation of reissue filing
fees.




Line 4,218: Line 4,244:
   
   


Reissue Application Fee Transmittal Form
sure required by 37 CFR 1.56, this does not relieve
applicant of the duties under 37 CFR 1.175 of, for
example, stating “at least one error being relied
upon.”


While 37 CFR 1.97(b) provides for the filing of an
information disclosure statement within 3 months of
the filing of an application or before the mailing date
of a first Office action, reissue applicants are encouraged
to file information disclosure statements at the
time of filing of the reissue application so that such
statements will be available to the public during the 2-
month period provided in MPEP § 1441. Form paragraph
14.11.01 may be used to remind applicant of the
duties to timely make the Office aware of (A) any
prior or concurrent proceeding (e.g., litigation or
Office proceedings) in which the patent to be reissued
is or was involved, and (B) any information which is
material to patentability of the claims in the reissue
application.
¶ 14.11.01 Reminder of Duties Imposed by 37 CFR
1.178(b) and 37 CFR 1.56
Applicant is reminded of the continuing obligation under 37
CFR 1.178(b), to timely apprise the Office of any prior or concurrent
proceeding in which Patent No. [1] is or was involved. These
proceedings would include interferences, reissues, reexaminations,
and litigation.
Applicant is further reminded of the continuing obligation
under 37 CFR 1.56, to timely apprise the Office of any information
which is material to patentability of the claims under consideration
in this reissue application.
These obligations rest with each individual associated with the
filing and prosecution of this application for reissue. See also
MPEP §§ 1404, 1442.01 and 1442.04.
Examiner Note:


1.This form paragraph is to be used in the first action in a reissue
application.


2.In bracket [1], insert the patent number of the original patent
for which reissue is requested.


==1430 Reissue Files Open to the Public and, Notice of Filing Reissue Announced in, Official Gazette==


37 CFR 1.11. Files open to the public.
 
Privacy Act Statment
Privacy Act Statement
ThePrivacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
with your submission of the attached form related to a patent application or patent. Accordingly,
pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
Office is to process and/or examine your submission related to a patent application or patent. If you do
not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
process and/or examine your submission, which may result in termination of proceedings or
abandonment of the application or expiration of the patent.
The information provided by you in this form will be subject to the following routine uses:
1. The information on this form will be treated confidentially to the extent allowed under the
Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
this system of records may be disclosed to the Department of Justice to determine whether
disclosure of these records is required by the Freedom of Information Act.
2. A record from this system of records may be disclosed, as a routine use, in the course of
presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
opposing counsel in the course of settlement negotiations.
3. A record in this system of records may be disclosed, as a routine use, to a Member of
Congress submitting a request involving an individual, to whom the record pertains, when the
individual has requested assistance from the Member with respect to the subject matter of the
record.
4. A record in this system of records may be disclosed, as a routine use, to a contractor of the
Agency having need for the information in order to perform a contract. Recipients of
information shall be required to comply with the requirements of the Privacy Act of 1974, as
amended, pursuant to 5 U.S.C. 552a(m).
5. A record related to an International Application filed under the Patent Cooperation Treaty in
this system of records may be disclosed, as a routine use, to the International Bureau of the
World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
6. A record in this system of records may be disclosed, as a routine use, to another federal
agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
the Atomic Energy Act (42 U.S.C. 218(c)).
7. A record from this system of records may be disclosed, as a routine use, to the Administrator,
General Services, or his/her designee, during an inspection of records conducted by GSA as
part of that agency’s responsibility to recommend improvements in records management
practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
be made in accordance with the GSA regulations governing inspection of records for this
purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
be used to make determinations about individuals.
8. A record from this system of records may be disclosed, as a routine use, to the public after
either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37  
CFR 1.14, as a routine use, to the public if the record was filed in an application which
became abandoned or in which the proceedings were terminated and which application is
referenced by either a published application, an application open to public inspection or an
issued patent.
9. A record from this system of records may be disclosed, as a routine use, to a Federal, State,
or local law enforcement agency, if the USPTO becomes aware of a violation or potential
violation of law or regulation.  
 
 
 
 




1415.01Maintenance Fees on the Original
Patent [R-5]


The filing of a reissue application does not alter the  
(b)All reissue applications, all applications in which the
schedule of payments of maintenance fees on the  
Office has accepted a request to open the complete application to
original patent. If maintenance fees have not been
inspection by the public, and related papers in the application file,
paid on the original patent as required by 35 U.S.C.  
are open to inspection by the public, and copies may be furnished
41(b) and 37 CFR 1.20, and the patent has expired, no
upon paying the fee therefor. The filing of reissue applications,
reissue patent can be granted. 35 U.S.C. 251, first
other than continued prosecution applications under § 1.53(d) of
paragraph, only authorizes the granting of a reissue  
reissue applications, will be announced in the Official Gazette.  
patent for the unexpired term of the original patent.
The announcement shall include at least the filing date, reissue  
Once a patent has expired, the Director of the USPTO
application and original patent numbers, title, class and subclass,
no longer has the authority under 35 U.S.C. 251 to
name of the inventor, name of the owner of record, name of the  
reissue the patent. See In re Morgan, 990 F.2d 1230,
attorney or agent of record, and examining group to which the  
26
reissue application is assigned.
USPQ2d 1392 (Fed. Cir. 1993).  


The examiner should determine whether all
required maintenance fees have been paid prior to
conducting an examination of a reissue application. In
addition, during the process of preparing the reissue
application for issue, the examiner should again determine
whether all required maintenance fees have been
paid up to date.


The history of maintenance fees is determined by
the following, all of which should be used (to provide
a check on the search made):


(A)Go to the USPTO Intranet (http://ptoweb/ptointranet/
Under 37 CFR 1.11(b) all reissue applications filed
index.htm) and select the PALM screen, then
after March 1, 1977, are open to inspection by the
the “General Information” screen, type in the patent
general public, and copies may be furnished upon
number and then select the “Fees” screen.
paying the fee therefor. The filing of reissue applications
(except for continued prosecution applications
(CPA’s) filed under 37
CFR 1.53(d)) will be
announced in the Official Gazette. The announcement
gives interested members of the public an opportunity
to submit to the examiner information pertinent to the
patentability of the reissue application. The announcement
includes the filing date, reissue application and
original patent numbers, title, class and subclass,
name of the inventor, name of the owner of record,
name of the attorney or agent of record, and the Technology
Center (TC) to which the reissue application is
initially assigned. A TC Director or other appropriate
Office official may, under appropriate circumstances,
postpone access to or the making of copies of a
paper reissue application file, such as, for example,
to avoid interruption of the examination or other
review of the application by an examiner. 
 
IFW reissue application files are open to inspection
by the general public by way of Public PAIR via
the USPTO Internet site. In viewing the images of the
files, members of the public will be able to view the
entire content of the reissue application file history.
To access Public PAIR, a member of the public would
(A) go to the USPTO web site at http://
www.uspto.gov, (B) click on “Patents”, (C) under
“Check Status, View Papers…” click on “Status &
IFW,” and (D) under “Patent Application Information
Retrieval” enter the reissue application number.
 
A notice of a reissue application in the Official
Gazette should be published prior to any examination
of the application. If an inadvertent failure to publish
notice of the filing of the reissue application in the  
Official Gazette is recognized later in the examination,  
action should be taken to have the notice published
as quickly as possible, and action on the  
application may be delayed until two months after the  
 


(B)Go to the USPTO Intranet and then the “Revenue
Accounting and Management” screen, then the
“File History” screen. Then type in the patent number.


(C)Go to the USPTO Internet Site (http://
www.uspto.gov) and select “eBusiness”, then the
“Patent Electronic Business Center” screen, then the
“Patent Application Information Retrieval (PAIR)”
screen (http://pair.uspto.gov/cgi-bin/final/home.pl),
and type in the patent number and select the “view
Maint. Statement” screen.


If the window for the maintenance fee due has
closed (maintenance fees are due by the day of the  
 
4th, 8th and 12th year anniversary of the grant of the  
publication, allowing for any protests to be filed. For
patent), but the maintenance fee has not been paid,
a discussion of protests, see MPEP Chapter 1900.
the Office of Patent Legal Administration (OPLA)
 
should be contacted by the Technology Center
The filing of a continued prosecution application
(TC) Special Program Examiner (SPRE) for instructions
(CPA) under 37 CFR 1.53(d) of a reissue application
as to what appropriate action to take.
will not be announced in the Official Gazette.
Although the filing of a CPA of a reissue application
constitutes the filing of a reissue application, the  
announcement of the filing of such CPA would be
redundant in view of the announcement of the filing
of the prior reissue application in the Official Gazetteand the fact that the same application number and file
will continue to be used for the CPA.


PAYMENT OF MAINTENANCE FEES WHERE
If applicant files a Request for Continued Examination
THE PATENT HAS BEEN REISSUED
(RCE) of the reissue application under 37 CFR
1.114 (which can be filed on or after May 29, 2000 for
a reissue application filed on or after June 8, 1995),
such filing will not be announced in the Official
Gazette. An RCE continues prosecution of the existing
reissue application and is not a filing of a new
application.


Pursuant to 37 CFR 1.362(b), maintenance fees are
not required for a reissue patent if the original patent
that was reissued did not require maintenance fees.


Where the original patent that was reissued did
require maintenance fees, the schedule of payments of
maintenance fees on the original patent will continue
for the reissue patent. 37 CFR 1.362(h). Once an original
patent reissues, maintenance fees are no longer
due in the original patent, but rather the maintenance
fees are due in the reissue patent. This is because upon
the issuance of the reissue patent, the original patent is
surrendered and ceases to exist.


In some instances, more than one reissue patents
The filing of all reissue applications, except for  
will be granted to replace a single original patent. The  
CPAs filed under 37 CFR 1.53(d), (note that effective
issuance of more than one reissue patent does not alter
July 14, 2003, CPA practice has been eliminated as to  
the schedule of payments of maintenance fees on the
utility and plant application) will be announced in the
original patent. The existence of multiple reissue patents
Official Gazette and will include certain identifying
for one original patent can arise where multiple
data as specified in 37 CFR 1.11(b). Access to a reissue  
divisional reissue applications are filed for the same
application that is maintained in paper must be  
patent, and the multiple applications issue as reissue
obtained from the area of the Office having jurisdiction
patents (all to replace the same original patent). In
over the reissue application file.  
addition, a divisional application or continuation
application of an existing reissue application may be  
filed, and both may then issue as reissue patents. In
such instances, 35 U.S.C. 41 does not provide for the
charging of more than one maintenance fee for the
multiple reissues. Thus, no payment of additional
maintenance fees is required for the second or subsequent
reissue patents, i.e., continuation or divisional
reissues, which are derived from a first reissue patent
which has issued. The maintenance fee must be  
directed to the first reissue patent that has issued. This
is unlike the instance where there is a reissue of a reissue
patent, and the maintenance fee must be directed
to the reissue of the reissue patent.


See MPEP Chapter 2500 for additional information
For reissue application files that are maintained in
pertaining to maintenance fees.
paper, the following access procedure will be
observed:


1416No Physical Surrender of Original
(A) Any member of the general public may
Patent [R-3]
request access to a particular reissue application filed
after March 1, 1977.  Since no record of such
request is intended to be kept, an oral request will suffice.
Reissue applications already on file prior to
March 1, 1977 are not automatically open to inspection,
but a liberal policy is followed by the Office of  
Patent Legal Administration and by the Board of
Patent Appeals and Interferences (see MPEP
§
1002.02(b)) in granting petitions for access to such
applications.


37 CFR 1.178. Original patent; continuing duty of  
(B)Paper reissue application files will be
applicant.
maintained in the TCs and inspection thereof will be
supervised by TC personnel. Although no general
limit is placed on the amount of time spent reviewing
the files, the Office may impose limitations, if necessary,
e.g., where the application is actively being processed.  


(a)The application for reissue of a patent shall constitute
an offer to surrender that patent, and the surrender shall take effect


(C)Where the reissue application file has left
the TC for administrative processing, requests for
access should be directed to the appropriate supervisory
personnel where the application is currently
located.


(D)Requests for copies of papers in the reissue
application file must be in writing and addressed to
the Mail Stop Document Services, Director of the
United States Patent and Trademark Office, P.O. Box
1450, Alexandria, VA 22313-1450. Such requests
may be either mailed or delivered to the Office Customer
Service Window (See MPEP § 502). The price
for copies made by the Office is set forth in 37 CFR
1.19.


==1440 Examination of Reissue Application==


37 CFR 1.176. Examination of reissue.
 
upon reissue of the patent. Until a reissue application is granted,
the original patent shall remain in effect.


(a)A reissue application will be examined in the same manner
as a non-reissue, non-provisional application, and will be subject
to all the requirements of the rules related to non-reissue
applications. Applications for reissue will be acted on by the
examiner in advance of other applications.


(b)Restriction between subject matter of the original patent
claims and previously unclaimed subject matter may be required
(restriction involving only subject matter of the original patent
claims will not be required). If restriction is required, the subject
matter of the original patent claims will be held to be constructively
elected unless a disclaimer of all the patent claims is filed in
the reissue application, which disclaimer cannot be withdrawn by
applicant.


37 CFR 1.178(a) was amended, effective October
37 CFR 1.176 provides that an original claim, if re-
21, 2004, to eliminate the requirement for physical
presented in a reissue application, will be fully examined
surrender of the original letters patent (i.e., the  
in the same manner, and subject to the same rules
“ribbon copy” of the original patent) in a reissue  
as if being presented for the first time in an original
application, and to make surrender of the original
non-reissue, nonprovisional application, except that
patent automatic upon the grant of the reissue patent.
division will not be required by the examiner. See
MPEP § 1450 and § 1451. Reissue applications are
normally examined by the same examiner who issued
the patent for which reissue is requested. In addition,
the application will be examined with respect to compliance
with 37 CFR 1.171-1.178 relating specifically
to reissue applications, for example, the reissue  
oath or declaration will be carefully reviewed for
compliance with 37 CFR 1.175. See MPEP § 1444 for
handling applications in which the oath or declaration


Amended 37 CFR 1.178(a) applies retroactively to
all pending applications. For those applications with
an outstanding requirement for the physical surrender
of the original letters patent, a reissue applicant must
timely reply that the requirement is moot in view of
the implementation of the amended rule. Such a reply
will be considered a complete reply to any requirement
directed toward the surrender of the original letters
patent. It is to be noted that the Office will not
conduct a search to withdraw Office actions where the
only outstanding requirement is compliance with the
physical surrender of the original letters patent.


Example 1:


An Office action issues prior to the effective date
of the amendment to 37 CFR 1.178 with only a
requirement for a return of the original letters
patent to the Office. A two-month period for reply
is set in the Office action. Applicant fails to timely
reply to the Office action, relying on the amendment
to 37 CFR 1.178 as mooting the requirement
for physical surrender of the original letters patent.
The six-month full statutory period for reply
expires. In this instance, the reissue application
would be abandoned (as of the day after the last
day of the two-month period set in the Office
action) for failure to timely reply to the Office
action, because no reply was timely filed.


Example 2:


An Office action issues prior to the effective date
lacks compliance with 37 CFR 1.175. Reissue applications
of the amendment to 37 CFR 1.178 with the only
with related litigation will be acted on by the  
requirement for a return of the original letters
examiner before any other special applications, and
patent to the Office. Applicant fails to reply to the
will be acted on immediately by the examiner, subject
Office action within the two-month period set in
only to a 2-month delay after publication for examining
the Office action, relying on the amendment to
reissue applications; see MPEP § 1441.
37
CFR 1.178 as mooting the requirement for
physical surrender of the original letters patent. In
reviewing the reissue application in connection
with a related application, the examiner notes the
omission prior to the expiration of the six-month  
full statutory period for reply. In this instance, the
examiner may telephone the applicant, and remind
the applicant of the need to file a timely reply.


Example 3:
The original patent file wrapper /file history should  
 
always be obtained and reviewed when examining a
An Office action issues prior to the effective date
reissue application thereof.
of the amendment to 37 CFR 1.178 with the only
requirement being a return of the original letters
patent to the Office. Applicant timely replies to the
Office that it should vacate/withdraw the requirement,
or otherwise indicates that return of the original
letters patent is now unnecessary. In this
instance, a complete reply would have been filed,
and the requirement would be withdrawn and the
application passed to issue.


Example 4:
==1441 Two-Month Delay Period==


An Office action issues prior to the effective date
37 CFR 1.176 provides that reissue applications
of the amendment to 37 CFR 1.178 with both (a) a  
will be acted on by the examiner in advance of other
requirement to return the original letters patent to
applications, i.e., “special.” Generally, a reissue application
the Office, and (b) a rejection of the claims under
will not be acted on sooner than 2 months after
35 U.S.C. 103. Applicant timely replies to the  
announcement of the filing of the reissue has
Office action addressing only the rejection under
appeared in the Official Gazette. The 2-month delay is
35 U.S.C. 103 (but not the need for physical surrender
provided in order that members of the public may
of the original letters patent). In this
have time to review the reissue application and submit
instance, the reply would be accepted as complete,
pertinent information to the Office before the examiner’s
and the Office would withdraw the requirement for
action. The pertinent information is submitted
physical surrender of the original letters patent.  
in the form of a protest under 37 CFR 1.291(a). For a  
(The requirement was proper when made, so the  
discussion as to protests under 37 CFR 1.291(a) in
Office would not vacate the action in regard to  
reissue applications, see MPEP § 1441.01. As set
submission of the original letters patent.).
forth in MPEP § 1901.04, the public should be aware
that such submissions should be made as
early as possible,
since, under certain circumstances, the 2-month
delay period will not be employed. For example, the  
Office may act on a continuation or a divisional reissue
application prior to the expiration of the 2-month
period after announcement. Additionally, the Office
will entertain a petition under 37 CFR 1.182 which is
accompanied by the required petition fee (37
CFR
1.17(f)) to act on a reissue application without
delaying for 2 months. Accordingly, protestors to reissue
applications (see MPEP § 1441.01) cannot automatically
assume that a full 2-month delay period will
always be available. Appropriate reasons for requesting
that the 2-month delay period not be employed
include that litigation involving a patent has been
stayed to permit the filing of an application for the  
reissue of the patent. Where the basis for the petition
is ongoing litigation, the petition must clearly
identify the litigation, and detail the specifics of the  
litigation that call for prompt action on the reissue
application prior to the expiration of the 2-month
delay period. Such petitions are decided by the
Office of Patent Legal Administration.


Where the patentee has submitted the original letters
1441.01Protest in Reissue Applications[R-3]
patent in a reissue application subject to
37
CFR 1.178 as it is now amended, the Office
may, in response to a timely request, return the
original letters patent, when it can be readily
retrieved from where it is stored, namely, the paper
application file, or the artifact storage area for an
Image File Wrapper (IFW) file. Any request for
return of the letters patent which is submitted after
the issue fee has been paid will require a petition
pursuant to 37 CFR 1.59(b) to expunge from the
file and return the original letters patent. Where
the original letters patent cannot be readily
retrieved, or in the rare instance that it has been
subsequently misplaced, the Office will not be able


A protest pursuant to 37 CFR 1.291 may be
filed throughout the pendency of a reissue application,
prior to the date of mailing of a notice of allowance,
subject to the timing constraints of the examination,
as set forth in MPEP § 1901.04. While a reissue application
is not published under 37 CFR 1.211, the reissue
application is published pursuant to 35 U.S.C.
122(b)(1)(A) via an announcement in the Official
Gazette (and public availability of the file content) per
37 CFR 1.11(b). Such a publication does not preclude
the filing of a protest. 35 U.S.C. 122(c) states:


“(c) PROTEST AND PRE-ISSUANCE OPPOSITION-
The Director shall establish appropriate procedures to
ensure that no protest or other form of pre-issuance
opposition to the grant of a patent on an application may be
initiated after publication of the application without the
express written consent of the applicant.” [Emphasis
added.]


A protest is precluded after publication for an application
for an original patent, as a “form of pre-issuance
opposition.” A reissue application is a post-
issuance proceeding. A protest filed in a reissue application
is not a “form of pre-issuance opposition to the
grant of a patent” since the patent to be reissued has
already been granted. Thus, the prohibition against
the filing of a protest after publication of an application
under 35 U.S.C. 122(c) is not applicable to a reissue
application and a protest is permitted after
publication of the reissue application.


   
  A protest with regard to a reissue application
should be filed within the 2-month period following
the announcement of the filing of the reissue application
in the Official Gazette. If the protest of a reissue
application cannot be filed within the 2-month delay
period, the
protest can be submitted at a later time.
Where the protest is submitted after the 2-month
period, no petition for entry of the protest under
37
CFR 1.182 is needed with respect to the protest
being submitted after the 2 months, unless a final
rejection has been issued or prosecution on the merits
has been otherwise closed for the reissue application.


to return the original letters patent and will not create
a new one.


Example 5:
A potential protestor should be aware that reissue
applications are taken up “special” and a protest
filed outside the 2-month delay period may be


In an application filed after the effective date of
the amendment to 37 CFR 1.178, applicant has
mistakenly submitted the original letters patent
and later seeks its return. In this instance, provided
applicant timely requests the return of the original
letters patent, the Office would return the patent,
provided it can be readily retrieved.


Example 6:


A reissue application was pending at the time of
the effective date of the amendment to 37 CFR
1.178, and an original letters patent was submitted.
Applicant requests return of the original letters
patent, although the application is abandoned at
the time the request for return is made. In this
instance, the Office would return the original letters
patent if it is readily retrievable. Even where
the reissue application was already abandoned at
the time of the effective date of the amendment to
37 CFR 1.178, the Office would also return the
original letters patent.


Example 7:


A reissue application is pending at the time of the  
received after action by the examiner. Once the
effective date of the amendment to 37 CFR 1.178.
first
An original letters patent was submitted, and the  
Office action is mailed (after the 2-month
issue fee has been paid for the reissue application
period), a member of the public may still submit pertinent
at the time the request for return of the original letters
information in the form of a protest under
patent is made. In this instance, the Office may
37  
similarly return the original letters patent, but only
CFR 1.291, and the examiner will consider the
if the request is accompanied by a grantable petition
information submitted in the next Office action, to the  
under 37 CFR 1.59(b).
extent that such consideration is appropriate.
Where a final rejection has been issued or the  
prosecution on the merits has been otherwise closed, a
petition under 37 CFR 1.182 along with the required
petition fee (37 CFR 1.17(f)) for entry of the protest
are required. The petition must include an explanation
as to why the additional time was necessary and the  
nature of the protest intended. A copy of the petition
must be served upon the applicant in accordance with
37 CFR 1.248. The petition should be directed to the
Office of Petitions.


Example 8:
If the protest of a reissue application cannot be filed
within the 2-month delay period, the protestor may
petition to request (A) an extension of the 2-month
period following the announcement in the Official
Gazette, and (B) a delay of the examination until the
extended period expires. Such a request will be considered
only if filed in the form of a petition under
37
CFR 1.182 and accompanied by the petition fee set
forth in 37 CFR 1.17(f). The petition under 37 CFR
1.182 and the petition fee must be filed prior to the
expiration of the 2-month period following the
announcement of the filing of the reissue application
in the Official Gazette. The petition must explain why
the additional time is necessary and the nature of the
protest intended. A copy of the petition must be
served upon applicant in accordance with 37 CFR
1.248. The petition should be directed to the appropriate
Technology Center (TC) which will forward the
petition to the Office of Patent Legal Administration.


A reissue application was pending at the time of
If the protest is a “REISSUE LITIGATION” protest,
the effective date of the amendment to 37 CFR
it is particularly important that it be filed early if
1.178. An original letters patent was submitted,
protestor wishes it considered at the time the Office
and the reissue application then issued as a reissue
first acts on the reissue application. Protestors should
patent. After the reissue patent issues, the request
be aware that the Office will entertain petitions from
for return of the original letters patent is made.  
the reissue applicants under 37 CFR 1.182 to waive
Once again, the Office may return the original letters
the 2-month delay period in appropriate circumstances.  
patent, but only if the request is accompanied
Accordingly, protestors to reissue applications
by a grantable petition under 37 CFR 1.59(b).
cannot automatically assume that the full 2-
month delay period will always be available.


Example 9:
The Technology Center (TC) to which the reissue
 
application is assigned is listed in the Official Gazettenotice of filing of the reissue application. Accordingly,  
A reissue application issued as a reissue patent
the indicated TC should retain jurisdiction
prior to the effective date of the amendment to
over the reissue application file for 2 months after
37
the date of the Official Gazette notice before transferring
CFR 1.178. The reissue applicant, now the patentee,  
the reissue application under the procedure set
requests return of the original letters patent
forth in MPEP §
that was submitted in the reissue application. In
this instance, the Office will not return the original
903.08(d).  
letters patent. The original letters patent was submitted
in reply to a requirement that was in effect
throughout the pendency of the reissue application.


The publication of a notice of a reissue application
in the Official Gazette should be done prior to any
examination of the reissue application. If an inadvertent
failure to publish notice of the filing of the reissue
application in the Official Gazette is recognized later
in the examination, action should be taken to have the
notice published as quickly as possible, and action on
the reissue application may be delayed until 2 months
after the publication, allowing for any protests to be
filed.


See MPEP § 1901.06 for general procedures on
examiner treatment of protests in reissue applications.


==1442 Special Status==


1417Claim for Benefit Under 35 U.S.C.
All reissue applications are taken up “special,” and
119(a)-(d) [R-5]
remain “special” even though applicant does not
respond promptly.


PRIORITY UNDER 35 U.S.C. 119(a)-(d) WAS
All reissue applications, except those under suspension
PERFECTED IN THE ORIGINAL PATENT
because of litigation, will be taken up for action
ahead of other “special” applications; this means that
all issues not deferred will be treated and responded to
immediately. Furthermore, reissue applications
involved in litigation will be taken up for action in
advance of other reissue applications.


A “claim” for the benefit of an earlier filing date in
1442.01Litigation-Related Reissues [R-5]
a foreign country under 35 U.S.C. 119(a)-(d) must be
made in a reissue application, even though such a
claim was previously made in the application for the
original patent to be reissued. However, no additional
certified copy of the foreign application is necessary.
The procedure is similar to that for “Continuing
Applications” in MPEP § 201.14(b).


In addition, 37 CFR 1.63 requires that in any application
During initial review, the examiner should determine
in which a claim for foreign priority is made
whether the patent for which the reissue has
pursuant to 37 CFR 1.55, the oath or declaration must
been filed is involved in litigation, and if so, the status
identify the foreign application for patent or inventors’
of that litigation. If the examiner becomes aware of
certificate on which priority is claimed unless
litigation involving the patent sought to be reissued
supplied on an application data sheet (37 CFR 1.76),  
during examination of the reissue application, and  
and any foreign applications having a filing date
applicant has not made the details regarding that litigation
before that of the application on which priority is
of record in the reissue application, the examiner,
claimed, by specifying:
in the next Office action, will inquire regarding
the specific details of the litigation.
 
Form paragraph 14.06 may be used for such an
inquiry.


(A)the application number of the foreign application;
¶ 14.06 Litigation-Related Reissue


The patent sought to be reissued by this application [1]
involved in litigation. Any documents and/or materials which


(B)the foreign country or intellectual property
authority; and


(C)the day, month, and year of the filing of the
foreign application.






would be material to patentability of this reissue application are
required to be made of record in response to this action.


Due to the related litigation status of this application, EXTENSIONS
OF TIME UNDER THE PROVISIONS OF 37 CFR
1.136(a) WILL NOT BE PERMITTED DURING THE PROSECUTION
OF THIS APPLICATION.


The examiner should note that the heading on
Examiner Note:
printed copies of the patent will not be carried forward
to the reissue from the original patent. Therefore,
it is important that the bibliographic data sheet
(or the front face of the reissue file wrapper for series
08/ and earlier paper applications) be endorsed by the
examiner under “FOREIGN APPLICATIONS.” For
an IFW reissue file, a copy of the bibliographic data
sheet should be printed from the IFW file history. The
printed copy should be annotated by the examiner and
then the annotated copy should be scanned into the
IFW.


PRIORITY UNDER 35 U.S.C. 119(a)-(d) IS
In bracket 1, insert either —is— or —has been—.  
NEWLY PERFECTED IN THE REISSUE APPLICATION


If additional details of the litigation appear to be
material to examination of the reissue application, the
examiner may make such additional inquiries as necessary
and appropriate.


A reissue was granted in Brenner v. State of Israel,
For reissue application files that are maintained in  
400 F.2d 789, 158 USPQ 584 (D.C. Cir. 1968), where
paper, if the existence of litigation has not already
the only ground urged was failure to file a certified
been noted, the examiner should place a prominent
copy of the original foreign application to obtain the  
notation on the application file to indicate the litigation
right of foreign priority under 35 U.S.C. 119(a)-(d)
(1) at the bottom of the face of the file in the box
before the patent was granted. In Brenner, the claim
just to the right of the box for the retention label, and
for priority had been made in the prosecution of the  
(2) on the pink Reissue Notice Card form. For reissue  
original patent, and it was only necessary to submit a
application files that are maintained in the Image
certified copy of the priority document in the reissue
File Wrapper (IFW) system, if the existence of litigation
application to perfect priority (the claim for priority
has not already been noted, the examiner should
must be repeated in the reissue application). Reissue
print out a copy of the bibliographic data sheet from
is also available to correct the “error” in failing to take
the IFW file history and annotate the printed bibliographic
any steps to obtain the right of foreign priority under
data sheet such that adequate notice is provided
35 U.S.C. 119(a)-(d) before the original patent was
of the existence of the litigation. The examiner
granted. See Fontijn v. Okamoto, 518 F.2d 610, 622,  
should place the annotation in a prominent place. The
186 USPQ 97, 106 (CCPA 1975) (“a patent may be
annotated sheet should be scanned into IFW.
reissued for the purpose of establishing a claim to priority
which was not asserted, or which was not perfected
during the prosecution of the original
application”) In a situation where it is necessary to
submit for the first time both the claim for priority and
the certified copy of the priority document in the reissue
application and the patent to be reissued resulted
from a utility or plant application filed on or after
November 29, 2000, the reissue applicant will have to
file a petition for an unintentionally delayed priority
claim under 37 CFR 1.55(c) in addition to filing a  
reissue application. See MPEP §
201.14(a).


1418Notification of Prior/Concurrent
Applicants will normally be given 1 month to reply
Proceedings and Decisions There-  
to Office actions in all reissue applications which are
on, and of Information Known to  
being examined during litigation, or after litigation
be Material to Patentability [R-3]
had been stayed, dismissed, etc., to allow for consideration
of the reissue by the Office. This 1-month
period may be extended only upon a showing of clear
justification pursuant to 37 CFR 1.136(b). The Office
action will inform applicant that the provisions of
37
CFR 1.136(a) are not available. Of course, up to  
3  
months may be set for reply if the examiner determines
such a period is clearly justified.


37 CFR 1.178. Original patent; continuing duty of
===1442.02 Concurrent Litigation===
applicant.


In order to avoid duplication of effort, action in
reissue applications in which there is an indication of
concurrent litigation will be suspended automatically
unless and until it is evident to the examiner, or the
applicant indicates, that any one of the following
applies:


(A)a stay of the litigation is in effect;


(b)In any reissue application before the Office, the applicant
(B)the litigation has been terminated;
must call to the attention of the Office any prior or concurrent proceedings
in which the patent (for which reissue is requested) is or
was involved, such as interferences, reissues, reexaminations, or
litigations and the results of such proceedings (see also
§
1.173(a)(1)).


37 CFR 1.178(b) requires reissue applicants to call
(C)there are no significant overlapping issues
to the attention of the Office any prior or concurrent
between the application and the litigation; or  
proceeding in which the patent (for which reissue is
requested) is or was involved and the results of such
proceedings. These proceedings would include interferences,
reissues, reexaminations, and litigations.
Litigation would encompass any papers filed in the  
court or issued by the court, which may include, for
example, motions, pleadings, and court decisions.
This duty to submit information is continuing, and
runs from the time the reissue application is filed until
the reissue application is abandoned or issues as a
reissue patent.


In addition, a reissue application is subject to the  
(D)it is applicant’s desire that the application be  
same duty of disclosure requirements as is any other
examined at that time.  
nonprovisional application. The provisions of 37 CFR
1.63 require acknowledgment in the reissue oath or
declaration of the “duty to disclose to the Office all
information known to the [applicants] to be material
to patentability as defined in §
1.56.” Note that the
Office imposes no responsibility on a reissue applicant
to resubmit, in a reissue application, all the “References
Cited” in the patent for which reissue is
sought. Rather, applicant has a continuing duty under
37 CFR 1.56 to timely apprise the Office of any information
which is material to the patentability of the
claims under consideration in the reissue application.


37 CFR 1.97 and 37 CFR 1.98 provide a mechanism
Where any of (A) - (D) above apply, form paragraphs
to submit information known to applicants to be
14.08-14.10 may be used to deny a suspension
material to patentability. Information submitted in  
of action in the reissue, i.e., to deny a stay of the reissue  
compliance with 37 CFR 1.97 and 37 CFR 1.98 will
proceeding.
be considered by the Office. See MPEP § 609.  
Although a reissue applicant may utilize 37 CFR 1.97and 37 CFR 1.98 to comply with the duty of disclo


Where none of (A) through (D) above apply, action
in the reissue application in which there is an indication
of concurrent litigation will be suspended by the
examiner. The examiner should consult with the
Technology Center Special Program Examiner
prior to suspending action in the reissue. Form paragraph
14.11 may be used to suspend action, i.e., stay
action, in a reissue application with concurrent litigation.


An ex parte reexamination proceeding will not be
stayed where there is litigation. See Ethicon v. Quigg,
849 F.2d 1422, 7 USPQ2d 1152 (Fed. Cir. 1988).
Thus, where a reissue application has been merged
with an ex parte reexamination proceeding, the
merged proceeding will not be stayed where there is
litigation. In a merged ex parte reexamination/reissue
proceeding, the ex parte reexamination will control
because of the statutory (35 U.S.C. 305) requirement
that ex parte reexamination proceedings be conducted
with special dispatch. See MPEP § 2285 and § 2286.
As to a stay or suspension where reissue proceedings
are merged with inter partes reexamination proceedings,
see 37 CFR 1.937 and MPEP § 2686.


===1442.03 Litigation Stayed===


All reissue applications, except those under suspension
because of litigation, will be taken up for action
ahead of other “special” applications; this means that
all issues not deferred will be treated and responded to
immediately. Furthermore, reissue applications
involved in “stayed litigation” will be taken up for
action in advance of other reissue applications. Great
emphasis is placed on the expedited processing of
such reissue applications. The courts are especially
interested in expedited processing in the Office where
litigation is stayed.


In reissue applications with “stayed litigation,” the
 
Office will entertain petitions under 37 CFR 1.182,  
sure required by 37 CFR 1.56, this does not relieve
which are accompanied by the fee under 37 CFR  
applicant of the duties under 37 CFR 1.175 of, for
1.17(f), to not apply the 2-month delay period  
example, stating “at least one error being relied
stated in MPEP § 1441. Such petitions are decided by  
upon.”
the Office of Patent Legal Administration.
 
While 37 CFR 1.97(b) provides for the filing of an
information disclosure statement within 3 months of
the filing of an application or before the mailing date
of a first Office action, reissue applicants are encouraged
to file information disclosure statements at the
time of filing of the reissue application so that such
statements will be available to the public during the 2-
month period provided in MPEP § 1441. Form paragraph
14.11.01 may be used to remind applicant of the
duties to timely make the Office aware of (A) any
prior or concurrent proceeding (e.g., litigation or
Office proceedings) in which the patent to be reissued
is or was involved, and (B) any information which is
material to patentability of the claims in the reissue
application.
 
¶ 14.11.01 Reminder of Duties Imposed by 37 CFR
1.178(b) and 37 CFR 1.56
 
Applicant is reminded of the continuing obligation under 37
CFR 1.178(b), to timely apprise the Office of any prior or concurrent
proceeding in which Patent No. [1] is or was involved. These
proceedings would include interferences, reissues, reexaminations,
and litigation.  


Applicant is further reminded of the continuing obligation
Time-monitoring systems have been put into effect
under 37 CFR 1.56, to timely apprise the Office of any information
which will closely monitor the time used by applicants,
which is material to patentability of the claims under consideration
protestors, and examiners in processing reissue  
in this reissue application.
applications of patents involved in litigation in which
 
the court has stayed further action. Monthly reports on
These obligations rest with each individual associated with the  
the status of reissue applications with related litigation
filing and prosecution of this application for reissue. See also
are required from each Technology Center (TC).  
MPEP §§ 1404, 1442.01 and 1442.04.  
Delays in reissue processing are to be followed up.  
The TC Special Program Examiner is responsible for
oversight of reissue applications with related litigation.


Examiner Note:
The purpose of these procedures and those deferring
consideration of certain issues, until all other
issues are resolved or the application is otherwise
ready for consideration by the Board of Patent
Appeals and Interferences (note MPEP § 1448), is to
reduce the time between filing of the reissue application
and final action thereon, while still giving all parties
sufficient time to be heard.


1.This form paragraph is to be used in the first action in a reissue
===1442.04 Litigation Involving Patent===
application.


2.In bracket [1], insert the patent number of the original patent
37 CFR 1.178. Original patent; continuing duty of  
for which reissue is requested.
applicant.


1430Reissue Files Open to the Public
(b)In any reissue application before the Office, the applicant
and, Notice of Filing Reissue Announced
must call to the attention of the Office any prior or concurrent proceedings
in, Official Gazette [R-3]
in which the patent (for which reissue is requested) is or
was involved, such as interferences, reissues, reexaminations, or
litigations and the results of such proceedings (see also
§ 1.173(a)(1)).


37 CFR 1.11. Files open to the public.
Where the patent for which reissue is being sought
is, or has been, involved in litigation, the applicant
should bring the existence of such litigation to the
attention of the Office. 37 CFR 1.178(b). This should
be done at the time of, or shortly after, the applicant
files the application, either in the reissue oath or declaration,
or in a separate paper, preferably accompanying
the application as filed. Litigation begun after
filing of the reissue application also should be
promptly brought to the attention of the Office.  


Litigation encompasses any papers filed in the
court or issued by the court. This may include, for
example, motions, pleadings, and court decisions, as
well as the results of such proceedings. When applicant
notifies the Office of the existence of the litigation,
enough information should be submitted so that
the Office can reasonably evaluate the need for asking
for further materials in the litigation. Note that the
existence of supporting materials which may substantiate
allegations of invalidity should, at least, be fully
described, and preferably submitted. The Office is not
interested in receiving voluminous litigation materials
which are not relevant to the Office’s consideration of
the reissue application. The status of the litigation
should be updated in the reissue application as soon as
significant events happen in the litigation.


When a reissue application is filed, the examiner
should determine whether the original patent has been
adjudicated by a court. The decision(s) of the court,
and also other papers in the suit, may provide information
essential to the examination of the reissue.
Examiners should inform the applicant of the duty to
supply information as to litigation involving the
patent. Form paragraph 14.11.01 may be used for this
purpose. See MPEP § 1418.


(b)All reissue applications, all applications in which the  
Additionally, the patented file will contain notices
Office has accepted a request to open the complete application to  
of the filing and termination of infringement suits on
inspection by the public, and related papers in the application file,
the patent. Such notices are required by law to be filed
are open to inspection by the public, and copies may be furnished
by the clerks of the Federal District Courts. These
upon paying the fee therefor. The filing of reissue applications,  
notices do not indicate if there was an opinion by the  
other than continued prosecution applications under § 1.53(d) of  
court, nor whether a decision was published. Shepard’s
reissue applications, will be announced in the Official Gazette.  
Federal Citations and the cumulative digests of
The announcement shall include at least the filing date, reissue
the United States Patents Quarterly, both of which are
application and original patent numbers, title, class and subclass,  
in the Lutrelle F. Parker, Sr., Memorial Law Library,  
name of the inventor, name of the owner of record, name of the
contain tables of patent numbers giving the citation of  
attorney or agent of record, and examining group to which the  
published decisions concerning the patent.  
reissue application is assigned.


A litigation computer search by the Scientific and
Technical Information Center (STIC) should be
requested by the examiner to determine whether the
patent has been, or is, involved in litigation. For
reissue application files that are maintained in paper,
the “Search Notes” box on the application file wrapper
is then  completed to indicate that the review
was conducted. A copy of the STIC search should be
hole-punched and placed in the reissue file. For
IFW reissue application files, the “Search Notes” box
on the OACS “Search Notes” page is annotated to
indicate that the review was conducted, and the
OACS “Search Notes” page is then scanned into the
reissue application file history.


Additional information or guidance as to making a
litigation search may be obtained from the library of
the Office of the Solicitor. Where papers are not otherwise
conveniently obtainable, the applicant may be
requested to supply copies of papers and records in
suits, or the Office of the Solicitor may be requested
to obtain them from the court. The information thus
obtained should be carefully considered for its bearing
on the proposed claims of the reissue, particularly
when the reissue application was filed in view of the
holding of a court.


Under 37 CFR 1.11(b) all reissue applications filed
If the examiner becomes aware of litigation involving
after March 1, 1977, are open to inspection by the  
the patent sought to be reissued during examination
general public, and copies may be furnished upon
of the reissue application, and applicant has not
paying the fee therefor. The filing of reissue applications
made the details regarding that litigation of record in
(except for continued prosecution applications
the reissue application, the examiner, in the next
(CPA’s) filed under 37
Office action, should inquire regarding the same.
CFR 1.53(d)) will be
Form paragraph 14.06 may be used for such an
announced in the Official Gazette. The announcement
inquiry. See MPEP § 1442.01.
gives interested members of the public an opportunity
to submit to the examiner information pertinent to the
patentability of the reissue application. The announcement
includes the filing date, reissue application and
original patent numbers, title, class and subclass,
name of the inventor, name of the owner of record,
name of the attorney or agent of record, and the Technology
Center (TC) to which the reissue application is
initially assigned. A TC Director or other appropriate
Office official may, under appropriate circumstances,
postpone access to or the making of copies of a
paper reissue application file, such as, for example,
to avoid interruption of the examination or other
review of the application by an examiner.


IFW reissue application files are open to inspection
If the additional details of the litigation appear to be
by the general public by way of Public PAIR via
material to patentability of the reissue application, the  
the USPTO Internet site. In viewing the images of the  
examiner may make such additional inquiries as necessary
files, members of the public will be able to view the
and appropriate.
entire content of the reissue application file history.
To access Public PAIR, a member of the public would
(A) go to the USPTO web site at http://
www.uspto.gov, (B) click on “Patents”, (C) under
“Check Status, View Papers…” click on “Status &
IFW,” and (D) under “Patent Application Information
Retrieval” enter the reissue application number.


A notice of a reissue application in the Official
===1442.05 Court Ordered Filing of Reissue Application===
Gazette should be published prior to any examination
of the application. If an inadvertent failure to publish
notice of the filing of the reissue application in the
Official Gazette is recognized later in the examination,
action should be taken to have the notice published
as quickly as possible, and action on the
application may be delayed until two months after the


In most instances, the reissue-examination procedure
is instituted by a patent owner who voluntarily
files a reissue application as a consequence of related
patent litigation. Some Federal district courts in
earlier decisions have required a patentee-litigant to
file a reissue application as a consequence of the
patent litigation. However, the Court of Appeals for
the Federal Circuit held in Green v. The Rich Iron Co.,
944 F.2d 852, 853, 20 USPQ2d 1075, 1076 (Fed. Cir.
1991) that a Federal district court in an infringement
case could not compel a patentee to seek reissue
by the USPTO.


It is to be noted that only a patentee or his or her
assignee may file a reissue patent application. An
order by a court for a different party to file a reissue
will not be binding on the Office.


==1443 Initial Examiner Review==


As part of an examiner’s preparation for the examination
 
of a reissue application, the Examiner Reissue
publication, allowing for any protests to be filed. For
Guide and Checklist should be consulted for basic
a discussion of protests, see MPEP Chapter 1900.
guidance and suggestions for handling the prosecution.  
The Technology Center (TC) Special Program
Examiners (SPREs) should make the Guide and
Checklist available at the time a reissue application is
docketed to an examiner.


The filing of a continued prosecution application  
On initial receipt of a reissue application, the examiner
(CPA) under 37 CFR 1.53(d) of a reissue application
should inspect the submission under 37 CFR  
will not be announced in the Official Gazette.
1.172 as to documentary evidence of a chain of title
Although the filing of a CPA of a reissue application
from the original owner to the assignee to determine
constitutes the filing of a reissue application, the  
whether the consent requirement of 37 CFR 1.172 has
announcement of the filing of such CPA would be  
been met. The examiner will compare the consent and
redundant in view of the announcement of the filing
documentary evidence of ownership; the assignee
of the prior reissue application in the Official Gazetteand the fact that the same application number and file
indicated by the documentary evidence must be the
will continue to be used for the CPA.
same assignee which signed the consent. Also, the  
 
person who signs the consent for the assignee and the  
If applicant files a Request for Continued Examination
person who signs the submission of evidence of ownership
(RCE) of the reissue application under 37 CFR
for the assignee must both be persons having
1.114 (which can be filed on or after May 29, 2000 for
authority to do so. See also MPEP § 324.  
a reissue application filed on or after June 8, 1995),
such filing will not be announced in the Official
Gazette. An RCE continues prosecution of the existing
reissue application and is not a filing of a new
application.


Where the application is assigned, and there is no
submission under 37 CFR 1.172 as to documentary
evidence in the application, the examiner should
require the submission using form paragraph 14.16.
Once the submission under 37 CFR 1.172 as to documentary
evidence is received, it must be compared
with the consent to determine whether the assignee
indicated by the documentary evidence is the same
assignee which signed the consent. See MPEP
§ 1410.01 for further discussion as to the required
consent and documentary evidence.


Where there is a statement of record that the application
is not assigned, there should be no submission
under 37
CFR 1.172 as to documentary evidence of
ownership in the application, and none should be
required by the examiner.


The filing of all reissue applications, except for  
The filing of all reissue applications, except for  
CPAs filed under 37 CFR 1.53(d), (note that effective
continued prosecution applications (CPAs) filed under  
July 14, 2003, CPA practice has been eliminated as to
37 CFR 1.53(d), must be announced in the Official
utility and plant application) will be announced in the  
Gazette. Accordingly, for any reissue application
Official Gazette and will include certain identifying
other than a CPA, the examiner should determine if
data as specified in 37 CFR 1.11(b). Access to a reissue  
the filing of the reissue application has been  
application that is maintained in paper must be  
announced in the Official Gazette as provided in  
obtained from the area of the Office having jurisdiction
37 CFR 1.11(b). The contents entry on the PALM
over the reissue application file.  
Intranet Contents screen should be checked for the
presence of “NRE” and “NOTICE OF REISSUE
PUBLISHED IN OFFICIAL GAZETTE” entries in
the contents, and the date of publication. Where the
reissue application is maintained in a paper file, the
date of the Official Gazette notice can usually be  
found on the pink “REISSUE” tag which protrudes
from the top of the application file of 08/ or earlier
series.  For 09/ and later series reissue applications,
the Official Gazette publication date appears on the
face of the file wrapper.  If the filing of the reissue
application has not been announced in the Official
Gazette, the reissue application should be returned to
the Office of Initial Patent Examination (Special Processing)
to handle the announcement. The examiner
should not further act on the reissue until 2 months
after announcement of the filing of the reissue has
appeared in the Official Gazette. See MPEP § 1440.


For reissue application files that are maintained in  
The examiner should determine if there is concurrent
paper, the following access procedure will be
litigation, and if so, the status thereof (MPEP
observed:
§ 1442.01), and whether the reissue file wrapper
(for reissue application files maintained in paper) or
file history (for IFW reissue applications) has been
appropriately marked. Note MPEP § 1404.


(A) Any member of the general public may
The examiner should determine if a protest has
request access to a particular reissue application filed  
been filed, and if so, it should be handled as set forth
after March 1, 1977. Since no record of such
in MPEP § 1901.06. For a discussion of protests
request is intended to be kept, an oral request will suffice.  
under 37 CFR 1.291 in reissue applications, see
Reissue applications already on file prior to
MPEP § 1441.01.
March 1, 1977 are not automatically open to inspection,  
but a liberal policy is followed by the Office of
Patent Legal Administration and by the Board of
Patent Appeals and Interferences (see MPEP  
§
1002.02(b)) in granting petitions for access to such
applications.  


(B)Paper reissue application files will be
The examiner should determine whether the patent
maintained in the TCs and inspection thereof will be
is involved in an interference, and if so, should refer
supervised by TC personnel. Although no general
to MPEP § 1449.01 before taking any action on the  
limit is placed on the amount of time spent reviewing
reissue application.
the files, the Office may impose limitations, if necessary,  
e.g., where the application is actively being processed.  


The examiner should verify that all Certificate of
Correction changes have been properly incorporated
into the reissue application. See MPEP § 1411.01.


(C)Where the reissue application file has left
The examiner should verify that the patent on
the TC for administrative processing, requests for
which the reissue application is based has not expired,
access should be directed to the appropriate supervisory
either because its term has run or because required
personnel where the application is currently
maintenance fees have not been paid. Once a patent
located.  
has expired, the Director of the USPTO no longer has
the authority under 35 U.S.C. 251 to  
reissue the patent. See In re Morgan, 990 F.2d 1230, 26 USPQ2d
1392 (Fed. Cir. 1992). See also MPEP § 1415.01.  


(D)Requests for copies of papers in the reissue
==1444 Review of Reissue Oath/Declaration==
application file must be in writing and addressed to
the Mail Stop Document Services, Director of the
United States Patent and Trademark Office, P.O. Box
1450, Alexandria, VA 22313-1450. Such requests
may be either mailed or delivered to the Office Customer
Service Window (See MPEP § 502). The price
for copies made by the Office is set forth in 37 CFR
1.19.


1440Examination of Reissue Application
In accordance with 37 CFR 1.175, the following is
[R-3]
required in the reissue oath/declaration:


37 CFR 1.176. Examination of reissue.
(A)A statement that the applicant believes the
original patent to be wholly or partly inoperative or
invalid-


(a)A reissue application will be examined in the same manner
(1)by reason of a defective specification or
as a non-reissue, non-provisional application, and will be subject
drawing, or
to all the requirements of the rules related to non-reissue
applications. Applications for reissue will be acted on by the
examiner in advance of other applications.


(b)Restriction between subject matter of the original patent
(2)by reason of the patentee claiming more or
claims and previously unclaimed subject matter may be required
less than patentee had the right to claim in the patent;
(restriction involving only subject matter of the original patent
claims will not be required). If restriction is required, the subject
matter of the original patent claims will be held to be constructively
elected unless a disclaimer of all the patent claims is filed in
the reissue application, which disclaimer cannot be withdrawn by
applicant.


37 CFR 1.176 provides that an original claim, if re-
(B)A statement of at least one error which is
presented in a reissue application, will be fully examined
relied upon to support the reissue application, i.e.,
in the same manner, and subject to the same rules
which provides a basis for the reissue;
as if being presented for the first time in an original
non-reissue, nonprovisional application, except that
division will not be required by the examiner. See
MPEP § 1450 and § 1451. Reissue applications are
normally examined by the same examiner who issued
the patent for which reissue is requested. In addition,
the application will be examined with respect to compliance
with 37 CFR 1.171-1.178 relating specifically
to reissue applications, for example, the reissue  
oath or declaration will be carefully reviewed for
compliance with 37 CFR 1.175. See MPEP § 1444 for
handling applications in which the oath or declaration


(C)A statement that all errors which are being
corrected in the reissue application up to the time of
filing of the oath/declaration arose without any deceptive
intention on the part of the applicant; and


(D)The information required by 37 CFR 1.63.


MPEP § 1414 contains a discussion of each of the
above elements (i.e., requirements of a reissue oath/
declaration). The examiner should carefully review
the reissue oath/declaration in conjunction with that
discussion, in order to ensure that each element is provided
in the oath/declaration. If the examiner’s review
of the oath/declaration reveals a lack of compliance
with any of the requirements of 37 CFR 1.175, a
rejection of all the claims under 35
U.S.C. 251 should
be made on the basis that the reissue oath/declaration
is insufficient.


In preparing an Office action, the examiner should
use form paragraphs 14.01 through 14.01.04 to state
the objection(s) to the oath/declaration, i.e., the
defects in the oath/declaration. These form paragraphs
are reproduced in MPEP § 1414. The examiner should
then use form paragraph 14.14 to reject the claims
under 35 U.S.C. 251, based upon the improper oath/
declaration.


lacks compliance with 37 CFR 1.175. Reissue applications
A lack of signature on a reissue oath/declaration
with related litigation will be acted on by the  
(except as otherwise provided in 37 CFR 1.42, 1.43,
examiner before any other special applications, and  
and 1.47 and in 37 CFR 1.172) would be considered a
will be acted on immediately by the examiner, subject
lack of compliance with 37 CFR 1.175(a) and result in
only to a 2-month delay after publication for examining
a rejection, including final rejection, of all the claims
reissue applications; see MPEP § 1441.
on the basis that the reissue oath/declaration is insufficient.  
If the unsigned reissue oath/declaration is submitted
as part of a reply which is otherwise properly
signed and responsive to the outstanding Office
action, the reply should be accepted by the examiner  
as proper and responsive, and the oath/declaration
considered fully in the next Office action. The reply
should not be treated as an unsigned or improperly
signed amendment (see MPEP § 714.01(a)), nor do
the holdings of Ex parte Quayle apply in this situation.
The lack of signature, along with any other oath/
declaration deficiencies, should be noted in the next
Office action rejecting the claims as being based upon
an insufficient reissue oath/declaration.


The original patent file wrapper /file history should
I.HANDLING OF THE REISSUE OATH/
always be obtained and reviewed when examining a
DECLARATION DURING THE REISSUE
reissue application thereof.
PROCEEDING


1441Two-Month Delay Period [R-3]
An initial reissue oath/declaration is submitted with
 
the reissue application (or within the time period set
37 CFR 1.176 provides that reissue applications
for filing the oath/declaration in a Notice To File
will be acted on by the examiner in advance of other
Missing Parts under 37 CFR 1.53(f)). Where the reissue
applications, i.e., “special.” Generally, a reissue application  
oath/declaration fails to comply with 37 CFR  
will not be acted on sooner than 2 months after
1.175(a), the examiner will so notify the applicant in
announcement of the filing of the reissue has
an Office action, rejecting the claims under 35 U.S.C.  
appeared in the Official Gazette. The 2-month delay is
251 as discussed above. In reply to the Office action, a  
provided in order that members of the public may
supplemental reissue oath/declaration should be submitted
have time to review the reissue application and submit
dealing with the noted defects in the reissue  
pertinent information to the Office before the examiner’s
oath/declaration.
action. The pertinent information is submitted
in the form of a protest under 37 CFR 1.291(a). For a
discussion as to protests under 37 CFR 1.291(a) in
reissue applications, see MPEP § 1441.01. As set
forth in MPEP § 1901.04, the public should be aware
that such submissions should be made as
early as possible,
since, under certain circumstances, the 2-month
delay period will not be employed. For example, the  
Office may act on a continuation or a divisional reissue
application prior to the expiration of the 2-month
period after announcement. Additionally, the Office
will entertain a petition under 37 CFR 1.182 which is
accompanied by the required petition fee (37
CFR
1.17(f)) to act on a reissue application without
delaying for 2 months. Accordingly, protestors to reissue
applications (see MPEP § 1441.01) cannot automatically
assume that a full 2-month delay period will
always be available. Appropriate reasons for requesting
that the 2-month delay period not be employed
include that litigation involving a patent has been
stayed to permit the filing of an application for the
reissue of the patent. Where the basis for the petition
is ongoing litigation, the petition must clearly
identify the litigation, and detail the specifics of the
litigation that call for prompt action on the reissue  
application prior to the expiration of the 2-month
delay period. Such petitions are decided by the
Office of Patent Legal Administration.


1441.01Protest in Reissue Applications[R-3]
Where the initial reissue oath/declaration (1) failed
 
to provide any error statement, or (2) attempted to
A protest pursuant to 37 CFR 1.291 may be  
provide an error statement, but failed to identify any
filed throughout the pendency of a reissue application,
error under 35 U.S.C. 251 upon which reissue can be  
prior to the date of mailing of a notice of allowance,  
based (see MPEP § 1402), the examiner should reject
subject to the timing constraints of the examination,
all the claims as being based upon a defective reissue  
as set forth in MPEP § 1901.04. While a reissue application
oath/declaration under 35 U.S.C. 251. To support the  
is not published under 37 CFR 1.211, the reissue  
rejection, the examiner should specifically point out
application is published pursuant to 35 U.S.C.  
the failure of the initial oath/declaration to comply
122(b)(1)(A) via an announcement in the Official
with 37 CFR 1.175 because an “error” under
Gazette (and public availability of the file content) per
35 U.S.C. 251 upon which reissue can be based was
37 CFR 1.11(b). Such a publication does not preclude
not identified therein. In reply to the rejection under  
the filing of a protest. 35 U.S.C. 122(c) states:
35 U.S.C. 251, a supplemental reissue oath/declaration
must be submitted stating an error under
35 U.S.C. 251 which can be relied upon to support the
reissue application. Submission of this supplemental
reissue oath/declaration to obviate the rejection cannot
be deferred by applicant until the application is
otherwise in condition for allowance. In this instance,
a proper statement of error was never provided in the  
initial reissue oath/declaration, thus a supplemental
oath/declaration is required in reply to the Office
action in order to properly establish grounds for reissue.


“(c) PROTEST AND PRE-ISSUANCE OPPOSITION-
A different situation may arise where the initial
The Director shall establish appropriate procedures to
reissue oath/declaration does properly identify one or
ensure that no protest or other form of pre-issuance
more errors under 35 U.S.C. 251 as being the basis for
opposition to the grant of a patent on an application may be  
reissue, however, because of changes or amendments
initiated after publication of the application without the
made during prosecution, none of the identified errors
express written consent of the applicant.” [Emphasis
are relied upon any more. A supplemental oath/declaration
added.]
will be needed to identify at least one error nowbeing relied upon as the basis for reissue, even though
the prior oath/declaration was earlier found proper by
the examiner. The supplemental oath/declaration need
not also indicate that the error(s) identified in the prior
oath(s)/declaration(s) is/are no longer being corrected.
In this instance, applicant’s submission of the supplemental
reissue oath/declaration to obviate the rejection
under 35 U.S.C. 251 can, at applicant’s option, be
deferred until the application is otherwise in condition
for allowance. The submission can be deferred
because a proper statement of error was provided in
the initial reissue oath/declaration. Applicant need
only request that submission of the supplemental reissue
oath/declaration be deferred until allowance, and
such a request will be considered a complete reply to
the rejection.


A protest is precluded after publication for an application
II.SUPPLEMENTAL REISSUE OATH/DECLARATION UNDER 37 CFR 1.175(b)(1):
for an original patent, as a “form of pre-issuance
opposition.” A reissue application is a post-
issuance proceeding. A protest filed in a reissue application
is not a “form of pre-issuance opposition to the
grant of a patent” since the patent to be reissued has
already been granted. Thus, the prohibition against
the filing of a protest after publication of an application
under 35 U.S.C. 122(c) is not applicable to a reissue
application and a protest is permitted after
publication of the reissue application.


A protest with regard to a reissue application
Once the reissue oath/declaration is found to comply
should be filed within the 2-month period following
with 37 CFR 1.175(a), it is not required, nor is it
the announcement of the filing of the reissue application
suggested, that a new reissue oath/declaration be submitted
in the Official Gazette. If the protest of a reissue  
together with each new amendment and correction
application cannot be filed within the 2-month delay
of error in the patent. During the prosecution of a  
period, the  
reissue application, amendments are often made
protest can be submitted at a later time.  
and additional errors in the patent are corrected. A
Where the protest is submitted after the 2-month
supplemental oath/declaration need not be submitted  
period, no petition for entry of the protest under
with each amendment and additional correction.  
37  
Rather, it is suggested that the reissue applicant wait
CFR 1.182 is needed with respect to the protest
until the case is in condition for allowance, and then
being submitted after the 2 months, unless a final
submit a cumulative supplemental reissue oath/declaration
rejection has been issued or prosecution on the merits
pursuant to 37 CFR 1.175(b)(1).
has been otherwise closed for the reissue application.


See MPEP § 1414.01 for a discussion of the
required content of a supplemental reissue oath/declaration
under 37 CFR 1.175(b)(1).


A potential protestor should be aware that reissue
A supplemental oath/declaration under 37 CFR
applications are taken up “special” and a protest
1.175(b)(1) must be submitted before allowance. It
filed outside the 2-month delay period may be
may be submitted with any reply prior to allowance. It
may be submitted to overcome a rejection under
35
U.S.C. 251 made by the examiner, where it is indicated
that the submission of the supplemental oath/
declaration will overcome the rejection.


A supplemental oath/declaration under 37 CFR
1.175(b)(1) will be required where:


(A)the application is otherwise (other than the
need for this supplemental oath/declaration) in condition
for allowance;


(B)amendments or other corrections of errors in
the patent have been made subsequent to the last oath/
declaration filed in the application; and


(C)at least one of the amendments or other corrections
corrects an error under 35 U.S.C. 251.


received after action by the examiner. Once the
When a supplemental oath/declaration under  
first
37 CFR 1.175(b)(1) directed to the amendments or
Office action is mailed (after the 2-month
other corrections of error is required, the examiner is  
period), a member of the public may still submit pertinent
encouraged to telephone the applicant and request the  
information in the form of a protest under  
submission of the supplemental oath/declaration by
37  
fax. If the circumstances do not permit making a telephone
CFR 1.291, and the examiner will consider the  
call, or if applicant declines or is unable to  
information submitted in the next Office action, to the  
promptly submit the oath/declaration, the examiner
extent that such consideration is appropriate.
should issue a final Office action (final rejection) and
Where a final rejection has been issued or the  
use form paragraph 14.05.02 where the action issued
prosecution on the merits has been otherwise closed, a
is a second or subsequent action on the merits.
petition under 37 CFR 1.182 along with the required
petition fee (37 CFR 1.17(f)) for entry of the protest
are required. The petition must include an explanation
as to why the additional time was necessary and the
nature of the protest intended. A copy of the petition
must be served upon the applicant in accordance with
37 CFR 1.248. The petition should be directed to the  
Office of Petitions.


If the protest of a reissue application cannot be filed
As noted above, the examiner will issue a final
within the 2-month delay period, the protestor may
Office action where the application is otherwise in
petition to request (A) an extension of the 2-month
condition for allowance, and amendments or other
period following the announcement in the Official
corrections of error in the patent have been made subsequent
Gazette, and (B) a delay of the examination until the
to the last oath/declaration filed in the application.
extended period expires. Such a request will be considered
The examiner will be introducing (via form  
only if filed in the form of a petition under
paragraph 14.05.02) a rejection into the case for the  
37
first time in the prosecution, when the claims have
CFR 1.182 and accompanied by the petition fee set
been determined to be otherwise allowable. This
forth in 37 CFR 1.17(f). The petition under 37 CFR
introduction of a new ground of rejection under
1.182 and the petition fee must be filed prior to the  
35
expiration of the 2-month period following the  
U.S.C. 251 will not prevent the action from being
announcement of the filing of the reissue application
made final on a second or subsequent action because
in the Official Gazette. The petition must explain why
of the following factors:
the additional time is necessary and the nature of the
protest intended. A copy of the petition must be
served upon applicant in accordance with 37 CFR
1.248. The petition should be directed to the appropriate
Technology Center (TC) which will forward the
petition to the Office of Patent Legal Administration.


If the protest is a “REISSUE LITIGATION” protest,
(A)The finding of the case in condition for allowance
it is particularly important that it be filed early if
is the first opportunity that the examiner has to  
protestor wishes it considered at the time the Office
make the rejection;
first acts on the reissue application. Protestors should
be aware that the Office will entertain petitions from
the reissue applicants under 37 CFR 1.182 to waive
the 2-month delay period in appropriate circumstances.
Accordingly, protestors to reissue applications
cannot automatically assume that the full 2-
month delay period will always be available.


The Technology Center (TC) to which the reissue
(B)The rejection is being made in reply to, i.e.,  
application is assigned is listed in the Official Gazettenotice of filing of the reissue application. Accordingly,  
was caused by, an amendment of the application (to
the indicated TC should retain jurisdiction
correct errors in the patent);
over the reissue application file for 2 months after
the date of the Official Gazette notice before transferring
the reissue application under the procedure set
forth in MPEP §
903.08(d).


The publication of a notice of a reissue application
(C)All applicants are on notice that this rejection
in the Official Gazette should be done prior to any
will be made upon finding of the case otherwise in
examination of the reissue application. If an inadvertent
condition for allowance where errors have been corrected
failure to publish notice of the filing of the reissue
subsequent to the last oath/declaration filed in  
application in the Official Gazette is recognized later
the case, so that the rejection should have been
in the examination, action should be taken to have the
expected by applicant; and  
notice published as quickly as possible, and action on
the reissue application may be delayed until 2 months
after the publication, allowing for any protests to be
filed.


See MPEP § 1901.06 for general procedures on
(D)The rejection will not prevent applicant from
examiner treatment of protests in reissue applications.
exercising any rights to cure the rejection, since applicant
need only submit a supplemental oath/declaration
with the above-described language, and it will be
entered to cure the rejection.


1442Special Status
Where the application is in condition for allowance
and no amendments or other corrections of error
in the patent have been made subsequent to the
last oath/declaration filed in the application, a supplemental
reissue oath/declaration under 37 CFR
1.175(b)(1) should not be required by the examiner.
Instead, the examiner should issue a Notice of
Allowability indicating allowance of the claims.


All reissue applications are taken up “special,” and
III.AFTER ALLOWANCE
remain “special” even though applicant does not
respond promptly.


All reissue applications, except those under suspension
Where applicant seeks to correct an error after
because of litigation, will be taken up for action
allowance of the application, any amendment of the
ahead of other “special” applications; this means that
patent correcting the error must be submitted in accordance
all issues not deferred will be treated and responded to
with 37 CFR 1.312. As set forth in 37 CFR
immediately. Furthermore, reissue applications
1.312, no amendment may be made as a matter of
involved in litigation will be taken up for action in
right in an application after the mailing of the notice
advance of other reissue applications.
of allowance. An amendment filed under 37 CFR
1.312 must be filed before or with the payment of the
issue fee and may be entered on the recommendation
of the primary examiner, and approved by the supervisory
patent examiner, without withdrawing the case
from issue.  


1442.01Litigation-Related Reissues [R-5]
Because the amendment seeks to correct an error in
the patent, the amendment will affect the disclosure,
the scope of a claim, or add a claim. Thus, in accordance
with MPEP § 714.16, the remarks accompanying
the amendment must fully and clearly state:


During initial review, the examiner should determine
(A)why the amendment is needed;
whether the patent for which the reissue has
been filed is involved in litigation, and if so, the status
of that litigation. If the examiner becomes aware of
litigation involving the patent sought to be reissued
during examination of the reissue application, and
applicant has not made the details regarding that litigation
of record in the reissue application, the examiner,
in the next Office action, will inquire regarding
the specific details of the litigation.


Form paragraph 14.06 may be used for such an
(B)why the proposed amended or new claims
inquiry.
require no additional search or examination;


¶ 14.06 Litigation-Related Reissue
(C)why the claims are patentable; and


The patent sought to be reissued by this application [1]
(D)why they were not presented earlier.
involved in litigation. Any documents and/or materials which


A supplemental reissue oath/declaration must
accompany the amendment. The supplemental reissue
oath/declaration must state that the error(s) to be corrected
arose without any deceptive intention on the
part of the applicant. The supplemental reissue oath/
declaration submitted after allowance must be
directed to the error(s) applicant seeks to correct after
allowance. This oath/declaration need not cover any
earlier errors, since all earlier errors should have been
covered by a reissue oath/declaration submitted prior
to allowance.


Occasionally correcting an error after allowance
does not include an amendment of the specification or
claims of the patent. For example, the correction of
the error could be the filing of a certified copy of the
original foreign application (prior to the payment of
the issue fee - see 37 CFR 1.55(a)(2)) to obtain the
right of foreign priority under 35 U.S.C. 119 (see
Brenner v. State of Israel, 400 F.2d 789, 158 USPQ
584 (D.C. Cir. 1968)) where the claim for foreign priority
had been timely made in the application for the
original patent. In such a case, the requirements of
37
CFR 1.312 must still be met. This is so, because
the correction of the patent is an amendment of the
patent, even though no amendment is physically
entered into the case. Thus, for a reissue oath/declaration
submitted after allowance to correct an additional
error (or errors), the reissue applicant must comply
with 37 CFR 1.312 in the manner discussed above.


==1445 Reissue Application Examined in Same Manner as Original Application==


As stated in 37 CFR 1.176, a reissue application,
 
including all the claims therein, is subject to “be
would be material to patentability of this reissue application are  
examined in the same manner as a non-reissue, non-
required to be made of record in response to this action.
provisional application.” Accordingly, the claims in a
reissue application are subject to any and all rejections
which the examiner deems appropriate. It does
not matter whether the claims are identical to those of
the patent or changed from those in the patent. It also
does not matter that a rejection was not made in the
prosecution of the patent, or could have been made, or
was in fact made and dropped during prosecution of
the patent; the prior action in the prosecution of the
patent does not prevent that rejection from being
made in the reissue application. Claims in a reissue
application enjoy no “presumption of validity.” In re
Doyle, 482 F.2d 1385, 1392, 179 USPQ 227, 232-233
(CCPA 1973); In re Sneed, 710 F.2d 1544, 1550 n.4,
218 USPQ 385, 389 n.4 (Fed. Cir. 1983). Likewise,
the fact that during prosecution of the patent the
examiner considered, may have considered, or should
have considered information such as, for example, a
specific prior art document, does not have any bearing
on, or prevent, its use as prior art during prosecution
of the reissue application.


Due to the related litigation status of this application, EXTENSIONS
==1448 Fraud, Inequitable Conduct, or Duty of Disclosure Issues==
OF TIME UNDER THE PROVISIONS OF 37 CFR
1.136(a) WILL NOT BE PERMITTED DURING THE PROSECUTION
OF THIS APPLICATION.


Examiner Note:
The Office no longer investigates and rejects reissue
applications under 37 CFR 1.56. The Office will
not comment upon duty of disclosure issues which are
brought to the attention of the Office in reissue applications
except to note in the application, in appropriate
circumstances, that such issues are no longer
considered by the Office during its examination of
patent applications. Examination as to the lack of
deceptive intent requirement in reissue applications
will continue but without any investigation of fraud,
inequitable conduct, or duty of disclosure issues.
Applicant’s statement in the reissue oath or declaration
of lack of deceptive intent will be accepted as dispositive
except in special circumstances such as an
admission or judicial determination of fraud, inequitable
conduct, or violation of the duty of disclosure.


In bracket 1, insert either —is— or —has been—.
ADMISSION OR JUDICIAL DETERMINATION


If additional details of the litigation appear to be  
An admission or judicial determination of fraud,
material to examination of the reissue application, the  
inequitable conduct, or violation of the duty of disclosure
examiner may make such additional inquiries as necessary
is a special circumstance, because no investigation
and appropriate.  
need be made. Accordingly, after consulting with
the Technology Center (TC) Special Program Examiner
(SPRE), a rejection should be made using the  
appropriate one of form paragraphs 14.21.09 or 14.22as reproduced below.


For reissue application files that are maintained in
Any admission of fraud, inequitable conduct or violation
paper, if the existence of litigation has not already
of the duty of disclosure must be explicit,
been noted, the examiner should place a prominent
unequivocal, and not subject to other interpretation.
notation on the application file to indicate the litigation
Where a rejection is made based upon such an admission and applicant
(1) at the bottom of the face of the file in the box
responds with any reasonable interpretation of the  
just to the right of the box for the retention label, and
facts that would not lead to a conclusion of fraud,
(2) on the pink Reissue Notice Card form. For reissue
inequitable conduct or violation of the duty of disclosure,  
application files that are maintained in the Image
the rejection should be withdrawn. Alternatively,
File Wrapper (IFW) system, if the existence of litigation
if applicant argues that the admission noted by the  
has not already been noted, the examiner should  
examiner was not in fact an admission, the rejection
print out a copy of the bibliographic data sheet from
should also be withdrawn.
the IFW file history and annotate the printed bibliographic
 
data sheet such that adequate notice is provided
See MPEP § 2012 for additional discussion as to
of the existence of the litigation. The examiner
fraud, inequitable conduct or violation of duty of disclosure
should place the annotation in a prominent place. The
in a reissue application.
annotated sheet should be scanned into IFW.


Applicants will normally be given 1 month to reply
==1449 Protest Filed in Reissue Where Patent Is in Interference==
to Office actions in all reissue applications which are
being examined during litigation, or after litigation
had been stayed, dismissed, etc., to allow for consideration
of the reissue by the Office. This 1-month
period may be extended only upon a showing of clear
justification pursuant to 37 CFR 1.136(b). The Office
action will inform applicant that the provisions of
37
CFR 1.136(a) are not available. Of course, up to
3
months may be set for reply if the examiner determines
such a period is clearly justified.


1442.02Concurrent Litigation [R-5]
If a protest (see MPEP Chapter 1900) is filed in a
reissue application related to a patent involved in a
pending interference proceeding, the reissue application
should be referred to the Office of Patent Legal
Administration (OPLA) before considering the protest
and acting on the reissue application.  


In order to avoid duplication of effort, action in
The OPLA will check to see that:
reissue applications in which there is an indication of
concurrent litigation will be suspended automatically
unless and until it is evident to the examiner, or the
applicant indicates, that any one of the following
applies:  


(A)a stay of the litigation is in effect;  
(A)all parties to the interference are aware of the
filing of the reissue; and


(B)the litigation has been terminated;
(B)the Office does not allow claims in the reissue
which are unpatentable over the pending interference
count(s), or found unpatentable in the interference
proceeding. After the reissue application has been  
reviewed by the OPLA, the reissue application with
the protest will be returned to the examiner. See
MPEP § 1441.01 for a discussion as to protests under
37 CFR 1.291 in reissue applications.


(C)there are no significant overlapping issues
===1449.01 Concurrent Office Proceedings===
between the application and the litigation; or


(D)it is applicant’s desire that the application be
I.CONCURRENT REEXAMINATION PROCEEDINGS:
examined at that time.  


Where any of (A) - (D) above apply, form paragraphs
37 CFR 1.565(d) provides that if “a reissue application
14.08-14.10 may be used to deny a suspension
and an ex parte reexamination proceeding on
of action in the reissue, i.e., to deny a stay of the reissue  
which an order pursuant to 37 CFR 1.525 has been
proceeding.
mailed are pending concurrently on a patent, a decision
will normally be made to merge the two proceedings
or to suspend one of the two proceedings.”
37 CFR 1.991 provides that if “a reissue application
and an inter partes reexamination proceeding on
which an order pursuant to 37 CFR 1.931 has been
mailed are pending concurrently on a patent, a decision
may be made to merge the two proceedings or to  
suspend one of the two proceedings”. If an examiner
becomes aware that a reissue application and an ex
parte or inter partes reexamination proceeding are
both pending for the same patent, he or she should
immediately inform the Technology Center (TC)
or Central Reexamination Unit (CRU) Special Program
Examiner (SPRE).


¶ 14.08 Action in Reissue Not Stayed — Related Litigation
Pursuant to 37 CFR 1.177, a patent owner may file
Terminated
more than one reissue application for the same patent.
If an examiner becomes aware that multiple reissue
applications are pending for the same patent, and an
ex parte or inter partes reexamination proceeding is
pending for the same patent, he or she should immediately
inform the TC SPRE.


Since the litigation related to this reissue application is terminated
Where a reissue application and a reexamination
and final, action in this reissue application will NOT be
proceeding are pending concurrently on a patent, and  
stayed. Due to the related litigation status of this reissue application,  
an order granting reexamination has been issued for
EXTENSIONS OF TIME UNDER THE PROVISIONS OF
the reexamination proceeding, the Office of Patent
37 CFR 1.136(a) WILL NOT BE PERMITTED.
Legal Administration (OPLA) must be notified that
the proceedings are ready for a decision as to whether
to merge the reissue and the reexamination, or stay
one of the two. See MPEP § 2285 for the  
procedure of  
notifying OPLA and general guidance, if a reissue  
application and an ex parte reexamination proceeding
are both pending for the same patent, and
an inter
partes reexamination proceeding is not involved. See
MPEP § 2686.03 where a reissue application and an
inter partes reexamination proceeding are both pending
for the same patent, regardless of whether an ex
parte reexamination proceeding is also pending.


¶ 14.09 Action in Reissue Not Stayed — Related Litigation
Where a reissue application and a reexamination
Not Overlapping
proceeding are pending concurrently on a patent, the  
 
patent owner, i.e., the reissue applicant, has a responsibility
While there is concurrent litigation related to this reissue application,
to notify the Office of the concurrent proceeding.
action in this reissue application will NOT be stayed
37 CFR § 1.178(b), 37 CFR 1.565(a), and
because there are no significant overlapping issues between the  
37
application and that litigation. Due to the related litigation status
CFR 1.985(a). The patent owner should file in the
of this reissue application, EXTENSIONS OF TIME UNDER
reissue application, as early as possible, a Notification
THE PROVISIONS OF 37 CFR 1.136(a) WILL NOT BE PERMITTED.
of Concurrent Proceedings pursuant to 37 CFR
 
1.178(b) in order to alert the Office of the existence of
 
the reexamination proceeding on the same patent. See
¶ 14.10 Action in Reissue Not Stayed — Applicant’s
MPEP § 1418. In addition, the patent owner should
Request
file in the reexamination proceeding, as early as possible,  
 
a Notification of Concurrent Proceedings pursuant
While there is concurrent litigation related to this reissue application,  
to 37 CFR 1.565(a) or 1.985(a) (depending on
action in this reissue application will NOT be stayed
whether the reexamination proceeding is an ex partereexamination proceeding or an inter partes reexamination
because of applicant's request that the application be examined at
proceeding) to provide a notification to the
this time. Due to the related litigation status of this reissue application,  
Office in the reexamination proceeding of the existence
EXTENSIONS OF TIME UNDER THE PROVISIONS
of the two concurrent proceedings.
OF 37 CFR 1.136(a) WILL NOT BE PERMITTED.
 
 
The patent owner may file a petition under 37 CFR
Where none of (A) through (D) above apply, action
1.182 in a reissue application to merge the reissue
in the reissue application in which there is an indication
application with the reexamination proceeding, or to
of concurrent litigation will be suspended by the  
stay one of the proceedings because of the other. This
examiner. The examiner should consult with the  
petition must be filed after the issuance of the order to  
Technology Center Special Program Examiner
reexamine (37 CFR 1.525, 37 CFR 1.931) in the reexamination
prior to suspending action in the reissue. Form paragraph
proceeding. If the petition is filed prior to
14.11 may be used to suspend action, i.e., stay
the reexamination order, it will not be considered, and
action, in a reissue application with concurrent litigation.
will be returned to the patent owner by the TC or
CRU Director. If the petition is filed after the issuance
of the order to reexamine, the petition and the
files for the reissue application and the reexamination
proceeding will be forwarded to OPLA for decision.
 
II.CONCURRENT INTERFERENCE PROCEEDINGS


If the original patent is involved in an interference,
the examiner must consult the administrative patent
judge in charge of the interference before taking any
action on the reissue application. It is particularly
important that the reissue application not be granted
without the administrative patent judge’s approval.
See MPEP Chapter 2300.


¶ 14.11 Action in Reissue Stayed - Related Litigation
III.CONCURRENT REISSUE PROCEEDINGS


In view of concurrent litigation, and in order to avoid duplication
Where more than one reissue applications are pending
of effort between the two proceedings, action in this reissue
concurrently on the same patent, see MPEP
application is STAYED until such time as it is evident to the
§§
examiner that (1) a stay of the litigation is in effect, (2) the litigation
has been terminated, (3) there are no significant overlapping
1450 and 1451.
issues between the application and the litigation, or (4) applicant
requests that the application be examined.


1449.02Interference in Reissue [R-5]


37 CFR 41.8. Mandatory notices.


(a)In an appeal brief (§§ 41.37, 41.67, or 41.68) or at the
initiation of a contested case (§ 41.101), and within 20 days of any
change during the proceeding, a party must identify:


(1)Its real party-in-interest, and


An ex parte reexamination proceeding will not be
(2)Each judicial or administrative proceeding that could
stayed where there is litigation. See Ethicon v. Quigg,
affect, or be affected by, the Board proceeding.
849 F.2d 1422, 7 USPQ2d 1152 (Fed. Cir. 1988).
Thus, where a reissue application has been merged
with an ex parte reexamination proceeding, the  
merged proceeding will not be stayed where there is
litigation. In a merged ex parte reexamination/reissue
proceeding, the ex parte reexamination will control
because of the statutory (35 U.S.C. 305) requirement
that ex parte reexamination proceedings be conducted
with special dispatch. See MPEP §
2285 and § 2286.
As to a stay or suspension where reissue proceedings
are merged with inter partes reexamination proceedings,
see 37 CFR 1.937 and MPEP § 2686.


1442.03Litigation Stayed [R-3]
(b)For contested cases, a party seeking judicial review of a
Board proceeding must file a notice with the Board of the judicial
review within 20 days of the filing of the complaint or the notice
of appeal. The notice to the Board must include a copy of the
complaint or notice of appeal. See also §§ 1.301 to 1.304 of this
title.


All reissue applications, except those under suspension
37 CFR 41.202. Suggesting an interference.
because of litigation, will be taken up for action
ahead of other “special” applications; this means that
all issues not deferred will be treated and responded to
immediately. Furthermore, reissue applications
involved in “stayed litigation” will be taken up for
action in advance of other reissue applications. Great
emphasis is placed on the expedited processing of
such reissue applications. The courts are especially
interested in expedited processing in the Office where
litigation is stayed.


In reissue applications with “stayed litigation,” the
(a)Applicant. An applicant, including a reissue applicant,  
Office will entertain petitions under 37 CFR 1.182,  
may suggest an interference with another application or a patent.  
which are accompanied by the fee under 37 CFR
The suggestion must:
1.17(f), to not apply the 2-month delay period
stated in MPEP § 1441. Such petitions are decided by
the Office of Patent Legal Administration.


Time-monitoring systems have been put into effect
(1)Provide sufficient information to identify the application
which will closely monitor the time used by applicants,
or patent with which the applicant seeks an interference,
protestors, and examiners in processing reissue
applications of patents involved in litigation in which
the court has stayed further action. Monthly reports on
the status of reissue applications with related litigation
are required from each Technology Center (TC).
Delays in reissue processing are to be followed up.
The TC Special Program Examiner is responsible for
oversight of reissue applications with related litigation.


(2)Identify all claims the applicant believes interfere,
propose one or more counts, and show how the claims correspond
to one or more counts,


The purpose of these procedures and those deferring
(3)For each count, provide a claim chart comparing at
consideration of certain issues, until all other
least one claim of each party corresponding to the count and show
issues are resolved or the application is otherwise
why the claims interfere within the meaning of § 41.203(a),
ready for consideration by the Board of Patent
Appeals and Interferences (note MPEP § 1448), is to
reduce the time between filing of the reissue application
and final action thereon, while still giving all parties
sufficient time to be heard.


Requests for stays or suspension of action in reissues
(4)Explain in detail why the applicant will prevail on priority,
where litigation has been stayed may be
answered with form paragraph 14.07.


¶ 14.07 Action in Reissue Not Stayed or Suspended —
(5)If a claim has been added or amended to provoke an
Related Litigation Stayed
interference, provide a claim chart showing the written description
for each claim in the applicant’s specification, and


While there is a stay of the concurrent litigation related to this
(6)For each constructive reduction to practice for which
reissue application, action in this reissue application will NOT be
the applicant wishes to be accorded benefit, provide a chart showing
stayed or suspended because a stay of that litigation is in effect for
where the disclosure provides a constructive reduction to practice
the purpose of awaiting the outcome of these reissue proceedings.
within the scope of the interfering subject matter.
Due to the related litigation status of this reissue application,
EXTENSIONS OF TIME UNDER THE PROVISIONS OF 37
CFR 1.136(a) WILL NOT BE PERMITTED.


1442.04Litigation Involving Patent [R-3]
(c)Examiner. An examiner may require an applicant to add
a claim to provoke an interference. Failure to satisfy the requirement
within a period (not less than one month) the examiner sets
will operate as a concession of priority for the subject matter of
the claim. If the interference would be with a patent, the applicant
must also comply with paragraphs (a)(2) through (a)(6) of this
section. The claim the examiner proposes to have added must,
apart from the question of priority under 35 U.S.C. 102 (g):


37 CFR 1.178. Original patent; continuing duty of
(1)Be patentable to the applicant, and
applicant.


(2)Be drawn to patentable subject matter claimed by
another applicant or patentee.


In appropriate circumstances, a reissue application
may be placed into interference with a patent or pending
application. A patentee may provoke an interference
with a patent or pending application by filing a
reissue application, if the reissue application includes
an appropriate reissue error as required by 35 U.S.C.
251. Reissue error must be based upon applicant
error; a reissue cannot be based solely on the error of
the Office for failing to declare an interference or to
suggest copying claims for the purpose of establishing
an interference. See In re Keil, 808 F.2d 830,
1
USPQ2d 1427 (Fed. Cir. 1987); In re Dien, 680 F.2d
151, 214 USPQ 10 (CCPA 1982); In re Bostwick, 102
F.2d 886, 888, 41 USPQ 279, 281 (CCPA 1939); and
In re Guastavino, 83 F.2d 913, 916, 29 USPQ 532,
535 (CCPA 1936). See also Slip Track Systems, Inc. v.
Metal Lite, Inc., 159 F.3d 1337, 48 USPQ2d 1055
(Fed. Cir. 1998) (Two patents issued claiming the
same patentable subject matter, and the patentee with
the earlier filing date requested reexamination of the
patent with the later filing date (Slip Track’s patent).
A stay of litigation in a priority of invention suit under
35 U.S.C. 291, pending the outcome of the reexamination,
was reversed. The suit under 35 U.S.C. 291was the only option available to Slip Track to determine
priority of invention. Slip Track could not file a
reissue application solely to provoke an interference
proceeding before the Office because it did not assert
that there was any error as required by 35 U.S.C. 251in the patent.). A reissue application can be employed
to provoke an interference if the reissue application:


(b)In any reissue application before the Office, the applicant
(A)adds copied claims which are not present in
must call to the attention of the Office any prior or concurrent proceedings
the original patent;
in which the patent (for which reissue is requested) is or
was involved, such as interferences, reissues, reexaminations, or
litigations and the results of such proceedings (see also
§
1.173(a)(1)).


Where the patent for which reissue is being sought
(B)amends claims to correspond to those of the  
is, or has been, involved in litigation, the applicant
patent or application with which an interference is
should bring the existence of such litigation to the
sought; or
attention of the Office. 37 CFR 1.178(b). This should
be done at the time of, or shortly after, the applicant
files the application, either in the reissue oath or declaration,
or in a separate paper, preferably accompanying
the application as filed. Litigation begun after
filing of the reissue application also should be
promptly brought to the attention of the Office.


Litigation encompasses any papers filed in the
(C)contains at least one error (not directed to
court or issued by the court. This may include, for
provoking an interference) appropriate for the reissue.
example, motions, pleadings, and court decisions, as
well as the results of such proceedings. When applicant
notifies the Office of the existence of the litigation,
enough information should be submitted so that
the Office can reasonably evaluate the need for asking
for further materials in the litigation. Note that the
existence of supporting materials which may substantiate
allegations of invalidity should, at least, be fully
described, and preferably submitted. The Office is not
interested in receiving voluminous litigation materials


In the first two situations, the reissue oath/declaration
must assert that applicant erred in failing to
include claims of the proper scope to provoke an
interference in the original patent application. Note
that in In re Metz, 173 F.3d 433 (Fed. Cir. 1998)
(table), the Federal Circuit permitted a patentee to file
a reissue application to copy claims from a patent in
order to provoke an interference with that patent. Furthermore,
the subject matter of the copied or amended
claims in the reissue application must be supported by
the disclosure of the original patent under 35 U.S.C.
112, first paragraph. See In re Molins, 368 F.2d 258,
261, 151 USPQ 570, 572
(CCPA 1966) and In re
Spencer, 273 F.2d 181, 124 USPQ 175 (CCPA 1959).


A reissue applicant cannot present added or
amended claims to provoke an interference, if the
claims were deliberately omitted from the patent. If
there is evidence that the claims were not inadvertently
omitted from the original patent, e.g., the subject
matter was described in the original patent as being
undesirable, the reissue application may lack proper
basis for the reissue. See In re Bostwick, 102 F.2d at
889, 41 USPQ at 282 (CCPA 1939)(reissue lacked a
proper basis because the original patent pointed out
the disadvantages of the embodiment that provided
support for the copied claims).


The issue date of the patent, or the publication date
of the application publication (whichever is applicable
under 35 U.S.C. 135(b)), with which an interference
is sought must be less than 1 year prior to the presentation
of the copied or amended claims in the reissue
application. See 35 U.S.C. 135(b) and MPEP § 715.05and MPEP Chapter 2300. If the reissue application
includes broadened claims, the reissue application
must be filed within two years from the issue date of
the original patent. See 35 U.S.C. 251 and MPEP §
1412.03.


An examiner may, pursuant to 37 CFR 41.202(c),
 
require a reissue applicant to add a claim to provoke
which are not relevant to the Office’s consideration of
an interference, unless the reissue applicant cannot
the reissue application. The status of the litigation
present the added claim to provoke an interference
should be updated in the reissue application as soon as
based upon the provisions of the reissue statute and
significant events happen in the litigation.
rules, e.g., if the claim was deliberately omitted from
 
the patent, or if the claim enlarges the scope of the  
When a reissue application is filed, the examiner
claims of the original patent and was not “applied for
should determine whether the original patent has been
within two years from the grant of the original
adjudicated by a court. The decision(s) of the court,
patent.” Failure to satisfy the requirement within a  
and also other papers in the suit, may provide information
period (not less than one month) the examiner sets
essential to the examination of the reissue.  
will operate as a concession of priority for the subject
Examiners should inform the applicant of the duty to
matter of the claim. If the interference would be with
supply information as to litigation involving the  
a patent, the reissue applicant must also comply with
patent. Form paragraph 14.11.01 may be used for this
37 CFR 41.202(a)(2) through (a)(6). The claim the  
purpose. See MPEP § 1418.  
examiner proposes to have added must, apart from the  
question of priority under 35 U.S.C. 102(g), be patentable
to the reissue applicant, and be drawn to patentable
subject matter claimed by another applicant or
patentee.


Additionally, the patented file will contain notices
REISSUE APPLICATION FILED WHILE
of the filing and termination of infringement suits on
PATENT IS IN INTERFERENCE
the patent. Such notices are required by law to be filed
by the clerks of the Federal District Courts. These
notices do not indicate if there was an opinion by the
court, nor whether a decision was published. Shepard’s
Federal Citations and the cumulative digests of
the United States Patents Quarterly, both of which are
in the Lutrelle F. Parker, Sr., Memorial Law Library,
contain tables of patent numbers giving the citation of
published decisions concerning the patent.


A litigation computer search by the Scientific and
If a reissue application is filed while the original
Technical Information Center (STIC) should be
patent is in an interference proceeding, the reissue
requested by the examiner to determine whether the  
applicant must promptly notify the Board of Patent
patent has been, or is, involved in litigation. For
Appeals and Interferences of the filing of the reissue  
reissue application files that are maintained in paper,  
application within 20 days from the filing date. See 37
the “Search Notes” box on the application file wrapper
CFR 41.8 and MPEP Chapter 2300.
is then  completed to indicate that the review
was conducted. A copy of the STIC search should be
hole-punched and placed in the reissue file. For
IFW reissue application files, the “Search Notes” box
on the OACS “Search Notes” page is annotated to
indicate that the review was conducted, and the
OACS “Search Notes” page is then scanned into the
reissue application file history.  


Additional information or guidance as to making a
==1450 Restriction and Election of Species Made in Reissue Application==
litigation search may be obtained from the library of
the Office of the Solicitor. Where papers are not otherwise
conveniently obtainable, the applicant may be
requested to supply copies of papers and records in
suits, or the Office of the Solicitor may be requested
to obtain them from the court. The information thus
obtained should be carefully considered for its bearing
on the proposed claims of the reissue, particularly
when the reissue application was filed in view of the
holding of a court.


If the examiner becomes aware of litigation involving
37 CFR 1.176. Examination of reissue.
the patent sought to be reissued during examination
of the reissue application, and applicant has not
made the details regarding that litigation of record in
the reissue application, the examiner, in the next
Office action, should inquire regarding the same.
Form paragraph 14.06 may be used for such an
inquiry. See MPEP § 1442.01.


If the additional details of the litigation appear to be  
(a)A reissue application will be examined in the same manner
material to patentability of the reissue application, the  
as a non-reissue, non-provisional application, and will be subject
examiner may make such additional inquiries as necessary
to all the requirements of the rules related to non-reissue
and appropriate.
applications. Applications for reissue will be acted on by the  
examiner in advance of other applications.


1442.05Court Ordered Filing of Reissue
(b)Restriction between subject matter of the original patent
Application [R-3]
claims and previously unclaimed subject matter may be required
(restriction involving only subject matter of the original patent
claims will not be required). If restriction is required, the subject
matter of the original patent claims will be held to be constructively
elected unless a disclaimer of all the patent claims is filed in
the reissue application, which disclaimer cannot be withdrawn by
applicant.


In most instances, the reissue-examination procedure
37 CFR 1.176(b) permits the examiner to require
is instituted by a patent owner who voluntarily
restriction in a reissue application between claims
files a reissue application as a consequence of related
newly added in a reissue application and the original
patent litigation. Some Federal district courts in
patent claims, where the added claims are directed to
earlier decisions have required a patentee-litigant to
an invention which is separate and distinct from the
file a reissue application as a consequence of the  
invention(s) defined by the original patent claims. The
patent litigation. However, the Court of Appeals for
criteria for making a restriction requirement in a reissue  
the Federal Circuit held in Green v. The Rich Iron Co.,
application between the newly added claims and
944 F.2d 852, 853, 20 USPQ2d 1075, 1076 (Fed. Cir.  
the original claims are the same as that applied in a
1991) that a Federal district court in an infringement
non-reissue application. See MPEP §§ 806 through
case could not compel a patentee to seek reissue
806.05(i). The authority to make a “restriction”
by the USPTO.
requirement under 37 CFR 1.176(b) extends to and
includes the authority to make an election of species.


It is to be noted that only a patentee or his or her
Where a restriction requirement is made by the
assignee may file a reissue patent application. An
examiner, the original patent claims will be held to be  
order by a court for a different party to file a reissue
constructively elected (except for the limited situation
will not be binding on the Office.
where a disclaimer is filed as discussed in the next
paragraph). Thus, the examiner will issue an Office
action in the reissue application (1) providing notification
of the restriction requirement, (2) holding the
added claims to be constructively non-elected and
withdrawn from consideration,  (3) treating the original
patent claims on the merits, and (4) informing
applicant that if the original claims are found allowable,
and a divisional application has been filed for  
the non-elected claims, further action in the application
will be suspended, pending resolution of the divisional
application..  


1443Initial Examiner Review [R-3]
If a disclaimer of all the original patent claims is
filed in the reissue application containing newly
added claims that are separate and distinct from the
original patent claims, only the newly added claims
will be present for examination. In this situation, the
examiner’s Office action will treat the newly added
claims in the reissue application on the merits. The
disclaimer of all the original patent claims must be
filed in the reissue application prior to the issuance of
the examiner’s Office action containing the restriction
requirement, in order for the newly added claims to be
treated on the merits. Once the examiner has issued
the Office action providing notification of the restriction
requirement and treating the patent claims on the
merits, it is too late to obtain an examination on
the added claims in the reissue application by filing a
disclaimer of all the original patent claims. If reissue
applicant wishes to have the newly added claims be
treated on the merits, a divisional reissue application
must be filed to obtain examination of the added
claims. Reissue applicants should carefully note that
once a disclaimer of the patent claims is filed, it cannot
be withdrawn. It does not matter whether the reissue
application is still pending, or whether the reissue
application has been abandoned or issued as a reissue
patent. For all these situations, 37 CFR 1.176(b) states
that the disclaimer cannot be withdrawn; the disclaimer
will be given effect.


As part of an examiner’s preparation for the examination
Claims elected pursuant to a restriction requirement
of a reissue application, the Examiner Reissue
will receive a complete examination on the merits,
Guide and Checklist should be consulted for basic
while the non-elected claims (to any added invention(s)) will be held in abeyance in a withdrawn status,
guidance and suggestions for handling the prosecution.  
and will only be examined if filed in a divisional
The Technology Center (TC) Special Program
reissue application. If the reissue application containing
Examiners (SPREs) should make the Guide and
only original unamended claims becomes allowable
Checklist available at the time a reissue application is
first (and no “error” under 35 U.S.C. 251exists),
docketed to an examiner.
 
further action in that reissue application will
On initial receipt of a reissue application, the examiner  
be suspended to await examination in the divisional
should inspect the submission under 37 CFR  
reissue application(s) containing the added claims.  
1.172 as to documentary evidence of a chain of title
Multiple suspensions (usually six-month periods)  
from the original owner to the assignee to determine
may be necessary. The Office will not  permit
whether the consent requirement of 37 CFR 1.172 has
claims to issue in a reissue application which
application does not correct any error in the original
patent. Once a divisional reissue application containing
the added claims is examined and becomes
allowable, the examiner will issue a requirement
under 37 CFR 1.177(c) for applicant to merge the
claims of the suspended first reissue application with
the allowable claims of the divisional reissue application
into a single application, by placing all of the
claims in one of the applications and expressly abandoning
the other. The Office action making this
requirement will set a two-month period for compliance
with the requirement. If applicant fails to timely
respond to the Office action, or otherwise refuses to  
comply with the requirement made, then the divisional
reissue application (claiming the invention
which was non-elected in the now-suspended first
reissue application) will be passed to issue alone,
since the claims of the divisional reissue application,
by themselves, do correct an error in the original
patent. Prosecution will be reopened in the suspended
first reissue application, and a rejection based on a
lack of error under 35
U.S.C. 251 will then be made.
This rejection may be made final, since applicant is on
notice of the consequences of not complying with the
merger requirement.


If the divisional reissue application becomes abandoned,
prosecution will be reopened in the suspended
first reissue application, and a rejection based on a
lack of error under 35 U.S.C. 251 will then be made in
the first reissue application. Since no error in the original
patent is being corrected in the first reissue application,
no reissue patent will issue.


As stated in 37 CFR 1.176(b), the examiner is not
permitted to require restriction among original
claims of the patent (i.e., among claims that were in
the patent prior to filing the reissue application). Even
where the original patent contains claims to different
inventions which the examiner considers independent
or distinct, and the reissue application claims the same
inventions, a restriction requirement would be
improper. If such a restriction requirement is made, it
must be withdrawn.


Restriction between multiple inventions recited in
the newly added claims will be permitted provided
the added claims are drawn to several separate and
distinct inventions. In such a situation, the original
patent claims would be examined in the first reissue
application, and applicant is permitted to file a divisional
reissue application for each of the several separate
and distinct inventions identified in the
examiner’s restriction requirement.


A situation will sometimes arise where the examiner
makes an election of species requirement
between the species claimed in the original patent
claims and a species of claims added in the reissue
application. In such a situation, if (1) the non-elected
claims to the added species depend from (or otherwise
include all limitations of) a generic claim which
embraces all species claims, and (2) the generic claim
is found allowable, then the non-elected claims of the
added species must be rejoined with the elected
claims of the original patent. See MPEP §
821.04(a).
 
==1451 Divisional Reissue Applications;Continuation Reissue Applications Where the Parent is Pending==


been met. The examiner will compare the consent and
35 U.S.C. 251. Reissue of defective patents.
documentary evidence of ownership; the assignee
indicated by the documentary evidence must be the
same assignee which signed the consent. Also, the
person who signs the consent for the assignee and the
person who signs the submission of evidence of ownership
for the assignee must both be persons having
authority to do so. See also MPEP § 324.  


Where the application is assigned, and there is no
The Director may issue several reissued patents for distinct and  
submission under 37 CFR 1.172 as to documentary
separate parts of the thing patented, upon demand of the applicant,  
evidence in the application, the examiner should
and upon payment of the required fee for a reissue for each of
require the submission using form paragraph 14.16.
such reissued patents.
Once the submission under 37 CFR 1.172 as to documentary
evidence is received, it must be compared
with the consent to determine whether the assignee
indicated by the documentary evidence is the same
assignee which signed the consent. See MPEP
§
1410.01 for further discussion as to the required
consent and documentary evidence.


Where there is a statement of record that the application
37 CFR 1.177. Issuance of multiple reissue patents.
is not assigned, there should be no submission
under 37  
CFR 1.172 as to documentary evidence of  
ownership in the application, and none should be
required by the examiner.


The filing of all reissue applications, except for
(a)The Office may reissue a patent as multiple reissue patents.  
continued prosecution applications (CPAs) filed under
If applicant files more than one application for the reissue of
37 CFR 1.53(d), must be announced in the Official
a single patent, each such application must contain or be amended
Gazette. Accordingly, for any reissue application
to contain in the first sentence of the specification a notice stating
other than a CPA, the examiner should determine if
that more than one reissue application has been filed and identifying
the filing of the reissue application has been  
each of the reissue applications by relationship, application  
announced in the Official Gazette as provided in
number and filing date. The Office may correct by certificate of  
37
correction under § 1.322 any reissue patent resulting from an application to which this paragraph applies that does not contain the required notice.
CFR 1.11(b). The contents entry on the PALM
Intranet Contents screen should be checked for the
presence of “NRE” and “NOTICE OF REISSUE
PUBLISHED IN OFFICIAL GAZETTE” entries in
the contents, and the date of publication. Where the  
reissue application is maintained in a paper file, the
date of the Official Gazette notice can usually be
found on the pink “REISSUE” tag which protrudes
from the top of the application file of 08/ or earlier
series.  For 09/ and later series reissue applications,
the Official Gazette publication date appears on the
face of the file wrapper. If the filing of the reissue
application has not been announced in the Official
Gazette, the reissue application should be returned to  
the Office of Initial Patent Examination (Special Processing)
to handle the announcement. The examiner
should not further act on the reissue until 2 months
after announcement of the filing of the reissue has
appeared in the Official Gazette. See MPEP §
1440.


The examiner should determine if there is concurrent
(b)If applicant files more than one application for the reissue
litigation, and if so, the status thereof (MPEP
of a single patent, each claim of the patent being reissued must
§
be presented in each of the reissue applications as an amended,
unamended, or canceled (shown in brackets) claim, with each
1442.01), and whether the reissue file wrapper
such claim bearing the same number as in the patent being reissued.  
(for reissue application files maintained in paper) or
The same claim of the patent being reissued may not be presented
file history (for IFW reissue applications) has been
in its original unamended form for examination in more
appropriately marked. Note MPEP § 1404.  
than one of such multiple reissue applications. The numbering of
any added claims in any of the multiple reissue applications must
follow the number of the highest numbered original patent claim.


The examiner should determine if a protest has
(c)If any one of the several reissue applications by itself
been filed, and if so, it should be handled as set forth
fails to correct an error in the original patent as required by 35
in MPEP §
U.S.C. 251 but is otherwise in condition for allowance, the Office
may suspend action in  
1901.06. For a discussion of protests
the allowable application until all issues
under 37 CFR 1.291 in reissue applications, see
are resolved as to at least one of the remaining reissue applications.  
MPEP § 1441.01.
The Office may also merge two or more of the multiple reissue
applications into a single reissue application. No reissue
application containing only unamended patent claims and not correcting
an error in the original patent will be passed to issue by
itself.


The examiner should determine whether the patent
The court in In re Graff, 111 F.3d 874, 876-77,
is involved in an interference, and if so, should refer
42 USPQ2d 1471, 1473 (Fed. Cir. 1997) stated that
to MPEP § 1449.01 before taking any action on the  
“[t]he statute does not prohibit divisional or continuation
reissue application.
reissue applications, and does not place stricter
limitations on such applications when they are presented
by reissue, provided of course that the statutory
requirements specific to reissue applications are met.”
Following the decision in Graff, the Office has
adopted a policy of treating continuations and divisionals
of reissue applications, to the extent possible,  
in the same manner as continuations and divisionals
of non-reissue applications.


Questions relating to the propriety of divisional
reissue applications and continuation reissue applications
should be referred via the Technology Center
(TC) Special Program Examiner to the Office of
Patent Legal Administration.


I. DIVISIONAL REISSUE APPLICATIONS


The examiner should verify that all Certificate of  
37 CFR 1.176(b) permits the examiner to require
Correction changes have been properly incorporated
restriction in a reissue application between the original
into the reissue application. See MPEP § 1411.01.
claims of the patent and any newly added claims
which are directed to a separate and distinct invention(
s). See also MPEP § 1450. As a result of such a
restriction requirement, divisional applications may
be filed for each of the inventions identified in the
restriction requirement.  


The examiner should verify that the patent on
In addition, applicant may initiate a division of the  
which the reissue application is based has not expired,
claims by filing more than one reissue application in
either because its term has run or because required
accordance with 37 CFR 1.177. The multiple reissue
maintenance fees have
applications which are filed may contain different
not been paid. Once a patent  
groups of claims from among the original patent  
has expired, the Director of the USPTO no longer has
claims, or some of the reissue applications may contain
the authority under 35 U.S.C. 251 to
newly added groups (not present in the original
reissue the
patent). There is no requirement that the claims of the
patent. See In re Morgan, 990 F.2d 1230, 26 USPQ2d
multiple reissue applications be independent and distinct
1392 (Fed. Cir. 1992). See also MPEP §
from one another; if they are not independent
and distinct from one another, the examiner must
1415.01.  
apply the appropriate double patenting rejections.


1444Review of Reissue Oath/Declaration
There is no requirement that a family of divisional
[R-5]
reissue applications issue at the same time; however,
it is required that they contain a cross reference to
each other in the specification. 37 CFR 1.177(a)
requires that all multiple reissue applications resulting
from a single patent must include as the first sentence
of their respective specifications a cross reference to
the other reissue application(s). Accordingly, the first
sentence of each reissue specification must provide
notice stating that more than one reissue application
has been filed, and it must identify each of the reissue
applications and their relationship within the family
of reissue applications, and to the original patent. An
example of the suggested language to be inserted is as
follows:


In accordance with 37 CFR 1.175, the following is
Notice: More than one reissue application has
required in the reissue oath/declaration:
been filed for the reissue of Patent No. 9,999,999. The
reissue applications are application numbers 09/
999,994 (the present application), 09/999,995, and 09/
999,998, all of which are divisional reissues of Patent
No. 9,999,999.


(A)A statement that the applicant believes the  
The examiner should object to the specification
original patent to be wholly or partly inoperative or
and require an appropriate amendment if applicant  
invalid-
fails to include such a cross reference to the other reissue
applications in the first sentence of the specification
of each of the reissue applications.


(1)by reason of a defective specification or
In addition to the amendment to the first sentence
drawing, or
of the specification, the reissue application cross references
will also be reflected in the file. For an
IFW reissue application file, a copy of the bibliographic
data sheet from the IFW file history should be
printed and the examiner should annotate the printed
sheet such that adequate notice is provided that more
than one reissue application has been filed for a single
original patent. The annotated sheet should be
scanned into IFW. For reissue application files that are
maintained in paper, the bibliographic data sheet
should be reprinted (for 09/ and later series), or
the front face of the reissue file wrapper should be
marked (for 08/ and earlier series), for all the multiple
reissue applications, so that adequate notice is provided
that more than one reissue application has been
filed for a single original patent.


(2)by reason of the patentee claiming more or  
Pursuant to 37 CFR 1.177(b) all of the claims of the  
less than patentee had the right to claim in the patent;
patent to be reissued must be presented in each reissue
application in some form, i.e., as amended, as
unamended or as canceled. Further,  any added
claims must be numbered beginning with the next
highest number following the last patent claim. It is
noted that the same claim of the patent cannot be presented
for examination in more than one of the divisional
reissue applications, as a pending claim, in
either its original or amended versions. Once a claim  
in the patent has been reissued, it does not exist in the  
original patent; thus, it cannot be reissued from the
original patent in another reissue application. If the
same claim of the patent, e.g., patent claim 1 is presented
for examination in more than one of the reissue
applications, in different amended versions, the following
rejections should be made in the reissue applications
with that patent claim:


(B)A statement of at least one error which is
A rejection under 35 U.S.C. 251, in that the reissue  
relied upon to support the reissue application, i.e.,  
application is not correcting an error in the original
which provides a basis for the reissue;
patent, because original claim 1 would be superseded
 
by the reissuance of claim 1 in the other reissue application.
(C)A statement that all errors which are being
corrected in the reissue application up to the time of


A rejection under 35 U.S.C. 112, in that claim 1 is
indefinite because the invention of claim 1 is not particularly
pointed out and distinctly claimed. Claim 1
presents one coverage in divisional reissue application
X and another in the present reissue application. This
is inconsistent.


The reissue applicant should then be advised to follow
a procedure similar to the following example:


If there are patent claims 1 – 10 in two divisional
reissue applications and an applicant wishes to revise
claim 1, which is directed to AB (for example) to
ABC in one divisional reissue application, and to
ABD in a second divisional reissue application, applicant
should do the following: Claim 1 in the first divisional
reissue application can be revised to recite
ABC. Claim 1 in the second divisional reissue application
would be canceled, and new claim 11 would be
added to recite ABD. The physical cancellation of
claim 1 in the second divisional reissue application
will not prejudice applicant’s rights in the amended
version of claim 1 since those rights are retained via
the first reissue application. Claim 1 continues to exist
in the first reissue application, and both the first and
second reissue applications taken together make up
the totality of the correction of the original patent.


If the same or similar claims are presented in more
 
than one of the multiple reissue applications, the possibility
filing of the oath/declaration arose without any deceptive
of statutory double patenting (35 U.S.C. 101)
intention on the part of the applicant; and
or non-statutory (judicially created doctrine) double
 
patenting should be considered by the examiner during
(D)The information required by 37 CFR 1.63.
examination, and the appropriate rejections made.
 
A terminal disclaimer may be filed to overcome an
MPEP § 1414 contains a discussion of each of the  
obviousness type double patenting rejection. The terminal
above elements (i.e., requirements of a reissue oath/
disclaimer is necessary in order to ensure common
declaration). The examiner should carefully review
ownership of the reissue patents throughout the
the reissue oath/declaration in conjunction with that
remainder of the unexpired term of the original patent.
discussion, in order to ensure that each element is provided
Whenever a divisional reissue application is filed with
in the oath/declaration. If the examiner’s review
a copy of the oath/declaration and assignee consent
of the oath/declaration reveals a lack of compliance
from the parent reissue application, the copy of the
with any of the requirements of 37 CFR 1.175, a
assignee consent from the parent reissue application
rejection of all the claims under 35  
should not be accepted. The copy of the consent from
U.S.C. 251 should
the parent reissue application does not indicate that
be made on the basis that the reissue oath/declaration  
the assignee has consented to the addition of the new
is insufficient.
invention of the divisional reissue application to the
 
original patent. The Office of Initial Patent Examination
In preparing an Office action, the examiner should
(OIPE) should accord a filing date and send out a
use form paragraphs 14.01 through 14.01.04 to state
notice of missing parts stating that there is no proper
the objection(s) to the oath/declaration, i.e., the  
consent and setting a period of time for filing the
defects in the oath/declaration. These form paragraphs
missing part and for payment of any surcharge
are reproduced in MPEP § 1414. The examiner should
required under 37 CFR 1.53(f) and 1.16(f). See
then use form paragraph 14.14 to reject the claims
MPEP § 1410.01. The copy of the reissue oath/declaration
under 35 U.S.C. 251, based upon the improper oath/
should be accepted by OIPE, since it is an oath/
declaration.  
declaration, even though it may be improper under
35 U.S.C. 251. The examiner should check the copy
of the oath/declaration to ensure that it identifies an
error being corrected by the divisional reissue application.  
The copy of the oath/declaration from the parent
reissue application may or may not cover the error
being corrected by the divisional reissue application
since the divisional reissue application is (by definition)
directed to a new invention. If it does not, the
examiner should reject the claims of the divisional
reissue application under 35 U.S.C. 251 as being
based on an oath/declaration that does not identify an
error being corrected by the divisional reissue application,
and require a new oath/declaration. See MPEP §
1414. If the copy of the reissue oath/declaration from
the parent reissue application does in fact cover an
error being corrected in the divisional reissue application,  
no such rejection should be made. However,  
since a new invention is being added by the filing of
the divisional reissue application, a supplemental reissue
oath/declaration pursuant to 37 CFR 1.175 (b)(1)
will be required. See MPEP § 1414.01.


¶ 14.14 Rejection, Defective Reissue Oath or Declaration
Situations yielding divisional reissues occur infrequently
and usually involve only two such files. It
should be noted, however, that in rare instances in the
past, there have been more than two (and as many as
five) divisional reissues of a
patent. For treatment of a
plurality of divisional reissue applications resulting
from a requirement to restrict to distinct inventions or  
a requirement to elect species, see MPEP § 1450.


Claim [1] rejected as being based upon a defective reissue [2]
II. CONTINUATION REISSUE APPLI-
under 35 U.S.C. 251 as set forth above. See 37 CFR 1.175.
CATIONS


The nature of the defect(s) in the [3] is set forth in the discussion
A continuation of a reissue is not ordinarily filed
above in this Office action.
“for distinct and separate parts of the thing patented”
as called for in the second paragraph of 35 U.S.C.
251. The decision of In re Graff, 111 F.3d 874,
42 USPQ2d 1471 (Fed. Cir. 1997) interprets
35 U.S.C. 251 to permit multiple reissue patents to
issue even where the multiple reissue patents are not
for “distinct and separate parts of the thing patented.”
The court stated:


Examiner Note:
Section 251[2] is plainly intended as enabling, not as limiting.
 
Section 251[2] has the effect of assuring that a different
1.In bracket 1, list all claims in the reissue application. See
burden is not placed on divisional or continuation
MPEP §
reissue applications, compared with divisions and continuations
of original applications, by codifying the Supreme
706.03(x).
Court decision which recognized that more than one
 
patent can result from a reissue proceeding. Thus § 251[2]
2.This paragraph should be preceded by at least one of the
places no greater burden on Mr. Graff’s continuation reissue
paragraphs 14.01 to 14.01.04.
application than upon a continuation of an original
application; § 251[2] neither overrides, enlarges, nor limits the statement in § 251[3] that the provisions of Title 5 apply to reissues.


3.In brackets 2 and 3, insert either --oath-- or --declaration--.
111 F.3d at 877, 42 USPQ2d at 1473. Accordingly,
prosecution of a continuation of a reissue application
will be permitted (despite the existence of the pending
parent reissue application) where the continuation
complies with the rules for reissue.


A lack of signature on a reissue oath/declaration
The parent and the continuation reissue applications
(except as otherwise provided in 37 CFR 1.42, 1.43,
should be examined together if possible. In
and 1.47 and in 37 CFR 1.172) would be considered a
order that the parent-continuation relationship of the  
lack of compliance with 37 CFR 1.175(a) and result in
reissue applications be specifically identified and  
a rejection, including final rejection, of all the claims
notice be provided of both reissue applications for
on the basis that the reissue oath/declaration is insufficient.
both the parent and the continuation reissue applications,  
If the unsigned reissue oath/declaration is submitted
the following is done:
as part of a reply which is otherwise properly
signed and responsive to the outstanding Office
action, the reply should be accepted by the examiner
as proper and responsive, and the oath/declaration
considered fully in the next Office action. The reply
should not be treated as an unsigned or improperly
signed amendment (see MPEP § 714.01(a)), nor do
the holdings of Ex parte Quayle apply in this situation.
The lack of signature, along with any other oath/
declaration deficiencies, should be noted in the next
Office action rejecting the claims as being based upon
an insufficient reissue oath/declaration.


I.HANDLING OF THE REISSUE OATH/
(A) An appropriate amendment to the continuing
DECLARATION DURING THE REISSUE
data entries must be made to the first sentence of
PROCEEDING
the specification, (see the discussion above under the
heading “Divisional Reissue Applications”).


An initial reissue oath/declaration is submitted with
(B)For an IFW reissue application file, a copy of
the reissue application (or within the time period set
the bibliographic data sheet from the IFW file history
for filing the oath/declaration in a Notice To File
should be printed and the examiner should annotate
Missing Parts under 37 CFR 1.53(f)). Where the reissue
the printed sheet such that adequate notice is provided
oath/declaration fails to comply with 37 CFR
that more than one reissue application has been filed
1.175(a), the examiner will so notify the applicant in
for a single original patent. The annotated sheet
an Office action, rejecting the claims under 35 U.S.C.
should be scanned into IFW. For reissue application
251 as discussed above. In reply to the Office action, a
files that are maintained in paper, the bibliographic
supplemental reissue oath/declaration should be submitted
data sheet should be reprinted (for 09/ and later
dealing with the noted defects in the reissue
series), or the front face of the reissue file wrapper
oath/declaration.
should be marked (for 08/ and earlier series), for all
the multiple reissue applications, so that adequate
notice is provided that more than one reissue application
has been filed for a single original patent.


Where the initial reissue oath/declaration (1) failed
As is true for the case of multiple divisional reissue  
to provide any error statement, or (2) attempted to  
applications, all of the claims of the patent to be reissued
provide an error statement, but failed to identify any
must be presented in both the parent reissue
error under 35 U.S.C. 251 upon which reissue can be  
application and the continuation reissue application in
based (see MPEP § 1402), the examiner should reject
some form, i.e., as amended, as unamended, or as canceled.  
all the claims as being based upon a defective reissue  
The same claim of the patent cannot, however
oath/declaration under 35 U.S.C. 251. To support the
be presented for examination in both the parent reissue  
rejection, the examiner should specifically point out
application and the continuation reissue application,
the failure of the initial oath/declaration to comply
as a pending claim, in either its original or
with 37 CFR 1.175 because an “error” under
amended versions. See the discussion in subsection I.
35
above for treatment of this situation. Further, any
U.S.C. 251 upon which reissue can be based was
added claims must be numbered beginning with the  
not identified therein. In reply to the rejection under
next highest number following the past patent
35 U.S.C. 251, a supplemental reissue oath/declaration
claims.
must be submitted stating an error under
35
U.S.C. 251 which can be relied upon to support the  
reissue application. Submission of this supplemental
reissue oath/declaration to obviate the rejection cannot
be deferred by applicant until the application is
otherwise in condition for allowance. In this instance,  
a proper statement of error was never provided in the  
initial reissue oath/declaration, thus a supplemental
oath/declaration is required in reply to the Office
action in order to properly establish grounds for reissue.


Where the parent reissue application issues prior to
the examination of the continuation, the claims of the
continuation should be carefully reviewed for double
patenting over the claims of the parent. Where the
parent and the continuation reissue applications are
examined together, a provisional double patenting
rejection should be made in both cases as to any overlapping
claims. See MPEP § 804 - §
804.04 as to double
patenting rejections. Any terminal disclaimer filed
to obviate an obviousness-type double patenting
rejection ensures common ownership of the reissue
patents throughout the remainder of the unexpired
term of the original patent.


A different situation may arise where the initial
If the parent reissue application issues without any
reissue oath/declaration does properly identify one or
cross reference to the continuation, amendment of the  
more errors under 35 U.S.C. 251 as being the basis for
parent
reissue, however, because of changes or amendments
reissue patent to include a cross-reference to
made during prosecution, none of the identified errors
the continuation must be effected at the time of allowance
of the continuation application by Certificate of
Correction. See the discussion above under the heading
“Divisional Reissue Applications” as to how the
Certificate of Correction is to be provided.


Again, the examiner should make reference in the
pending divisional reissue application to the fact that
an actual request for a Certificate of Correction has
been generated in the first reissue patent pursuant to
37 CFR 1.177(a), e.g., by an entry in the search notes
or in an examiner’s amendment.


Where a continuation reissue application is filed
with a copy of the oath/declaration and assignee consent
from the parent reissue application, and the parent
reissue application is not to be abandoned, the
copy of the consent of the parent reissue application
should not be accepted. The copy of the consent of the
parent reissue application does not indicate that the
assignee has consented to the addition of the new
error correction of the continuation reissue application
to the original patent. Presumably, a new correction
has been added, since the parent reissue
application is still pending. OIPE should accord a filing
date and send out a notice of missing parts stating
that there is no proper consent and setting a period of
time for filing the missing part and for payment of any
surcharge required under 37 CFR 1.53(f) and
1.16(f). See MPEP § 1410.01. The copy of the
reissue oath/declaration should be accepted by OIPE,
since it is a oath/declaration, albeit improper under
35 U.S.C. 251. The examiner should reject the claims
of the continuation reissue application under 35 U.S.C. 251 as being based on an oath/declaration
that does not identify an error being corrected by the
continuation reissue application, and should require a
new oath/declaration. See 37 CFR 1.175(e). One of
form paragraphs 14.01.01 through 14.01.03 may be
used. See MPEP § 1414.


Where a continuation reissue application is filed
with a copy of the oath/declaration and assignee consent
from the parent reissue application, and the parent
reissue application is, or will be abandoned, the
copy of the consent should be accepted by both OIPE
and the examiner. The reissue oath/declaration should
be accepted by OIPE, and the examiner should check
to ensure that the oath/declaration identifies an error
that is being corrected in the continuation reissue
application. See MPEP § 1414. If a preliminary
amendment was filed with the continuation reissue
application, the examiner should check for the need of
a supplemental reissue oath/declaration. Pursuant to
37 CFR 1.175 (b)(1), for any error corrected via the
preliminary amendment which is not covered by the
oath or declaration submitted in the parent reissue
application, applicant must submit a supplemental
oath/declaration stating that every such error arose
without any deceptive intention on the part of the
applicant. See MPEP § 1414 and § 1414.01.


==1452 Request for Continued Examination of Reissue Application==


are relied upon any more. A supplemental oath/declaration
A request for continued examination (RCE) under
will be needed to identify at least one error nowbeing relied upon as the basis for reissue, even though
37 CFR 1.114 is available for a reissue application.  
the prior oath/declaration was earlier found proper by
Effective May 29, 2000, an applicant in a reissue
the examiner. The supplemental oath/declaration need
application may file a request for continued examination
not also indicate that the error(s) identified in the prior
of the reissue application, if the reissue application
oath(s)/declaration(s) is/are no longer being corrected.
was filed on or after June 8, 1995. This applies
In this instance, applicant’s submission of the supplemental
even where the application, which resulted in the original
reissue oath/declaration to obviate the rejection
patent, was filed prior to June 8, 1995.
under 35 U.S.C. 251 can, at applicant’s option, be
deferred until the application is otherwise in condition
for allowance. The submission can be deferred
because a proper statement of error was provided in  
the initial reissue oath/declaration. Applicant need
only request that submission of the supplemental reissue
oath/declaration be deferred until allowance, and
such a request will be considered a complete reply to  
the rejection.


II.SUPPLEMENTAL REISSUE OATH/DECLARATION
An RCE continues the prosecution of the existing
UNDER 37 CFR 1.175(b)(1):
reissue application and is not a filing of a new reissue
application. Thus, the filing of an RCE will not be
announced in the Official Gazette. Additionally, if a
reissue application is merged with a reexamination
proceeding (see MPEP § 1449.01), the filing of an
RCE will not dissolve the merger, since the reissue
application does not become abandoned.


Once the reissue oath/declaration is found to comply
==1453 Amendments to Reissue Applications==
with 37 CFR 1.175(a), it is not required, nor is it
suggested, that a new reissue oath/declaration be submitted
together with each new amendment and correction
of error in the patent. During the prosecution of a
reissue application, amendments are often made
and
additional errors in the patent are corrected. A
supplemental oath/declaration need not be submitted
with each amendment and additional correction.
Rather, it is suggested that the reissue applicant wait
until the case is in condition for allowance, and then
submit a cumulative supplemental reissue oath/declaration
pursuant to 37 CFR 1.175(b)(1).


See MPEP § 1414.01 for a discussion of the
37 CFR 1.121. Manner of making amendments in
required content of a supplemental reissue oath/declaration
application.
under 37 CFR 1.175(b)(1).


A supplemental oath/declaration under 37 CFR
(i)Amendments in reissue applications. Any amendment to  
1.175(b)(1) must be submitted before allowance. It
the description and claims in reissue applications must be made in
may be submitted with any reply prior to allowance. It
accordance with § 1.173.
may be submitted to overcome a rejection under
35
U.S.C. 251 made by the examiner, where it is indicated
that the submission of the supplemental oath/
declaration will overcome the rejection.


A supplemental oath/declaration under 37 CFR  
37 CFR 1.173. Reissue specification, drawings, and
1.175(b)(1) will be required where:
amendments.


(A)the application is otherwise (other than the  
(b)Making amendments in a reissue application. An amendment
need for this supplemental oath/declaration) in condition
in a reissue application is made either by physically incorporating
for allowance;
the changes into the specification when the application is  
filed, or by a separate amendment paper. If amendment is made by
incorporation, markings pursuant to paragraph (d) of this section
must be used. If amendment is made by an amendment paper, the  
paper must direct that specified changes be made, as follows:


(B)amendments or other corrections of errors in
(1)Specification other than the claims. Changes to the
the patent have been made subsequent to the last oath/
specification, other than to the claims, must be made by submission
declaration filed in the application; and
of the entire text of an added or rewritten paragraph, including
markings pursuant to paragraph (d) of this section, except that
an entire paragraph may be deleted by a statement deleting the  
paragraph without presentation of the text of the paragraph. The
precise point in the specification must be identified where any
added or rewritten paragraph is located. This paragraph applies
whether the amendment is submitted on paper or compact disc
(see §§ 1.52(e)(1) and 1.821(c), but not for discs submitted under
§ 1.821(e)).


(C)at least one of the amendments or other corrections
(2)Claims. An amendment paper must include the entire
corrects an error under 35 U.S.C. 251.
text of each claim being changed by such amendment paper and of
 
each claim being added by such amendment paper. For any claim
When a supplemental oath/declaration under
changed by the amendment paper, a parenthetical expression
37
“amended,” “twice amended,” etc., should follow the claim number.
CFR 1.175(b)(1) directed to the amendments or
Each changed patent claim and each added claim must
other corrections of error is required, the examiner is
include markings pursuant to paragraph (d) of this section, except
encouraged to telephone the applicant and request the
that a patent claim or added claim should be canceled by a statement
submission of the supplemental oath/declaration by  
canceling the claim without presentation of the text of the
fax. If the circumstances do not permit making a telephone
claim.
call, or if applicant declines or is unable to
promptly submit the oath/declaration, the examiner
should issue a final Office action (final rejection) and  
use form paragraph 14.05.02 where the action issued
is a second or subsequent action on the merits.


(3)Drawings. One or more patent drawings shall be
amended in the following manner: Any changes to a patent drawing
must be submitted as a replacement sheet of drawings which
shall be an attachment to the amendment document. Any replacement
sheet of drawings must be in compliance with § 1.84 and
shall include all of the figures appearing on the original version of
the sheet, even if only one figure is amended. Amended figures
must be identified as “Amended,” and any added figure must be
identified as “New.” In the event that a figure is canceled, the figure
must be surrounded by brackets and identified as “Canceled.”
All changes to the drawing(s) shall be explained, in detail, beginning on a separate sheet accompanying the papers including the
amendment to the drawings.


(i)A marked-up copy of any amended drawing figure,
including annotations indicating the changes made, may be
included. The marked-up copy must be clearly labeled as “Annotated
Marked-up Drawings” and must be presented in the amendment
or remarks section that explains the change to the drawings.


¶ 14.05.02 Supplemental Oath or Declaration Required
(ii)A marked-up copy of any amended drawing figure,
Prior to Allowance
including annotations indicating the changes made, must be
provided when required by the examiner.


In accordance with 37 CFR 1.175(b)(1), a supplemental reissue
(c)Status of claims and support for claim changes. Whenever
oath/declaration under 37 CFR 1.175(b)(1) must be received
there is an amendment to the claims pursuant to paragraph
before this reissue application can be allowed.
(b) of this section, there must also be supplied, on pages separate
from the pages containing the changes, the status (i.e., pending or
canceled), as of the date of the amendment, of all patent claims
and of all added claims, and an explanation of the support in the
disclosure of the patent for the changes made to the claims.


Claim [1] rejected as being based upon a defective reissue [2]
(d)Changes shown by markings. Any changes relative to the
under 35 U.S.C. 251. See 37 CFR 1.175. The nature of the defect
patent being reissued which are made to the specification, including
is set forth above.
the claims, upon filing, or by an amendment paper in the reissue  
application, must include the following markings:


Receipt of an appropriate supplemental oath/declaration under
(1)The matter to be omitted by reissue must be enclosed
37 CFR 1.175(b)(1) will overcome this rejection under 35 U.S.C.
in brackets; and
251. An example of acceptable language to be used in the supplemental
oath/declaration is as follows:


“Every error in the patent which was corrected in the
(2)The matter to be added by reissue must be underlined,  
present reissue application, and is not covered by a prior
except for amendments submitted on compact discs (§§ 1.96 and  
oath/declaration submitted in this application, arose without
1.821(c)). Matter added by reissue on compact discs must be preceded
any deceptive intention on the part of the applicant.
with “U” and end with “/U” to properly identify the
material being added.


See MPEP § 1414.01.
(e)Numbering of patent claims preserved. Patent claims
may not be renumbered. The numbering of any claim added in the
reissue application must follow the number of the highest numbered
patent claim.


Examiner Note:
(f)Amendment of disclosure may be required. The disclosure
must be amended, when required by the Office, to correct
inaccuracies of description and definition, and to secure substantial
correspondence between the claims, the remainder of the specification,
and the drawings.


1.In bracket 1, list all claims in the reissue application.
(g)Amendments made relative to the patent. All amendments
must be made relative to the patent specification, including
the claims, and drawings, which are in effect as of the date of filing
of the reissue application.


2.In bracket 2, insert either --oath-- or --declaration--.
The provisions of 37 CFR 1.173(b)-(g) and those of
 
37 CFR 1.121(i) apply to amendments in reissue  
3.This form paragraph is used in an Office action to: (a) remind
applications. Any amendments submitted in a reissue
applicant of the requirement for submission of the supplemental
application must comply with 37 CFR 1.173(b).
reissue oath/declaration under 37 CFR 1.175(b)(1) before allowance
and (b) at the same time, reject all the claims since the reissue  
application is defective until the supplemental oath/
declaration is submitted.
 
4.Do not use this form paragraph if no amendments (or other
corrections of the patent) have been made subsequent to the last
oath/declaration filed in the case; instead allow the case.


Amendments submitted in a reissue application,
including preliminary amendments (i.e., amendments
filed as a separate paper to accompany the filing of a
reissue application), must comply with the practice
outlined below in this section; however, for examiner’s
amendments to the specification and claims,
37
CFR 1.121(g) provides certain exceptions to that
practice in the interest of expediting prosecution. The
exceptions set forth in 37 CFR 1.121(g) also apply in
reissue applications.


Pursuant to 37 CFR 1.173(a), no amendment in a
reissue application may enlarge the scope of the
claims, unless “applied for within two years from the
grant of the original patent.” Further, the amendment
may not introduce new matter. See MPEP § 1412.03for further discussion as to the time limitation on
enlarging the scope of the patent claims in a reissue
application.


All amendment changes must be made relative to
the patent to be reissued. Pursuant to 37 CFR
1.173(d), any such changes which are made to the
specification, including the claims, must be shown by
employing the following “markings:”


(A)The matter to be omitted by reissue must be
enclosed in brackets; and


5.This form paragraph cannot be used in an Ex parte Quayleaction to require the supplemental oath/declaration, because the
(B)The matter to be added by reissue must be  
rejection under 35 U.S.C. 251 is more than a matter of form.  
underlined, except for amendments submitted on
compact discs (pursuant to 37 CFR 1.96 for computer
printouts or programs, and 37 CFR 1.825 for
sequence listings). Matter added by reissue on compact
discs must be preceded with “U” and end with
“/U” to properly identify the material being added.


6.Do not use this form paragraph in an examiner’s amendment.
I.THE SPECIFICATION
The supplemental oath/declaration must be filed prior to mailing
of the Notice of Allowability.


37 CFR 1.173(b)(1) relates to the manner of making
amendments to the specification other than the
claims. It is not to be used for making amendments to
the claims or the drawings.


All amendments which include any deletions or
additions must be made by submission of the entire
text of each added or rewritten paragraph with markings
(as defined above), except that an entire paragraph
of specification text may be deleted by a
statement deleting the paragraph without presentation
of the text of the paragraph. Applicant must indicate
the precise point where each amendment is made. All
bracketing and underlining is made in comparison to
the original patent, not in comparison to any prior
amendment in the reissue application. Thus, all paragraphs
which are newly added to the specification of
the original patent must be submitted as completely
underlined each time they are re-submitted in the reissue
application.


As noted above, the examiner will issue a final
II.THE CLAIMS
Office action where the application is otherwise in
condition for allowance, and amendments or other
corrections of error in the patent have been made subsequent
to the last oath/declaration filed in the application.  
The examiner will be introducing (via form
paragraph 14.05.02) a rejection into the case for the
first time in the prosecution, when the claims have
been determined to be otherwise allowable. This
introduction of a new ground of rejection under
35
U.S.C. 251 will not prevent the action from being
made final on a second or subsequent action because
of the following factors:


(A)The finding of the case in condition for allowance
37 CFR 1.173(b)(2) relates to the manner of making
is the first opportunity that the examiner has to  
amendments to the claims in reissue applications.
make the rejection;
It is not to be used for making amendments to the  
remainder of the specification or to the drawings. 37
CFR 1.173(b)(2) requires that:


(B)The rejection is being made in reply to, i.e.,  
(A)For each claim that is being amended by the
was caused by, an amendment of the application (to
amendment being submitted (the current amendment),  
correct errors in the patent);
the entire text of the claim must be presented with
markings as defined above;


(C)All applicants are on notice that this rejection
(B)For each new claim added to the reissue by
will be made upon finding of the case otherwise in
the amendment being submitted (the current amendment),
condition for allowance where errors have been corrected
the entire text of the added claim must be presented
subsequent to the last oath/declaration filed in
completely underlined;
the case, so that the rejection should have been
expected by applicant; and


(D)The rejection will not prevent applicant from
(C)A patent claim should be canceled by a direction
exercising any rights to cure the rejection, since applicant
to cancel that claim, there is no need to present
need only submit a supplemental oath/declaration
the patent claim surrounded by brackets; and
with the above-described language, and it will be
entered to cure the rejection.


Where the application is in condition for allowance
(D)A new claim (previously added in the reissue)
and no amendments or other corrections of error
should be canceled by a direction to cancel that claim.
in the patent have been made subsequent to the
last oath/declaration filed in the application, a supplemental
reissue oath/declaration under 37 CFR
1.175(b)(1) should not be required by the examiner.
Instead, the examiner should issue a Notice of
Allowability indicating allowance of the claims.


III.AFTER ALLOWANCE
Original patent claims are never to be renumbered;
see 37 CFR 1.173(e). A patent claim retains its number
even if it is canceled in the reissue proceeding,
and the numbering of any added claims must begin
after the last original patent claim.  


Where applicant seeks to correct an error after
Pursuant to 37 CFR 1.173(c), each amendment submitted
allowance of the application, any amendment of the  
must set forth the status of all patent claims
patent correcting the error must be submitted in accordance
and all added claims as of the date of the submission.
with 37 CFR 1.312. As set forth in 37 CFR
The status to be set forth is whether the claim is pending
1.312, no amendment may be made as a matter of
or canceled. The failure to submit the claim status
right in an application after the mailing of the notice
will generally result in a notification to applicant that
of allowance. An amendment filed under 37 CFR  
the amendment prior to final rejection is not completely
1.312 must be filed before or with the payment of the
responsive (see 37 CFR 1.135(c)). Such an
issue fee and may be entered on the recommendation
amendment after final rejection will not be entered.
of the primary examiner, and approved by the supervisory
patent examiner, without withdrawing the case
from issue.  


Because the amendment seeks to correct an error in  
Also pursuant to 37 CFR 1.173(c), each claim
the patent, the amendment will affect the disclosure,
amendment must be accompanied by an explanation
the scope of a claim, or add a claim. Thus, in accordance
of the support in the disclosure of the patent for the  
with MPEP § 714.16, the remarks accompanying
amendment (i.e., support for all changes made in the  
the amendment must fully and clearly state:
claim(s), whether insertions or deletions). The failure
to submit an explanation will generally result in a
notification to applicant that the amendment prior to
final rejection is not completely responsive (see
37
CFR 1.135(c)). Such an amendment after final
rejection will not be entered.


(A)why the amendment is needed;
III.THE DRAWINGS


(B)why the proposed amended or new claims
37 CFR 1.173(a)(2) states that amendments to the
require no additional search or examination;
original patent drawings are not permitted, and that
any change to the drawings must be by way of
37
CFR 1.173(b)(3). See MPEP § 1413 for the manner
of making amendments to the drawings in a reissue
application.


(C)why the claims are patentable; and
IV.ALL CHANGES ARE MADE VIS-À-VISTHE PATENT TO BE REISSUED


(D)why they were not presented earlier.
When a reissue patent is printed, all underlined
matter is printed in italics and all brackets are printed
as inserted in the application, in order to show exactly
which additions and deletions have been made to
the
patent being reissued. Therefore, all underlining
and bracketing in the reissue application should be
made relative to the text of the patent, as follows. In
accordance with 37 CFR 1.173(g), all amendments in
the reissue application must be made relative to (i.e.,
vis-à-vis) the patent specification in effect as of the
date of the filing of the reissue application. The patent
specification includes the claims and drawings. If
there was a prior change to the patent (made via a
prior concluded reexamination certificate, reissue of
the patent, certificate of correction, etc.), the first
amendment of the subject reissue application must be
made relative to the patent specification as changed
by the prior proceeding or other mechanism for
changing the patent. All amendments subsequent to
the first amendment must also be made relative to the
patent specification in effect as of the date of the filing
of the reissue application, and not relative to the prior
amendment.


A supplemental reissue oath/declaration must
The Subject Patent Already Has Underlining or
accompany the amendment. The supplemental reissue
Bracketing
oath/declaration must state that the error(s) to be corrected
 
arose without any deceptive intention on the  
If the original (or previously changed) patent
part of the applicant. The supplemental reissue oath/
includes a formula or equation already having underlining
declaration submitted after allowance must be  
or bracketing therein as part of the formula or
directed to the error(s) applicant seeks to correct after
equation, any amendment of such formula or equation
allowance. This oath/declaration need not cover any
should be made by bracketing the entire formula and
earlier errors, since all earlier errors should have been
rewriting and totally underlining the amended formula
covered by a reissue oath/declaration submitted prior
in the re-presented paragraph of the specification or
to allowance.
rewritten claim in which the changed formula or
equation appears. Amendments of segments of a formula
or equation should not be made. If the original
patent includes bracketing and underlining from an
earlier reexamination or reissue, double brackets and
double underlining should be used in the subject reissue
application to identify and distinguish the present
changes being made. The subject reissue, when
printed, would include double brackets (indicating
deletions made in the subject reissue) and boldface
type (indicating material added in the subject reissue).


Occasionally correcting an error after allowance
V.EXAMPLES OF PROPER AMENDMENTS
does not include an amendment of the specification or
claims of the patent. For example, the correction of
the error could be the filing of a certified copy of the
original foreign application (prior to the payment of
the issue fee - see 37 CFR 1.55(a)(2)) to obtain the
right of foreign priority under 35 U.S.C. 119 (see
Brenner v. State of Israel, 400 F.2d 789, 158 USPQ
584 (D.C. Cir. 1968)) where the claim for foreign priority
had been timely made in the application for the
original patent. In such a case, the requirements of
37
CFR 1.312 must still be met. This is so, because
the correction of the patent is an amendment of the


A substantial number of problems arise in the
Office because of improper submission of amendments
in reissue applications. The following examples
are provided to assist in preparation of proper amendments
to reissue applications.


A.Original Patent Description or Patent Claim
Amended


'''Example (1)'''


If it is desired to change the specification at column
4 line 23, to replace “is” with --are--, submit a
copy of the entire paragraph of specification of the
patent being amended with underlining and bracketing,
and point out where the paragraph is located,
e.g.,


patent, even though no amendment is physically
<code>Replace the paragraph beginning at column 4, line 23
entered into the case. Thus, for a reissue oath/declaration
with the following:</code>
submitted after allowance to correct an additional
error (or errors), the reissue applicant must comply
with 37 CFR 1.312 in the manner discussed above.


1445Reissue Application Examined in  
<code>Scanning [is] <u>are</u> controlled by clocks which are, in turn,
Same Manner as Original Application
controlled from the display tube line synchronization. The
signals resulting from scanning the scope of the character
are delivered in parallel, then converted into serial mode
through a shift register wherein the shift signal frequency is
controlled by a clock that is, in turn, controlled from the display
tube line synchronization.</code>


'''Example (2)'''


As stated in 37 CFR 1.176, a reissue application,
For changes to the claims, one must submit a copy
including all the claims therein, is subject to “be
of the entire patent claim with the amendments
examined in the same manner as a non-reissue, non-
shown by underlining and bracketing, e.g.,
provisional application.” Accordingly, the claims in a
 
reissue application are subject to any and all rejections
<code>Amend claim 6 as follows:</code>
which the examiner deems appropriate. It does
not matter whether the claims are identical to those of  
the patent or changed from those in the patent. It also
does not matter that a rejection was not made in the  
prosecution of the patent, or could have been made, or
was in fact made and dropped during prosecution of
the patent; the prior action in the prosecution of the
patent does not prevent that rejection from being
made in the reissue application. Claims in a reissue
application enjoy no “presumption of validity.” In re
Doyle, 482 F.2d 1385, 1392, 179 USPQ 227, 232-233
(CCPA 1973); In re Sneed, 710 F.2d 1544, 1550 n.4,  
218 USPQ 385, 389 n.4 (Fed. Cir. 1983). Likewise,
the fact that during prosecution of the patent the
examiner considered, may have considered, or should
have considered information such as, for example, a
specific prior art document, does not have any bearing
on, or prevent, its use as prior art during prosecution
of the reissue application.


1448Fraud, Inequitable Conduct, or
<code>Claim 6 (Amended). The apparatus of claim [5] <u>1</u> wherein
Duty of Disclosure Issues [R-2]
the [first] <u>second</u> piezoelectric element is parallel to the
[second] <u>third</u> piezoelectric element.</code>


The Office no longer investigates and rejects reissue
If the dependency of any original patent claim is to  
applications under 37 CFR 1.56. The Office will
be changed by amendment, it is proper to make
not comment upon duty of disclosure issues which are
that original patent claim dependent upon a later
brought to the attention of the Office in reissue applications
filed higher numbered claim.
except to note in the application, in appropriate
circumstances, that such issues are no longer
considered by the Office during its examination of
patent applications. Examination as to the lack of
deceptive intent requirement in reissue applications
will continue but without any investigation of fraud,
inequitable conduct, or duty of disclosure issues.
Applicant’s statement in the reissue oath or declaration
of lack of deceptive intent will be accepted as dispositive
except in special circumstances such as an
admission or judicial determination of fraud, inequitable
conduct, or violation of the duty of disclosure.  


ADMISSION OR JUDICIAL DETERMINATION
B.Cancellation of Claim(s)


An admission or judicial determination of fraud,
'''Example (3)'''
inequitable conduct, or violation of the duty of disclosure
is a special circumstance, because no investigation
need be made. Accordingly, after consulting with
the Technology Center (TC) Special Program Examiner
(SPRE), a rejection should be made using the
appropriate one of form paragraphs 14.21.09 or 14.22as reproduced below.


Any admission of fraud, inequitable conduct or violation
To cancel an original patent claim, in writing,  
of the duty of disclosure must be explicit,  
direct cancellation of the patent claim, e.g.,
unequivocal, and not subject to other interpretation.  
Where a rejection is made based upon such an admission
(see form paragraph 14.22 below) and applicant
responds with any reasonable interpretation of the
facts that would not lead to a conclusion of fraud,
inequitable conduct or violation of the duty of disclosure,
the rejection should be withdrawn. Alternatively,  
if applicant argues that the admission noted by the
examiner was not in fact an admission, the rejection
should also be withdrawn.


Form paragraph 14.21.09 should be used where the
<code>Cancel claim 6.</code>
examiner becomes aware of a judicial determination
of fraud, inequitable conduct or violation of the duty
of disclosure on the part of the applicant independently
of the record of the case, i.e., the examiner
has external knowledge of the judicial determination.


Form paragraph 14.22 should be used where, in the
'''Example (4)'''
application record, there is (a) an explicit, unequivocal
admission by applicant of fraud, inequitable conduct
or violation of the duty of disclosure which is not
subject to other interpretation, or (b) information as to
a judicial determination of fraud, inequitable conduct
or violation of the duty of disclosure on the part of the
applicant. External information which the examiner
believes to be an admission by applicant should never
be used by the examiner, and such external information
should never be made of record in the reissue
application.


To cancel a new claim (previously added in the
reissue), in writing, direct cancellation of the new
claim, e.g.,


<code>Cancel claim 15.</code>


C.Presentation of New Claims


'''Example (5)'''


¶ 14.21.09 Rejection, 35 U.S.C. 251, No Error Without
Each new claim (i.e., a claim not found in the
Deceptive Intention - External Knowledge
patent, that is newly presented in the reissue application)
should be presented with underlining
throughout the claim, e.g.,


Claims [1] rejected under 35 U.S.C. 251 since error “without
<code>Add claim 7 as follows:</code>
any
deceptive intention” has not been established. In view of the
judicial determination in [2] of [3] on the part of applicant, a conclusion
that any error was “without deceptive intention” cannot be
supported. [4]


Examiner Note:
<code><u>Claim 7. The apparatus of claim 5 further comprising
electrodes attaching to said opposite faces of the first and
second piezoelectric elements.</u></code>


1.In bracket 1, list all claims in the reissue application.  
Even though original claims may have been canceled,
the numbering of the original claims does
not change. Accordingly, any added claims are
numbered beginning with the number next higher
than the number of claims in the original patent. If
new claims have been added to the reissue application  
which are later canceled prior to issuance of
the reissue patent, the examiner will renumber any
remaining new claims in numerical order to follow
the number of claims in the original patent.


2.In bracket 2, list the Court or administrative body which
D.Amendment of New Claims
made the determination of fraud or inequitable conduct on the
part of applicant.


3.In bracket 3, insert --fraud--, --inequitable conduct-- and/or -
An amendment of a “new claim” (i.e., a claim not
-violation of duty of disclosure--.  
found in the patent, that was previously presented
in
the reissue application) must be done by presenting
the amended “new claim” containing the amendatory
material, and completely underlining the claim. The
presentation cannot contain any bracketing or other
indication of what was in the previous version of
the
claim. This is because all changes in the
reissue
are
made vis-à-vis the original patent, and not
in comparison to the prior amendment. Although the
presentation of the amended claim does not contain
any indication of
what is changed from the previous
version of the claim, applicant must point out what is
changed in the “Remarks” portion of the amendment.
Also, per 37 CFR 1.173(c), each change made in the
claim must be accompanied by an explanation of the
support in the disclosure of the patent for the change.


4.In bracket 4, point out where in the opinion (or holding) of  
E.Amendment of Original Patent Claims More
the Court or administrative body the determination of fraud, inequitable
Than Once
conduct or violation of duty of disclosure is set forth. Page
number, column number, and paragraph information should be
given as to the opinion (or holding) of the Court or administrative
body. The examiner may add explanatory comments.


The following illustrates proper claim amendment
of original patent claims in reissue applications:


A. Patent claim.


¶ 14.22 Rejection, 35 U.S.C. 251, No Error Without
<code>Claim 1. A cutting means having a handle portion
Deceptive Intention-Evidence in the Application
and a blade portion.</code>


Claims [1] rejected under 35 U.S.C. 251 since error “without
B. Proper first amendment format.  
any deceptive intention” has not been established. In view of the
reply filed on [2], a conclusion that any error was “without deceptive
intention” cannot be supported.


[3]
<code>Claim 1 (Amended). A [cutting means] <u>knife</u> having
a <u>bone</u> handle portion and a <u>notched</u> blade portion.</code>


Examiner Note:
C. Proper second amendment format.


1.In bracket 1, list all claims in the reissue application.  
<code>Claim 1 (Twice Amended). A [cutting means]
<u>knife</u> having a handle portion and a <u>serrated</u> blade
portion.</code>


2.In bracket 2, insert the filing date of the reply which provides
Note that the second amendment must include the
an admission of fraud, inequitable conduct or violation of duty of
changes previously presented in the first amendment,
disclosure, or that there was a judicial determination of same.  
i.e., [cutting means] <u>knife</u>, as well as the new changes
presented in the second amendment, i.e., <u>serrated</u>.  


3.In bracket 3, insert a statement that there has been an admission
The word <u>bone</u> was presented in the first amendment
or a judicial determination of fraud, inequitable conduct or
and is now to be deleted in the second amendment.
violation of duty of disclosure which provide circumstances why
The word "bone" is NOT to be shown in
applicant’s statement in the oath or declaration of lack of deceptive
brackets in the second amendment. Rather, the word
intent should not be taken as dispositive. Any admission of
"bone" is simply omitted from the claim, since "bone"
fraud, inequitable conduct or violation of duty of disclosure must
never appeared in the patent. An explanation of the
be explicit, unequivocal, and not subject to other interpretation.  
deletion should appear in the remarks.


The word <u>notched</u> which was presented in the first
amendment is replaced by the word serrated in the
second amendment. The word <u>notched</u> is being
deleted in the second amendment and did not appear
in the patent; accordingly, "notched" is not shown in
any form in the claim. The word <u>serrated</u> is being
added in the second amendment, and accordingly
"serrated" is added to the claim and is underlined.


In the second amendment, the deletions of
"notched" and "bone" are not changes from the original
patent claim text and therefore are not shown in
brackets in the second amendment. In both the first
and the second amendments, the entire claim is presented
only with the changes from the <u>original patent
text</u>.


See MPEP § 2012 for additional discussion as to
VI.ADDITIONAL EXAMPLES
fraud, inequitable conduct or violation of duty of disclosure
in a reissue application.


1449Protest Filed in Reissue Where
(A)For a reissue application, where the patent
Patent Is in Interference [R-3]
was previously reissued:


If a protest (see MPEP Chapter 1900) is filed in a
As per MPEP § 1411, double underlining and
reissue application related to a patent involved in a
double bracketing are used in the second reissue  
pending interference proceeding, the reissue application  
application to show amendments made relative to the  
should be referred to the Office of Patent Legal
first reissued patent
Administration (OPLA) before considering the protest
and acting on the reissue application.


The OPLA will check to see that:
(B)For a reissue application, where the patent
was previously reexamined and a reexamination certificate
has issued for the patent:


(A)all parties to the interference are aware of the  
An amendment in the reissue application must be
filing of the reissue; and
presented as if the changes made to the original patent
text via the reexamination certificate are a part of the  
original patent. Thus, all italicized text of the reexamination
certificate is presented in the amendment
(made in the reissue application) without italics. Further,
any text found in brackets in the reexamination
certificate is omitted in the amendment (made in the
reissue application).


(B)the Office does not allow claims in the reissue  
(C)For a reissue application, where a certificate
which are unpatentable over the pending interference
of correction has issued for the patent:
count(s), or found unpatentable in the interference
proceeding. After the reissue application has been
reviewed by the OPLA, the reissue application with
the protest will be returned to the examiner. See
MPEP § 1441.01 for a discussion as to protests under
37 CFR 1.291 in reissue applications.


1449.01Concurrent Office Proceedings
An amendment in the reissue application must be
[R-5]
presented as if the changes made to the original patent
text via the certificate of correction are a part of the
original patent. Thus, all text added by certificate of
correction is presented in the amendment (made in the
reissue application) without italics. Further, any text
deleted by certificate of correction is entirely omitted
in the amendment (made in the reissue application).


I.CONCURRENT REEXAMINATION PROCEEDINGS:
(D)For a reissue application, where a statutory
disclaimer has issued for the patent:


Any claim statutorily disclaimed is no longer in
the patent, and such a claim cannot be amended. The
statutorily disclaimed claim(s) should be lined
through, and not surrounded by brackets.
==1454 Appeal Brief==


37 CFR 1.565(d) provides that if “a reissue application
The requirements for an appeal brief are set forth in
and an ex parte reexamination proceeding on
37 CFR 41.37 and MPEP § 1206, and they apply
which an order pursuant to 37 CFR 1.525 has been
to a reissue application in the same manner that they
mailed are pending concurrently on a patent, a decision
apply to a non-reissue application. There is, however,
will normally be made to merge the two proceedings
a difference in practice as to presentation of the copy
or to suspend one of the two proceedings.”
of the claims in the appeal brief for a reissue application.  
37
The claims on appeal presented in an appeal
CFR 1.991 provides that if “a reissue application  
brief for a reissue application should include all
and an inter partes reexamination proceeding on
underlining and bracketing necessary to reflect the  
which an order pursuant to 37 CFR 1.931 has been
changes made to the patent claims during the prosecution
mailed are pending concurrently on a patent, a decision
of the reissue application. In addition, any new
may be made to merge the two proceedings or to
claims added in the reissue application should be
suspend one of the two proceedings”. If an examiner
completely underlined.  
becomes aware that a reissue application and an ex
parte or inter partes reexamination proceeding are
both pending for the same patent, he or she should  
immediately inform the Technology Center (TC)
or Central Reexamination Unit (CRU) Special Program
Examiner (SPRE).
 
Pursuant to 37 CFR 1.177, a patent owner may file
more than one reissue application for the same patent.  
If an examiner becomes aware that multiple reissue
applications are pending for the same patent, and an
ex parte or inter partes reexamination proceeding is
pending for the same patent, he or she should immediately
inform the TC SPRE.


Where a reissue application and a reexamination
==1455 Allowance and Issue==
proceeding are pending concurrently on a patent, and
an order granting reexamination has been issued for
the reexamination proceeding, the Office of Patent


I.ISSUE CLASSIFICATION SHEET


For IFW reissue applications:


The examiner completes the Issue Classification
sheet in the same manner as for a non-reissue application.
In addition, a copy of the “Final SPRE Review”
form must also be completed.


For reissue application files that are maintained in
paper:


Legal Administration (OPLA) must be notified that
In all reissue applications prepared for issue where
the proceedings are ready for a decision as to whether
a blue slip is needed (i.e., 08/ and earlier series), the
to merge the reissue and the reexamination, or stay
patent number of the original patent which is being
one of the two. See MPEP § 2285 for the  
reissued should be placed in the box provided therefor
procedure of
below the box for the applicant’s name on the blue
notifying OPLA and general guidance, if a reissue
Issue Classification Slip (form PTO-270) or design
application and an ex parte reexamination proceeding
Issue Classification Slip (form PTO-328). Otherwise,  
are both pending for the same patent, and
the Issue Classification Slip is prepared in the same  
an inter
manner as for a non-reissue application.  
partes reexamination proceeding is not involved. See
MPEP § 2686.03 where a reissue application and an
inter partes reexamination proceeding are both pending
for the same patent, regardless of whether an ex
parte reexamination proceeding is also pending.


Where a reissue application and a reexamination
II. CHANGES TO THE ORIGINAL
proceeding are pending concurrently on a patent, the
PATENT
patent owner, i.e., the reissue applicant, has a responsibility
to notify the Office of the concurrent proceeding.
37 CFR § 1.178(b), 37 CFR 1.565(a), and
37
CFR 1.985(a). The patent owner should file in the
reissue application, as early as possible, a Notification
of Concurrent Proceedings pursuant to 37 CFR
1.178(b) in order to alert the Office of the existence of
the reexamination proceeding on the same patent. See
MPEP § 1418. In addition, the patent owner should
file in the reexamination proceeding, as early as possible,
a Notification of Concurrent Proceedings pursuant
to 37 CFR 1.565(a) or 1.985(a) (depending on
whether the reexamination proceeding is an ex partereexamination proceeding or an inter partes reexamination
proceeding) to provide a notification to the
Office in the reexamination proceeding of the existence
of the two concurrent proceedings.


The patent owner may file a petition under 37 CFR
The specifications of reissue patents will be printed
1.182 in a reissue application to merge the reissue
in such a manner as to show the changes over the  
application with the reexamination proceeding, or to
original patent text by enclosing any material omitted
stay one of the proceedings because of the other. This
by the reissue in heavy brackets [ ] and printing material
petition must be filed after the issuance of the order to
added by the  
reexamine (37 CFR 1.525, 37 CFR 1.931) in the reexamination
reissue in italics. 37 CFR 1.173 (see
proceeding. If the petition is filed prior to  
MPEP § 1411) requires the specification of a reissue
the reexamination order, it will not be considered, and
application to be presented in a specified form, specifically
will be returned to the patent owner by the TC or
designed to facilitate this different manner of
CRU Director. If the petition is filed after the issuance
printing, as well as for other reasons.  
of the order to reexamine, the petition and the
files for the reissue application and the reexamination
proceeding will be forwarded to OPLA for decision.


II.CONCURRENT INTERFERENCE PROCEEDINGS
The printed reissue patent specification will carry
the following heading, which will be added by the
Publishing Division of the Office of Patent Publication:


“Matter enclosed in heavy brackets [ ] appears in the original
patent but forms no part of this reissue specification;
matter printed in italics indicates the additions made by
reissue.”


If the original patent is involved in an interference,
The examiners should see that the specification is  
the examiner must consult the administrative patent
in proper form for printing. Examiners should carefully check the entry of all amendments to ensure that
judge in charge of the interference before taking any  
the changes directed by applicant will be accurately
action on the reissue application. It is particularly
printed in any reissue patent that may ultimately issue.
important that the reissue application not be granted
Matter appearing in the original patent which is omitted
without the administrative patent judge’s approval.
by reissue should be enclosed in brackets, while
See MPEP Chapter 2300.
matter added by reissue should be underlined.  


III.CONCURRENT REISSUE PROCEEDINGS
Any material added by amendment in the reissue
application (as underlined text) which is later canceled
should be crossed through, and not bracketed.
Material cancelled from the original patent should be
enclosed in brackets, and not lined through.


All the claims of the original patent should appear
in the reissue patent, with canceled patent claims
being enclosed in brackets.


Where more than one reissue applications are pending
III. CLAIM NUMBERING
concurrently on the same patent, see MPEP
§§
1450 and 1451.


1449.02Interference in Reissue [R-5]
No renumbering of the original patent claims is permitted,
even if the dependency of a dependent patent
claim is changed by reissue so that it is to be dependent
on a subsequent higher numbered claim.


37 CFR 41.8. Mandatory notices.
When a dependent claim in a reissue application
depends upon a claim which has been canceled, and
the dependent claim is not thereafter made dependent
upon a pending claim, such a dependent claim must
be rewritten in independent form.


(a)In an appeal brief (§§ 41.37, 41.67, or 41.68) or at the  
New claims added during the prosecution of the
initiation of a contested case (§ 41.101), and within 20 days of any  
reissue application should follow the number of the
change during the proceeding, a party must identify:
highest numbered patent claim and should be completely
 
underlined to indicate they are to be printed in
(1)Its real party-in-interest, and
italics on the printed patent. Often, as a result of the
 
prosecution and examination, some new claims are
(2)Each judicial or administrative proceeding that could
canceled while other new claims remain. When the  
affect, or be affected by, the Board proceeding.
reissue application is allowed, any claims remaining
 
which are additional to the patent claims (i.e., claims
(b)For contested cases, a party seeking judicial review of a
added via the reissue application) should be renumbered
Board proceeding must file a notice with the Board of the judicial
in sequence starting with the number next
review within 20 days of the filing of the complaint or the notice
higher than the number of the last claim in the original
of appeal. The notice to the Board must include a copy of the  
patent (the printed patent). Therefore, the number of  
complaint or notice of appeal. See also §§ 1.301 to 1.304 of this
claims allowed will not necessarily correspond to the  
title.
number of the last claim in the reissue application, as
allowed. The number of claims appearing in the  
“Total Claims Allowed” box on the Issue Classification
sheet (or for reissue application files that are
maintained in paper, the “CLAIMS ALLOWED -
Total Claims” box on the lower right of the file wrapper
face) at the time of allowance should be consistent
with the number of claims indicated as allowable
on the Notice of Allowability (Form PTOL-37).  


37 CFR 41.202. Suggesting an interference.
IV. CLAIM DESIGNATED FOR PRINTING


(a)Applicant. An applicant, including a reissue applicant,  
At least one claim of an allowable reissue application
may suggest an interference with another application or a patent.  
must be designated for printing in the Official
The suggestion must:
Gazette. Whenever at least one claim has been
amended or added in the reissue, the claim (claims)
designated for printing must be (or include) a claim
which has been changed or added by the reissue. A
canceled claim is not to be designated as the claim for
the Official Gazette.


(1)Provide sufficient information to identify the application
If there is no change in the claims of the allowable
or patent with which the applicant seeks an interference,
reissue application (i.e., when they are the same as the
claims of the original patent) or, if the only change in
the claims is the cancellation of claims, then the most
representative pending allowed claim is designated
for printing in the Official Gazette.


(2)Identify all claims the applicant believes interfere,
V. PROVIDING PROPER FORMAT
propose one or more counts, and show how the claims correspond
to one or more counts,


(3)For each count, provide a claim chart comparing at
Where a reissue application has not been prepared
least one claim of each party corresponding to the count and show
in the above-indicated manner, the examiner may
why the claims interfere within the meaning of § 41.203(a),
obtain from the applicant a clean copy of the reissue
 
specification prepared in the indicated form, or a
(4)Explain in detail why the applicant will prevail on priority,
proper submission of a previously improperly submitted
amendment. However, if the deletions from the
original patent are small, the reissue application can
be prepared for issue by putting the bracketed inserts
at the appropriate places and suitably numbering the  
added claims.


When applicant submits a clean copy of the reissue
specification, or a proper submission of a previous
improper amendment, a supplemental reissue declaration
should not be provided to address this submission,
because the correction of format does not correct
a 35 U.S.C. 251 error in the patent.


(5)If a claim has been added or amended to provoke an
VI. PARENT APPLICATION DATA
interference, provide a claim chart showing the written description
for each claim in the applicant’s specification, and


(6)For each constructive reduction to practice for which
All parent application data on the bibliographic
the applicant wishes to be accorded benefit, provide a chart showing
data sheet of the original patent file (or front face of
where the disclosure provides a constructive reduction to practice
the original patent file wrapper if the original patent is
within the scope of the interfering subject matter.
a paper file) should be present on the bibliographic
data sheet of the reissue application.


It sometimes happens that the reissue is a continuation
of another reissue application, and there is also
original-patent parent application data. The examiner
should ensure that the parent application data on the
original patent is properly combined with the parent
application data of the reissue, in the text of the specification
and on the bibliographic data sheet (or
on the front face of the reissue file wrapper for 08/
and earlier series applications).  The combined
statement as to parent application data should be
checked carefully for proper bracketing and underlining.


VII. REFERENCES CITED AND PRINTED


The list of references to be printed in the reissue
patent includes all the references cited during the
prosecution of the reissue application. It is noted that
the Office will not print in the reissue patent “References
Cited” section any reference cited in the patent
but not again cited in the reissue application. A patent
cannot be reissued solely for the purpose of adding
citations of additional prior art.


VIII. EXAMINER'S AMENDMENT AND SUP-
PLEMENTAL DECLARATION


When it is necessary to amend the reissue application
in order to place the application in condition for
allowance, the examiner may:


(A)request that applicant provide the amendments
(e.g., by facsimile transmission or by hand-
carry); or


(c)Examiner. An examiner may require an applicant to add
(B)make the amendments, with the applicant’s
a claim to provoke an interference. Failure to satisfy the requirement
approval, by a formal examiner’s amendment.
within a period (not less than one month) the examiner sets
will operate as a concession of priority for the subject matter of
the claim. If the interference would be with a patent, the applicant
must also comply with paragraphs (a)(2) through (a)(6) of this
section. The claim the examiner proposes to have added must,
apart from the question of priority under 35 U.S.C. 102 (g):


(1)Be patentable to the applicant, and
If the changes are made by a formal examiner’s
 
amendment, the entire paragraph(s) or claim(s) being
(2)Be drawn to patentable subject matter claimed by  
amended need not be presented in rewritten form for
another applicant or patentee.
any deletions or additions. Changes to the specification
including the claims of an application made by
the Office in an examiner’s amendment may be made
by specific instructions to insert or delete subject matter  
set forth in the examiner’s amendment by identifying
the precise point in the specification or the
claim(s) where the insertion or deletion is to be made.
37 CFR 1.121(g).


If it is necessary to amend a claim or the specification
in order to correct an “error” under 35 U.S.C. 251and thereby place the application in condition for
allowance, then a supplemental oath or declaration
will be required. See MPEP § 1444. The examiner
should telephone applicant and request the supplemental
oath or declaration, which must be filed before
the application can be counted as an allowance.


IX. FINAL REVIEW OF THE REISSUE
APPLICATION BY THE EXAMINER


In appropriate circumstances, a reissue application
Prior to forwarding a reissue application to the  
may be placed into interference with a patent or pending
Technology Center (TC) Special Program Examiner
application. A patentee may provoke an interference
(SPRE) for final review, the examiner should complete
with a patent or pending application by filing a
and initial an Examiner Reissue Checklist. A
reissue application, if the reissue application includes
copy of the checklist should be available from the  
an appropriate reissue error as required by 35 U.S.C.
SPRE or from the Paralegal Specialist of the TC.
251. Reissue error must be based upon applicant
error; a reissue cannot be based solely on the error of
the Office for failing to declare an interference or to  
suggest copying claims for the purpose of establishing
an interference. See In re Keil, 808 F.2d 830,
1
USPQ2d 1427 (Fed. Cir. 1987); In re Dien, 680 F.2d
151, 214 USPQ 10 (CCPA 1982); In re Bostwick, 102
F.2d 886, 888, 41 USPQ 279, 281 (CCPA 1939); and
In re Guastavino, 83 F.2d 913, 916, 29 USPQ 532,
535 (CCPA 1936). See also Slip Track Systems, Inc. v.
Metal Lite, Inc., 159 F.3d 1337, 48 USPQ2d 1055
(Fed. Cir. 1998) (Two patents issued claiming the  
same patentable subject matter, and the patentee with
the earlier filing date requested reexamination of the
patent with the later filing date (Slip Track’s patent).  
A stay of litigation in a priority of invention suit under
35 U.S.C. 291, pending the outcome of the reexamination,
was reversed. The suit under 35 U.S.C. 291was the only option available to Slip Track to determine
priority of invention. Slip Track could not file a
reissue application solely to provoke an interference
proceeding before the Office because it did not assert
that there was any error as required by 35 U.S.C. 251in the patent.). A reissue application can be employed
to provoke an interference if the reissue application:


(A)adds copied claims which are not present in
==1456 Reissue Review==
the original patent;


(B)amends claims to correspond to those of the  
All reissue applications are monitored and
patent or application with which an interference is  
reviewed in the Technology Centers (TCs) by the
sought; or
Office of TC Special Program Examiners (which
includes TC SPREs, paralegals or other technical support
who might be assigned as backup) at several
stages during the prosecution. The review by the
Office of the TC SPREs is made to check that practice
and procedure unique to reissue has been carried out
for the reissue application. In addition to the SPRE
review of the reissue applications, a patentability
review is made in a sample of reissue applications by
the TC Quality Assurance Specialist (QAS) in the
manner previously carried out by the former Office of
Patent Quality Review. In order to ensure that SPREs
are aware of the reissue applications in their TCs, a
pair of terminal-specific PALM flags have been created
which must be set by the SPRE before certain
PALM transactions can be completed. First, when a
new reissue application enters the TC, a SPRE must
set a PALM “flag” by entering the reissue application  
number in an Office-wide computer grouping before a
docketing transaction will be accepted. By having to
set this first flag, the SPRE is made aware of the
assignment of the reissue application to the TC and
can take steps, as may be appropriate, to instruct the
examiner on reissue-specific procedures before the
examination process begins, as well as throughout the
period that the examiner is handling the reissue application.
Second, the SPRE must remove the above-
described PALM “flag” before a Notice of Allowance
can be generated or the PALM transaction for an issue
revision can be entered, thereby ensuring that the
SPRE is made aware of when the reissue application
is being allowed so that the SPRE may be able to conduct
a final review of the reissue application, if appropriate.
 
When the reissue application has been reviewed
and is ready to be released to issue, the TC SPRE
should do the following:


(C)contains at least one error (not directed to
== 1457 Design Reissue Applications and Patents==
provoking an interference) appropriate for the reissue.


In the first two situations, the reissue oath/declaration
A reissue application can be filed for a design
must assert that applicant erred in failing to
patent in the same manner that a reissue application is
include claims of the proper scope to provoke an
filed for a utility patent. There are, however, a few
interference in the original patent application. Note
aspects of a design reissue application that are
that in In re Metz, 173 F.3d 433 (Fed. Cir. 1998)
addressed as follows:
(table), the Federal Circuit permitted a patentee to file
a reissue application to copy claims from a patent in
order to provoke an interference with that patent. Furthermore,  
the subject matter of the copied or amended
claims in the reissue application must be supported by
the disclosure of the original patent under 35 U.S.C.
112, first paragraph. See In re Molins, 368 F.2d 258,
261, 151 USPQ 570, 572
(CCPA 1966) and In re
Spencer, 273 F.2d 181, 124 USPQ 175 (CCPA 1959).


A reissue applicant cannot present added or
I.EXPEDITED EXAMINATION PROCE-
amended claims to provoke an interference, if the
DURE
claims were deliberately omitted from the patent. If
there is evidence that the claims were not inadvertently
omitted from the original patent, e.g., the subject
matter was described in the original patent as being
undesirable, the reissue application may lack proper
basis for the reissue. See In re Bostwick, 102 F.2d at
889, 41 USPQ at 282 (CCPA 1939)(reissue lacked a
proper basis because the original patent pointed out
the disadvantages of the embodiment that provided
support for the copied claims).


The issue date of the patent, or the publication date
Design reissue applications requesting expedited
of the application publication (whichever is applicable
examination and complying with the requirements of  
under 35 U.S.C. 135(b)), with which an interference
37 CFR 1.155 are examined with priority and undergo
is sought must be less than 1 year prior to the presentation
expedited processing throughout the entire course of
of the copied or amended claims in the reissue
prosecution in the Office, including appeal, if any, to
application. See 35 U.S.C. 135(b) and MPEP § 715.05and MPEP Chapter 2300. If the reissue application
the Board of Patent Appeals and Interferences. All
includes broadened claims, the reissue application
processing is expedited from the date the request is
must be filed within two years from the issue date of
granted.
the original patent. See 35 U.S.C. 251 and MPEP §
1412.03.


An examiner may, pursuant to 37 CFR 41.202(c),
Design reissue applicants seeking expedited examination
require a reissue applicant to add a claim to provoke
may file a design reissue application in the
an interference, unless the reissue applicant cannot
Office together with a corresponding request under 37
present the added claim to provoke an interference
CFR 1.155 pursuant to the guidelines set forth in
based upon the provisions of the reissue statute and
MPEP § 1504.30.
rules, e.g., if the claim was deliberately omitted from
the patent, or if the claim enlarges the scope of the
claims of the original patent and was not “applied for
within two years from the grant of the original


The design reissue application and the request are
processed by the Office of Initial Patent Examination
(OIPE). OIPE enters the appropriate information
into PALM specifying when notice of the design
reissue application will be published in the Official
Gazette (see MPEP § 1441).  After processing in
OIPE, the design reissue application and the request
are forwarded to the Design TC Director’s Office.
Upon a decision by the Design TC Director to grant
the request for expedited examination, fees are immediately
processed, and the application papers are
promptly assigned an application number. The design
reissue application file is then forwarded to the Office
of Patent Legal Administration (OPLA) for a decision
under 37 CFR 1.182 to sua sponte waive the requirement
for delaying action in the application until 2
months after announcement of the design reissue
application filing is published in the Official Gazette(see MPEP § 1441). Once the decision under 37 CFR
1.182 is mailed, the design reissue application file
will be returned to the Design TC Director’s Office. In
accordance with the waiver, the Design Group will
begin expedited examination of the application under
37 CFR 1.155 promptly after the return of the design
reissue application file from OPLA, rather than delay
examination until after 2 months from the date the
announcement is published in the Official Gazette and
the applicant will be notified that examination is
being expedited. The decision under 37 CFR 1.182will require that no Notice of Allowance be mailed in
the design reissue application until after 2 months
from the date the announcement is published in the
Official Gazette. For example, if the design reissue






patent.” Failure to satisfy the requirement within a
period (not less than one month) the examiner sets
will operate as a concession of priority for the subject
matter of the claim. If the interference would be with
a patent, the reissue applicant must also comply with
37 CFR 41.202(a)(2) through (a)(6). The claim the
examiner proposes to have added must, apart from the
question of priority under 35 U.S.C. 102(g), be patentable
to the reissue applicant, and be drawn to patentable
subject matter claimed by another applicant or
patentee.
REISSUE APPLICATION FILED WHILE
PATENT IS IN INTERFERENCE
If a reissue application is filed while the original
patent is in an interference proceeding, the reissue
applicant must promptly notify the Board of Patent
Appeals and Interferences of the filing of the reissue
application within 20 days from the filing date. See 37
CFR 41.8 and MPEP Chapter 2300.
1450Restriction and Election of Species
Made in Reissue Application
[R-2]


37 CFR 1.176. Examination of reissue.


(a)A reissue application will be examined in the same manner
application is allowed on the first Office action, then
as a non-reissue, non-provisional application, and will be subject
jurisdiction over the reissue application will be  
to all the requirements of the rules related to non-reissue
retained in the TC, and the Notice of Allowance
applications. Applications for reissue will be acted on by the  
will not be mailed until the expiration of 2 months
examiner in advance of other applications.
after publication of the filing of the design reissue  
application in the Official Gazette (plus time for
matching any protest filed with the application). (For
IFW processing, see IFW Manual.) The examiner will  
check  the PALM contents to ascertain when publication
actually occurred. The delay in the mailing of  
the Notice of Allowance is to ensure that any potential
protests complying with 37 CFR 1.291 submitted
within the 2-month delay period will be considered by  
the Office. (see MPEP § 1441.01).


(b)Restriction between subject matter of the original patent
The expedited examination procedure under
claims and previously unclaimed subject matter may be required
37
(restriction involving only subject matter of the original patent
CFR 1.155 occurs through initial examination processing
claims will not be required). If restriction is required, the subject
and throughout the entire prosecution in the  
matter of the original patent claims will be held to be constructively
Office. Once a request for expedited examination is  
elected unless a disclaimer of all the patent claims is filed in  
granted, prosecution of the design reissue application
the reissue application, which disclaimer cannot be withdrawn by
will proceed according to the procedure under
applicant.
37
CFR 1.155, and there is no provision for “withdrawal”
from expedited examination procedure.
 
II.DESIGN REISSUE FEE
 
The design reissue application fee is set forth for in
37 CFR 1.16(e). For design reissue applications
filed on or after December 8, 2004, a search fee
(37
CFR 1.16(n)) and an examination fee (37 CFR
1.16(r)) are also required. The additional fees in
37
CFR 1.16(h) and 37 CFR 1.16(i) do not
apply for a design reissue application since more than
one claim in not permitted in a design application pursuant
to the last sentence of 37 CFR 1.153(a).
 
The fee for issuing a design reissue patent is set
forth in 37 CFR 1.18(a).


37 CFR 1.176(b) permits the examiner to require
III.MULTIPLE DESIGN REISSUE APPLICATIONS
restriction in a reissue application between claims
newly added in a reissue application and the original
patent claims, where the added claims are directed to
an invention which is separate and distinct from the
invention(s) defined by the original patent claims. The
criteria for making a restriction requirement in a reissue
application between the newly added claims and
the original claims are the same as that applied in a
non-reissue application. See MPEP §§ 806 through
806.05(i). The authority to make a “restriction”
requirement under 37 CFR 1.176(b) extends to and
includes the authority to make an election of species.


Where a restriction requirement is made by the
examiner, the original patent claims will be held to be
constructively elected (except for the limited situation
where a disclaimer is filed as discussed in the next
paragraph). Thus, the examiner will issue an Office
action in the reissue application (1) providing notification
of the restriction requirement, (2) holding the
added claims to be constructively non-elected and
withdrawn from consideration,  (3) treating the original
patent claims on the merits, and (4) informing
applicant that if the original claims are found allowable,
and a divisional application has been filed for
the non-elected claims, further action in the application
will be suspended, pending resolution of the divisional
application..


If a disclaimer of all the original patent claims is
The design reissue application can be filed based on
filed in the reissue application containing newly
the “error” of failing to include a design for a patentably
added claims that are separate and distinct from the  
distinct segregable part of the design claimed in
original patent claims, only the newly added claims
the original patent or a patentably distinct subcombination
will be present for examination. In this situation, the  
of the claimed design. A reissue design application  
examiner’s Office action will treat the newly added
claiming both the entire article and the  
claims in the reissue application on the merits. The
patentably distinct subcombination or segregable part
disclaimer of all the original patent claims must be  
would be proper under 35 U.S.C. 251, if such a reissue
filed in the reissue application prior to the issuance of
application is filed within two years of the issuance
the examiner’s Office action containing the restriction  
of the design patent, since it is considered a
requirement, in order for the newly added claims to be
broadening of the scope of the patent claim. Restriction
treated on the merits. Once the examiner has issued
will be required under 37 CFR 1.176(b) in such a
the Office action providing notification of the restriction
reissue design application, and the added design to the  
requirement and treating the patent claims on the
segregable part or subcombination will be held to be
merits, it is too late to obtain an examination on  
constructively non-elected and withdrawn from consideration.
the  
See MPEP § 1450. In the Office action  
added claims in the reissue application by filing a
containing the restriction requirement, the examiner
disclaimer of all the original patent claims. If reissue
should suggest to the applicant that a divisional
applicant wishes to have the newly added claims be  
design reissue application directed to the constructively
treated on the merits, a divisional reissue application  
non-elected segregable part or subcombination
must be filed to obtain examination of the added
subject matter may be filed. The claim to the patented
claims. Reissue applicants should carefully note that
design for the entire article will then be examined and,
once a disclaimer of the patent claims is filed, it cannot
if found allowable without change from the patent, a
be withdrawn. It does not matter whether the reissue  
rejection will be made under 35 U.S.C. 251 based on  
application is still pending, or whether the reissue
the fact that there is no “error” in the non-amended
application has been abandoned or issued as a reissue
original patent claim. In the Office action making this
patent. For all these situations, 37 CFR 1.176(b) states
rejection, applicant should be advised that a proper
that the disclaimer cannot be withdrawn; the disclaimer
response to the rejection must include (A) a request to
will be given effect.
suspend action in this original reissue application  
 
pending completion of examination of a divisional
Claims elected pursuant to a restriction requirement
reissue application directed to the constructively non-
will receive a complete examination on the merits,  
elected segregable part or subcombination subject
while the non-elected claims (to any added inven
matter, (B) the filing of the divisional reissue application,  
 
or a statement that one has already been filed
 
(identifying it at least by application number), and (C)  
 
an argument that a complete response to the rejection
 
has been made based upon the filing of the divisional
 
reissue application and the request for suspension.  
Action in the original design reissue application will
then be suspended, and the divisional will be examined.


tion(s)) will be held in abeyance in a withdrawn status,
and will only be examined if filed in a divisional
reissue application. If the reissue application containing
only original unamended claims becomes allowable
first (and no “error” under 35 U.S.C. 251exists),
further action in that reissue application will
be suspended to await examination in the divisional
reissue application(s) containing the added claims.
Multiple suspensions (usually six-month periods)
may be necessary. The Office will not  permit
claims to issue in a reissue application which
application does not correct any error in the original
patent. Once a divisional reissue application containing
the added claims is examined and becomes
allowable,  the examiner will issue a requirement
under 37 CFR 1.177(c) for applicant to merge the
claims of the suspended first reissue application with
the allowable claims of the divisional reissue application
into a single application, by placing all of the
claims in one of the applications and expressly abandoning
the other. The Office action making this
requirement will set a two-month period for compliance
with the requirement. If applicant fails to timely
respond to the Office action, or otherwise refuses to
comply with the requirement made, then the divisional
reissue application (claiming the invention
which was non-elected in the now-suspended first
reissue application) will be passed to issue alone,
since the claims of the divisional reissue application,
by themselves, do correct an error in the original
patent. Prosecution will be reopened in the suspended
first reissue application, and a rejection based on a
lack of error under 35
U.S.C. 251 will then be made.
This rejection may be made final, since applicant is on
notice of the consequences of not complying with the
merger requirement.


If the divisional reissue application becomes abandoned,  
If, after examination, the divisional design reissue  
prosecution will be reopened in the suspended
application is also determined to be allowable, a
first reissue application, and a rejection based on a  
requirement must be made in the divisional design
lack of error under 35 U.S.C. 251 will then be made in  
reissue application to submit a petition under 37 CFR
the first reissue application. Since no error in the original
1.183 requesting waiver of 37 CFR 1.153 in order to
patent is being corrected in the first reissue application,  
permit the rejoining of the designs to the entire article
no reissue patent will issue.
(of the original application) and the segregable part or
subcombination (of the divisional) under a single
claim into a single design reissue application for issuance,  
the single application being the first design reissue  
application.


As stated in 37 CFR 1.176(b), the examiner is not  
It should be noted that the filing of a design reissue
permitted to require restriction among original
application would not be proper if applicant did in
claims of the patent (i.e., among claims that were in  
fact include the design for a segregable part or subcombination
the patent prior to filing the reissue application). Even
thereof in the original design patent  
where the original patent contains claims to different
application, a restriction was thus made, and then
inventions which the examiner considers independent
applicant failed to file a divisional reissue application
or distinct, and the reissue application claims the same
for a non-elected invention that was canceled in view
inventions, a restriction requirement would be
of a restriction requirement (prior to issue of the original
improper. If such a restriction requirement is made, it
application. See In re Watkinson, 900 F.2d 230,
must be withdrawn.
14
USPQ2d 1407 (Fed. Cir. 1990); In re Orita,  
550
F.2d 1277, 1280, 193 USPQ 145, 148 (CCPA
1977).


Restriction between multiple inventions recited in
IV.CONVERSION TO UTILITY PATENT
the newly added claims will be permitted provided
the added claims are drawn to several separate and
distinct inventions. In such a situation, the original
patent claims would be examined in the first reissue
application, and applicant is permitted to file a divisional
reissue application for each of the several separate
and distinct inventions identified in the
examiner’s restriction requirement.


A situation will sometimes arise where the examiner
A design patent cannot be converted to a utility
makes an election of species requirement
patent via reissue.
between the species claimed in the original patent  
claims and a species of claims added in the reissue
application. In such a situation, if (1) the non-elected
claims to the added species depend from (or otherwise
include all limitations of) a generic claim which
embraces all species claims, and (2) the generic claim
is found allowable, then the non-elected claims of the
added species must be rejoined with the elected
claims of the original patent. See MPEP §
821.04(a).
 
 
 
1451Divisional Reissue Applications;
Continuation Reissue ApplicationsWhere the Parent is Pending [R-3]
 
35 U.S.C. 251. Reissue of defective patents.


Converting a design patent to a utility patent will,
in most instances, involve the introduction of new
matter into the patent. The disclosure of a design
patent is not directed to how the invention is made
and used, and the introduction of new matter is
required to bridge this gap and provide support for the
utility patent. Accordingly, the examiner should consider
rejections based on the introduction of new matter
under 35 U.S.C. 251, first paragraph, and lack of
enablement and/or description under 35 U.S.C. 112,
first paragraph, when a reissue application is filed to
convert a design patent to a utility patent.


Further, the term of a design patent may not be
extended by reissue. Ex parte Lawrence, 70 USPQ
326 (Comm’r Pat. 1946). Thus, any reissue application
filed to convert a design patent to a utility patent,
which conversion would thereby extend the term of
the patent, should be rejected as failing to comply
with 35 U.S.C. 251, first paragraph, which permits
reissue only “for the unexpired part of the term of the
original patent.” The statute requires that the reissued
patent shall not extend the term of the original patent.


The Director may issue several reissued patents for distinct and
==1460 Effect of Reissue==
separate parts of the thing patented, upon demand of the applicant,
and upon payment of the required fee for a reissue for each of
such reissued patents.


35 U.S.C. 252. Effect of reissue.


The surrender of the original patent shall take effect upon the
issue of the reissued patent, and every reissued patent shall have
the same effect and operation in law, on the trial of actions for
causes thereafter arising, as if the same had been originally
granted in such amended form, but in so far as the claims of the
original and reissued patents are substantially identical, such surrender
shall not affect any action then pending nor abate any cause
of action then existing, and the reissued patent, to the extent that
its claims are substantially identical with the original patent, shall
constitute a continuation thereof and have effect continuously
from the date of the original patent.


37 CFR 1.177. Issuance of multiple reissue patents.
A reissued patent shall not abridge or affect the right of any
person or that person’s successors in business who, prior to the
grant of a reissue, made, purchased, offered to sell, or used within
the United States, or imported into the United States, anything patented
by the reissued patent, to continue the use of, to offer to sell,
or to sell to others to be used, offered for sale, or sold, the specific
thing so made, purchased, offered for sale, used, or imported
unless the making, using, offering for sale, or selling of such thing
infringes a valid claim of the reissued patent which was in the
original patent. The court before which such matter is in question
may provide for the continued manufacture, use, offer for sale, or
sale of the thing made, purchased, offered for sale, used, or
imported as specified, or for the manufacture, use, offer for sale,
or sale in the United States of which substantial preparation was
made before the grant of the reissue, and the court may also provide
for the continued practice of any process patented by the reissue
that is practiced, or for the practice of which substantial
preparation was made, before the grant of the reissue, to the extent
and under such terms as the court deems equitable for the protection
of investments made or business commenced before the grant
of the reissue.


(a)The Office may reissue a patent as multiple reissue patents.  
The effect of the reissue of a patent is stated in
If applicant files more than one application for the reissue of  
35
a single patent, each such application must contain or be amended
U.S.C. 252. With respect to the Office treatment of  
to contain in the first sentence of the specification a notice stating
the reissued patent, the reissued patent will be viewed
that more than one reissue application has been filed and identifying
as if the original patent had been originally granted in  
each of the reissue applications by relationship, application
the amended form provided by the reissue. With
number and filing date. The Office may correct by certificate of
respect to intervening rights resulting from the reissue  
correction under §
of an original patent, the second paragraph of 35
U.S.C. 252 provides for two separate and distinct
1.322 any reissue patent resulting from an
defenses to patent infringement under the doctrine of
intervening rights:


“Absolute” intervening rights are available for a
party that “prior to the grant of a reissue, made, purchased,
offered to sell, or used within the United
States, or imported into the United States, anything
patented by the reissued patent,” and “equitable”
intervening rights may be provided where “substantial
preparation was made before the grant of the reissue.”
See BIC Leisure Prods., Inc., v. Windsurfing Int’l,
Inc., 1 F.3d 1214, 1220, 27 USPQ2d 1671, 1676 (Fed.
Cir. 1993).


==1470 Public Access of Reissue Applications==


37 CFR 1.11(b) opens all reissue applications filed
after March 1, 1977, to inspection by the general public.
37 CFR 1.11(b) also provides for announcement
of the filings of reissue applications in the Official
Gazette (except for continued prosecution applications
filed under 37 CFR 1.53(d)). This announcement
will give interested members of the public an
opportunity to submit to the examiner information
pertinent to patentability of the reissue application.


The filing of a continued prosecution application
under 37 CFR 1.53(d) of a reissue application will notbe announced in the Official Gazette. Although the
filing of a continued prosecution application of a reissue
application constitutes the filing of a reissue
application, the announcement of the filing of such
continued prosecution application would be redundant
in view of the announcement of the filing of the prior
reissue application in the Official Gazette.


application to which this paragraph applies that does not contain
37 CFR 1.11(b) is applicable to all reissue
the required notice.
applications filed on or after March 1, 1977. Those
reissue applications previously on file will not be
automatically open to inspection but a liberal policy
will be followed in granting petitions for access to
such applications.  


(b)If applicant files more than one application for the reissue
IFW reissue application files are open to
of a single patent, each claim of the patent being reissued must
inspection by the general public by way of Public
be presented in each of the reissue applications as an amended,  
PAIR via the USPTO Internet site. In viewing the  
unamended, or canceled (shown in brackets) claim, with each
images of the files, members of the public will be able
such claim bearing the same number as in the patent being reissued.
to view the entire content of the reissue application
The same claim of the patent being reissued may not be presented
file history. To access Public PAIR, a member of the
in its original unamended form for examination in more
public would (A) go to the USPTO web site at http://
than one of such multiple reissue applications. The numbering of
www.uspto.gov, (B) click on “Patents,” (C) under
any added claims in any of the multiple reissue applications must
“Check Status, View Papers…” click on “Status &
follow the number of the highest numbered original patent claim.
IFW,” and (D) under “Patent Application Information
Retrieval” enter the reissue application number.


(c)If any one of the several reissue applications by itself
Access to a reissue application that is maintained in
fails to correct an error in the original patent as required by 35
paper must be obtained from the area of the Office  
U.S.C. 251 but is otherwise in condition for allowance, the Office  
having jurisdiction over the file. The following access
may suspend action in
procedure will be observed for reissue application  
the allowable application until all issues
files that are maintained in paper:
are resolved as to at least one of the remaining reissue applications.  
The Office may also merge two or more of the multiple reissue
applications into a single reissue application. No reissue
application containing only unamended patent claims and not correcting
an error in the original patent will be passed to issue by
itself.


The court in In re Graff, 111 F.3d 874, 876-77,
(A)Any member of the general public may
42
request access to a particular reissue application filed
USPQ2d 1471, 1473 (Fed. Cir. 1997) stated that
after March 1, 1977. Since no record of such request
“[t]he statute does not prohibit divisional or continuation
is intended to be kept, an oral request will suffice.  
reissue applications, and does not place stricter
(Reissue applications already on file prior to March 1,  
limitations on such applications when they are presented
1977 are not automatically open to inspection, but a  
by reissue, provided of course that the statutory
liberal policy is followed by the Office of Patent
requirements specific to reissue applications are met.
Legal Administration (OPLA) and by the Board of  
Following the decision in Graff, the Office has
Patent Appeals and Interferences in granting petitions
adopted a policy of treating continuations and divisionals
for access to such applications.);
of reissue applications, to the extent possible,
in the same manner as continuations and divisionals
of non-reissue applications.


Questions relating to the propriety of divisional
(B)Paper reissue application files will be maintained
reissue applications and continuation reissue applications
in the TCs and inspection thereof will be supervised
should be referred via the Technology Center
by TC personnel. A TC Director or other
(TC) Special Program Examiner to the Office of
appropriate Office official may, under appropriate circumstances,
Patent Legal Administration.  
postpone access to or the making of copies
of a paper reissue application file, in order, for
example, to avoid interruption of the examination or
other review of the application by an examiner. In
addition, though no general limit is placed on the  
amount of time spent reviewing the files, the Office  
may impose limitations, if necessary, e.g., where the
application is actively being processed;


(C)In any instance where the reissue application
file has left the TC for administrative processing,
requests for access should be directed to the appropriate
supervisory personnel where the application is
currently located;
(D)A paper reissue application file is not
available to the public once the reissue application file
has been released and forwarded by the TC for publication
of the reissue patent. This would include any
reissue application files which have been selected for
a post-allowance screening at OPLA. Unless
prosecution is reopened pursuant to the screening, the
reissue application files are not available to the public
until the reissue patent issues. This is because the reissue
application file has been put into a special format
for printing purposes and public access at this stage
would disrupt the publication process;


(E)Requests for copies of papers in the reissue
application file must be in writing addressed to Mail
Stop Document Services, Director of the U.S. Patent
and Trademark Office, P.O. Box 1450, Alexandria,
VA 22313-1450. Such requests may be either mailed
or delivered to the Customer Service Window. The
price for a copy of an application as filed is set forth
in 37 CFR 1.19(b)(1). Since no useful purpose is seen
for retaining such written requests for copies of
papers in reissue applications, the request(s) should be
destroyed after the order has been completed.


I. DIVISIONAL REISSUE APPLICATIONS
See also MPEP § 103.
 
37 CFR 1.176(b) permits the examiner to require
restriction in a reissue application between the original
claims of the patent and any newly added claims
which are directed to a separate and distinct invention(
s). See also MPEP § 1450. As a result of such a
restriction requirement, divisional applications may
be filed for each of the inventions identified in the
restriction requirement.
 
In addition, applicant may initiate a division of the
claims by filing more than one reissue application in
accordance with 37 CFR 1.177. The multiple reissue
applications which are filed may contain different
groups of claims from among the original patent
claims, or some of the reissue applications may contain
newly added groups (not present in the original
patent). There is no requirement that the claims of the
multiple reissue applications be independent and distinct
from one another; if they are not independent
and distinct from one another, the examiner must
apply the appropriate double patenting rejections.


There is no requirement that a family of divisional
==1480 Certificates of Correction — Office Mistake==
reissue applications issue at the same time; however,
it is required that they contain a cross reference to
each other in the specification. 37 CFR 1.177(a)
requires that all multiple reissue applications resulting
from a single patent must include as the first sentence
of their respective specifications a cross reference to
the other reissue application(s). Accordingly, the first
sentence of each reissue specification must provide
notice stating that more than one reissue application
has been filed, and it must identify each of the reissue
applications and their relationship within the family
of reissue applications, and to the original patent. An
example of the suggested language to be inserted is as
follows:


Notice: More than one reissue application has
35 U.S.C. 254. Certificate of correction of Patent and
been
Trademark Office mistake.
filed for the reissue of Patent No. 9,999,999. The
reissue applications are application numbers 09/
999,994 (the present application), 09/999,995, and 09/
999,998, all of which are divisional reissues of Patent  
No. 9,999,999.  


The examiner should object to the specification
Whenever a mistake in a patent, incurred through the fault of
and require an appropriate amendment if applicant
the Patent and Trademark Office, is clearly disclosed by the
fails to include such a cross reference to the other reissue
records of the Office, the Director may issue a certificate of correction
applications in the first sentence of the specification
stating the fact and nature of such mistake, under seal,
of each of the reissue applications.
without charge, to be recorded in the records of patents. A printed
copy thereof shall be attached to each printed copy of the patent,
and such certificate shall be considered as part of the original
patent. Every such patent, together with such certificate, shall
have the same effect and operation in law on the trial of actions
for causes thereafter arising as if the same had been originally
issued in such corrected form. The Director may issue a corrected
patent without charge in lieu of and with like effect as a certificate
of correction.


Where one of the divisional applications of the
37 CFR 1.322. Certificate of correction of Office mistake.
family has issued without the required cross reference
to the other reissue application(s), the examiner will
refer the matter to his/her Supervisory Patent Examiner
(SPE). The SPE will initiate a certificate of correction
under 37 CFR 1.322 to include the appropriate
cross reference in the already issued first reissue
patent before passing the pending reissue application
to issue. Form paragraph 10.19 may be used for such
purpose. After the SPE prepares the memorandum as


(a)(1) The Director may issue a certificate of correction pursuant
to 35 U.S.C. 254 to correct a mistake in a patent, incurred
through the fault of the Office, which mistake is clearly disclosed
in the records of the Office:


(i)At the request of the patentee or the patentee’s
assignee;


(ii)Acting sua sponte for mistakes that the Office discovers;
or


(iii)Acting on information about a mistake supplied by a
third party.


per form paragraph 10.19, the patent file with the  
(2)(i) There is no obligation on the Office to act on or
memorandum should be forwarded to the Certificates
respond to a submission of information or request to issue a certificate  
of Correction Branch for issuance of a certificate. The
of correction by a third party under paragraph (a)(1)(iii) of
examiner should make a reference in the pending
this section.
divisional reissue application to the fact that an actual
request for a Certificate of Correction has been initiated
in the first reissue patent pursuant to 37 CFR
1.177(a), e.g., by an entry in the search notes or in an
examiner’s amendment.


¶ 10.19 Memorandum - Certificate of Correction (Cross-
(ii)Papers submitted by a third party under this section
Reference to Other Reissues in Family)
will not be made of record in the file that they relate to nor be
retained by the Office.


DATE: [1]
(3)If the request relates to a patent involved in an
interference, the request must comply with the requirements of
this section and be accompanied by a motion under § 41.121(a)(2)
or § 41.121(a)(3) of this title.


TO: Certificates of Correction Branch
(4)The Office will not issue a certificate of correction
under this section without first notifying the patentee (including
any assignee of record) at the correspondence address of record as
specified in § 1.33(a) and affording the patentee or an assignee an
opportunity to be heard.


FROM: [2], SPE, Art Unit [3]
(b)If the nature of the mistake on the part of the Office is
such that a certificate of correction is deemed inappropriate in
form, the Director may issue a corrected patent in lieu thereof as a
more appropriate form for certificate of correction, without
expense to the patentee.


SUBJECT: Request for Certificate of Correction
Mistakes incurred through the fault of the Office
 
may be the subject of Certificates of Correction under
Please issue a Certificate of Correction in U. S. Letters Patent
37 CFR 1.322. The Office, however, has discretion
No. [4] as specified on the attached Certificate.
under 35 U.S.C. 254 to decline to issue a Certificate  
 
of Correction even though an Office mistake exists. If
______________________
Office mistakes are of such a nature that the meaning
 
intended is obvious from the context, the Office may
[5], SPE
decline to issue a certificate and merely place the correspondence
 
in the patented file, where it serves to
Art Unit [6]
call attention to the matter in case any question as to it
subsequently arises. Such is the case, even where a
correction is requested by the patentee or patentee’s
assignee.


UNITED STATES PATENT AND TRADEMARK OFFICE
In order to expedite all proper requests, a Certificate
CERTIFICATE
of Correction should be requested only for errors
of consequence. Instead of a request for a Certificate
of Correction, letters making errors of record should
be utilized whenever possible. Thus, where errors are
of a minor typographical nature, or are readily apparent
to one skilled in the art, a letter making the error(s)
of record can be submitted in lieu of a request for a
Certificate of Correction. There is no fee for the submission
of such a letter.


Patent No. [7]
It is strongly advised that the text of the correction
requested be submitted on a Certificate of Correction
form, PTO/SB/44 (also referred to as PTO 1050). Submission
of this form in duplicate is not necessary. The
location of the error in the printed patent should be
identified on form PTO/SB/44 by column and line
number or claim and line number. See MPEP § 1485for a discussion of the preparation and submission of
a request for a Certificate of Correction.


Patented: [8]
I. THIRD PARTY INFORMATION ON
MISTAKES IN PATENT


The present reissue patent issued from an application that is
Third parties do not have standing to demand that  
one of a family of divisional reissue applications resulting from
the Office issue, or refuse to issue, a Certificate of  
Patent No. [9]. The present reissue patent has issued without the
Correction. See Hallmark Cards, Inc. v. Lehman, 959
cross reference to the other reissue application(s) of the family
F. Supp. 539, 543-44, 42 USPQ2d 1134, 1138 (D.D.C.  
which is required pursuant to 37 CFR 1.177(a). Accordingly,  
1997). 37 CFR 1.322(a)(2) makes it clear that third
insert in the first sentence of the specification as follows:
parties do not have standing to demand that the Office
act on, respond to, issue, or refuse to issue a Certificate
of Correction. The Office is, however, cognizant
of the need for the public to have correct information
about published patents and may therefore accept
information about mistakes in patents from third parties.
37 CFR 1.322(a)(1)(iii). Where appropriate, the
Office may issue certificates of correction based on
information supplied by third parties, whether or not
such information is accompanied by a specific request
for issuance of a Certificate of Correction.


Notice: More than one reissue application has been filed for the  
While third parties are permitted to submit information
reissue of patent [9]. The reissue applications are [10].
about mistakes in patents which information
will be reviewed, the Office need not act on that information
nor deny any accompanying request for issuance
of a Certificate of Correction. Accordingly, a fee
for submission of the information by a third party has  
not been imposed. The Office may, however, choose
to issue a Certificate of Correction on its own initiative
based on the information supplied by a third
party, if it desires to do so. Regardless of whether the
third party information is acted upon, the information
will not be made of record in the file that it relates to,
nor be retained by the Office. 37 CFR 1.322(a)(2)(ii).


_________________________
When such third party information (about mistakes
 
in patents) is received by the Office, the Office will
[11], Supervisory Patent Examiner
not correspond with third parties about the information
 
they submitted either (1) to inform the third parties
Art Unit [12]
of whether it intends to issue a Certificate of
 
Correction, or (2) to issue a denial of any request for
Examiner Note:
issuance of a Certificate of Correction that may
accompany the information. The Office will confirm
to the party submitting such information that the
Office has in fact received the information if a
stamped, self-addressed post card has been submitted.
See MPEP § 503.


1In bracket 9, insert the patent number of the patent for which
II. PUBLICATION IN THE OFFICIAL
multiple reissue divisional applications have been filed.
GAZETTE


2This is an internal memo and must not be mailed to the applicant.
Each issue of the Official Gazette (patents section)
This memo should accompany the patented file to the Certificates  
numerically lists all United States patents having Certificates  
of Correction Branch as noted in form paragraphs 10.13 and
of Correction. The list appears under the
10.14.
heading “Certificates of Correction for the week of
(date).


3.In brackets 5 and 11, insert the name of SPE and provide the
===1480.01 Expedited Issuance of Certificates of Correction - Error Attributable to Office===
signature of the SPE above each line.


4.In brackets 6 and 12, insert the Art Unit number.
In an effort to reduce the overall time required in
processing and granting Certificate of Correction
requests, the Office will expedite processing and
granting of patentee requests where such requests are
accompanied by evidence to show that the error is
attributable solely to the Office (i.e., requests filed
pursuant to 37 CFR 1.322 only).


5.Two separate pages of USPTO letterhead will be printed
The following requirements must be met for consideration
when using this form paragraph.
of expedited issuance of Certificates of
Correction:
 
The text of the correction requested should be submitted
on a Certificate of Correction form, PTO/SB/
44 (also referred to as PTO 1050). Submission of this
form in duplicate is not necessary. The location of the
error in the printed patent should be identified on
form PTO/SB/44 by column and line number or claim
and line number. See also MPEP § 1485.


6.In bracket 10, identify each of the reissue applications
Where the correction requested was incurred
(including the present application) and their relationship within
through the fault of the Office, and the matter is
the family of reissue applications, and to the original patent.
clearly disclosed in the records of the Office, and is
accompanied by documentation that unequivocally
supports the patentee’s assertion(s), a Certificate of
Correction will be expeditiously issued. Such supporting
documentation can consist of relevant photocopied
receipts, manuscript pages, correspondence dated
and received by the Office, photocopies of Examiners’
responses regarding entry of amendments, or any
other validation that supports the patentee’s request so
that the request can be processed without the patent  
file.


In addition to the amendment to the first sentence
Where only part of a request can be approved, the  
of the specification, the reissue application cross references
appropriate modifications will be made on the form
will also be reflected in the file. For an
PTO/SB/44 and the patentee then notified by mail.
IFW reissue application file, a copy of the bibliographic
Further consideration will be given to initially
data sheet from the IFW file history should be  
rejected requests upon a request for reconsideration.  
printed and the examiner should annotate the printed
In this instance, however, or in the case where it is  
sheet such that adequate notice is provided that more
determined that the Office was not responsible for the
than one reissue application has been filed for a single
error(s) cited by the patentee, accelerated issuance of  
original patent. The annotated sheet should be
Certificates of Correction cannot be anticipated
scanned into IFW. For reissue application files that are
(although the Office will make every effort to process
maintained in paper, the bibliographic data sheet
the request expeditiously).
should be reprinted (for 09/ and later series), or  
the front face of the reissue file wrapper should be
marked (for 08/ and earlier series), for all the multiple
reissue applications, so that adequate notice is provided
that more than one reissue application has been
filed for a single original patent.
 
Pursuant to 37 CFR 1.177(b) all of the claims of the
patent to be reissued must be presented in each reissue
application in some form, i.e., as amended, as
unamended or as canceled. Further, any added
claims must be numbered beginning with the next
highest number following the last patent claim. It is
noted that the same claim of the patent cannot be presented
for examination in more than one of the divisional
reissue applications, as a pending claim, in
either its original or amended versions. Once a claim
in the patent has been reissued, it does not exist in the
original patent; thus, it cannot be reissued from the
original patent in another reissue application. If the  
same claim of the patent, e.g., patent claim 1 is presented
for examination in more than one of the reissue
applications, in different amended versions, the following
rejections should be made in the reissue applications
with that patent claim:


A rejection under 35 U.S.C. 251, in that the reissue
==1481 Certificates of Correction - Applicant’s Mistake==
application is not correcting an error in the original
patent, because original claim 1 would be superseded
by the reissuance of claim 1 in the other reissue application.


35 U.S.C. 255. Certificate of correction of applicant’s
mistake.


A rejection under 35 U.S.C. 112, in that claim 1 is
Whenever a mistake of a clerical or typographical nature, or of
indefinite because the invention of claim 1 is not particularly
minor character, which was not the fault of the Patent and Trademark
pointed out and distinctly claimed. Claim 1
Office, appears in a patent and a showing has been made that  
presents one coverage in divisional reissue application
such mistake occurred in good faith, the Director may, upon payment
X and another in the present reissue application. This
of the required fee, issue a certificate of correction, if the
is inconsistent.
correction does not involve such changes in the patent as would
constitute new matter or would require reexamination. Such
patent, together with the certificate, shall have the same effect and  
operation in law on the trial of actions for causes thereafter
arising as if the same had been originally issued in such corrected
form.


The reissue applicant should then be advised to follow
37 CFR 1.323. Certificate of correction of applicant’s
a procedure similar to the following example:
mistake.


The Office may issue a certificate of correction under the
conditions specified in 35 U.S.C. 255 at the request of the patentee
or the patentee’s assignee, upon payment of the fee set forth in
§ 1.20(a). If the request relates to a patent involved in an interference,
the request must comply with the requirements of this section
and be accompanied by a motion under § 41.121(a)(2) or
§ 41.121(a)(3) of this title.


37 CFR 1.323 relates to the issuance of Certificates
of Correction for the correction of errors which were
not the fault of the Office. Mistakes in a patent which
are not correctable by Certificate of Correction may
be correctable via filing a reissue application (see
MPEP § 1401 - § 1460). See Novo Industries, L.P. v.
Micro Molds Corporation, 350 F.3d 1348,
69 USPQ2d 1128 (Fed. Cir. 2003) (The Federal Circuit
stated that when Congress in 1952 defined
USPTO authority to make corrections with prospective
effect, it did not deny correction authority to the
district courts. A court, however, can correct only if
“(1) the correction is not subject to reasonable debate
based on consideration of the claim language and the
specification and (2) the prosecution history does not
suggest a different interpretation...”).


In re Arnott, 19 USPQ2d 1049, 1052 (Comm’r Pat.
1991) specifies the criteria of 35 U.S.C. 255 (for a
Certificate of Correction) as follows:


Two separate statutory requirements must be met
before a Certificate of Correction for an applicant’s mistake
may issue. The first statutory requirement concerns
the nature, i.e., type, of the mistake for which a correction
is sought. The mistake must be:
 
(1) of a clerical nature,
 
(2) of a typographical nature, or
 
(3) a mistake of minor character.


If there are patent claims 1 – 10 in two divisional
The second statutory requirement concerns the nature
reissue applications and an applicant wishes to revise
of the proposed correction. The correction must not  
claim 1, which is directed to AB (for example) to
involve changes which would:
ABC in one divisional reissue application, and to
ABD in a second divisional reissue application, applicant
should do the following: Claim 1 in the first divisional
reissue application can be revised to recite
ABC. Claim 1 in the second divisional reissue application
would be canceled, and new claim 11 would be
added to recite ABD. The physical cancellation of
claim 1 in the second divisional reissue application
will not prejudice applicant’s rights in the amended
version of claim 1 since those rights are retained via
the first reissue application. Claim 1 continues to exist
in the first reissue application, and both the first and
second reissue applications taken together make up
the totality of the correction of the original patent.


If the same or similar claims are presented in more
(1) constitute new matter or
than one of the multiple reissue applications, the possibility
of statutory double patenting (35 U.S.C. 101)
or non-statutory (judicially created doctrine) double
patenting should be considered by the examiner during
examination, and the appropriate rejections made.
A terminal disclaimer may be filed to overcome an
obviousness type double patenting rejection. The terminal
disclaimer is necessary in order to ensure common
ownership of the reissue patents throughout the
remainder of the unexpired term of the original patent.
Whenever a divisional reissue application is filed with
a copy of the oath/declaration and assignee consent
from the parent reissue application, the copy of the
assignee consent from the parent reissue application
should not be accepted. The copy of the consent from
the parent reissue application does not indicate that
the assignee has consented to the addition of the new  
invention of the divisional reissue application to the
original patent. The Office of Initial Patent Examination
(OIPE) should accord a filing date and send out a
notice of missing parts stating that there is no proper
consent and setting a period of time for filing the
missing part and for payment of any surcharge
required under 37 CFR 1.53(f) and 1.16(f). See
MPEP § 1410.01. The copy of the reissue oath/declaration
should be accepted by OIPE, since it is an oath/
declaration, even though it may be improper under
35
U.S.C. 251. The examiner should check the copy
of the oath/declaration to ensure that it identifies an
error being corrected by the divisional reissue application.
The copy of the oath/declaration from the parent
reissue application may or may not cover the error
being corrected by the divisional reissue application
since the divisional reissue application is (by definition)
directed to a new invention. If it does not, the
examiner should reject the claims of the divisional
reissue application under 35 U.S.C. 251 as being
based on an oath/declaration that does not identify an
error being corrected by the divisional reissue application,
and require a new oath/declaration. See MPEP §
1414. If the copy of the reissue oath/declaration from
the parent reissue application does in fact cover an
error being corrected in the divisional reissue application,
no such rejection should be made. However,
since a new invention is being added by the filing of
the divisional reissue application, a supplemental reissue
oath/declaration pursuant to 37 CFR 1.175 (b)(1)
will be required. See MPEP § 1414.01.


Situations yielding divisional reissues occur infrequently
(2) require reexamination.
and usually involve only two such files. It
should be noted, however, that in rare instances in the
past, there have been more than two (and as many as
five) divisional reissues of a
patent. For treatment of a
plurality of divisional reissue applications resulting
from a requirement to restrict to distinct inventions or
a requirement to elect species, see MPEP § 1450.


If the above criteria are not satisfied, then a Certificate
of Correction for an applicant’s mistake will not issue,
and reissue must be employed as the vehicle to “correct”
the patent. Usually, any mistake affecting claim
scope must be corrected by reissue.


A mistake is not considered to be of the “minor”
character required for the issuance of a Certificate of
Correction if the requested change would materially
affect the scope or meaning of the patent. See also
MPEP § 1412.04 as to correction of inventorship via
certificate of correction or reissue.


II. CONTINUATION REISSUE APPLI-
The fee for providing a correction of applicant’s
CATIONS
mistake, other than inventorship, is set forth in
37 CFR 1.20(a). The fee for correction of inventorship
in a patent is set forth in 37 CFR 1.20(b).


A continuation of a reissue is not ordinarily filed
===1481.01 Correction of Assignees’ Names===
“for distinct and separate parts of the thing patented”
as called for in the second paragraph of 35 U.S.C.
251. The decision of In re Graff, 111 F.3d 874,
42
USPQ2d 1471 (Fed. Cir. 1997) interprets
35
U.S.C. 251 to permit multiple reissue patents to
issue even where the multiple reissue patents are not
for “distinct and separate parts of the thing patented.”
The court stated:


Section 251[2] is plainly intended as enabling, not as limiting.
The Fee(s) Transmittal Form portion (PTOL-
Section 251[2] has the effect of assuring that a different
85B) of the Notice of Allowance provides a space
burden is not placed on divisional or continuation
(item 3) for assignment data which should be completed
reissue applications, compared with divisions and continuations
in order to comply with 37 CFR 3.81. Unless
of original applications, by codifying the Supreme
an assignee’s name and  
Court decision which recognized that more than one
address are identified in the  
patent can result from a reissue proceeding. Thus § 251[2]
appropriate space for
places no greater burden on Mr. Graff’s continuation reissue
specifying the assignee, (i.e.,
application than upon a continuation of an original
item 3 of the Fee(s) Transmittal Form PTOL-
application; § 251[2] neither overrides, enlarges, nor lim
85B), the patent will issue to the applicant. Assignment
data printed on the patent will be based solely on
the information so supplied.


Any request for the issuance of an application
in the name of the assignee submitted after the date of
payment of the issue fee, and any request for a patent
to be corrected to state the name of the assignee must:


(A)state that the assignment was submitted for
recordation as set forth in 37 CFR 3.11 before issuance
of the patent;


(B)include a request for a certificate of correction
under 37 CFR 1.323 along with the fee set forth in
37 CFR 1.20(a); and


(C)include the processing fee set forth in 37 CFR
1.17(i).


See 37 CFR 3.81(b).


its the statement in § 251[3] that the provisions of Title 5
===1481.02 Correction of Inventors’ Names===
apply to reissues.


111 F.3d at 877, 42 USPQ2d at 1473. Accordingly,
35 U.S.C. 256. Correction of named inventor.
prosecution of a continuation of a reissue application
will be permitted (despite the existence of the pending
parent reissue application) where the continuation
complies with the rules for reissue.


The parent and the continuation reissue applications
Whenever through error a person is named in an issued patent
should be examined together if possible. In
as the inventor, or through error an inventor is not named in an
order that the parent-continuation relationship of the  
issued patent and such error arose without any deceptive intention
reissue applications be specifically identified and  
on his part, the Director may, on application of all the parties and  
notice be provided of both reissue applications for
assignees, with proof of the facts and such other requirements as
both the parent and the continuation reissue applications,  
may be imposed, issue a certificate correcting such error.
the following is done:


(A) An appropriate amendment to the continuing
The error of omitting inventors or naming persons who are not
data entries must be made to the first sentence of  
inventors shall not invalidate the patent in which such error
the specification, (see the discussion above under the
occurred if it can be corrected as provided in this section. The
heading “Divisional Reissue Applications”).
court before which such matter is called in question may order
correction of the patent on notice and hearing of all parties concerned
and the Director shall issue a certificate accordingly.


(B)For an IFW reissue application file, a copy of
In requesting the Office to effectuate a court order
the bibliographic data sheet from the IFW file history
correcting inventorship in a patent pursuant to
should be printed and the examiner should annotate
35 U.S.C. 256, a copy of the court order and a Certificate
the printed sheet such that adequate notice is provided
of Correction under 37 CFR 1.323 should be submitted
that more than one reissue application has been filed
to the Certificates of Corrections Branch.
for a single original patent. The annotated sheet
should be scanned into IFW. For reissue application
files that are maintained in paper, the bibliographic
data sheet should be reprinted (for 09/ and later
series), or the front face of the reissue file wrapper
should be marked (for 08/ and earlier series), for all
the multiple reissue applications, so that adequate
notice is provided that more than one reissue application
has been filed for a single original patent.


As is true for the case of multiple divisional reissue
37 CFR 1.324. Correction of inventorship in patent,  
applications, all of the claims of the patent to be reissued
pursuant to 35 U.S.C. 256.
must be presented in both the parent reissue
application and the continuation reissue application in
some form, i.e., as amended, as unamended, or as canceled.
The same claim of the patent cannot, however
be presented for examination in both the parent reissue
application and the continuation reissue application,
as a pending claim, in either its original or
amended versions. See the discussion in subsection I.  
above for treatment of this situation. Further, any
added claims must be numbered beginning with the
next highest number following the past patent
claims.


Where the parent reissue application issues prior to
(a)Whenever through error a person is named in an
the examination of the continuation, the claims of the
issued patent as the inventor, or through error an inventor is not
continuation should be carefully reviewed for double
named in an issued patent and such error arose without any deceptive
patenting over the claims of the parent. Where the
intention on his or her part, the Director, pursuant to 35
parent and the continuation reissue applications are
U.S.C. 256, may, on application of all the parties and assignees, or
examined together, a provisional double patenting
on order of a court before which such matter is called in question,
rejection should be made in both cases as to any overlapping
issue a certificate naming only the actual inventor or inventors. A
claims. See MPEP § 804 - §
petition to correct inventorship of a patent involved in an interference
must comply with the requirements of this section and must
804.04 as to double
be accompanied by a motion under § 41.121(a)(2) or §
patenting rejections. Any terminal disclaimer filed
41.121(a)(3) of this title.
to obviate an obviousness-type double patenting
rejection ensures common ownership of the reissue
patents throughout the remainder of the unexpired
term of the original patent.


If the parent reissue application issues without any
(b)Any request to correct inventorship of a patent pursuant
cross reference to the continuation, amendment of the
to paragraph (a) of this section must be accompanied by:
parent
reissue patent to include a cross-reference to
the continuation must be effected at the time of allowance
of the continuation application by Certificate of
Correction. See the discussion above under the heading
“Divisional Reissue Applications” as to how the
Certificate of Correction is to be provided.


Again, the examiner should make reference in the
(1)Where one or more persons are being added, a statement
pending divisional reissue application to the fact that  
from each person who is being added as an inventor that the  
an actual request for a Certificate of Correction has
inventorship error occurred without any deceptive intention on his
been generated in the first reissue patent pursuant to
or her part;
37 CFR 1.177(a), e.g., by an entry in the search notes
or in an examiner’s amendment.


Where a continuation reissue application is filed
(2)A statement from the current named inventors who
with a copy of the oath/declaration and assignee consent
have not submitted a statement under paragraph (b)(1) of this section
from the parent reissue application, and the parent
either agreeing to the change of inventorship or stating that
reissue application is not to be abandoned, the
they have no disagreement in regard to the requested change;
copy of the consent of the parent reissue application
should not be accepted. The copy of the consent of the
parent reissue application does not indicate that the
assignee has consented to the addition of the new
error correction of the continuation reissue application
to the original patent. Presumably, a new correction
has been added, since the parent reissue
application is still pending. OIPE should accord a filing
date and send out a notice of missing parts stating
that there is no proper consent and setting a period of
time for filing the missing part and for payment of any
surcharge required under 37 CFR 1.53(f) and
1.16(f). See MPEP § 1410.01. The copy of the
reissue oath/declaration should be accepted by OIPE,
since it is a oath/declaration, albeit improper under
35
U.S.C. 251. The examiner should reject the claims
of the continuation reissue application under


(3)A statement from all assignees of the parties submitting
a statement under paragraphs (b)(1) and (b)(2) of this section
agreeing to the change of inventorship in the patent, which statement
must comply with the requirements of § 3.73(b) of this chapter;
and


(4)The fee set forth in § 1.20(b).


(c)For correction of inventorship in an application, see
§§ 1.48 and 1.497.


(d)In a contested case before the Board of Patent Appeals
and Interferences under part 41, subpart D, of this title, a request
for correction of a patent must be in the form of a motion under
§ 41.121(a)(2) or § 41.121(a)(3) of this title.


35
The petition to correct inventorship under 37 CFR
U.S.C. 251 as being based on an oath/declaration
1.324 must include the statements and fee required by
that does not identify an error being corrected by the  
37 CFR 1.324(b).
continuation reissue application, and should require a
new oath/declaration. See 37 CFR 1.175(e). One of
form paragraphs 14.01.01 through 14.01.03 may be
used. See MPEP § 1414.


Where a continuation reissue application is filed
Under 37 CFR 1.324(b)(1), a statement is required
with a copy of the oath/declaration and assignee consent
from each person who is being added as an inventor
from the parent reissue application, and the parent
that the inventorship error occurred without any  
reissue application is, or will be abandoned, the
deceptive intention on their part. In order to satisfy
copy of the consent should be accepted by both OIPE
this, a statement such as the following is sufficient:
and the examiner. The reissue oath/declaration should
be accepted by OIPE, and the examiner should check
to ensure that the oath/declaration identifies an error
that is being corrected in the continuation reissue
application. See MPEP § 1414. If a preliminary
amendment was filed with the continuation reissue
application, the examiner should check for the need of
a supplemental reissue oath/declaration. Pursuant to
37 CFR 1.175 (b)(1), for any error corrected via the
preliminary amendment which is not covered by the
oath or declaration submitted in the parent reissue
application, applicant must submit a supplemental
oath/declaration stating that every such error arose
without any deceptive intention on the part of the  
applicant. See MPEP § 1414 and § 1414.01.


1452Request for Continued Examination
“The inventorship error of failing to include John Smith
of Reissue Application
as an inventor of the patent occurred without any deceptive
intention on the part of John Smith.”


A request for continued examination (RCE) under
Nothing more is required. The examiner will determine
37 CFR 1.114 is available for a reissue application.  
only whether the statement contains the required
Effective May 29, 2000, an applicant in a reissue
language; the examiner will not make any commentas to whether or not it appears that there was in fact
application may file a request for continued examination
deceptive intention (see MPEP § 2022.05).
of the reissue application, if the reissue application
was filed on or after June 8, 1995. This applies
even where the application, which resulted in the original
patent, was filed prior to June 8, 1995.


An RCE continues the prosecution of the existing
Under 37 CFR 1.324(b)(2), all current inventors
reissue application and is not a filing of a new reissue
who did not submit a statement under 37 CFR
application. Thus, the filing of an RCE will not be
1.324(b)(1) must submit a statement either agreeing to
announced in the Official Gazette. Additionally, if a
the change of inventorship, or stating that they have
reissue application is merged with a reexamination
no disagreement with regard to the requested change.  
proceeding (see MPEP § 1449.01), the filing of an
“Current inventors” include the inventor(s) being
RCE will not dissolve the merger, since the reissue
retained as such and the inventor(s) to be deleted.  
application does not become abandoned.
These current inventors need not make a statement as
to whether the inventorship error occurred without
deceptive intention.


1453Amendments to Reissue Applications
If an inventor is not available, or refuses, to submit
[R-5]
a statement, the assignee of the patent may wish to
consider filing a reissue application to correct inventorship,
since the inventor’s statement is not required
for a non-broadening reissue application to correct
inventorship. See MPEP § 1412.04.


37 CFR 1.121. Manner of making amendments in  
Under 37 CFR 1.324(b)(3), a statement is required
application.
from the assignee(s) of the patent agreeing to the
change of inventorship in the patent. The assignee
statement agreeing to the change of inventorship must
be accompanied by a proper statement under 37 CFR
3.73(b) establishing ownership, unless a proper 37
CFR 3.73(b) statement is already in the file. See
MPEP § 324 as to the requirements of a statement
under 37 CFR 3.73(b).


While a request under 37 CFR 1.48 is appropriate
to correct inventorship in a nonprovisional application,
a petition under 37 CFR 1.324 is the appropriate
vehicle to correct inventorship in a patent. If a request
under 37 CFR 1.48(a), (b), or (c) is inadvertently filed
in a patent, the request may be treated as a petition
under 37 CFR 1.324, and if it is grantable, form paragraph
10.14 set forth below should be used.


Similarly, if a request under 37 CFR 1.48(a), (b), or
(c) is filed in a pending application but not acted upon
until after the application becomes a patent, the
request may be treated as a petition under 37 CFR 1.324, and if it is grantable, form paragraph 10.14 set
forth below should be used.


(i)Amendments in reissue applications. Any amendment to
The statutory basis for correction of inventorship
the description and claims in reissue applications must be made in  
in a patent under 37 CFR 1.324 is 35 U.S.C. 256. It is
accordance with § 1.173.
important to recognize that 35 U.S.C. 256 is stricter
than 35 U.S.C. 116, the statutory basis for corrections
of inventorship in applications under 37 CFR 1.48.
35 U.S.C. 256 requires “on application of all the parties
and assignees,” while 35 U.S.C. 116 does not
have the same requirement. Under 35 U.S.C. 116 and
37 CFR 1.48, waiver requests under 37 CFR 1.183may be submitted (see, e.g., MPEP § 201.03, under
the heading “Statement of Lack of Deceptive Intention”).
This is not possible under 35 U.S.C. 256 and  
37 CFR 1.324. In correction of inventorship in a nonprovisional
application under 37 CFR 1.48(a), the
requirement for a statement by each originally named
inventor may be waived pursuant to 37 CFR 1.183;
however, correction of inventorship in a patent under
37 CFR 1.324 requires petition of all the parties, i.e.,
originally named inventors and assignees, in accordance  
with statute (35 U.S.C. 256) and thus the
requirement cannot be waived.


===1481.03 Correction of 35 U.S.C. 119 and 35 U.S.C. 120 Benefits===


I.CORRECTION TO PERFECT CLAIM
FOR 35 U.S.C. 119 (a)-(d) AND (f) BENEFITS


37 CFR 1.173. Reissue specification, drawings, and  
See MPEP § 201.16 for a discussion of when
amendments.
35 U.S.C. 119 (a)-(d) and (f) benefits can be perfected
by certificate of correction.


II.CORRECTION AS TO 35 U.S.C. 120 AND
35 U.S.C. 119(e) BENEFITS


A.For Applications Filed Prior to November 29, 2000


(b)Making amendments in a reissue application. An amendment
For applications filed prior to November 29, 2000,
in a reissue application is made either by physically incorporating
it is the version of 37 CFR 1.78, which was in effect
the changes into the specification when the application is
as of November 29, 2000, that applies. The pre-
filed, or by a separate amendment paper. If amendment is made by
November 29, 2000 version reads as follows:
incorporation, markings pursuant to paragraph (d) of this section
must be used. If amendment is made by an amendment paper, the
paper must direct that specified changes be made, as follows:


(1)Specification other than the claims. Changes to the
37 CFR 1.78. Claiming benefit of earlier filing date andcross-references to other applications.  
specification, other than to the claims, must be made by submission
of the entire text of an added or rewritten paragraph, including
markings pursuant to paragraph (d) of this section, except that
an entire paragraph may be deleted by a statement deleting the
paragraph without presentation of the text of the paragraph. The
precise point in the specification must be identified where any
added or rewritten paragraph is located. This paragraph applies
whether the amendment is submitted on paper or compact disc
(see §§ 1.52(e)(1) and 1.821(c), but not for discs submitted under
§ 1.821(e)).


(2)Claims. An amendment paper must include the entire
(a)(1) A nonprovisional application may claim an invention
text of each claim being changed by such amendment paper and of
disclosed in one or more prior filed copending nonprovisional
each claim being added by such amendment paper. For any claim
applications or copending international applications designating
changed by the amendment paper, a parenthetical expression
the United States of America. In order for a nonprovisional application
“amended,” “twice amended,” etc., should follow the claim number.  
to claim the benefit of a prior filed copending nonprovisional
Each changed patent claim and each added claim must
application or copending international application
include markings pursuant to paragraph (d) of this section, except
designating the United States of America, each prior application
that a patent claim or added claim should be canceled by a statement
must name as an inventor at least one inventor named in the later
canceling the claim without presentation of the text of the
filed nonprovisional application and disclose the named inventor’s
claim.
invention claimed in at least one claim of the later filed nonprovisional
 
application in the manner provided by the first
(3)Drawings. One or more patent drawings shall be
paragraph of 35 U.S.C. 112. In addition, each prior application
amended in the following manner: Any changes to a patent drawing
must be:
must be submitted as a replacement sheet of drawings which
shall be an attachment to the amendment document. Any replacement
sheet of drawings must be in compliance with § 1.84 and  
shall include all of the figures appearing on the original version of  
the sheet, even if only one figure is amended. Amended figures
must be identified as “Amended,” and any added figure must be
identified as “New.In the event that a figure is canceled, the figure
must be surrounded by brackets and identified as “Canceled.”
All changes to the drawing(s) shall be explained, in detail, begin


(i)An international application entitled to a filing date in
accordance with PCT Article 11 and designating the United States
of America; or


(ii)Complete as set forth in § 1.51(b); or


(iii)Entitled to a filing date as set forth in § 1.53(b) or
§ 1.53(d) and include the basic filing fee set forth in § 1.16; or


(iv)Entitled to a filing date as set forth in § 1.53(b) and
have paid therein the processing and retention fee set forth in
§ 1.21(l) within the time period set forth in § 1.53(f).


(2)Except for a continued prosecution application filed
under §
   
   
1.53(d), any nonprovisional application claiming the benefit
of one or more prior filed copending nonprovisional applications
or international applications designating the United States of
America must contain a reference to each such prior application,
identifying it by application number (consisting of the series code
and serial number) or international application number and international
filing date and indicating the relationship of the applications.
Unless the reference required by this paragraph is included
in an application data sheet (§ 1.76), the specification must contain
or be amended to contain such reference in the first sentence
following any title. The request for a continued prosecution application
under § 1.53(d) is the specific reference required by
35
U.S.C. 120 to the prior application. The identification of an
application by application number under this section is the specific
reference required by 35 U.S.C. 120 to every application
assigned that application number. Cross-references to other
related applications may be made when appropriate (see
§ 1.14(a)).


ning on a separate sheet accompanying the papers including the  
(3)A nonprovisional application other than for a design
amendment to the drawings.  
patent may claim an invention disclosed in one or more prior filed
copending provisional applications. In order for a nonprovisional
application to claim the benefit of one or more prior filed copending
provisional applications, each prior provisional application
must name as an inventor at least one inventor named in the later
filed nonprovisional application and disclose the named inventor's
invention claimed in at least one claim of the later filed nonprovisional
application in the manner provided by the first paragraph of
35 U.S.C. 112. In addition, each prior provisional application
must be entitled to a filing date as set forth in § 1.53(c), have any
required English-language translation filed therein within the time
period set forth in § 1.52(d), and have paid therein the basic filing
fee set forth in § 1.16(k) within the time period set forth in
§ 1.53(g).


(i)A marked-up copy of any amended drawing figure,  
(4)Any nonprovisional application claiming the benefit
including annotations indicating the changes made, may be
of one or more prior filed copending provisional applications must
included. The marked-up copy must be clearly labeled as “Annotated
contain a reference to each such prior provisional application,  
Marked-up Drawings” and must be presented in the amendment
identifying it as a provisional application, and including the provisional
or remarks section that explains the change to the drawings.  
application number (consisting of series code and serial
number). Unless the reference required by this paragraph is
included in an application data sheet (§ 1.76), the specification
must contain or be amended to contain such reference in the first
sentence following any title.


(ii)A marked-up copy of any amended drawing figure,  
Under certain conditions specified below, a Certificate
including annotations indicating the changes made, must be
of Correction can be used, with respect to
provided when required by the examiner.
35
U.S.C. 120 and 119(e) priority, to correct:


(c)Status of claims and support for claim changes. Whenever
(A)the failure to make reference to a prior
there is an amendment to the claims pursuant to paragraph
copending application pursuant to 37 CFR 1.78(a)(2)  
(b) of this section, there must also be supplied, on pages separate
and (a)(4); or
from the pages containing the changes, the status (i.e., pending or
canceled), as of the date of the amendment, of all patent claims
and of all added claims, and an explanation of the support in the
disclosure of the patent for the changes made to the claims.


(d)Changes shown by markings. Any changes relative to the
(B)an incorrect reference to a prior copending
patent being reissued which are made to the specification, including
application pursuant to 37 CFR 1.78(a)(2) and (a)(4).
the claims, upon filing, or by an amendment paper in the reissue
application, must include the following markings:


(1)The matter to be omitted by reissue must be enclosed
For all situations other than where priority is based
in brackets; and
upon 35 U.S.C. 365(c), the conditions are as follows:


(2)The matter to be added by reissue must be underlined,
(A)for 35 U.S.C. 120 priority, all requirements
except for amendments submitted on compact discs (§§ 1.96 and
set forth in 37 CFR 1.78(a)(1) must have been met in
1.821(c)). Matter added by reissue on compact discs must be preceded
the application which became the patent to be corrected;
with “U” and end with “/U” to properly identify the
material being added.


(e)Numbering of patent claims preserved. Patent claims
(B)for 35 U.S.C. 119(e) priority, all requirements
may not be renumbered. The numbering of any claim added in the  
set forth in 37 CFR 1.78(a)(3) must have been met in  
reissue application must follow the number of the highest numbered
the application which became the patent to be corrected;
patent claim.
and


(f)Amendment of disclosure may be required. The disclosure
(C)it must be clear from the record of the patent
must be amended, when required by the Office, to correct
and the parent application(s) that priority is appropriate.
inaccuracies of description and definition, and to secure substantial
See MPEP § 201.1l for requirements under
correspondence between the claims, the remainder of the specification,
35 U.S.C. 119(e) and 120.
and the drawings.


(g)Amendments made relative to the patent. All amendments
Where 35 U.S.C. 120 and 365(c) priority based on
must be made relative to the patent specification, including
an international application is to be asserted or corrected
the claims, and drawings, which are in effect as of the date of filing
in a patent via a Certificate of Correction, the  
of the reissue application.
following conditions must be satisfied:


The provisions of 37 CFR 1.173(b)-(g) and those of
(A)all requirements set forth in 37 CFR  
37 CFR 1.121(i) apply to amendments in reissue
1.78(a)(1) must have been met in the application
applications. Any amendments submitted in a reissue
which became the patent to be corrected;
application must comply with 37 CFR 1.173(b).


Amendments submitted in a reissue application,
(B)it must be clear from the record of the patent
including preliminary amendments (i.e., amendments
and the parent application(s) that priority is appropriate
filed as a separate paper to accompany the filing of a
(see MPEP § 201.11); and
reissue application), must comply with the practice
outlined below in this section; however, for examiner’s
amendments to the specification and claims,
37
CFR 1.121(g) provides certain exceptions to that  
practice in the interest of expediting prosecution. The
exceptions set forth in 37 CFR 1.121(g) also apply in
reissue applications.


Pursuant to 37 CFR 1.173(a), no amendment in a
(C)the patentee must submit with the request for
reissue application may enlarge the scope of the
the certificate copies of documentation showing designation
claims, unless “applied for within two years from the  
of states and any other information needed to
grant of the original patent.” Further, the amendment
make it clear from the record that the 35 U.S.C. 120priority is appropriate. See MPEP § 201.13(b) as to  
may not introduce new matter. See MPEP § 1412.03for further discussion as to the time limitation on  
the requirements for 35
enlarging the scope of the patent claims in a reissue
U.S.C. 120 priority based on  
application.  
an international application.


All amendment changes must be made relative to  
If all the above-stated conditions are satisfied, a
the patent to be reissued. Pursuant to 37 CFR
Certificate of Correction can be used to amend the
1.173(d), any such changes which are made to the
patent to make reference to a prior copending application,
specification, including the claims, must be shown by
or to correct an incorrect reference to the prior
employing the following “markings:”
copending application. Note In re Schuurs, 218 USPQ
443 (Comm’r Pat. 1983) which suggests that a Certificate
of Correction is an appropriate remedy for correcting,  
in a patent, reference to a prior copending
application. Also, note In re Lambrech, 202 USPQ
620 (Comm’r Pat. 1976), citing In re Van Esdonk,
187
USPQ 671 (Comm’r Pat. 1975).


(A)The matter to be omitted by reissue must be
If any of the above-stated conditions is not satisfied,
enclosed in brackets; and
the filing of a reissue application (see MPEP
§ 1401 - § 1460) would be appropriate to pursue the
desired correction of the patent.


(B)The matter to be added by reissue must be
B.For Applications Filed on or After November
underlined, except for amendments submitted on  
29, 2000
compact discs (pursuant to 37 CFR 1.96 for computer
printouts or programs, and 37 CFR 1.825 for
sequence listings). Matter added by reissue on compact
discs must be preceded with “U” and end with
“/U” to properly identify the material being added.


I.THE SPECIFICATION
For applications filed on or after November 29,
 
2000, the version of 37 CFR 1.78 reproduced below
37 CFR 1.173(b)(1) relates to the manner of making
applies (note that amendments to 37 CFR 1.78 took
amendments to the specification other than the
effect on November 29, 2000, December 28, 2001,
claims. It is not to be used for making amendments to
May 1, 2003, January 21, 2004, September 21, 2004,
the claims or the drawings.  
December 8, 2004,  July 1, 2005, and November
25, 2005).


All amendments which include any deletions or
37 CFR 1.78. Claiming benefit of earlier filing date and  
additions must be made by submission of the entire
cross-references to other applications.
text of each added or rewritten paragraph with markings
(as defined above), except that an entire paragraph
of specification text may be deleted by a
statement deleting the paragraph without presentation
of the text of the paragraph. Applicant must indicate
the precise point where each amendment is made. All
bracketing and underlining is made in comparison to
the original patent, not in comparison to any prior
amendment in the reissue application. Thus, all paragraphs
which are newly added to the specification of
the original patent must be submitted as completely
underlined each time they are re-submitted in the reissue
application.  


(a)(1)A nonprovisional application or international application
designating the United States of America may claim an
invention disclosed in one or more prior-filed copending nonprovisional
applications or international applications designating the
United States of America. In order for an application to claim the
benefit of a prior-filed copending nonprovisional application or
international application designating the United States of America,
each prior-filed application must name as an inventor at least
one inventor named in the later-filed application and disclose the
named inventor’s invention claimed in at least one claim of the
later-filed application in the manner provided by the first paragraph
of 35 U.S.C. 112. In addition, each prior-filed application
must be:


(i) An international application entitled to a filing date
in accordance with PCT Article 11 and designating the United
States of America; or


(ii) Entitled to a filing date as set forth in § 1.53(b) or §
1.53(d) and have paid therein the basic filing fee set forth in § 1.16within the pendency of the application.


(2)(i)Except for a continued prosecution application
filed under § 1.53(d), any nonprovisional application or international
application designating the United States of America claiming
the benefit of one or more prior-filed copending
nonprovisional applications or international applications designating
the United States of America must contain or be amended to
contain a reference to each such prior-filed application, identifying
it by application number (consisting of the series code and
serial number) or international application number and international
filing date and indicating the relationship of the applications.
Cross references to other related applications may be made
when appropriate (see § 1.14).


II.THE CLAIMS
(ii)This reference must be submitted during the pendency
 
of the later-filed application. If the later-filed application is
37 CFR 1.173(b)(2) relates to the manner of making
an application filed under 35
amendments to the claims in reissue applications.  
U.S.C. 111(a), this reference must
It is not to be used for making amendments to the  
also be submitted within the later of four months from the actual
remainder of the specification or to the drawings. 37
filing date of the later-filed application or sixteen months from the
CFR 1.173(b)(2) requires that:
filing date of the prior-filed application. If the later-filed application
is a nonprovisional application which entered the national
stage from an international application after compliance with
35
U.S.C. 371, this reference must also be submitted within the  
later of four months from the date on which the national stage
commenced under 35 U.S.C. 371 (b) or (f) in the later-filed international
application or sixteen months from the filing date of the
prior-filed application. These time periods are not extendable.
Except as provided in paragraph (a)(3) of this section, the failure
to timely submit the reference required by 35 U.S.C. 120 and
paragraph (a)(2)(i) of this section is considered a waiver of any
benefit under 35
U.S.C. 120, 121, or 365(c) to such prior-filed
application. The time periods in this paragraph do not apply if the
later-filed application is:


(A)For each claim that is being amended by the
(A)An application for a design patent;
amendment being submitted (the current amendment),
the entire text of the claim must be presented with
markings as defined above;


(B)For each new claim added to the reissue by
(B)An application filed under 35 U.S.C. 111 (a)  
the amendment being submitted (the current amendment),  
before November 29, 2000; or
the entire text of the added claim must be presented
completely underlined;


(C)A patent claim should be canceled by a direction
(C)A nonprovisional application which entered the
to cancel that claim, there is no need to present
national stage after compliance with 35 U.S.C. 371 from an international
the patent claim surrounded by brackets; and
application filed under 35 U.S.C. 363 before November
29, 2000.


(D)A new claim (previously added in the reissue)
(iii)If the later-filed application is a nonprovisional
should be canceled by a direction to cancel that claim.
application, the reference required by this paragraph must be
included in an application data sheet (§ 1.76), or the specification
must contain or be amended to contain such reference in the first
sentence(s) following the title.


Original patent claims are never to be renumbered;
(iv)The request for a continued prosecution application
see 37 CFR 1.173(e). A patent claim retains its number  
under § 1.53(d) is the specific reference required by
even if it is canceled in the reissue proceeding,
35 U.S.C. 120 to the prior-filed application. The identification of
and the numbering of any added claims must begin
an application by application number under this section is the  
after the last original patent claim.  
identification of every application assigned that application number
necessary for a specific reference required by 35 U.S.C. 120 to
every such application assigned that application number.


Pursuant to 37 CFR 1.173(c), each amendment submitted
(3)If the reference required by 35 U.S.C. 120 and paragraph
must set forth the status of all patent claims
(a)(2) of this section is presented after the time period provided
and all added claims as of the date of the submission.
by paragraph (a)(2)(ii) of this section, the claim under
The status to be set forth is whether the claim is pending
35 U.S.C. 120, 121, or 365(c) for the benefit of a prior-filed
or canceled. The failure to submit the claim status
copending nonprovisional application or international application
will generally result in a notification to applicant that
designating the United States of America may be accepted if the  
the amendment prior to final rejection is not completely
reference identifying the prior-filed application by application
responsive (see 37 CFR 1.135(c)). Such an
number or international application number and international filing
amendment after final rejection will not be entered.
date was unintentionally delayed. A petition to accept an unintentionally
delayed claim under 35 U.S.C. 120, 121, or 365(c) for
the benefit of a prior-filed application must be accompanied by:


Also pursuant to 37 CFR 1.173(c), each claim
(i)The reference required by 35 U.S.C. 120 and paragraph
amendment must be accompanied by an explanation
(a)(2) of this section to the prior-filed application, unless
of the support in the disclosure of the patent for the
previously submitted;
amendment (i.e., support for all changes made in the
claim(s), whether insertions or deletions). The failure
to submit an explanation will generally result in a
notification to applicant that the amendment prior to
final rejection is not completely responsive (see
37
CFR 1.135(c)). Such an amendment after final
rejection will not be entered.


III.THE DRAWINGS
(ii)The surcharge set forth in § 1.17(t); and


37 CFR 1.173(a)(2) states that amendments to the  
(iii)A statement that the entire delay between the date
original patent drawings are not permitted, and that
the claim was due under paragraph (a)(2)(ii) of this section and
any change to the drawings must be by way of
the date the claim was filed was unintentional. The Director may
37
require additional information where there is a question whether
CFR 1.173(b)(3). See MPEP § 1413 for the manner
the delay was unintentional.
of making amendments to the drawings in a reissue
application.


Form paragraph 14.20.01 may be used to advise
(4)A nonprovisional application, other than for a design
applicant of the proper manner of making amendments
patent, or an international application designating the United
in a reissue application.
States of America may claim an invention disclosed in one or
more prior-filed provisional applications. In order for an application
to claim the benefit of one or more prior-filed provisional
applications, each prior-filed provisional application must name
as an inventor at least one inventor named in the later-filed application
and disclose the named inventor’s invention claimed in at
least one claim of the later-filed application in the manner provided
by the first paragraph of 35
U.S.C. 112. In addition, each
prior-filed provisional application must be entitled to a filing date
as set forth in § 1.53(c), and the basic filing fee set forth in
§ 1.16(d) must be paid within the time period set forth in  
§ 1.53(g).


(5)(i) Any nonprovisional application or international
application designating the United States of America claiming the
benefit of one or more prior-filed provisional applications must
contain or be amended to contain a reference to each such prior-
filed provisional application, identifying it by the provisional
application number (consisting of series code and serial number).


(ii)This reference must be submitted during the pendency
of the later-filed application. If the later-filed application is
an application filed under 35
U.S.C. 111(a), this reference must
also be submitted within the later of four months from the actual
filing date of the later-filed application or sixteen months from the
filing date of the prior-filed provisional application. If the later-
filed application is a nonprovisional application which entered the
national stage from an international application after compliance
with 35 U.S.C. 371, this reference must also be submitted within
the later of four months from the date on which the national stage
commenced under 35
U.S.C. 371(b) or (f) in the later-filed international
application or sixteen months from the filing date of the
prior-filed provisional application. These time periods are not
extendable. Except as provided in paragraph(a)(6) of this section,
the failure to timely submit the reference is considered a waiver of
any benefit under 35 U.S.C. 119(e) to such prior-filed provisional
application. The time periods in this paragraph do not apply if the
later-filed application is:


¶ 14.20.01 Amendments To Reissue-37 CFR 1.173(b)
(A)An application filed under 35 U.S.C. 111(a)  
before November 29, 2000; or


Applicant is notified that any subsequent amendment to the  
(B)A nonprovisional application which entered the  
specification and/or claims must comply with 37 CFR 1.173(b).  
national stage after compliance with 35 U.S.C. 371 from an international
In addition, when any substantive amendment is filed in the reissue
application filed under 35 U.S.C. 363 before November
application, which amendment otherwise places the reissue
29, 2000.
application in condition for allowance, a supplemental oath/declaration
will be required. See MPEP § 1414.01.


Examiner Note:
(iii)If the later-filed application is a nonprovisional
application, the reference required by this paragraph must be
included in an application data sheet (§ 1.76), or the specification
must contain or be amended to contain such reference in the first
sentence(s) following the title.


This form paragraph may be used in the first Office action to
(iv)If the prior-filed provisional application was filed
advise applicant of the proper manner of making amendments,  
in a language other than English and both an English-language
and to notify applicant of the need to file a supplemental oath/declaration
translation of the prior-filed provisional application and a statement
before the application can be allowed.
that the translation is accurate were not previously filed in
the prior-filed provisional application, applicant will be notified
and given a period of time within which to file, in the prior-filed
provisional application, the translation and the statement. If the
notice is mailed in a pending nonprovisional application, a timely
reply to such a notice must include the filing in the nonprovisional
application of either a confirmation that the translation and statement
were filed in the provisional application, or an amendment
or Supplemental Application Data Sheet withdrawing the benefit
claim, or the nonprovisional application will be abandoned. The
translation and statement may be filed in the provisional application,
even if the provisional application has become abandoned.


(6)If the reference required by 35 U.S.C. 119(e) and
paragraph (a)(5) of this section is presented in a nonprovisional
application after the time period provided by paragraph (a)(5)(ii)
of this section, the claim under 35
U.S.C. 119(e) for the benefit of
a prior filed provisional application may be accepted during the
pendency of the later-filed application if the reference identifying
the prior-filed application by provisional application number was
unintentionally delayed. A petition to accept an unintentionally
delayed claim under 35
U.S.C. 119(e) for the benefit of a prior
filed provisional application must be accompanied by:


(i)The reference required by 35 U.S.C. 119(e) and
paragraph (a)(5) of this section to the prior-filed provisional application,
unless previously submitted;


Form paragraph 14.21.01 may be used to notify
(ii)The surcharge set forth in § 1.17(t); and
applicant that proposed amendments filed prior to
final rejection in the reissue application do not comply
with 37 CFR 1.173(b).
 
¶ 14.21.01 Improper Amendment To Reissue - 37 CFR
1.173(b)


The amendment filed [1] proposes amendments to [2] that do
(iii)A statement that the entire delay between the date
not comply with 37 CFR 1.173(b), which sets forth the manner of  
the claim was due under paragraph (a)(5)(ii) of this section and
making amendments in reissue applications. A supplemental
the date the claim was filed was unintentional. The Director may
paper correctly amending the reissue application is required.  
require additional information where there is a question whether
the delay was unintentional.


A shortened statutory period for reply to this letter is set to
(b)Where two or more applications filed by the same applicant
expire ONE MONTH or THIRTY DAYS, whichever is longer,  
contain conflicting claims, elimination of such claims from
from the mailing date of this letter.
all but one application may be required in the absence of good and
sufficient reason for their retention during pendency in more than
one application.


Examiner Note:
(c)If an application or a patent under reexamination and at
least one other application naming different inventors are owned
by the same person and contain conflicting claims, and there is no
statement of record indicating that the claimed inventions were
commonly owned or subject to an obligation of assignment to the
same person at the time the later invention was made, the Office
may require the assignee to state whether the claimed inventions
were commonly owned or subject to an obligation of assignment
to the same person at the time the later invention was made, and if
not, indicate which named inventor is the prior inventor. Even if
the claimed inventions were commonly owned, or subject to an
obligation of assignment to the same person, at the time the later
invention was made, the conflicting claims may be rejected under
the doctrine of double patenting in view of such commonly owned
or assigned applications or patents under reexamination.


1.This form paragraph may be used for any 37 CFR 1.173(b)
Under no circumstances can a Certificate of Correction
informality as to an amendment submitted in a reissue application  
be employed to correct an applicant’s mistake
prior to final rejection. After final rejection, applicant should be
by adding or correcting a priority claim under
informed that the amendment will not be entered by way of an
35
Advisory Office action.
U.S.C. 119(e) for an application filed on or after
November 29, 2000.  


2.In bracket 2, specify the proposed amendments that are not in
Section 4503 of the American Inventors Protection
compliance.
Act of 1999 (AIPA) amended 35 U.S.C. 119(e)(1) to
state that:


Note that if an informal amendment is submitted  
No application shall be entitled to the benefit of an earlier
after final rejection, form paragraph 14.21.01 should
filed provisional application under this subsection
not be used. Rather, an advisory Office action should
unless an amendment containing the specific reference to
be issued using Form PTO-303 indicating that the  
the earlier filed provisional application is submitted at such
amendment was not entered because it does not comply
time during the pendency of the application as required by
with 37 CFR 1.173(b), which sets forth the manner
the Director. The Director may consider the failure to submit
of making amendments in reissue applications.
such an amendment within that time period as a waiver
of any benefit under this subsection. The Director may
establish procedures, including the payment of a surcharge,
to accept an unintentionally delayed submission of an
amendment under this section during the pendency of the
application. (emphasis added)


A Certificate of Correction is NOT a
valid mechanism for adding or correcting a priority
claim under 35
U.S.C. 119(e) after a patent has been
granted on an application filed on or after November
29, 2000.


Under certain conditions as specified below, however,
a Certificate of Correction can still be used, with
respect to 35 U.S.C. 120 priority, to correct:


(A)the failure to make reference to a prior
copending application pursuant to 37 CFR 1.78(a)(2);
or


(B)an incorrect reference to a prior copending
application pursuant to 37 CFR 1.78(a)(2).


IV.ALL CHANGES ARE MADE VIS-À-VISTHE PATENT TO BE REISSUED
Where priority is based upon 35 U.S.C. 120 to a
national application, the following conditions must
be satisfied:


When a reissue patent is printed, all underlined
(A)all requirements set forth in 37 CFR  
matter is printed in italics and all brackets are printed
1.78(a)(1) must have been met in the application  
as inserted in the application, in order to show exactly
which became the patent to be corrected;
which additions and deletions have been made to
the
patent being reissued. Therefore, all underlining
and bracketing in the reissue application should be
made relative to the text of the patent, as follows. In
accordance with 37 CFR 1.173(g), all amendments in
the reissue application must be made relative to (i.e.,
vis-à-vis) the patent specification in effect as of the
date of the filing of the reissue application. The patent
specification includes the claims and drawings. If
there was a prior change to the patent (made via a
prior concluded reexamination certificate, reissue of
the patent, certificate of correction, etc.), the first
amendment of the subject reissue application must be
made relative to the patent specification as changed
by the prior proceeding or other mechanism for
changing the patent. All amendments subsequent to
the first amendment must also be made relative to the
patent specification in effect as of the date of the filing
of the reissue application, and not relative to the prior
amendment.


The Subject Patent Already Has Underlining or
(B) it must be clear from the record of the patent
Bracketing
and the parent application(s) that priority is appropriate
(see MPEP § 201.11); and


If the original (or previously changed) patent
(C)a grantable petition to accept an unintentionally
includes a formula or equation already having underlining
delayed claim for the benefit of a prior application
or bracketing therein as part of the formula or
must be filed, including a surcharge as set forth in  
equation, any amendment of such formula or equation
37 CFR 1.17(t), as required by 37 CFR 1.78(a)(3).
should be made by bracketing the entire formula and
rewriting and totally underlining the amended formula
in the re-presented paragraph of the specification or
rewritten claim in which the changed formula or
equation appears. Amendments of segments of a formula
or equation should not be made. If the original
patent includes bracketing and underlining from an
earlier reexamination or reissue, double brackets and
double underlining should be used in the subject reissue
application to identify and distinguish the present
changes being made. The subject reissue, when
printed, would include double brackets (indicating
deletions made in the subject reissue) and boldface
type (indicating material added in the subject reissue).


V.EXAMPLES OF PROPER AMEND-
Where 35 U.S.C. 120 and 365(c) priority based on
MENTS
an international application is to be asserted or corrected
 
in a patent via a Certificate of Correction, the  
A substantial number of problems arise in the  
following conditions must be satisfied:
Office because of improper submission of amendments
in reissue applications. The following examples
are provided to assist in preparation of proper amendments
to reissue applications.


A.Original Patent Description or Patent Claim
(A)all requirements set forth in 37 CFR
Amended
1.78(a)(1) must have been met in the application
which became the patent to be corrected;


Example (1)
(B)it must be clear from the record of the patent
and the parent application(s) that priority is appropriate
(see MPEP § 201.11);


If it is desired to change the specification at column
(C)the patentee must submit together with the
4 line 23, to replace “is” with --are--, submit a
request for the certificate, copies of documentation
copy of the entire paragraph of specification of the
showing designation of states and any other information
patent being amended with underlining and bracketing,
needed to make it clear from the record that the  
and point out where the paragraph is located,
35 U.S.C. 120 priority is appropriate (see MPEP
e.g.,
§ 201.13(b) as to the requirements for 35 U.S.C. 120priority based on an international application; and


Replace the paragraph beginning at column 4, line 23
(D)a grantable petition to accept an unintentionally
with the following:
delayed claim for the benefit of a prior application
must be filed, including a surcharge as set forth in
37 CFR 1.17(t), as required by 37 CFR 1.78(a)(3).


Scanning [is] are controlled by clocks which are, in turn,
If all the above-stated conditions are satisfied, a
controlled from the display tube line synchronization. The
Certificate of Correction can be used to amend the  
signals resulting from scanning the scope of the character
patent to make reference to a prior copending application,  
are delivered in parallel, then converted into serial mode
or to correct an incorrect reference to the prior
through a shift register wherein the shift signal frequency is
copending application, for benefit claims under
controlled by a clock that is, in turn, controlled from the display
35 U.S.C. 120 and 365(c).
tube line synchronization.


Example (2)
If any of the above-stated conditions is not satisfied,
the filing of a reissue application (see MPEP
§ 1401 - § 1460) may be appropriate to pursue the
desired correction of the patent for benefit claims
under 35 U.S.C. 120 and 365(c).


For changes to the claims, one must submit a copy
==1485 Handling of Request for Certificates of Correction==
of the entire patent claim with the amendments
shown by underlining and bracketing, e.g.,


Amend claim 6 as follows:
A request for a Certificate of Correction should be
addressed to:  


Claim 6 (Amended). The apparatus of claim [5] 1 wherein
Commissioner for Patents
the [first] second piezoelectric element is parallel to the
[second] third piezoelectric element.


If the dependency of any original patent claim is to
Office of Patent Publication
be changed by amendment, it is proper to make
that original patent claim dependent upon a later
filed higher numbered claim.


B.Cancellation of Claim(s)
ATTN: Certificate of Correction Branch


Example (3)
P.O. Box 1450


To cancel an original patent claim, in writing,
Alexandria, VA 22313-1450
direct cancellation of the patent claim, e.g.,


Cancel claim 6.
Requests for Certificates of Correction will be forwarded
to the Certificate of Correction Branch of the
Office of Patent Publication, where they will be listed
in a permanent record book.


If the patent is involved in an interference, a Certificate
of Correction under 37 CFR 1.324 will not be
issued unless a corresponding motion under 37 CFR
41.121(a)(2) or 41.121(a)(3) has been granted by the
administrative patent judge. Otherwise, determination
as to whether an error has been made, the responsibility
for the error, if any, and whether the error is of
such a nature as to justify the issuance of a Certificate
of Correction will be made by the Certificate of Correction
Branch. If a report is necessary in making such
determination, the case will be forwarded to the
appropriate group with a request that the report be furnished.
If no certificate is to issue, the party making
the request is so notified and the request, report, if
any, and copy of the communication to the person
making the request are placed in the file wrapper (for
a paper file) or entered into the file history (for an
IFW file), and entered into the “Contents” for the file
by the Certificate of Correction Branch. The case is
then returned to the patented files. If a certificate is to
issue, it will be prepared and forwarded to the person
making the request by the Office of Patent Publication.
In that case, the request, the report, if any, and a
copy of the letter transmitting the Certificate of Correction
to the person making the request will be
placed in the file wrapper (for a paper file) or entered
into the file history (for an IFW file), and entered into
the “Contents” for the file.


Applicants, or their attorneys or agents, are urged to
submit the text of the correction on a special Certificate
of Correction form, PTO/SB/44 (also referred to
as Form PTO-1050), which can serve as the camera
copy for use in direct offset printing of the Certificate
of Correction.


Where only a part of a request can be approved, or
where the Office discovers and includes additional
corrections, the appropriate alterations are made on
the form PTO/SB/44 by the Office. The patentee is
notified of the changes on the Notification of
Approval-in-part form PTOL-404. The certificate is
issued approximately 6 weeks thereafter.


Form PTO/SB/44 should be used exclusively
regardless of the length or complexity of the subject
matter. Intricate chemical formulas or page of specification
or drawings may be reproduced and mounted
on a blank copy of PTO/SB/44. Failure to use the
form has frequently delayed issuance since the
text
must be retyped by the Office onto a PTO/SB/44.


Example (4)
The exact page and line number where the errors
occur in the application file should be identified on
the request. However, on form PTO/SB/44, only the
column and line number in the printed patent should
be used.


To cancel a new claim (previously added in the  
The patent grant should be retained by the patentee.
reissue), in writing, direct cancellation of the new
The Office does not attach the Certificate of Correction
claim, e.g.,
to patentee’s copy of the patent. The patent grant
will be returned to the patentee if submitted.


Cancel claim 15.
Below is a sample form illustrating a variety of corrections
and the suggested manner of setting out the
format. Particular attention is directed to:


C.Presentation of New Claims
(A)Identification of the exact point of error by
reference to column and line number of the printed
patent for changes in the specification or to claim
number and line where a claim is involved.


Example (5)  
(B)Conservation of space on the form by typing
single space, beginning two lines down from the
printed message.


Each new claim (i.e., a claim not found in the  
(C)Starting the correction to each separate column
patent, that is newly presented in the reissue application)  
as a sentence, and using semicolons to separate
should be presented with underlining
corrections within the same column, where possible.
throughout the claim, e.g.,
 
(D)Leaving a two-inch space blank at bottom of
the last sheet for the signature of the attesting officer.


Add claim 7 as follows:
(E)Using quotation marks to enclose the exact
subject matter to be deleted or corrected; using double
hyphens (-- --) to enclose subject matter to be added,
except for formulas.


Claim 7. The apparatus of claim 5 further comprising
(F)Where a formula is involved, setting out
electrodes attaching to said opposite faces of the first and
only
second piezoelectric elements.
that portion thereof which is to be corrected or,
if
necessary, pasting a photocopy onto form PTO/SB/
44.


Even though original claims may have been canceled,
ELECTRONIC PUBLICATION OF CERTIFICATES
the numbering of the original claims does
OF CORRECTION WITH LATER LISTING
not change. Accordingly, any added claims are
IN THE OFFICIAL GAZETTE
numbered beginning with the number next higher
than the number of claims in the original patent. If
new claims have been added to the reissue application
which are later canceled prior to issuance of
the reissue patent, the examiner will renumber any
remaining new claims in numerical order to follow
the number of claims in the original patent.


D.Amendment of New Claims
Effective August 2001, the U.S. Patent and Trademark
Office (USPTO) publishes on the USPTO web
site at http://www.uspto.gov/web/patents/certofcorrect
a listing by patent number of the patents for
which certificates of correction are being issued.


An amendment of a “new claim” (i.e., a claim not
The USPTO is now automating the publication
found in the patent, that was previously presented
process for certificates of correction. This new process
in
will result in certificates of correction being published
the reissue application) must be done by presenting
quicker electronically on the USPTO’s web site
the amended “new claim” containing the amendatory
as compared to their paper publication and the listing
material, and completely underlining the claim. The
of the certificates of correction in the Official Gazette.  
presentation cannot contain any bracketing or other
Under the newly automated process, each issue of certificates
indication of what was in the previous version of  
of correction will be electronically published
the  
on the USPTO web site at http://www.uspto.gov/web/
claim. This is because all changes in the
patents/certofcorrect, and will also subsequently be
reissue
listed in the Official Gazette (and in the Official
are
Gazette Notices posted at http://www.uspto.gov/web/
made vis-à-vis the original patent, and not
offices/com/sol/og) approximately three weeks thereafter.  
in comparison to the prior amendment. Although the
The listing of certificates of correction in the  
presentation of the amended claim does not contain
Official Gazette will include the certificate’s date of  
any indication of  
issuance.  
what is changed from the previous
version of the claim,
applicant must point out what is
changed in the “Remarks” portion of the amendment.  
Also, per 37 CFR 1.173(c), each change made in the
claim must be accompanied by an explanation of the  
support in the disclosure of the patent for the change.


E.Amendment of Original Patent Claims More
On the date on which the listing of certificates of
Than Once
correction is electronically published on the USPTO
web site: (A) the certificate of correction will be
entered into the file wrapper of a paper-file patent, or
entered into the file history of an IFW-file patent and
will be available to the public; (B) a printed copy of
the certificate of correction will be mailed to the patentee
or the patent’s assignee; and (C) an image of the
printed certificate of correction will be added to the
image of the patent on the patent database at http://
www.uspto.gov.patft. Dissemination of all other paper
copies of the certificate of correction will occur
shortly thereafter.


The following illustrates proper claim amendment
The date on which the USPTO makes the certificate
of original patent claims in reissue applications:
of correction available to the public (e.g., by adding
the certificate of correction to the file wrapper/file
history) will be regarded as the date of issuance of the
certificate of correction, not the date of the certificate
of correction appearing in the Official Gazette. (For
IFW processing, see IFW Manual.) Certificates of
correction published in the above-described manner
will provide the public with prompt notice and access,
and this is consistent with the legislative intent behind
the American Inventors Protection Act of 1999. See


A. Patent claim.  
35 U.S.C. 10(a) (authorizing the USPTO to publish in electronic form).
 
Claim 1. A cutting means having a handle portion
and a blade portion.
 
B. Proper first amendment format.
 
Claim 1 (Amended). A [cutting means] knife having
a bone handle portion and a notched blade portion.


The listing of certificates of correction can be electronically
accessed on the day of issuance at http://
www.uspto.gov/web/patents/certofcorrect. The electronic
image of the printed certificate of correction
can be accessed on the patent database at http://
www.uspto.gov/patft and the listing of the certificates
of correction, as published in the Official Gazettethree weeks later, will be electronically accessible at
http://www.uspto.gov/web/offices/com/sol/og.


C. Proper second amendment format.
==1490 Disclaimers==


Claim 1 (Twice Amended). A [cutting means]
35 U.S.C. 253. Disclaimer.
knife having a handle portion and a serrated blade
portion.


Note that the second amendment must include the  
Whenever, without any deceptive intention, a claim of a patent
changes previously presented in the first amendment,  
is invalid the remaining claims shall not thereby be rendered
i.e., [cutting means] knife, as well as the new changes
invalid. A patentee, whether of the whole or any sectional interest
presented in the second amendment, i.e., serrated.  
therein, may, on payment of the fee required by law, make disclaimer
of any complete claim, stating therein the extent of his
interest in such patent. Such disclaimer shall be in writing, and
recorded in the Patent and Trademark Office; and it shall thereafter
be considered as part of the original patent to the extent of the  
interest possessed by the disclaimant and by those claiming under
him.


The word bone was presented in the first amendment
In like manner any patentee or applicant may disclaim or dedicate
and is now to be deleted in the second amendment.
to the public the entire term, or any terminal part of the term,  
The word “bone” is NOT to be shown in
of the patent granted or to be granted.
brackets in the second amendment. Rather, the word
“bone” is simply omitted from the claim, since “bone”
never appeared in the patent. An explanation of the
deletion should appear in the remarks.


The word notched which was presented in the first
37 CFR 1.321. Statutory disclaimers, including terminal
amendment is replaced by the word serrated in the
disclaimers.
second amendment. The word notched is being
deleted in the second amendment and did not appear
in the patent; accordingly, “notched” is not shown in
any form in the claim. The word serrated is being
added in the second amendment, and accordingly
“serrated” is added to the claim and is underlined.


In the second amendment, the deletions of  
(a)A patentee owning the whole or any sectional interest in
“notched” and “bone” are not changes from the original
a patent may disclaim any complete claim or claims in a patent. In  
patent claim text and therefore are not shown in
like manner any patentee may disclaim or dedicate to the public
brackets in the second amendment. In both the first
the entire term, or any terminal part of the term, of the patent
and the second amendments, the entire claim is presented
granted. Such disclaimer is binding upon the grantee and its successors
only with the changes from the original patent
or assigns. A notice of the disclaimer is published in the  
text.
Official Gazette and attached to the printed copies of the specification.
The disclaimer, to be recorded in the Patent and Trademark
Office, must:


VI.ADDITIONAL EXAMPLES
(1)be signed by the patentee, or an attorney or agent of
record;


(A)For a reissue application, where the patent  
(2)identify the patent and complete claim or claims, or
was previously reissued:
term being disclaimed. A disclaimer which is not a disclaimer of a
complete claim or claims, or term, will be refused recordation;


As per MPEP § 1411, double underlining and
(3)state the present extent of patentee’s ownership interest
double bracketing are used in the second reissue
in the patent; and


(4)be accompanied by the fee set forth in § 1.20(d).


(b)An applicant or assignee may disclaim or dedicate to the
public the entire term, or any terminal part of the term, of a patent
to be granted. Such terminal disclaimer is binding upon the
grantee and its successors or assigns. The terminal disclaimer, to
be recorded in the Patent and Trademark Office, must:


(1)be signed:


(i)by the applicant, or


application to show amendments made relative to the  
(ii)if there is an assignee of record of an undivided
first reissued patent
part interest, by the applicant and such assignee, or


(B)For a reissue application, where the patent
(iii)if there is an assignee of record of the entire interest,  
was previously reexamined and a reexamination certificate
by such assignee, or
has issued for the patent:


An amendment in the reissue application must be
(iv)by an attorney or agent of record;
presented as if the changes made to the original patent
text via the reexamination certificate are a part of the
original patent. Thus, all italicized text of the reexamination
certificate is presented in the amendment
(made in the reissue application) without italics. Further,
any text found in brackets in the reexamination
certificate is omitted in the amendment (made in the
reissue application).


(C)For a reissue application, where a certificate
(2)specify the portion of the term of the patent being disclaimed;
of correction has issued for the patent:
 
An amendment in the reissue application must be
presented as if the changes made to the original patent
text via the certificate of correction are a part of the  
original patent. Thus, all text added by certificate of
correction is presented in the amendment (made in the
reissue application) without italics. Further, any text
deleted by certificate of correction is entirely omitted
in the amendment (made in the reissue application).


(D)For a reissue application, where a statutory
disclaimer has issued for the patent:


Any claim statutorily disclaimed is no longer in  
(3)state the present extent of applicant’s or assignee’s
the patent, and such a claim cannot be amended. The
ownership interest in the patent to be granted; and  
statutorily disclaimed claim(s) should be lined
through, and not surrounded by brackets.


1454Appeal Brief [R-3]
(4)be accompanied by the fee set forth in § 1.20(d).


The requirements for an appeal brief are set forth in
(c)A terminal disclaimer, when filed to obviate judicially
37
created double patenting in a patent application or in a reexamination
CFR 41.37 and MPEP § 1206, and they apply
proceeding except as provided for in paragraph (d) of this
to a reissue application in the same manner that they
section, must:
apply to a non-reissue application. There is, however,
a difference in practice as to presentation of the copy
of the claims in the appeal brief for a reissue application.
The claims on appeal presented in an appeal
brief for a reissue application should include all
underlining and bracketing necessary to reflect the
changes made to the patent claims during the prosecution
of the reissue application. In addition, any new
claims added in the reissue application should be
completely underlined.


1455Allowance and Issue [R-3]
(1)Comply with the provisions of paragraphs (b)(2)
through (b)(4) of this section;


(2)Be signed in accordance with paragraph (b)(1) of this
section if filed in a patent application or in accordance with paragraph
(a)(1) of this section if filed in a reexamination proceeding;
and


(3)Include a provision that any patent granted on that
application or any patent subject to the reexamination proceeding
shall be enforceable only for and during such period that said
patent is commonly owned with the application or patent which
formed the basis for the judicially created double patenting.


I.ISSUE CLASSIFICATION SHEET
(d)A terminal disclaimer, when filed in a patent application
or in a reexamination proceeding to obviate double patenting
based upon a patent or application that is not commonly owned
but was disqualified under 35 U.S.C. 103(c) as resulting from
activities undertaken within the scope of a joint research agreement,
must:


For IFW reissue applications:
(1)Comply with the provisions of paragraphs (b)(2)
through (b)(4) of this section;


The examiner completes the Issue Classification
(2)Be signed in accordance with paragraph (b)(1) of this
sheet in the same manner as for a non-reissue application.
section if filed in a patent application or be signed in accordance
In addition, a copy of the “Final SPRE Review”
with paragraph (a)(1) of this section if filed in a reexamination
form must also be completed.
proceeding;


For reissue application files that are maintained in
(3)Include a provision waiving the right to separately
paper:
enforce any patent granted on that application or any patent subject
to the reexamination proceeding and the patent or any patent
granted on the application which formed the basis for the double
patenting, and that any patent granted on that application or any
patent subject to the reexamination proceeding shall be enforceable
only for and during such period that said patent and the
patent, or any patent granted on the application, which formed the
basis for the double patenting are not separately enforced.


In all reissue applications prepared for issue where
A disclaimer is a statement filed by an owner (in
a blue slip is needed (i.e., 08/ and earlier series), the  
part or in entirety) of a patent or of a patent to be
patent number of the original patent which is being
granted (i.e., an application), in which said owner
reissued should be placed in the box provided therefor
relinquishes certain legal rights to the patent. There
below the box for the applicant’s name on the blue
are two types of disclaimers: a statutory disclaimer
Issue Classification Slip (form PTO-270) or design
and a terminal disclaimer. The owner of a patent or an
Issue Classification Slip (form PTO-328). Otherwise,
application is the original inventor(s) or the assignee
the Issue Classification Slip is prepared in the same
of the original inventor(s). The patent or application is
manner as for a non-reissue application.
assigned by one assignment or by multiple assignments
 
which establish a chain of title from the inventor(
For 09/ and later series applications, the patent
s) to the assignee(s). The owner of the patent or
number of the original patent which is being reissued
application can sign a disclaimer, and a person
should be placed on the face of the file wrapper above
empowered by the owner to sign the disclaimer can
the box “PREPARED AND APPROVED FOR
also sign it. Per 37 CFR 1.321(b)(1)(iv), an attorney
ISSUE” just after “(Exr. Initials)” in the line reading
or agent of record is permitted to sign the disclaimer.  
“SURRENDER OF ORIGINAL PATENT________
A registered practitioner acting in a representative
(Exr. Initials).
capacity under 37 CFR 1.34 is not permitted to sign
 
the disclaimer. For a disclaimer to be accepted, it must
 
be signed by the proper party as follows:
 
II. CHANGES TO THE ORIGINAL
PATENT


The specifications of reissue patents will be printed
(A)A disclaimer filed in an application must be  
in such a manner as to show the changes over the
signed by
original patent text by enclosing any material omitted
by the reissue in heavy brackets [ ] and printing material
added by the
reissue in italics. 37 CFR 1.173 (see
MPEP § 1411) requires the specification of a reissue
application to be presented in a specified form, specifically
designed to facilitate this different manner of
printing, as well as for other reasons.


The printed reissue patent specification will carry
(1)the applicant where the application has not
the following heading, which will be added by the  
been assigned,
Publishing Division of the Office of Patent Publication:


(2)the applicant and the assignee where each
owns a part interest in the application,


“Matter enclosed in heavy brackets [ ] appears in the original
(3)the assignee where assignee owns the  
patent but forms no part of this reissue specification;
entire interest in the application, or
matter printed in italics indicates the additions made by
reissue.”


The examiners should see that the specification is
(4)an attorney or agent of record.
in proper form for printing. Examiners should care


(B)A disclaimer filed in a patent or a reexamination
proceeding must be signed by either


(1)the patentee (the assignee, the inventor(s) if
the patent is not assigned, or the assignee and the
inventors if the patent is assigned-in-part), or


(2)an attorney or agent of record.


(C)Where the assignee (of an application or of a
patent being reexamined or to be reissued) signs the
disclaimer, there is a requirement to comply with
37
CFR 3.73(b) in order to satisfy 37 CFR 1.321,
unless an attorney or agent of record signs the disclaimer.
In order to comply with 37 CFR 3.73(b), the
assignee’s ownership interest must be established by:


(1)filing in the application or patent evidence
of a chain of title from the original owner to the
assignee and a statement affirming that the documentary
evidence of the chain of title from the original
owner to the assignee was, or concurrently is
being, submitted for recordation pursuant to 37 CFR
3.11, or


fully check the entry of all amendments to ensure that
(2)specifying in the record of the application
the changes directed by applicant will be accurately
or patent where such evidence is recorded in the  
printed in any reissue patent that may ultimately issue.
Office (e.g., reel and frame number, etc.).  
Matter appearing in the original patent which is omitted
by reissue should be enclosed in brackets, while
matter added by reissue should be underlined.  


Any material added by amendment in the reissue
The submission with respect to 37 CFR 3.73(b)
application (as underlined text) which is later canceled
to establish ownership must be signed by a party
should be crossed through, and not bracketed.
authorized to act on behalf of the assignee. See also
Material cancelled from the original patent should be
MPEP § 324 as to compliance with 37 CFR 3.73(b).
enclosed in brackets, and not lined through.
A copy of the “Statement Under 37 CFR 3.73 (b),”
which is reproduced in MPEP § 324, may be sent by
the examiner to applicant to provide an acceptable
way to comply with the requirements of 37 CFR 3.73(b).  


All the claims of the original patent should appear
(D)Where the attorney or agent of record signs
in the reissue patent, with canceled patent claims
the disclaimer, there is no need to comply with  
being enclosed in brackets.
37
CFR 3.73(b).


(E)The signature on the disclaimer need not be
an original signature. Pursuant to 37 CFR
1.4(d)(1)(ii), the submitted disclaimer can be a copy,
such as a photocopy or facsimile transmission of an
original disclaimer.


I.STATUTORY DISCLAIMERS


III. CLAIM NUMBERING
Under 37 CFR 1.321(a) the owner of a patent may
disclaim a complete claim or claims of his or her
patent. This may result from a lawsuit or because he
or she has reason to believe that the claim or claims
are too broad or otherwise invalid. If the patent is
involved in an interference, see 37 CFR 41.121(a).


No renumbering of the original patent claims is permitted,
As noted above, a statutory disclaimer is a statement
even if the dependency of a dependent patent  
in which a patent owner relinquishes legal rights
claim is changed by reissue so that it is to be dependent
to one or more claims of a patent. A statutory disclaimer
on a subsequent higher numbered claim.
is not, however, a vehicle for adding or
amending claims, since there is no provision for such
in the statute (35 U.S.C. 253) nor the rules (37 CFR
1.321). Thus, claims of a patent cannot be disclaimed
in favor of new claims to be added to the patent or an
amendment to existing claims.


When a dependent claim in a reissue application
II.TERMINAL DISCLAIMERS
depends upon a claim which has been canceled, and
the dependent claim is not thereafter made dependent
upon a pending claim, such a dependent claim must
be rewritten in independent form.


New claims added during the prosecution of the
37 CFR 1.321(a) also provides for the filing by an
reissue application should follow the number of the
applicant or patentee of a terminal disclaimer which
highest numbered patent claim and should be completely
disclaims or dedicates to the public the entire term or  
underlined to indicate they are to be printed in
any portion of the term of a patent or patent to be  
italics on the printed patent. Often, as a result of the
granted.
prosecution and examination, some new claims are
canceled while other new claims remain. When the
reissue application is allowed, any claims remaining
which are additional to the patent claims (i.e., claims
added via the reissue application) should be renumbered
in sequence starting with the number next
higher than the number of the last claim in the original
patent (the printed patent). Therefore, the number of
claims allowed will not necessarily correspond to the  
number of the last claim in the reissue application, as
allowed. The number of claims appearing in the
“Total Claims Allowed” box on the Issue Classification
sheet (or for reissue application files that are
maintained in paper, the “CLAIMS ALLOWED -
Total Claims” box on the lower right of the file wrapper
face) at the time of allowance should be consistent
with the number of claims indicated as allowable
on the Notice of Allowability (Form PTOL-37).  


37 CFR 1.321(c) specifically provides for the filing
of a terminal disclaimer in an application or a reexamination
proceeding for the purpose of overcoming
a
nonstatutory double patenting rejection. See MPEP
§ 804.02.


37 CFR 1.321(d) specifically provides for the filing
of a terminal disclaimer in an application or a reexamination
proceeding for the purpose of overcoming a
nonstatutory double patenting rejection based on a
U.S. patent or application that is not commonly
owned but was disqualified under 35 U.S.C. 103(c).


IV. CLAIM DESIGNATED FOR PRINTING
III.PROCESSING


At least one claim of an allowable reissue application
Certificate of Correction Branch
must be designated for printing in the Official
Gazette. Whenever at least one claim has been
amended or added in the reissue, the claim (claims)
designated for printing must be (or include) a claim
which has been changed or added by the reissue. A
canceled claim is not to be designated as the claim for
the Official Gazette.


If there is no change in the claims of the allowable
The Certificate of Correction Branch is responsible
reissue application (i.e., when they are the same as the
for the handling of all statutory disclaimers filed
claims of the original patent) or, if the only change in
under the first paragraph of 35 U.S.C. 253, whether
the claims is the cancellation of claims, then the most
the case is pending or patented, and all terminal disclaimers
representative pending allowed claim is designated
(filed under the second paragraph of  
for printing in the Official Gazette.
35
U.S.C. 253) except for those filed in an application
or reexamination proceeding pending in a Technology
Center (TC). This involves:


(A)Determining the compliance of the disclaimer
with 35 U.S.C. 253 and 37 CFR 1.321 and 3.73;


(B)Notifying applicant or patentee when the disclaimer
is informal and thus not acceptable;


V. PROVIDING PROPER FORMAT
(C)Recording the disclaimers in the record of the
application file; and


Where a reissue application has not been prepared
(D)Providing the disclaimer data for printing in  
in the above-indicated manner, the examiner may
the Official Gazette.
obtain from the applicant a clean copy of the reissue
specification prepared in the indicated form, or a
proper submission of a previously improperly submitted
amendment. However, if the deletions from the
original patent are small, the reissue application can
be prepared for issue by putting the bracketed inserts
at the appropriate places and suitably numbering the
added claims.  


When applicant submits a clean copy of the reissue
IV.TERMINAL DISCLAIMER IN PENDING APPLICATION PRACTICE IN THE TECHNOLOGY CENTERS
specification, or a proper submission of a previous
improper amendment, a supplemental reissue declaration
should not be provided to address this submission,
because the correction of format does not correct
a 35 U.S.C. 251 error in the patent.  


Where a terminal disclaimer is filed in an application
pending in a TC, it will be processed by the paralegal
of the Office of the Special Program Examiner
of the TC having responsibility for the application.
The paralegal will:


(A)Determine compliance with 35 U.S.C. 253and 37
CFR 1.321 and 3.73, and ensure that the
appropriate terminal disclaimer fee set forth in
37
CFR 1.20(d) is/was applied;


VI. PARENT APPLICATION DATA
(B)Notify the examiner having charge of the
application whether the terminal disclaimer is acceptable
or not;


All parent application data on the bibliographic
(C)Where the terminal disclaimer is not acceptable,
data sheet of the original patent file (or front face of
indicate the nature of the informalities so that the
the original patent file wrapper if the original patent is
examiner can inform applicant in the next Office
a paper file) should be present on the bibliographic
action. For an IFW application, complete the IFW terminal
data sheet of the reissue application.
disclaimer form by checking the “Disapproved”
box and have the form scanned into IFW;


It sometimes happens that the reissue is a continuation
(D)Where the terminal disclaimer is acceptable,
of another reissue application, and there is also
record the terminal disclaimer in the record of the
application as set forth below.


The paralegal will record an acceptable terminal
disclaimer as being present in an application by:


For IFW applications:


(A)Completing the IFW terminal disclaimer form
by checking the “Approved” box and having the form
scanned into IFW; and


(B)Entering the terminal disclaimer into PALM
for the application.


original-patent parent application data. The examiner
For application files that are maintained in paper:
should ensure that the parent application data on the
original patent is properly combined with the parent
application data of the reissue, in the text of the specification
and on the bibliographic data sheet (or
on the front face of the reissue file wrapper for 08/
and earlier series applications).  The combined
statement as to parent application data should be
checked carefully for proper bracketing and underlining.


For paper applications with 08/ and earlier series
code


(A)Attaching a green label to the file wrapper;


(B)Stamping a notice on the file of the term
which has been disclaimed (note that the blanks on
the stamped notice for entering information on the
patent(s) being disclaimed are no longer filled in);


VII. REFERENCES CITED AND PRINTED
(C)Endorsing the paper containing the terminal
disclaimer submission on the “Contents” flap of the
application file; and


The list of references to be printed in the reissue
(D)Entering the terminal disclaimer into the  
patent includes all the references cited during the  
PALM system records, for the application.
prosecution of the reissue application. It is noted that
the Office will not print in the reissue patent “References
Cited” section any reference cited in the patent
but not again cited in the reissue application. A patent
cannot be reissued solely for the purpose of adding
citations of additional prior art.


For paper applications with 09/ and later series
code


(A)Checking a box on the file wrapper which
states that the terminal disclaimer has been filed (Any
blanks for entering information on the patent(s) being
disclaimed are no longer filled in. Note that applications
with 10/ and later series codes no longer have
such blanks to complete);


VIII. EXAMINER'S AMENDMENT AND SUP-
(B)Endorsing the paper containing the terminal
PLEMENTAL DECLARATION
disclaimer submission on the “Contents” flap of the
application file; and


When it is necessary to amend the reissue application
(C)Entering the terminal disclaimer into the  
in order to place the application in condition for
PALM system records, for the application.
allowance, the examiner may:


(A)request that applicant provide the amendments
The paralegal completes a Terminal Disclaimer
(e.g., by facsimile transmission or by hand-
Informal Memo to notify the examiner of the nature
carry); or
of any informalities in the terminal disclaimer. The
 
examiner should notify the applicant of the informalities
(B)make the amendments, with the applicant’s
in the next Office action, or by interview with
approval, by a formal examiner’s amendment.
applicant if such will expedite prosecution of the  
 
application. Further, the examiner should initial and
If the changes are made by a formal examiner’s
date the Terminal Disclaimer Informal Memo and
amendment, the entire paragraph(s) or claim(s) being
return it to the paralegal to indicate that the examiner
amended need not be presented in rewritten form for
has appropriately notified applicant about the terminal
any deletions or additions. Changes to the specification
disclaimer. The paralegal will then discard the Terminal
including the claims of an application made by
Disclaimer Informal Memo.
the Office in an examiner’s amendment may be made
by specific instructions to insert or delete subject matter
set forth in the examiner’s amendment by identifying
the precise point in the specification or the
claim(s) where the insertion or deletion is to be made.
37 CFR 1.121(g).


If it is necessary to amend a claim or the specification
V.OTHER MATTERS DIRECTED TO TERMINAL DISCLAIMERS
in order to correct an “error” under 35 U.S.C. 251and thereby place the application in condition for
allowance, then a supplemental oath or declaration
will be required. See MPEP § 1444. The examiner
should telephone applicant and request the supplemental
oath or declaration, which must be filed before
the application can be counted as an allowance.


A.Requirements of Terminal Disclaimers


A proper terminal disclaimer must disclaim the terminal
part of the statutory term of any patent granted
on the application being examined which would
extend beyond the expiration date of the full statutory
term, shortened by any terminal disclaimer, of the
patent (or of any patent granted on the application) to
which the disclaimer is directed. Note the exculpatory
language in the second paragraph of the sample terminal
disclaimer forms, PTO/SB/25 and PTO/SB/26,
provided at the end of this Chapter. That language
(“In making the above disclaimer, the owner does not
disclaim...”) is permissible in a terminal disclaimer.


IX. FINAL REVIEW OF THE REISSUE
A terminal disclaimer filed to obviate a nonstatutory
APPLICATION BY THE EXAMINER
double patenting rejection based on a commonly
owned patent or application must comply with the
requirements of 37 CFR 1.321(c). The terminal disclaimer
must state that any patent granted on the
application being examined will be enforceable only
for and during the period that it and the patent to
which the disclaimer is directed or the patent granted
on the application to which the disclaimer is directed
are commonly owned. See MPEP § 706.02(1)(2) for
examples of common ownership, or lack thereof.


Prior to forwarding a reissue application to the  
A terminal disclaimer filed to obviate a nonstatutory
Technology Center (TC) Special Program Examiner
double patenting rejection based on a non-commonly
(SPRE) for final review, the examiner should complete
owned patent or application disqualified under
and initial an Examiner Reissue Checklist. A
35 U.S.C. 103(c) as a result of activities undertaken
copy of the checklist should be available from the
within the scope of a joint research agreement under
SPRE or from the Paralegal Specialist of the TC.
35 U.S.C. 103(c)(2) and (3) must comply with 37
CFR 1.321(d), which sets forth signature, waiver
rights and enforceability requirements.


1456Reissue Review [R-3]
The terminal disclaimer must include a provision:


All reissue applications are monitored and
(1)waiving the right to separately enforce (a) any
reviewed in the Technology Centers (TCs) by the  
patent granted on that application or the patent being
Office of TC Special Program Examiners (which
reexamined and (b) the reference patent, or any patent
includes TC SPREs, paralegals or other technical support
granted on the reference application which formed the  
who might be assigned as backup) at several
basis for the double patenting; and
stages during the prosecution. The review by the
Office of the TC SPREs is made to check that practice
and procedure unique to reissue has been carried out
for the reissue application. In addition to the SPRE
review of the reissue applications, a patentability
review is made in a sample of reissue applications by
the TC Quality Assurance Specialist (QAS) in the
manner previously carried out by the former Office of
Patent Quality Review. In order to ensure that SPREs
are aware of the reissue applications in their TCs, a
pair of terminal-specific PALM flags have been created
which must be set by the SPRE before certain
PALM transactions can be completed. First, when a
new reissue application enters the TC, a SPRE must
set a PALM “flag” by entering the reissue application  
number in an Office-wide computer grouping before a
docketing transaction will be accepted. By having to
set this first flag, the SPRE is made aware of the  
assignment of the reissue application to the TC and  
can take steps, as may be appropriate, to instruct the
examiner on reissue-specific procedures before the
examination process begins, as well as throughout the
period that the examiner is handling the reissue application.
Second, the SPRE must remove the above-
described PALM “flag” before a Notice of Allowance
can be generated or the PALM transaction for an issue


(2)agreeing that any patent granted on that application
or patent being reexamined shall be enforceable
only for and during such period that said patent
and the reference patent, or any patent granted on the
reference application, which formed the basis for the
double patenting are not separately enforced.


A terminal disclaimer must state that the agreement
is to run with any patent granted on the application
being examined and is to be binding upon the grantee,
its successors, or assigns.


A statement of assignee interest in a terminal disclaimer
that “A and B are the owners of 100% of the
instant application...” is sufficient to satisfy the
37
CFR 1.321(b)(3) requirement that a terminal disclaimer
“state the present extent of applicant’s or
assignee’s ownership interest in the patent to be
granted.” Although the quoted statement does not
identify what specific percentage is owned by A and
what specific percentage is owned by B, the statement
does provide consent to the terminal disclaimer by the
entirety of the ownership of the application (A and B
own all of the invention, regardless of the individual
percentages they own).


   
  The appropriate one of form paragraphs 14.27.04to 14.27.08 (reproduced below) may be used to provide
applicant or patent owner with an example of
acceptable terminal disclaimer language. Additionally,
copies of forms PTO/SB/25 and PTO/SB/26 (provided
at the end of this Chapter) may be attached to
the Office action to provide sample terminal disclaimers.


revision can be entered, thereby ensuring that the  
Pursuant to the last sentence of 35 U.S.C. 253, “any
SPRE is made aware of when the reissue application
patentee or applicant may disclaim or dedicate to the
is being allowed so that the SPRE may be able to conduct
public... any terminal part of the term, of the patent
a final review of the reissue application, if appropriate.
granted or to be granted”. Accordingly, the disclaimer
must be of a terminal portion of the term of the entire
patent to be granted. A disclaimer of a terminal portion
of the term of an individual claim, or individual
claims will not be accepted. It is further noted that a
disclaimer of the term of individual claims would not
be appropriate since the claims of a pending application
or proceeding are subject to cancelation, amendment,
or renumbering. The statute does not provide
for conditional disclaimers and accordingly, a proposed
disclaimer which is made contingent on the
allowance of certain claims cannot be accepted. The
disclaimer should identify the disclaimant and his or
her interest in the application and should specify the
date when the disclaimer is to become effective.


B.Effect of Disclaimers in Continuing Applications
and in Reissues


When the reissue application has been reviewed
A terminal disclaimer filed to obviate a double patenting
and is ready to be released to issue, the TC SPRE
rejection is effective only with respect to the  
should do the following:
application identified in the disclaimer unless by its
 
terms it extends to continuing applications. For example,
For IFW reissue applications:
a terminal disclaimer filed in a parent application
 
normally has no effect on a continuing application
The SPRE should complete the “Final SPRE
claiming filing date benefits of the parent application
Review” form. The SPRE will discard any informal
under 35 U.S.C. 120. A terminal disclaimer filed in a
papers that were forwarded to the SPRE, such as the
parent application to obviate a double patenting rejection
informal Reissue Check List that was filled out by the
does, however, carry over to a continued prosecution
examiner. The SPRE will then forward (message) the
application (CPA) filed under 37 CFR 1.53(d)
reissue file to the Office of Patent Legal Administration
(effective July 14, 2003, CPAs are only available in
(OPLA). The file for any original paper patent
design applications). The terminal disclaimer filed in
should be forwarded to OPLA.
the parent application carries over because the CPA
 
retains the same application number as the parent
For reissue application files that are maintained in
application, i.e., the application number to which the
paper:
previously filed terminal disclaimer is directed. If
 
applicant does not want the terminal disclaimer to
The SPRE should initial the face of the file wrapper,
carry over to the CPA, applicant must file a petition
and forward the reissue file to  OPLA.
under 37 CFR 1.182, along with the required petition
Along with the reissue file, the file for the original
fee, requesting the terminal disclaimer filed in the parent
patent should be forwarded to OPLA.
application not be carried over to the CPA; see
 
below “Withdrawing a Terminal Disclaimer” (paragraph
After leaving the TC, all reissue applications go
“A. Before Issuance of Patent”). If applicant
through a screening process which is currently performed
files a Request for Continued Examination (RCE) of  
in OPLA. The screening process which
an application under 37 CFR 1.114 (which can be
includes review of the reissue oath or declaration for
filed on or after May 29, 2000 for an application filed
compliance with 37 CFR 1.175, review of the presentation
on or after June 8, 1995), any terminal disclaimer
and entry of reissue amendments for compliance
present will continue to operate, since a new application
with 37 CFR 1.173(b), and review of other
has not been filed, but rather prosecution has
matters to ensure adherence to current reissue practices.
been continued in the existing application. A petition
The above identified review processes are
under 37 CFR 1.182, along with the required petition
appropriate vehicles for correcting errors, identifying
fee, may be filed, if withdrawal of the terminal disclaimer
problem areas and recognizing trends, providing
is to be requested.  
information on the uniformity of practice, and providing
 
feedback to the TC personnel responsible for processing
Reissue applications: Where a terminal disclaimer
and examining reissue applications.
was filed in an original application, a copy of that terminal
 
disclaimer is not required be filed by applicant
1457Design Reissue Applications and
in the reissue.  
Patents [R-3]
 
A reissue application can be filed for a design
patent in the same manner that a reissue application is
filed for a utility patent. There are, however, a few
aspects of a design reissue application that are
addressed as follows:


I.EXPEDITED EXAMINATION PROCE-
For reissue application files that are maintained in
DURE
paper:


Design reissue applications requesting expedited
The face of the file wrapper of the reissue application
examination and complying with the requirements of  
should, however, be marked by the examiner in
37 CFR 1.155 are examined with priority and undergo
order to indicate that a terminal disclaimer has been
expedited processing throughout the entire course of
filed for the patent (and will be effective for the patent
prosecution in the Office, including appeal, if any, to  
as it will be reissued). Further, a copy of the terminal
the Board of Patent Appeals and Interferences. All
disclaimer should be placed in the reissue application
processing is expedited from the date the request is
file by the Technology Center.  
granted.


Design reissue applicants seeking expedited examination
For IFW reissue applications:
may file a design reissue application in the
Office together with a corresponding request under 37
CFR 1.155 pursuant to the guidelines set forth in
MPEP § 1504.30.


The design reissue application and the request are
The “Final SPRE Review” form will be filled in to  
processed by the Office of Initial Patent Examination
indicate that a terminal disclaimer has been filed for  
(OIPE). OIPE enters the appropriate information
the patent (and will be effective for the patent as it
into PALM specifying when notice of the design
will be reissued). Further, a copy of the terminal disclaimer
reissue application will be published in the Official
should be scanned into the reissue application  
Gazette (see MPEP § 1441).  After processing in
file history by the Technology Center.
OIPE, the design reissue application and the request
are forwarded to the Design TC Director’s Office.
Upon a decision by the Design TC Director to grant
the request for expedited examination, fees are immediately
processed, and the application papers are
promptly assigned an application number. The design
reissue application file is then forwarded to the Office
of Patent Legal Administration (OPLA) for a decision
under 37 CFR 1.182 to sua sponte waive the requirement
for delaying action in the application until 2
months after announcement of the design reissue
application filing is published in the Official Gazette(see MPEP § 1441). Once the decision under 37 CFR
1.182 is mailed, the design reissue application file
will be returned to the Design TC Director’s Office. In
accordance with the waiver, the Design Group will
begin expedited examination of the application under
37 CFR 1.155 promptly after the return of the design
reissue application file from OPLA, rather than delay
examination until after 2 months from the date the
announcement is published in the Official Gazette and
the applicant will be notified that examination is
being expedited. The decision under 37 CFR 1.182will require that no Notice of Allowance be mailed in
the design reissue application until after 2 months
from the date the announcement is published in the  
Official Gazette. For example, if the design reissue


C.Disclaimer Identifies the Wrong Target
Application or Patent


In some instances a terminal disclaimer filed to
obviate an obviousness type double patenting rejection
will identify the wrong target application or
patent (i.e., an application or patent which is not the
basis for the double patenting rejection). In these
instances, a replacement terminal disclaimer identifying
the correct target application or patent would be
required by the examiner. Once a correct replacement
terminal disclaimer is received, the next Office action
should make it clear that “the second terminal disclaimer
replaces the first terminal disclaimer, and the
first terminal disclaimer is thus void.” A second terminal
disclaimer fee should not be assessed/charged,
since the first fee is applied to the second terminal disclaimer.


D.Two or More Copending Applications


If two (or more) pending applications are filed, in
each of which a rejection of one claimed invention
over the other on the ground of provisional obviousness-
type double patenting (ODP) is proper, the ODP
rejection will be made in each application. If the ODP
rejection is the only rejection remaining in the earlier
filed of the two pending applications, (but the later-
filed application is rejectable on other grounds),
the examiner should then withdraw that rejection
and permit the earlier-filed application to issue as a
patent without a terminal disclaimer. If the ODP rejection
is the only rejection remaining in the later-filed
application, (while the earlier-filed application is
rejectable on other grounds), a terminal disclaimer
must be required in the later-filed application, before
the ODP rejection can be withdrawn.


application is allowed on the first Office action, then
If the ODP rejections in both applications are the  
jurisdiction over the reissue application will be
only rejections remaining in those applications, the  
retained in the TC, and the Notice of Allowance
examiner should then withdraw the ODP rejection in
will not be mailed until the expiration of 2 months
the earlier filed application thereby permitting that
after publication of the filing of the design reissue
application to issue without need of a terminal disclaimer.  
application in the Official Gazette (plus time for
A terminal disclaimer must be required in the  
matching any protest filed with the application). (For
later-filed application before the ODP rejection can be
IFW processing, see IFW Manual.) The examiner will
withdrawn and the application be permitted to issue.
check  the PALM contents to ascertain when publication
actually occurred. The delay in the mailing of
the Notice of Allowance is to ensure that any potential
protests complying with 37 CFR 1.291 submitted
within the 2-month delay period will be considered by
the Office. (see MPEP § 1441.01).


The expedited examination procedure under
If both applications are filed on the same day, the
37
examiner should determine which application claims
CFR 1.155 occurs through initial examination processing
the base invention and which application claims the
and throughout the entire prosecution in the  
improvement (added limitations). The ODP rejection
Office. Once a request for expedited examination is
in the base application can be withdrawn without a  
granted, prosecution of the design reissue application
terminal disclaimer, while the ODP rejection in the  
will proceed according to the procedure under
improvement application cannot be withdrawn without
37
a terminal disclaimer.
CFR 1.155, and there is no provision for “withdrawal”
from expedited examination procedure.


II.DESIGN REISSUE FEE
Where there are three applications containing
claims that conflict such that an ODP rejection is
made in each application based upon the other two, it
is not sufficient to file a terminal disclaimer in only
one of the applications addressing the other two applications.
Rather, an appropriate terminal disclaimer
must be filed in at least two of the applications to link
all three together. This is because a terminal disclaimer
filed to obviate a double patenting rejection is
effective only with respect to the application in which
the terminal disclaimer is filed; it is not effective to
link the other two applications to each other.


The design reissue application fee is set forth for in
VI. WITHDRAWING A RECORDED TERMINAL DISCLAIMER
37 CFR 1.16(e). For design reissue applications
filed on or after December 8, 2004, a search fee
(37
CFR 1.16(n)) and an examination fee (37 CFR
1.16(r)) are also required. The additional fees in
37
CFR 1.16(h) and 37 CFR 1.16(i) do not
apply for a design reissue application since more than
one claim in not permitted in a design application pursuant
to the last sentence of 37 CFR 1.153(a).


The fee for issuing a design reissue patent is set
If timely requested, a recorded terminal disclaimer
forth in 37 CFR 1.18(a).
may be withdrawn before the application in which it
is filed issues as a patent, or in a reexamination proceeding,
before the reexamination certificate issues.
After a patent or reexamination certificate issues, it is  
unlikely that a recorded terminal disclaimer will be
nullified.
 
A. Before Issuance Of Patent
 
While the filing and recordation of an unnecessary
terminal disclaimer has been characterized as an
“unhappy circumstance” in In re Jentoft, 392 F.2d
633, 157 USPQ 363 (CCPA 1968), there is no statutory
prohibition against nullifying or otherwise canceling
the effect of a recorded terminal disclaimer
which was erroneously filed before the patent issues.
Since the terminal disclaimer would not take effect
until the patent is granted, and the public has not had
the opportunity to rely on the terminal disclaimer,
relief from this unhappy circumstance may be available
by way of petition or by refiling the application
(other than by refiling it as a CPA).  


III.MULTIPLE DESIGN REISSUE APPLICATIONS
Under appropriate circumstances, consistent with
the orderly administration of the examination process, the nullification of a recorded terminal disclaimer
may be addressed by filing a petition under 37 CFR
1.182 requesting withdrawal of the recorded terminal
disclaimer. Petitions seeking to reopen the question of
the propriety of the double patenting rejection that
prompted the filing of the terminal disclaimer have
not been favorably considered. The filing of a continuing
application other than a CPA, while abandoning
the application in which the terminal disclaimer
has been filed, will typically nullify the effect of a terminal
disclaimer. The filing of a Request for Continued
Examination (RCE) of an application under
37
CFR 1.114 will not nullify the effect of a terminal
disclaimer, since a new application has not been filed,
but rather prosecution has been continued in the existing
application.


B.After Issuance Of Patent


The design reissue application can be filed based on
The mechanisms to correct a patent — Certificate
the “error” of failing to include a design for a patentably
of Correction (35 U.S.C. 255), reissue (35 U.S.C.  
distinct segregable part of the design claimed in
251), and reexamination (35 U.S.C. 305) — are not
the original patent or a patentably distinct subcombination
available to withdraw or otherwise nullify the effect
of the claimed design. A reissue design application
of a recorded terminal disclaimer. As a general principle,  
claiming both the entire article and the
public policy does not favor the restoration to the  
patentably distinct subcombination or segregable part
patent owner of something that has been freely dedicated
would be proper under 35 U.S.C. 251, if such a reissue  
to the public, particularly where the public interest
application is filed within two years of the issuance
is not protected in some manner — e.g.,
of the design patent, since it is considered a
intervening rights in the case of a reissue patent. See,
broadening of the scope of the patent claim. Restriction
e.g., Altoona Publix Theatres v. American Tri-Ergon
will be required under 37 CFR 1.176(b) in such a
Corp., 294
reissue design application, and the added design to the
U.S. 477, 24 USPQ 308 (1935).  
segregable part or subcombination will be held to be
constructively non-elected and withdrawn from consideration.  
See MPEP § 1450. In the Office action
containing the restriction requirement, the examiner
should suggest to the applicant that a divisional
design reissue application directed to the constructively
non-elected segregable part or subcombination
subject matter may be filed. The claim to the patented
design for the entire article will then be examined and,
if found allowable without change from the patent, a
rejection will be made under 35 U.S.C. 251 based on
the fact that there is no “error” in the non-amended
original patent claim. In the Office action making this
rejection, applicant should be advised that a proper
response to the rejection must include (A) a request to
suspend action in this original reissue application
pending completion of examination of a divisional
reissue application directed to the constructively non-
elected segregable part or subcombination subject
matter, (B) the filing of the divisional reissue application,
or a statement that one has already been filed
(identifying it at least by application number), and (C)
an argument that a complete response to the rejection
has been made based upon the filing of the divisional
reissue application and the request for suspension.  
Action in the original design reissue application will
then be suspended, and the divisional will be examined.


Certificates of Correction (35 U.S.C. 255) are
available for the correction of an applicant’s mistake.
The scope of this remedial provision is limited in
two
ways — by the nature of the mistake for which
correction is sought and the nature of the proposed
correction. In re Arnott, 19 USPQ2d 1049 (Comm’r
Pat. 1991). The nature of the mistake for which correction
is sought is limited to those mistakes that are:


If, after examination, the divisional design reissue
(A)of a clerical nature,  
application is also determined to be allowable, a
requirement must be made in the divisional design
reissue application to submit a petition under 37 CFR
1.183 requesting waiver of 37 CFR 1.153 in order to
permit the rejoining of the designs to the entire article
(of the original application) and the segregable part or
subcombination (of the divisional) under a single
claim into a single design reissue application for issuance,  
the single application being the first design reissue
application.


It should be noted that the filing of a design reissue
(B)of a typographical nature, or  
application would not be proper if applicant did in
fact include the design for a segregable part or subcombination
thereof in the original design patent
application, a restriction was thus made, and then
applicant failed to file a divisional reissue application


(C)of a minor character.


The nature of the proposed correction is limited to
those situations where the correction does not involve
changes which would:


(A)constitute new matter, or


(B)require reexamination.


for a non-elected invention that was canceled in view
A mistake in filing a terminal disclaimer does not
of a restriction requirement (prior to issue of the original
fall within any of the categories of mistake for which
application. See In re Watkinson, 900 F.2d 230,  
a certificate of correction of applicant’s mistake is
14
permissible, and any attempt to remove or nullify the
USPQ2d 1407 (Fed. Cir. 1990); In re Orita,
effect of the terminal disclaimer would typically
550
require reexamination of the circumstances under
F.2d 1277, 1280, 193 USPQ 145, 148 (CCPA
which it was filed.  
1977).


IV.CONVERSION TO UTILITY PATENT
Although the remedial nature of reissue (35 U.S.C. 251) is well recognized, reissue is not available to correct all errors. It has been the Office position that reissue is not available to withdraw or otherwise nullify the effect of a terminal disclaimer recorded in an issued patent. First, the reissue statute only authorizes the Director of the USPTO to reissue a patent “for the unexpired part of the term of the original patent.” Since the granting of a reissue patent without the
effect of a recorded terminal disclaimer would result
in extending the term of the original patent, reissue
under these circumstances would be contrary to the
statute. Second, the principle against recapturing
something that has been intentionally dedicated to the
public dates back to Leggett v. Avery, 101 U.S. 256
(1879). The attempt to restore that portion of the
patent term that was dedicated to the public to secure
the grant of the original patent would be contrary to
this recapture principle. Finally, applicants have the
opportunity to challenge the need for a terminal disclaimer
during the prosecution of the application that
issues as a patent. “Reissue is not a substitute for
Patent Office appeal procedures.” Ball Corp. v. United
States, 729
F.2d 1429, 1435, 221 USPQ 289, 293
(Fed. Cir. 1984). Where applicants did not challenge
the propriety of the examiner’s obvious-type double
patenting rejection, but filed a terminal disclaimer to
avoid the rejection, the filing of the terminal disclaimer
did not constitute error within the meaning of
35 U.S.C. 251. Ex parte Anthony, 230 USPQ 467 (Bd.
App. 1982), aff’d, No. 84-1357 (Fed. Cir. June 14,
1985).  


A design patent cannot be converted to a utility
Finally, the nullification of a recorded terminal disclaimer
patent via reissue.
would not be appropriate in a reexamination
 
proceeding. There is a prohibition (35 U.S.C. 305)
Converting a design patent to a utility patent will,
against enlarging the scope of a claim during a reexamination
in most instances, involve the introduction of new
proceeding. As noted by the Board in
matter into the patent. The disclosure of a design
Anthony, supra, if a terminal disclaimer was nullified,
patent is not directed to how the invention is made
“claims would be able to be sued upon for a longer
and used, and the introduction of new matter is
period than would the claims of the original patent.  
required to bridge this gap and provide support for the  
Therefore, the vertical scope, as opposed to the horizontal
utility patent. Accordingly, the examiner should consider
scope (where the subject matter is enlarged),
rejections based on the introduction of new matter  
would be enlarged.
under 35 U.S.C. 251, first paragraph, and lack of
{{MPEP Chapter|1300|1500}}
enablement and/or description under 35 U.S.C. 112,
first paragraph, when a reissue application is filed to
convert a design patent to a utility patent.
 
Further, the term of a design patent may not be  
extended by reissue. Ex parte Lawrence, 70 USPQ
326 (Comm’r Pat. 1946). Thus, any reissue application
filed to convert a design patent to a utility patent,
which conversion would thereby extend the term of
the patent, should be rejected as failing to comply
with 35 U.S.C. 251, first paragraph, which permits
reissue only “for the unexpired part of the term of the
original patent.” The statute requires that the reissued
patent shall not extend the term of the original patent.
 
1460Effect of Reissue [R-2]
 
35 U.S.C. 252. Effect of reissue.
 
The surrender of the original patent shall take effect upon the
issue of the reissued patent, and every reissued patent shall have
the same effect and operation in law, on the trial of actions for
causes thereafter arising, as if the same had been originally
granted in such amended form, but in so far as the claims of the
original and reissued patents are substantially identical, such surrender
shall not affect any action then pending nor abate any cause
of action then existing, and the reissued patent, to the extent that
its claims are substantially identical with the original patent, shall
constitute a continuation thereof and have effect continuously
from the date of the original patent.
 
A reissued patent shall not abridge or affect the right of any
person or that person’s successors in business who, prior to the
grant of a reissue, made, purchased, offered to sell, or used within
the United States, or imported into the United States, anything patented
by the reissued patent, to continue the use of, to offer to sell,
or to sell to others to be used, offered for sale, or sold, the specific
thing so made, purchased, offered for sale, used, or imported
unless the making, using, offering for sale, or selling of such thing
infringes a valid claim of the reissued patent which was in the
original patent. The court before which such matter is in question
may provide for the continued manufacture, use, offer for sale, or
sale of the thing made, purchased, offered for sale, used, or
imported as specified, or for the manufacture, use, offer for sale,
or sale in the United States of which substantial preparation was
made before the grant of the reissue, and the court may also provide
for the continued practice of any process patented by the reissue
that is practiced, or for the practice of which substantial
preparation was made, before the grant of the reissue, to the extent
and under such terms as the court deems equitable for the protection
of investments made or business commenced before the grant
of the reissue.
 
The effect of the reissue of a patent is stated in
35
U.S.C. 252. With respect to the Office treatment of
the reissued patent, the reissued patent will be viewed
as if the original patent had been originally granted in
the amended form provided by the reissue. With
respect to intervening rights resulting from the reissue
of an original patent, the second paragraph of 35
U.S.C. 252 provides for two separate and distinct
defenses to patent infringement under the doctrine of
intervening rights:
 
“Absolute” intervening rights are available for a
party that “prior to the grant of a reissue, made, purchased,
offered to sell, or used within the United
States, or imported into the United States, anything
patented by the reissued patent,” and “equitable”
intervening rights may be provided where “substantial
preparation was made before the grant of the reissue.”
See BIC Leisure Prods., Inc., v. Windsurfing Int’l,
Inc., 1 F.3d 1214, 1220, 27 USPQ2d 1671, 1676 (Fed.
Cir. 1993).
 
1470Public Access of Reissue Applications
[R-3]
 
37 CFR 1.11(b) opens all reissue applications filed
after March 1, 1977, to inspection by the general public.
37 CFR 1.11(b) also provides for announcement
of the filings of reissue applications in the Official
Gazette (except for continued prosecution applications
filed under 37 CFR 1.53(d)). This announcement
will give interested members of the public an
opportunity to submit to the examiner information
pertinent to patentability of the reissue application.
 
 
 
 
 
The filing of a continued prosecution application
under 37 CFR 1.53(d) of a reissue application will notbe announced in the Official Gazette. Although the
filing of a continued prosecution application of a reissue
application constitutes the filing of a reissue
application, the announcement of the filing of such
continued prosecution application would be redundant
in view of the announcement of the filing of the prior
reissue application in the Official Gazette.
 
37 CFR 1.11(b) is applicable to all reissue
applications filed on or after March 1, 1977. Those
reissue applications previously on file will not be
automatically open to inspection but a liberal policy
will be followed in granting petitions for access to
such applications.
 
IFW reissue application files are open to
inspection by the general public by way of Public
PAIR via the USPTO Internet site. In viewing the
images of the files, members of the public will be able
to view the entire content of the reissue application
file history. To access Public PAIR, a member of the
public would (A) go to the USPTO web site at http://
www.uspto.gov, (B) click on “Patents,” (C) under
“Check Status, View Papers…” click on “Status &
IFW,” and (D) under “Patent Application Information
Retrieval” enter the reissue application number.
 
Access to a reissue application that is maintained in
paper must be obtained from the area of the Office
having jurisdiction over the file. The following access
procedure will be observed for reissue application
files that are maintained in paper:
 
(A)Any member of the general public may
request access to a particular reissue application filed
after March 1, 1977. Since no record of such request
is intended to be kept, an oral request will suffice.
(Reissue applications already on file prior to March 1,
1977 are not automatically open to inspection, but a
liberal policy is followed by the Office of Patent
Legal Administration (OPLA) and by the Board of
Patent Appeals and Interferences in granting petitions
for access to such applications.);
 
(B)Paper reissue application files will be maintained
in the TCs and inspection thereof will be supervised
by TC personnel. A TC Director or other
appropriate Office official may, under appropriate circumstances,
postpone access to or the making of copies
of a paper reissue application file, in order, for
example, to avoid interruption of the examination or
other review of the application by an examiner. In
addition, though no general limit is placed on the
amount of time spent reviewing the files, the Office
may impose limitations, if necessary, e.g., where the
application is actively being processed;
 
(C)In any instance where the reissue application
file has left the TC for administrative processing,
requests for access should be directed to the appropriate
supervisory personnel where the application is
currently located;
 
(D)A paper reissue application file is not
available to the public once the reissue application file
has been released and forwarded by the TC for publication
of the reissue patent. This would include any
reissue application files which have been selected for
a post-allowance screening at OPLA. Unless
prosecution is reopened pursuant to the screening, the
reissue application files are not available to the public
until the reissue patent issues. This is because the reissue
application file has been put into a special format
for printing purposes and public access at this stage
would disrupt the publication process;
 
(E)Requests for copies of papers in the reissue
application file must be in writing addressed to Mail
Stop Document Services, Director of the U.S. Patent
and Trademark Office, P.O. Box 1450, Alexandria,
VA 22313-1450. Such requests may be either mailed
or delivered to the Customer Service Window. The
price for a copy of an application as filed is set forth
in 37 CFR 1.19(b)(1). Since no useful purpose is seen
for retaining such written requests for copies of
papers in reissue applications, the request(s) should be
destroyed after the order has been completed.
 
See also MPEP § 103.
 
1480Certificates of Correction — OfficeMistake [R-3]
 
35 U.S.C. 254. Certificate of correction of Patent and
Trademark Office mistake.
 
Whenever a mistake in a patent, incurred through the fault of
the Patent and Trademark Office, is clearly disclosed by the
records of the Office, the Director may issue a certificate of correction
stating the fact and nature of such mistake, under seal,
without charge, to be recorded in the records of patents. A printed
copy thereof shall be attached to each printed copy of the patent,
and such certificate shall be considered as part of the original
patent. Every such patent, together with such certificate, shall
have the same effect and operation in law on the trial of actions
for causes thereafter arising as if the same had been originally
 
 
 
 
 
issued in such corrected form. The Director may issue a corrected
patent without charge in lieu of and with like effect as a certificate
of correction.
 
37 CFR 1.322. Certificate of correction of Office mistake.
 
(a)(1) The Director may issue a certificate of correction pursuant
to 35 U.S.C. 254 to correct a mistake in a patent, incurred
through the fault of the Office, which mistake is clearly disclosed
in the records of the Office:
 
(i)At the request of the patentee or the patentee’s
assignee;
 
(ii)Acting sua sponte for mistakes that the Office discovers;
or
 
(iii)Acting on information about a mistake supplied by a
third party.
 
(2)(i) There is no obligation on the Office to act on or
respond to a submission of information or request to issue a certificate
of correction by a third party under paragraph (a)(1)(iii) of
this section.
 
(ii)Papers submitted by a third party under this section
will not be made of record in the file that they relate to nor be
retained by the Office.
 
(3)If the request relates to a patent involved in an
interference, the request must comply with the requirements of
this section and be accompanied by a motion under § 41.121(a)(2)
or § 41.121(a)(3) of this title.
 
(4)The Office will not issue a certificate of correction
under this section without first notifying the patentee (including
any assignee of record) at the correspondence address of record as
specified in § 1.33(a) and affording the patentee or an assignee an
opportunity to be heard.
 
(b)If the nature of the mistake on the part of the Office is
such that a certificate of correction is deemed inappropriate in
form, the Director may issue a corrected patent in lieu thereof as a
more appropriate form for certificate of correction, without
expense to the patentee.
 
Mistakes incurred through the fault of the Office
may be the subject of Certificates of Correction under
37 CFR 1.322. The Office, however, has discretion
under 35 U.S.C. 254 to decline to issue a Certificate
of Correction even though an Office mistake exists. If
Office mistakes are of such a nature that the meaning
intended is obvious from the context, the Office may
decline to issue a certificate and merely place the correspondence
in the patented file, where it serves to
call attention to the matter in case any question as to it
subsequently arises. Such is the case, even where a
correction is requested by the patentee or patentee’s
assignee.
 
In order to expedite all proper requests, a Certificate
of Correction should be requested only for errors
of consequence. Instead of a request for a Certificate
of Correction, letters making errors of record should
be utilized whenever possible. Thus, where errors are
of a minor typographical nature, or are readily apparent
to one skilled in the art, a letter making the error(s)
of record can be submitted in lieu of a request for a
Certificate of Correction. There is no fee for the submission
of such a letter.
 
It is strongly advised that the text of the correction
requested be submitted on a Certificate of Correction
form, PTO/SB/44 (also referred to as PTO 1050). Submission
of this form in duplicate is not necessary. The
location of the error in the printed patent should be
identified on form PTO/SB/44 by column and line
number or claim and line number. See MPEP § 1485for a discussion of the preparation and submission of
a request for a Certificate of Correction.
 
A request for a Certificate of Correction should be
addressed to:
 
ATTN: Certificate of Correction Branch
 
Commissioner for Patents
 
P.O. Box 1450
 
Alexandria, VA 22313-1450
 
 
 
I. THIRD PARTY INFORMATION ON
MISTAKES IN PATENT
 
Third parties do not have standing to demand that
the Office issue, or refuse to issue, a Certificate of
Correction. See Hallmark Cards, Inc. v. Lehman, 959
F. Supp. 539, 543-44, 42 USPQ2d 1134, 1138 (D.D.C.
1997). 37 CFR 1.322(a)(2) makes it clear that third
parties do not have standing to demand that the Office
act on, respond to, issue, or refuse to issue a Certificate
of Correction. The Office is, however, cognizant
of the need for the public to have correct information
about published patents and may therefore accept
information about mistakes in patents from third parties.
37 CFR 1.322(a)(1)(iii). Where appropriate, the
Office may issue certificates of correction based on
information supplied by third parties, whether or not
such information is accompanied by a specific request
for issuance of a Certificate of Correction.
 
While third parties are permitted to submit information
about mistakes in patents which information
will be reviewed, the Office need not act on that information
nor deny any accompanying request for issuance
of a Certificate of Correction. Accordingly, a fee
for submission of the information by a third party has
not been imposed. The Office may, however, choose
 
 
 
 
 
to issue a Certificate of Correction on its own initiative
based on the information supplied by a third
party, if it desires to do so. Regardless of whether the
third party information is acted upon, the information
will not be made of record in the file that it relates to,
nor be retained by the Office. 37 CFR 1.322(a)(2)(ii).
 
When such third party information (about mistakes
in patents) is received by the Office, the Office will
not correspond with third parties about the information
they submitted either (1) to inform the third parties
of whether it intends to issue a Certificate of
Correction, or (2) to issue a denial of any request for
issuance of a Certificate of Correction that may
accompany the information. The Office will confirm
to the party submitting such information that the
Office has in fact received the information if a
stamped, self-addressed post card has been submitted.
See MPEP § 503.
 
 
 
II. PUBLICATION IN THE OFFICIAL
GAZETTE
 
Each issue of the Official Gazette (patents section)
numerically lists all United States patents having Certificates
of Correction. The list appears under the
heading “Certificates of Correction for the week of
(date).”
 
 
 
1480.01Expedited Issuance of
Certificates of Correction -
Error Attributable to Office [R-
2]
 
In an effort to reduce the overall time required in
processing and granting Certificate of Correction
requests, the Office will expedite processing and
granting of patentee requests where such requests are
accompanied by evidence to show that the error is
attributable solely to the Office (i.e., requests filed
pursuant to 37 CFR 1.322 only).
 
The following requirements must be met for consideration
of expedited issuance of Certificates of
Correction:
 
The text of the correction requested should be submitted
on a Certificate of Correction form, PTO/SB/
44 (also referred to as PTO 1050). Submission of this
form in duplicate is not necessary. The location of the
error in the printed patent should be identified on
form PTO/SB/44 by column and line number or claim
and line number. See also MPEP § 1485.
 
Where the correction requested was incurred
through the fault of the Office, and the matter is
clearly disclosed in the records of the Office, and is
accompanied by documentation that unequivocally
supports the patentee’s assertion(s), a Certificate of
Correction will be expeditiously issued. Such supporting
documentation can consist of relevant photocopied
receipts, manuscript pages, correspondence dated
and received by the Office, photocopies of Examiners’
responses regarding entry of amendments, or any
other validation that supports the patentee’s request so
that the request can be processed without the patent
file.
 
Where only part of a request can be approved, the
appropriate modifications will be made on the form
PTO/SB/44 and the patentee then notified by mail.
Further consideration will be given to initially
rejected requests upon a request for reconsideration.
In this instance, however, or in the case where it is
determined that the Office was not responsible for the
error(s) cited by the patentee, accelerated issuance of
Certificates of Correction cannot be anticipated
(although the Office will make every effort to process
the request expeditiously).
 
As in the case of a request for a Certificate of Correction,
a Request for Expedited Issuance of Certificate
of Correction should be addressed to:
 
ATTN: Certificate of Correction Branch
 
Commissioner for Patents
 
P.O. Box 1450
 
Alexandria, VA 22313-1450
 
1481Certificates of Correction - Applicant’s
Mistake [R-3]
 
35 U.S.C. 255. Certificate of correction of applicant’s
mistake.
 
Whenever a mistake of a clerical or typographical nature, or of
minor character, which was not the fault of the Patent and Trademark
Office, appears in a patent and a showing has been made that
such mistake occurred in good faith, the Director may, upon payment
of the required fee, issue a certificate of correction, if the
correction does not involve such changes in the patent as would
constitute new matter or would require reexamination. Such
patent, together with the certificate, shall have the same effect and
operation in law on the trial of actions for causes thereafter
 
 
 
 
 
arising
as if the same had been originally issued in such corrected
form.
 
37 CFR 1.323. Certificate of correction of applicant’s
mistake.
 
The Office may issue a certificate of correction under the
conditions specified in 35 U.S.C. 255 at the request of the patentee
or the patentee’s assignee, upon payment of the fee set forth in
§ 1.20(a). If the request relates to a patent involved in an interference,
the request must comply with the requirements of this section
and be accompanied by a motion under § 41.121(a)(2) or
§
41.121(a)(3) of this title.
 
37 CFR 1.323 relates to the issuance of Certificates
of Correction for the correction of errors which were
not the fault of the Office. Mistakes in a patent which
are not correctable by Certificate of Correction may
be correctable via filing a reissue application (see
MPEP § 1401 - § 1460). See Novo Industries, L.P. v.
Micro Molds Corporation, 350 F.3d 1348,
69
USPQ2d 1128 (Fed. Cir. 2003) (The Federal Circuit
stated that when Congress in 1952 defined
USPTO authority to make corrections with prospective
effect, it did not deny correction authority to the
district courts. A court, however, can correct only if
“(1) the correction is not subject to reasonable debate
based on consideration of the claim language and the
specification and (2) the prosecution history does not
suggest a different interpretation...”).
 
In re Arnott, 19 USPQ2d 1049, 1052 (Comm’r Pat.
1991) specifies the criteria of 35 U.S.C. 255 (for a
Certificate of Correction) as follows:
 
Two separate statutory requirements must be met
before a Certificate of Correction for an applicant’s mistake
may issue. The first statutory requirement concerns
the nature, i.e., type, of the mistake for which a correction
is sought. The mistake must be:
 
(1) of a clerical nature,
 
(2) of a typographical nature, or
 
(3) a mistake of minor character.
 
The second statutory requirement concerns the nature
of the proposed correction. The correction must not
involve changes which would:
 
(1) constitute new matter or
 
(2) require reexamination.
 
If the above criteria are not satisfied, then a Certificate
of Correction for an applicant’s mistake will not issue,
and reissue must be employed as the vehicle to “correct”
the patent. Usually, any mistake affecting claim
scope must be corrected by reissue.
 
A mistake is not considered to be of the “minor”
character required for the issuance of a Certificate of
Correction if the requested change would materially
affect the scope or meaning of the patent. See also
MPEP § 1412.04 as to correction of inventorship via
certificate of correction or reissue.
 
The fee for providing a correction of applicant’s
mistake, other than inventorship, is set forth in
37
CFR 1.20(a). The fee for correction of inventorship
in a patent is set forth in 37 CFR 1.20(b).
 
 
 
1481.01Correction of Assignees’ Names[R-3]
 
 
 
The Fee(s) Transmittal Form portion (PTOL-
85B) of the Notice of Allowance provides a space
(item 3) for assignment data which should be completed
in order to comply with 37 CFR 3.81. Unless
an assignee’s name and
address are identified in the
appropriate space for
specifying the assignee, (i.e.,
item 3 of the Fee(s) Transmittal Form PTOL-
85B), the patent will issue to the applicant. Assignment
data printed on the patent will be based solely on
the information so supplied.
 
Any request for the issuance of an application
in the name of the assignee submitted after the date of
payment of the issue fee, and any request for a patent
to be corrected to state the name of the assignee must:
 
(A)state that the assignment was submitted for
recordation as set forth in 37 CFR 3.11 before issuance
of the patent;
 
(B)include a request for a certificate of correction
under 37 CFR 1.323 along with the fee set forth in
37
CFR 1.20(a); and
 
(C)include the processing fee set forth in 37 CFR
1.17(i).
 
See 37 CFR 3.81(b).
 
1481.02Correction of Inventors’ Names[R-3]
 
 
 
35 U.S.C. 256. Correction of named inventor.
 
Whenever through error a person is named in an issued patent
as the inventor, or through error an inventor is not named in an
issued patent and such error arose without any deceptive intention
on his part, the Director may, on application of all the parties and
 
 
 
 
 
assignees, with proof of the facts and such other requirements as
may be imposed, issue a certificate correcting such error.
 
The error of omitting inventors or naming persons who are not
inventors shall not invalidate the patent in which such error
occurred if it can be corrected as provided in this section. The
court before which such matter is called in question may order
correction of the patent on notice and hearing of all parties concerned
and the Director shall issue a certificate accordingly.
 
In requesting the Office to effectuate a court order
correcting inventorship in a patent pursuant to
35
U.S.C. 256, a copy of the court order and a Certificate
of Correction under 37 CFR 1.323 should be submitted
to the Certificates of Corrections Branch.
 
37 CFR 1.324. Correction of inventorship in patent,
pursuant to 35 U.S.C. 256.
 
(a)Whenever through error a person is named in an
issued patent as the inventor, or through error an inventor is not
named in an issued patent and such error arose without any deceptive
intention on his or her part, the Director, pursuant to 35
U.S.C. 256, may, on application of all the parties and assignees, or
on order of a court before which such matter is called in question,
issue a certificate naming only the actual inventor or inventors. A
petition to correct inventorship of a patent involved in an interference
must comply with the requirements of this section and must
be accompanied by a motion under § 41.121(a)(2) or §
41.121(a)(3) of this title.
 
(b)Any request to correct inventorship of a patent pursuant
to paragraph (a) of this section must be accompanied by:
 
(1)Where one or more persons are being added, a statement
from each person who is being added as an inventor that the
inventorship error occurred without any deceptive intention on his
or her part;
 
(2)A statement from the current named inventors who
have not submitted a statement under paragraph (b)(1) of this section
either agreeing to the change of inventorship or stating that
they have no disagreement in regard to the requested change;
 
(3)A statement from all assignees of the parties submitting
a statement under paragraphs (b)(1) and (b)(2) of this section
agreeing to the change of inventorship in the patent, which statement
must comply with the requirements of § 3.73(b) of this chapter;
and
 
(4)The fee set forth in § 1.20(b).
 
(c)For correction of inventorship in an application, see
§§ 1.48 and 1.497.
 
(d)In a contested case before the Board of Patent Appeals
and Interferences under part 41, subpart D, of this title, a request
for correction of a patent must be in the form of a motion under
§
41.121(a)(2) or § 41.121(a)(3) of this title.
 
The petition to correct inventorship under 37 CFR
1.324 must include the statements and fee required by
37 CFR 1.324(b).
 
Under 37 CFR 1.324(b)(1), a statement is required
from each person who is being added as an inventor
that the inventorship error occurred without any
deceptive intention on their part. In order to satisfy
this, a statement such as the following is sufficient:
 
“The inventorship error of failing to include John Smith
as an inventor of the patent occurred without any deceptive
intention on the part of John Smith.”
 
Nothing more is required. The examiner will determine
only whether the statement contains the required
language; the examiner will not make any commentas to whether or not it appears that there was in fact
deceptive intention (see MPEP § 2022.05).
 
Under 37 CFR 1.324(b)(2), all current inventors
who did not submit a statement under 37 CFR
1.324(b)(1) must submit a statement either agreeing to
the change of inventorship, or stating that they have
no disagreement with regard to the requested change.
“Current inventors” include the inventor(s) being
retained as such and the inventor(s) to be deleted.
These current inventors need not make a statement as
to whether the inventorship error occurred without
deceptive intention.
 
If an inventor is not available, or refuses, to submit
a statement, the assignee of the patent may wish to
consider filing a reissue application to correct inventorship,
since the inventor’s statement is not required
for a non-broadening reissue application to correct
inventorship. See MPEP § 1412.04.
 
Under 37 CFR 1.324(b)(3), a statement is required
from the assignee(s) of the patent agreeing to the
change of inventorship in the patent. The assignee
statement agreeing to the change of inventorship must
be accompanied by a proper statement under 37 CFR
3.73(b) establishing ownership, unless a proper 37
CFR 3.73(b) statement is already in the file. See
MPEP § 324 as to the requirements of a statement
under 37 CFR 3.73(b).
 
While a request under 37 CFR 1.48 is appropriate
to correct inventorship in a nonprovisional application,
a petition under 37 CFR 1.324 is the appropriate
vehicle to correct inventorship in a patent. If a request
under 37 CFR 1.48(a), (b), or (c) is inadvertently filed
in a patent, the request may be treated as a petition
under 37 CFR 1.324, and if it is grantable, form paragraph
10.14 set forth below should be used.
 
Similarly, if a request under 37 CFR 1.48(a), (b), or
(c) is filed in a pending application but not acted upon
until after the application becomes a patent, the
request may be treated as a petition under 37 CFR
 
 
 
 
 
1.324, and if it is grantable, form paragraph 10.14 set
forth below should be used.
 
The statutory basis for correction of inventorship
in a patent under 37 CFR 1.324 is 35 U.S.C. 256. It is
important to recognize that 35 U.S.C. 256 is stricter
than 35 U.S.C. 116, the statutory basis for corrections
of inventorship in applications under 37 CFR 1.48.
35
U.S.C. 256 requires “on application of all the parties
and assignees,” while 35 U.S.C. 116 does not
have the same requirement. Under 35 U.S.C. 116 and
37 CFR 1.48, waiver requests under 37 CFR 1.183may be submitted (see, e.g., MPEP § 201.03, under
the heading “Statement of Lack of Deceptive Intention”).
This is not possible under 35 U.S.C. 256 and
37 CFR 1.324. In correction of inventorship in a nonprovisional
application under 37 CFR 1.48(a), the
requirement for a statement by each originally named
inventor may be waived pursuant to 37 CFR 1.183;
however, correction of inventorship in a patent under
37 CFR 1.324 requires petition of all the parties, i.e.,
originally named inventors and assignees, in accordance
with statute (35 U.S.C. 256) and thus the
requirement cannot be waived. Correction of inventorship
requests under 37 CFR 1.324 should be
directed to the Supervisory Patent Examiner whose
unit handles the subject matter of the patent. Form
paragraphs 10.13 through 10.18 may be used.
 
¶ 10.13 Petition Under 37 CFR 1.324, Granted
 
In re Patent No. [1]:
 
Issue Date: [2]: DECISION
 
Appl. No.: [3]: GRANTING
 
Filed: [4]: PETITION
 
For: [5]: 37 CFR 1.324
 
This is a decision on the petition filed [6] to correct inventorship
under 37 CFR 1.324.
 
The petition is granted.
 
The patented file is being forwarded to Certificate of Corrections
Branch for issuance of a certificate naming only the actual
inventor or inventors.
 
_______________________
 
[7]
 
Supervisory Patent Examiner,
 
Art Unit [8],
 
Technology Center [9]
 
[10]
 
Examiner Note:
 
1.Petitions to correct inventorship of an issued patent are
decided by the Supervisory Patent Examiner, as set forth in the
Commissioner’s memorandum dated June 2, 1989.
 
2.In bracket 10, insert the correspondence address of record.
 
3.This form paragraph is printed with the USPTO letterhead.
 
4.Prepare Certificate using form paragraph 10.15.
 
¶ 10.14 Treatment of Request Under 37 CFR 1.48 Petition
Under 37 CFR 1.324, Petition Granted
 
In re Patent No. [1]:
 
Issue Date: [2]: DECISION
 
Appl. No.: [3]: GRANTING
 
Filed: [4]: PETITION
 
For: [5]: 37 CFR 1.324
 
This is a decision on the request under 37 CFR 1.48, filed [6].
In view of the fact that the patent has already issued, the request
under 37 CFR 1.48 has been treated as a petition to correct inventorship
under 37 CFR 1.324.
 
The petition is granted.
 
The patented file is being forwarded to Certificate of Corrections
Branch for issuance of a certificate naming only the actual
inventor or inventors.
 
_______________________
 
[7]
 
Supervisory Patent Examiner,
 
Art Unit [8],
 
Technology Center [9]
 
[10]
 
Examiner Note:
 
1.Petitions to correct inventorship of an issued patent are
decided by the Supervisory Patent Examiner, as set forth in the
Commissioner’s memorandum dated June 2, 1989.
 
2.This form paragraph is printed with the USPTO letterhead.
 
3.Prepare Certificate using form paragraph 10.15.
 
4.In bracket 10, insert the correspondence address of record.
 
¶ 10.15 Memorandum - Certificate of Correction
(Inventorship)
 
DATE: [1]
 
TO: Certificates of Correction Branch
 
FROM: [2], SPE, Art Unit [3]
 
SUBJECT: Request for Certificate of Correction
 
Please issue a Certificate of Correction in U. S. Letters Patent
No. [4] as specified on the attached Certificate.
 
______________________
 
[5], SPE
 
Art Unit [6]
 
UNITED STATES PATENT AND TRADEMARK OFFICE
CERTIFICATE
 
Patent No. [7]
 
Patented: [8]
 
On petition requesting issuance of a certificate for correction of
inventorship pursuant to 35 U.S.C. 256, it has been found that the
above identified patent, through error and without deceptive
intent, improperly sets forth the inventorship. Accordingly, it is
hereby certified that the correct inventorship of this patent is:
 
[9]
 
 
 
 
 
_________________________
 
[10], Supervisory Patent Examiner
 
Art Unit [11]
 
Examiner Note:
 
1.In bracket 9, insert the full name and residence (City, State)
of each actual inventor.
 
2.This is an internal memo, not to be mailed to applicant,
which accompanies the patented file to Certificates of Correction
Branch as noted in form paragraphs 10.13 and 10.14.
 
3.In brackets 5 and 10, insert name of SPE; in brackets 6 and
11 the Art Unit and sign above each line.
 
4.Two separate pages of USPTO letterhead will be printed
when using this form paragraph.
 
¶ 10.16 Petition Under 37 CFR 1.324, Dismissed
 
In re Patent No. [1]:
 
Issue Date: [2]: DECISION
 
Appl. No.: [3]: DISMISSING
 
Filed: [4]: PETITION
 
For: [5]: 37 CFR 1.324
 
This is a decision on the petition filed [6] to correct inventorship
under 37 CFR 1.324.
 
The petition is dismissed.
 
A petition to correct inventorship as provided by 37 CFR 1.324requires (1) a statement from each person who is being added as
an inventor that the inventorship error occurred without any
deceptive intention on their part, (2) a statement from the current
named inventors (including any “inventor” being deleted) who
have not submitted a statement as per “(1)” either agreeing to the
change of inventorship or stating that they have no disagreement
in regard to the requested change, (3) a statement from all assignees
of the parties submitting a statement under “(1)” and “(2)”
agreeing to the change of inventorship in the patent; such statement
must comply with the requirements of 37 CFR 3.73(b); and
(4) the fee set forth in 37 CFR 1.20(b).This petition lacks item(s)
[7].
 
_______________________
 
[8]
 
Supervisory Patent Examiner,
 
Art Unit [9],
 
Technology Center [10]
 
[11]
 
Examiner Note:
 
1.If each of the four specified items has been submitted but one
or more is insufficient, the petition should be denied. See paragraph
10.17. However, if the above noted deficiency can be cured
by the submission of a renewed petition, a dismissal would be
appropriate.
 
2.If the petition includes a request for suspension of the rules
(37 CFR 1.183) of one or more provisions of 37 CFR 1.324 that
are required by the statute (35 U.S.C. 256), form paragraph 10.18should follow this form paragraph.
 
3.In bracket 7, pluralize as necessary and insert the item number(
s) which are missing.
 
4.In bracket 11, insert correspondence address of record.
 
5.This form paragraph is printed with the USPTO letterhead.
 
¶ 10.17 Petition Under 37 CFR 1.324, Denied
 
In re Patent No. [1]:
 
Issue Date: [2]:DECISION DENYING PETITION
 
Appl. No.: [3]:37 CFR 1.324
 
Filed: [4]:
 
For: [5]:
 
This is a decision on the petition filed [6] to correct inventorship
under 37 CFR 1.324.
 
The petition is denied.
 
[7]
 
_______________________
 
[8]
 
Supervisory Patent Examiner,
 
Art Unit [9],
 
Technology Center [10]
 
[11]
 
Examiner Note:
 
1.In bracket 7, a full explanation of the deficiency must be provided.
 
 
2.If the petition lacks one or more of the required parts set forth
in 37 CFR 1.324, it should be dismissed using form paragraph
10.14 or 10.20, rather than being denied.
 
3.In bracket 11, insert correspondence address of record.
 
4.This form paragraph is printed with the USPTO letterhead.
 
¶ 10.18 Waiver of Requirements of 37 CFR 1.324 Under 37
CFR 1.183, Dismissed
 
Suspension of the rules under 37 CFR 1.183 may be granted
for any requirement of the regulations which is not a requirement
of the statutes. In this instance, 35 U.S.C. 256 requires [1].
Accordingly, the petition under 37 CFR 1.183 is dismissed as
moot.
 
Examiner Note:
 
1. This form paragraph should follow form paragraph 10.16whenever the petition requests waiver of one or more of the provisions
of 37 CFR 1.324 that are also requirements of 35 U.S.C.
256.
 
2. If the petition requests waiver of requirements of 37 CFR
1.324 that are not specific requirements of the statute (i.e., the fee
or the oath or declaration by all inventors), the application must be
forwarded to a petitions attorney in the Office of the Deputy Commissioner
for Patent Examination Policy for decision.
 
 
 
 
 
1481.03Correction of 35 U.S.C. 119 and
35 U.S.C. 120 Benefits [R-5]
 
I.CORRECTION TO PERFECT CLAIM
FOR 35
U.S.C. 119 (a)-(d) AND (f) BENEFITS
 
 
See MPEP § 201.16 for a discussion of when
35
U.S.C. 119 (a)-(d) and (f) benefits can be perfected
by certificate of correction.
 
II.CORRECTION AS TO 35 U.S.C. 120 AND
35
U.S.C. 119(e) BENEFITS
 
A.For Applications Filed Prior to November 29,
2000
 
For applications filed prior to November 29, 2000,
it is the version of 37 CFR 1.78, which was in effect
as of November 29, 2000, that applies. The pre-
November 29, 2000 version reads as follows:
 
37 CFR 1.78. Claiming benefit of earlier filing date andcross-references to other applications.
 
(a)(1) A nonprovisional application may claim an invention
disclosed in one or more prior filed copending nonprovisional
applications or copending international applications designating
the United States of America. In order for a nonprovisional application
to claim the benefit of a prior filed copending nonprovisional
application or copending international application
designating the United States of America, each prior application
must name as an inventor at least one inventor named in the later
filed nonprovisional application and disclose the named inventor’s
invention claimed in at least one claim of the later filed nonprovisional
application in the manner provided by the first
paragraph of 35 U.S.C. 112. In addition, each prior application
must be:
 
(i)An international application entitled to a filing date in
accordance with PCT Article 11 and designating the United States
of America; or
 
(ii)Complete as set forth in § 1.51(b); or
 
(iii)Entitled to a filing date as set forth in § 1.53(b) or
§
1.53(d) and include the basic filing fee set forth in § 1.16; or
 
(iv)Entitled to a filing date as set forth in § 1.53(b) and
have paid therein the processing and retention fee set forth in
§
1.21(l) within the time period set forth in § 1.53(f).
 
(2)Except for a continued prosecution application filed
under §
1.53(d), any nonprovisional application claiming the benefit
of one or more prior filed copending nonprovisional applications
or international applications designating the United States of
America must contain a reference to each such prior application,
identifying it by application number (consisting of the series code
and serial number) or international application number and international
filing date and indicating the relationship of the applications.
Unless the reference required by this paragraph is included
in an application data sheet (§ 1.76), the specification must contain
or be amended to contain such reference in the first sentence
following any title. The request for a continued prosecution application
under § 1.53(d) is the specific reference required by
35
U.S.C. 120 to the prior application. The identification of an
application by application number under this section is the specific
reference required by 35 U.S.C. 120 to every application
assigned that application number. Cross-references to other
related applications may be made when appropriate (see
§
1.14(a)).
 
(3)A nonprovisional application other than for a design
patent may claim an invention disclosed in one or more prior filed
copending provisional applications. In order for a nonprovisional
application to claim the benefit of one or more prior filed copending
provisional applications, each prior provisional application
must name as an inventor at least one inventor named in the later
filed nonprovisional application and disclose the named inventor's
invention claimed in at least one claim of the later filed nonprovisional
application in the manner provided by the first paragraph of
35 U.S.C. 112. In addition, each prior provisional application
must be entitled to a filing date as set forth in § 1.53(c), have any
required English-language translation filed therein within the time
period set forth in § 1.52(d), and have paid therein the basic filing
fee set forth in § 1.16(k) within the time period set forth in
§
1.53(g).
 
(4)Any nonprovisional application claiming the benefit
of one or more prior filed copending provisional applications must
contain a reference to each such prior provisional application,
identifying it as a provisional application, and including the provisional
application number (consisting of series code and serial
number). Unless the reference required by this paragraph is
included in an application data sheet (§ 1.76), the specification
must contain or be amended to contain such reference in the first
sentence following any title.
 
 
 
Under certain conditions specified below, a Certificate
of Correction can be used, with respect to
35
U.S.C. 120 and 119(e) priority, to correct:
 
(A)the failure to make reference to a prior
copending application pursuant to 37 CFR 1.78(a)(2)
and (a)(4); or
 
(B)an incorrect reference to a prior copending
application pursuant to 37 CFR 1.78(a)(2) and (a)(4).
 
For all situations other than where priority is based
upon 35 U.S.C. 365(c), the conditions are as follows:
 
(A)for 35 U.S.C. 120 priority, all requirements
set forth in 37 CFR 1.78(a)(1) must have been met in
the application which became the patent to be corrected;
 
 
(B)for 35 U.S.C. 119(e) priority, all requirements
set forth in 37 CFR 1.78(a)(3) must have been met in
 
 
 
 
 
the application which became the patent to be corrected;
and
 
(C)it must be clear from the record of the patent
and the parent application(s) that priority is appropriate.
See MPEP § 201.1l for requirements under
35
U.S.C. 119(e) and 120.
 
Where 35 U.S.C. 120 and 365(c) priority based on
an international application is to be asserted or corrected
in a patent via a Certificate of Correction, the
following conditions must be satisfied:
 
(A)all requirements set forth in 37 CFR
1.78(a)(1) must have been met in the application
which became the patent to be corrected;
 
(B)it must be clear from the record of the patent
and the parent application(s) that priority is appropriate
(see MPEP § 201.11); and
 
(C)the patentee must submit with the request for
the certificate copies of documentation showing designation
of states and any other information needed to
make it clear from the record that the 35 U.S.C. 120priority is appropriate. See MPEP § 201.13(b) as to
the requirements for 35
U.S.C. 120 priority based on
an international application.
 
If all the above-stated conditions are satisfied, a
Certificate of Correction can be used to amend the
patent to make reference to a prior copending application,
or to correct an incorrect reference to the prior
copending application. Note In re Schuurs, 218 USPQ
443 (Comm’r Pat. 1983) which suggests that a Certificate
of Correction is an appropriate remedy for correcting,
in a patent, reference to a prior copending
application. Also, note In re Lambrech, 202 USPQ
620 (Comm’r Pat. 1976), citing In re Van Esdonk,
187
USPQ 671 (Comm’r Pat. 1975).
 
If any of the above-stated conditions is not satisfied,
the filing of a reissue application (see MPEP
§
1401 - § 1460) would be appropriate to pursue the
desired correction of the patent.
 
B.For Applications Filed on or After November
29, 2000
 
For applications filed on or after November 29,
2000, the version of 37 CFR 1.78 reproduced below
applies (note that amendments to 37 CFR 1.78 took
effect on November 29, 2000, December 28, 2001,
May 1, 2003, January 21, 2004, September 21, 2004,
December 8, 2004,  July 1, 2005, and November
25, 2005).
 
37 CFR 1.78. Claiming benefit of earlier filing date and
cross-references to other applications.
 
(a)(1)A nonprovisional application or international application
designating the United States of America may claim an
invention disclosed in one or more prior-filed copending nonprovisional
applications or international applications designating the
United States of America. In order for an application to claim the
benefit of a prior-filed copending nonprovisional application or
international application designating the United States of America,
each prior-filed application must name as an inventor at least
one inventor named in the later-filed application and disclose the
named inventor’s invention claimed in at least one claim of the
later-filed application in the manner provided by the first paragraph
of 35 U.S.C. 112. In addition, each prior-filed application
must be:
 
(i) An international application entitled to a filing date
in accordance with PCT Article 11 and designating the United
States of America; or
 
(ii) Entitled to a filing date as set forth in § 1.53(b) or §
1.53(d) and have paid therein the basic filing fee set forth in § 1.16within the pendency of the application.
 
(2)(i)Except for a continued prosecution application
filed under § 1.53(d), any nonprovisional application or international
application designating the United States of America claiming
the benefit of one or more prior-filed copending
nonprovisional applications or international applications designating
the United States of America must contain or be amended to
contain a reference to each such prior-filed application, identifying
it by application number (consisting of the series code and
serial number) or international application number and international
filing date and indicating the relationship of the applications.
Cross references to other related applications may be made
when appropriate (see § 1.14).
 
(ii)This reference must be submitted during the pendency
of the later-filed application. If the later-filed application is
an application filed under 35
U.S.C. 111(a), this reference must
also be submitted within the later of four months from the actual
filing date of the later-filed application or sixteen months from the
filing date of the prior-filed application. If the later-filed application
is a nonprovisional application which entered the national
stage from an international application after compliance with
35
U.S.C. 371, this reference must also be submitted within the
later of four months from the date on which the national stage
commenced under 35 U.S.C. 371 (b) or (f) in the later-filed international
application or sixteen months from the filing date of the
prior-filed application. These time periods are not extendable.
Except as provided in paragraph (a)(3) of this section, the failure
to timely submit the reference required by 35 U.S.C. 120 and
paragraph (a)(2)(i) of this section is considered a waiver of any
benefit under 35
U.S.C. 120, 121, or 365(c) to such prior-filed
application. The time periods in this paragraph do not apply if the
later-filed application is:
 
 
 
 
 
(A)An application for a design patent;
 
(B)An application filed under 35 U.S.C. 111 (a)
before November 29, 2000; or
 
(C)A nonprovisional application which entered the
national stage after compliance with 35 U.S.C. 371 from an international
application filed under 35 U.S.C. 363 before November
29, 2000.
 
(iii)If the later-filed application is a nonprovisional
application, the reference required by this paragraph must be
included in an application data sheet (§ 1.76), or the specification
must contain or be amended to contain such reference in the first
sentence(s) following the title.
 
(iv)The request for a continued prosecution application
under § 1.53(d) is the specific reference required by
35
U.S.C. 120 to the prior-filed application. The identification of
an application by application number under this section is the
identification of every application assigned that application number
necessary for a specific reference required by 35 U.S.C. 120 to
every such application assigned that application number.
 
(3)If the reference required by 35 U.S.C. 120 and paragraph
(a)(2) of this section is presented after the time period provided
by paragraph (a)(2)(ii) of this section, the claim under
35
U.S.C. 120, 121, or 365(c) for the benefit of a prior-filed
copending nonprovisional application or international application
designating the United States of America may be accepted if the
reference identifying the prior-filed application by application
number or international application number and international filing
date was unintentionally delayed. A petition to accept an unintentionally
delayed claim under 35 U.S.C. 120, 121, or 365(c) for
the benefit of a prior-filed application must be accompanied by:
 
(i)The reference required by 35 U.S.C. 120 and paragraph
(a)(2) of this section to the prior-filed application, unless
previously submitted;
 
(ii)The surcharge set forth in § 1.17(t); and
 
(iii)A statement that the entire delay between the date
the claim was due under paragraph (a)(2)(ii) of this section and
the date the claim was filed was unintentional. The Director may
require additional information where there is a question whether
the delay was unintentional.
 
(4)A nonprovisional application, other than for a design
patent, or an international application designating the United
States of America may claim an invention disclosed in one or
more prior-filed provisional applications. In order for an application
to claim the benefit of one or more prior-filed provisional
applications, each prior-filed provisional application must name
as an inventor at least one inventor named in the later-filed application
and disclose the named inventor’s invention claimed in at
least one claim of the later-filed application in the manner provided
by the first paragraph of 35
U.S.C. 112. In addition, each
prior-filed provisional application must be entitled to a filing date
as set forth in § 1.53(c), and the basic filing fee set forth in
§
1.16(d) must be paid within the time period set forth in
§
1.53(g).
 
(5)(i) Any nonprovisional application or international
application designating the United States of America claiming the
benefit of one or more prior-filed provisional applications must
contain or be amended to contain a reference to each such prior-
filed provisional application, identifying it by the provisional
application number (consisting of series code and serial number).
 
(ii)This reference must be submitted during the pendency
of the later-filed application. If the later-filed application is
an application filed under 35
U.S.C. 111(a), this reference must
also be submitted within the later of four months from the actual
filing date of the later-filed application or sixteen months from the
filing date of the prior-filed provisional application. If the later-
filed application is a nonprovisional application which entered the
national stage from an international application after compliance
with 35 U.S.C. 371, this reference must also be submitted within
the later of four months from the date on which the national stage
commenced under 35
U.S.C. 371(b) or (f) in the later-filed international
application or sixteen months from the filing date of the
prior-filed provisional application. These time periods are not
extendable. Except as provided in paragraph(a)(6) of this section,
the failure to timely submit the reference is considered a waiver of
any benefit under 35 U.S.C. 119(e) to such prior-filed provisional
application. The time periods in this paragraph do not apply if the
later-filed application is:
 
(A)An application filed under 35 U.S.C. 111(a)
before November 29, 2000; or
 
(B)A nonprovisional application which entered the
national stage after compliance with 35 U.S.C. 371 from an international
application filed under 35 U.S.C. 363 before November
29, 2000.
 
(iii)If the later-filed application is a nonprovisional
application, the reference required by this paragraph must be
included in an application data sheet (§ 1.76), or the specification
must contain or be amended to contain such reference in the first
sentence(s) following the title.
 
 
 
(iv)If the prior-filed provisional application was filed
in a language other than English and both an English-language
translation of the prior-filed provisional application and a statement
that the translation is accurate were not previously filed in
the prior-filed provisional application, applicant will be notified
and given a period of time within which to file, in the prior-filed
provisional application, the translation and the statement. If the
notice is mailed in a pending nonprovisional application, a timely
reply to such a notice must include the filing in the nonprovisional
application of either a confirmation that the translation and statement
were filed in the provisional application, or an amendment
or Supplemental Application Data Sheet withdrawing the benefit
claim, or the nonprovisional application will be abandoned. The
translation and statement may be filed in the provisional application,
even if the provisional application has become abandoned.
 
(6)If the reference required by 35 U.S.C. 119(e) and
paragraph (a)(5) of this section is presented in a nonprovisional
application after the time period provided by paragraph (a)(5)(ii)
of this section, the claim under 35
U.S.C. 119(e) for the benefit of
a prior filed provisional application may be accepted during the
pendency of the later-filed application if the reference identifying
the prior-filed application by provisional application number was
unintentionally delayed. A petition to accept an unintentionally
delayed claim under 35
U.S.C. 119(e) for the benefit of a prior
filed provisional application must be accompanied by:
 
 
 
 
 
(i)The reference required by 35 U.S.C. 119(e) and
paragraph (a)(5) of this section to the prior-filed provisional application,
unless previously submitted;
 
(ii)The surcharge set forth in § 1.17(t); and
 
(iii)A statement that the entire delay between the date
the claim was due under paragraph (a)(5)(ii) of this section and
the date the claim was filed was unintentional. The Director may
require additional information where there is a question whether
the delay was unintentional.
 
(b)Where two or more applications filed by the same applicant
contain conflicting claims, elimination of such claims from
all but one application may be required in the absence of good and
sufficient reason for their retention during pendency in more than
one application.
 
(c)If an application or a patent under reexamination and at
least one other application naming different inventors are owned
by the same person and contain conflicting claims, and there is no
statement of record indicating that the claimed inventions were
commonly owned or subject to an obligation of assignment to the
same person at the time the later invention was made, the Office
may require the assignee to state whether the claimed inventions
were commonly owned or subject to an obligation of assignment
to the same person at the time the later invention was made, and if
not, indicate which named inventor is the prior inventor. Even if
the claimed inventions were commonly owned, or subject to an
obligation of assignment to the same person, at the time the later
invention was made, the conflicting claims may be rejected under
the doctrine of double patenting in view of such commonly owned
or assigned applications or patents under reexamination.
 
Under no circumstances can a Certificate of Correction
be employed to correct an applicant’s mistake
by adding or correcting a priority claim under
35
U.S.C. 119(e) for an application filed on or after
November 29, 2000.
 
Section 4503 of the American Inventors Protection
Act of 1999 (AIPA) amended 35 U.S.C. 119(e)(1) to
state that:
 
No application shall be entitled to the benefit of an earlier
filed provisional application under this subsection
unless an amendment containing the specific reference to
the earlier filed provisional application is submitted at such
time during the pendency of the application as required by
the Director. The Director may consider the failure to submit
such an amendment within that time period as a waiver
of any benefit under this subsection. The Director may
establish procedures, including the payment of a surcharge,
to accept an unintentionally delayed submission of an
amendment under this section during the pendency of the
application. (emphasis added)
 
A Certificate of Correction is NOT a
valid mechanism for adding or correcting a priority
claim under 35
U.S.C. 119(e) after a patent has been
granted on an application filed on or after November
29, 2000.
 
Under certain conditions as specified below, however,
a Certificate of Correction can still be used, with
respect to 35 U.S.C. 120 priority, to correct:
 
(A)the failure to make reference to a prior
copending application pursuant to 37 CFR 1.78(a)(2);
or
 
(B)an incorrect reference to a prior copending
application pursuant to 37 CFR 1.78(a)(2).
 
Where priority is based upon 35 U.S.C. 120 to a
national application, the following conditions must
be satisfied:
 
(A)all requirements set forth in 37 CFR
1.78(a)(1) must have been met in the application
which became the patent to be corrected;
 
(B) it must be clear from the record of the patent
and the parent application(s) that priority is appropriate
(see MPEP § 201.11); and
 
(C)a grantable petition to accept an unintentionally
delayed claim for the benefit of a prior application
must be filed, including a surcharge as set forth in
37 CFR 1.17(t), as required by 37 CFR 1.78(a)(3).
 
Where 35 U.S.C. 120 and 365(c) priority based on
an international application is to be asserted or corrected
in a patent via a Certificate of Correction, the
following conditions must be satisfied:
 
(A)all requirements set forth in 37 CFR
1.78(a)(1) must have been met in the application
which became the patent to be corrected;
 
(B)it must be clear from the record of the patent
and the parent application(s) that priority is appropriate
(see MPEP § 201.11);
 
(C)the patentee must submit together with the
request for the certificate, copies of documentation
showing designation of states and any other information
needed to make it clear from the record that the
35 U.S.C. 120 priority is appropriate (see MPEP
§
201.13(b) as to the requirements for 35 U.S.C. 120priority based on an international application; and
 
(D)a grantable petition to accept an unintentionally
delayed claim for the benefit of a prior application
must be filed, including a surcharge as set forth in
37 CFR 1.17(t), as required by 37 CFR 1.78(a)(3).
 
 
 
 
 
If all the above-stated conditions are satisfied, a
Certificate of Correction can be used to amend the
patent to make reference to a prior copending application,
or to correct an incorrect reference to the prior
copending application, for benefit claims under
35
U.S.C. 120 and 365(c).
 
If any of the above-stated conditions is not satisfied,
the filing of a reissue application (see MPEP
§
1401 - § 1460) may be appropriate to pursue the
desired correction of the patent for benefit claims
under 35 U.S.C. 120 and 365(c).
 
1485Handling of Request for Certificates
of Correction [R-5]
 
A request for a Certificate of Correction should be
addressed to:
 
Commissioner for Patents
 
Office of Patent Publication
 
ATTN: Certificate of Correction Branch
 
 
 
P.O. Box 1450
 
Alexandria, VA 22313-1450
 
Requests for Certificates of Correction will be forwarded
to the Certificate of Correction Branch of the
Office of Patent Publication, where they will be listed
in a permanent record book.
 
If the patent is involved in an interference, a Certificate
of Correction under 37 CFR 1.324 will not be
issued unless a corresponding motion under 37 CFR
41.121(a)(2) or 41.121(a)(3) has been granted by the
administrative patent judge. Otherwise, determination
as to whether an error has been made, the responsibility
for the error, if any, and whether the error is of
such a nature as to justify the issuance of a Certificate
of Correction will be made by the Certificate of Correction
Branch. If a report is necessary in making such
determination, the case will be forwarded to the
appropriate group with a request that the report be furnished.
If no certificate is to issue, the party making
the request is so notified and the request, report, if
any, and copy of the communication to the person
making the request are placed in the file wrapper (for
a paper file) or entered into the file history (for an
IFW file), and entered into the “Contents” for the file
by the Certificate of Correction Branch. The case is
then returned to the patented files. If a certificate is to
issue, it will be prepared and forwarded to the person
making the request by the Office of Patent Publication.
In that case, the request, the report, if any, and a
copy of the letter transmitting the Certificate of Correction
to the person making the request will be
placed in the file wrapper (for a paper file) or entered
into the file history (for an IFW file), and entered into
the “Contents” for the file.
 
Applicants, or their attorneys or agents, are urged to
submit the text of the correction on a special Certificate
of Correction form, PTO/SB/44 (also referred to
as Form PTO-1050), which can serve as the camera
copy for use in direct offset printing of the Certificate
of Correction.
 
Where only a part of a request can be approved, or
where the Office discovers and includes additional
corrections, the appropriate alterations are made on
the form PTO/SB/44 by the Office. The patentee is
notified of the changes on the Notification of
Approval-in-part form PTOL-404. The certificate is
issued approximately 6 weeks thereafter.
 
Form PTO/SB/44 should be used exclusively
regardless of the length or complexity of the subject
matter. Intricate chemical formulas or page of specification
or drawings may be reproduced and mounted
on a blank copy of PTO/SB/44. Failure to use the
form has frequently delayed issuance since the
text
must be retyped by the Office onto a PTO/SB/44.
 
The exact page and line number where the errors
occur in the application file should be identified on
the request. However, on form PTO/SB/44, only the
column and line number in the printed patent should
be used.
 
The patent grant should be retained by the patentee.
The Office does not attach the Certificate of Correction
to patentee’s copy of the patent. The patent grant
will be returned to the patentee if submitted.
 
Below is a sample form illustrating a variety of corrections
and the suggested manner of setting out the
format. Particular attention is directed to:
 
(A)Identification of the exact point of error by
reference to column and line number of the printed
patent for changes in the specification or to claim
number and line where a claim is involved.
 
(B)Conservation of space on the form by typing
single space, beginning two lines down from the
printed message.
 
 
 
 
 
(C)Starting the correction to each separate column
as a sentence, and using semicolons to separate
corrections within the same column, where possible.
 
(D)Leaving a two-inch space blank at bottom of
the last sheet for the signature of the attesting officer.
 
(E)Using quotation marks to enclose the exact
subject matter to be deleted or corrected; using double
hyphens (-- --) to enclose subject matter to be added,
except for formulas.
 
(F)Where a formula is involved, setting out
only
that portion thereof which is to be corrected or,
if
necessary, pasting a photocopy onto form PTO/SB/
44.
 
UNITED STATES PATENT AND TRADEMARK
OFFICE CERTIFICATE OF CORRECTION
 
 
Patent No. :9,999,999
 
Application No. :10/999,999
 
Issue Date :May 1, 2002
 
Inventor(s) :Eli Y. Rosenthal
 
 
 
It is certified that error appears in the above-identified
patent and that said Letters Patent is hereby corrected as
shown below:
 
In the drawings, Sheet 3, Fig. 3, the reference numeral
225 should be applied to the plate element attached to the
support member 207:
 
Column 2, line 68 and column 3, lines 3, 8 and 13, for
the claim reference numeral '2', each occurrence, should
read -1-.
 
Column 7, lines 45 to 49, the left-hand formula should
appear as follows:
 
-R3 -CHF
 
Column 8, Formula XVII, that portion of the formula
reading “-CHClCH-” should read --CHFCH2 --; line 5,
“chlorine” should be changed to --fluorine--.
 
Column 10, line 29, cancel the text beginning with “12.
A sensor device” to and ending “active strips.” in column
11, line 10, and insert the following claim:
 
12. A control circuit of the character set forth in claim
4 and for an automobile having a convertible top, and
including; means for moving the top between a raised and
lowered retracted position; and control means responsive
to a sensor relay for energizing the top moving means for
moving said top from a retracted position to a raised position.
 
 
ELECTRONIC PUBLICATION OF CERTIFICATES
OF CORRECTION WITH LATER LISTING
IN THE OFFICIAL GAZETTE
 
Effective August 2001, the U.S. Patent and Trademark
Office (USPTO) publishes on the USPTO web
site at http://www.uspto.gov/web/patents/certofcorrect
a listing by patent number of the patents for
which certificates of correction are being issued.
 
The USPTO is now automating the publication
process for certificates of correction. This new process
will result in certificates of correction being published
quicker electronically on the USPTO’s web site
as compared to their paper publication and the listing
of the certificates of correction in the Official Gazette.
Under the newly automated process, each issue of certificates
of correction will be electronically published
on the USPTO web site at http://www.uspto.gov/web/
patents/certofcorrect, and will also subsequently be
listed in the Official Gazette (and in the Official
Gazette Notices posted at http://www.uspto.gov/web/
offices/com/sol/og) approximately three weeks thereafter.
The listing of certificates of correction in the
Official Gazette will include the certificate’s date of
issuance.
 
On the date on which the listing of certificates of
correction is electronically published on the USPTO
web site: (A) the certificate of correction will be
entered into the file wrapper of a paper-file patent, or
entered into the file history of an IFW-file patent and
will be available to the public; (B) a printed copy of
the certificate of correction will be mailed to the patentee
or the patent’s assignee; and (C) an image of the
printed certificate of correction will be added to the
image of the patent on the patent database at http://
www.uspto.gov.patft. Dissemination of all other paper
copies of the certificate of correction will occur
shortly thereafter.
 
The date on which the USPTO makes the certificate
of correction available to the public (e.g., by adding
the certificate of correction to the file wrapper/file
history) will be regarded as the date of issuance of the
certificate of correction, not the date of the certificate
of correction appearing in the Official Gazette. (For
IFW processing, see IFW Manual.) Certificates of
correction published in the above-described manner
will provide the public with prompt notice and access,
and this is consistent with the legislative intent behind
the American Inventors Protection Act of 1999. See
 
 
 
 
 
35 U.S.C. 10(a) (authorizing the USPTO to publish in
electronic form).
 
The listing of certificates of correction can be electronically
accessed on the day of issuance at http://
www.uspto.gov/web/patents/certofcorrect. The electronic
image of the printed certificate of correction
can be accessed on the patent database at http://
www.uspto.gov/patft and the listing of the certificates
of correction, as published in the Official Gazettethree weeks later, will be electronically accessible at
http://www.uspto.gov/web/offices/com/sol/og.
 
 
 
 
 
Certificate of Correction
PTO/SB/44 (04-05)
Approved for use through 04/30/2007. OMB 0651-0033
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
(Also Form PTO-1050)
UNITED STATES PATENT AND TRADEMARK OFFICE
CERTIFICATE OF CORRECTION
Page _____ of _____
PATENT NO. :
APPLICATION NO.:
ISSUE DATE :
INVENTOR(S) :
It is certified that an error appears or errors appear in the above-identified patent and that said Letters Patent
is hereby corrected as shown below:
MAILING ADDRESS OF SENDER (Please do not use customer number below):
This collection of information is required by 37 CFR 1.322, 1.323, and 1.324. The information is required to obtain or retain a benefit by the public which is to file
(and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.14. This collection is estimated to take 1.0 hour to
complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any
comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer,
U.S. Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED
FORMS TO THIS ADDRESS. SEND TO: Attention Certificate of Corrections Branch,Commissioner for Patents, P.O. Box 1450, Alexandria,
VA 22313-1450.
If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
DOC Code: COCIN
 
 
 
 
 
 
Privacy Act Statment
Privacy Act Statement
ThePrivacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
with your submission of the attached form related to a patent application or patent. Accordingly,
pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
Office is to process and/or examine your submission related to a patent application or patent. If you do
not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
process and/or examine your submission, which may result in termination of proceedings or
abandonment of the application or expiration of the patent.
The information provided by you in this form will be subject to the following routine uses:
1. The information on this form will be treated confidentially to the extent allowed under the
Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
this system of records may be disclosed to the Department of Justice to determine whether
disclosure of these records is required by the Freedom of Information Act.
2. A record from this system of records may be disclosed, as a routine use, in the course of
presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
opposing counsel in the course of settlement negotiations.
3. A record in this system of records may be disclosed, as a routine use, to a Member of
Congress submitting a request involving an individual, to whom the record pertains, when the
individual has requested assistance from the Member with respect to the subject matter of the
record.
4. A record in this system of records may be disclosed, as a routine use, to a contractor of the
Agency having need for the information in order to perform a contract. Recipients of
information shall be required to comply with the requirements of the Privacy Act of 1974, as
amended, pursuant to 5 U.S.C. 552a(m).
5. A record related to an International Application filed under the Patent Cooperation Treaty in
this system of records may be disclosed, as a routine use, to the International Bureau of the
World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
6. A record in this system of records may be disclosed, as a routine use, to another federal
agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
the Atomic Energy Act (42 U.S.C. 218(c)).
7. A record from this system of records may be disclosed, as a routine use, to the Administrator,
General Services, or his/her designee, during an inspection of records conducted by GSA as
part of that agency’s responsibility to recommend improvements in records management
practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
be made in accordance with the GSA regulations governing inspection of records for this
purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
be used to make determinations about individuals.
8. A record from this system of records may be disclosed, as a routine use, to the public after
either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
CFR 1.14, as a routine use, to the public if the record was filed in an application which
became abandoned or in which the proceedings were terminated and which application is
referenced by either a published application, an application open to public inspection or an
issued patent.
9. A record from this system of records may be disclosed, as a routine use, to a Federal, State,
or local law enforcement agency, if the USPTO becomes aware of a violation or potential
violation of law or regulation.
 
 
 
 
 
 
1490Disclaimers [R-5]
 
35 U.S.C. 253. Disclaimer.
 
Whenever, without any deceptive intention, a claim of a patent
is invalid the remaining claims shall not thereby be rendered
invalid. A patentee, whether of the whole or any sectional interest
therein, may, on payment of the fee required by law, make disclaimer
of any complete claim, stating therein the extent of his
interest in such patent. Such disclaimer shall be in writing, and
recorded in the Patent and Trademark Office; and it shall thereafter
be considered as part of the original patent to the extent of the
interest possessed by the disclaimant and by those claiming under
him.
 
In like manner any patentee or applicant may disclaim or dedicate
to the public the entire term, or any terminal part of the term,
of the patent granted or to be granted.
 
37 CFR 1.321. Statutory disclaimers, including terminal
disclaimers.
 
(a)A patentee owning the whole or any sectional interest in
a patent may disclaim any complete claim or claims in a patent. In
like manner any patentee may disclaim or dedicate to the public
the entire term, or any terminal part of the term, of the patent
granted. Such disclaimer is binding upon the grantee and its successors
or assigns. A notice of the disclaimer is published in the
Official Gazette and attached to the printed copies of the specification.
The disclaimer, to be recorded in the Patent and Trademark
Office, must:
 
(1)be signed by the patentee, or an attorney or agent of
record;
 
(2)identify the patent and complete claim or claims, or
term being disclaimed. A disclaimer which is not a disclaimer of a
complete claim or claims, or term, will be refused recordation;
 
(3)state the present extent of patentee’s ownership interest
in the patent; and
 
(4)be accompanied by the fee set forth in § 1.20(d).
 
(b)An applicant or assignee may disclaim or dedicate to the
public the entire term, or any terminal part of the term, of a patent
to be granted. Such terminal disclaimer is binding upon the
grantee and its successors or assigns. The terminal disclaimer, to
be recorded in the Patent and Trademark Office, must:
 
(1)be signed:
 
(i)by the applicant, or
 
(ii)if there is an assignee of record of an undivided
part interest, by the applicant and such assignee, or
 
(iii)if there is an assignee of record of the entire interest,
by such assignee, or
 
(iv)by an attorney or agent of record;
 
(2)specify the portion of the term of the patent being disclaimed;
 
 
(3)state the present extent of applicant’s or assignee’s
ownership interest in the patent to be granted; and
 
(4)be accompanied by the fee set forth in § 1.20(d).
 
(c)A terminal disclaimer, when filed to obviate judicially
created double patenting in a patent application or in a reexamination
proceeding except as provided for in paragraph (d) of this
section, must:
 
(1)Comply with the provisions of paragraphs (b)(2)
through (b)(4) of this section;
 
(2)Be signed in accordance with paragraph (b)(1) of this
section if filed in a patent application or in accordance with paragraph
(a)(1) of this section if filed in a reexamination proceeding;
and
 
(3)Include a provision that any patent granted on that
application or any patent subject to the reexamination proceeding
shall be enforceable only for and during such period that said
patent is commonly owned with the application or patent which
formed the basis for the judicially created double patenting.
 
 
 
(d)A terminal disclaimer, when filed in a patent application
or in a reexamination proceeding to obviate double patenting
based upon a patent or application that is not commonly owned
but was disqualified under 35 U.S.C. 103(c) as resulting from
activities undertaken within the scope of a joint research agreement,
must:
 
(1)Comply with the provisions of paragraphs (b)(2)
through (b)(4) of this section;
 
(2)Be signed in accordance with paragraph (b)(1) of this
section if filed in a patent application or be signed in accordance
with paragraph (a)(1) of this section if filed in a reexamination
proceeding;
 
(3)Include a provision waiving the right to separately
enforce any patent granted on that application or any patent subject
to the reexamination proceeding and the patent or any patent
granted on the application which formed the basis for the double
patenting, and that any patent granted on that application or any
patent subject to the reexamination proceeding shall be enforceable
only for and during such period that said patent and the
patent, or any patent granted on the application, which formed the
basis for the double patenting are not separately enforced.
 
A disclaimer is a statement filed by an owner (in
part or in entirety) of a patent or of a patent to be
granted (i.e., an application), in which said owner
relinquishes certain legal rights to the patent. There
are two types of disclaimers: a statutory disclaimer
and a terminal disclaimer. The owner of a patent or an
application is the original inventor(s) or the assignee
of the original inventor(s). The patent or application is
assigned by one assignment or by multiple assignments
which establish a chain of title from the inventor(
s) to the assignee(s). The owner of the patent or
application can sign a disclaimer, and a person
empowered by the owner to sign the disclaimer can
also sign it. Per 37 CFR 1.321(b)(1)(iv), an attorney
 
 
 
 
 
or agent of record is permitted to sign the disclaimer.
A registered practitioner acting in a representative
capacity under 37 CFR 1.34 is not permitted to sign
the disclaimer. For a disclaimer to be accepted, it must
be signed by the proper party as follows:
 
(A)A disclaimer filed in an application must be
signed by
 
(1)the applicant where the application has not
been assigned,
 
(2)the applicant and the assignee where each
owns a part interest in the application,
 
(3)the assignee where assignee owns the
entire interest in the application, or
 
(4)an attorney or agent of record.
 
(B)A disclaimer filed in a patent or a reexamination
proceeding must be signed by either
 
(1)the patentee (the assignee, the inventor(s) if
the patent is not assigned, or the assignee and the
inventors if the patent is assigned-in-part), or
 
(2)an attorney or agent of record.
 
(C)Where the assignee (of an application or of a
patent being reexamined or to be reissued) signs the
disclaimer, there is a requirement to comply with
37
CFR 3.73(b) in order to satisfy 37 CFR 1.321,
unless an attorney or agent of record signs the disclaimer.
In order to comply with 37 CFR 3.73(b), the
assignee’s ownership interest must be established by:
 
(1)filing in the application or patent evidence
of a chain of title from the original owner to the
assignee and a statement affirming that the documentary
evidence of the chain of title from the original
owner to the assignee was, or concurrently is
being, submitted for recordation pursuant to 37 CFR
3.11, or
 
(2)specifying in the record of the application
or patent where such evidence is recorded in the
Office (e.g., reel and frame number, etc.).
 
The submission with respect to 37 CFR 3.73(b)
to establish ownership must be signed by a party
authorized to act on behalf of the assignee. See also
MPEP § 324 as to compliance with 37 CFR 3.73(b).
A copy of the “Statement Under 37 CFR 3.73 (b),”
which is reproduced in MPEP § 324, may be sent by
the examiner to applicant to provide an acceptable
way to comply with the requirements of 37 CFR 3.73(b).
 
(D)Where the attorney or agent of record signs
the disclaimer, there is no need to comply with
37
CFR 3.73(b).
 
(E)The signature on the disclaimer need not be
an original signature. Pursuant to 37 CFR
1.4(d)(1)(ii), the submitted disclaimer can be a copy,
such as a photocopy or facsimile transmission of an
original disclaimer.
 
I.STATUTORY DISCLAIMERS
 
Under 37 CFR 1.321(a) the owner of a patent may
disclaim a complete claim or claims of his or her
patent. This may result from a lawsuit or because he
or she has reason to believe that the claim or claims
are too broad or otherwise invalid. If the patent is
involved in an interference, see 37 CFR 41.121(a).
 
As noted above, a statutory disclaimer is a statement
in which a patent owner relinquishes legal rights
to one or more claims of a patent. A statutory disclaimer
is not, however, a vehicle for adding or
amending claims, since there is no provision for such
in the statute (35 U.S.C. 253) nor the rules (37 CFR
1.321). Thus, claims of a patent cannot be disclaimed
in favor of new claims to be added to the patent or an
amendment to existing claims.
 
II.TERMINAL DISCLAIMERS
 
37 CFR 1.321(a) also provides for the filing by an
applicant or patentee of a terminal disclaimer which
disclaims or dedicates to the public the entire term or
any portion of the term of a patent or patent to be
granted.
 
37 CFR 1.321(c) specifically provides for the filing
of a terminal disclaimer in an application or a reexamination
proceeding for the purpose of overcoming
a
nonstatutory double patenting rejection. See MPEP
§ 804.02.
 
37 CFR 1.321(d) specifically provides for the filing
of a terminal disclaimer in an application or a reexamination
proceeding for the purpose of overcoming a
nonstatutory double patenting rejection based on a
U.S. patent or application that is not commonly
owned but was disqualified under 35 U.S.C. 103(c).
 
 
 
 
 
III.PROCESSING
 
Certificate of Correction Branch
 
The Certificate of Correction Branch is responsible
for the handling of all statutory disclaimers filed
under the first paragraph of 35 U.S.C. 253, whether
the case is pending or patented, and all terminal disclaimers
(filed under the second paragraph of
35
U.S.C. 253) except for those filed in an application
or reexamination proceeding pending in a Technology
Center (TC). This involves:
 
(A)Determining the compliance of the disclaimer
with 35 U.S.C. 253 and 37 CFR 1.321 and 3.73;
 
(B)Notifying applicant or patentee when the disclaimer
is informal and thus not acceptable;
 
(C)Recording the disclaimers in the record of the
application file; and
 
(D)Providing the disclaimer data for printing in
the Official Gazette.
 
IV.TERMINAL DISCLAIMER IN PENDING
APPLICATION PRACTICE IN THE
TECHNOLOGY CENTERS
 
Where a terminal disclaimer is filed in an application
pending in a TC, it will be processed by the paralegal
of the Office of the Special Program Examiner
of the TC having responsibility for the application.
The paralegal will:
 
(A)Determine compliance with 35 U.S.C. 253and 37
CFR 1.321 and 3.73, and ensure that the
appropriate terminal disclaimer fee set forth in
37
CFR 1.20(d) is/was applied;
 
(B)Notify the examiner having charge of the
application whether the terminal disclaimer is acceptable
or not;
 
(C)Where the terminal disclaimer is not acceptable,
indicate the nature of the informalities so that the
examiner can inform applicant in the next Office
action. For an IFW application, complete the IFW terminal
disclaimer form by checking the “Disapproved”
box and have the form scanned into IFW;
 
(D)Where the terminal disclaimer is acceptable,
record the terminal disclaimer in the record of the
application as set forth below.
 
The paralegal will record an acceptable terminal
disclaimer as being present in an application by:
 
For IFW applications:
 
(A)Completing the IFW terminal disclaimer form
by checking the “Approved” box and having the form
scanned into IFW; and
 
(B)Entering the terminal disclaimer into PALM
for the application.
 
For application files that are maintained in paper:
 
For paper applications with 08/ and earlier series
code
 
(A)Attaching a green label to the file wrapper;
 
(B)Stamping a notice on the file of the term
which has been disclaimed (note that the blanks on
the stamped notice for entering information on the
patent(s) being disclaimed are no longer filled in);
 
(C)Endorsing the paper containing the terminal
disclaimer submission on the “Contents” flap of the
application file; and
 
(D)Entering the terminal disclaimer into the
PALM system records, for the application.
 
For paper applications with 09/ and later series
code
 
(A)Checking a box on the file wrapper which
states that the terminal disclaimer has been filed (Any
blanks for entering information on the patent(s) being
disclaimed are no longer filled in. Note that applications
with 10/ and later series codes no longer have
such blanks to complete);
 
(B)Endorsing the paper containing the terminal
disclaimer submission on the “Contents” flap of the
application file; and
 
(C)Entering the terminal disclaimer into the
PALM system records, for the application.
 
The paralegal completes a Terminal Disclaimer
Informal Memo to notify the examiner of the nature
of any informalities in the terminal disclaimer. The
examiner should notify the applicant of the informalities
in the next Office action, or by interview with
applicant if such will expedite prosecution of the
application. Further, the examiner should initial and
date the Terminal Disclaimer Informal Memo and
return it to the paralegal to indicate that the examiner
has appropriately notified applicant about the terminal
disclaimer. The paralegal will then discard the Terminal
Disclaimer Informal Memo.
 
 
 
 
 
V.OTHER MATTERS DIRECTED TO
TERMINAL DISCLAIMERS
 
A.Requirements of Terminal Disclaimers
 
A proper terminal disclaimer must disclaim the terminal
part of the statutory term of any patent granted
on the application being examined which would
extend beyond the expiration date of the full statutory
term, shortened by any terminal disclaimer, of the
patent (or of any patent granted on the application) to
which the disclaimer is directed. Note the exculpatory
language in the second paragraph of the sample terminal
disclaimer forms, PTO/SB/25 and PTO/SB/26,
provided at the end of this Chapter. That language
(“In making the above disclaimer, the owner does not
disclaim...”) is permissible in a terminal disclaimer.
 
A terminal disclaimer filed to obviate a nonstatutory
double patenting rejection based on a commonly
owned patent or application must comply with the
requirements of 37 CFR 1.321(c). The terminal disclaimer
must state that any patent granted on the
application being examined will be enforceable only
for and during the period that it and the patent to
which the disclaimer is directed or the patent granted
on the application to which the disclaimer is directed
are commonly owned. See MPEP § 706.02(1)(2) for
examples of common ownership, or lack thereof.
 
 
 
A terminal disclaimer filed to obviate a nonstatutory
double patenting rejection based on a non-commonly
owned patent or application disqualified under
35 U.S.C. 103(c) as a result of activities undertaken
within the scope of a joint research agreement under
35 U.S.C. 103(c)(2) and (3) must comply with 37
CFR 1.321(d), which sets forth signature, waiver
rights and enforceability requirements.
 
 
 
The terminal disclaimer must include a provision:
 
(1)waiving the right to separately enforce (a) any
patent granted on that application or the patent being
reexamined and (b) the reference patent, or any patent
granted on the reference application which formed the
basis for the double patenting; and
 
(2)agreeing that any patent granted on that application
or patent being reexamined shall be enforceable
only for and during such period that said patent
and the reference patent, or any patent granted on the
reference application, which formed the basis for the
double patenting are not separately enforced.
 
A terminal disclaimer must state that the agreement
is to run with any patent granted on the application
being examined and is to be binding upon the grantee,
its successors, or assigns.
 
A statement of assignee interest in a terminal disclaimer
that “A and B are the owners of 100% of the
instant application...” is sufficient to satisfy the
37
CFR 1.321(b)(3) requirement that a terminal disclaimer
“state the present extent of applicant’s or
assignee’s ownership interest in the patent to be
granted.” Although the quoted statement does not
identify what specific percentage is owned by A and
what specific percentage is owned by B, the statement
does provide consent to the terminal disclaimer by the
entirety of the ownership of the application (A and B
own all of the invention, regardless of the individual
percentages they own).
 
The appropriate one of form paragraphs 14.27.04to 14.27.08 (reproduced below) may be used to provide
applicant or patent owner with an example of
acceptable terminal disclaimer language. Additionally,
copies of forms PTO/SB/25 and PTO/SB/26 (provided
at the end of this Chapter) may be attached to
the Office action to provide sample terminal disclaimers.
 
 
Pursuant to the last sentence of 35 U.S.C. 253, “any
patentee or applicant may disclaim or dedicate to the
public... any terminal part of the term, of the patent
granted or to be granted”. Accordingly, the disclaimer
must be of a terminal portion of the term of the entire
patent to be granted. A disclaimer of a terminal portion
of the term of an individual claim, or individual
claims will not be accepted. It is further noted that a
disclaimer of the term of individual claims would not
be appropriate since the claims of a pending application
or proceeding are subject to cancelation, amendment,
or renumbering. The statute does not provide
for conditional disclaimers and accordingly, a proposed
disclaimer which is made contingent on the
allowance of certain claims cannot be accepted. The
disclaimer should identify the disclaimant and his or
her interest in the application and should specify the
date when the disclaimer is to become effective.
 
 
 
 
 
B.Effect of Disclaimers in Continuing Applications
and in Reissues
 
A terminal disclaimer filed to obviate a double patenting
rejection is effective only with respect to the
application identified in the disclaimer unless by its
terms it extends to continuing applications. For example,
a terminal disclaimer filed in a parent application
normally has no effect on a continuing application
claiming filing date benefits of the parent application
under 35 U.S.C. 120. A terminal disclaimer filed in a
parent application to obviate a double patenting rejection
does, however, carry over to a continued prosecution
application (CPA) filed under 37 CFR 1.53(d)
(effective July 14, 2003, CPAs are only available in
design applications). The terminal disclaimer filed in
the parent application carries over because the CPA
retains the same application number as the parent
application, i.e., the application number to which the
previously filed terminal disclaimer is directed. If
applicant does not want the terminal disclaimer to
carry over to the CPA, applicant must file a petition
under 37 CFR 1.182, along with the required petition
fee, requesting the terminal disclaimer filed in the parent
application not be carried over to the CPA; see
below “Withdrawing a Terminal Disclaimer” (paragraph
“A. Before Issuance of Patent”). If applicant
files a Request for Continued Examination (RCE) of
an application under 37 CFR 1.114 (which can be
filed on or after May 29, 2000 for an application filed
on or after June 8, 1995), any terminal disclaimer
present will continue to operate, since a new application
has not been filed, but rather prosecution has
been continued in the existing application. A petition
under 37 CFR 1.182, along with the required petition
fee, may be filed, if withdrawal of the terminal disclaimer
is to be requested.
 
Reissue applications: Where a terminal disclaimer
was filed in an original application, a copy of that terminal
disclaimer is not required be filed by applicant
in the reissue.
 
For reissue application files that are maintained in
paper:
 
The face of the file wrapper of the reissue application
should, however, be marked by the examiner in
order to indicate that a terminal disclaimer has been
filed for the patent (and will be effective for the patent
as it will be reissued). Further, a copy of the terminal
disclaimer should be placed in the reissue application
file by the Technology Center.
 
For IFW reissue applications:
 
The “Final SPRE Review” form will be filled in to
indicate that a terminal disclaimer has been filed for
the patent (and will be effective for the patent as it
will be reissued). Further, a copy of the terminal disclaimer
should be scanned into the reissue application
file history by the Technology Center.
 
C.Disclaimer Identifies the Wrong Target
Application or Patent
 
In some instances a terminal disclaimer filed to
obviate an obviousness type double patenting rejection
will identify the wrong target application or
patent (i.e., an application or patent which is not the
basis for the double patenting rejection). In these
instances, a replacement terminal disclaimer identifying
the correct target application or patent would be
required by the examiner. Once a correct replacement
terminal disclaimer is received, the next Office action
should make it clear that “the second terminal disclaimer
replaces the first terminal disclaimer, and the
first terminal disclaimer is thus void.” A second terminal
disclaimer fee should not be assessed/charged,
since the first fee is applied to the second terminal disclaimer.
 
 
D.Two or More Copending Applications
 
If two (or more) pending applications are filed, in
each of which a rejection of one claimed invention
over the other on the ground of provisional obviousness-
type double patenting (ODP) is proper, the ODP
rejection will be made in each application. If the ODP
rejection is the only rejection remaining in the earlier
filed of the two pending applications, (but the later-
filed application is rejectable on other grounds),
the
examiner should then withdraw that rejection
and
permit the earlier-filed application to issue as a
patent without a terminal disclaimer. If the ODP rejection
is the only rejection remaining in the later-filed
application, (while the earlier-filed application is
rejectable on other grounds), a terminal disclaimer
 
 
 
 
 
must be required in the later-filed application, before
the ODP rejection can be withdrawn.
 
If the ODP rejections in both applications are the
only rejections remaining in those applications, the
examiner should then withdraw the ODP rejection in
the earlier filed application thereby permitting that
application to issue without need of a terminal disclaimer.
A terminal disclaimer must be required in the
later-filed application before the ODP rejection can be
withdrawn and the application be permitted to issue.
 
If both applications are filed on the same day, the
examiner should determine which application claims
the base invention and which application claims the
improvement (added limitations). The ODP rejection
in the base application can be withdrawn without a
terminal disclaimer, while the ODP rejection in the
improvement application cannot be withdrawn without
a terminal disclaimer.
 
Where there are three applications containing
claims that conflict such that an ODP rejection is
made in each application based upon the other two, it
is not sufficient to file a terminal disclaimer in only
one of the applications addressing the other two applications.
Rather, an appropriate terminal disclaimer
must be filed in at least two of the applications to link
all three together. This is because a terminal disclaimer
filed to obviate a double patenting rejection is
effective only with respect to the application in which
the terminal disclaimer is filed; it is not effective to
link the other two applications to each other.
 
VI.FORM PARAGRAPHS
 
The following form paragraphs may be used to
inform the applicant (or patent owner) of the status of
a submitted terminal disclaimer.
 
¶ 14.23 Terminal Disclaimer Proper
 
The terminal disclaimer filed on [1] disclaiming the terminal
portion of any patent granted on this application which would
extend beyond the expiration date of [2] has been reviewed and is
accepted. The terminal disclaimer has been recorded.
 
Examiner Note:
 
1.In bracket 1, insert the date the terminal disclaimer was filed.
 
2.In bracket 2, list the Patent Number and/or Application Number
(including series code and serial no.). Where an Application
Number is listed, it must be preceded by the phrase --any patent
granted on Application Number--.
 
3.If an assignment is submitted to support the terminal disclaimer,
also use form paragraph 14.34 to suggest that the assignment
be separately submitted for recording in the Office.
 
4.See MPEP § 1490 for discussion of requirements for a
proper terminal disclaimer.
 
5.Use form paragraph 14.23.01 for reexamination proceedings.
 
6.For improper terminal disclaimers, see form paragraphs14.24et seq.
 
¶ 14.23.01 Terminal Disclaimer Proper (Reexamination
Only)
 
The terminal disclaimer filed on [1] disclaiming the terminal
portion of the patent being reexamined which would extend
beyond the expiration date of [2] has been reviewed and is
accepted. The terminal disclaimer has been recorded.
 
Examiner Note:
 
1.In bracket 1, insert the date the terminal disclaimer was filed.
 
2.In bracket 2, list the Patent Number and/or Application Number
(including series code and serial no.). Where an Application
Number is listed, it must be preceded by the phrase --any patent
granted on Application Number--.
 
3.If an assignment is submitted to support the terminal disclaimer,
also use 14.34 to suggest that the assignment be separately
submitted for recording in the Office.
 
4.See MPEP § 1490 for discussion of requirements for a
proper terminal disclaimer.
 
5.For improper terminal disclaimers, see the form paragraphs
which follow.
 
 
 
¶ 14.24 Terminal Disclaimer Not Proper - Introductory
Paragraph
 
The terminal disclaimer filed on [1] disclaiming the terminal
portion of any patent granted on this application which would
extend beyond the expiration date of [2] has been reviewed and is
NOT accepted.
 
Examiner Note:
 
1.In bracket 1, insert the date the terminal disclaimer was filed.
 
2.In bracket 2, list the Patent Number and/or Application Number
(including series code and serial no.). Where an Application
Number is listed, it must be preceded by the phrase --any patent
granted on Application Number--.
 
3.One or more of the appropriate form paragraphs 14.26 to
14.32 MUST follow this form paragraph to indicate why the terminal
disclaimer is not accepted.
 
4.Form paragraph 14.33 includes the full text of 37 CFR 3.73and may be included in the Office action when deemed appropriate.
 
 
5.Form paragraph 14.35 may be used to inform applicant that
an additional disclaimer fee will not be required for the submission
of a replacement or supplemental terminal disclaimer.
 
6.Do not use in reexamination proceedings, use form paragraph
14.25 instead.
 
 
 
 
 
 
 
¶ 14.25 Terminal Disclaimer Not Proper - Introductory
Paragraph (Reexamination Only)
 
The terminal disclaimer filed on [1] disclaiming the terminal
portion of the patent being reexamined which would extend
beyond the expiration date of [2] has been reviewed and is NOT
accepted.
 
Examiner Note:
 
1.In bracket 1, insert the date the terminal disclaimer was filed.
 
2.In bracket 2, list the Patent Number and/or the Application
Number (including series code and serial no.). Where an Application
Number is listed, it must be preceded by the phrase --any
patent granted on Application Number--.
 
3.One or more of the appropriate form paragraphs 14.26 to
14.32 MUST follow this form paragraph to indicate why the terminal
disclaimer is not accepted.
 
4.Form paragraph 14.33 includes the full text of 37 CFR 3.73and may be included in the Office action when deemed appropriate.
 
 
5.Form paragraph 14.35 may be used to inform applicant that
an additional disclaimer fee will not be required for the submission
of a replacement or supplemental terminal disclaimer.
 
¶ 14.26 Does Not Comply With 37 CFR 1.321(b) and/or
(c) “Sub-Heading” Only
 
The terminal disclaimer does not comply with 37 CFR
1.321(b) and/or (c) because:
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 and followed by one or more of the appropriate
form paragraphs 14.26.01 to 14.27.03.
 
¶ 14.26.01 Extent of Interest Not Stated
 
The person who has signed the disclaimer has not stated the
extent of his/her interest, or the business entity’s interest, in the
application/patent. See 37 CFR 1.321(b)(3).
 
Examiner Note:
 
This form paragraph MUST be preceded by form paragraph
14.24 or 14.25 AND 14.26.
 
¶ 14.26.02 Directed to Particular Claim(s)
 
It is directed to a particular claim or claims, which is not
acceptable, since “the disclaimer must be of a terminal portion of
the term of the entire [patent or] patent to be granted.” See MPEP
§ 1490.
 
Examiner Note:
 
This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26.
 
¶ 14.26.03 Not Signed
 
The terminal disclaimer was not signed.
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26.
 
¶ 14.26.04 Application/Patent Not Identified
 
The application/patent being disclaimed has not been identified.
 
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26.
 
¶ 14.26.05 Application/Patent Improperly Identified
 
The application/patent being disclaimed has been improperly
identified since the number used to identify the [1] being disclaimed
is incorrect. The correct number is [2].
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26.
 
2.In bracket 1, insert --application-- or --patent--.
 
3.In bracket 2, insert the correct Application Number (including
series code and serial no.) or the correct Patent Number being
disclaimed.
 
4.A terminal disclaimer is acceptable if it includes the correct
Patent Number or the correct Application Number or the serial
number together with the proper filing date or the proper series
code.
 
¶ 14.26.06 Not Signed by All Owners
 
It was not signed by all owners and, therefore, supplemental
terminal disclaimers are required from the remaining owners.
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26.
 
¶ 14.26.07 No Disclaimer Fee Submitted
 
The disclaimer fee of $ [1] in accordance with 37 CFR 1.20(d)
has not been submitted, nor is there any authorization in the application
file to charge a specified Deposit Account or credit card.
 
Examiner Note:
 
1.In bracket 1, insert the fee for a disclaimer.
 
2.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26. If the disclaimer fee was paid for a
terminal disclaimer which was not accepted, applicant does nothave to pay another disclaimer fee when submitting a replacement
or supplemental terminal disclaimer, and this form paragraph
should not be used.
 
¶ 14.27.01 Lacks Clause of Enforceable Only During
Period of Common Ownership
 
It does not include a recitation that any patent granted shall be
enforceable only for and during such period that said patent is
commonly owned with the application(s) or patent(s) which
formed the basis for the double patenting rejection. See 37 CFR
1.321(c)(3).
 
Examiner Note:
 
This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26.
 
 
 
 
 
 
 
¶ 14.27.011 Lacks 37 CFR 1.321(d) statement for joint
research agreement under 35 U.S.C. 103(c)(2)&(3)
 
It does not include the waiver and enforceability provisions of
37 CFR 1.321(d). The terminal disclaimer must include a provision:
 
 
(1) waiving the right to separately enforce (a) any patent
granted on that application or the patent being reexamined and (b)
the reference patent, or any patent granted on the reference application
which formed the basis of the double patenting; and
 
(2) agreeing that any patent granted on that application or
patent being reexamined shall be enforceable only for and during
such period that said patent and the reference patent, or any patent
granted on the reference application, which formed the basis for
the double patenting are not separately enforced.
 
See 37 CFR 1.321(d)(3).
 
Examiner Note:
 
This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.26, and this paragraph should be followed
by either form paragraph 14.27.07 or form paragraph 14.27.08.
 
 
 
¶ 14.27.02 Fails To Disclaim Terminal Portion of Any
Patent Granted On Subject Application
 
It fails to disclaim the terminal portion of any patent granted on
the subject application.
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraph
14.24 or 14.25 AND 14.26.
 
2.Use this form paragraph when the period disclaimed is not
the correct period or when no period is specified at all.
 
3.When using this form paragraph, give an example of proper
terminal disclaimer language using form paragraph 14.27.04 following
this or the series of statements concerning the defective
terminal disclaimer.
 
¶ 14.27.03 Fails To Disclaim Terminal Portion of Subject
Patent
 
It fails to disclaim the terminal portion of the subject patent.
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraph
14.24 or 14.25 AND 14.26.
 
2.Use this form paragraph in a reissue application or reexamination
proceeding when the period disclaimed is not the correct
period or when no period is specified at all.
 
 
 
¶ 14.27.04 Examples of Acceptable Terminal Disclaimer
Language in Patent To Be Granted
 
Examples of acceptable language for making the disclaimer of
the terminal portion of any patent granted on the subject application
follow:
 
I. If a Provisional Obviousness-Type Double Patenting
Rejection Over A Pending Application was made, use:
 
The owner, _________________________________,
of ____________ percent interest in the instant application
hereby disclaims the terminal part of the statutory term of
any patent granted on the instant application which would
extend beyond the expiration date of the full statutory term
of any patent granted on pending reference Application
Number ________________, filed on _____________, as
such term is defined in 35 U.S.C. 154 and 173, and as the
term of any patent granted on said reference application
may be shortened by any terminal disclaimer filed prior to
the grant of any patent on the pending reference application.
The owner hereby agrees that any patent so granted on
the instant application shall be enforceable only for and during
such period that it and any patent granted on the reference
application are commonly owned. This agreement
runs with any patent granted on the instant application and
is binding upon the grantee, its successors or assigns.
 
II. If an Obviousness-Type Double Patenting Rejection
Over A Prior Patent was made, use:
 
The owner, _________________________________,
of ____________ percent interest in the instant application
hereby disclaims the terminal part of the statutory term of
any patent granted on the instant application which would
extend beyond the expiration date of the full statutory term
of reference patent No. ________________ as the term of
said prior patent is defined in 35 U.S.C. 154 and 173 , and
as the term of said reference patent is presently shortened
by any terminal disclaimer. The owner hereby agrees that
any patent so granted on the instant application shall be
enforceable only for and during such period that it and the
reference patent are commonly owned. This agreement
runs with any patent granted on the instant application and
is binding upon the grantee, its successors or assigns.
 
Alternatively, Form PTO/SB/25 may be used for situation I,
and Form PTO/SB/26 may be used for situation II; a copy of each
form may be found at the end of MPEP § 1490.
 
Examiner Note:
 
1.To provide examples of acceptable terminal disclaimer language
in a patent (e.g., for a reexamination situation), other than
for a terminal disclaimer based on activities undertaken within the
scope of a joint research agreement, use form paragraph 14.27.06.
 
2.To provide examples of acceptable terminal disclaimer language
for a terminal disclaimer based on activities undertaken
within the scope of a joint research agreement, (a) use form paragraph
14.27.07 for making the disclaimer of the terminal portion
of a patent to be granted on an application (generally, an application
being examined), and (b) use form paragraph 14.27.08 for
making the disclaimer of the terminal portion of an existing patent
(e.g., for a reexamination situation).
 
 
 
 
 
 
 
¶ 14.27.06 Examples of Acceptable Terminal Disclaimer
Language in Patent (Reexamination Situation)
 
Examples of acceptable language for making the disclaimer of
the terminal portion of the patent being reexamined (or otherwise
for an existing patent) follow:
 
I. If a Provisional Obviousness-Type Double Patenting
Rejection Over A Pending Application was made, or is
otherwise believed to be applicable to the patent, use:
 
The patent owner hereby disclaims the terminal part of
the instant patent, which would extend beyond the expiration
date of the full statutory term of any patent granted on
pending Application Number ______________, filed on
______________, as such term is defined in 35 U.S.C. 154and 173, and as the term of any patent granted on said application
may be shortened by any terminal disclaimer filed
prior to the grant of any patent on the pending application.
The patent owner hereby agrees that the instant patent shall
be enforceable only for and during such period that the
instant patent and any patent granted on the above-listed
pending application are commonly owned. This agreement
is binding upon the patent owner, its successors, or assigns.
 
II. If an Obviousness-Type Double Patenting Rejection
Over A Prior Patent was made, or is otherwise believed
to be applicable to the patent, use:
 
The patent owner hereby disclaims the terminal part of
the instant patent, which would extend beyond the expiration
date of the full statutory term of reference patent No.
______________ as the term of said reference patent is
defined in 35 U.S.C. 154 and 173, and as the term of said
reference patent is presently shortened by any terminal disclaimer.
The patent owner hereby agrees that the instant
patent shall be enforceable only for and during such period
that the instant patent and the reference patent are commonly
owned. This agreement is binding upon the patent
owner, its successors, or assign.
 
Examiner Note:
 
1.To provide examples of acceptable terminal disclaimer language
in a patent to be granted on an application (generally, an
application being examined), other than for a terminal disclaimer
based on activities undertaken within the scope of a joint research
agreement, use form paragraph 14.27.04.
 
2.To provide examples of acceptable terminal disclaimer language
for a terminal disclaimer based on activities undertaken
within the scope of a joint research agreement, (a) use form paragraph
14.27.07 for making the disclaimer of the terminal portion
of a patent to be granted on an application (generally, an application
being examined), and (b) use form paragraph 14.27.08 for
making the disclaimer of the terminal portion of an existing patent
(e.g., for a reexamination situation).
 
 
 
¶ 14.27.07 Examples of Acceptable Terminal Disclaimer
Language in Patent To Be Granted (activities undertaken
within the scope of a joint research agreement)
 
Examples of acceptable language for making the disclaimer of
the terminal portion of any patent granted on the subject application
follow:
 
I. If a Provisional Obviousness-Type Double Patenting
Rejection Over A Pending Application was made, use:
 
The owner, __________________, of _______ percent
interest in the instant application hereby disclaims the terminal
part of the statutory term of any patent granted on the
instant application which would extend beyond the expiration
date of the full statutory term of any patent granted on
pending reference Application Number ______________,
filed on ______________, as such term is defined in 35
U.S.C. 154 and 173, and as the term of any patent granted
on said reference application may be shortened by any terminal
disclaimer filed prior to the grant of any patent on the
pending reference application.
 
The owner of the instant application waives the right to
separately enforce any patent granted on the instant application
and any patent granted on the reference application.
The owner of the instant application hereby agrees that any
patent granted on the instant application and any patent
granted on the reference application shall be enforceable
only for and during such period that the instant application
and the reference application are not separately enforced.
The waiver, and this agreement, run with any patent granted
on the instant application and any patent granted on the reference
application, and are binding upon the owner of the
instant application, its successors, or assigns.
 
Owner, or attorney/agent of record, of the instant application:
 
Signature:__________________________
 
Printed/Typed name:_________________
 
II. If an Obviousness-Type Double Patenting Rejection
Over A Prior Patent was made, use:
 
The owner, __________________, of _______ percent
interest in the instant application hereby disclaims the terminal
part of the statutory term of any patent granted on the
instant application which would extend beyond the expiration
date of the full statutory term of reference patent No.
_________________, as the term of said prior patent is
defined in 35 U.S.C. 154 and 173, and as the term of said
reference patent is presently shortened by any terminal disclaimer.
 
 
The owner of the instant application waives the right to
separately enforce the reference patent and any patent
granted on the instant application. The owner of the instant
application hereby agrees that the reference patent and any
patent granted on the instant application shall be enforce
 
 
 
 
 
 
able only for and during such period that the reference
patent and any patent granted on the instant application are
not separately enforced. The waiver, and this agreement, run
with any patent granted on the instant application and are
binding upon the owner of the instant application, its successors,
or assigns.
 
Owner, or attorney/agent of record, of the instant application:
 
Signature:___________________________
 
Printed/Typed name:__________________
 
Examiner Note:
 
1.To provide examples of acceptable terminal disclaimer language
in a patent (e.g., for a reexamination situation) for a terminal
disclaimer based on activities undertaken within the scope of a
joint research agreement, use form paragraph 14.27.08.
 
2.To provide examples of acceptable terminal disclaimer language
for a terminal disclaimer in a situation other than one based
on activities undertaken within the scope of a joint research agreement,
(a) use form paragraph 14.27.04 for making the disclaimer
of the terminal portion of a patent to be granted on an application
(generally, an application being examined), and (b) use form paragraph
14.27.06 for making the disclaimer of the terminal portion
of an existing patent (e.g., for a reexamination situation).
 
¶ 14.27.08 Examples of Acceptable Terminal Disclaimer
Language in Patent (Reexamination Situation; activities
undertaken within the scope of a joint research agreement)
 
Examples of acceptable language for making the disclaimer of
the terminal portion of the patent being reexamined (or otherwise
for an existing patent) follow:
 
I. If a provisional obviousness-type double patenting
rejection over a Pending Application was made, or is otherwise
believed to be applicable to the patent, use:
 
The patent owner hereby disclaims the terminal part of
the instant patent, which would extend beyond the expiration
date of the full statutory term of any patent granted on
pending Application Number ______________, filed on
______________, as such term is defined in 35 U.S.C. 154and 173, and as the term of any patent granted on said application
may be shortened by any terminal disclaimer filed
prior to the grant of any patent on the pending application.
 
The patent owner waives the right to separately enforce
the instant patent and the above-listed pending application.
The patent owner agrees that the instant patent and any
patent granted on the above-listed pending application shall
be enforceable only for and during such period that the
instant patent and the patent granted on the above-listed
pending application are not separately enforced. The
waiver, and this agreement, run with any patent granted on
the above-listed pending application, and are binding upon
the patent owner, its successors, or assigns.
 
Patent Owner, or attorney/agent of record:
 
Signature:_________________________
 
Printed/Typed name:________________
 
II. If an obviousness-type double patenting rejection
over a Reference Patent was made, or is otherwise believed
to be applicable to the patent, use:
 
The patent owner hereby disclaims the terminal part of
the instant patent, which would extend beyond the expiration
date of the full statutory term of reference patent No.
_________________, as the term of said reference patentis defined in 35 U.S.C. 154 and 173, and as the term of said
reference patent is presently shortened by any terminal disclaimer.
 
 
The patent owner waives the right to separately enforce
the instant patent and the reference patent. The patent
owner agrees that the instant patent and the reference
patent shall be enforceable only for and during such period
that the instant patent and the reference patent are not separately
enforced. The waiver, and this agreement, are binding
upon the patent owner, its successors, or assigns.
 
Patent Owner, or attorney/agent of record:
 
Signature:_________________________
 
Printed/Typed name:________________
 
Examiner Note:
 
1.To provide examples of acceptable terminal disclaimer language
in a patent to be granted on an application (generally, an
application being examined) for a terminal disclaimer based on
activities undertaken within the scope of a joint research agreement,
use form paragraph 14.27.07.
 
2.To provide examples of acceptable terminal disclaimer language
for a terminal disclaimer in a situation other than one based
on activities undertaken within the scope of a joint research agreement,
(a) use form paragraph 14.27.04 for making the disclaimer
of the terminal portion of a patent to be granted on an application
(generally, an application being examined), and (b) use form paragraph
14.27.06 for making the disclaimer of the terminal portion
of an existing patent (e.g., for a reexamination situation).
 
 
 
¶ 14.28 Failure To State Capacity To Sign
 
The person who signed the terminal disclaimer has failed to
state his/her capacity to sign for the corporation, or other business
entity or organization, and he/she has not been established as
being authorized to act on behalf of the assignee.
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraph
14.24 or 14.25 AND 14.26.
 
¶ 14.29 Not Recognized as Officer of Assignee - “Sub-
Heading” Only
 
The person who signed the terminal disclaimer is not recognized
as an officer of the assignee, and he/she has not been established
as being authorized to act on behalf of the assignee. See
MPEP § 324.
 
 
 
 
 
Examiner Note:
 
1.This form paragraph is to be used when the person signing
the terminal disclaimer is not an authorized officer as defined in
MPEP § 324.
 
2.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 and followed by form paragraphs 14.29.01 and/or
14.29.02 when appropriate. An attorney or agent of record is
always authorized to sign the terminal disclaimer, even though
there is no indication that he or she is an officer of the assignee.
 
3.Use form paragraph 14.29.02 to explain how an official,
other than a recognized officer, may properly sign a terminal disclaimer.
 
 
¶ 14.29.01 Attorney/Agent Not of Record
 
An attorney or agent, not of record, is not authorized to sign a
terminal disclaimer in the capacity as an attorney or agent acting
in a representative capacity as provided by 37 CFR 1.34 (a). See
37 CFR 1.321(b) and/or
(c).
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.29.
 
2.An attorney or agent, however, may sign a terminal disclaimer
provided he/she is an attorney or agent of record or is
established as an appropriate official of the assignee. To suggest to
the attorney or agent, not of record, how he/she may establish status
as an appropriate official of the assignee to sign a terminal disclaimer,
use form paragraph 14.29.02.
 
¶ 14.29.02 Criteria To Accept Terminal Disclaimer When
Signed by a Non-Recognized Officer
 
It would be acceptable for a person, other than a recognized
officer, to sign a terminal disclaimer, provided the record for the
application includes a statement that the person is empowered to
sign terminal disclaimers and/or act on behalf of the assignee.
 
Accordingly, a new terminal disclaimer which includes the
above empowerment statement will be considered to be signed by
an appropriate official of the assignee. A separately filed paper
referencing the previously filed terminal disclaimer and containing
a proper empowerment statement would also be acceptable.
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraphs
14.24 or 14.25 AND 14.29.
 
2.When form paragraph 14.29 is used to indicate that a terminal
disclaimer is denied because it was not signed by a recognized
officer nor by an attorney or agent of record, this form paragraph
should be used to point out one way to correct the problem.
 
3.While an indication of the person’s title is desirable, its inclusion
is not mandatory when this option is employed.
 
4.A sample terminal disclaimer should be sent with the Office
action.
 
 
 
¶ 14.30 No Evidence of Chain of Title to Assignee -
Application
 
The assignee has not established its ownership interest in the
application, in order to support the terminal disclaimer. There is
no submission in the record establishing the ownership interest by
either (a) providing documentary evidence of a chain of title from
the original inventor(s) to the assignee and a statement affirming
that the documentary evidence of the chain of title form the original
owner to the assignee was, or concurrently is being, submitted
for recordatoin pursuant to 37 CFR 3.11, or (b) specifying (by reel
and frame number) where such documentary evidence is recorded
in the Office (37 CFR 3.73(b)).
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraph
14.24 or 14.25.
 
2.Where an attorney or agent of record signs a terminal disclaimer,
there is no need to provide a statement under 37 CFR
3.73(b). Thus, this form paragraph should not be used.
 
3.It should be noted that the documentary evidence or the specifying
of reel and frame number may be found in the terminal disclaimer
itself or in a separate paper.
 
¶ 14.30.01 No Evidence of Chain of Title to Assignee -
Patent
 
The assignee has not established its ownership interest in the
patent, in order to support the terminal disclaimer. There is no
submission in the record establishing the ownership interest by
either (a) providing documentary evidence of a chain of title from
the original inventor(s) to the assignee and a statement affirming
that the documentary evidence of the chain of title form the original
owner to the assignee was, or concurrently is being, submitted
for recordatoin pursuant to 37 CFR 3.11, or (b) specifying (by reel
and frame number) where such documentary evidence is recorded
in the Office (37 CFR 3.73(b)).
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraph
14.24 or 14.25.
 
2.Where an attorney or agent of record signs a terminal disclaimer,
there is no need to provide a statement under 37 CFR
3.73(b). Thus, this form paragraph should not be used.
 
3.It should be noted that the documentary evidence or the specifying
of reel and frame number may be found in the terminal disclaimer
itself or in a separate paper in the application.
 
 
 
¶ 14.30.02 Evidence of Chain of Title to Assignee -
Submission Not Signed by Appropriate Party - Terminal
Disclaimer Is Thus Not Entered
 
The submission establishing the ownership interest of the
assignee is informal. There is no indication of record that the party
who signed the submission establishing the ownership interest is
authorized to sign the submission (37 CFR 3.73(b)).
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraph
14.24 or 14.25.
 
2.Where an attorney or agent of record signs a terminal disclaimer,
there is no need to provide any statement under 37 CFR
3.73(b). Thus, this form paragraph should not be used.
 
 
 
 
 
3.This form paragraph should be followed by one of form paragraphs
14.16.02 or 14.16.03. In rare situations where BOTH form
paragraphs 14.16.02 and 14.16.03 do not apply and thus cannot be
used, the examiner should instead follow this form paragraph with
a detailed statement of why the there is no authorization to sign.
 
4.Use form paragraph 14.16.06 to point out one way to correct
the problem.
 
¶ 14.32 Application/Patent Which Forms Basis for
Rejection Not Identified
 
The application/patent which forms the basis for the double
patenting rejection is not identified in the terminal disclaimer.
 
Examiner Note:
 
1.This form paragraph MUST be preceded by form paragraph
14.24 or 14.25.
 
2.Use this form paragraph when no information is presented. If
incorrect information is contained in the terminal disclaimer, use
form paragraphs 14.26 and 14.26.05.
 
 
 
¶ 14.33 37 CFR 3.73 - Establishing Right of Assignee To
Take Action
 
The following is a statement of 37 CFR 3.73:
 
37 CFR 3.73 Establishing right of assignee to take action.
 
(a) The inventor is presumed to be the owner of a patent
application, and any patent that may issue therefrom, unless
there is an assignment. The original applicant is presumed
to be the owner of a trademark application or registration,
unless there is an assignment.
 
(b)(1) In order to request or take action in a patent or trademark
matter, the assignee must establish its ownership of
the patent or trademark property of paragraph (a) of this section
to the satisfaction of the Director. The establishment of
ownership by the assignee may be combined with the paper
that requests or takes the action. Ownership is established
by submitting to the Office a signed statement identifying
the assignee, accompanied by either:
 
(i) Documentary evidence of a chain of title from the original
owner to the assignee (e.g., copy of an executed assignment).
For trademark matters only, the documents submitted
to establish ownership may be required to be recorded pursuant
to § 3.11 in the assignment records of the Office as a
condition to permitting the assignee to take action in a matter
pending before the Office. For patent matters only, the
submission of the documentary evidence must be accompanied
by a statement affirming that the documentary evidence
of the chain of title from the original owner to the
assignee was, or concurrently is being, submitted for recordation
pursuant to § 3.11; or
 
(ii) A statement specifying where documentary evidence of
a chain of title from the original owner to the assignee is
recorded in the assignment records of the Office (e.g., reel
and frame number).
 
(2) The submission establishing ownership must show that
the person signing the submission is a person authorized to
act on behalf of the assignee by:
 
(i) Including a statement that the person signing the submission
is authorized to act on behalf of the assignee; or
 
(ii) Being signed by a person having apparent authority to
sign on behalf of the assignee, e.g., an officer of the
assignee.
 
(c) For patent matters only:
 
(1) Establishment of ownership by the assignee must be
submitted prior to, or at the same time as, the paper requesting
or taking action is submitted.
 
(2) If the submission under this section is by an assignee of
less than the entire right, title and interest, such assignee
must indicate the extent (by percentage) of its ownership
interest, or the Office may refuse to accept the submission
as an establishment of ownership.
 
¶ 14.34 Requirement for Statement To Record Assignment
Submitted With Terminal Disclaimer
 
The assignment document filed on [1] is not acceptable as the
documentary evidence required by 37 CFR 3.73. The submission
of the documentary evidence was not accompanied by a statement
affirming that the documentary evidence of the chain of title from
the original owner to the assignee was, or concurrently is being,
submitted for recordation pursuant to 37 CFR 3.11. See 37 CFR
3.11 and MPEP § 302.
 
Examiner Note:
 
1.In bracket 1, insert the date the assignment document was
filed.
 
2.This form paragraph should be used when an assignment
document (an original, facsimile, or copy) is submitted to satisfy
37 CFR 3.73(b) was not accompanied by a statement affirming
that the documentary evidence of the chain of title from the original
owner to the assignee was, or concurrently is being, submitted
for recordation, and the documentary evidence has not been
recorded among the assignment records of the Office.
 
 
 
¶ 14.35 Disclaimer Fee Not Required Twice - Applicant
 
It should be noted that applicant is not required to pay another
disclaimer fee as set forth in 37 CFR 1.20(d) when submitting a
replacement or supplemental terminal disclaimer.
 
Examiner Note:
 
1.This form paragraph can be used to notify an applicant that
another disclaimer fee will not be required when a replacement or
supplemental terminal disclaimer is submitted.
 
2.Use form paragraph 14.35.01 for providing notification to
patent owner, rather than an applicant.
 
 
 
 
 
¶ 14.35.01 Disclaimer Fee Not Required Twice - Patent
Owner
 
It should be noted that patent owner is not required to pay
another disclaimer fee as set forth in 37 CFR 1.20(d) when submitting
a replacement or supplemental terminal disclaimer.
 
Examiner Note:
 
This form paragraph can be used to notify a patent owner that
another disclaimer fee will not be required when a replacement or
supplemental terminal disclaimer is submitted.
 
¶ 14.36 Suggestion That “Applicant” Request a Refund
 
Since the required fee for the terminal disclaimer was previously
paid, applicant’s payment of an additional terminal disclaimer
fee is not required. Applicant may request a refund of this
additional terminal disclaimer fee by submitting a written request
for a refund and a copy of this Office action to: Mail Stop 16,
Director of the United States Patent and Trademark Office, P.O.
Box 1450, Alexandria, Virginia 22313-1450.
 
Examiner Note:
 
1.This form paragraph should be used to notify applicant that a
refund can be obtained if another terminal disclaimer fee was paid
when a replacement or supplemental terminal disclaimer was submitted.
 
 
2.Note - If applicant has authorized or requested a fee refund to
be credited to a specific Deposit Account or credit card, then an
appropriate credit should be made to that Deposit Account or
credit card and this paragraph should NOT be used.
 
3.Use form paragraph 14.36.01 for providing notification to
patent owner, rather than an applicant.
 
¶ 14.36.01 Suggestion That “Patent Owner” Request a
Refund
 
Since the required fee for the terminal disclaimer was previously
paid, patent owner’s payment of an additional terminal disclaimer
fee is not required. Patent owner may request a refund of
this additional terminal disclaimer fee by submitting a written
request for a refund and a copy of this Office action to: Mail Stop
16, Director of the United States Patent and Trademark Office,
P.O. Box 1450, Alexandria, Virginia 22313-1450.
 
Examiner Note:
 
1.This form paragraph should be used to notify patent owner
that a refund can be obtained if another terminal disclaimer fee
was paid when a replacement or supplemental terminal disclaimer
was submitted.
 
2.Note - If patent owner has authorized or requested a fee
refund to be credited to a specific Deposit Account or credit card,
then an appropriate credit should be made to that Deposit Account
or credit card and this form paragraph should NOT be used.
 
 
 
¶ 14.37 Samples of a Terminal Disclaimer Over a Pending
Application and Assignee Statement Enclosed
 
Enclosed with this Office action is a sample terminal disclaimer
which is effective to overcome a provisional obviousness-
type double patenting rejection over a pending application (37
CFR 1.321(b) and (c)).
 
Also enclosed is a sample Statement Under 37 CFR 3.73(b)
(Form PTO/SB/96) which an assignee may use in order to ensure
compliance with the rule. Part A of the Statement is used when
there is a single assignment from the inventor(s). Part B of the
Statement is used when there is a chain of title. The “Copies of
assignments...” box should be checked when the assignment document(
s) (set forth in part A or part B) is/are not recorded in the
Office, and a copy of the assignment document(s) is/are attached.
When the “Copies of assignments...” box is checked, either the
part A box or the part B box, as appropriate, must be checked, and
the “Reel_____, Frame_____” entries should be left blank. If the
part B box is checked, and copies of assignments are not included,
the “From:______ To:______” blank(s) must be filled in. This
statement should be used the first time an assignee seeks to take
action in an application under 37 CFR 3.73(b), e.g., when signing
a terminal disclaimer or a power of attorney.
 
Examiner Note:
 
1.This form paragraph can be used to provide applicant samples
of a terminal disclaimer which contains the necessary clauses
to overcome a provisional obviousness-type double patenting
rejection over a pending application and a Statement to be signed
by an assignee to ensure compliance with 37 CFR 3.73(b).
 
2.Note that the requirements for compliance with 37 CFR 3.73(b) have been made more liberal, such that certain specifics of the
sample statement are no longer required. At present, in order to
comply with 37
CFR 3.73(b), the assignee’s ownership interest
must be established by (a) filing in the application or patent evidence
of a chain of title from the original owner to the assignee
and a statement affirming that the documentary evidence of the
chain of title from the original owner to the assignee was, or concurrently
is being, submitted for recordation pursuant to 37 CFR
3.11, or (b) specifying in the record of the application or patent
where such evidence is recorded in the Office (e.g., reel and frame
number, etc.). The submission with respect to (a) and (b) to establish
ownership must be signed by a party authorized to act on
behalf of the assignee.
 
(See your Technology Center Paralegal or Special Program Examiner
for copies of the sample terminal disclaimer and Statement
Under 37 CFR 3.73(b) to enclose with the Office action. Alternatively,
it is permissible to copy the sample terminal disclaimer
found after MPEP § 1490 and the Sample Statement Under 37
CFR 3.73(b) found after MPEP § 324.)
 
¶ 14.38 Samples of a Terminal Disclaimer Over a Prior
Patent and Assignee Statement Enclosed
 
Enclosed with this Office action is a sample terminal disclaimer
which is effective to overcome an obviousness-type double
patenting rejection over a prior patent (37 CFR 1.321(b) and
(c)).
 
Also enclosed is a sample Statement Under 37 CFR 3.73(b)
(Form PTO/SB/96) which an assignee may use in order to ensure
compliance with the rule. Part A of the Statement is used when
there is a single assignment from the inventor(s). Part B of the
Statement is used when there is a chain of title. The “Copies of
assignments...” box should be checked when the assignment doc
 
 
 
 
 
 
ument(s) (set forth in part A or part B) is/are not recorded in the
Office, and a copy of the assignment document(s) is/are attached.
When the “Copies of assignments...” box is checked, either the
part A box or the part B box, as appropriate, must be checked, and
the “Reel_____, Frame_____” entries should be left blank. If the
part B box is checked, and copies of assignments are not included,
the “From:______ To:______” blank(s) must be filled in. This
statement should be used the first time an assignee seeks to take
action in an application under 37 CFR 3.73(b), e.g., when signing
a terminal disclaimer or a power of attorney.
 
Examiner Note:
 
1.This form paragraph can be used to provide applicant samples
of a terminal disclaimer which contains the necessary clauses
to overcome an obviousness-type double patenting rejection over
a prior patent and a Statement to be signed by an assignee to
ensure compliance with 37 CFR 3.73(b).
 
2.Note that the requirements for compliance with 37 CFR 3.73(b) have been made more liberal, such that certain specifics of the
sample statement are no longer required. At present, in order to
comply with 37
CFR 3.73(b), the assignee’s ownership interest
must be established by (a) filing in the application or patent evidence
of a chain of title from the original owner to the assignee
and a statement affirming that the documentary evidence of the
chain of title from the original owner to the assignee was, or concurrently
is being, submitted for recordation pursuant to 37 CFR
3.11, or (b) specifying in the record of the application or patent
where such evidence is recorded in the Office (e.g., reel and frame
number, etc.). The submission with respect to (a) and (b) to establish
ownership must be signed by a party authorized to act on
behalf of the assignee.
 
(See your Technology Center Paralegal or Special Program Examiner
for copies of the sample terminal disclaimer and Statement
Under 37 CFR 3.73(b) to enclose with the Office action. Alternatively,
it is permissible to copy the sample terminal disclaimer
found after MPEP § 1490 and the Sample Statement Under 37
CFR 3.73(b) found after MPEP § 324.)
 
¶ 14.39 Sample Assignee Statement Under 37 CFR 3.73(b)
Enclosed
 
Enclosed with this Office action is a sample Statement under
37 CFR 3.73(b) which an assignee may use in order to ensure
compliance with the Rule. Part A of the Statement is used when
there is a single assignment from the inventor(s). Part B of the
Statement is used when there is a chain of title. The “Copies of
assignments...” box should be checked when the assignment document(
s) (set forth in part A or part B) is/are not recorded in the
Office, and a copy of the assignment document(s) is/are attached.
When the “Copies of assignments...” box is checked, either the
part A box or the part B box, as appropriate, must be checked, and
the “Reel_____, Frame_____” entries should be left blank. If the
part B box is checked, and copies of assignments are not included,
the “From:______ To:______” blank(s) must be filled in. This
statement should be used the first time an assignee seeks to take
action in an application under 37 CFR 3.73(b).
 
Examiner Note:
 
1.This form paragraph can be used to provide applicant a sample
of a Statement to be signed by an assignee to ensure compliance
with 37 CFR 3.73(b).
 
2.Note that the requirements for compliance with 37 CFR 3.73(b) have been made more liberal, such that certain specifics of the
sample statement are no longer required. At present, in order to
comply with 37
CFR 3.73(b), the assignee’s ownership interest
must be established by (a) filing in the application or patent evidence
of a chain of title from the original owner to the assignee
and a statement affirming that the documentary evidence of the
chain of title from the original owner to the assignee was, or concurrently
is being, submitted for recordation pursuant to 37 CFR
3.11, or (b) specifying in the record of the application or patent
where such evidence is recorded in the Office (e.g., reel and frame
number, etc.). The submission with respect to (a) and (b) to establish
ownership must be signed by a party authorized to act on
behalf of the assignee.
 
(See your Technology Center Paralegal or Special Program Examiner
for a copy of the sample Statement Under 37 CFR 3.73(b) to
enclose with the Office action. Alternatively, it is permissible to
copy the sample Statement Under 37
CFR 3.73(b) found after
MPEP § 324.)
 
 
 
VII.WITHDRAWING A RECORDED TER-
MINAL DISCLAIMER
 
If timely requested, a recorded terminal disclaimer
may be withdrawn before the application in which it
is filed issues as a patent, or in a reexamination proceeding,
before the reexamination certificate issues.
After a patent or reexamination certificate issues, it is
unlikely that a recorded terminal disclaimer will be
nullified.
 
A. Before Issuance Of Patent
 
While the filing and recordation of an unnecessary
terminal disclaimer has been characterized as an
“unhappy circumstance” in In re Jentoft, 392 F.2d
633, 157 USPQ 363 (CCPA 1968), there is no statutory
prohibition against nullifying or otherwise canceling
the effect of a recorded terminal disclaimer
which was erroneously filed before the patent issues.
Since the terminal disclaimer would not take effect
until the patent is granted, and the public has not had
the opportunity to rely on the terminal disclaimer,
relief from this unhappy circumstance may be available
by way of petition or by refiling the application
(other than by refiling it as a CPA).
 
Under appropriate circumstances, consistent with
the orderly administration of the examination process,
 
 
 
 
 
the nullification of a recorded terminal disclaimer
may be addressed by filing a petition under 37 CFR
1.182 requesting withdrawal of the recorded terminal
disclaimer. Petitions seeking to reopen the question of
the propriety of the double patenting rejection that
prompted the filing of the terminal disclaimer have
not been favorably considered. The filing of a continuing
application other than a CPA, while abandoning
the application in which the terminal disclaimer
has been filed, will typically nullify the effect of a terminal
disclaimer. The filing of a Request for Continued
Examination (RCE) of an application under
37
CFR 1.114 will not nullify the effect of a terminal
disclaimer, since a new application has not been filed,
but rather prosecution has been continued in the existing
application.
 
B.After Issuance Of Patent
 
The mechanisms to correct a patent — Certificate
of Correction (35 U.S.C. 255), reissue (35 U.S.C.
251), and reexamination (35 U.S.C. 305) — are not
available to withdraw or otherwise nullify the effect
of a recorded terminal disclaimer. As a general principle,
public policy does not favor the restoration to the
patent owner of something that has been freely dedicated
to the public, particularly where the public interest
is not protected in some manner — e.g.,
intervening rights in the case of a reissue patent. See,
e.g., Altoona Publix Theatres v. American Tri-Ergon
Corp., 294
U.S. 477, 24 USPQ 308 (1935).
 
Certificates of Correction (35 U.S.C. 255) are
available for the correction of an applicant’s mistake.
The scope of this remedial provision is limited in
two
ways — by the nature of the mistake for which
correction is sought and the nature of the proposed
correction. In re Arnott, 19 USPQ2d 1049 (Comm’r
Pat. 1991). The nature of the mistake for which correction
is sought is limited to those mistakes that are:
 
(A)of a clerical nature,
 
(B)of a typographical nature, or
 
(C)of a minor character.
 
The nature of the proposed correction is limited to
those situations where the correction does not involve
changes which would:
 
(A)constitute new matter, or
 
(B)require reexamination.
 
A mistake in filing a terminal disclaimer does not
fall within any of the categories of mistake for which
a certificate of correction of applicant’s mistake is
permissible, and any attempt to remove or nullify the
effect of the terminal disclaimer would typically
require reexamination of the circumstances under
which it was filed.
 
Although the remedial nature of reissue (35 U.S.C.
251) is well recognized, reissue is not available to correct
all errors. It has been the Office position that reissue
is not available to withdraw or otherwise nullify
the effect of a terminal disclaimer recorded in an
issued patent. First, the reissue statute only authorizes
the Director of the USPTO to reissue a patent “for the
unexpired part of the term of the original patent.”
Since the
granting of a reissue patent without the
effect of
a
recorded terminal disclaimer would result
in extending the term of the original patent, reissue
under these circumstances would be contrary to the
statute. Second, the principle against recapturing
something that has been intentionally dedicated to the
public dates back to Leggett v. Avery, 101 U.S. 256
(1879). The attempt to restore that portion of the
patent term that was dedicated to the public to secure
the grant of the original patent would be contrary to
this recapture principle. Finally, applicants have the
opportunity to challenge the need for a terminal disclaimer
during the prosecution of the application that
issues as a patent. “Reissue is not a substitute for
Patent Office appeal procedures.” Ball Corp. v. United
States, 729
F.2d 1429, 1435, 221 USPQ 289, 293
(Fed. Cir. 1984). Where applicants did not challenge
the propriety of the examiner’s obvious-type double
patenting rejection, but filed a terminal disclaimer to
avoid the rejection, the filing of the terminal disclaimer
did not constitute error within the meaning of
35 U.S.C. 251. Ex parte Anthony, 230 USPQ 467 (Bd.
App. 1982), aff’d, No. 84-1357 (Fed. Cir. June 14,
1985).
 
Finally, the nullification of a recorded terminal disclaimer
would not be appropriate in a reexamination
proceeding. There is a prohibition (35 U.S.C. 305)
against enlarging the scope of a claim during a reexamination
proceeding. As noted by the Board in
Anthony, supra, if a terminal disclaimer was nullified,
“claims would be able to be sued upon for a longer
 
 
 
 
 
period than would the claims of the original patent.
Therefore, the vertical scope, as opposed to the horizontal
scope (where the subject matter is enlarged),
would be enlarged.”
 
 
 
 
 
 
 
TERMINAL DISCLAIMER TO OBVIATE A PROVISIONAL DOUBLE PATENTING REJECTION OVER A PENDING “REFERENCE” APPLICATION
PTO/SB/25(07-06)
Approved for use through 09/30/2006. OMB 0651-0031
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
TERMINAL DISCLAIMER TO OBVIATE A PROVISIONAL DOUBLE PATENTING
REJECTION OVER A PENDING “REFERENCE” APPLICATIONDocket Number (Optional)
In re Application of:
Application No.:
Filed:
For:
The owner, ________________________________________, of ________ percent interest in the instant application hereby disclaims,
except as provided below, the terminal part of the statutory term of any patent granted on the instant application which would extend beyond
the expiration date of the full statutory term of any patent granted on pending reference Application Number ______________________, filed
on ____________________, as such term is defined in 35 U.S.C. 154 and 173, and as the term of any patent granted on said referenceapplication may be shortened by any terminal disclaimer filed prior to the grant of any patent on the pending reference application. The owner
hereby agrees that any patent so granted on the instant application shall be enforceable only for and during such period that it and any patent
granted on the reference application are commonly owned. This agreement runs with any patent granted on the instant application and is
binding upon the grantee, its successors or assigns.
In making the above disclaimer, the owner does not disclaim the terminal part of any patent granted on the instant application that would
extend to the expiration date of the full statutory term as defined in 35 U.S.C. 154 and 173 of any patent granted on said referenceapplication, “as the term of any patent granted on said reference application may be shortened by any terminal disclaimer filed prior to the
grant of any patent on the pending reference application,” in the event that: any such patent: granted on the pending reference application:
expires for failure to pay a maintenance fee, is held unenforceable, is found invalid by a court of competent jurisdiction, is statutorily disclaimed
in whole or terminally disclaimed under 37 CFR 1.321, has all claims canceled by a reexamination certificate, is reissued, or is in any manner
terminated prior to the expiration of its full statutory term as shortened by any terminal disclaimer filed prior to its grant.
Check either box 1 or 2 below, if appropriate.
1. For submissions on behalf of a business/organization (e.g., corporation, partnership, university, government agency,
etc.), the undersigned is empowered to act on behalf of the business/organization.
I hereby declare that all statements made herein of my own knowledge are true and that all statements made on information and
belief are believed to be true; and further that these statements were made with the knowledge that willful false statements and the like so
made are punishable by fine or imprisonment, or both, under Section 1001 of Title 18 of the United States Code and that such willful false
statements may jeopardize the validity of the application or any patent issued thereon.
2. The undersigned is an attorney or agent of record. Reg. No. __________________
________________________________________________________________________ _______________________
Signature Date
________________________________________________________________________________________________
Typed or printed name
_________________________________
Telephone Number
Terminal disclaimer fee under 37 CFR 1.20(d) is included.
WARNING: Information on this form may become public. Credit card information should not
be included on this form. Provide credit card information and authorizationon PTO-2038.
Statement under 37 CFR 3.73(b) is required if terminal disclaimer is signed by the assignee (owner).
Form PTO/SB/96 may be used for making this statement. See MPEP § 324.
This collection of information is required by 37 CFR 1.321. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO
to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 12 minutes to complete,
including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on
the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
ADDRESS.SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
Doc Code:
 
 
 
 
 
 
Privacy Act Statment
 
 
 
 
 
 
TERMINAL DISCLAIMER TO OBVIATE A DOUBLE PATENTING REJECTION OVER A “PRIOR” PATENT
PTO/SB/26(07-06)
Approved for use through 09/30/2006. OMB 0651-0031
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it displays a valid OMB control number.
TERMINAL DISCLAIMER TO OBVIATE A DOUBLE PATENTING
REJECTION OVER A “PRIOR” PATENTDocket Number (Optional)
In re Application of:
Application No.:
Filed:
For:
The owner, _________________________________________, of ____________ percent interest in the instant application hereby disclaims,
except as provided below, the terminal part of the statutory term of any patent granted on the instant application which would extend beyond
the expiration date of the full statutory term prior patent No. __________________ as the term of said prior patent is defined in 35 U.S.C. 154
and 173, and as the term of said prior patent is presently shortened by any terminal disclaimer. The owner hereby agrees that any patent so
granted on the instant application shall be enforceable only for and during such period that it and the prior patent are commonly owned. This
agreement runs with any patent granted on the instant application and is binding upon the grantee, its successors or assigns.
In making the above disclaimer, the owner does not disclaim the terminal part of the term of any patent granted on the instant application that
would extend to the expiration date of the full statutory term as defined in 35 U.S.C. 154 and 173 of the prior patent, “as the term of said prior
patent is presently shortened by any terminal disclaimer,” in the event that said prior patent later:
expires for failure to pay a maintenance fee;
is held unenforceable;
is found invalid by a court of competent jurisdiction;
is statutorily disclaimed in whole or terminally disclaimed under 37 CFR 1.321;
has all claims canceled by a reexamination certificate;
is reissued; or
is in any manner terminated prior to the expiration of its full statutory term as presently shortened by any terminal disclaimer.
Check either box 1 or 2 below, if appropriate.
1. For submissions on behalf of a business/organization (e.g., corporation, partnership, university, government agency,
etc.), the undersigned is empowered to act on behalf of the business/organization.
I hereby declare that all statements made herein of my own knowledge are true and that all statements made on information and
belief are believed to be true; and further that these statements were made with the knowledge that willful false statements and the like so
made are punishable by fine or imprisonment, or both, under Section 1001 of Title 18 of the United States Code and that such willful false
statements may jeopardize the validity of the application or any patent issued thereon.
2. The undersigned is an attorney or agent of record. Reg. No.___________________
_______________________________________________________________________ _____________________
Signature Date
______________________________________________________________________________________________
Typed or printed name
_______________________________
Telephone Number
Terminal disclaimer fee under 37 CFR 1.20(d) included.
WARNING: Information on this form may become public. Credit card information should not
be included on this form. Provide credit card information and authorization on PTO-2038.
Statement under 37 CFR 3.73(b) is required if terminal disclaimer is signed by the assignee (owner).
Form PTO/SB/96 may be used for making this certification. See MPEP § 324.
This collection of information is required by 37 CFR 1.321. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO
to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 12 minutes to complete,
including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments
on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent
and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS
ADDRESS.SEND TO: Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2.
Doc Code:
 
 
 
 
 
 
Privacy Act StatementrPrivacy Act Statement
Privacy Act Statement
ThePrivacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection
with your submission of the attached form related to a patent application or patent. Accordingly,
pursuant to the requirements of the Act, please be advised that: (1) the general authority for the
collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary;
and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark
Office is to process and/or examine your submission related to a patent application or patent. If you do
not furnish the requested information, the U.S. Patent and Trademark Office may not be able to
process and/or examine your submission, which may result in termination of proceedings or
abandonment of the application or expiration of the patent.
The information provided by you in this form will be subject to the following routine uses:
1. The information on this form will be treated confidentially to the extent allowed under the
Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from
this system of records may be disclosed to the Department of Justice to determine whether
disclosure of these records is required by the Freedom of Information Act.
2. A record from this system of records may be disclosed, as a routine use, in the course of
presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to
opposing counsel in the course of settlement negotiations.
3. A record in this system of records may be disclosed, as a routine use, to a Member of
Congress submitting a request involving an individual, to whom the record pertains, when the
individual has requested assistance from the Member with respect to the subject matter of the
record.
4. A record in this system of records may be disclosed, as a routine use, to a contractor of the
Agency having need for the information in order to perform a contract. Recipients of
information shall be required to comply with the requirements of the Privacy Act of 1974, as
amended, pursuant to 5 U.S.C. 552a(m).
5. A record related to an International Application filed under the Patent Cooperation Treaty in
this system of records may be disclosed, as a routine use, to the International Bureau of the
World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
6. A record in this system of records may be disclosed, as a routine use, to another federal
agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to
the Atomic Energy Act (42 U.S.C. 218(c)).
7. A record from this system of records may be disclosed, as a routine use, to the Administrator,
General Services, or his/her designee, during an inspection of records conducted by GSA as
part of that agency’s responsibility to recommend improvements in records management
practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall
be made in accordance with the GSA regulations governing inspection of records for this
purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not
be used to make determinations about individuals.
8. A record from this system of records may be disclosed, as a routine use, to the public after
either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent
pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
CFR 1.14, as a routine use, to the public if the record was filed in an application which
became abandoned or in which the proceedings were terminated and which application is
referenced by either a published application, an application open to public inspection or an
issued patent.
9. A record from this system of records may be disclosed, as a routine use, to a Federal, State,
or local law enforcement agency, if the USPTO becomes aware of a violation or potential
violation of law or regulation.

Latest revision as of 22:42, May 31, 2020

← MPEP 1300 ↑ MPEP Table of Contents MPEP 1500 →


Chapter 1400 Correction of Patents

1400 [No Text][edit | edit source]

1400.01Introduction[edit | edit source]

A patent may be corrected or amended in four ways, namely:

(A)by reissue,

(B)by the issuance of a certificate of correction which becomes a part of the patent,

(C)by disclaimer, and

(D)by reexamination.

The first three ways are discussed in this chapter while the fourth way (reexamination) is discussed in MPEP Chapter 2200 for ex parte reexamination and MPEP Chapter 2600 for inter partes reexamination.

1401 Reissue[edit | edit source]

35 U.S.C. 251. Reissue of defective patents.

Whenever any patent is, through error without any deceptive intention, deemed wholly or partly inoperative or invalid, by reason of a defective specification or drawing, or by reason of the patentee claiming more or less than he had a right to claim in the patent, the Director shall, on the surrender of such patent and the payment of the fee required by law, reissue the patent for the invention disclosed in the original patent, and in accordance with a new and amended application, for the unexpired part of the term of the original patent. No new matter shall be introduced into the application for reissue.

The Director may issue several reissued patents for distinct and separate parts of the thing patented, upon demand of the applicant, and upon payment of the required fee for a reissue for each of such reissued patents.

The provisions of this title relating to applications for patent shall be applicable to applications for reissue of a patent, except that application for reissue may be made and sworn to by the assignee of the entire interest if the application does not seek to enlarge the scope of the claims of the original patent.

No reissued patent shall be granted enlarging the scope of the claims of the original patent unless applied for within two years from the grant of the original patent.


The provisions of 35 U.S.C. 251 permit the reissue of a patent to correct an error in the patent made without any deceptive intention and provide criteria for the reissue. 37 CFR 1.171 through 1.178 are rules directed to reissue.

1402 Grounds for Filing[edit | edit source]

A reissue application is filed to correct an error in the patent which was made without any deceptive intention, where, as a result of the error, the patent is deemed wholly or partly inoperative or invalid. An error in the patent arises out of an error in conduct which was made in the preparation and/or prosecution of the application which became the patent.

There must be at least one error in the patent to provide grounds for reissue of the patent. If there is no error in the patent, the patent will not be reissued. The present section provides a discussion of what may be considered an error in the patent upon which to base a reissue application.

In accordance with 35 U.S.C. 251, the error upon which a reissue is based must be one which causes the patent to be “deemed wholly or partly inoperative or invalid, by reason of a defective specification or drawing, or by reason of the patentee claiming more or less than he had a right to claim in the patent.” Thus, an error under 35 U.S.C. 251 has not been presented where the correction to the patent is one of spelling, or grammar, or a typographical, editorial or clerical error which does not cause the patent to be deemed wholly or partly inoperative or invalid for the reasons specified in 35 U.S.C. 251. These corrections to a patent do not provide a basis for reissue (although these corrections may also be included in a reissue application, where a 35 U.S.C. 251 error is already present).

These corrections may be made via a certificate of correction; see MPEP § 1481.

The most common bases for filing a reissue application are:

(A)the claims are too narrow or too broad;

(B)the disclosure contains inaccuracies;

(C)applicant failed to or incorrectly claimed foreign priority; and

(D)applicant failed to make reference to or incorrectly made reference to prior copending applications.

An attorney’s failure to appreciate the full scope of the invention was held to be an error correctable through reissue in the decision of In re Wilder, 736 F.2d 1516, 222 USPQ 369 (Fed. Cir. 1984). The correction of misjoinder of inventors in divisional reissues has been held to be a ground for reissue. See Ex parte Scudder, 169 USPQ 814 (Bd. App. 1971).The Board of Appeals held in Ex parte Scudder, 169 USPQ at 815, that 35 U.S.C. 251 authorizes reissue application to correct misjoinder of inventors where 35 U.S.C. 256 is inadequate.

Reissue may no longer be necessary under the facts in Ex parte Scudder, supra, in view of 35 U.S.C. 116which provides, inter alia, that:

“Inventors may apply for a patent jointly even though . . . (3) each did not make a contribution to the subject matter of every claim in the patent.”

See also 37 CFR 1.45(b)(3).

If the only change being made in the patent is correction of the inventorship, this can be accomplished by filing a request for a certificate of correction under the provisions of 35 U.S.C. 256 and 37 CFR 1.324. See MPEP § 1412.04 and § 1481. A Certificate of Correction will be issued if all parties are in agreement and the inventorship issue is not contested.

A reissue was granted in Brenner v. State of Israel, 400 F.2d 789, 158 USPQ 584 (D.C. Cir. 1968), where the only ground urged was failure to file a certified copy of the original foreign application to obtain the right of foreign priority under 35 U.S.C. 119(a)-(d) before the patent was granted.

In Brenner, the claim for priority had been made in the prosecution of the original patent, and it was only necessary to submit a certified copy of the priority document in the reissue application to perfect priority. Reissue is also available to convert the “error” in failing to take any steps to obtain the right of foreign priority under 35 U.S.C. 119(a)-(d) before the patent was granted. See Fontijn v. Okamoto, 518 F.2d 610, 622, 186 USPQ 97, 106 (CCPA 1975) (“a patent may be reissued for the purpose of establishing a claim to priority which was not asserted, or which was not perfected during the prosecution of the original application”) In a situation where it is necessary to submit for the first time both the claim for priority and the certified copy of the priority document in the reissue application, and the patent to be reissued resulted from a utility or plant application which became the patent to be reissued was filed on or after November 29, 2000, the reissue applicant must (where it is necessary to submit for the first time the claim for priority) also file a petition for an unintentionally delayed priority claim under 37 CFR 1.55(c) in addition to filing a reissue application. See MPEP § 201.14(a).

The courts have not addressed the question of correction of the failure to adequately claim benefit under 35 U.S.C. 119(e) in the application (which became the patent to be reissued) via reissue. If the application which became the patent to be reissued was filed prior to November 29, 2000, correction as to benefit under 35 U.S.C. 119(e) would be permitted in a manner somewhat analogous to that of the priority correction discussed above. Where the application, which became the patent to be reissued, was filed on or after November 29, 2000, reissue may be employed to correct an applicant’s mistake by adding or correcting a benefit claim under 35 U.S.C. 119(e). A petition under 37 CFR 1.78(a)(6) for an unintentionally delayed claim under 35 U.S.C. 119(e) would not be required in addition to filing a reissue application..

Section 4503 of the American Inventors Protection Act of 1999 (AIPA) amended 35 U.S.C. 119(e)(1) to state that:

No application shall be entitled to the benefit of an earlier filed provisional application under this subsection unless an amendment containing the specific reference to the earlier filed provisional application is submitted at such time during the pendency of the application as required by the Director. The Director may consider the failure to submit such an amendment within that time period as a waiver of any benefit under this subsection. The Director may establish procedures, including the payment of a surcharge, to accept an unintentionally delayed submission of an amendment under this section during the pendency of the application. (Emphasis added.)

The court in Fontijn held that 35 U.S.C. 251was sufficiently broad to correct a patent where the applicant failed to assert or failed to perfect a claim for foreign priority during the prosecution of the original application even though 35 U.S.C. 119(b) at that time required a claim and a certified copy of the foreign application to be filed before the patent is granted. Similarly, the Office may grant a reissue for adding or correcting a benefit claim under 35 U.S.C.119(e) that requires the benefit claim to a provisional application be submitted during the pendency of the application..

Correction of failure to adequately claim benefit under 35 U.S.C. 120 in an earlier filed copending U.S. patent application was held a proper ground for reissue. Sampson v. Comm’r Pat., 195 USPQ 136, 137 (D.D.C. 1976). If the utility or plant application which became the patent to be reissued was filed on or after November 29, 2000, the reissue applicant must file a petition for an unintentionally delayed priority claim under 37 CFR 1.78(a)(3) in addition to filing a reissue application. See MPEP § 201.11. For treatment of an error involving disclaimer of a benefit claim under 35 U.S.C. 120, see MPEP 1405. If the utility or plant application which became the patent to be reissued was filed prior to November 29, 2000 and therefore, not subject to the eighteen-month publication (e.g., one of the categories set forth in 37 CFR 1.78(a)(2)(ii)(A) – (C)), a petition for an unintentionally delayed benefit claim under 37 CFR 1.78(a)(3) would not be required to add/correct the benefit claim in the reissue application. This is so, even if the reissue application was filed on or after November 29, 2000. On the other hand, if applicant fails to file an amendment to add a claim for benefit of a prior-filed reissue application in a later-filed reissue application within the time period set forth in 37 CFR 1.78(a)(2), then a petition for an unintentionally delayed benefit claim under 37 CFR 1.78(a)(3) along with the surcharge set forth in 37 CFR 1.17(t) would be required if the later-filed reissue application is a utility or plant application filed on or after November 29, 2000 irrespective of whether the original application which became the original patent was filed prior to November 29, 2000. This is because the benefit claim is between the later-filed reissue application and the prior-filed reissue application and the benefit claim is not being added to make a correction as to a benefit of the original patent.

A reissue applicant’s failure to timely file a divisional application covering the non-elected invention( s) following a restriction requirement is not considered to be error causing a patent granted on elected claims to be partially inoperative by reason of claiming less than the applicant had a right to claim. Thus, such applicant’s error is not correctable by reissue of the original patent under 35 U.S.C. 251. See MPEP § 1412.01.

A reissue may be based on a drawing correction that is substantive in nature, because such a correction qualifies as correcting an “error” under 35 U.S.C. 251that may properly be deemed to render the patent wholly or partly inoperative. A reissue application cannot be based on a non-substantive drawing change, such as a reference numeral correction or addition, the addition of shading, or even the addition of an additional figure merely to “clarify” the disclosure. Non- substantive drawing changes may, however, be included in a reissue application that corrects at least one substantive “error ” under 35 U.S.C. 251.

1403 Diligence in Filing[edit | edit source]

When a reissue application is filed within 2 years from the date of the original patent, a rejection on the grounds of lack of diligence or delay in filing the reissue should not normally be made. Ex parte Lafferty, 190 USPQ 202 (Bd. App. 1975); but see Rohm & Haas Co. v. Roberts Chemical Inc., 142 F. Supp. 499, 110 USPQ 93 (S.W. Va. 1956), rev’d on other grounds, 245 F.2d 693, 113 USPQ 423 (4th Cir. 1957).

The fourth paragraph of 35 U.S.C. 251 states:

“No reissued patent shall be granted enlarging the scope of the claims of the original patent unless applied for within two years from the grant of the original patent.”

Where any broadening reissue application is filed within two years from the date of the original patent, 35 U.S.C. 251 presumes diligence, and the examiner should not inquire why applicant failed to file the reissue application earlier within the two year period.

See MPEP § 1412.03 for broadening reissue practice. See also In re Graff, 111 F.3rd 874, 42 USPQ2d 1471 (Fed. Cir. 1997); In re Bennett, 766 F.2d 524, 528, 226 USPQ 413, 416 (Fed. Cir. 1985); In re Fotland, 779 F.2d 31, 228 USPQ 193 (Fed. Cir. 1985).

A reissue application that is filed on the 2-year anniversary date of the patent grant is considered as being filed within 2 years. See Switzer v. Sockman, 333 F.2d 935, 142 USPQ 226 (CCPA 1964) (a similar rule in interferences).

A reissue application can be granted a filing date without an oath or declaration, or without the basic filing fee, search fee, or examination fee being present. See 37 CFR 1.53(f). Applicant will be given a period of time to provide the missing parts and to pay the surcharge under 37 CFR 1.16(f). See MPEP § 1410.01.

1404 Submission of Papers Where Reissue Patent Is in Litigation[edit | edit source]

Marking of envelope: Applicants and protestors (see MPEP § 1901.03) submitting papers for entry in reissue applications of patents involved in litigation are requested to mark the outside envelope and the top right-hand portion of the papers with the words “REISSUE LITIGATION” and with the art unit or other area of the United States Patent and Trademark Office in which the reissue application is located, e.g., Commissioner for Patents, Board of Patent Appeals and Interferences, Office of Patent Legal Administration, Technology Center, Office of Patent Publication, etc. Marking of papers: Any “Reissue Litigation” papers mailed to the Office should be so marked. The markings preferably should be written in a bright color with a felt point marker. Papers marked “REISSUE LITIGATION” will be given special attention and expedited handling. (For IFW processing, see IFW Manual.) See MPEP § 1442.01through § 1442.04 for examination of litigation- related reissue applications. Protestor’s participation, including the submission of papers, is limited in accordance with 37 CFR 1.291(c).

1405 Reissue and Patent Term[edit | edit source]

35 U.S.C. 251 prescribes the effect of reissue on the patent term by stating that “the Director shall… reissue the patent… for the unexpired term of the original patent.”

The maximum term of the original patent is fixed at the time the patent is granted. While the term may be subsequently shortened, e.g., through the filing of a terminal disclaimer, it cannot be extended through the filing of a reissue. Accordingly, a deletion in a reissue application of an earlier-obtained benefit claim under 35 U.S.C. 120 will not operate to lengthen the term of the patent to be reissued.

When a reissue application has been filed in an attempt to delete an earlier-obtained benefit claim under 35 U.S.C. 120, it should be treated as follows:

(A)More than one “error” (as defined by 35 U.S.C. 251) is described in a reissue declaration, and one of the errors identified is the failure to delete a 35 U.S.C. 120 benefit claim in the original patent, or the erroneous making of a claim for 35 U.S.C. 120 benefit.

If one of the errors identified is the presence of the claim for 35 U.S.C. 120 benefit in the patent, and patentee (1) states a belief that this error renders the original patent wholly or partly inoperative or invalid, and (2) is seeking to eliminate this error via the reissue proceeding, the Office will permit entry of an accompanying amendment deleting the benefit claim in the continuity data, and will not object to or reject the reissue declaration. Assuming the reissue declaration appropriately identifies or describes at least one other error being corrected, the reissue declaration would not be objected to for failure to comply with the requirements of 37 CFR 1.175.

Where the reissue declaration states that the patentee is making this correction in order to extend the term of the original patent, the examiner’s Office action will merely refer to the statement in the declaration and then point out with respect to such statement that 35 U.S.C. 251 only permits reissue “... for the unexpired part of the term of the original patent.”

(B)Only one “error” (as defined by 35 U.S.C. 251) is described in a reissue declaration, and that error is the failure to delete a 35 U.S.C. 120 benefit claim in the original patent, or the erroneous making of a claim for 35 U.S.C. 120 benefit.

(1)If the only error identified in the reissue declaration is stated to be the correction or adjustment of the patent term by deleting the 35 U.S.C. 120 benefit claim, a rejection under 35 U.S.C. 251 should be made, based on the lack of an appropriate error for reissue and failure to comply with 37 CFR 1.175.

(2)If the only error identified in the reissue declaration is the need to delete a 35 U.S.C. 120 benefit claim, which the patentee seeks to now delete in the reissue application, (and no reference is made as to increasing the term of the patent), the examiner should not make a rejection under 35 U.S.C. 251based on lack of an appropriate error for reissue and failure to comply with 37 CFR 1.175. The examiner should examine the reissue application in accordance with 37 CFR 1.176 (MPEP § 1440). A statement should, however, be made in an Office action pointing out the lack of effect (of the change in the patent) on the patent term because 35 U.S.C. 251 only permits reissue “... for the unexpired part of the term of the original patent.”

1406 Citation and Consideration of References Cited in Original Patent[edit | edit source]

In a reissue application, the examiner should consider and list on a PTO-892 form all references that have been cited during the original prosecution of the patent. See MPEP § 1455. An exception to this practice might be where the references cited in the original patent may no longer be relevant, e.g., in view of a narrowing of the claim scope in the reissue application.

Should applicants wish to ensure that all of the references which were cited in the original patent are considered and cited in the reissue application, an information disclosure statement (IDS) in compliance with 37 CFR 1.97 and 1.98 should be filed in the reissue application. See MPEP § 609. The requirement for a copy of each U.S. patent or U.S. patent application publication listed in an IDS has been eliminated, unless required by the Office. 37 CFR 1.98(a)(2) requires

(A) a legible copy of each foreign patent,

(B) each publication or that portion which caused it to be listed,

(C) each pending unpublished U.S. application unless the cited pending U.S. application is stored in the Image File Wrapper (IFW) system. The requirement in 37 CFR 1.98(a)(2)(iii) for a legible copy of the specification, including the claims and drawings of each cited pending U.S. patent application (or portion of the application which caused it to be listed) is sua sponte waived where the cited pending application is stored in the Office’ s IFW system. See Waiver of the Copy Requirement in 37 CFR 1.98 for Cited Pending U.S. Patent Applications, 1287 O.G. 163 (Oct. 19, 2004),

(D) all other information or that portion which caused it to be listed.

See MPEP § 609.04(a). The Office imposes no responsibility on a reissue applicant to resubmit, in a reissue application, all the “References Cited” in the patent for which reissue is sought. Rather, applicant has a continuing duty under 37 CFR 1.56 to timely apprise the Office of any information which is material to the patentability of the claims under consideration in the reissue application. See MPEP § 1418.

Where a copy of a reference other than a U.S. patent or U.S. patent application publication is not available and cannot be obtained through any source other than the reissue applicant (who has not submitted the copy), the examiner will not indicate on PTO- 892 or PTO/SB/08 submitted by applicant that a reference has been considered.

1410 Content of Reissue Application[edit | edit source]

37 CFR 1.171. Application for reissue.

An application for reissue must contain the same parts required for an application for an original patent, complying with all the rules relating thereto except as otherwise provided, and in addition, must comply with the requirements of the rules relating to reissue applications.


37 CFR 1.173. Reissue specification, drawings, and amendments.

(a) Contents of a reissue application. An application for reissue must contain the entire specification, including the claims, and the drawings of the patent. No new matter shall be introduced into the application. No reissue patent shall be granted enlarging the scope of the claims of the original patent unless applied for within two years from the grant of the original patent, pursuant to 35 U.S.C. 251.

(1) Specification, including claims. The entire specification, including the claims, of the patent for which reissue is requested must be furnished in the form of a copy of the printed patent, in double column format, each page on only one side of a single sheet of paper. If an amendment of the reissue application is to be included, it must be made pursuant to paragraph (b) of this section. The formal requirements for papers making up the reissue application other than those set forth in this section are set out in § 1.52. Additionally, a copy of any disclaimer (§ 1.321), certificate of correction (§§ 1.322 through 1.324), or reexamination certificate (§ 1.570) issued in the patent must be included. (See also § 1.178).

(2) Drawings. Applicant must submit a clean copy of each drawing sheet of the printed patent at the time the reissue application is filed. If such copy complies with § 1.84, no further drawings will be required. Where a drawing of the reissue application is to include any changes relative to the patent being reissued, the changes to the drawing must be made in accordance with paragraph (b)(3) of this section. The Office will not transfer the drawings from the patent file to the reissue application.

.          .          .


The specification (including the claims and any drawings) of the reissue application is the copy of the printed patent for which reissue is requested that is submitted by applicant as part of the initial application papers. The copy of the printed patent must be submitted in double column format, each page of double column format being on only one side of the piece of paper. It should be noted that a re-typed specification is not acceptable in a reissue application; the full copy of the printed patent must be used. In addition, an applicant for reissue is required to file a reissue oath or declaration which, in addition to complying with 37 CFR 1.63, must comply with 37 CFR 1.175. Where the patent has been assigned, the reissue applicant must also provide a consent of assignee to the reissue and evidence of ownership. Where the patent has not been assigned, the reissue applicant should affirmatively state that the patent is not assigned.

An amendment may be submitted at the time of filing of a reissue application. The amendment may be made either by:

(A) physically incorporating the changes within the specification by cutting the column of the printed patent and inserting the added material and rejoining the remainder of the column and then joining the resulting modified column to the other column of the printed patent. Markings pursuant to 37 CFR 1.173(d) must be used to show the changes. The columnar structure of the printed patent must be preserved, and the physically modified page must comply with 37 CFR 1.52(a)(1). As to compliance with 37 CFR 1.52(a)(1)(iv), the “written either by a typewriter or machine printer in permanent dark ink or its equivalent” requirement is deemed to be satisfied where a caret and line are drawn from a position within the text to a newly added phrase, clause, sentence, etc. typed legibly in the margin; or

(B) providing a separate amendment paper with the reissue application.

In either case, the amendment must be made pursuant to 37 CFR 1.173(b) and must comply with all the provisions of 37 CFR 1.173(b)– (e) and (g).

If the changes to be made to the patent are so extensive that reading and understanding the specification is extremely difficult and error-prone, a clean, typed copy of the specification may be submitted if accompanied by a grantable petition under 37 CFR 1.183 for waiver of 37 CFR 1.125(d) and 37 CFR 1.173(a)(1).

Pursuant to 37 CFR 1.173(a)(1), applicant is required to include a copy of any disclaimer (37 CFR 1.321), certificate of correction (37 CFR 1.322 – 1.324), or reexamination certificate (37 CFR 1.520) issued in the patent for which reissue is requested. It should also be noted that 37 CFR 1.178(b) requires reissue applicants to call to the attention of the Office any prior or concurrent proceedings in which the patent (for which reissue is requested) is or was involved, such as interferences, reissues, reexaminations, or litigation (litigation covers any papers filed in the court or issued by the court, such as, for example, motions, pleadings, and court decisions including court orders) and the results of such proceedings. This duty to submit such information is a continuing duty, and runs from the time the reissue application is filed until the reissue application is abandoned or issues as a reissue patent.

It is no longer required that the reissue applicant physically surrender the original patent, see MPEP § 1416.

Where appropriate, the reissue applicant may provide a claim for priority benefit under 35 U.S.C. 119or 120, and may also file an Information Disclosure Statement.

The initial contents of a reissue application are discussed in detail in MPEP § 1410.01 through § 1418.

For expedited processing, new and continuing reissue application filings under 37 CFR 1.53(b) may be addressed to: Mail Stop REISSUE, Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450. Mail Stop REISSUE should only be used for the initial filing of reissue applications, and should not be used for any subsequently filed correspondence in reissue applications. All new reissue filings should include a copy of a completed Reissue Patent Application Transmittal Form (PTO/SB/50) to ensure that the filing of the new application will be recognized as being for a reissue application.

The oath or declaration, any matters ancillary thereto (such as the consent of assignee), and the basic filing fee, search fee, and examination fee may be submitted after the filing date pursuant to 37 CFR 1.53(f).

The requirement for the assignee to consent to filing a reissue no longer includes a requirement for applicant to order a title report with the filing of the reissue application. Rather, the assignee entity is established by a statement on behalf of all the assignees under 37 CFR 1.172(a) and 37 CFR 3.73(b). See MPEP § 1410.01.

1410.01 Reissue Applicant, Oath or Declaration, and Consent of all Assignees[edit | edit source]

37 CFR 1.172. Applicants, assignees.

(a) A reissue oath must be signed and sworn to or declaration made by the inventor or inventors except as otherwise provided (see §§ 1.42, 1.43, 1.47), and must be accompanied by the written consent of all assignees, if any, owning an undivided interest in the patent, but a reissue oath may be made and sworn to or declaration made by the assignee of the entire interest if the application does not seek to enlarge the scope of the claims of the original patent. All assignees consenting to the reissue must establish their ownership interest in the patent by filing in the reissue application a submission in accordance with the provisions of § 3.73(b) of this chapter.

(b) A reissue will be granted to the original patentee, his legal representatives or assigns as the interest may appear.


37 CFR 3.73. Establishing right of assignee to take action.
.          .          .

(b)

(1) In order to request or take action in a patent or trademark matter, the assignee must establish its ownership of the patent or trademark property of paragraph (a) of this section to the satisfaction of the Director. The establishment of ownership by the assignee may be combined with the paper that requests or takes the action. Ownership is established by submitting to the Office a signed statement identifying the assignee, accompanied by either:

(i) Documentary evidence of a chain of title from the original owner to the assignee (e.g., copy of an executed assignment). For trademark matters only, the documents submitted to establish ownership may be required to be recorded pursuant to § 3.11 in the assignment records of the Office as a condition to permitting the assignee to take action in a matter pending before the Office. For patent matters only, the submission of the documentary evidence must be accompanied by a statement affirming that the documentary evidence of the chain of title from the original owner to the assignee was or concurrently is being submitted for recordation pursuant to § 3.11; or

(ii) A statement specifying where documentary evidence of a chain of title from the original owner to the assignee is recorded in the assignment records of the Office (e.g., reel and frame number).

(2) The submission establishing ownership must show that the person signing the submission is a person authorized to act on behalf of the assignee by:

(i) Including a statement that the person signing the submission is authorized to act on behalf of the assignee; or

(ii) Being signed by a person having apparent authority to sign on behalf of the assignee, e.g., an officer of the assignee.

(c) For patent matters only:

(1) Establishment of ownership by the assignee must be submitted prior to, or at the same time as, the paper requesting or taking action is submitted.

(2) If the submission under this section is by an assignee of less than the entire right, title and interest, such assignee must indicate the extent (by percentage) of its ownership interest, or the Office may refuse to accept the submission as an establishment of ownership.


The reissue oath must be signed and sworn to by all the inventors, or declaration made by all the inventors, except as otherwise provided in 37 CFR 1.42, 1.43, and 1.47 (see MPEP § 409). Pursuant to 37 CFR 1.172, where the reissue application does not seek to enlarge the scope of any of the claims of the original patent, the reissue oath may be made and sworn to, or declaration made, by the assignee of the entire interest. Depending on the circumstances, either Form PTO/SB/51, Reissue Application Declaration by the Inventor, or Form PTO/SB/52, Reissue Application Declaration by the Assignee, may be used to prepare a declaration in a reissue application. These forms are reproduced in MPEP § 1414.

If an inventor is to be added in a reissue application, a proper reissue oath or declaration including the signatures of all of the inventors is required. If one or more inventors are being deleted in a reissue application, an oath or declaration must be supplied over the signatures of the remaining inventors. Note that although an inventor being deleted in a reissue application need not sign the oath or declaration, if that inventor to be deleted has any ownership interest in the patent (e.g., that inventor did not assign away his/ her rights to the patent), the signature of that inventor must be supplied in the consent to filing the reissue application. See MPEP § 1412.04 as to correction of inventorship via reissue.

I.CONSENT TO THE REISSUE

Where no assignee exists, applicant should affirmatively state that fact. This can be done by simply checking the “NO” box of item 7 of Form PTO/SB/50 (which form may be signed by the inventors, or by a registered practitioner). If the file record is silent as to the existence of an assignee, it will be presumed that an assignee does exist. This presumption should be set forth by the examiner in the first Office action alerting applicant to the requirement. It should be noted that the mere filing of a written assertion of small entity status in no way relieves applicant of the requirement to affirmatively state that no assignee exists.

Where a written assertion of small entity status, or other paper in file indicates that the application/patent is assigned, and there is no consent by the assignee named in the written assertion of small entity, the examiner should make inquiry into the matter in an Office action, even if the record otherwise indicates that the application/patent is not assigned.

The reissue oath or declaration must be accompanied by the written consent of all assignees. 35 U.S.C. 111(a) and 37 CFR 1.53(b) provide, however, for according an application a filing date if filed with a specification, including claim(s), and any required drawings. Thus, where an application is filed without an oath or declaration, or without the consent of all assignees, if the application otherwise complies with 37 CFR 1.53(b) and the reissue rules, the Office of Initial Patent Examination (OIPE) will accord a filing date and send out a notice of missing parts setting a period of time for filing the missing part and for payment of any surcharge required under 37 CFR 1.53(f) and 1.16(f). If the reissue oath or declaration is filed but the assignee consent is lacking, the surcharge is required because, until the consent is filed, the reissue oath or declaration is defective, since it is not apparent that the signatures thereon are proper absent an indication that the assignees have consented to the filing.

The consent of assignee must be signed by a party authorized to act on behalf of the assignee. See MPEP § 324 for a discussion of parties authorized to act on behalf of the assignee.

Where the written consent of all the assignees to the filing of the reissue application cannot be obtained, applicant may under appropriate circumstances petition to the Office of Petitions (MPEP § 1002.02(b)) for a waiver under 37 CFR 1.183 of the requirement of 37 CFR 1.172, to permit the acceptance of the filing of the reissue application. The petition fee under 37 CFR 1.17(f) must be included with the petition.

The reissue application can then be examined, but will not be allowed or issued without the consent of all the assignees as required by 37 CFR 1.172. See Baker Hughes Inc. v. Kirk, 921 F.Supp. 801, 809, 38 USPQ2d 1885, 1892 (D.D.C. 1995), N. B. Fassett, 1877 C.D. 32, 11 O.G. 420 (Comm’r Pat. 1877); James D. Wright, 1876 C.D. 217, 10 O.G. 587 (Comm’r Pat. 1876).

Where a continuation reissue application is filed with a copy of the assignee consent from the parent reissue application, and the parent reissue application is not to be abandoned, the copy of the consent should not be accepted. Where a divisional reissue application is filed with a copy of the assignee consent from the parent reissue application, regardless of whether or not the parent reissue application is to be abandoned, the copy of the consent should not be accepted. The copy of the consent from the parent does not indicate that the assignee has consented to the addition of the new invention of the divisional reissue application to the original patent, or to the addition of the new error correction of the continuation reissue application. (Presumably, a new correction has been added via the continuation, since the parent is still pending.) As noted above, OIPE will accord a filing date and send out a notice of missing parts stating that there is no proper consent and setting a period of time for filing the missing part and for payment of any surcharge required under 37 CFR 1.53(f) and 1.16(f)

Where a continuation reissue application is filed with a copy of the assignee consent from the parent reissue application, and the parent reissue application is, or will be abandoned, the copy of the consent should be accepted by the Office.

II.PROOF OF OWNERSHIP OF ASSIGNEE

The assignee that consents to the filing of the reissue application (as discussed above) must also establish that it is the assignee, i.e., the owner, of the patent. See 37 CFR 1.172. Accordingly, a 37 CFR 3.73(b) paper establishing the ownership of the assignee should be submitted at the time of filing the reissue application, in order to support the consent of the assignee. The assignee must establish its ownership in accordance with 37 CFR 3.73(b) by:

(A) filing in the reissue application documentary evidence of a chain of title from the original owner to the assignee; or

(B) specifying in the record of the reissue application where such evidence is recorded in the Office (e.g., reel and frame number, etc.).

Compliance with 37 CFR 3.73(b) may be provided as part of the same paper in which the consent by assignee is provided.

In connection with option (A) above, the submission of the documentary evidence to establish ownership must be accompanied by a statement affirming that the documentary evidence of the chain of title from the original owners to the assignee was, or concurrently is, submitted for recordation pursuant to 37 CFR 3.11. Thus, when filing a 37 CFR 3.73(b) statement to establish ownership, an applicant or patent owner must also submit the relied-upon assignment document(s) to the Office for recordation, unless such a submission has already been previously made. If the 37 CFR 3.73(b) statement is not accompanied by a statement affirming that the documentary evidence was, or concurrently is, submitted for recordation pursuant to 37 CFR 3.11, then the 37 CFR 3.73(b) statement will not be accepted, and the assignee(s) will not have established the right to take action in the patent application or the patent for which the 37 CFR 3.73(b) statement was submitted. This could result, for example, in an incomplete response, where a party stated to be the “assignee” signs a consent to the reissue to obviate a requirement for submission of assignee consent made in an Office action.

Upon initial receipt of a reissue application, the examiner should inspect the application to determine whether the submission under 37 CFR 1.172 and 37 CFR 3.73(b) establishing the ownership of the assignee is present and sufficient.

If an assignment document is attached with the 37 CFR 3.73(b) submission, the assignment should be reviewed to ensure that the named assignee is the same for the assignment document and the 37 CFR 3.73(b) statement, and that the assignment document is an assignment of the patent to be reissued to the assignee. If an assignment document is not attached with the 37 CFR 3.73(b) statement, but rather the reel and frame number where the assignment document is recorded in the USPTO is referenced in the 37 CFR 3.73(b) statement, it will be presumed that the assignment recorded in the USPTO supports the statement identifying the assignee. It will not be necessary for the examiner to obtain a copy of the recorded assignment document.

Just as the consent of assignee must be signed by a party authorized to act on behalf of the assignee, the submission with respect to 37 CFR 3.73(b) to establish ownership must be signed by a party authorized to act on behalf of the assignee. The signature of an attorney or agent registered to practice before the Office is not sufficient, unless that attorney or agent is authorized to act on behalf of the assignee.

Where the submission establishes the assignee’s ownership as to the patent, ownership as to the reissue application will be presumed. Accordingly, a submission as to the ownership of the patent will be construed to satisfy the 37 CFR1.172 (and 37 CFR 3.73(b)) requirements for establishing ownership of the application. Thus, a terminal disclaimer can be filed in a reissue application where ownership of the patent has been established, without the need for a separate submission under 37 CFR 3.73(b) showing ownership of the reissue application.

Even if the submission states that it is establishing ownership of the reissue application (rather than the patent), the submission should be accepted by the examiner as also establishing ownership in the patent. The documentation in the submission establishing ownership of the reissue application must, of necessity, include chain of title as to the patent.

III.COMPARISON OF ASSIGNEE THAT CONSENTS TO ASSIGNEE SET FORTH IN SUBMISSION ESTABLISHING OWNERSHIP INTEREST

The examiner must inspect both the consent and documentary evidence of ownership to determine whether the requirements of 37 CFR 1.172 have been met. The assignee identified by the documentary evidence must be the same assignee which signed the consent. Also, the person who signs the consent for the assignee and the person who signs the submission of evidence of ownership for the assignee must both be persons having authority to do so. See also MPEP § 324.

The reissue patent will be granted to the original patentee, his or her legal representatives or assigns as the interest may appear.

1411 Form of Specification[edit | edit source]

37 CFR 1.173. Reissue specification, drawings, and amendments.

(a) Contents of a reissue application. An application for reissue must contain the entire specification, including the claims, and the drawings of the patent. No new matter shall be introduced into the application. No reissue patent shall be granted enlarging the scope of the claims of the original patent unless applied for within two years from the grant of the original patent, pursuant to 35 U.S.C. 251.

(1) Specification, including claims. The entire specification, including the claims, of the patent for which reissue is requested must be furnished in the form of a copy of the printed patent, in double column format, each page on only one side of a single sheet of paper. If an amendment of the reissue application is to be included, it must be made pursuant to paragraph (b) of this section. The formal requirements for papers making up the reissue application other than those set forth in this section are set out in § 1.52. Additionally, a copy of any disclaimer (§ 1.321), certificate of correction (§§ 1.322 through 1.324), or reexamination certificate (§ 1.570) issued in the patent must be included. (See also § 1.178).

(2) Drawings. Applicant must submit a clean copy of each drawing sheet of the printed patent at the time the reissue application is filed. If such copy complies with § 1.84, no further drawings will be required. Where a drawing of the reissue application is to include any changes relative to the patent being reissued, the changes to the drawing must be made in accordance with paragraph (b)(3) of this section. The Office will not transfer the drawings from the patent file to the reissue application.


The file wrappers of all /08 and earlier series reissue applications are stamped “REISSUE” above the application number on the front of the file. “Reissue” also appears below the application number on the printed label on the file wrapper of the application with 08/ and earlier series.

Reissue applications filed after July of 1998 (09/ series and later) are placed in an orange and white striped file wrapper and can be easily identified as reissue applications. (For IFW Processing, see IFW Manual.)

Reissue applications filed prior to November 7, 2000 should be furnished in the form of cut-up soft copies of the original patent, with only a single column of the printed patent securely mounted on a separate sheet of paper.

For reissue applications filed on or after November 7, 2000, 37 CFR 1.173(a)(1) requires that the application specification, including the claims, must be furnished in the form of a copy of the printed patent in double column format (so that the patent can be simply copied without cutting). Applicants are required to submit a clean copy of each drawing sheet of the printed patent at the time the reissue application is filed (37 CFR 1.173(a)(2)). Any changes to the drawings must be made in accordance with 37 CFR 1.173(b)(3). Thus, a full copy of the printed patent (including the front page) is used to provide the abstract, drawings, specification, and claims of the patent for the reissue application. Each page of the patent must appear on only one side of each individual page of the specification of the reissue application; a two-sided copy of the patent is not proper. It should be noted that a re-typed specification is not acceptable in a reissue application; the full copy of the printed patent must be used. If, however, the changes to be made to the patent are so extensive/numerous that reading and understanding the specification is extremely difficult and error-prone, a clean copy of the specification may be submitted if accompanied by a grantable petition under 37 CFR 1.183 for waiver of 37 CFR 1.125(d) and 37 CFR 1.173(a)(1).

Pursuant to 37 CFR 1.173(b), amendments may be made at the time of filing of a reissue application. The amendment may be made either by:

(A) physically incorporating the changes within the specification by cutting the column of the printed patent and inserting the added material and rejoining the remainder of the column and then joining the resulting modified column to the other column of the printed patent. Markings pursuant to 37 CFR 1.173(d) must be used to show the changes. The columnar structure of the printed patent must be preserved, and the physically modified page must comply with 37 CFR 1.52(a)(1). As to compliance with 37 CFR 1.52(a)(1)(iv), the “written either by a typewriter or machine printer in permanent dark ink or its equivalent” requirement is deemed to be satisfied where a caret and line are drawn from a position within the text to a newly added phrase, clause, sentence, etc. typed legibly in the margin; or

(B) providing a preliminary amendment (a separate amendment paper) directing that specified changes be made to the copy of the printed patent.

The presentation of the insertions or deletions as part of the original reissue specification is an amendment under 37 CFR 1.173(b). An amendment of the reissue application made at the time of filing of the reissue application must be made in accordance with 37 CFR 1.173(b)-(e) and (g); see MPEP § 1453. Thus, as required by 37 CFR 1.173(c), an amendment of the claims made at the time of filing of a reissue application must include a separate paper setting forth the status of all claims (i.e., pending or canceled), and an explanation of the support in the disclosure of the patent for the changes made to the claims.

If a chart, table, or chemical formula is amended and it spans two columns of the patent, it should not be split. Rather, the chart, table, or chemical formula should be provided in its entirety as part of the column of the patent to which it pertains, in order to provide a continuity of the description. When doing so, the chart, table, or chemical formula may extend beyond the width of the column. Change in only a part of a word or chemical formula is not permitted. Entire words or chemical formulas must be shown as being changed. Deletion of a chemical formula should be shown by brackets which are substantially larger and darker than any in the formula.

Where a terminal disclaimer was filed in the application for the patent to be reissued, a copy of that terminal disclaimer is not needed in the reissue application file. For a reissue application that is maintained in a paper file, the face of the file wrapper should be marked to indicate that a terminal disclaimer has been filed for the patent. For a reissue application that is maintained in IFW, the “Final SPRE Review” form will be filled in.

Twice reissued patent:

Examples of the form for a twice-reissued patent are found in Re. 23,558 and Re. 28,488. Double underlining and double bracketing are used in the second reissue application, while bold-faced type and double bracketing appear in the printed patent (the second reissue patent) to indicate further insertions and deletions, respectively, in the second reissue patent.

When a copy of a first reissue patent is used as the specification of a second reissue application (filed as a reissue of a reissue), additions made by the first reissue will already be printed in italics, and should remain in such format. Thus, applicants need only present additions to the specification/claims in the second reissue application as double underlined text. Subject matter to be deleted from the first reissue patent should be presented in the second reissue application within sets of double brackets.

1411.01 Certificate of Correction or Disclaimer in Original Patent[edit | edit source]

The applicant should include any changes, additions, or deletions that were made by a Certificate of Correction to the original patent grant in the reissue application without underlining or bracketing. The examiner should make certain that all Certificate of Correction changes in the patent have been properly incorporated into the reissue application.

Certificate of Correction changes and disclaimer of claim(s) under 37 CFR 1.321(a) should be made without using underlining or brackets. Since these are part of the original patent and were made before the reissue was filed, they should show up in the printed reissue patent document as part of the original patent, i.e., not in italics or bracketed. If the changes are extensive and/or applicant has submitted them improperly with underlining and brackets, a clean copy of the specification with the Certificate of Correction changes in it may be requested by the examiner. In order for the clean copy to be entered as a substitute specification, the reissue applicant must file a grantable petition under 37 CFR 1.183 for waiver of 37 CFR 1.125(d) and 37 CFR 1.173(a)(1). The examiner’ s request for the clean copy will generally serve as sufficient basis for granting the petition.

1411.02 New Matter[edit | edit source]

New matter, that is, matter not present in the patent sought to be reissued, is excluded from a reissue application in accordance with 35 U.S.C. 251.

The claims in the reissue application must be for subject matter which the applicant had the right to claim in the original patent. Any change in the patent made via the reissue application should be checked to ensure that it does not introduce new matter. Note that new matter may exist by virtue of the omission of a feature or of a step in a method. See United States Industrial Chemicals, Inc. v. Carbide & Carbon Chemicals Corp., 315 U.S. 668, 53 USPQ 6 (1942).

1412 Content of Claims[edit | edit source]

The content of claims in a reissue application is somewhat limited, as is indicated in MPEP § 1412.01through MPEP § 1412.03.

1412.01Reissue Claims Must Be for Same General Invention [R-2]

The reissue claims must be for the same invention as that disclosed as being the invention in the original patent, as required by 35 U.S.C. 251. This does not mean that the invention claimed in the reissue must have been claimed in the original patent, although this is evidence that applicants considered it their invention. The entire disclosure, not just the claim(s), is considered in determining what the patentee objectively intended as his or her invention. The proper test as to whether reissue claims are for the same invention as that disclosed as being the invention in the original patent is “an essentially factual inquiry confined to the objective intent manifested by the original patent.” In re Amos, 953 F.2d 613, 618, 21 USPQ2d 1271, 1274 (Fed. Cir. 1991) (quoting In re Rowand, 526 F.2d 558, 560, 187 USPQ 487, 489 (CCPA 1975)) (emphasis added). See also In re Mead, 581 F.2d 257, 198 USPQ 412 (CCPA 1978). The “original patent” requirement of 35 U.S.C. 251 must be understood in light of In re Amos, supra, where the Court of Appeals for the Federal Circuit stated:

We conclude that, under both Mead and Rowand, a claim submitted in reissue may be rejected under the “original patent” clause if the original specification demonstrates, to one skilled in the art, an absence of disclosure sufficient to indicate that a patentee could have claimed the subject matter. Merely finding that the subject matter was “not originally claimed, not an object of the original patent, and not depicted in the drawing,” does not answer the essential inquiry under the “original patent” clause of § 251, which is whether one skilled in the art, reading the




specification, would identify the subject matter of the new claims as invented and disclosed by the patentees. In short, the absence of an “intent,” even if objectively evident from the earlier claims, the drawings, or the original objects of the invention is simply not enough to establish that the new claims are not drawn to the invention disclosed in the original patent.

953 F.2d at 618-19, 21 USPQ2d at 1275. Claims presented in a reissue application are considered to satisfy the requirement of 35 U.S.C. 251 that the claims be “for the invention disclosed in the original patent” where:

(A)the claims presented in the reissue application are described in the original patent specification and enabled by the original patent specification such that 35 U.S.C. 112 first paragraph is satisfied; and

(B)nothing in the original patent specification indicates an intent not to claim the subject matter of the claims presented in the reissue application.

The presence of some disclosure (description and enablement) in the original patent should evidence that applicant intended to claim or that applicant considered the material now claimed to be his or her invention.

The original patent specification would indicate an intent not to claim the subject matter of the claims presented in the reissue application in a situation analogous to the following:

The original patent specification discloses that composition X is not suitable (or not satisfactory) for molding an item because composition X fails to provide quick drying. After the patent issues, it is found that composition X would be desirable for the molding in spite of the failure to provide quick drying, because of some other newly recognized benefit from composition X. A claim to composition X or a method of use thereof would not be permitted in a reissue application, because the original patent specification contained an explicit statement of intent not to claim composition X or a method of use thereof.

In most instances, however, the mere failure to claim a disclosed embodiment in the original patent (absent an explicit statement in the original patent specification of unsuitability of the embodiment) would not be grounds for prohibiting a claim to that embodiment in the reissue.

FAILURE TO TIMELY FILE A DIVISIONAL APPLICATION PRIOR TO ISSUANCE OF ORIGINAL PATENT

Where a restriction requirement was made in an application and applicant permitted the elected invention to issue as a patent without the filing of a divisional application on the non-elected invention(s), the non-elected invention(s) cannot be recovered by filing a reissue application. A reissue applicant’ s failure to timely file a divisional application covering the non- elected invention(s) in response to a restriction requirement is not considered to be error causing a patent granted on the elected claims to be partially inoperative by reason of claiming less than the applicant had a right to claim. Accordingly, such error is not correctable by reissue of the original patent under 35 U.S.C. 251. In re Watkinson, 900 F.2d 230, 14 USPQ2d 1407 (Fed. Cir. 1990); In re Orita, 550 F.2d 1277, 1280, 193 USPQ 145, 148 (CCPA 1977). See also In re Mead, 581 F.2d 251, 198 USPQ 412 (CCPA 1978). In this situation, the reissue claims should be rejected under 35 U.S.C. 251 for lack of defect in the original patent and lack of error in obtaining the original patent. Compare with In re Doyle, 293 F.3d 1355, 63 USPQ2d 1161 (Fed. Cir. 2002) where the court permitted the patentee to file a reissue application to present a so-called linking claim, a claim broad enough to read on or link the invention elected (and patented) together with the invention not elected. The non-elected invention(s) were inadvertently not filed as a divisional application.

1412.02Recapture of Canceled SubjectMatter [R-5]

A reissue will not be granted to “recapture” claimed subject matter which was surrendered in an application to obtain the original patent. North American Container, Inc. v. Plastipak Packaging, Inc., 415 F.3d 1335, 75 USPQ2d 1545 (Fed. Cir. 2005, Pannu v. Storz Instruments Inc., 258 F.3d 1366, 59 USPQ2d 1597 (Fed. Cir. 2001); Hester Industries, Inc. v. Stein, Inc., 142 F.3d 1472, 46 USPQ2d 1641 (Fed. Cir. 1998); In re Clement, 131 F.3d 1464, 45 USPQ2d 1161 (Fed. Cir. 1997); Ball Corp. v. United States, 729 F.2d 1429, 1436, 221 USPQ 289, 295 (Fed. Cir. 1984); In re Wadlinger, 496 F.2d 1200, 181 USPQ 826 (CCPA 1974); In re Richman, 409 F.2d 269, 276,




161 USPQ 359, 363-364 (CCPA 1969); In re Willingham, 282 F.2d 353, 127 USPQ 211 (CCPA 1960).

I.THREE STEP TEST FOR RECAPTURE:

In Clement, 131 F.3d at 1468-70, 45 USPQ2d at 1164-65, the Court of Appeals for the Federal Circuit set forth a three step test for recapture analysis. In Pannu, 258 F.3d at 1371, 59 USPQ2d at 1600, the court restated this test as follows:

Application of the recapture rule is a three-step process.


The first step is to ‘determine whether and in what aspect the reissue claims are broader than the patent claims.’....

‘The second step is to determine whether the broader aspects of the reissued claim related to surrendered subject matter’ ....

Finally, the court must determine whether the reissued claims were materially narrowed in other respects to avoid the recapture rule. [Emphasis added]

A.The First Step - Was There Broadening?

In every reissue application, the examiner must first review each claim for the presence of broadening, as compared with the scope of the claims of the patent to be reissued. A reissue claim is broadened where some limitation of the patent claims is no longer required in the reissue claim; see MPEP § 1412.03 for guidance as to the nature of a “broadening claim.” If the reissue claim is not broadened in any respect as compared to the patent claims, the analysis ends; there is no recapture.


B.The Second Step - Does Any Broadening Aspect of the Reissued Claim Relate to Surrendered Subject Matter?

Where a claim in a reissue application is broadened in some respect as compared to the patent claims, the examiner must next determine whether the broadening aspect(s) of that reissue claim relate(s) to subject matter that applicant previously surrendered during the prosecution of the original application (which became the patent to be reissued). Each limitation of the patent claims, which is omitted or broadened in the reissue claim, must be reviewed for this determination. This involves two sub-steps:

1.The Two Sub-Steps:

(A)It must first be determined whether there was any surrender of subject matter made in the prosecution of the original application which became the patent to be reissued.

If an original patent claim limitation now being omitted or broadened in the present reissue application was originally relied upon by applicant in the original application to make the claims allowable over the art, the omitted limitation relates to subject matter previously surrendered by applicant. The reliance by applicant to define the original patent claims over the art can be by way of presentation of new/amended claims to define over the art, or an argument/statement by applicant that a limitation of the claim(s) defines over the art. To determine whether such reliance occurred, the examiner must review the prosecution history of the original application file (of the patent to be reissued) for recapture. The prosecution history includes the rejections and applicant’s arguments made therein.

If there was no surrender of subject matter made in the prosecution of the original application, again the analysis ends and there is no recapture.

(B)If there was a surrender of subject matter in the original application prosecution, it must then be determined whether any of the broadening of the reissue claims is in the area of the surrendered subject matter. All of the broadening aspects of reissue claims must be analyzed to determine if any of the omitted/ broadened limitation(s) are directed to limitations relied upon by applicant in the original application to make the claims allowable over the art.

2.Examples of the Pannu Second Step Analysis:


(A)Example (1) - Argument without amendment:

In Hester, supra, the Federal Circuit held that the surrender which forms the basis for impermissible recapture “can occur through arguments alone”. 142 F.3d at 1482, 46 USPQ2d at 1649. For example, assume that limitation A of the patent claims is omitted in the reissue claims. This omission provides a broadening aspect in the reissue claims, as compared to the claims of the patent. If the omitted limitation A was argued in the original application to make the application claims allowable over the art in the appli




cation, then the omitted limitation relates to subject matter previously surrendered in the original application, and recapture will exist. Accordingly, where claims are broadened in a reissue application, the examiner should review the prosecution history of the original patent file for recapture, even where the claims were never amended during the prosecution of the application which resulted in the patent.

Note: The argument that the claim limitation defined over the rejection must have been specific as to the limitation relied upon, rather than a general statement regarding the claims as a whole. A general 'boiler plate' sentence in the original application will not, by itself, be sufficient to establish surrender and recapture.

An example of a general “boiler plate” sentence of argument is:

“In closing, it is argued that the limitations of claims 1-7 distinguish the claims from the teachings of the prior art, and claims 1-7 are thus patentable.”

An argument that merely states that all the limitations of the claims define over the prior art will also not, by itself, be sufficient to establish surrender and recapture. An example is:

“Claims 1-5 set forth a power-train apparatus which comprises the combination of A+B+C+D+E. The prior art of record does not disclose or render obvious a motivation to provide for a material-transfer apparatus as defined by the limitations of claim 1, including an A member and a B member, both connected to a C member, with all three being aligned with the D and E members.”

This statement is simply a restatement of the entirety of claim 1 as allowed. No measure of surrender could be gleaned from such a statement of reasons for allowance. See Ex parte Yamaguchi, 61 USPQ2d 1043 (Bd. Pat. App. & Inter. 2001)(reported but unpublished, precedential).

In both of the above examples, the argument does not provide an indication of what specific limitations, e.g., specific element or step of the claims, cooperative effect, or other aspect of the claims, are being relied upon for patentability. Thus, applicant has not surrendered anything.

(B)Example (2) - Amendment of the claims without argument:

The limitation omitted in the reissue claim(s) was added in the original application claims for the purpose of making the application claims allowable over a rejection or objection made in the application. Even though applicant made no argument on the record that the limitation was added to obviate the rejection, the nature of the addition to the claim can show that the limitation was added in direct reply to the rejection. This too will establish the omitted limitation as relating to subject matter previously surrendered. To illustrate this, note the following example:

The original application claims recite limitations A+B+C, and the Office action rejection combines two references to show A+B+C. In the amendment replying to the Office action, applicant adds limitation D to A+B+C in the claims, but makes no argument as to that addition. The examiner then allows the claims. Even though there is no argument as to the addition of limitation D, it must be presumed that the D limitation was added to obviate the rejection. The subsequent deletion of (omission of) limitation D in the reissue claims would be presumed to be a broadening in an aspect of the reissue claims related to surrendered subject matter. Accordingly, the reissued claims would be barred by the recapture doctrine.

The above result would be the same whether the addition of limitation D in the original application was by way of applicant’s amendment or by way of an examiner’s amendment with authorization by applicant.


(C)Example (3) - Who can make the surrendering argument?

Assume that the limitation A omitted in the reissue claims was present in the claims of the original application. The examiner’s reasons for allowance in the original application stated that it was that limitation A which distinguished over a potential combination of references X and Y. Applicant did not present on the record a counter statement or comment as to the examiner’s reasons for allowance, and permitted the claims to issue.

Ex parte Yamaguchi, supra, held that a surrender of claimed subject matter cannot be based solely upon an applicant’s failure to respond to, or failure to challenge, an examiner’s statement made during the prosecution of an application. Applicant is bound only by applicant’s revision of the application claims or a positive argument/statement by applicant. An applicant’s failure to present on the record a counter statement or




comment as to an examiner’s reasons for allowance does not give rise to any implication that applicant agreed with or acquiesced in the examiner’s reasoning for allowance. Thus, the failure to present a counter statement or comment as to the examiner’s statement of reasons for allowance does not give rise to any finding of surrender. The examiner’s statement of reasons for allowance in the original application cannot, by itself, provide the basis for establishing surrender and recapture.

It is only in the situation where applicant does file comments on the statement of reasons for allowance, that surrender may have occurred. Note the following two scenarios in which an applicant files comments:

Scenario 1- There is Surrender: The examiner’s statement of reasons for allowance in the original application stated that it was limitation C (of the combination of ABC) which distinguished over a potential combining of references X and Y, in that limitation C provided increased speed to the process. Applicant filed comments on the examiner’s statement of reasons for allowance essentially supporting the examiner’ s reasons. The limitation C is thus established as relating to subject matter previously surrendered.

Scenario 2- There is No Surrender: On the other hand, if applicant’s comments on the examiner’s statement of reasons for allowance contain a counter statement that it is limitation B (of the combination of ABC), rather than C, which distinguishes the claims over the art, then limitation B would constitute surrendered subject matter, and limitation C has not been surrendered.

C.The Third Step - Were the reissued claims materially narrowed in other respects to compensate for the broadening in the area of surrender, and thus avoid the recapture rule?

As pointed out above, the third prong of the recapture determination set forth in Pannu is directed to analysis of the broadening and narrowing effected via the reissue claims, and of the significance of the claim limitations added and deleted, using the prosecution history of the patent (to be reissued), to determine whether the reissue claims should be barred as recapture.


The following discussion addresses analyzing the reissue claims, and which claims are to be compared to the reissue claims in determining the issue of surrender (for reissue recapture).

When analyzing a reissue claim for the possibility of impermissible recapture, there are two different types of analysis that must be performed. If the reissue claim “fails” either analysis, recapture exists.

First, the reissue claim must be compared to any claims canceled or amended during prosecution of the original application. It is impermissible recapture for a reissue claim to be as broad or broader in scope than any claim that was canceled or amended in the original prosecution to define over the art. Claim scope that was canceled or amended is deemed surrendered and therefore barred from reissue. In re Clement, supra.

Second, it must be determined whether the reissue claim entirely omits any limitation that was added/ argued during the original prosecution to overcome an art rejection. Such an omission in a reissue claim, even if it includes other limitations making the reissue claim narrower than the patent claim in other aspects, is impermissible recapture. Pannu v. Storz Instruments Inc., supra. However, if the reissue claim recites a broader form of the key limitation added/ argued during original prosecution to overcome an art rejection (and therefore not entirely removing that key limitation), then the reissue claim may not be rejected under the recapture doctrine. Ex Parte Eggert, 67 USPQ2d 1716 (Bd. Pat. App. & Inter. 2003) (precedential). For example, if the key limitation added to overcome an art rejection was “an orange peel,” and the reissue claim instead recites “a citrus fruit peel”, the reissue claim may not be rejected on recapture grounds.

The following discussion is provided for analyzing the reissue claims.

1.Comparison of Reissue Claims Narrowed/ Broadened Vis-à-vis the Canceled Claims

DEFINITION: “Canceled claims,” in the context of recapture case law, are claims canceled from the original application to obtain the patent for which reissue is now being sought. The claims

(A)can simply be canceled and not replaced by others, or

(B)can be canceled and replaced by other claims which are more specific than the canceled claims in at least one aspect (to thereby define over the art of record). The “replacement claims” can be new claims which are narrower than the canceled claims, or can




be the same claims amended to be narrower than the canceled version of the claims.

(a)Reissue Claims are Same or Broader in Scope Than Canceled Claims in All Aspects:

The recapture rule bars the patentee from acquiring, through reissue, claims that are in all aspects (A) of the same scope as, or (B) broader in scope than, those claims canceled from the original application to obtain a patent. In re Ball Corp. v. United States, 729 F.2d at 1436, 221 USPQ at 295.

(b)Reissue Claims are Narrower in Scope Than Canceled Claims in at Least One Aspect:

If the reissue claims are equal in scope to, or narrower than, the claims of the original patent (as opposed to the claims “canceled from the application”) in all aspects, then there can never be recapture. The discussion that follows is not directed to that situation. It is rather directed to the situation where the reissue claims are narrower than the claims 'canceled' from the application in some aspect, but are broader than the claims of the original patent in some other aspect.

If the reissue claims are narrower in scope than the claims canceled from the original application by inclusion of the limitation added to define the original application claims over the art, there will be no recapture, even if the reissue claims are broader than the canceled claims in some other aspect (i.e., an aspect not related to the surrender made in the original application).


Assume combination AB was originally presented in the application, and was amended in response to an art rejection to add element C and thus provide ABC (after which the patent issued). The reissue claims are then directed to combination ABbroadenedC. The ABbroadenedC claims are narrower in scope when compared with the canceled claim subject matter AB in respect to the addition of C (which was added in the application to overcome the art), and there is no recapture.

As another example, assume combination ABZ was originally presented in the application, and was amended in response to an art rejection to add element C and thus provide ABZC (after which the patent issued). The reissue claims are then directed to combination ABC (i.e., element Z is deleted from the canceled claims, while element C remains present). The ABC claims of the reissue are narrower in scope as compared to the canceled-from-the-original-application claim subject matter ABZ in respect to the addition of C (which was added in the application to overcome the art), and there is thus no recapture.

2.Comparison of Reissue Claims Narrowed/ Broadened Via-à-vis the Patent Claims

The “patent claims,” in the context of recapture case law, are claims which issued in the original patent for which reissue is now being sought. As pointed out above, where the reissue claims are narrower than the claims of the original patent in all aspects, then there can never be recapture. If reissue claims are equal in scope to the patent claims, there is no recapture as to those reissue claims. Where, however, reissue claims are both broadened and narrowedas compared with the original patent claims, the nature of the broadening and narrowing must be examined to determine whether the reissue claims are barred as being recapture of surrendered subject matter. If the claims are 'broader than they are narrower in a manner directly pertinent to the subject matter... surrendered during prosecution' (Clement, 131 F.3d at 1471, 45 USPQ2d at 1166), then recapture will bar the claims. This narrowing/broadening vis-à-vis the patent is broken down into four possibilities that will now be addressed.

The “limitation” presented, argued, or stated to make the claims patentable over the art (in the application) “generates” the surrender of claimed subject matter. For the sake of simplification, this limitation will be referred to throughout this section as the surrender- generating limitation. If a claim is presented in a reissue application that omits, in its entirety, the surrender- generating limitation, that claim impermissibly recaptures what was previously surrendered, and that claim is barred under 35 U.S.C. 251. This terminology will be used in the discussion of the four categories of narrowing/broadening vis-à-vis the patent that follows.




(a)Reissue Claims are Narrower in Scope Than Patent Claims, in Area Not Directed to Amendment/Argument Made to Overcome Art Rejection in Original Prosecution; are Broader in Scope by Omitting Limitation(s) Added/Argued To Overcome Art Rejection in Original Prosecution:

In this case, there is recapture.

This situation is where the patent claims are directed to combination ABC and the reissue claims are directed to ABD. Element C was either a limitation added to AB to obtain allowance of the original patent, or was argued by applicant to define over the art (or both). Thus, addition of C (and/or argument as to C) has resulted in the surrender of any combination of A & B that does not include C; this is the surrendered subject matter. Element D, on the other hand, is not related to the surrendered subject matter. Thus, the reissue claim, which no longer contains C, is broadened in an area related to the surrender, and the narrowing via the addition of D does not save the claim from recapture since D is not related to the surrendered subject matter.

Reissue claims that are broader than the original patent claims by not including the surrender-generating limitation (element C, in the example given) will be barred by the recapture rule even though there is narrowing of the claims not related to the surrender- generating limitation. As stated in the decision of In re Clement, 131 F.3d at 1470, 45 USPQ2d at 1165, if the reissue claim is broader in an aspect germane to a prior art rejection, but narrower in another aspect completely unrelated to the rejection, the recapture rule bars the claim. Pannu v. Storz Instruments Inc., supra, then brings home the point by providing an actual fact situation in which this scenario was held to be recapture.

(b)Reissue Claims are Narrower or Equal in Scope, in Area Directed to Amendment/ Argument Made to Overcome Art Rejection in Original Prosecution; are Broader in Scope in Area Not Directed to Amendment/ Argument:

In this case, there is no recapture.

This situation is where the patent claims are directed to combination ABCDE and the reissue claims are directed to ABDE (element C is omitted). Assume that the combination of ABCD was present in the original application as it was filed, and element E was later added to define over that art. No argument was ever presented as to elements A-C defining over the art.

In this situation, the ABCDE combination of the patent can be broadened (in the reissue application) to omit element C, and thereby claim the combination of ABDE, where element E (the surrender generating limitation) is not omitted. There would be no recapture in this instance. (If an argument had been presented as to element C defining over the art, in addition to the addition of element E, then the ABCDE combination could not be broadened to omit element C and thereby claim combination of ABDE. This would be recapture; see the above discussion as to surrender and recapture based upon argument.)

Additionally, the reissue claims are certainly permitted to recite combination ABDEspecific (where surrender- generating element E is narrowed). The patent claims have been broadened in an area not directed to the surrender (by omitting element C) and narrowed in the area of surrender (by narrowing element E to Especific). This is clearly permitted.

As another example, assume limitation C was added to application claims AB to obtain the patent to ABC, and now the reissue application presents claims to AC or ABbroadC. Such reissue claims avoid the effect of the recapture rule because they are broader in a way that does not attempt to reclaim what was surrendered earlier. Mentor Corp. v. Coloplast, Inc., 998 F.2d 992, 994, 27 USPQ2d 1521, 1525 (Fed. Cir. 1993). Such claims are considered to be broader in an aspect not 'germane to a prior art rejection,' and thus are not barred by recapture. Note In re Clement, 131 F.3d at 1470, 45 USPQ2d at 1165.

Reissue claims that are broader than the original patent claims by deletion of a limitation or claim requirement other than the “surrender-generating limitation” will avoid the effect of the recapture rule, regardless of the nature of the narrowing in the claims, and even if the claims are not narrowed at all from the scope of the patent claims.




(c)Reissue Claims are Narrower in Scope in Area Not Directed to Amendment/Argument Made to Overcome Art Rejection in Original Prosecution; are Broader in Scope in Area Not Directed to the Amendment/Argument:

In this instance, there is clearly no recapture. In the reissue application, there has been no change in the claims related to the matter surrendered in the original application for the patent.

In this instance, element C was added to the AB combination to provide ABC and define over the art, and the patent was issued. The reissue omits element B and adds element Z, to thus claim ACZ. There is no recapture since the surrender generating element C has not been modified in any way. (Note, however, that if, when element C was added to AB, applicant argued that the association of newly added C with B provides a synergistic (unexpected) result to thus define over the art, then neither B nor C could be omitted in the reissue application.)

(d)Reissue Claims Broader in Scope in Area Directed to Amendment/Argument Made to Overcome Art Rejection in Original Prosecution; but Reissue Claims Retain, in Broadened Form, the Limitation(s) Argued/ Added to Overcome Art Rejection in Original Prosecution:

Assume the combination AB was originally claimed in the application, and was amended in reply to an art rejection to add element C and thus provide the combination ABC (after which the patent issued). A reissue application is then filed, and the reissue application claims are directed to the combination ABCbroadened. The ABCbroadened claims are narrowed in scope when compared with the canceled claim subject matter AB, because of the addition of Cbroadened. Thus, the claims retain, in broadened form, the limitation argued/added to overcome art rejection in original prosecution. There is no recapture, since ABCbroadened is narrower than canceled claim subject matter AB in an area related to the surrender. This is so, because it was element C that was added in the application to overcome the art. See Ex Parte Eggert, supra.

II.REISSUE TO TAKE ADVANTAGE OF 35 U.S.C. 103(b):

A patentee may file a reissue application to permit consideration of process claims which qualify for 35 U.S.C. 103(b) treatment if a patent is granted on an application entitled to the benefit of 35 U.S.C. 103(b), without an election having been made as a result of.. error without deceptive intent. See MPEP §

706.02(n). This is not to be considered a recapture. The addition of process claims, however, will generally be considered to be a broadening of the invention (Ex parte Wikdahl, 10 USPQ2d 1546 (Bd. Pat. App. & Inter. 1989)), and such addition must be applied for within two years of the grant of the original patent. See also MPEP § 1412.03 as to broadened claims.

III.REISSUE FOR ARTICLE CLAIMS WHICH ARE FUNCTIONAL DESCRIPTIVE MATERIAL STORED ON A COMPUTER- READABLE MEDIUM:

A patentee may file a reissue application to permit consideration of article of manufacture claims which are functional descriptive material stored on a computer- readable medium, where these article claims correspond to the process or machine claims which have been patented. The error in not presenting claims to this statutory category of invention (the “article” claims) must have been made as a result of error without deceptive intent. The addition of these “article” claims will generally be considered to be a broadening of the invention (Ex parte Wikdahl, 10 USPQ2d 1546 (Bd. Pat. App. & Inter. 1989)), and such addition must be applied for within two years of the grant of the original patent. See also MPEP § 1412.03 as to broadened claims.

IV.REJECTION BASED UPON RECAPTURE:


Reissue claims which recapture surrendered subject matter should be rejected using form paragraph 14.17.

¶ 14.17 Rejection, 35 U.S.C. 251, Recapture

Claim[1] rejected under 35 U.S.C. 251 as being an improper recapture of broadened claimed subject matter surrendered in the application for the patent upon which the present reissue is based. See Pannu v. Storz Instruments Inc., 258 F.3d 1366, 59 USPQ2d 1597 (Fed. Cir. 2001); Hester Industries, Inc. v. Stein, Inc., 142 F.3d 1472, 46 USPQ2d 1641 (Fed. Cir. 1998); In re Clement, 131




F.3d 1464, 45 USPQ2d 1161 (Fed. Cir. 1997); Ball Corp. v. United States, 729 F.2d 1429, 1436, 221 USPQ 289, 295 (Fed. Cir. 1984). A broadening aspect is present in the reissue which was not present in the application for patent. The record of the application for the patent shows that the broadening aspect (in the reissue) relates to claim subject matter that applicant previously surrendered during the prosecution of the application. Accordingly, the narrow scope of the claims in the patent was not an error within the meaning of 35 U.S.C. 251, and the broader scope of claim subject matter surrendered in the application for the patent cannot be recaptured by the filing of the present reissue application.

[2]

Examiner Note:

In bracket 2, the examiner should explain the specifics of why recapture exists, including an identification of the omitted/broadened claim limitations in the reissue which provide the “broadening aspect” to the claim(s), and where in the original application the narrowed claim scope was presented/argued to obviate a rejection/ objection. See MPEP §

1412.02.

See the recapture-analysis flow chart which follows for assistance in determining whether recapture is present, consistent with the case law discussed above.




Flowchart - Reissue Recapture - Determining its presence or absence




1412.03Broadening Reissue Claims [R-3]

35 U.S.C. 251 prescribes a 2-year limit for filing applications for broadening reissues:

No reissue patent shall be granted enlarging the scope of the original patent unless applied for within two years from the grant of the original patent.


I. MEANING OF “BROADENED REISSUE CLAIM”

A broadened reissue claim is a claim which enlarges the scope of the claims of the patent, i.e., a claim which is greater in scope than each and every claim of the original patent. If a disclaimer is filed in the patent prior to the filing of a reissue application, the disclaimed claims are not part of the “original patent” under 35 U.S.C. 251. The Court in Vectra Fitness Inc. v. TNWK Corp., 49 USPQ2d 1144, 1147, 162 F.3d 1379, 1383 (Fed. Cir. 1998) held that a reissue application violated the statutory prohibition under 35 U.S.C. 251 against broadening the scope of the patent more than 2 years after its grant because the reissue claims are broader than the claims that remain after the disclaimer, even though the reissue claims are narrower than the claims that were disclaimed by the patentee before reissue. The reissue application was bounded by the claims remaining in the patent after a disclaimer is filed.A claim of a reissue application enlarges the scope of the claims of the patent if it is broader in at least one respect, even though it may be narrower in other respects.

A claim in the reissue which includes subject matter not covered by the patent claims enlarges the scope of the patent claims. For example, if any amended or newly added claim in the reissue contains within its scope any conceivable product or process which would not have infringed the patent, then that reissue claim would be broader than the patent claims. Tillotson, Ltd. v. Walbro Corp., 831 F.2d 1033, 1037 n.2, 4 USPQ2d 1450, 1453 n.2 (Fed. Cir. 1987); In re Ruth, 278 F.2d 729, 730, 126 USPQ 155, 156 (CCPA 1960); In re Rogoff, 261 F.2d 601, 603, 120 USPQ 185, 186 (CCPA 1958). A claim which reads on something which the original claims do not is a broadened claim. A claim would be considered a broadening claim if the patent owner would be able to sue any party for infringement who previously could not have been sued for infringement. Thus, where the original patent claims only the process, and the reissue application adds (for the first time) product claims, the scope of the claims has been broadened since a party could not be sued for infringement of the product based on the claims of the original patent.

The addition of combination claims in a reissue application where only subcombination claims were present in the original patent could be a broadening of the invention. The question which must be resolved in this case is whether the combination claims added in the reissue would be for “the invention as claimed” in the original patent. See Ex parte Wikdahl, 10 USPQ2d at 1549. The newly added combination claims should be analyzed to determine whether they contain every limitation of the subcombination of any claim of the original patent. If the combination claims (added in the reissue) contain every limitation of the subcombination (which was claimed in the original application), then infringement of the combination must also result in infringement of the subcombination. Accordingly, the patent owner could not, if a reissue patent issues with the combination claims, sue any new party for infringement who could not have been sued for infringement of the original patent. Therefore, broadening does not exist, in spite of the addition of the combination.


II. SCOPE OF DEPENDENT CLAIM ENLARGED-NOT BROADENING

As pointed out above, a claim will be considered a broadened reissue claim when it is greater in scope than each and every claim of the patent to be reissued. A corollary of this is that a claim which has been broadened in a reissue as compared to its scope in the patent is not a broadened reissue claim if it is narrower than, or equal in scope to, any other claim which appears in the patent. A common example of this is where dependent claim 2 is broadened via the reissue (other than the addition of a process step to convert an intermediate to a final product as discussed in the preceding subsection), but independent claim 1 on which it is based is not broadened. Since a dependent claim is construed to contain all the limitations of the claim upon which it depends, claim 2 must be at




least as narrow as claim 1 and is thus not a broadened reissue claim.


III. NEW CATEGORY OF INVENTION ADDED IN REISSUE - GENERALLY IS BROADENING

The addition of process claims as a new category of invention to be claimed in the patent (i.e., where there were no method claims present in the original patent) is generally considered as being a broadening of the invention. See Ex parte Wikdahl, 10 USPQ2d 1546 (Bd. Pat. App. & Inter. 1989). A situation may arise, however, where the reissue application adds a limitation (or limitations) to process A of making the product A claimed in the original patent claims. For example:

(1)a process of using the product A (made by the process of the original patent) to make a product B, disclosed but not claimed in the original patent; or

(2)a process of using the product A to carry out a process B disclosed but not claimed in the original patent.

Although this amendment of the claims adds a method of making product B or adds a method of using product A, this is not broadening (i.e., this is not an enlargement of the scope of the original patent) because the “newly claimed invention” contains all the limitations of the original patent claim(s).


IV. WHEN A BROADENED CLAIM CAN BE PRESENTED

A broadened claim can be presented within two years from the grant of the original patent in a reissue application. In addition, a broadened claim can be presented after two years from the grant of the original patent in a broadening reissue application which was filed within two years from the grant. Where any intent to broaden is indicated in the reissue application within the two years from the patent grant, a broadened claim can subsequently be presented in the reissue after the two year period. Thus, a broadened claim may be presented in a reissue application after the two years, even though the broadened claim presented after the two years is different than the broadened claim presented within the two years. Finally, if intent to broaden is indicated in a parent reissue application within the two years, a broadened claim can be presented in a continuing (continuation or divisional) reissue application after the two year period. In any other situation, a broadened claim cannot be presented, and the examiner should check carefully for the improper presentation of broadened claims.

A reissue application filed on the 2-year anniversary date from the patent grant is considered to be filed within 2 years of the patent grant. See Switzer v. Sockman, 333 F.2d 935, 142 USPQ 226 (CCPA 1964) for a similar rule in interferences.

See also the following cases which pertain to broadened reissues:

In re Graff, 111 F.3d 874, 877, 42 USPQ2d 1471, 1473-74 (Fed. Cir. 1997) (Broadened claims in a continuing reissue application were properly rejected under 35 U.S.C. 251 because the proposal for broadened claims was not made (in the parent reissue application) within two years from the grant of the original patent and the public was not notified that broadened claims were being sought until after the two-year period elapsed.);

In re Fotland, 779 F.2d 31, 228 USPQ 193 (Fed. Cir. 1985), cert. denied, 476 U.S. 1183 (1986) (The failure by an applicant to include an oath or declaration indicating a desire to seek broadened claimswithin two years of the patent grant will bar a subsequent attempt to broaden the claims after the two year limit. Under the former version of 37 CFR 1.175 (the former 37 CFR 1.175(a)(4)), applicant timely sought a “no-defect” reissue, but the Court did not permit an attempt made beyond the two year limit to convert the reissue into a broadening reissue. In this case, applicant did not indicate any intent to broaden within the two years.);

In re Bennett, 766 F.2d 524, 528, 226 USPQ 413, 416 (Fed. Cir. 1985) (en banc) (A reissue application with broadened claims was filed within two years of the patent grant; however, the declaration was executed by the assignee rather than the inventor. The Federal Circuit permitted correction of the improperly executed declaration to be made more than two years after the patent grant.);

In re Doll, 419 F.2d 925, 928, 164 USPQ 218, 220 (CCPA 1970) (If the reissue application is timely filed within two years of the original patent grant and the




applicant indicates in the oath or declaration that the claims will be broadened, then applicant may subsequently broaden the claims in the pending reissue prosecution even if the additional broadening occurs beyond the two year limit.).

Form paragraphs 14.12 and 14.13 may be used in rejections based on improper broadened reissue claims.

¶ 14.12 Rejection, 35 U.S.C. 251, Broadened Claims After Two Years

Claim [1] rejected under 35 U.S.C. 251 as being broadened in a reissue application filed outside the two year statutory period. [2] A claim is broader in scope than the original claims if it contains within its scope any conceivable product or process which would not have infringed the original patent. A claim is broadened if it is broader in any one respect even though it may be narrower in other respects.

Examiner Note:

The claim limitations that broaden the scope should be identified and explained in bracket 2. See MPEP §§ 706.03(x) and 1412.03.

¶ 14.13 Rejection, 35 U.S.C. 251, Broadened Claims Filed by Assignee

Claim [1] rejected under 35 U.S.C. 251 as being improperly broadened in a reissue application made and sworn to by the assignee and not the patentee. [2]A claim is broader in scope than the original claims if it contains within its scope any conceivable product or process which would not have infringed the original patent. A claim is broadened if it is broader in any one respecteven though it may be narrower in other respects.

Examiner Note:

The claim limitations that broaden the scope should be identified and explained in bracket 2. See MPEP §§ 706.03(x) and 1412.03.


V. BROADENING REISSUE - OATH/ DECLARATION REQUIREMENTS

A broadening reissue application must be applied for by all of the inventors (patentees), that is, the original reissue oath or declaration must be signed by all of the inventors. See also MPEP § 1414. If a supplemental oath or declaration in a broadening reissue application is needed in the application in order to fulfill the requirements of 37 CFR 1.175, the supplemental reissue oath or declaration must be signed by all of the inventors. See In re Hayes, 53 USPQ2d 1222 (Comm’r Pat. 1999) and MPEP § 1414.01.

1412.04Correction of Inventorship [R-5]

The correction of misjoinder of inventors has been held to be a ground for reissue. See Ex parte Scudder, 169 USPQ 814, 815 (Bd. App. 1971) wherein the Board held that 35 U.S.C. 251 authorizes reissue applications to correct misjoinder of inventors where35 U.S.C. 256 is inadequate. See also A.F. Stoddard & Co. v. Dann, 564 F.2d 556, 567 n.16, 195 USPQ 97, 106 n.16 (D.C. Cir. 1977) wherein correction of inventorship from sole inventor A to sole inventor B was permitted in a reissue application. The court noted that reissue by itself is a vehicle for correcting inventorship in a patent.

I.CERTIFICATE OF CORRECTION AS A VEHICLE FOR CORRECTING INVEN- TORSHIP

While reissue is a vehicle for correcting inventorship in a patent, correction of inventorship should be effected under the provisions of 35 U.S.C. 256 and 37 CFR 1.324 by filing a request for a Certificate of Correction if:

(A)the only change being made in the patent is to correct the inventorship; and

(B)all parties are in agreement and the inventorship issue is not contested.

See MPEP § 1481 for the procedure to be followed 

to obtain a Certificate of Correction for correction of inventorship.

II.REISSUE AS A VEHICLE FOR CORRECTING INVENTORSHIP

Where the provisions of 35 U.S.C. 256 and 

37 CFR 1.324 do not apply, a reissue application is the appropriate vehicle to correct inventorship. The failure to name the correct inventive entity is an error in the patent which is correctable under 35 U.S.C. 251. The reissue oath or declaration pursuant to 37 CFR 1.175 must state that the applicant believes the original patent to be wholly or partly inoperative or invalid through error of a person being incorrectly named in an issued patent as the inventor, or through error of an inventor incorrectly not named in an issued patent, and that such error arose without any deceptive intention on the part of the applicant. The




reissue oath or declaration must, as stated in 37 CFR 1.175, also comply with 37CFR 1.63.

The correction of inventorship does not enlarge the 

scope of the patent claims. Where a reissue application does not seek to enlarge the scope of the claims of the original patent, the reissue oath may be made and sworn to, or the declaration made, by the assignee of the entire interest under 37 CFR 1.172. An assignee of part interest may not file a reissue application to correct inventorship where the other co-owner did not join in the reissue application and has not consented to the reissue proceeding. See Baker Hughes Inc. v. Kirk, 921 F. Supp. 801, 809, 38 USPQ2d 1885, 1892 (D.D.C. 1995). See 35 U.S.C. 251, third paragraph. Thus, the signatures of the inventors are not needed on the reissue oath or declaration where the assignee of the entire interest signs the reissue oath/declaration. Accordingly, an assignee of the entire interest can add or delete the name of an inventor by reissue (e.g., correct inventorship from inventor A to inventors A and B) without the original inventor’s consent. See also 37 CFR 3.71(a) (“One or more assignees as defined in paragraph (b) of this section may, after becoming of record pursuant to paragraph (c) of this section, conduct prosecution of a national patent application or reexamination proceeding to the exclusion of either the inventive entity, or the assignee(s) previously entitled to conduct prosecution.” Emphasis added). Thus, the assignee of the entire interest can file a reissue to change the inventorship to one which the assignee believes to be correct, even though an inventor might disagree. The protection of the assignee’s property rights in the application and patent are statutorily based in 35 U.S.C. 118.

Where the name of an inventor X is to be deleted in a reissue application to correct inventorship in a patent, and inventor X has not assigned his/her rights to the patent, inventor X has an ownership interest in the patent. Inventor X must consent to the reissue (37 CFR 1.172(a)), even though inventor X’s name is being deleted as an inventor and need not sign the reissue oath or declaration. If inventor X has assigned his/her rights to the patent, then inventor X’s assignee must consent. In addition to providing the consent, even though inventor X does not sign the reissue oath or declaration as an inventor (since the correction of inventorship does not enlarge the scope of the patent claims), the assignee of the entire interest must sign the reissue oath or declaration as assignee (37 CFR 1.172(a)). Thus, if inventor X has not assigned his/her patent rights, inventor X’s signature must be included in the reissue oath or declaration as the assignee. If inventor X has assigned his/her patent rights, inventor X’s assignee must sign the reissue oath or declaration as the assignee. For example, a patent to inventors X and Y has no assignee. A reissue application is filed by inventor Y to delete the name of inventor X as an inventor. 37 CFR 1.172(a) provides that a reissue oath or declaration may be made by the assignee/owners of the entire interest, rather than by the inventors, where the scope of the claims is not to be enlarged. However, since inventor X has not assigned his/her patent rights, inventor X must sign the reissue oath or declaration as one of the owners, and consent to the filing of the reissue application by inventor Y. See MPEP §

1410.01.

Where a reissue to correct inventorship also 

changes the claims to enlarge the scope of the patent claims, the signature of all the inventors is needed. However, if an inventor refuses to sign the reissue oath or declaration because he or she believes the change in inventorship (to be effected) is not correct, the reissue application can still be filed with a petition under 37 CFR 1.47 without that inventor’s signature provided the written consent of all owners/assignees as required by 37 CFR 1.172(a) is also submitted. In the situation where a patent to inventors X and Y has no assignee and a reissue application is filed by inventor Y to delete the name of inventor X as an inventor and to broaden the patent. Inventor X refuses to sign the reissue oath or declaration and refuses to provide the consent as required by 37 CFR 1.172(a). In this instance, a 37 CFR 1.47 petition would not be appropriate to permit the filing of the reissue application since the consent requirement of 37 CFR 1.172(a) for each owner/assignee is not met. Resort to the courts would be required to delete the name of inventor X as an inventor where X will not consent to the filing of a reissue application. As stated in the second paragraph of 35 U.S.C. 256, “[t]he court before which such matter is called in question may order correction of the patent on notice and hearing of all parties concerned and the Director shall issue a certificate accordingly.”

The reissue application with its reissue oath or declaration 

under 37 CFR 1.175 provides a complete mechanism to correct inventorship. See A.F. Stoddard




& Co. v. Dann, 564 F.2d at 567, 195 USPQ at 106. A request under 37 CFR 1.48 or a petition under 37 CFR 1.324 cannot be used to correct the inventorship of a reissue application. If a request under 37 CFR 1.48 or a petition under 37 CFR 1.324 is filed in a reissue application, the request or petition should be dismissed and the processing or petition fee refunded. The material submitted with the request or petition should then be considered to determine if it complies with 37 CFR 1.175. If the material submitted with the request or petition does comply with the requirements of 37 CFR 1.175 (and the reissue application is otherwise in order), the correction of inventorship will be permitted as a correction of an error in the patent under 35 U.S.C. 251.

Where a reissue application seeks to correct inventorship in the patent and the inventors are required to sign the reissue oath or declaration (rather than an assignee of the entire interest under 37 CFR 1.172) due to a broadening of any claims of the original patent, the correct inventive entity must sign the reissue oath or declaration. Where an inventor is being added in a reissue application to correct inventorship in a patent, the inventor being added must sign the reissue oath or declaration together with the inventors previously designated on the patent. For example, a reissue application is filed to correct the inventorship from inventors A and B (listed as inventors on the patent) to inventors A, B, and C. Inventor C is the inventor being added. In such a case, A, B, and C are the correct inventors, and accordingly, each of A, B, and C must sign the reissue oath or declaration. Where an inventor is being deleted in a reissue application to correct inventorship in a patent and the inventors are required to sign the oath or declaration due to a broadening of any claims of the original patent, the inventor being deleted need not sign the reissue oath or declaration. The reissue oath or declaration must be signed by the correct inventive entity. For example, a reissue application is filed to correct inventorship from inventors A, B, and C (listed as inventors on the patent) to inventors A and B. Inventor C is being deleted as a named inventor. In such a case, A and B are the correct inventors, and accordingly, inventors A and B must sign the reissue oath or declaration but inventor C need not sign the reissue oath or declaration.

1413 Drawings[edit | edit source]

37 CFR 1.173. Reissue specification, drawings, and amendments.


(a)(2) Drawings. Applicant must submit a clean copy of each drawing sheet of the printed patent at the time the reissue application is filed. If such copy complies with § 1.84, no further drawings will be required. Where a drawing of the reissue application is to include any changes relative to the patent being reissued, the changes to the drawing must be made in accordance with paragraph (b)(3) of this section. The Office will not transfer the drawings from the patent file to the reissue application.


A clean copy (e.g., good quality photocopies free of any extraneous markings) of each drawing sheet of the printed patent must be supplied by the applicant at the time of filing of the reissue application. If the copies meet the requirements of 37 CFR 1.84, no further formal drawings will be required. New drawing sheets are not to be submitted, unless some change is made in the original patent drawings. Such changes must be made in accordance with 37 CFR 1.173(b)(3).

The prior reissue practice of transferring drawings from the patent file has been eliminated, since clean photocopies of the printed patent drawings are acceptable for use in the printing of the reissue patent.

AMENDMENT OF DRAWINGS

37 CFR 1.173. Reissue specification, drawings, and amendments.



(b)(3) Drawings. One or more patent drawings shall be amended in the following manner: Any changes to a patent drawing must be submitted as a replacement sheet of drawings which shall be an attachment to the amendment document. Any replacement sheet of drawings must be in compliance with § 1.84 and shall include all of the figures appearing on the original version of the sheet, even if only one figure is amended. Amended figures must be identified as “Amended,” and any added figure must be identified as “New.” In the event that a figure is canceled, the figure must be surrounded by brackets and identified as “Canceled.” All changes to the drawing(s) shall be explained, in detail, beginning on a separate sheet accompanying the papers including the amendment to the drawings.


The provisions of 37 CFR 1.173(b)(3) govern the manner of making amendments (changes) to the




drawings in a reissue application. The following guidance is provided as to the procedure for amending drawings:

(A)Amending the original or printed patent drawing sheets by physically changing or altering them is not permitted. Any request to do so should be denied.

(B)Where a change to the drawings is desired, applicant must submit a replacement sheet for each sheet of drawings containing a Figure to be revised. Any replacement sheet must comply with 37 CFR 1.84 and include all of the figures appearing on the original version of the sheet, even if only one figure is being amended. Each figure that is amended must be identified by placing the word “Amended” at the bottom of that figure. Any added figure must be identified as “New.” In the event that a figure is canceled, the figure must be identified as “Canceled” and also surrounded by brackets. All changes to the figure(s) must be explained, in detail, beginning on a separate sheet which accompanies the papers including the amendment to the drawings.

(C)If desired, applicant may include a marked-up copy of any amended drawing figure, including annotations indicating the changes made. Such a marked- up copy must be clearly labeled as “Annotated Marked-up Drawings”, and it must be presented in the amendment or remarks section that explains the change to the drawings.

In addition, the examiner may desire a marked-up copy of any amended drawing figure, and so state in an Office action. A marked-up copy of any amended drawing figure, including annotations indicating the changes made, must be provided when required by the examiner.

(D)For each proper new drawing sheet being added, the new sheet should be inserted after the existing drawing sheets. For each proper drawing sheet being added which replaces an existing drawing sheet, the existing sheet should be canceled by placing the sheet face down in the file and placing a large “X” on the back of the sheet. The new sheet should be inserted in place of the turned over existing sheet.

(E)If any drawing change is not approved, or if any submitted sheet of formal drawings is not entered, the examiner will so inform the reissue applicant in the next Office action, and the examiner will set forth the reasons for same.

1414 Content of Reissue Oath/Declaration[edit | edit source]

37 CFR 1.175. Reissue oath or declaration.

(a)The reissue oath or declaration in addition to complying with the requirements of § 1.63, must also state that:

(1)The applicant believes the original patent to be wholly or partly inoperative or invalid by reason of a defective specification or drawing, or by reason of the patentee claiming more or less than the patentee had the right to claim in the patent, stating at least one error being relied upon as the basis for reissue; and

(2)All errors being corrected in the reissue application up to the time of filing of the oath or declaration under this paragraph arose without any deceptive intention on the part of the applicant.

(b)(1) For any error corrected, which is not covered by the oath or declaration submitted under paragraph (a) of this section, applicant must submit a supplemental oath or declaration stating that every such error arose without any deceptive intention on the part of the applicant. Any supplemental oath or declaration required by this paragraph must be submitted before allowance and may be submitted:

(i) With any amendment prior to allowance; or

(ii) In order to overcome a rejection under 35 U.S.C. 251 made by the examiner where it is indicated that the submission of a supplemental oath or declaration as required by this paragraph will overcome the rejection.

(2)For any error sought to be corrected after allowance, a supplemental oath or declaration must accompany the requested correction stating that the error(s) to be corrected arose without any deceptive intention on the part of the applicant.

(c)Having once stated an error upon which the reissue is based, as set forth in paragraph (a)(1), unless all errors previously stated in the oath or declaration are no longer being corrected, a subsequent oath or declaration under paragraph (b) of this section need not specifically identify any other error or errors being corrected.


(d)The oath or declaration required by paragraph (a) of this section may be submitted under the provisions of § 1.53(f).

(e)The filing of any continuing reissue application which does not replace its parent reissue application must include an oath or declaration which, pursuant to paragraph (a)(1) of this section, identifies at least one error in the original patent which has not been corrected by the parent reissue application or an earlier reissue application. All other requirements relating to oaths or declarations must also be met.

The reissue oath/declaration is an essential part of a reissue application and must be filed with the application, or within the time period set under 37 CFR 1.53(f) along with the required surcharge as set forth in 37 CFR 1.16(f) in order to avoid abandonment.

The question of the sufficiency of the reissue oath/ declaration filed under 37 CFR 1.175 must in each case be reviewed and decided personally by the primary examiner.




Reissue oaths or declarations must contain the following:


(A)A statement that the applicant believes the original patent to be wholly or partly inoperative or invalid—

(1)by reason of a defective specification or drawing, or

(2)by reason of the patentee claiming more or less than patentee had the right to claim in the patent;

(B)A statement of at least one error which is relied upon to support the reissue application, i.e., as the basis for the reissue;

(C)A statement that all errors which are being corrected in the reissue application up to the time of filing of the oath/declaration arose without any deceptive intention on the part of the applicant; and

(D)The information required by 37 CFR 1.63.

These elements will now be discussed:

I.A STATEMENT THAT THE APPLICANT BELIEVES THE ORIGINAL PATENT TO BE WHOLLY OR PARTLY INOPERATIVE OR INVALID BY REASON OF A DEFECTIVE SPECIFICATION OR DRAWING, OR BY REASON OF THE PATENTEE CLAIMING MORE OR LESS THAN PATENTEE HAD THE RIGHT TO CLAIM IN THE PATENT.

In order to satisfy this requirement, a declaration can state as for example:


1. “Applicant believes the original patent to be partly inoperative or invalid by reason of a defective specification or drawing.”


2. “Applicant believes the original patent to be partly inoperative or invalid by reason of the patentee claiming more than patentee had a right to claim in the patent.”


3. “Applicant believes the original patent to be partly inoperative or invalid by reason of the patentee claiming less than patentee had a right to claim in the patent.”

Where the specification or drawing is defective andpatentee claimed both more and less than patentee had the right to claim in the patent, then all three statements should be included in the reissue oath/declaration. A statement that the original patent is “wholly or partly inoperative or invalid” (emphasis added) by reason of the patentee “claiming more or less than the patentee had the right to claim in the patent” (emphasis added) is improper since a claim cannot claim “more or less” at the same time. Where, however, a given independent claim is considered to be overly broad, and another independent claim is considered to be overly narrow, patentee has claimed both more andless than he or she had a right to claim. In such an instance, both the second and third above-quoted statements would be used. See MPEP § 1412.04 for an exemplary declaration statement when the error being corrected is an error in inventorship.

The above examples will be sufficient to satisfy this requirement without any further statement.

It should be noted that the reissue oath/declaration must also satisfy the requirement for a statement of at least one error being relied upon as the basis for reissue, in the manner set forth in subsection II. below.

Form paragraph 14.01 may be used where the reissue oath/declaration does not provide the required statement as to applicant’s belief that the original patent is wholly or partly inoperative or invalid.

¶ 14.01 Defective Reissue Oath/Declaration, 37 CFR 1.175(a)(1) - No Statement of Defect in the Patent

The reissue oath/declaration filed with this application is defective because it fails to contain the statement required under 37 CFR 1.175(a)(1) as to applicant’s belief that the original patent is wholly or partly inoperative or invalid. See 37 CFR 1.175(a)(1) and see MPEP §

1414. [1]

Examiner Note:

1.Use this form paragraph when applicant: (a) fails to allege that the original patent is inoperative or invalid and/or (b) fails to state the reason of a defective specification or drawing, or of patentee claiming more or less than patentee had the right to claim in the patent . In bracket 1, point out the specific defect to applicant by using the language of (a) and/or (b), as it is appropriate.

2.Form paragraph 14.14 must follow this form paragraph.

II.A STATEMENT OF AT LEAST ONE ERROR WHICH IS RELIED UPON TO SUPPORT THE REISSUE APPLICATION (I.E., THE BASIS FOR THE REISSUE).

(A)A reissue applicant must acknowledge the existence of an error in the specification, drawings, or claims, which error causes the original patent to be




defective. In re Wilder, 736 F.2d 1516, 222 USPQ 369 (Fed. Cir. 1984). A change or departure from the original specification or claims represents an “error” in the original patent under 35 U.S.C. 251. See MPEP §

1402 for a discussion of grounds for filing a reissue that may constitute the “error” required by 35 U.S.C. 251. Not all changes with respect to the patent constitute the “error” required by 35 U.S.C. 251.

(B)Applicant need only specify in the reissue oath/declaration one of the errors upon which reissue is based. Where applicant specifies one such error, this requirement of a reissue oath/declaration is satisfied. Applicant may specify more than one error.

Where more than one error is specified in the oath/declaration and some of the designated “errors” are found to not be “errors” under 35 U.S.C. 251, any remaining error which is an error under 35 U.S.C. 251will still support the reissue.

The “at least one error” which is relied upon to support the reissue application must be set forth in the oath/declaration. It is not necessary, however, to point out how (or when) the error arose or occurred. Further, it is not necessary to point out how (or when) the error was discovered. If an applicant chooses to point out these matters, the statements directed to these matters will not be reviewed by the examiner, and the applicant should be so informed in the next Office action. All that is needed for the oath/declaration statement as to error is the identification of “at least one error” relied upon.

In identifying the error, it is sufficient that the reissue oath/declaration identify a single word, phrase, or expression in the specification or in an original claim, and how it renders the original patent wholly or partly inoperative or invalid. The corresponding corrective action which has been taken to correct the original patent need not be identified in the oath/declaration. If the initial reissue oath/declaration “states at least one error” in the original patent, and, in addition, recites the specific corrective action taken in the reissue application, the oath/declaration would be considered acceptable, even though the corrective action statement is not required.

(C)It is not sufficient for an oath/declaration to merely state “this application is being filed to correct errors in the patent which may be noted from the changes made in the disclosure.” Rather, the oath/declaration must specifically identify an error. In addition, it is not sufficient to merely reproduce the claims with brackets and underlining and state that such will identify the error. See In re Constant, 827 F.2d 728, 729, 3 USPQ2d 1479 (Fed. Cir.), cert. denied, 484 U.S. 894 (1987). Any error in the claims must be identified by reference to the specific claim(s) and the specific claim language wherein lies the error.

A statement of “…failure to include a claim directed to…” and then presenting a newly added claim, would not be considered a sufficient “error” statement since applicant has not pointed out what the other claims lacked that the newly added claim has, or vice versa. Such a statement would be no better than saying in the reissue oath or declaration that “this application is being filed to correct errors in the patent which may be noted from the change made by adding new claim 10.” In both cases, the error has not been identified.

(D)Where a continuation reissue application is filed with a copy of the reissue oath/declaration from the parent reissue application, and the parent reissue application is not to be abandoned, the reissue oath/ declaration should be accepted by the Office of Initial Patent Examination without further evaluation, since it is an oath/declaration, albeit improper under 35 U.S.C. 251. The examiner should, however, reject the claims of the continuation reissue application under 35 U.S.C. 251 as being based on an oath/declaration that does not identify an error being corrected by the continuation reissue application, and should require a new oath/declaration. 37 CFR 1.175(e) states that “the filing of any continuing reissue application which does not replace its parent reissue application must include an oath or declaration, which pursuant to [37 CFR 1.175(a)(1)], identifies at least one error in the original patent which has not been corrected by the parent reissue application or an earlier reissue application.” One of form paragraphs 14.01.01 through 14.01.03 may be used.

Where a continuation reissue application is filed with a copy of the reissue oath/declaration from the parent reissue application, and the parent reissue application is, or will be abandoned, the copy of the reissue oath/declaration should be accepted by OIPE, and the examiner should check to ensure that the oath/ declaration identifies an error which is still being corrected in the continuation application. If a preliminary amendment was filed with the continuation reissue




application, the examiner should check for the need of a supplemental reissue oath/declaration. Pursuant to 37 CFR 1.175 (b)(1), for any error corrected via the preliminary amendment which is not covered by the oath or declaration submitted in the parent reissue application, applicant must submit a supplemental oath/declaration stating that such error arose without any deceptive intention on the part of the applicant. See MPEP § 1414.01.

Where a divisional reissue application is filed with a copy of the reissue oath/declaration from the parent reissue application, the reissue oath/declaration should be accepted by OIPE, since it is an oath/ declaration, though it may be improper under 35 U.S.C. 251. The examiner should check the copy of the oath/declaration to ensure that it identifies an error being corrected by the divisional reissue application. The copy of the oath/declaration from the parent reissue application may or may not cover an error being corrected by the divisional reissue application since the divisional reissue application is (by definition) directed to a new invention. If it does not, the examiner should reject the claims of the divisional reissue application under 35 U.S.C. 251 as being based on an oath/declaration that does not identify an error being corrected by the divisional reissue application, and require a new oath/declaration. If the copy of the reissue oath/declaration from the parent reissue application does in fact cover an error being corrected in the divisional reissue application, no such rejection should be made. However, since a new invention is being added by the filing of the divisional reissue application, a supplemental reissue oath/declaration pursuant to 37 CFR 1.175 (b)(1) will be required. See MPEP § 1414.01.

Form paragraph 14.01.01 may be used where the reissue oath/declaration does not identify an error.

¶ 14.01.01 Defective Reissue Oath/Declaration, 37 CFR 1.175(a)(1) - No Statement of a Specific Error

The reissue oath/declaration filed with this application is defective because it fails to identify at least one error which is relied upon to support the reissue application. See 37 CFR 1.175(a)(1) and MPEP § 1414.

Examiner Note:

1.Use this form paragraph when the reissue oath or declaration does not contain any statement of an error which is relied upon to support the reissue application.

2.This form paragraph can be used where the reissue oath or declaration does not even mention error. It can also can be used where the reissue oath or declaration contains some discussion of the concept of error but never in fact identifies a specific error to be relied upon. For example, it is not sufficient for an oath or declaration to merely state “this application is being filed to correct errors in the patent which may be noted from the changes made in the disclosure.”

3.Form paragraph 14.14 must follow this form paragraph.

Where the reissue oath/declaration does identify an error or errors, the oath/declaration must be checked carefully to ensure that at least one of the errors identified is indeed an “error” which will support the filing of a reissue, i.e., an “error” that will provide grounds for reissue of the patent. See MPEP § 1402. If the error identified in the oath/declaration is not an appropriate error upon which a reissue can be based, then the oath/declaration must be indicated to be defective in the examiner’s Office action.

Form paragraphs 14.01.02 and 14.01.03 may be used where the reissue oath/declaration fails to provide at least one error upon which a reissue can be based.

¶ 14.01.02 Defective Reissue Oath/Declaration, 37 CFR 1.175(a)(1)-The Identified “Error” Is Not Appropriate Error

The reissue oath/declaration filed with this application is defective because the error which is relied upon to support the reissue application is not an error upon which a reissue can be based. See 37 CFR 1.175(a)(1) and MPEP § 1414.

Examiner Note:

1.Use this form paragraph when the reissue oath/declaration identifies only one error which is relied upon to support the reissue application, and that one error is not an appropriate error upon which a reissue can be based.

2.Form paragraph 14.14 must follow this form paragraph.

¶ 14.01.03 Defective Reissue Oath/Declaration, 37 CFR 1.175(a)(1) - Multiple Identified “Errors” Not Appropriate Errors

The reissue oath/declaration filed with this application is defective because none of the errors which are relied upon to support the reissue application are errors upon which a reissue can be based. See 37 CFR 1.175(a)(1) and MPEP § 1414.

Examiner Note:

1.Use this form paragraph when the reissue oath/declaration identifies more than one error relied upon to support the reissue application, and none of the errors are appropriate errors upon which a reissue can be based.

2.Note that if the reissue oath/declaration identifies more than one error relied upon, and at least one of the errors is an error upon which reissue can be based, this form paragraph should not be used, despite the additional reliance by applicant on “errors”




which do not support the reissue. Only one appropriate error is needed to support a reissue.

3.Form paragraph 14.14 must follow this form paragraph.

III.A STATEMENT THAT ALL ERRORS WHICH ARE BEING CORRECTED IN THE REISSUE APPLICATION UP TO THE TIME OF SIGNING OF THE OATH/ DECLARATION AROSE WITHOUT ANY DECEPTIVE INTENTION ON THE PART OF THE APPLICANT.

In order to satisfy this requirement, the following statement may be included in an oath or declaration:

“All errors in the present reissue application up to the time of signing of this oath/declaration, or errors which are being corrected by a paper filed concurrently with this oath/declaration which correction of errors I/we have reviewed, arose without any deceptive intention on the part of the applicant.”

Nothing more is required. The examiner will determine only whether the reissue oath/declaration contains the required averment; the examiner will not make any comment as to whether it appears that there was in fact deceptive intention (see MPEP § 2022.05). It is noted that a reissue oath/declaration will not be effective for any errors which are corrected by a filing made after the execution of the reissue oath/declaration, unless it is clear from the record that the parties executing the document were aware of the nature of the correction when they executed the document. Further, a reissue oath/declaration with an early date of execution cannot be filed after a correction made later in time, to cover the correction made after the execution date. This is so, even if the reissue oath/declaration states that all errors up to the filing of the oath/ declaration arose without any deceptive intention on the part of the applicant.

Form paragraph 14.01.04 may be used where the reissue oath/declaration does not provide the required statement as to “without any deceptive intention on the part of the applicant.”

¶ 14.01.04 Defective Reissue Oath/Declaration, 37 CFR 1.175- Lack of Statement of “Without Any Deceptive Intention”

The reissue oath/declaration filed with this application is defective because it fails to contain a statement that all errors which are being corrected in the reissue application up to the time of filing of the oath/declaration arose without any deceptive intention on the part of the applicant. See 37 CFR 1.175 and MPEP § 1414.

Examiner Note:

1.Use this form paragraph when the reissue oath/declaration does not contain the statement required by 37 CFR 1.175 that all errors being corrected in the reissue application arose without any deceptive intention on the part of the applicant.

2.This form paragraph is appropriate to use for a failure by applicant to comply with the requirement, as to any of 37 CFR 1.175(a)(2), 37 CFR 1.175(b)(1), or 37 CFR 1.175(b)(2).

3.Form paragraph 14.14 must follow.

IV.THE REISSUE OATH/DECLARATION MUST COMPLY WITH 37 CFR 1.63.

The reissue oath/declaration must include the averments required by 37 CFR 1.63(a) and (b), e.g., that applicants for reissue

(A)have reviewed and understand the contents of the specification, including the claims, as amended by any amendment specifically referred to in the oath/ declaration;

(B)believe the named inventor or inventors to be the original and the first inventor or inventors of the subject matter which is claimed and for which a patent is sought; and

(C)acknowledge the duty to disclose to the Office all information known to the person to be material to patentability as defined in 37 CFR 1.56. See also the discussion regarding the requirements of an oath/declaration beginning at MPEP § 602.

The examiner should check carefully to ensure that all the requirements of 37 CFR 1.63 are met. Form paragraph 14.01.05 should be used in conjunction with the content of form paragraphs 6.05 through 6.05.20 as appropriate, where the reissue oath/declaration fails to comply with the requirements of 37 CFR 1.63.

¶ 14.01.05 Defective Reissue Oath/Declaration, 37 CFR 1.175 - General

The reissue oath/declaration filed with this application is defective (see 37 CFR 1.175 and MPEP § 1414) because of the following:

Examiner Note:

1.Use this form paragraph when the reissue oath/declaration does not comply with 37 CFR 1.175, and none of form paragraphs 14.01 - 14.01.04 or 14.05.02 apply.

2.This form paragraph must be followed by an explanation of why the reissue oath/declaration is defective.




3.Form paragraph 14.14 must follow the explanation of the defect.

See MPEP § 1414.01 for a discussion of the requirements for a supplemental reissue oath/declaration.


Depending on the circumstances, either form PTO/

SB/51, Reissue Application Declaration By The Inventor, or form PTO/SB/52, Reissue Application Declaration By The Assignee may be used to prepare a declaration in a reissue application.





Reissue Application Declaration by the Inventor




Reissue Application Declaration by the Inventor (page 2)




Privacy Act Statment




Reissue Application Declaration by the Assognee




Reissue Application Declaration by the Assognee (page 2)




Privacy Act Statment





1414.01Supplemental Reissue Oath/ Declaration [R-5]

If additional defects or errors are corrected in the reissue after the filing of the application and the original reissue oath or declaration, a supplemental reissue oath/declaration must be filed, unless all additional errors corrected are spelling, grammar, typographical, editorial or clerical errors which are not errors under 35 U.S.C. 251 (see MPEP § 1402). In other words, a supplemental oath/declaration is required where any “error” under 35 U.S.C. 251 has been corrected and the error was not identified in the original reissue oath/declaration.

The supplemental reissue oath/declaration must 

state that every error which was corrected in the reissue application not covered by the prior oath(s)/declaration( s) submitted in the application arose without any deceptive intention on the part of the applicant.

An example of acceptable language is as follows:

“Every error in the patent which was corrected in the present reissue application, and is not covered by the prior declaration submitted in this application, arose without any deceptive intention on the part of the applicant.”

A supplemental reissue oath/declaration will not be effective for any errors which are corrected by a filing made after the execution of the supplemental reissue oath/declaration, unless it is clear from the record that the parties executing the document were aware of the nature of the correction when they executed the document. Further, a supplemental reissue oath/declaration with an early date of execution cannot be filed after a correction made later in time, to cover the correction made after the execution date. This is so, even if the supplemental reissue oath/declaration states that all errors up to the filing of the supplemental reissue oath/declaration oath or declaration arose without any deceptive intention on the part of the applicant.


Form PTO/SB/51S, “Supplemental Declaration For Reissue Patent Application To Correct ‘Errors’ Statement (37 CFR 1.175),” may be used to prepare a supplemental reissue declaration. Form PTO/SB/51S serves to indicate that every error in the patent that was corrected in the reissue application, but was not covered by a prior reissue oath/declaration submitted in the reissue application, arose without any deceptive intention on the part of the applicant.

In the event that the applicant for a reissue applicant is required to file a supplemental reissue oath/ declaration that also includes a specific statement of the error being corrected by reissue in accordance with 37 CFR 1.175(c), as discussed in subsection I. below, applicant must also include in the supplemental declaration language equivalent to the “Every error …” language in the example of acceptable language set forth above. Therefore, if either form PTO/SB/51, “Reissue Application Declaration By The Inventor,” or form PTO/SB/52, “Declaration By The Assignee” (see MPEP § 1414) is used for the purpose of filing such supplemental reissue oath/declaration, the form must be completed so that it is clear that the supplemental reissue oath/declaration addresses all errors corrected subsequent to the date upon which the last previously reissue oath/declaration (whether original or supplemental) was filed. For example, the form could be completed by specifying the date upon which the reissue application was originally filed, the reissue application number, and the date(s) of every amendment filed subsequent to the date upon which the last reissue oath/declaration (whether original or supplemental) was filed. Any manner of completing the form so that affiant/declarant unambiguously states that every error corrected subsequent to the filing of the last filed reissue oath/declaration (whether original or supplemental) arose without deceptive intent will be acceptable. It will not be acceptable for the new (“catch-up”) oath/declaration to simply refer to the reissue application as filed, even though the new oath/declaration may be submitted after an amendment.

I.WHEN AN ERROR MUST BE STATED IN THE SUPPLEMENTAL OATH/ DECLARATION

In the supplemental reissue oath/declaration, there is no need to state an error which is relied upon to support the reissue application if:

(A)an error to support a reissue has been previously and properly stated in a reissue oath/declaration in the application; and

(B)that error is still being corrected in the reissue application.




If applicant chooses to state any further error at this point (even though such is not needed), the examiner should not review the statement of the further error.

The supplemental reissue oath/declaration muststate an error which is relied upon to support the reissue application only where one of the following is true:

(A)the prior reissue oath/declaration failed to state an error;

(B)the prior reissue oath/declaration attempted to state an error but did not do so properly; or

(C)all errors under 35 U.S.C. 251 stated in the prior reissue oath(s)/declaration(s) are no longer being corrected in the reissue application.

II.WHEN A SUPPLEMENTAL OATH/DE- CLARATION MUST BE SUBMITTED

The supplemental oath/declaration in accordance with 37 CFR 1.175(b)(1) must be submitted before allowance. See MPEP § 1444 for a discussion of the action to be taken by the examiner to obtain the supplemental oath/declaration in accordance with 37 CFR 1.175(b)(1), where such is needed.

Where applicant seeks to correct an error after allowance of the reissue application, a supplemental reissue oath/declaration must accompany the requested correction stating that the error(s) to be corrected arose without any deceptive intention on the part of the applicant. The supplemental reissue oath/ declaration submitted after allowance will be directed to the error applicant seeks to correct after allowance. This supplemental oath/declaration need not cover any earlier errors, since all earlier errors should have been covered by a reissue oath/declaration submitted prior to allowance.

III.SUPPLEMENTAL OATH/DECLARA- TION IN BROADENING REISSUE

A broadening reissue application must be applied for by all of the inventors (patentees), that is, the original reissue oath/declaration must be signed by all of the inventors. See MPEP § 1414. If a supplemental oath/declaration in a broadening reissue application is subsequently needed in the application in order to fulfill the requirements of 37 CFR 1.175, the supplemental reissue oath/declaration must be signed by all of the inventors. In re Hayes, 53 USPQ2d 1222, 1224 (Comm’r Pat. 1999) (“37 CFR 1.175(b)(1), taken in conjunction with Section 1.172, requires a supplemental declaration be signed by all of the inventors. This is because all oaths or declarations necessary to fulfill the rule requirements in a reissue application are taken together collectively as a single oath or declaration. Thus, each oath and declaration must bear the appropriate signatures of all the inventors.”).

If a joint inventor refuses or cannot be found or 

reached to sign a supplemental oath/declaration, a supplemental oath/declaration listing all the inventors, and signed by all the available inventors may be filed provided it is accompanied by a petition under 37 CFR 1.183 along with the petition fee, requesting waiver of the signature requirement of the nonsigning inventor.






SUPPLEMENTAL DECLARATION FOR REISSUE PATENT APPLICATION TO CORRECT “ERRORS” STATEMENT (37 CFR 1.175) PTO/SB/51S (09-04) Approved for use through 04/30/2007. OMB 0651-0033 U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number. Attorney Docket Number First Named Inventor COMPLETE if known Application Number Filing Date Art Unit SUPPLEMENTAL DECLARATION FOR REISSUE PATENT APPLICATION TO CORRECT “ERRORS” STATEMENT (37 CFR 1.175) Examiner Name I/We hereby declare that: Every error in the patent which was corrected in the present reissue application, and which is not covered by the prior oath(s) and/or declaration(s) submitted in this application, arose without any deceptive intention on the part of the applicant. I/We hereby declare that all statements made herein of my/our own knowledge are true and that all statements made on information and belief are believed to be true; and further that these statements were made with the knowledge that willful false statements and the like so made are punishable by fine or imprisonment, or both, under 18 U.S.C. 1001 and that such willful false statements may jeopardize the validity of the application or any patent issued thereon. Name of Sole or First Inventor: A petition has been filed for this unsigned inventor Given Name (first and middle [if any]) Family Name or Surname Inventor’s SignatureDate Name of Second Inventor: A petition has been filed for this unsigned inventor Given Name (first and middle [if any]) Family Name or Surname Inventor’s SignatureDate Name of Third Inventor: A petition has been filed for this unsigned inventor Given Name (first and middle [if any]) Family Name or Surname Inventor’s SignatureDate Name of Fourth Inventor: A petition has been filed for this unsigned inventor Given Name (first and middle [if any]) Family Name or SurnameInventor’s SignatureDate Additional inventors or legal representatives(s) are being named on the __________ supplemental sheets PTO/SB/02A or 02LR attached hereto. This collection of information is required by 37 CFR 1.175. The information is required to obtain or retain a benefit by the public which is to file (and by the USPTO to process) an application. Confidentiality is governed by 35 U.S.C. 122 and 37 CFR 1.11 and 1.14. This collection is estimated to take 1.8 minutes to complete, including gathering, preparing, and submitting the completed application form to the USPTO. Time will vary depending upon the individual case. Any comments on the amount of time you require to complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR COMPLETED FORMS TO THIS ADDRESS. SEND TO:Commissioner for Patents, P.O. Box 1450, Alexandria, VA 22313-1450. If you need assistance in completing the form, call 1-800-PTO-9199 and select option 2. Doc Code:





1415 Reissue Application and Issue Fees[edit | edit source]

I.BASIC REISSUE APPLICATION FILING, SEARCH, AND EXAMINATION FEES

The Consolidated Appropriations Act, 2005 (Consolidated Appropriations Act), effective December 8, 2004, provides for a separate reissue application filing fee, search fee, and examination fee during fiscal years 2005 and 2006. For reissue applications filed on or after December 8, 2004, the following fees are required: basic filing fee as set forth in 37 CFR 1.16(e)(1); search fee as set forth in 37 CFR 1.16(n); examination fee as set forth in 37 CFR 1.16(r); application size fee, if applicable (see subsection II. below); and excess claims fees, if applicable (see subsection III. below).

For reissue applications filed prior to December 8, 2004, the following fees are required: basic filing fee as set forth in 37 CFR 1.16(e)(2); and excess claims fees, if applicable (see subsection III below). No search and examination fees are required for reissue applications filed before December 8, 2004.

The basic filing, search and examination fees are due on filing of the reissue application. These fees may be paid on a date later than the filing date of the reissue application provided they are paid within the time period set forth in 37 CFR 1.53(f) and include the surcharge set forth in 37 CFR 1.16(f). For reissue applications filed on or after December 8, 2004 but prior to July 1, 2005, which have been accorded a filing date under 37 CFR 1.53(b), if the search and/or examination fees are paid on a date later than the filing date of the reissue application, the surcharge under 37 CFR 1.16(f) is not required. For reissue applications filed on or after July 1, 2005, which have been accorded a filing date under 37 CFR 1.53(b), if any of the basic filing fee, the search fee, or the examination fee are paid on a date later than the filing date of the reissue application, the surcharge under 37 CFR 1.16(f) is required.

For reissue applications filed on or after December 8, 2004, in which a petition under 37 CFR 1.138(d) to expressly abandon the application was filed on or after March 10, 2006, applicant may file a request for refund of the search fee and excess claims fee paid in the application. See MPEP § 711.01.

II.APPLICATION SIZE FEE

The Consolidated Appropriations Act also provides for an application size fee. 37 CFR 1.16(s) sets forth the application size fee for reissue applications filed on or after December 8, 2004, the specification and drawings of which, excluding a sequence listing or computer program listing filed in an electronic medium in compliance with the rules (see 37 CFR 1.52(f)), exceed 100 sheets of paper. The application size fee does not apply to reissue applications filed before December 8, 2004. The application size fee applies for each additional 50 sheets or fraction thereof over 100 sheets of paper. Any sequence listing in an electronic medium in compliance with 37 CFR 1.52(e) and 37 CFR 1.821(c) or (e), and any computer program listing filed in an electronic medium in compliance with 37 CFR 1.52(e) and 1.96, will be excluded when determining the application size fee required by 37 CFR 1.16(s). See also MPEP § 607.

III.EXCESS CLAIMS FEES

37 CFR 1.16(h) sets forth the excess claims fee for each independent claim in excess of three. 37 CFR 1.16(i) sets forth the excess claims fee for each claim (whether independent or dependent) in excess of twenty. The access claims fees specified in 37 CFR 1.16(h) and (i) apply to all reissue applications pending on or after December 8, 2004. The excess claims fees specified in 37 CFR 1.16(h) and (i) apply to any excess claims fee paid on or after December 8, 2004, regardless of the filing date of the reissue application and regardless of the date on which the claim necessitating the excess claims fee payment was added to the reissue application.

For reissue applications filed on or after December 8, 2004, in which a petition under 37 CFR 1.138(d) to expressly abandon the application was filed on or after March 10, 2006, applicant may file a request for refund of the search fee and excess claims fee paid in the application. See MPEP § 711.01.

Under 35 U.S.C. 41(a)(2) as amended by the Consolidated Appropriations Act, the claims in the original patent are not taken into account in determining the excess claims fee for a reissue application.

Example 1:

Applicant filed a reissue application before December 8, 2004, with the same number of




claims as in the patent. The patent has more than 3 independent claims and more than 20 total claims. If applicant added one more independent claim in the reissue application by filing an amendment before December 8, 2004, but did not pay for the excess claims fees prior to December 8, 2004, on or after December 8, 2004, applicant will have to pay for one additional independent claim per the fee set forth in 37 CFR 1.16(h) and one additional total claim per the fee set forth in 37 CFR 1.16(i).

Example 2:

Applicant filed a reissue application on or after December 8, 2004, with the same number of claims as in the patent. The patent has 4 independent claims and 21 total claims. Excess claims fees for the 4th independent claim (one additional independent claim per the fee set forth in 37 CFR 1.16(h)) and the 21st claim (one additional total claim per the fee set forth in 37 CFR 1.16(i)) are required. Under 35 U.S.C. 41(a)(2) as amended by the Consolidated Appropriations Act, the claims in the original patent are not taken into account in determining the excess claims fees for a reissue application.

The excess claims fees, if any, due with an amendment are required prior to any consideration of the amendment by the examiner. Upon submission of an amendment (whether entered or not) affecting the claims, payment of fees for those claims in excess of the number previously paid for is required. The additional fees, if any, due with an amendment are calculated on the basis of the claims (total and independent) which would be present, if the amendment were entered. If an amendment is limited to revising the existing claims and it does not result in the addition of any new claim, there is no excess claim fee. Excess claims fees apply only to the addition of claims. It is to be noted that where excess claims fees have been previously paid, a later amendment affecting the claims cannot serve as the basis for granting any refund. See 37 CFR 1.26(a).

Amendments filed before a first Office action, or otherwise not filed in reply to an Office action, presenting additional claims in excess of the number already paid for, not accompanied by the full additional claims fee due, will not be entered in whole or in part and applicant will be so notified. Such amendments filed in reply to an Office action will be regarded as being non-responsive to the Office action and the practice set forth in MPEP § 714.03 will be followed.

An amendment canceling claims accompanying the papers constituting the reissue application will be effective to diminish the number of claims to be considered in calculating the filing fees to be paid. A preliminary amendment filed concurrently with a reply to a Notice To File Missing Parts of Application that required the filing fees, which preliminary amendment cancels or adds claims, will be taken into account in determining the appropriate filing fees due in response to the Notice To File Missing Parts of Application. However, no refund will be made for claims being canceled in the reply that have already been paid for.

After a requirement for restriction, non-elected claims will be included in determining the fees due in connection with a subsequent amendment unless such claims are canceled.

IV.ISSUE FEE

The issue fee for issuing each reissue patent is set forth in 37 CFR 1.18(a).

V.REISSUE APPLICATION FEE TRANS- MITTAL FORM

The Office has prepared Form PTO/SB/56, Reissue Application Fee Transmittal Form which is designed to assist in the correct calculation of reissue filing fees.




Reissue Application Fee Transmittal Form




Privacy Act Statment Privacy Act Statement ThePrivacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that: (1) the general authority for the collection of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information solicited is voluntary; and (3) the principal purpose for which the information is used by the U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent. If you do not furnish the requested information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may result in termination of proceedings or abandonment of the application or expiration of the patent. The information provided by you in this form will be subject to the following routine uses: 1. The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552) and the Privacy Act (5 U.S.C 552a). Records from this system of records may be disclosed to the Department of Justice to determine whether disclosure of these records is required by the Freedom of Information Act. 2. A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or administrative tribunal, including disclosures to opposing counsel in the course of settlement negotiations. 3. A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an individual, to whom the record pertains, when the individual has requested assistance from the Member with respect to the subject matter of the record. 4. A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for the information in order to perform a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as amended, pursuant to 5 U.S.C. 552a(m). 5. A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed, as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty. 6. A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security review (35 U.S.C. 181) and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)). 7. A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee, during an inspection of records conducted by GSA as part of that agency’s responsibility to recommend improvements in records management practices and programs, under authority of 44 U.S.C. 2904 and 2906. Such disclosure shall be made in accordance with the GSA regulations governing inspection of records for this purpose, and any other relevant (i.e., GSA or Commerce) directive. Such disclosure shall not be used to make determinations about individuals. 8. A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuant to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37 CFR 1.14, as a routine use, to the public if the record was filed in an application which became abandoned or in which the proceedings were terminated and which application is referenced by either a published application, an application open to public inspection or an issued patent. 9. A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency, if the USPTO becomes aware of a violation or potential violation of law or regulation.




1415.01Maintenance Fees on the Original Patent [R-5]

The filing of a reissue application does not alter the schedule of payments of maintenance fees on the original patent. If maintenance fees have not been paid on the original patent as required by 35 U.S.C. 41(b) and 37 CFR 1.20, and the patent has expired, no reissue patent can be granted. 35 U.S.C. 251, first paragraph, only authorizes the granting of a reissue patent for the unexpired term of the original patent. Once a patent has expired, the Director of the USPTO no longer has the authority under 35 U.S.C. 251 to reissue the patent. See In re Morgan, 990 F.2d 1230, 26 USPQ2d 1392 (Fed. Cir. 1993).

The examiner should determine whether all required maintenance fees have been paid prior to conducting an examination of a reissue application. In addition, during the process of preparing the reissue application for issue, the examiner should again determine whether all required maintenance fees have been paid up to date.

The history of maintenance fees is determined by the following, all of which should be used (to provide a check on the search made):

(A)Go to the USPTO Intranet (http://ptoweb/ptointranet/ index.htm) and select the PALM screen, then the “General Information” screen, type in the patent number and then select the “Fees” screen.

(B)Go to the USPTO Intranet and then the “Revenue Accounting and Management” screen, then the “File History” screen. Then type in the patent number.

(C)Go to the USPTO Internet Site (http:// www.uspto.gov) and select “eBusiness”, then the “Patent Electronic Business Center” screen, then the “Patent Application Information Retrieval (PAIR)” screen (http://pair.uspto.gov/cgi-bin/final/home.pl), and type in the patent number and select the “view Maint. Statement” screen.

If the window for the maintenance fee due has closed (maintenance fees are due by the day of the 4th, 8th and 12th year anniversary of the grant of the patent), but the maintenance fee has not been paid, the Office of Patent Legal Administration (OPLA) should be contacted by the Technology Center (TC) Special Program Examiner (SPRE) for instructions as to what appropriate action to take.

PAYMENT OF MAINTENANCE FEES WHERE THE PATENT HAS BEEN REISSUED

Pursuant to 37 CFR 1.362(b), maintenance fees are not required for a reissue patent if the original patent that was reissued did not require maintenance fees.

Where the original patent that was reissued did require maintenance fees, the schedule of payments of maintenance fees on the original patent will continue for the reissue patent. 37 CFR 1.362(h). Once an original patent reissues, maintenance fees are no longer due in the original patent, but rather the maintenance fees are due in the reissue patent. This is because upon the issuance of the reissue patent, the original patent is surrendered and ceases to exist.

In some instances, more than one reissue patents will be granted to replace a single original patent. The issuance of more than one reissue patent does not alter the schedule of payments of maintenance fees on the original patent. The existence of multiple reissue patents for one original patent can arise where multiple divisional reissue applications are filed for the same patent, and the multiple applications issue as reissue patents (all to replace the same original patent). In addition, a divisional application or continuation application of an existing reissue application may be filed, and both may then issue as reissue patents. In such instances, 35 U.S.C. 41 does not provide for the charging of more than one maintenance fee for the multiple reissues. Thus, no payment of additional maintenance fees is required for the second or subsequent reissue patents, i.e., continuation or divisional reissues, which are derived from a first reissue patent which has issued. The maintenance fee must be directed to the first reissue patent that has issued. This is unlike the instance where there is a reissue of a reissue patent, and the maintenance fee must be directed to the reissue of the reissue patent.

See MPEP Chapter 2500 for additional information pertaining to maintenance fees.

1416 No Physical Surrender of Original Patent[edit | edit source]

37 CFR 1.178. Original patent; continuing duty of applicant.

(a)The application for reissue of a patent shall constitute an offer to surrender that patent, and the surrender shall take effect




upon reissue of the patent. Until a reissue application is granted, the original patent shall remain in effect.


37 CFR 1.178(a) was amended, effective October 21, 2004, to eliminate the requirement for physical surrender of the original letters patent (i.e., the “ribbon copy” of the original patent) in a reissue application, and to make surrender of the original patent automatic upon the grant of the reissue patent.

Amended 37 CFR 1.178(a) applies retroactively to all pending applications. For those applications with an outstanding requirement for the physical surrender of the original letters patent, a reissue applicant must timely reply that the requirement is moot in view of the implementation of the amended rule. Such a reply will be considered a complete reply to any requirement directed toward the surrender of the original letters patent. It is to be noted that the Office will not conduct a search to withdraw Office actions where the only outstanding requirement is compliance with the physical surrender of the original letters patent.

Example 1:

An Office action issues prior to the effective date of the amendment to 37 CFR 1.178 with only a requirement for a return of the original letters patent to the Office. A two-month period for reply is set in the Office action. Applicant fails to timely reply to the Office action, relying on the amendment to 37 CFR 1.178 as mooting the requirement for physical surrender of the original letters patent. The six-month full statutory period for reply expires. In this instance, the reissue application would be abandoned (as of the day after the last day of the two-month period set in the Office action) for failure to timely reply to the Office action, because no reply was timely filed.

Example 2:

An Office action issues prior to the effective date of the amendment to 37 CFR 1.178 with the only requirement for a return of the original letters patent to the Office. Applicant fails to reply to the Office action within the two-month period set in the Office action, relying on the amendment to 37 CFR 1.178 as mooting the requirement for physical surrender of the original letters patent. In reviewing the reissue application in connection with a related application, the examiner notes the omission prior to the expiration of the six-month full statutory period for reply. In this instance, the examiner may telephone the applicant, and remind the applicant of the need to file a timely reply.

Example 3:

An Office action issues prior to the effective date of the amendment to 37 CFR 1.178 with the only requirement being a return of the original letters patent to the Office. Applicant timely replies to the Office that it should vacate/withdraw the requirement, or otherwise indicates that return of the original letters patent is now unnecessary. In this instance, a complete reply would have been filed, and the requirement would be withdrawn and the application passed to issue.

Example 4:

An Office action issues prior to the effective date of the amendment to 37 CFR 1.178 with both (a) a requirement to return the original letters patent to the Office, and (b) a rejection of the claims under 35 U.S.C. 103. Applicant timely replies to the Office action addressing only the rejection under 35 U.S.C. 103 (but not the need for physical surrender of the original letters patent). In this instance, the reply would be accepted as complete, and the Office would withdraw the requirement for physical surrender of the original letters patent. (The requirement was proper when made, so the Office would not vacate the action in regard to submission of the original letters patent.).

Where the patentee has submitted the original letters patent in a reissue application subject to 37 CFR 1.178 as it is now amended, the Office may, in response to a timely request, return the original letters patent, when it can be readily retrieved from where it is stored, namely, the paper application file, or the artifact storage area for an Image File Wrapper (IFW) file. Any request for return of the letters patent which is submitted after the issue fee has been paid will require a petition pursuant to 37 CFR 1.59(b) to expunge from the file and return the original letters patent. Where the original letters patent cannot be readily retrieved, or in the rare instance that it has been subsequently misplaced, the Office will not be able




to return the original letters patent and will not create a new one.

Example 5:

In an application filed after the effective date of the amendment to 37 CFR 1.178, applicant has mistakenly submitted the original letters patent and later seeks its return. In this instance, provided applicant timely requests the return of the original letters patent, the Office would return the patent, provided it can be readily retrieved.

Example 6:

A reissue application was pending at the time of the effective date of the amendment to 37 CFR 1.178, and an original letters patent was submitted. Applicant requests return of the original letters patent, although the application is abandoned at the time the request for return is made. In this instance, the Office would return the original letters patent if it is readily retrievable. Even where the reissue application was already abandoned at the time of the effective date of the amendment to 37 CFR 1.178, the Office would also return the original letters patent.

Example 7:

A reissue application is pending at the time of the effective date of the amendment to 37 CFR 1.178. An original letters patent was submitted, and the issue fee has been paid for the reissue application at the time the request for return of the original letters patent is made. In this instance, the Office may similarly return the original letters patent, but only if the request is accompanied by a grantable petition under 37 CFR 1.59(b).

Example 8:

A reissue application was pending at the time of the effective date of the amendment to 37 CFR 1.178. An original letters patent was submitted, and the reissue application then issued as a reissue patent. After the reissue patent issues, the request for return of the original letters patent is made. Once again, the Office may return the original letters patent, but only if the request is accompanied by a grantable petition under 37 CFR 1.59(b).

Example 9:

A reissue application issued as a reissue patent prior to the effective date of the amendment to 37 CFR 1.178. The reissue applicant, now the patentee, requests return of the original letters patent that was submitted in the reissue application. In this instance, the Office will not return the original letters patent. The original letters patent was submitted in reply to a requirement that was in effect throughout the pendency of the reissue application.



1417 Claim for Benefit Under 35 U.S.C. 119(a)-(d)[edit | edit source]

PRIORITY UNDER 35 U.S.C. 119(a)-(d) WAS PERFECTED IN THE ORIGINAL PATENT

A “claim” for the benefit of an earlier filing date in a foreign country under 35 U.S.C. 119(a)-(d) must be made in a reissue application, even though such a claim was previously made in the application for the original patent to be reissued. However, no additional certified copy of the foreign application is necessary. The procedure is similar to that for “Continuing Applications” in MPEP § 201.14(b).

In addition, 37 CFR 1.63 requires that in any application in which a claim for foreign priority is made pursuant to 37 CFR 1.55, the oath or declaration must identify the foreign application for patent or inventors’ certificate on which priority is claimed unless supplied on an application data sheet (37 CFR 1.76), and any foreign applications having a filing date before that of the application on which priority is claimed, by specifying:

(A)the application number of the foreign application;


(B)the foreign country or intellectual property authority; and

(C)the day, month, and year of the filing of the foreign application.




The examiner should note that the heading on printed copies of the patent will not be carried forward to the reissue from the original patent. Therefore, it is important that the bibliographic data sheet (or the front face of the reissue file wrapper for series 08/ and earlier paper applications) be endorsed by the examiner under “FOREIGN APPLICATIONS.” For an IFW reissue file, a copy of the bibliographic data sheet should be printed from the IFW file history. The printed copy should be annotated by the examiner and then the annotated copy should be scanned into the IFW.

PRIORITY UNDER 35 U.S.C. 119(a)-(d) IS NEWLY PERFECTED IN THE REISSUE APPLICATION


A reissue was granted in Brenner v. State of Israel, 400 F.2d 789, 158 USPQ 584 (D.C. Cir. 1968), where the only ground urged was failure to file a certified copy of the original foreign application to obtain the right of foreign priority under 35 U.S.C. 119(a)-(d) before the patent was granted. In Brenner, the claim for priority had been made in the prosecution of the original patent, and it was only necessary to submit a certified copy of the priority document in the reissue application to perfect priority (the claim for priority must be repeated in the reissue application). Reissue is also available to correct the “error” in failing to take any steps to obtain the right of foreign priority under 35 U.S.C. 119(a)-(d) before the original patent was granted. See Fontijn v. Okamoto, 518 F.2d 610, 622, 186 USPQ 97, 106 (CCPA 1975) (“a patent may be reissued for the purpose of establishing a claim to priority which was not asserted, or which was not perfected during the prosecution of the original application”) In a situation where it is necessary to submit for the first time both the claim for priority and the certified copy of the priority document in the reissue application and the patent to be reissued resulted from a utility or plant application filed on or after November 29, 2000, the reissue applicant will have to file a petition for an unintentionally delayed priority claim under 37 CFR 1.55(c) in addition to filing a reissue application. See MPEP §

201.14(a).

1418 Notification of Prior/Concurrent Proceedings and Decisions Thereon, and of Information Known to be Material to Patentability[edit | edit source]

37 CFR 1.178. Original patent; continuing duty of applicant.


(b)In any reissue application before the Office, the applicant must call to the attention of the Office any prior or concurrent proceedings in which the patent (for which reissue is requested) is or was involved, such as interferences, reissues, reexaminations, or litigations and the results of such proceedings (see also §

1.173(a)(1)).

37 CFR 1.178(b) requires reissue applicants to call to the attention of the Office any prior or concurrent proceeding in which the patent (for which reissue is requested) is or was involved and the results of such proceedings. These proceedings would include interferences, reissues, reexaminations, and litigations. Litigation would encompass any papers filed in the court or issued by the court, which may include, for example, motions, pleadings, and court decisions. This duty to submit information is continuing, and runs from the time the reissue application is filed until the reissue application is abandoned or issues as a reissue patent.

In addition, a reissue application is subject to the same duty of disclosure requirements as is any other nonprovisional application. The provisions of 37 CFR 1.63 require acknowledgment in the reissue oath or declaration of the “duty to disclose to the Office all information known to the [applicants] to be material to patentability as defined in §

1.56.” Note that the Office imposes no responsibility on a reissue applicant to resubmit, in a reissue application, all the “References Cited” in the patent for which reissue is sought. Rather, applicant has a continuing duty under 37 CFR 1.56 to timely apprise the Office of any information which is material to the patentability of the claims under consideration in the reissue application.

37 CFR 1.97 and 37 CFR 1.98 provide a mechanism to submit information known to applicants to be material to patentability. Information submitted in compliance with 37 CFR 1.97 and 37 CFR 1.98 will be considered by the Office. See MPEP § 609. Although a reissue applicant may utilize 37 CFR 1.97and 37 CFR 1.98 to comply with the duty of disclo




sure required by 37 CFR 1.56, this does not relieve applicant of the duties under 37 CFR 1.175 of, for example, stating “at least one error being relied upon.”

While 37 CFR 1.97(b) provides for the filing of an information disclosure statement within 3 months of the filing of an application or before the mailing date of a first Office action, reissue applicants are encouraged to file information disclosure statements at the time of filing of the reissue application so that such statements will be available to the public during the 2- month period provided in MPEP § 1441. Form paragraph 14.11.01 may be used to remind applicant of the duties to timely make the Office aware of (A) any prior or concurrent proceeding (e.g., litigation or Office proceedings) in which the patent to be reissued is or was involved, and (B) any information which is material to patentability of the claims in the reissue application.

¶ 14.11.01 Reminder of Duties Imposed by 37 CFR 1.178(b) and 37 CFR 1.56

Applicant is reminded of the continuing obligation under 37 CFR 1.178(b), to timely apprise the Office of any prior or concurrent proceeding in which Patent No. [1] is or was involved. These proceedings would include interferences, reissues, reexaminations, and litigation.

Applicant is further reminded of the continuing obligation under 37 CFR 1.56, to timely apprise the Office of any information which is material to patentability of the claims under consideration in this reissue application.

These obligations rest with each individual associated with the filing and prosecution of this application for reissue. See also MPEP §§ 1404, 1442.01 and 1442.04.

Examiner Note:

1.This form paragraph is to be used in the first action in a reissue application.

2.In bracket [1], insert the patent number of the original patent for which reissue is requested.

1430 Reissue Files Open to the Public and, Notice of Filing Reissue Announced in, Official Gazette[edit | edit source]

37 CFR 1.11. Files open to the public.


(b)All reissue applications, all applications in which the Office has accepted a request to open the complete application to inspection by the public, and related papers in the application file, are open to inspection by the public, and copies may be furnished upon paying the fee therefor. The filing of reissue applications, other than continued prosecution applications under § 1.53(d) of reissue applications, will be announced in the Official Gazette. The announcement shall include at least the filing date, reissue application and original patent numbers, title, class and subclass, name of the inventor, name of the owner of record, name of the attorney or agent of record, and examining group to which the reissue application is assigned.


Under 37 CFR 1.11(b) all reissue applications filed after March 1, 1977, are open to inspection by the general public, and copies may be furnished upon paying the fee therefor. The filing of reissue applications (except for continued prosecution applications (CPA’s) filed under 37 CFR 1.53(d)) will be announced in the Official Gazette. The announcement gives interested members of the public an opportunity to submit to the examiner information pertinent to the patentability of the reissue application. The announcement includes the filing date, reissue application and original patent numbers, title, class and subclass, name of the inventor, name of the owner of record, name of the attorney or agent of record, and the Technology Center (TC) to which the reissue application is initially assigned. A TC Director or other appropriate Office official may, under appropriate circumstances, postpone access to or the making of copies of a paper reissue application file, such as, for example, to avoid interruption of the examination or other review of the application by an examiner.

IFW reissue application files are open to inspection by the general public by way of Public PAIR via the USPTO Internet site. In viewing the images of the files, members of the public will be able to view the entire content of the reissue application file history. To access Public PAIR, a member of the public would (A) go to the USPTO web site at http:// www.uspto.gov, (B) click on “Patents”, (C) under “Check Status, View Papers…” click on “Status & IFW,” and (D) under “Patent Application Information Retrieval” enter the reissue application number.

A notice of a reissue application in the Official Gazette should be published prior to any examination of the application. If an inadvertent failure to publish notice of the filing of the reissue application in the Official Gazette is recognized later in the examination, action should be taken to have the notice published as quickly as possible, and action on the application may be delayed until two months after the




publication, allowing for any protests to be filed. For a discussion of protests, see MPEP Chapter 1900.

The filing of a continued prosecution application (CPA) under 37 CFR 1.53(d) of a reissue application will not be announced in the Official Gazette. Although the filing of a CPA of a reissue application constitutes the filing of a reissue application, the announcement of the filing of such CPA would be redundant in view of the announcement of the filing of the prior reissue application in the Official Gazetteand the fact that the same application number and file will continue to be used for the CPA.

If applicant files a Request for Continued Examination (RCE) of the reissue application under 37 CFR 1.114 (which can be filed on or after May 29, 2000 for a reissue application filed on or after June 8, 1995), such filing will not be announced in the Official Gazette. An RCE continues prosecution of the existing reissue application and is not a filing of a new application.


The filing of all reissue applications, except for CPAs filed under 37 CFR 1.53(d), (note that effective July 14, 2003, CPA practice has been eliminated as to utility and plant application) will be announced in the Official Gazette and will include certain identifying data as specified in 37 CFR 1.11(b). Access to a reissue application that is maintained in paper must be obtained from the area of the Office having jurisdiction over the reissue application file.

For reissue application files that are maintained in paper, the following access procedure will be observed:

(A) Any member of the general public may request access to a particular reissue application filed after March 1, 1977. Since no record of such request is intended to be kept, an oral request will suffice. Reissue applications already on file prior to March 1, 1977 are not automatically open to inspection, but a liberal policy is followed by the Office of Patent Legal Administration and by the Board of Patent Appeals and Interferences (see MPEP §

1002.02(b)) in granting petitions for access to such applications.

(B)Paper reissue application files will be maintained in the TCs and inspection thereof will be supervised by TC personnel. Although no general limit is placed on the amount of time spent reviewing the files, the Office may impose limitations, if necessary, e.g., where the application is actively being processed.


(C)Where the reissue application file has left the TC for administrative processing, requests for access should be directed to the appropriate supervisory personnel where the application is currently located.

(D)Requests for copies of papers in the reissue application file must be in writing and addressed to the Mail Stop Document Services, Director of the United States Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450. Such requests may be either mailed or delivered to the Office Customer Service Window (See MPEP § 502). The price for copies made by the Office is set forth in 37 CFR 1.19.

1440 Examination of Reissue Application[edit | edit source]

37 CFR 1.176. Examination of reissue.

(a)A reissue application will be examined in the same manner as a non-reissue, non-provisional application, and will be subject to all the requirements of the rules related to non-reissue applications. Applications for reissue will be acted on by the examiner in advance of other applications.

(b)Restriction between subject matter of the original patent claims and previously unclaimed subject matter may be required (restriction involving only subject matter of the original patent claims will not be required). If restriction is required, the subject matter of the original patent claims will be held to be constructively elected unless a disclaimer of all the patent claims is filed in the reissue application, which disclaimer cannot be withdrawn by applicant.

37 CFR 1.176 provides that an original claim, if re- presented in a reissue application, will be fully examined in the same manner, and subject to the same rules as if being presented for the first time in an original non-reissue, nonprovisional application, except that division will not be required by the examiner. See MPEP § 1450 and § 1451. Reissue applications are normally examined by the same examiner who issued the patent for which reissue is requested. In addition, the application will be examined with respect to compliance with 37 CFR 1.171-1.178 relating specifically to reissue applications, for example, the reissue oath or declaration will be carefully reviewed for compliance with 37 CFR 1.175. See MPEP § 1444 for handling applications in which the oath or declaration




lacks compliance with 37 CFR 1.175. Reissue applications with related litigation will be acted on by the examiner before any other special applications, and will be acted on immediately by the examiner, subject only to a 2-month delay after publication for examining reissue applications; see MPEP § 1441.

The original patent file wrapper /file history should always be obtained and reviewed when examining a reissue application thereof.

1441 Two-Month Delay Period[edit | edit source]

37 CFR 1.176 provides that reissue applications will be acted on by the examiner in advance of other applications, i.e., “special.” Generally, a reissue application will not be acted on sooner than 2 months after announcement of the filing of the reissue has appeared in the Official Gazette. The 2-month delay is provided in order that members of the public may have time to review the reissue application and submit pertinent information to the Office before the examiner’s action. The pertinent information is submitted in the form of a protest under 37 CFR 1.291(a). For a discussion as to protests under 37 CFR 1.291(a) in reissue applications, see MPEP § 1441.01. As set forth in MPEP § 1901.04, the public should be aware that such submissions should be made as early as possible, since, under certain circumstances, the 2-month delay period will not be employed. For example, the Office may act on a continuation or a divisional reissue application prior to the expiration of the 2-month period after announcement. Additionally, the Office will entertain a petition under 37 CFR 1.182 which is accompanied by the required petition fee (37 CFR 1.17(f)) to act on a reissue application without delaying for 2 months. Accordingly, protestors to reissue applications (see MPEP § 1441.01) cannot automatically assume that a full 2-month delay period will always be available. Appropriate reasons for requesting that the 2-month delay period not be employed include that litigation involving a patent has been stayed to permit the filing of an application for the reissue of the patent. Where the basis for the petition is ongoing litigation, the petition must clearly identify the litigation, and detail the specifics of the litigation that call for prompt action on the reissue application prior to the expiration of the 2-month delay period. Such petitions are decided by the Office of Patent Legal Administration.

1441.01Protest in Reissue Applications[R-3]

A protest pursuant to 37 CFR 1.291 may be filed throughout the pendency of a reissue application, prior to the date of mailing of a notice of allowance, subject to the timing constraints of the examination, as set forth in MPEP § 1901.04. While a reissue application is not published under 37 CFR 1.211, the reissue application is published pursuant to 35 U.S.C. 122(b)(1)(A) via an announcement in the Official Gazette (and public availability of the file content) per 37 CFR 1.11(b). Such a publication does not preclude the filing of a protest. 35 U.S.C. 122(c) states:

“(c) PROTEST AND PRE-ISSUANCE OPPOSITION- The Director shall establish appropriate procedures to ensure that no protest or other form of pre-issuance opposition to the grant of a patent on an application may be initiated after publication of the application without the express written consent of the applicant.” [Emphasis added.]

A protest is precluded after publication for an application for an original patent, as a “form of pre-issuance opposition.” A reissue application is a post- issuance proceeding. A protest filed in a reissue application is not a “form of pre-issuance opposition to the grant of a patent” since the patent to be reissued has already been granted. Thus, the prohibition against the filing of a protest after publication of an application under 35 U.S.C. 122(c) is not applicable to a reissue application and a protest is permitted after publication of the reissue application.

A protest with regard to a reissue application 

should be filed within the 2-month period following the announcement of the filing of the reissue application in the Official Gazette. If the protest of a reissue application cannot be filed within the 2-month delay period, the protest can be submitted at a later time. Where the protest is submitted after the 2-month period, no petition for entry of the protest under 37 CFR 1.182 is needed with respect to the protest being submitted after the 2 months, unless a final rejection has been issued or prosecution on the merits has been otherwise closed for the reissue application.


A potential protestor should be aware that reissue applications are taken up “special” and a protest filed outside the 2-month delay period may be




received after action by the examiner. Once the first Office action is mailed (after the 2-month period), a member of the public may still submit pertinent information in the form of a protest under 37 CFR 1.291, and the examiner will consider the information submitted in the next Office action, to the extent that such consideration is appropriate. Where a final rejection has been issued or the prosecution on the merits has been otherwise closed, a petition under 37 CFR 1.182 along with the required petition fee (37 CFR 1.17(f)) for entry of the protest are required. The petition must include an explanation as to why the additional time was necessary and the nature of the protest intended. A copy of the petition must be served upon the applicant in accordance with 37 CFR 1.248. The petition should be directed to the Office of Petitions.

If the protest of a reissue application cannot be filed within the 2-month delay period, the protestor may petition to request (A) an extension of the 2-month period following the announcement in the Official Gazette, and (B) a delay of the examination until the extended period expires. Such a request will be considered only if filed in the form of a petition under 37 CFR 1.182 and accompanied by the petition fee set forth in 37 CFR 1.17(f). The petition under 37 CFR 1.182 and the petition fee must be filed prior to the expiration of the 2-month period following the announcement of the filing of the reissue application in the Official Gazette. The petition must explain why the additional time is necessary and the nature of the protest intended. A copy of the petition must be served upon applicant in accordance with 37 CFR 1.248. The petition should be directed to the appropriate Technology Center (TC) which will forward the petition to the Office of Patent Legal Administration.

If the protest is a “REISSUE LITIGATION” protest, it is particularly important that it be filed early if protestor wishes it considered at the time the Office first acts on the reissue application. Protestors should be aware that the Office will entertain petitions from the reissue applicants under 37 CFR 1.182 to waive the 2-month delay period in appropriate circumstances. Accordingly, protestors to reissue applications cannot automatically assume that the full 2- month delay period will always be available.

The Technology Center (TC) to which the reissue application is assigned is listed in the Official Gazettenotice of filing of the reissue application. Accordingly, the indicated TC should retain jurisdiction over the reissue application file for 2 months after the date of the Official Gazette notice before transferring the reissue application under the procedure set forth in MPEP §

903.08(d).

The publication of a notice of a reissue application in the Official Gazette should be done prior to any examination of the reissue application. If an inadvertent failure to publish notice of the filing of the reissue application in the Official Gazette is recognized later in the examination, action should be taken to have the notice published as quickly as possible, and action on the reissue application may be delayed until 2 months after the publication, allowing for any protests to be filed.

See MPEP § 1901.06 for general procedures on examiner treatment of protests in reissue applications.

1442 Special Status[edit | edit source]

All reissue applications are taken up “special,” and remain “special” even though applicant does not respond promptly.

All reissue applications, except those under suspension because of litigation, will be taken up for action ahead of other “special” applications; this means that all issues not deferred will be treated and responded to immediately. Furthermore, reissue applications involved in litigation will be taken up for action in advance of other reissue applications.

1442.01Litigation-Related Reissues [R-5]

During initial review, the examiner should determine whether the patent for which the reissue has been filed is involved in litigation, and if so, the status of that litigation. If the examiner becomes aware of litigation involving the patent sought to be reissued during examination of the reissue application, and applicant has not made the details regarding that litigation of record in the reissue application, the examiner, in the next Office action, will inquire regarding the specific details of the litigation.

Form paragraph 14.06 may be used for such an inquiry.

¶ 14.06 Litigation-Related Reissue

The patent sought to be reissued by this application [1] involved in litigation. Any documents and/or materials which




would be material to patentability of this reissue application are required to be made of record in response to this action.

Due to the related litigation status of this application, EXTENSIONS OF TIME UNDER THE PROVISIONS OF 37 CFR 1.136(a) WILL NOT BE PERMITTED DURING THE PROSECUTION OF THIS APPLICATION.

Examiner Note:

In bracket 1, insert either —is— or —has been—.

If additional details of the litigation appear to be material to examination of the reissue application, the examiner may make such additional inquiries as necessary and appropriate.

For reissue application files that are maintained in paper, if the existence of litigation has not already been noted, the examiner should place a prominent notation on the application file to indicate the litigation (1) at the bottom of the face of the file in the box just to the right of the box for the retention label, and (2) on the pink Reissue Notice Card form. For reissue application files that are maintained in the Image File Wrapper (IFW) system, if the existence of litigation has not already been noted, the examiner should print out a copy of the bibliographic data sheet from the IFW file history and annotate the printed bibliographic data sheet such that adequate notice is provided of the existence of the litigation. The examiner should place the annotation in a prominent place. The annotated sheet should be scanned into IFW.

Applicants will normally be given 1 month to reply to Office actions in all reissue applications which are being examined during litigation, or after litigation had been stayed, dismissed, etc., to allow for consideration of the reissue by the Office. This 1-month period may be extended only upon a showing of clear justification pursuant to 37 CFR 1.136(b). The Office action will inform applicant that the provisions of 37 CFR 1.136(a) are not available. Of course, up to 3 months may be set for reply if the examiner determines such a period is clearly justified.

1442.02 Concurrent Litigation[edit | edit source]

In order to avoid duplication of effort, action in reissue applications in which there is an indication of concurrent litigation will be suspended automatically unless and until it is evident to the examiner, or the applicant indicates, that any one of the following applies:

(A)a stay of the litigation is in effect;

(B)the litigation has been terminated;

(C)there are no significant overlapping issues between the application and the litigation; or

(D)it is applicant’s desire that the application be examined at that time.

Where any of (A) - (D) above apply, form paragraphs 14.08-14.10 may be used to deny a suspension of action in the reissue, i.e., to deny a stay of the reissue proceeding.

Where none of (A) through (D) above apply, action in the reissue application in which there is an indication of concurrent litigation will be suspended by the examiner. The examiner should consult with the Technology Center Special Program Examiner prior to suspending action in the reissue. Form paragraph 14.11 may be used to suspend action, i.e., stay action, in a reissue application with concurrent litigation.

An ex parte reexamination proceeding will not be stayed where there is litigation. See Ethicon v. Quigg, 849 F.2d 1422, 7 USPQ2d 1152 (Fed. Cir. 1988). Thus, where a reissue application has been merged with an ex parte reexamination proceeding, the merged proceeding will not be stayed where there is litigation. In a merged ex parte reexamination/reissue proceeding, the ex parte reexamination will control because of the statutory (35 U.S.C. 305) requirement that ex parte reexamination proceedings be conducted with special dispatch. See MPEP § 2285 and § 2286. As to a stay or suspension where reissue proceedings are merged with inter partes reexamination proceedings, see 37 CFR 1.937 and MPEP § 2686.

1442.03 Litigation Stayed[edit | edit source]

All reissue applications, except those under suspension because of litigation, will be taken up for action ahead of other “special” applications; this means that all issues not deferred will be treated and responded to immediately. Furthermore, reissue applications involved in “stayed litigation” will be taken up for action in advance of other reissue applications. Great emphasis is placed on the expedited processing of such reissue applications. The courts are especially interested in expedited processing in the Office where litigation is stayed.

In reissue applications with “stayed litigation,” the Office will entertain petitions under 37 CFR 1.182, which are accompanied by the fee under 37 CFR 1.17(f), to not apply the 2-month delay period stated in MPEP § 1441. Such petitions are decided by the Office of Patent Legal Administration.

Time-monitoring systems have been put into effect which will closely monitor the time used by applicants, protestors, and examiners in processing reissue applications of patents involved in litigation in which the court has stayed further action. Monthly reports on the status of reissue applications with related litigation are required from each Technology Center (TC). Delays in reissue processing are to be followed up. The TC Special Program Examiner is responsible for oversight of reissue applications with related litigation.

The purpose of these procedures and those deferring consideration of certain issues, until all other issues are resolved or the application is otherwise ready for consideration by the Board of Patent Appeals and Interferences (note MPEP § 1448), is to reduce the time between filing of the reissue application and final action thereon, while still giving all parties sufficient time to be heard.

1442.04 Litigation Involving Patent[edit | edit source]

37 CFR 1.178. Original patent; continuing duty of applicant.

(b)In any reissue application before the Office, the applicant must call to the attention of the Office any prior or concurrent proceedings in which the patent (for which reissue is requested) is or was involved, such as interferences, reissues, reexaminations, or litigations and the results of such proceedings (see also § 1.173(a)(1)).

Where the patent for which reissue is being sought is, or has been, involved in litigation, the applicant should bring the existence of such litigation to the attention of the Office. 37 CFR 1.178(b). This should be done at the time of, or shortly after, the applicant files the application, either in the reissue oath or declaration, or in a separate paper, preferably accompanying the application as filed. Litigation begun after filing of the reissue application also should be promptly brought to the attention of the Office.

Litigation encompasses any papers filed in the court or issued by the court. This may include, for example, motions, pleadings, and court decisions, as well as the results of such proceedings. When applicant notifies the Office of the existence of the litigation, enough information should be submitted so that the Office can reasonably evaluate the need for asking for further materials in the litigation. Note that the existence of supporting materials which may substantiate allegations of invalidity should, at least, be fully described, and preferably submitted. The Office is not interested in receiving voluminous litigation materials which are not relevant to the Office’s consideration of the reissue application. The status of the litigation should be updated in the reissue application as soon as significant events happen in the litigation.

When a reissue application is filed, the examiner should determine whether the original patent has been adjudicated by a court. The decision(s) of the court, and also other papers in the suit, may provide information essential to the examination of the reissue. Examiners should inform the applicant of the duty to supply information as to litigation involving the patent. Form paragraph 14.11.01 may be used for this purpose. See MPEP § 1418.

Additionally, the patented file will contain notices of the filing and termination of infringement suits on the patent. Such notices are required by law to be filed by the clerks of the Federal District Courts. These notices do not indicate if there was an opinion by the court, nor whether a decision was published. Shepard’s Federal Citations and the cumulative digests of the United States Patents Quarterly, both of which are in the Lutrelle F. Parker, Sr., Memorial Law Library, contain tables of patent numbers giving the citation of published decisions concerning the patent.

A litigation computer search by the Scientific and Technical Information Center (STIC) should be requested by the examiner to determine whether the patent has been, or is, involved in litigation. For reissue application files that are maintained in paper, the “Search Notes” box on the application file wrapper is then completed to indicate that the review was conducted. A copy of the STIC search should be hole-punched and placed in the reissue file. For IFW reissue application files, the “Search Notes” box on the OACS “Search Notes” page is annotated to indicate that the review was conducted, and the OACS “Search Notes” page is then scanned into the reissue application file history.

Additional information or guidance as to making a litigation search may be obtained from the library of the Office of the Solicitor. Where papers are not otherwise conveniently obtainable, the applicant may be requested to supply copies of papers and records in suits, or the Office of the Solicitor may be requested to obtain them from the court. The information thus obtained should be carefully considered for its bearing on the proposed claims of the reissue, particularly when the reissue application was filed in view of the holding of a court.

If the examiner becomes aware of litigation involving the patent sought to be reissued during examination of the reissue application, and applicant has not made the details regarding that litigation of record in the reissue application, the examiner, in the next Office action, should inquire regarding the same. Form paragraph 14.06 may be used for such an inquiry. See MPEP § 1442.01.

If the additional details of the litigation appear to be material to patentability of the reissue application, the examiner may make such additional inquiries as necessary and appropriate.

1442.05 Court Ordered Filing of Reissue Application[edit | edit source]

In most instances, the reissue-examination procedure is instituted by a patent owner who voluntarily files a reissue application as a consequence of related patent litigation. Some Federal district courts in earlier decisions have required a patentee-litigant to file a reissue application as a consequence of the patent litigation. However, the Court of Appeals for the Federal Circuit held in Green v. The Rich Iron Co., 944 F.2d 852, 853, 20 USPQ2d 1075, 1076 (Fed. Cir. 1991) that a Federal district court in an infringement case could not compel a patentee to seek reissue by the USPTO.

It is to be noted that only a patentee or his or her assignee may file a reissue patent application. An order by a court for a different party to file a reissue will not be binding on the Office.

1443 Initial Examiner Review[edit | edit source]

As part of an examiner’s preparation for the examination of a reissue application, the Examiner Reissue Guide and Checklist should be consulted for basic guidance and suggestions for handling the prosecution. The Technology Center (TC) Special Program Examiners (SPREs) should make the Guide and Checklist available at the time a reissue application is docketed to an examiner.

On initial receipt of a reissue application, the examiner should inspect the submission under 37 CFR 1.172 as to documentary evidence of a chain of title from the original owner to the assignee to determine whether the consent requirement of 37 CFR 1.172 has been met. The examiner will compare the consent and documentary evidence of ownership; the assignee indicated by the documentary evidence must be the same assignee which signed the consent. Also, the person who signs the consent for the assignee and the person who signs the submission of evidence of ownership for the assignee must both be persons having authority to do so. See also MPEP § 324.

Where the application is assigned, and there is no submission under 37 CFR 1.172 as to documentary evidence in the application, the examiner should require the submission using form paragraph 14.16. Once the submission under 37 CFR 1.172 as to documentary evidence is received, it must be compared with the consent to determine whether the assignee indicated by the documentary evidence is the same assignee which signed the consent. See MPEP § 1410.01 for further discussion as to the required consent and documentary evidence.

Where there is a statement of record that the application is not assigned, there should be no submission under 37 CFR 1.172 as to documentary evidence of ownership in the application, and none should be required by the examiner.

The filing of all reissue applications, except for continued prosecution applications (CPAs) filed under 37 CFR 1.53(d), must be announced in the Official Gazette. Accordingly, for any reissue application other than a CPA, the examiner should determine if the filing of the reissue application has been announced in the Official Gazette as provided in 37 CFR 1.11(b). The contents entry on the PALM Intranet Contents screen should be checked for the presence of “NRE” and “NOTICE OF REISSUE PUBLISHED IN OFFICIAL GAZETTE” entries in the contents, and the date of publication. Where the reissue application is maintained in a paper file, the date of the Official Gazette notice can usually be found on the pink “REISSUE” tag which protrudes from the top of the application file of 08/ or earlier series. For 09/ and later series reissue applications, the Official Gazette publication date appears on the face of the file wrapper. If the filing of the reissue application has not been announced in the Official Gazette, the reissue application should be returned to the Office of Initial Patent Examination (Special Processing) to handle the announcement. The examiner should not further act on the reissue until 2 months after announcement of the filing of the reissue has appeared in the Official Gazette. See MPEP § 1440.

The examiner should determine if there is concurrent litigation, and if so, the status thereof (MPEP § 1442.01), and whether the reissue file wrapper (for reissue application files maintained in paper) or file history (for IFW reissue applications) has been appropriately marked. Note MPEP § 1404.

The examiner should determine if a protest has been filed, and if so, it should be handled as set forth in MPEP § 1901.06. For a discussion of protests under 37 CFR 1.291 in reissue applications, see MPEP § 1441.01.

The examiner should determine whether the patent is involved in an interference, and if so, should refer to MPEP § 1449.01 before taking any action on the reissue application.

The examiner should verify that all Certificate of Correction changes have been properly incorporated into the reissue application. See MPEP § 1411.01.

The examiner should verify that the patent on which the reissue application is based has not expired, either because its term has run or because required maintenance fees have not been paid. Once a patent has expired, the Director of the USPTO no longer has the authority under 35 U.S.C. 251 to reissue the patent. See In re Morgan, 990 F.2d 1230, 26 USPQ2d 1392 (Fed. Cir. 1992). See also MPEP § 1415.01.

1444 Review of Reissue Oath/Declaration[edit | edit source]

In accordance with 37 CFR 1.175, the following is required in the reissue oath/declaration:

(A)A statement that the applicant believes the original patent to be wholly or partly inoperative or invalid-

(1)by reason of a defective specification or drawing, or

(2)by reason of the patentee claiming more or less than patentee had the right to claim in the patent;

(B)A statement of at least one error which is relied upon to support the reissue application, i.e., which provides a basis for the reissue;

(C)A statement that all errors which are being corrected in the reissue application up to the time of filing of the oath/declaration arose without any deceptive intention on the part of the applicant; and

(D)The information required by 37 CFR 1.63.

MPEP § 1414 contains a discussion of each of the above elements (i.e., requirements of a reissue oath/ declaration). The examiner should carefully review the reissue oath/declaration in conjunction with that discussion, in order to ensure that each element is provided in the oath/declaration. If the examiner’s review of the oath/declaration reveals a lack of compliance with any of the requirements of 37 CFR 1.175, a rejection of all the claims under 35 U.S.C. 251 should be made on the basis that the reissue oath/declaration is insufficient.

In preparing an Office action, the examiner should use form paragraphs 14.01 through 14.01.04 to state the objection(s) to the oath/declaration, i.e., the defects in the oath/declaration. These form paragraphs are reproduced in MPEP § 1414. The examiner should then use form paragraph 14.14 to reject the claims under 35 U.S.C. 251, based upon the improper oath/ declaration.

A lack of signature on a reissue oath/declaration (except as otherwise provided in 37 CFR 1.42, 1.43, and 1.47 and in 37 CFR 1.172) would be considered a lack of compliance with 37 CFR 1.175(a) and result in a rejection, including final rejection, of all the claims on the basis that the reissue oath/declaration is insufficient. If the unsigned reissue oath/declaration is submitted as part of a reply which is otherwise properly signed and responsive to the outstanding Office action, the reply should be accepted by the examiner as proper and responsive, and the oath/declaration considered fully in the next Office action. The reply should not be treated as an unsigned or improperly signed amendment (see MPEP § 714.01(a)), nor do the holdings of Ex parte Quayle apply in this situation. The lack of signature, along with any other oath/ declaration deficiencies, should be noted in the next Office action rejecting the claims as being based upon an insufficient reissue oath/declaration.

I.HANDLING OF THE REISSUE OATH/ DECLARATION DURING THE REISSUE PROCEEDING

An initial reissue oath/declaration is submitted with the reissue application (or within the time period set for filing the oath/declaration in a Notice To File Missing Parts under 37 CFR 1.53(f)). Where the reissue oath/declaration fails to comply with 37 CFR 1.175(a), the examiner will so notify the applicant in an Office action, rejecting the claims under 35 U.S.C. 251 as discussed above. In reply to the Office action, a supplemental reissue oath/declaration should be submitted dealing with the noted defects in the reissue oath/declaration.

Where the initial reissue oath/declaration (1) failed to provide any error statement, or (2) attempted to provide an error statement, but failed to identify any error under 35 U.S.C. 251 upon which reissue can be based (see MPEP § 1402), the examiner should reject all the claims as being based upon a defective reissue oath/declaration under 35 U.S.C. 251. To support the rejection, the examiner should specifically point out the failure of the initial oath/declaration to comply with 37 CFR 1.175 because an “error” under 35 U.S.C. 251 upon which reissue can be based was not identified therein. In reply to the rejection under 35 U.S.C. 251, a supplemental reissue oath/declaration must be submitted stating an error under 35 U.S.C. 251 which can be relied upon to support the reissue application. Submission of this supplemental reissue oath/declaration to obviate the rejection cannot be deferred by applicant until the application is otherwise in condition for allowance. In this instance, a proper statement of error was never provided in the initial reissue oath/declaration, thus a supplemental oath/declaration is required in reply to the Office action in order to properly establish grounds for reissue.

A different situation may arise where the initial reissue oath/declaration does properly identify one or more errors under 35 U.S.C. 251 as being the basis for reissue, however, because of changes or amendments made during prosecution, none of the identified errors are relied upon any more. A supplemental oath/declaration will be needed to identify at least one error nowbeing relied upon as the basis for reissue, even though the prior oath/declaration was earlier found proper by the examiner. The supplemental oath/declaration need not also indicate that the error(s) identified in the prior oath(s)/declaration(s) is/are no longer being corrected. In this instance, applicant’s submission of the supplemental reissue oath/declaration to obviate the rejection under 35 U.S.C. 251 can, at applicant’s option, be deferred until the application is otherwise in condition for allowance. The submission can be deferred because a proper statement of error was provided in the initial reissue oath/declaration. Applicant need only request that submission of the supplemental reissue oath/declaration be deferred until allowance, and such a request will be considered a complete reply to the rejection.

II.SUPPLEMENTAL REISSUE OATH/DECLARATION UNDER 37 CFR 1.175(b)(1):

Once the reissue oath/declaration is found to comply with 37 CFR 1.175(a), it is not required, nor is it suggested, that a new reissue oath/declaration be submitted together with each new amendment and correction of error in the patent. During the prosecution of a reissue application, amendments are often made and additional errors in the patent are corrected. A supplemental oath/declaration need not be submitted with each amendment and additional correction. Rather, it is suggested that the reissue applicant wait until the case is in condition for allowance, and then submit a cumulative supplemental reissue oath/declaration pursuant to 37 CFR 1.175(b)(1).

See MPEP § 1414.01 for a discussion of the required content of a supplemental reissue oath/declaration under 37 CFR 1.175(b)(1).

A supplemental oath/declaration under 37 CFR 1.175(b)(1) must be submitted before allowance. It may be submitted with any reply prior to allowance. It may be submitted to overcome a rejection under 35 U.S.C. 251 made by the examiner, where it is indicated that the submission of the supplemental oath/ declaration will overcome the rejection.

A supplemental oath/declaration under 37 CFR 1.175(b)(1) will be required where:

(A)the application is otherwise (other than the need for this supplemental oath/declaration) in condition for allowance;

(B)amendments or other corrections of errors in the patent have been made subsequent to the last oath/ declaration filed in the application; and

(C)at least one of the amendments or other corrections corrects an error under 35 U.S.C. 251.

When a supplemental oath/declaration under 37 CFR 1.175(b)(1) directed to the amendments or other corrections of error is required, the examiner is encouraged to telephone the applicant and request the submission of the supplemental oath/declaration by fax. If the circumstances do not permit making a telephone call, or if applicant declines or is unable to promptly submit the oath/declaration, the examiner should issue a final Office action (final rejection) and use form paragraph 14.05.02 where the action issued is a second or subsequent action on the merits.

As noted above, the examiner will issue a final Office action where the application is otherwise in condition for allowance, and amendments or other corrections of error in the patent have been made subsequent to the last oath/declaration filed in the application. The examiner will be introducing (via form paragraph 14.05.02) a rejection into the case for the first time in the prosecution, when the claims have been determined to be otherwise allowable. This introduction of a new ground of rejection under 35 U.S.C. 251 will not prevent the action from being made final on a second or subsequent action because of the following factors:

(A)The finding of the case in condition for allowance is the first opportunity that the examiner has to make the rejection;

(B)The rejection is being made in reply to, i.e., was caused by, an amendment of the application (to correct errors in the patent);

(C)All applicants are on notice that this rejection will be made upon finding of the case otherwise in condition for allowance where errors have been corrected subsequent to the last oath/declaration filed in the case, so that the rejection should have been expected by applicant; and

(D)The rejection will not prevent applicant from exercising any rights to cure the rejection, since applicant need only submit a supplemental oath/declaration with the above-described language, and it will be entered to cure the rejection.

Where the application is in condition for allowance and no amendments or other corrections of error in the patent have been made subsequent to the last oath/declaration filed in the application, a supplemental reissue oath/declaration under 37 CFR 1.175(b)(1) should not be required by the examiner. Instead, the examiner should issue a Notice of Allowability indicating allowance of the claims.

III.AFTER ALLOWANCE

Where applicant seeks to correct an error after allowance of the application, any amendment of the patent correcting the error must be submitted in accordance with 37 CFR 1.312. As set forth in 37 CFR 1.312, no amendment may be made as a matter of right in an application after the mailing of the notice of allowance. An amendment filed under 37 CFR 1.312 must be filed before or with the payment of the issue fee and may be entered on the recommendation of the primary examiner, and approved by the supervisory patent examiner, without withdrawing the case from issue.

Because the amendment seeks to correct an error in the patent, the amendment will affect the disclosure, the scope of a claim, or add a claim. Thus, in accordance with MPEP § 714.16, the remarks accompanying the amendment must fully and clearly state:

(A)why the amendment is needed;

(B)why the proposed amended or new claims require no additional search or examination;

(C)why the claims are patentable; and

(D)why they were not presented earlier.

A supplemental reissue oath/declaration must accompany the amendment. The supplemental reissue oath/declaration must state that the error(s) to be corrected arose without any deceptive intention on the part of the applicant. The supplemental reissue oath/ declaration submitted after allowance must be directed to the error(s) applicant seeks to correct after allowance. This oath/declaration need not cover any earlier errors, since all earlier errors should have been covered by a reissue oath/declaration submitted prior to allowance.

Occasionally correcting an error after allowance does not include an amendment of the specification or claims of the patent. For example, the correction of the error could be the filing of a certified copy of the original foreign application (prior to the payment of the issue fee - see 37 CFR 1.55(a)(2)) to obtain the right of foreign priority under 35 U.S.C. 119 (see Brenner v. State of Israel, 400 F.2d 789, 158 USPQ 584 (D.C. Cir. 1968)) where the claim for foreign priority had been timely made in the application for the original patent. In such a case, the requirements of 37 CFR 1.312 must still be met. This is so, because the correction of the patent is an amendment of the patent, even though no amendment is physically entered into the case. Thus, for a reissue oath/declaration submitted after allowance to correct an additional error (or errors), the reissue applicant must comply with 37 CFR 1.312 in the manner discussed above.

1445 Reissue Application Examined in Same Manner as Original Application[edit | edit source]

As stated in 37 CFR 1.176, a reissue application, including all the claims therein, is subject to “be examined in the same manner as a non-reissue, non- provisional application.” Accordingly, the claims in a reissue application are subject to any and all rejections which the examiner deems appropriate. It does not matter whether the claims are identical to those of the patent or changed from those in the patent. It also does not matter that a rejection was not made in the prosecution of the patent, or could have been made, or was in fact made and dropped during prosecution of the patent; the prior action in the prosecution of the patent does not prevent that rejection from being made in the reissue application. Claims in a reissue application enjoy no “presumption of validity.” In re Doyle, 482 F.2d 1385, 1392, 179 USPQ 227, 232-233 (CCPA 1973); In re Sneed, 710 F.2d 1544, 1550 n.4, 218 USPQ 385, 389 n.4 (Fed. Cir. 1983). Likewise, the fact that during prosecution of the patent the examiner considered, may have considered, or should have considered information such as, for example, a specific prior art document, does not have any bearing on, or prevent, its use as prior art during prosecution of the reissue application.

1448 Fraud, Inequitable Conduct, or Duty of Disclosure Issues[edit | edit source]

The Office no longer investigates and rejects reissue applications under 37 CFR 1.56. The Office will not comment upon duty of disclosure issues which are brought to the attention of the Office in reissue applications except to note in the application, in appropriate circumstances, that such issues are no longer considered by the Office during its examination of patent applications. Examination as to the lack of deceptive intent requirement in reissue applications will continue but without any investigation of fraud, inequitable conduct, or duty of disclosure issues. Applicant’s statement in the reissue oath or declaration of lack of deceptive intent will be accepted as dispositive except in special circumstances such as an admission or judicial determination of fraud, inequitable conduct, or violation of the duty of disclosure.

ADMISSION OR JUDICIAL DETERMINATION

An admission or judicial determination of fraud, inequitable conduct, or violation of the duty of disclosure is a special circumstance, because no investigation need be made. Accordingly, after consulting with the Technology Center (TC) Special Program Examiner (SPRE), a rejection should be made using the appropriate one of form paragraphs 14.21.09 or 14.22as reproduced below.

Any admission of fraud, inequitable conduct or violation of the duty of disclosure must be explicit, unequivocal, and not subject to other interpretation. Where a rejection is made based upon such an admission and applicant responds with any reasonable interpretation of the facts that would not lead to a conclusion of fraud, inequitable conduct or violation of the duty of disclosure, the rejection should be withdrawn. Alternatively, if applicant argues that the admission noted by the examiner was not in fact an admission, the rejection should also be withdrawn.

See MPEP § 2012 for additional discussion as to fraud, inequitable conduct or violation of duty of disclosure in a reissue application.

1449 Protest Filed in Reissue Where Patent Is in Interference[edit | edit source]

If a protest (see MPEP Chapter 1900) is filed in a reissue application related to a patent involved in a pending interference proceeding, the reissue application should be referred to the Office of Patent Legal Administration (OPLA) before considering the protest and acting on the reissue application.

The OPLA will check to see that:

(A)all parties to the interference are aware of the filing of the reissue; and

(B)the Office does not allow claims in the reissue which are unpatentable over the pending interference count(s), or found unpatentable in the interference proceeding. After the reissue application has been reviewed by the OPLA, the reissue application with the protest will be returned to the examiner. See MPEP § 1441.01 for a discussion as to protests under 37 CFR 1.291 in reissue applications.

1449.01 Concurrent Office Proceedings[edit | edit source]

I.CONCURRENT REEXAMINATION PROCEEDINGS:

37 CFR 1.565(d) provides that if “a reissue application and an ex parte reexamination proceeding on which an order pursuant to 37 CFR 1.525 has been mailed are pending concurrently on a patent, a decision will normally be made to merge the two proceedings or to suspend one of the two proceedings.” 37 CFR 1.991 provides that if “a reissue application and an inter partes reexamination proceeding on which an order pursuant to 37 CFR 1.931 has been mailed are pending concurrently on a patent, a decision may be made to merge the two proceedings or to suspend one of the two proceedings”. If an examiner becomes aware that a reissue application and an ex parte or inter partes reexamination proceeding are both pending for the same patent, he or she should immediately inform the Technology Center (TC) or Central Reexamination Unit (CRU) Special Program Examiner (SPRE).

Pursuant to 37 CFR 1.177, a patent owner may file more than one reissue application for the same patent. If an examiner becomes aware that multiple reissue applications are pending for the same patent, and an ex parte or inter partes reexamination proceeding is pending for the same patent, he or she should immediately inform the TC SPRE.

Where a reissue application and a reexamination proceeding are pending concurrently on a patent, and an order granting reexamination has been issued for the reexamination proceeding, the Office of Patent Legal Administration (OPLA) must be notified that the proceedings are ready for a decision as to whether to merge the reissue and the reexamination, or stay one of the two. See MPEP § 2285 for the procedure of notifying OPLA and general guidance, if a reissue application and an ex parte reexamination proceeding are both pending for the same patent, and an inter partes reexamination proceeding is not involved. See MPEP § 2686.03 where a reissue application and an inter partes reexamination proceeding are both pending for the same patent, regardless of whether an ex parte reexamination proceeding is also pending.

Where a reissue application and a reexamination proceeding are pending concurrently on a patent, the patent owner, i.e., the reissue applicant, has a responsibility to notify the Office of the concurrent proceeding. 37 CFR § 1.178(b), 37 CFR 1.565(a), and 37 CFR 1.985(a). The patent owner should file in the reissue application, as early as possible, a Notification of Concurrent Proceedings pursuant to 37 CFR 1.178(b) in order to alert the Office of the existence of the reexamination proceeding on the same patent. See MPEP § 1418. In addition, the patent owner should file in the reexamination proceeding, as early as possible, a Notification of Concurrent Proceedings pursuant to 37 CFR 1.565(a) or 1.985(a) (depending on whether the reexamination proceeding is an ex partereexamination proceeding or an inter partes reexamination proceeding) to provide a notification to the Office in the reexamination proceeding of the existence of the two concurrent proceedings.

The patent owner may file a petition under 37 CFR 1.182 in a reissue application to merge the reissue application with the reexamination proceeding, or to stay one of the proceedings because of the other. This petition must be filed after the issuance of the order to reexamine (37 CFR 1.525, 37 CFR 1.931) in the reexamination proceeding. If the petition is filed prior to the reexamination order, it will not be considered, and will be returned to the patent owner by the TC or CRU Director. If the petition is filed after the issuance of the order to reexamine, the petition and the files for the reissue application and the reexamination proceeding will be forwarded to OPLA for decision.

II.CONCURRENT INTERFERENCE PROCEEDINGS

If the original patent is involved in an interference, the examiner must consult the administrative patent judge in charge of the interference before taking any action on the reissue application. It is particularly important that the reissue application not be granted without the administrative patent judge’s approval. See MPEP Chapter 2300.

III.CONCURRENT REISSUE PROCEEDINGS

Where more than one reissue applications are pending concurrently on the same patent, see MPEP §§

1450 and 1451.

1449.02Interference in Reissue [R-5]

37 CFR 41.8. Mandatory notices.

(a)In an appeal brief (§§ 41.37, 41.67, or 41.68) or at the initiation of a contested case (§ 41.101), and within 20 days of any change during the proceeding, a party must identify:

(1)Its real party-in-interest, and

(2)Each judicial or administrative proceeding that could affect, or be affected by, the Board proceeding.

(b)For contested cases, a party seeking judicial review of a Board proceeding must file a notice with the Board of the judicial review within 20 days of the filing of the complaint or the notice of appeal. The notice to the Board must include a copy of the complaint or notice of appeal. See also §§ 1.301 to 1.304 of this title.

37 CFR 41.202. Suggesting an interference.

(a)Applicant. An applicant, including a reissue applicant, may suggest an interference with another application or a patent. The suggestion must:

(1)Provide sufficient information to identify the application or patent with which the applicant seeks an interference,

(2)Identify all claims the applicant believes interfere, propose one or more counts, and show how the claims correspond to one or more counts,

(3)For each count, provide a claim chart comparing at least one claim of each party corresponding to the count and show why the claims interfere within the meaning of § 41.203(a),

(4)Explain in detail why the applicant will prevail on priority,

(5)If a claim has been added or amended to provoke an interference, provide a claim chart showing the written description for each claim in the applicant’s specification, and

(6)For each constructive reduction to practice for which the applicant wishes to be accorded benefit, provide a chart showing where the disclosure provides a constructive reduction to practice within the scope of the interfering subject matter.

(c)Examiner. An examiner may require an applicant to add a claim to provoke an interference. Failure to satisfy the requirement within a period (not less than one month) the examiner sets will operate as a concession of priority for the subject matter of the claim. If the interference would be with a patent, the applicant must also comply with paragraphs (a)(2) through (a)(6) of this section. The claim the examiner proposes to have added must, apart from the question of priority under 35 U.S.C. 102 (g):

(1)Be patentable to the applicant, and

(2)Be drawn to patentable subject matter claimed by another applicant or patentee.

In appropriate circumstances, a reissue application may be placed into interference with a patent or pending application. A patentee may provoke an interference with a patent or pending application by filing a reissue application, if the reissue application includes an appropriate reissue error as required by 35 U.S.C. 251. Reissue error must be based upon applicant error; a reissue cannot be based solely on the error of the Office for failing to declare an interference or to suggest copying claims for the purpose of establishing an interference. See In re Keil, 808 F.2d 830, 1 USPQ2d 1427 (Fed. Cir. 1987); In re Dien, 680 F.2d 151, 214 USPQ 10 (CCPA 1982); In re Bostwick, 102 F.2d 886, 888, 41 USPQ 279, 281 (CCPA 1939); and In re Guastavino, 83 F.2d 913, 916, 29 USPQ 532, 535 (CCPA 1936). See also Slip Track Systems, Inc. v. Metal Lite, Inc., 159 F.3d 1337, 48 USPQ2d 1055 (Fed. Cir. 1998) (Two patents issued claiming the same patentable subject matter, and the patentee with the earlier filing date requested reexamination of the patent with the later filing date (Slip Track’s patent). A stay of litigation in a priority of invention suit under 35 U.S.C. 291, pending the outcome of the reexamination, was reversed. The suit under 35 U.S.C. 291was the only option available to Slip Track to determine priority of invention. Slip Track could not file a reissue application solely to provoke an interference proceeding before the Office because it did not assert that there was any error as required by 35 U.S.C. 251in the patent.). A reissue application can be employed to provoke an interference if the reissue application:

(A)adds copied claims which are not present in the original patent;

(B)amends claims to correspond to those of the patent or application with which an interference is sought; or

(C)contains at least one error (not directed to provoking an interference) appropriate for the reissue.

In the first two situations, the reissue oath/declaration must assert that applicant erred in failing to include claims of the proper scope to provoke an interference in the original patent application. Note that in In re Metz, 173 F.3d 433 (Fed. Cir. 1998) (table), the Federal Circuit permitted a patentee to file a reissue application to copy claims from a patent in order to provoke an interference with that patent. Furthermore, the subject matter of the copied or amended claims in the reissue application must be supported by the disclosure of the original patent under 35 U.S.C. 112, first paragraph. See In re Molins, 368 F.2d 258, 261, 151 USPQ 570, 572 (CCPA 1966) and In re Spencer, 273 F.2d 181, 124 USPQ 175 (CCPA 1959).

A reissue applicant cannot present added or amended claims to provoke an interference, if the claims were deliberately omitted from the patent. If there is evidence that the claims were not inadvertently omitted from the original patent, e.g., the subject matter was described in the original patent as being undesirable, the reissue application may lack proper basis for the reissue. See In re Bostwick, 102 F.2d at 889, 41 USPQ at 282 (CCPA 1939)(reissue lacked a proper basis because the original patent pointed out the disadvantages of the embodiment that provided support for the copied claims).

The issue date of the patent, or the publication date of the application publication (whichever is applicable under 35 U.S.C. 135(b)), with which an interference is sought must be less than 1 year prior to the presentation of the copied or amended claims in the reissue application. See 35 U.S.C. 135(b) and MPEP § 715.05and MPEP Chapter 2300. If the reissue application includes broadened claims, the reissue application must be filed within two years from the issue date of the original patent. See 35 U.S.C. 251 and MPEP § 1412.03.

An examiner may, pursuant to 37 CFR 41.202(c), require a reissue applicant to add a claim to provoke an interference, unless the reissue applicant cannot present the added claim to provoke an interference based upon the provisions of the reissue statute and rules, e.g., if the claim was deliberately omitted from the patent, or if the claim enlarges the scope of the claims of the original patent and was not “applied for within two years from the grant of the original patent.” Failure to satisfy the requirement within a period (not less than one month) the examiner sets will operate as a concession of priority for the subject matter of the claim. If the interference would be with a patent, the reissue applicant must also comply with 37 CFR 41.202(a)(2) through (a)(6). The claim the examiner proposes to have added must, apart from the question of priority under 35 U.S.C. 102(g), be patentable to the reissue applicant, and be drawn to patentable subject matter claimed by another applicant or patentee.

REISSUE APPLICATION FILED WHILE PATENT IS IN INTERFERENCE

If a reissue application is filed while the original patent is in an interference proceeding, the reissue applicant must promptly notify the Board of Patent Appeals and Interferences of the filing of the reissue application within 20 days from the filing date. See 37 CFR 41.8 and MPEP Chapter 2300.

1450 Restriction and Election of Species Made in Reissue Application[edit | edit source]

37 CFR 1.176. Examination of reissue.

(a)A reissue application will be examined in the same manner as a non-reissue, non-provisional application, and will be subject to all the requirements of the rules related to non-reissue applications. Applications for reissue will be acted on by the examiner in advance of other applications.

(b)Restriction between subject matter of the original patent claims and previously unclaimed subject matter may be required (restriction involving only subject matter of the original patent claims will not be required). If restriction is required, the subject matter of the original patent claims will be held to be constructively elected unless a disclaimer of all the patent claims is filed in the reissue application, which disclaimer cannot be withdrawn by applicant.

37 CFR 1.176(b) permits the examiner to require restriction in a reissue application between claims newly added in a reissue application and the original patent claims, where the added claims are directed to an invention which is separate and distinct from the invention(s) defined by the original patent claims. The criteria for making a restriction requirement in a reissue application between the newly added claims and the original claims are the same as that applied in a non-reissue application. See MPEP §§ 806 through 806.05(i). The authority to make a “restriction” requirement under 37 CFR 1.176(b) extends to and includes the authority to make an election of species.

Where a restriction requirement is made by the examiner, the original patent claims will be held to be constructively elected (except for the limited situation where a disclaimer is filed as discussed in the next paragraph). Thus, the examiner will issue an Office action in the reissue application (1) providing notification of the restriction requirement, (2) holding the added claims to be constructively non-elected and withdrawn from consideration, (3) treating the original patent claims on the merits, and (4) informing applicant that if the original claims are found allowable, and a divisional application has been filed for the non-elected claims, further action in the application will be suspended, pending resolution of the divisional application..

If a disclaimer of all the original patent claims is filed in the reissue application containing newly added claims that are separate and distinct from the original patent claims, only the newly added claims will be present for examination. In this situation, the examiner’s Office action will treat the newly added claims in the reissue application on the merits. The disclaimer of all the original patent claims must be filed in the reissue application prior to the issuance of the examiner’s Office action containing the restriction requirement, in order for the newly added claims to be treated on the merits. Once the examiner has issued the Office action providing notification of the restriction requirement and treating the patent claims on the merits, it is too late to obtain an examination on the added claims in the reissue application by filing a disclaimer of all the original patent claims. If reissue applicant wishes to have the newly added claims be treated on the merits, a divisional reissue application must be filed to obtain examination of the added claims. Reissue applicants should carefully note that once a disclaimer of the patent claims is filed, it cannot be withdrawn. It does not matter whether the reissue application is still pending, or whether the reissue application has been abandoned or issued as a reissue patent. For all these situations, 37 CFR 1.176(b) states that the disclaimer cannot be withdrawn; the disclaimer will be given effect.

Claims elected pursuant to a restriction requirement will receive a complete examination on the merits, while the non-elected claims (to any added invention(s)) will be held in abeyance in a withdrawn status, and will only be examined if filed in a divisional reissue application. If the reissue application containing only original unamended claims becomes allowable first (and no “error” under 35 U.S.C. 251exists),

further action in that reissue application will be suspended to await examination in the divisional reissue application(s) containing the added claims. Multiple suspensions (usually six-month periods) may be necessary. The Office will not permit claims to issue in a reissue application which application does not correct any error in the original patent. Once a divisional reissue application containing the added claims is examined and becomes allowable, the examiner will issue a requirement under 37 CFR 1.177(c) for applicant to merge the claims of the suspended first reissue application with the allowable claims of the divisional reissue application into a single application, by placing all of the claims in one of the applications and expressly abandoning the other. The Office action making this requirement will set a two-month period for compliance with the requirement. If applicant fails to timely respond to the Office action, or otherwise refuses to comply with the requirement made, then the divisional reissue application (claiming the invention which was non-elected in the now-suspended first reissue application) will be passed to issue alone, since the claims of the divisional reissue application, by themselves, do correct an error in the original patent. Prosecution will be reopened in the suspended first reissue application, and a rejection based on a lack of error under 35 U.S.C. 251 will then be made. This rejection may be made final, since applicant is on notice of the consequences of not complying with the merger requirement.

If the divisional reissue application becomes abandoned, prosecution will be reopened in the suspended first reissue application, and a rejection based on a lack of error under 35 U.S.C. 251 will then be made in the first reissue application. Since no error in the original patent is being corrected in the first reissue application, no reissue patent will issue.

As stated in 37 CFR 1.176(b), the examiner is not permitted to require restriction among original claims of the patent (i.e., among claims that were in the patent prior to filing the reissue application). Even where the original patent contains claims to different inventions which the examiner considers independent or distinct, and the reissue application claims the same inventions, a restriction requirement would be improper. If such a restriction requirement is made, it must be withdrawn.

Restriction between multiple inventions recited in the newly added claims will be permitted provided the added claims are drawn to several separate and distinct inventions. In such a situation, the original patent claims would be examined in the first reissue application, and applicant is permitted to file a divisional reissue application for each of the several separate and distinct inventions identified in the examiner’s restriction requirement.

A situation will sometimes arise where the examiner makes an election of species requirement between the species claimed in the original patent claims and a species of claims added in the reissue application. In such a situation, if (1) the non-elected claims to the added species depend from (or otherwise include all limitations of) a generic claim which embraces all species claims, and (2) the generic claim is found allowable, then the non-elected claims of the added species must be rejoined with the elected claims of the original patent. See MPEP § 821.04(a).

1451 Divisional Reissue Applications;Continuation Reissue Applications Where the Parent is Pending[edit | edit source]

35 U.S.C. 251. Reissue of defective patents.

The Director may issue several reissued patents for distinct and separate parts of the thing patented, upon demand of the applicant, and upon payment of the required fee for a reissue for each of such reissued patents.

37 CFR 1.177. Issuance of multiple reissue patents.

(a)The Office may reissue a patent as multiple reissue patents. If applicant files more than one application for the reissue of a single patent, each such application must contain or be amended to contain in the first sentence of the specification a notice stating that more than one reissue application has been filed and identifying each of the reissue applications by relationship, application number and filing date. The Office may correct by certificate of correction under § 1.322 any reissue patent resulting from an application to which this paragraph applies that does not contain the required notice.

(b)If applicant files more than one application for the reissue of a single patent, each claim of the patent being reissued must be presented in each of the reissue applications as an amended, unamended, or canceled (shown in brackets) claim, with each such claim bearing the same number as in the patent being reissued. The same claim of the patent being reissued may not be presented in its original unamended form for examination in more than one of such multiple reissue applications. The numbering of any added claims in any of the multiple reissue applications must follow the number of the highest numbered original patent claim.

(c)If any one of the several reissue applications by itself fails to correct an error in the original patent as required by 35 U.S.C. 251 but is otherwise in condition for allowance, the Office may suspend action in the allowable application until all issues are resolved as to at least one of the remaining reissue applications. The Office may also merge two or more of the multiple reissue applications into a single reissue application. No reissue application containing only unamended patent claims and not correcting an error in the original patent will be passed to issue by itself.

The court in In re Graff, 111 F.3d 874, 876-77, 42 USPQ2d 1471, 1473 (Fed. Cir. 1997) stated that “[t]he statute does not prohibit divisional or continuation reissue applications, and does not place stricter limitations on such applications when they are presented by reissue, provided of course that the statutory requirements specific to reissue applications are met.” Following the decision in Graff, the Office has adopted a policy of treating continuations and divisionals of reissue applications, to the extent possible, in the same manner as continuations and divisionals of non-reissue applications.

Questions relating to the propriety of divisional reissue applications and continuation reissue applications should be referred via the Technology Center (TC) Special Program Examiner to the Office of Patent Legal Administration.

I. DIVISIONAL REISSUE APPLICATIONS

37 CFR 1.176(b) permits the examiner to require restriction in a reissue application between the original claims of the patent and any newly added claims which are directed to a separate and distinct invention( s). See also MPEP § 1450. As a result of such a restriction requirement, divisional applications may be filed for each of the inventions identified in the restriction requirement.

In addition, applicant may initiate a division of the claims by filing more than one reissue application in accordance with 37 CFR 1.177. The multiple reissue applications which are filed may contain different groups of claims from among the original patent claims, or some of the reissue applications may contain newly added groups (not present in the original patent). There is no requirement that the claims of the multiple reissue applications be independent and distinct from one another; if they are not independent and distinct from one another, the examiner must apply the appropriate double patenting rejections.

There is no requirement that a family of divisional reissue applications issue at the same time; however, it is required that they contain a cross reference to each other in the specification. 37 CFR 1.177(a) requires that all multiple reissue applications resulting from a single patent must include as the first sentence of their respective specifications a cross reference to the other reissue application(s). Accordingly, the first sentence of each reissue specification must provide notice stating that more than one reissue application has been filed, and it must identify each of the reissue applications and their relationship within the family of reissue applications, and to the original patent. An example of the suggested language to be inserted is as follows:

Notice: More than one reissue application has been filed for the reissue of Patent No. 9,999,999. The reissue applications are application numbers 09/ 999,994 (the present application), 09/999,995, and 09/ 999,998, all of which are divisional reissues of Patent No. 9,999,999.

The examiner should object to the specification and require an appropriate amendment if applicant fails to include such a cross reference to the other reissue applications in the first sentence of the specification of each of the reissue applications.

In addition to the amendment to the first sentence of the specification, the reissue application cross references will also be reflected in the file. For an IFW reissue application file, a copy of the bibliographic data sheet from the IFW file history should be printed and the examiner should annotate the printed sheet such that adequate notice is provided that more than one reissue application has been filed for a single original patent. The annotated sheet should be scanned into IFW. For reissue application files that are maintained in paper, the bibliographic data sheet should be reprinted (for 09/ and later series), or the front face of the reissue file wrapper should be marked (for 08/ and earlier series), for all the multiple reissue applications, so that adequate notice is provided that more than one reissue application has been filed for a single original patent.

Pursuant to 37 CFR 1.177(b) all of the claims of the patent to be reissued must be presented in each reissue application in some form, i.e., as amended, as unamended or as canceled. Further, any added claims must be numbered beginning with the next highest number following the last patent claim. It is noted that the same claim of the patent cannot be presented for examination in more than one of the divisional reissue applications, as a pending claim, in either its original or amended versions. Once a claim in the patent has been reissued, it does not exist in the original patent; thus, it cannot be reissued from the original patent in another reissue application. If the same claim of the patent, e.g., patent claim 1 is presented for examination in more than one of the reissue applications, in different amended versions, the following rejections should be made in the reissue applications with that patent claim:

A rejection under 35 U.S.C. 251, in that the reissue application is not correcting an error in the original patent, because original claim 1 would be superseded by the reissuance of claim 1 in the other reissue application.

A rejection under 35 U.S.C. 112, in that claim 1 is indefinite because the invention of claim 1 is not particularly pointed out and distinctly claimed. Claim 1 presents one coverage in divisional reissue application X and another in the present reissue application. This is inconsistent.

The reissue applicant should then be advised to follow a procedure similar to the following example:

If there are patent claims 1 – 10 in two divisional reissue applications and an applicant wishes to revise claim 1, which is directed to AB (for example) to ABC in one divisional reissue application, and to ABD in a second divisional reissue application, applicant should do the following: Claim 1 in the first divisional reissue application can be revised to recite ABC. Claim 1 in the second divisional reissue application would be canceled, and new claim 11 would be added to recite ABD. The physical cancellation of claim 1 in the second divisional reissue application will not prejudice applicant’s rights in the amended version of claim 1 since those rights are retained via the first reissue application. Claim 1 continues to exist in the first reissue application, and both the first and second reissue applications taken together make up the totality of the correction of the original patent.

If the same or similar claims are presented in more than one of the multiple reissue applications, the possibility of statutory double patenting (35 U.S.C. 101) or non-statutory (judicially created doctrine) double patenting should be considered by the examiner during examination, and the appropriate rejections made. A terminal disclaimer may be filed to overcome an obviousness type double patenting rejection. The terminal disclaimer is necessary in order to ensure common ownership of the reissue patents throughout the remainder of the unexpired term of the original patent. Whenever a divisional reissue application is filed with a copy of the oath/declaration and assignee consent from the parent reissue application, the copy of the assignee consent from the parent reissue application should not be accepted. The copy of the consent from the parent reissue application does not indicate that the assignee has consented to the addition of the new invention of the divisional reissue application to the original patent. The Office of Initial Patent Examination (OIPE) should accord a filing date and send out a notice of missing parts stating that there is no proper consent and setting a period of time for filing the missing part and for payment of any surcharge required under 37 CFR 1.53(f) and 1.16(f). See MPEP § 1410.01. The copy of the reissue oath/declaration should be accepted by OIPE, since it is an oath/ declaration, even though it may be improper under 35 U.S.C. 251. The examiner should check the copy of the oath/declaration to ensure that it identifies an error being corrected by the divisional reissue application. The copy of the oath/declaration from the parent reissue application may or may not cover the error being corrected by the divisional reissue application since the divisional reissue application is (by definition) directed to a new invention. If it does not, the examiner should reject the claims of the divisional reissue application under 35 U.S.C. 251 as being based on an oath/declaration that does not identify an error being corrected by the divisional reissue application, and require a new oath/declaration. See MPEP § 1414. If the copy of the reissue oath/declaration from the parent reissue application does in fact cover an error being corrected in the divisional reissue application, no such rejection should be made. However, since a new invention is being added by the filing of the divisional reissue application, a supplemental reissue oath/declaration pursuant to 37 CFR 1.175 (b)(1) will be required. See MPEP § 1414.01.

Situations yielding divisional reissues occur infrequently and usually involve only two such files. It should be noted, however, that in rare instances in the past, there have been more than two (and as many as five) divisional reissues of a patent. For treatment of a plurality of divisional reissue applications resulting from a requirement to restrict to distinct inventions or a requirement to elect species, see MPEP § 1450.

II. CONTINUATION REISSUE APPLI- CATIONS

A continuation of a reissue is not ordinarily filed “for distinct and separate parts of the thing patented” as called for in the second paragraph of 35 U.S.C. 251. The decision of In re Graff, 111 F.3d 874, 42 USPQ2d 1471 (Fed. Cir. 1997) interprets 35 U.S.C. 251 to permit multiple reissue patents to issue even where the multiple reissue patents are not for “distinct and separate parts of the thing patented.” The court stated:

Section 251[2] is plainly intended as enabling, not as limiting. Section 251[2] has the effect of assuring that a different burden is not placed on divisional or continuation reissue applications, compared with divisions and continuations of original applications, by codifying the Supreme Court decision which recognized that more than one patent can result from a reissue proceeding. Thus § 251[2] places no greater burden on Mr. Graff’s continuation reissue application than upon a continuation of an original application; § 251[2] neither overrides, enlarges, nor limits the statement in § 251[3] that the provisions of Title 5 apply to reissues.

111 F.3d at 877, 42 USPQ2d at 1473. Accordingly, prosecution of a continuation of a reissue application will be permitted (despite the existence of the pending parent reissue application) where the continuation complies with the rules for reissue.

The parent and the continuation reissue applications should be examined together if possible. In order that the parent-continuation relationship of the reissue applications be specifically identified and notice be provided of both reissue applications for both the parent and the continuation reissue applications, the following is done:

(A) An appropriate amendment to the continuing data entries must be made to the first sentence of the specification, (see the discussion above under the heading “Divisional Reissue Applications”).

(B)For an IFW reissue application file, a copy of the bibliographic data sheet from the IFW file history should be printed and the examiner should annotate the printed sheet such that adequate notice is provided that more than one reissue application has been filed for a single original patent. The annotated sheet should be scanned into IFW. For reissue application files that are maintained in paper, the bibliographic data sheet should be reprinted (for 09/ and later series), or the front face of the reissue file wrapper should be marked (for 08/ and earlier series), for all the multiple reissue applications, so that adequate notice is provided that more than one reissue application has been filed for a single original patent.

As is true for the case of multiple divisional reissue applications, all of the claims of the patent to be reissued must be presented in both the parent reissue application and the continuation reissue application in some form, i.e., as amended, as unamended, or as canceled. The same claim of the patent cannot, however be presented for examination in both the parent reissue application and the continuation reissue application, as a pending claim, in either its original or amended versions. See the discussion in subsection I. above for treatment of this situation. Further, any added claims must be numbered beginning with the next highest number following the past patent claims.

Where the parent reissue application issues prior to the examination of the continuation, the claims of the continuation should be carefully reviewed for double patenting over the claims of the parent. Where the parent and the continuation reissue applications are examined together, a provisional double patenting rejection should be made in both cases as to any overlapping claims. See MPEP § 804 - §

804.04 as to double patenting rejections. Any terminal disclaimer filed to obviate an obviousness-type double patenting rejection ensures common ownership of the reissue patents throughout the remainder of the unexpired term of the original patent.

If the parent reissue application issues without any cross reference to the continuation, amendment of the parent reissue patent to include a cross-reference to the continuation must be effected at the time of allowance of the continuation application by Certificate of Correction. See the discussion above under the heading “Divisional Reissue Applications” as to how the Certificate of Correction is to be provided.

Again, the examiner should make reference in the pending divisional reissue application to the fact that an actual request for a Certificate of Correction has been generated in the first reissue patent pursuant to 37 CFR 1.177(a), e.g., by an entry in the search notes or in an examiner’s amendment.

Where a continuation reissue application is filed with a copy of the oath/declaration and assignee consent from the parent reissue application, and the parent reissue application is not to be abandoned, the copy of the consent of the parent reissue application should not be accepted. The copy of the consent of the parent reissue application does not indicate that the assignee has consented to the addition of the new error correction of the continuation reissue application to the original patent. Presumably, a new correction has been added, since the parent reissue application is still pending. OIPE should accord a filing date and send out a notice of missing parts stating that there is no proper consent and setting a period of time for filing the missing part and for payment of any surcharge required under 37 CFR 1.53(f) and 1.16(f). See MPEP § 1410.01. The copy of the reissue oath/declaration should be accepted by OIPE, since it is a oath/declaration, albeit improper under 35 U.S.C. 251. The examiner should reject the claims of the continuation reissue application under 35 U.S.C. 251 as being based on an oath/declaration that does not identify an error being corrected by the continuation reissue application, and should require a new oath/declaration. See 37 CFR 1.175(e). One of form paragraphs 14.01.01 through 14.01.03 may be used. See MPEP § 1414.

Where a continuation reissue application is filed with a copy of the oath/declaration and assignee consent from the parent reissue application, and the parent reissue application is, or will be abandoned, the copy of the consent should be accepted by both OIPE and the examiner. The reissue oath/declaration should be accepted by OIPE, and the examiner should check to ensure that the oath/declaration identifies an error that is being corrected in the continuation reissue application. See MPEP § 1414. If a preliminary amendment was filed with the continuation reissue application, the examiner should check for the need of a supplemental reissue oath/declaration. Pursuant to 37 CFR 1.175 (b)(1), for any error corrected via the preliminary amendment which is not covered by the oath or declaration submitted in the parent reissue application, applicant must submit a supplemental oath/declaration stating that every such error arose without any deceptive intention on the part of the applicant. See MPEP § 1414 and § 1414.01.

1452 Request for Continued Examination of Reissue Application[edit | edit source]

A request for continued examination (RCE) under 37 CFR 1.114 is available for a reissue application. Effective May 29, 2000, an applicant in a reissue application may file a request for continued examination of the reissue application, if the reissue application was filed on or after June 8, 1995. This applies even where the application, which resulted in the original patent, was filed prior to June 8, 1995.

An RCE continues the prosecution of the existing reissue application and is not a filing of a new reissue application. Thus, the filing of an RCE will not be announced in the Official Gazette. Additionally, if a reissue application is merged with a reexamination proceeding (see MPEP § 1449.01), the filing of an RCE will not dissolve the merger, since the reissue application does not become abandoned.

1453 Amendments to Reissue Applications[edit | edit source]

37 CFR 1.121. Manner of making amendments in application.

(i)Amendments in reissue applications. Any amendment to the description and claims in reissue applications must be made in accordance with § 1.173.

37 CFR 1.173. Reissue specification, drawings, and amendments.

(b)Making amendments in a reissue application. An amendment in a reissue application is made either by physically incorporating the changes into the specification when the application is filed, or by a separate amendment paper. If amendment is made by incorporation, markings pursuant to paragraph (d) of this section must be used. If amendment is made by an amendment paper, the paper must direct that specified changes be made, as follows:

(1)Specification other than the claims. Changes to the specification, other than to the claims, must be made by submission of the entire text of an added or rewritten paragraph, including markings pursuant to paragraph (d) of this section, except that an entire paragraph may be deleted by a statement deleting the paragraph without presentation of the text of the paragraph. The precise point in the specification must be identified where any added or rewritten paragraph is located. This paragraph applies whether the amendment is submitted on paper or compact disc (see §§ 1.52(e)(1) and 1.821(c), but not for discs submitted under § 1.821(e)).

(2)Claims. An amendment paper must include the entire text of each claim being changed by such amendment paper and of each claim being added by such amendment paper. For any claim changed by the amendment paper, a parenthetical expression “amended,” “twice amended,” etc., should follow the claim number. Each changed patent claim and each added claim must include markings pursuant to paragraph (d) of this section, except that a patent claim or added claim should be canceled by a statement canceling the claim without presentation of the text of the claim.

(3)Drawings. One or more patent drawings shall be amended in the following manner: Any changes to a patent drawing must be submitted as a replacement sheet of drawings which shall be an attachment to the amendment document. Any replacement sheet of drawings must be in compliance with § 1.84 and shall include all of the figures appearing on the original version of the sheet, even if only one figure is amended. Amended figures must be identified as “Amended,” and any added figure must be identified as “New.” In the event that a figure is canceled, the figure must be surrounded by brackets and identified as “Canceled.” All changes to the drawing(s) shall be explained, in detail, beginning on a separate sheet accompanying the papers including the amendment to the drawings.

(i)A marked-up copy of any amended drawing figure, including annotations indicating the changes made, may be included. The marked-up copy must be clearly labeled as “Annotated Marked-up Drawings” and must be presented in the amendment or remarks section that explains the change to the drawings.

(ii)A marked-up copy of any amended drawing figure, including annotations indicating the changes made, must be provided when required by the examiner.

(c)Status of claims and support for claim changes. Whenever there is an amendment to the claims pursuant to paragraph (b) of this section, there must also be supplied, on pages separate from the pages containing the changes, the status (i.e., pending or canceled), as of the date of the amendment, of all patent claims and of all added claims, and an explanation of the support in the disclosure of the patent for the changes made to the claims.

(d)Changes shown by markings. Any changes relative to the patent being reissued which are made to the specification, including the claims, upon filing, or by an amendment paper in the reissue application, must include the following markings:

(1)The matter to be omitted by reissue must be enclosed in brackets; and

(2)The matter to be added by reissue must be underlined, except for amendments submitted on compact discs (§§ 1.96 and 1.821(c)). Matter added by reissue on compact discs must be preceded with “U” and end with “/U” to properly identify the material being added.

(e)Numbering of patent claims preserved. Patent claims may not be renumbered. The numbering of any claim added in the reissue application must follow the number of the highest numbered patent claim.

(f)Amendment of disclosure may be required. The disclosure must be amended, when required by the Office, to correct inaccuracies of description and definition, and to secure substantial correspondence between the claims, the remainder of the specification, and the drawings.

(g)Amendments made relative to the patent. All amendments must be made relative to the patent specification, including the claims, and drawings, which are in effect as of the date of filing of the reissue application.

The provisions of 37 CFR 1.173(b)-(g) and those of 37 CFR 1.121(i) apply to amendments in reissue applications. Any amendments submitted in a reissue application must comply with 37 CFR 1.173(b).

Amendments submitted in a reissue application, including preliminary amendments (i.e., amendments filed as a separate paper to accompany the filing of a reissue application), must comply with the practice outlined below in this section; however, for examiner’s amendments to the specification and claims, 37 CFR 1.121(g) provides certain exceptions to that practice in the interest of expediting prosecution. The exceptions set forth in 37 CFR 1.121(g) also apply in reissue applications.

Pursuant to 37 CFR 1.173(a), no amendment in a reissue application may enlarge the scope of the claims, unless “applied for within two years from the grant of the original patent.” Further, the amendment may not introduce new matter. See MPEP § 1412.03for further discussion as to the time limitation on enlarging the scope of the patent claims in a reissue application.

All amendment changes must be made relative to the patent to be reissued. Pursuant to 37 CFR 1.173(d), any such changes which are made to the specification, including the claims, must be shown by employing the following “markings:”

(A)The matter to be omitted by reissue must be enclosed in brackets; and

(B)The matter to be added by reissue must be underlined, except for amendments submitted on compact discs (pursuant to 37 CFR 1.96 for computer printouts or programs, and 37 CFR 1.825 for sequence listings). Matter added by reissue on compact discs must be preceded with “U” and end with “/U” to properly identify the material being added.

I.THE SPECIFICATION

37 CFR 1.173(b)(1) relates to the manner of making amendments to the specification other than the claims. It is not to be used for making amendments to the claims or the drawings.

All amendments which include any deletions or additions must be made by submission of the entire text of each added or rewritten paragraph with markings (as defined above), except that an entire paragraph of specification text may be deleted by a statement deleting the paragraph without presentation of the text of the paragraph. Applicant must indicate the precise point where each amendment is made. All bracketing and underlining is made in comparison to the original patent, not in comparison to any prior amendment in the reissue application. Thus, all paragraphs which are newly added to the specification of the original patent must be submitted as completely underlined each time they are re-submitted in the reissue application.

II.THE CLAIMS

37 CFR 1.173(b)(2) relates to the manner of making amendments to the claims in reissue applications. It is not to be used for making amendments to the remainder of the specification or to the drawings. 37 CFR 1.173(b)(2) requires that:

(A)For each claim that is being amended by the amendment being submitted (the current amendment), the entire text of the claim must be presented with markings as defined above;

(B)For each new claim added to the reissue by the amendment being submitted (the current amendment), the entire text of the added claim must be presented completely underlined;

(C)A patent claim should be canceled by a direction to cancel that claim, there is no need to present the patent claim surrounded by brackets; and

(D)A new claim (previously added in the reissue) should be canceled by a direction to cancel that claim.

Original patent claims are never to be renumbered; see 37 CFR 1.173(e). A patent claim retains its number even if it is canceled in the reissue proceeding, and the numbering of any added claims must begin after the last original patent claim.

Pursuant to 37 CFR 1.173(c), each amendment submitted must set forth the status of all patent claims and all added claims as of the date of the submission. The status to be set forth is whether the claim is pending or canceled. The failure to submit the claim status will generally result in a notification to applicant that the amendment prior to final rejection is not completely responsive (see 37 CFR 1.135(c)). Such an amendment after final rejection will not be entered.

Also pursuant to 37 CFR 1.173(c), each claim amendment must be accompanied by an explanation of the support in the disclosure of the patent for the amendment (i.e., support for all changes made in the claim(s), whether insertions or deletions). The failure to submit an explanation will generally result in a notification to applicant that the amendment prior to final rejection is not completely responsive (see 37 CFR 1.135(c)). Such an amendment after final rejection will not be entered.

III.THE DRAWINGS

37 CFR 1.173(a)(2) states that amendments to the original patent drawings are not permitted, and that any change to the drawings must be by way of 37 CFR 1.173(b)(3). See MPEP § 1413 for the manner of making amendments to the drawings in a reissue application.

IV.ALL CHANGES ARE MADE VIS-À-VISTHE PATENT TO BE REISSUED

When a reissue patent is printed, all underlined matter is printed in italics and all brackets are printed as inserted in the application, in order to show exactly which additions and deletions have been made to the patent being reissued. Therefore, all underlining and bracketing in the reissue application should be made relative to the text of the patent, as follows. In accordance with 37 CFR 1.173(g), all amendments in the reissue application must be made relative to (i.e., vis-à-vis) the patent specification in effect as of the date of the filing of the reissue application. The patent specification includes the claims and drawings. If there was a prior change to the patent (made via a prior concluded reexamination certificate, reissue of the patent, certificate of correction, etc.), the first amendment of the subject reissue application must be made relative to the patent specification as changed by the prior proceeding or other mechanism for changing the patent. All amendments subsequent to the first amendment must also be made relative to the patent specification in effect as of the date of the filing of the reissue application, and not relative to the prior amendment.

The Subject Patent Already Has Underlining or Bracketing

If the original (or previously changed) patent includes a formula or equation already having underlining or bracketing therein as part of the formula or equation, any amendment of such formula or equation should be made by bracketing the entire formula and rewriting and totally underlining the amended formula in the re-presented paragraph of the specification or rewritten claim in which the changed formula or equation appears. Amendments of segments of a formula or equation should not be made. If the original patent includes bracketing and underlining from an earlier reexamination or reissue, double brackets and double underlining should be used in the subject reissue application to identify and distinguish the present changes being made. The subject reissue, when printed, would include double brackets (indicating deletions made in the subject reissue) and boldface type (indicating material added in the subject reissue).

V.EXAMPLES OF PROPER AMENDMENTS

A substantial number of problems arise in the Office because of improper submission of amendments in reissue applications. The following examples are provided to assist in preparation of proper amendments to reissue applications.

A.Original Patent Description or Patent Claim Amended

Example (1)

If it is desired to change the specification at column 4 line 23, to replace “is” with --are--, submit a copy of the entire paragraph of specification of the patent being amended with underlining and bracketing, and point out where the paragraph is located, e.g.,

Replace the paragraph beginning at column 4, line 23 with the following:

Scanning [is] are controlled by clocks which are, in turn, controlled from the display tube line synchronization. The signals resulting from scanning the scope of the character are delivered in parallel, then converted into serial mode through a shift register wherein the shift signal frequency is controlled by a clock that is, in turn, controlled from the display tube line synchronization.

Example (2)

For changes to the claims, one must submit a copy of the entire patent claim with the amendments shown by underlining and bracketing, e.g.,

Amend claim 6 as follows:

Claim 6 (Amended). The apparatus of claim [5] 1 wherein the [first] second piezoelectric element is parallel to the [second] third piezoelectric element.

If the dependency of any original patent claim is to be changed by amendment, it is proper to make that original patent claim dependent upon a later filed higher numbered claim.

B.Cancellation of Claim(s)

Example (3)

To cancel an original patent claim, in writing, direct cancellation of the patent claim, e.g.,

Cancel claim 6.

Example (4)

To cancel a new claim (previously added in the reissue), in writing, direct cancellation of the new claim, e.g.,

Cancel claim 15.

C.Presentation of New Claims

Example (5)

Each new claim (i.e., a claim not found in the patent, that is newly presented in the reissue application) should be presented with underlining throughout the claim, e.g.,

Add claim 7 as follows:

Claim 7. The apparatus of claim 5 further comprising electrodes attaching to said opposite faces of the first and second piezoelectric elements.

Even though original claims may have been canceled, the numbering of the original claims does not change. Accordingly, any added claims are numbered beginning with the number next higher than the number of claims in the original patent. If new claims have been added to the reissue application which are later canceled prior to issuance of the reissue patent, the examiner will renumber any remaining new claims in numerical order to follow the number of claims in the original patent.

D.Amendment of New Claims

An amendment of a “new claim” (i.e., a claim not found in the patent, that was previously presented in the reissue application) must be done by presenting the amended “new claim” containing the amendatory material, and completely underlining the claim. The presentation cannot contain any bracketing or other indication of what was in the previous version of the claim. This is because all changes in the reissue are made vis-à-vis the original patent, and not in comparison to the prior amendment. Although the presentation of the amended claim does not contain any indication of what is changed from the previous version of the claim, applicant must point out what is changed in the “Remarks” portion of the amendment. Also, per 37 CFR 1.173(c), each change made in the claim must be accompanied by an explanation of the support in the disclosure of the patent for the change.

E.Amendment of Original Patent Claims More Than Once

The following illustrates proper claim amendment of original patent claims in reissue applications:

A. Patent claim.

Claim 1. A cutting means having a handle portion and a blade portion.

B. Proper first amendment format.

Claim 1 (Amended). A [cutting means] knife having a bone handle portion and a notched blade portion.

C. Proper second amendment format.

Claim 1 (Twice Amended). A [cutting means] knife having a handle portion and a serrated blade portion.

Note that the second amendment must include the changes previously presented in the first amendment, i.e., [cutting means] knife, as well as the new changes presented in the second amendment, i.e., serrated.

The word bone was presented in the first amendment and is now to be deleted in the second amendment. The word "bone" is NOT to be shown in brackets in the second amendment. Rather, the word "bone" is simply omitted from the claim, since "bone" never appeared in the patent. An explanation of the deletion should appear in the remarks.

The word notched which was presented in the first amendment is replaced by the word serrated in the second amendment. The word notched is being deleted in the second amendment and did not appear in the patent; accordingly, "notched" is not shown in any form in the claim. The word serrated is being added in the second amendment, and accordingly "serrated" is added to the claim and is underlined.

In the second amendment, the deletions of "notched" and "bone" are not changes from the original patent claim text and therefore are not shown in brackets in the second amendment. In both the first and the second amendments, the entire claim is presented only with the changes from the original patent text.

VI.ADDITIONAL EXAMPLES

(A)For a reissue application, where the patent was previously reissued:

As per MPEP § 1411, double underlining and double bracketing are used in the second reissue application to show amendments made relative to the first reissued patent

(B)For a reissue application, where the patent was previously reexamined and a reexamination certificate has issued for the patent:

An amendment in the reissue application must be presented as if the changes made to the original patent text via the reexamination certificate are a part of the original patent. Thus, all italicized text of the reexamination certificate is presented in the amendment (made in the reissue application) without italics. Further, any text found in brackets in the reexamination certificate is omitted in the amendment (made in the reissue application).

(C)For a reissue application, where a certificate of correction has issued for the patent:

An amendment in the reissue application must be presented as if the changes made to the original patent text via the certificate of correction are a part of the original patent. Thus, all text added by certificate of correction is presented in the amendment (made in the reissue application) without italics. Further, any text deleted by certificate of correction is entirely omitted in the amendment (made in the reissue application).

(D)For a reissue application, where a statutory disclaimer has issued for the patent:

Any claim statutorily disclaimed is no longer in the patent, and such a claim cannot be amended. The statutorily disclaimed claim(s) should be lined through, and not surrounded by brackets.

1454 Appeal Brief[edit | edit source]

The requirements for an appeal brief are set forth in 37 CFR 41.37 and MPEP § 1206, and they apply to a reissue application in the same manner that they apply to a non-reissue application. There is, however, a difference in practice as to presentation of the copy of the claims in the appeal brief for a reissue application. The claims on appeal presented in an appeal brief for a reissue application should include all underlining and bracketing necessary to reflect the changes made to the patent claims during the prosecution of the reissue application. In addition, any new claims added in the reissue application should be completely underlined.

1455 Allowance and Issue[edit | edit source]

I.ISSUE CLASSIFICATION SHEET

For IFW reissue applications:

The examiner completes the Issue Classification sheet in the same manner as for a non-reissue application. In addition, a copy of the “Final SPRE Review” form must also be completed.

For reissue application files that are maintained in paper:

In all reissue applications prepared for issue where a blue slip is needed (i.e., 08/ and earlier series), the patent number of the original patent which is being reissued should be placed in the box provided therefor below the box for the applicant’s name on the blue Issue Classification Slip (form PTO-270) or design Issue Classification Slip (form PTO-328). Otherwise, the Issue Classification Slip is prepared in the same manner as for a non-reissue application.

II. CHANGES TO THE ORIGINAL PATENT

The specifications of reissue patents will be printed in such a manner as to show the changes over the original patent text by enclosing any material omitted by the reissue in heavy brackets [ ] and printing material added by the reissue in italics. 37 CFR 1.173 (see MPEP § 1411) requires the specification of a reissue application to be presented in a specified form, specifically designed to facilitate this different manner of printing, as well as for other reasons.

The printed reissue patent specification will carry the following heading, which will be added by the Publishing Division of the Office of Patent Publication:

“Matter enclosed in heavy brackets [ ] appears in the original patent but forms no part of this reissue specification; matter printed in italics indicates the additions made by reissue.”

The examiners should see that the specification is in proper form for printing. Examiners should carefully check the entry of all amendments to ensure that the changes directed by applicant will be accurately printed in any reissue patent that may ultimately issue. Matter appearing in the original patent which is omitted by reissue should be enclosed in brackets, while matter added by reissue should be underlined.

Any material added by amendment in the reissue application (as underlined text) which is later canceled should be crossed through, and not bracketed. Material cancelled from the original patent should be enclosed in brackets, and not lined through.

All the claims of the original patent should appear in the reissue patent, with canceled patent claims being enclosed in brackets.

III. CLAIM NUMBERING

No renumbering of the original patent claims is permitted, even if the dependency of a dependent patent claim is changed by reissue so that it is to be dependent on a subsequent higher numbered claim.

When a dependent claim in a reissue application depends upon a claim which has been canceled, and the dependent claim is not thereafter made dependent upon a pending claim, such a dependent claim must be rewritten in independent form.

New claims added during the prosecution of the reissue application should follow the number of the highest numbered patent claim and should be completely underlined to indicate they are to be printed in italics on the printed patent. Often, as a result of the prosecution and examination, some new claims are canceled while other new claims remain. When the reissue application is allowed, any claims remaining which are additional to the patent claims (i.e., claims added via the reissue application) should be renumbered in sequence starting with the number next higher than the number of the last claim in the original patent (the printed patent). Therefore, the number of claims allowed will not necessarily correspond to the number of the last claim in the reissue application, as allowed. The number of claims appearing in the “Total Claims Allowed” box on the Issue Classification sheet (or for reissue application files that are maintained in paper, the “CLAIMS ALLOWED - Total Claims” box on the lower right of the file wrapper face) at the time of allowance should be consistent with the number of claims indicated as allowable on the Notice of Allowability (Form PTOL-37).

IV. CLAIM DESIGNATED FOR PRINTING

At least one claim of an allowable reissue application must be designated for printing in the Official Gazette. Whenever at least one claim has been amended or added in the reissue, the claim (claims) designated for printing must be (or include) a claim which has been changed or added by the reissue. A canceled claim is not to be designated as the claim for the Official Gazette.

If there is no change in the claims of the allowable reissue application (i.e., when they are the same as the claims of the original patent) or, if the only change in the claims is the cancellation of claims, then the most representative pending allowed claim is designated for printing in the Official Gazette.

V. PROVIDING PROPER FORMAT

Where a reissue application has not been prepared in the above-indicated manner, the examiner may obtain from the applicant a clean copy of the reissue specification prepared in the indicated form, or a proper submission of a previously improperly submitted amendment. However, if the deletions from the original patent are small, the reissue application can be prepared for issue by putting the bracketed inserts at the appropriate places and suitably numbering the added claims.

When applicant submits a clean copy of the reissue specification, or a proper submission of a previous improper amendment, a supplemental reissue declaration should not be provided to address this submission, because the correction of format does not correct a 35 U.S.C. 251 error in the patent.

VI. PARENT APPLICATION DATA

All parent application data on the bibliographic data sheet of the original patent file (or front face of the original patent file wrapper if the original patent is a paper file) should be present on the bibliographic data sheet of the reissue application.

It sometimes happens that the reissue is a continuation of another reissue application, and there is also original-patent parent application data. The examiner should ensure that the parent application data on the original patent is properly combined with the parent application data of the reissue, in the text of the specification and on the bibliographic data sheet (or on the front face of the reissue file wrapper for 08/ and earlier series applications). The combined statement as to parent application data should be checked carefully for proper bracketing and underlining.

VII. REFERENCES CITED AND PRINTED

The list of references to be printed in the reissue patent includes all the references cited during the prosecution of the reissue application. It is noted that the Office will not print in the reissue patent “References Cited” section any reference cited in the patent but not again cited in the reissue application. A patent cannot be reissued solely for the purpose of adding citations of additional prior art.

VIII. EXAMINER'S AMENDMENT AND SUP- PLEMENTAL DECLARATION

When it is necessary to amend the reissue application in order to place the application in condition for allowance, the examiner may:

(A)request that applicant provide the amendments (e.g., by facsimile transmission or by hand- carry); or

(B)make the amendments, with the applicant’s approval, by a formal examiner’s amendment.

If the changes are made by a formal examiner’s amendment, the entire paragraph(s) or claim(s) being amended need not be presented in rewritten form for any deletions or additions. Changes to the specification including the claims of an application made by the Office in an examiner’s amendment may be made by specific instructions to insert or delete subject matter set forth in the examiner’s amendment by identifying the precise point in the specification or the claim(s) where the insertion or deletion is to be made. 37 CFR 1.121(g).

If it is necessary to amend a claim or the specification in order to correct an “error” under 35 U.S.C. 251and thereby place the application in condition for allowance, then a supplemental oath or declaration will be required. See MPEP § 1444. The examiner should telephone applicant and request the supplemental oath or declaration, which must be filed before the application can be counted as an allowance.

IX. FINAL REVIEW OF THE REISSUE APPLICATION BY THE EXAMINER

Prior to forwarding a reissue application to the Technology Center (TC) Special Program Examiner (SPRE) for final review, the examiner should complete and initial an Examiner Reissue Checklist. A copy of the checklist should be available from the SPRE or from the Paralegal Specialist of the TC.

1456 Reissue Review[edit | edit source]

All reissue applications are monitored and reviewed in the Technology Centers (TCs) by the Office of TC Special Program Examiners (which includes TC SPREs, paralegals or other technical support who might be assigned as backup) at several stages during the prosecution. The review by the Office of the TC SPREs is made to check that practice and procedure unique to reissue has been carried out for the reissue application. In addition to the SPRE review of the reissue applications, a patentability review is made in a sample of reissue applications by the TC Quality Assurance Specialist (QAS) in the manner previously carried out by the former Office of Patent Quality Review. In order to ensure that SPREs are aware of the reissue applications in their TCs, a pair of terminal-specific PALM flags have been created which must be set by the SPRE before certain PALM transactions can be completed. First, when a new reissue application enters the TC, a SPRE must set a PALM “flag” by entering the reissue application number in an Office-wide computer grouping before a docketing transaction will be accepted. By having to set this first flag, the SPRE is made aware of the assignment of the reissue application to the TC and can take steps, as may be appropriate, to instruct the examiner on reissue-specific procedures before the examination process begins, as well as throughout the period that the examiner is handling the reissue application. Second, the SPRE must remove the above- described PALM “flag” before a Notice of Allowance can be generated or the PALM transaction for an issue revision can be entered, thereby ensuring that the SPRE is made aware of when the reissue application is being allowed so that the SPRE may be able to conduct a final review of the reissue application, if appropriate.

When the reissue application has been reviewed and is ready to be released to issue, the TC SPRE should do the following:

1457 Design Reissue Applications and Patents[edit | edit source]

A reissue application can be filed for a design patent in the same manner that a reissue application is filed for a utility patent. There are, however, a few aspects of a design reissue application that are addressed as follows:

I.EXPEDITED EXAMINATION PROCE- DURE

Design reissue applications requesting expedited examination and complying with the requirements of 37 CFR 1.155 are examined with priority and undergo expedited processing throughout the entire course of prosecution in the Office, including appeal, if any, to the Board of Patent Appeals and Interferences. All processing is expedited from the date the request is granted.

Design reissue applicants seeking expedited examination may file a design reissue application in the Office together with a corresponding request under 37 CFR 1.155 pursuant to the guidelines set forth in MPEP § 1504.30.

The design reissue application and the request are processed by the Office of Initial Patent Examination (OIPE). OIPE enters the appropriate information into PALM specifying when notice of the design reissue application will be published in the Official Gazette (see MPEP § 1441). After processing in OIPE, the design reissue application and the request are forwarded to the Design TC Director’s Office. Upon a decision by the Design TC Director to grant the request for expedited examination, fees are immediately processed, and the application papers are promptly assigned an application number. The design reissue application file is then forwarded to the Office of Patent Legal Administration (OPLA) for a decision under 37 CFR 1.182 to sua sponte waive the requirement for delaying action in the application until 2 months after announcement of the design reissue application filing is published in the Official Gazette(see MPEP § 1441). Once the decision under 37 CFR 1.182 is mailed, the design reissue application file will be returned to the Design TC Director’s Office. In accordance with the waiver, the Design Group will begin expedited examination of the application under 37 CFR 1.155 promptly after the return of the design reissue application file from OPLA, rather than delay examination until after 2 months from the date the announcement is published in the Official Gazette and the applicant will be notified that examination is being expedited. The decision under 37 CFR 1.182will require that no Notice of Allowance be mailed in the design reissue application until after 2 months from the date the announcement is published in the Official Gazette. For example, if the design reissue




application is allowed on the first Office action, then jurisdiction over the reissue application will be retained in the TC, and the Notice of Allowance will not be mailed until the expiration of 2 months after publication of the filing of the design reissue application in the Official Gazette (plus time for matching any protest filed with the application). (For IFW processing, see IFW Manual.) The examiner will check the PALM contents to ascertain when publication actually occurred. The delay in the mailing of the Notice of Allowance is to ensure that any potential protests complying with 37 CFR 1.291 submitted within the 2-month delay period will be considered by the Office. (see MPEP § 1441.01).

The expedited examination procedure under 37 CFR 1.155 occurs through initial examination processing and throughout the entire prosecution in the Office. Once a request for expedited examination is granted, prosecution of the design reissue application will proceed according to the procedure under 37 CFR 1.155, and there is no provision for “withdrawal” from expedited examination procedure.

II.DESIGN REISSUE FEE

The design reissue application fee is set forth for in 37 CFR 1.16(e). For design reissue applications filed on or after December 8, 2004, a search fee (37 CFR 1.16(n)) and an examination fee (37 CFR 1.16(r)) are also required. The additional fees in 37 CFR 1.16(h) and 37 CFR 1.16(i) do not apply for a design reissue application since more than one claim in not permitted in a design application pursuant to the last sentence of 37 CFR 1.153(a).

The fee for issuing a design reissue patent is set forth in 37 CFR 1.18(a).

III.MULTIPLE DESIGN REISSUE APPLICATIONS


The design reissue application can be filed based on the “error” of failing to include a design for a patentably distinct segregable part of the design claimed in the original patent or a patentably distinct subcombination of the claimed design. A reissue design application claiming both the entire article and the patentably distinct subcombination or segregable part would be proper under 35 U.S.C. 251, if such a reissue application is filed within two years of the issuance of the design patent, since it is considered a broadening of the scope of the patent claim. Restriction will be required under 37 CFR 1.176(b) in such a reissue design application, and the added design to the segregable part or subcombination will be held to be constructively non-elected and withdrawn from consideration. See MPEP § 1450. In the Office action containing the restriction requirement, the examiner should suggest to the applicant that a divisional design reissue application directed to the constructively non-elected segregable part or subcombination subject matter may be filed. The claim to the patented design for the entire article will then be examined and, if found allowable without change from the patent, a rejection will be made under 35 U.S.C. 251 based on the fact that there is no “error” in the non-amended original patent claim. In the Office action making this rejection, applicant should be advised that a proper response to the rejection must include (A) a request to suspend action in this original reissue application pending completion of examination of a divisional reissue application directed to the constructively non- elected segregable part or subcombination subject matter, (B) the filing of the divisional reissue application, or a statement that one has already been filed (identifying it at least by application number), and (C) an argument that a complete response to the rejection has been made based upon the filing of the divisional reissue application and the request for suspension. Action in the original design reissue application will then be suspended, and the divisional will be examined.


If, after examination, the divisional design reissue application is also determined to be allowable, a requirement must be made in the divisional design reissue application to submit a petition under 37 CFR 1.183 requesting waiver of 37 CFR 1.153 in order to permit the rejoining of the designs to the entire article (of the original application) and the segregable part or subcombination (of the divisional) under a single claim into a single design reissue application for issuance, the single application being the first design reissue application.

It should be noted that the filing of a design reissue application would not be proper if applicant did in fact include the design for a segregable part or subcombination thereof in the original design patent application, a restriction was thus made, and then applicant failed to file a divisional reissue application for a non-elected invention that was canceled in view of a restriction requirement (prior to issue of the original application. See In re Watkinson, 900 F.2d 230, 14 USPQ2d 1407 (Fed. Cir. 1990); In re Orita, 550 F.2d 1277, 1280, 193 USPQ 145, 148 (CCPA 1977).

IV.CONVERSION TO UTILITY PATENT

A design patent cannot be converted to a utility patent via reissue.

Converting a design patent to a utility patent will, in most instances, involve the introduction of new matter into the patent. The disclosure of a design patent is not directed to how the invention is made and used, and the introduction of new matter is required to bridge this gap and provide support for the utility patent. Accordingly, the examiner should consider rejections based on the introduction of new matter under 35 U.S.C. 251, first paragraph, and lack of enablement and/or description under 35 U.S.C. 112, first paragraph, when a reissue application is filed to convert a design patent to a utility patent.

Further, the term of a design patent may not be extended by reissue. Ex parte Lawrence, 70 USPQ 326 (Comm’r Pat. 1946). Thus, any reissue application filed to convert a design patent to a utility patent, which conversion would thereby extend the term of the patent, should be rejected as failing to comply with 35 U.S.C. 251, first paragraph, which permits reissue only “for the unexpired part of the term of the original patent.” The statute requires that the reissued patent shall not extend the term of the original patent.

1460 Effect of Reissue[edit | edit source]

35 U.S.C. 252. Effect of reissue.

The surrender of the original patent shall take effect upon the issue of the reissued patent, and every reissued patent shall have the same effect and operation in law, on the trial of actions for causes thereafter arising, as if the same had been originally granted in such amended form, but in so far as the claims of the original and reissued patents are substantially identical, such surrender shall not affect any action then pending nor abate any cause of action then existing, and the reissued patent, to the extent that its claims are substantially identical with the original patent, shall constitute a continuation thereof and have effect continuously from the date of the original patent.

A reissued patent shall not abridge or affect the right of any person or that person’s successors in business who, prior to the grant of a reissue, made, purchased, offered to sell, or used within the United States, or imported into the United States, anything patented by the reissued patent, to continue the use of, to offer to sell, or to sell to others to be used, offered for sale, or sold, the specific thing so made, purchased, offered for sale, used, or imported unless the making, using, offering for sale, or selling of such thing infringes a valid claim of the reissued patent which was in the original patent. The court before which such matter is in question may provide for the continued manufacture, use, offer for sale, or sale of the thing made, purchased, offered for sale, used, or imported as specified, or for the manufacture, use, offer for sale, or sale in the United States of which substantial preparation was made before the grant of the reissue, and the court may also provide for the continued practice of any process patented by the reissue that is practiced, or for the practice of which substantial preparation was made, before the grant of the reissue, to the extent and under such terms as the court deems equitable for the protection of investments made or business commenced before the grant of the reissue.

The effect of the reissue of a patent is stated in 35 U.S.C. 252. With respect to the Office treatment of the reissued patent, the reissued patent will be viewed as if the original patent had been originally granted in the amended form provided by the reissue. With respect to intervening rights resulting from the reissue of an original patent, the second paragraph of 35 U.S.C. 252 provides for two separate and distinct defenses to patent infringement under the doctrine of intervening rights:

“Absolute” intervening rights are available for a party that “prior to the grant of a reissue, made, purchased, offered to sell, or used within the United States, or imported into the United States, anything patented by the reissued patent,” and “equitable” intervening rights may be provided where “substantial preparation was made before the grant of the reissue.” See BIC Leisure Prods., Inc., v. Windsurfing Int’l, Inc., 1 F.3d 1214, 1220, 27 USPQ2d 1671, 1676 (Fed. Cir. 1993).

1470 Public Access of Reissue Applications[edit | edit source]

37 CFR 1.11(b) opens all reissue applications filed after March 1, 1977, to inspection by the general public. 37 CFR 1.11(b) also provides for announcement of the filings of reissue applications in the Official Gazette (except for continued prosecution applications filed under 37 CFR 1.53(d)). This announcement will give interested members of the public an opportunity to submit to the examiner information pertinent to patentability of the reissue application.

The filing of a continued prosecution application under 37 CFR 1.53(d) of a reissue application will notbe announced in the Official Gazette. Although the filing of a continued prosecution application of a reissue application constitutes the filing of a reissue application, the announcement of the filing of such continued prosecution application would be redundant in view of the announcement of the filing of the prior reissue application in the Official Gazette.

37 CFR 1.11(b) is applicable to all reissue applications filed on or after March 1, 1977. Those reissue applications previously on file will not be automatically open to inspection but a liberal policy will be followed in granting petitions for access to such applications.

IFW reissue application files are open to inspection by the general public by way of Public PAIR via the USPTO Internet site. In viewing the images of the files, members of the public will be able to view the entire content of the reissue application file history. To access Public PAIR, a member of the public would (A) go to the USPTO web site at http:// www.uspto.gov, (B) click on “Patents,” (C) under “Check Status, View Papers…” click on “Status & IFW,” and (D) under “Patent Application Information Retrieval” enter the reissue application number.

Access to a reissue application that is maintained in paper must be obtained from the area of the Office having jurisdiction over the file. The following access procedure will be observed for reissue application files that are maintained in paper:

(A)Any member of the general public may request access to a particular reissue application filed after March 1, 1977. Since no record of such request is intended to be kept, an oral request will suffice. (Reissue applications already on file prior to March 1, 1977 are not automatically open to inspection, but a liberal policy is followed by the Office of Patent Legal Administration (OPLA) and by the Board of Patent Appeals and Interferences in granting petitions for access to such applications.);

(B)Paper reissue application files will be maintained in the TCs and inspection thereof will be supervised by TC personnel. A TC Director or other appropriate Office official may, under appropriate circumstances, postpone access to or the making of copies of a paper reissue application file, in order, for example, to avoid interruption of the examination or other review of the application by an examiner. In addition, though no general limit is placed on the amount of time spent reviewing the files, the Office may impose limitations, if necessary, e.g., where the application is actively being processed;

(C)In any instance where the reissue application file has left the TC for administrative processing, requests for access should be directed to the appropriate supervisory personnel where the application is currently located;

(D)A paper reissue application file is not available to the public once the reissue application file has been released and forwarded by the TC for publication of the reissue patent. This would include any reissue application files which have been selected for a post-allowance screening at OPLA. Unless prosecution is reopened pursuant to the screening, the reissue application files are not available to the public until the reissue patent issues. This is because the reissue application file has been put into a special format for printing purposes and public access at this stage would disrupt the publication process;

(E)Requests for copies of papers in the reissue application file must be in writing addressed to Mail Stop Document Services, Director of the U.S. Patent and Trademark Office, P.O. Box 1450, Alexandria, VA 22313-1450. Such requests may be either mailed or delivered to the Customer Service Window. The price for a copy of an application as filed is set forth in 37 CFR 1.19(b)(1). Since no useful purpose is seen for retaining such written requests for copies of papers in reissue applications, the request(s) should be destroyed after the order has been completed.

See also MPEP § 103.

1480 Certificates of Correction — Office Mistake[edit | edit source]

35 U.S.C. 254. Certificate of correction of Patent and Trademark Office mistake.

Whenever a mistake in a patent, incurred through the fault of the Patent and Trademark Office, is clearly disclosed by the records of the Office, the Director may issue a certificate of correction stating the fact and nature of such mistake, under seal, without charge, to be recorded in the records of patents. A printed copy thereof shall be attached to each printed copy of the patent, and such certificate shall be considered as part of the original patent. Every such patent, together with such certificate, shall have the same effect and operation in law on the trial of actions for causes thereafter arising as if the same had been originally issued in such corrected form. The Director may issue a corrected patent without charge in lieu of and with like effect as a certificate of correction.

37 CFR 1.322. Certificate of correction of Office mistake.

(a)(1) The Director may issue a certificate of correction pursuant to 35 U.S.C. 254 to correct a mistake in a patent, incurred through the fault of the Office, which mistake is clearly disclosed in the records of the Office:

(i)At the request of the patentee or the patentee’s assignee;

(ii)Acting sua sponte for mistakes that the Office discovers; or

(iii)Acting on information about a mistake supplied by a third party.

(2)(i) There is no obligation on the Office to act on or respond to a submission of information or request to issue a certificate of correction by a third party under paragraph (a)(1)(iii) of this section.

(ii)Papers submitted by a third party under this section will not be made of record in the file that they relate to nor be retained by the Office.

(3)If the request relates to a patent involved in an interference, the request must comply with the requirements of this section and be accompanied by a motion under § 41.121(a)(2) or § 41.121(a)(3) of this title.

(4)The Office will not issue a certificate of correction under this section without first notifying the patentee (including any assignee of record) at the correspondence address of record as specified in § 1.33(a) and affording the patentee or an assignee an opportunity to be heard.

(b)If the nature of the mistake on the part of the Office is such that a certificate of correction is deemed inappropriate in form, the Director may issue a corrected patent in lieu thereof as a more appropriate form for certificate of correction, without expense to the patentee.

Mistakes incurred through the fault of the Office may be the subject of Certificates of Correction under 37 CFR 1.322. The Office, however, has discretion under 35 U.S.C. 254 to decline to issue a Certificate of Correction even though an Office mistake exists. If Office mistakes are of such a nature that the meaning intended is obvious from the context, the Office may decline to issue a certificate and merely place the correspondence in the patented file, where it serves to call attention to the matter in case any question as to it subsequently arises. Such is the case, even where a correction is requested by the patentee or patentee’s assignee.

In order to expedite all proper requests, a Certificate of Correction should be requested only for errors of consequence. Instead of a request for a Certificate of Correction, letters making errors of record should be utilized whenever possible. Thus, where errors are of a minor typographical nature, or are readily apparent to one skilled in the art, a letter making the error(s) of record can be submitted in lieu of a request for a Certificate of Correction. There is no fee for the submission of such a letter.

It is strongly advised that the text of the correction requested be submitted on a Certificate of Correction form, PTO/SB/44 (also referred to as PTO 1050). Submission of this form in duplicate is not necessary. The location of the error in the printed patent should be identified on form PTO/SB/44 by column and line number or claim and line number. See MPEP § 1485for a discussion of the preparation and submission of a request for a Certificate of Correction.

I. THIRD PARTY INFORMATION ON MISTAKES IN PATENT

Third parties do not have standing to demand that the Office issue, or refuse to issue, a Certificate of Correction. See Hallmark Cards, Inc. v. Lehman, 959 F. Supp. 539, 543-44, 42 USPQ2d 1134, 1138 (D.D.C. 1997). 37 CFR 1.322(a)(2) makes it clear that third parties do not have standing to demand that the Office act on, respond to, issue, or refuse to issue a Certificate of Correction. The Office is, however, cognizant of the need for the public to have correct information about published patents and may therefore accept information about mistakes in patents from third parties. 37 CFR 1.322(a)(1)(iii). Where appropriate, the Office may issue certificates of correction based on information supplied by third parties, whether or not such information is accompanied by a specific request for issuance of a Certificate of Correction.

While third parties are permitted to submit information about mistakes in patents which information will be reviewed, the Office need not act on that information nor deny any accompanying request for issuance of a Certificate of Correction. Accordingly, a fee for submission of the information by a third party has not been imposed. The Office may, however, choose to issue a Certificate of Correction on its own initiative based on the information supplied by a third party, if it desires to do so. Regardless of whether the third party information is acted upon, the information will not be made of record in the file that it relates to, nor be retained by the Office. 37 CFR 1.322(a)(2)(ii).

When such third party information (about mistakes in patents) is received by the Office, the Office will not correspond with third parties about the information they submitted either (1) to inform the third parties of whether it intends to issue a Certificate of Correction, or (2) to issue a denial of any request for issuance of a Certificate of Correction that may accompany the information. The Office will confirm to the party submitting such information that the Office has in fact received the information if a stamped, self-addressed post card has been submitted. See MPEP § 503.

II. PUBLICATION IN THE OFFICIAL GAZETTE

Each issue of the Official Gazette (patents section) numerically lists all United States patents having Certificates of Correction. The list appears under the heading “Certificates of Correction for the week of (date).”

1480.01 Expedited Issuance of Certificates of Correction - Error Attributable to Office[edit | edit source]

In an effort to reduce the overall time required in processing and granting Certificate of Correction requests, the Office will expedite processing and granting of patentee requests where such requests are accompanied by evidence to show that the error is attributable solely to the Office (i.e., requests filed pursuant to 37 CFR 1.322 only).

The following requirements must be met for consideration of expedited issuance of Certificates of Correction:

The text of the correction requested should be submitted on a Certificate of Correction form, PTO/SB/ 44 (also referred to as PTO 1050). Submission of this form in duplicate is not necessary. The location of the error in the printed patent should be identified on form PTO/SB/44 by column and line number or claim and line number. See also MPEP § 1485.

Where the correction requested was incurred through the fault of the Office, and the matter is clearly disclosed in the records of the Office, and is accompanied by documentation that unequivocally supports the patentee’s assertion(s), a Certificate of Correction will be expeditiously issued. Such supporting documentation can consist of relevant photocopied receipts, manuscript pages, correspondence dated and received by the Office, photocopies of Examiners’ responses regarding entry of amendments, or any other validation that supports the patentee’s request so that the request can be processed without the patent file.

Where only part of a request can be approved, the appropriate modifications will be made on the form PTO/SB/44 and the patentee then notified by mail. Further consideration will be given to initially rejected requests upon a request for reconsideration. In this instance, however, or in the case where it is determined that the Office was not responsible for the error(s) cited by the patentee, accelerated issuance of Certificates of Correction cannot be anticipated (although the Office will make every effort to process the request expeditiously).

1481 Certificates of Correction - Applicant’s Mistake[edit | edit source]

35 U.S.C. 255. Certificate of correction of applicant’s mistake.

Whenever a mistake of a clerical or typographical nature, or of minor character, which was not the fault of the Patent and Trademark Office, appears in a patent and a showing has been made that such mistake occurred in good faith, the Director may, upon payment of the required fee, issue a certificate of correction, if the correction does not involve such changes in the patent as would constitute new matter or would require reexamination. Such patent, together with the certificate, shall have the same effect and operation in law on the trial of actions for causes thereafter arising as if the same had been originally issued in such corrected form.

37 CFR 1.323. Certificate of correction of applicant’s mistake.

The Office may issue a certificate of correction under the conditions specified in 35 U.S.C. 255 at the request of the patentee or the patentee’s assignee, upon payment of the fee set forth in § 1.20(a). If the request relates to a patent involved in an interference, the request must comply with the requirements of this section and be accompanied by a motion under § 41.121(a)(2) or § 41.121(a)(3) of this title.

37 CFR 1.323 relates to the issuance of Certificates of Correction for the correction of errors which were not the fault of the Office. Mistakes in a patent which are not correctable by Certificate of Correction may be correctable via filing a reissue application (see MPEP § 1401 - § 1460). See Novo Industries, L.P. v. Micro Molds Corporation, 350 F.3d 1348, 69 USPQ2d 1128 (Fed. Cir. 2003) (The Federal Circuit stated that when Congress in 1952 defined USPTO authority to make corrections with prospective effect, it did not deny correction authority to the district courts. A court, however, can correct only if “(1) the correction is not subject to reasonable debate based on consideration of the claim language and the specification and (2) the prosecution history does not suggest a different interpretation...”).

In re Arnott, 19 USPQ2d 1049, 1052 (Comm’r Pat. 1991) specifies the criteria of 35 U.S.C. 255 (for a Certificate of Correction) as follows:

Two separate statutory requirements must be met before a Certificate of Correction for an applicant’s mistake may issue. The first statutory requirement concerns the nature, i.e., type, of the mistake for which a correction is sought. The mistake must be:

(1) of a clerical nature,

(2) of a typographical nature, or

(3) a mistake of minor character.

The second statutory requirement concerns the nature of the proposed correction. The correction must not involve changes which would:

(1) constitute new matter or

(2) require reexamination.

If the above criteria are not satisfied, then a Certificate of Correction for an applicant’s mistake will not issue, and reissue must be employed as the vehicle to “correct” the patent. Usually, any mistake affecting claim scope must be corrected by reissue.

A mistake is not considered to be of the “minor” character required for the issuance of a Certificate of Correction if the requested change would materially affect the scope or meaning of the patent. See also MPEP § 1412.04 as to correction of inventorship via certificate of correction or reissue.

The fee for providing a correction of applicant’s mistake, other than inventorship, is set forth in 37 CFR 1.20(a). The fee for correction of inventorship in a patent is set forth in 37 CFR 1.20(b).

1481.01 Correction of Assignees’ Names[edit | edit source]

The Fee(s) Transmittal Form portion (PTOL- 85B) of the Notice of Allowance provides a space (item 3) for assignment data which should be completed in order to comply with 37 CFR 3.81. Unless an assignee’s name and address are identified in the appropriate space for specifying the assignee, (i.e., item 3 of the Fee(s) Transmittal Form PTOL- 85B), the patent will issue to the applicant. Assignment data printed on the patent will be based solely on the information so supplied.

Any request for the issuance of an application in the name of the assignee submitted after the date of payment of the issue fee, and any request for a patent to be corrected to state the name of the assignee must:

(A)state that the assignment was submitted for recordation as set forth in 37 CFR 3.11 before issuance of the patent;

(B)include a request for a certificate of correction under 37 CFR 1.323 along with the fee set forth in 37 CFR 1.20(a); and

(C)include the processing fee set forth in 37 CFR 1.17(i).

See 37 CFR 3.81(b).

1481.02 Correction of Inventors’ Names[edit | edit source]

35 U.S.C. 256. Correction of named inventor.

Whenever through error a person is named in an issued patent as the inventor, or through error an inventor is not named in an issued patent and such error arose without any deceptive intention on his part, the Director may, on application of all the parties and assignees, with proof of the facts and such other requirements as may be imposed, issue a certificate correcting such error.

The error of omitting inventors or naming persons who are not inventors shall not invalidate the patent in which such error occurred if it can be corrected as provided in this section. The court before which such matter is called in question may order correction of the patent on notice and hearing of all parties concerned and the Director shall issue a certificate accordingly.

In requesting the Office to effectuate a court order correcting inventorship in a patent pursuant to 35 U.S.C. 256, a copy of the court order and a Certificate of Correction under 37 CFR 1.323 should be submitted to the Certificates of Corrections Branch.

37 CFR 1.324. Correction of inventorship in patent, pursuant to 35 U.S.C. 256.

(a)Whenever through error a person is named in an issued patent as the inventor, or through error an inventor is not named in an issued patent and such error arose without any deceptive intention on his or her part, the Director, pursuant to 35 U.S.C. 256, may, on application of all the parties and assignees, or on order of a court before which such matter is called in question, issue a certificate naming only the actual inventor or inventors. A petition to correct inventorship of a patent involved in an interference must comply with the requirements of this section and must be accompanied by a motion under § 41.121(a)(2) or § 41.121(a)(3) of this title.

(b)Any request to correct inventorship of a patent pursuant to paragraph (a) of this section must be accompanied by:

(1)Where one or more persons are being added, a statement from each person who is being added as an inventor that the inventorship error occurred without any deceptive intention on his or her part;

(2)A statement from the current named inventors who have not submitted a statement under paragraph (b)(1) of this section either agreeing to the change of inventorship or stating that they have no disagreement in regard to the requested change;

(3)A statement from all assignees of the parties submitting a statement under paragraphs (b)(1) and (b)(2) of this section agreeing to the change of inventorship in the patent, which statement must comply with the requirements of § 3.73(b) of this chapter; and

(4)The fee set forth in § 1.20(b).

(c)For correction of inventorship in an application, see §§ 1.48 and 1.497.

(d)In a contested case before the Board of Patent Appeals and Interferences under part 41, subpart D, of this title, a request for correction of a patent must be in the form of a motion under § 41.121(a)(2) or § 41.121(a)(3) of this title.

The petition to correct inventorship under 37 CFR 1.324 must include the statements and fee required by 37 CFR 1.324(b).

Under 37 CFR 1.324(b)(1), a statement is required from each person who is being added as an inventor that the inventorship error occurred without any deceptive intention on their part. In order to satisfy this, a statement such as the following is sufficient:

“The inventorship error of failing to include John Smith as an inventor of the patent occurred without any deceptive intention on the part of John Smith.”

Nothing more is required. The examiner will determine only whether the statement contains the required language; the examiner will not make any commentas to whether or not it appears that there was in fact deceptive intention (see MPEP § 2022.05).

Under 37 CFR 1.324(b)(2), all current inventors who did not submit a statement under 37 CFR 1.324(b)(1) must submit a statement either agreeing to the change of inventorship, or stating that they have no disagreement with regard to the requested change. “Current inventors” include the inventor(s) being retained as such and the inventor(s) to be deleted. These current inventors need not make a statement as to whether the inventorship error occurred without deceptive intention.

If an inventor is not available, or refuses, to submit a statement, the assignee of the patent may wish to consider filing a reissue application to correct inventorship, since the inventor’s statement is not required for a non-broadening reissue application to correct inventorship. See MPEP § 1412.04.

Under 37 CFR 1.324(b)(3), a statement is required from the assignee(s) of the patent agreeing to the change of inventorship in the patent. The assignee statement agreeing to the change of inventorship must be accompanied by a proper statement under 37 CFR 3.73(b) establishing ownership, unless a proper 37 CFR 3.73(b) statement is already in the file. See MPEP § 324 as to the requirements of a statement under 37 CFR 3.73(b).

While a request under 37 CFR 1.48 is appropriate to correct inventorship in a nonprovisional application, a petition under 37 CFR 1.324 is the appropriate vehicle to correct inventorship in a patent. If a request under 37 CFR 1.48(a), (b), or (c) is inadvertently filed in a patent, the request may be treated as a petition under 37 CFR 1.324, and if it is grantable, form paragraph 10.14 set forth below should be used.

Similarly, if a request under 37 CFR 1.48(a), (b), or (c) is filed in a pending application but not acted upon until after the application becomes a patent, the request may be treated as a petition under 37 CFR 1.324, and if it is grantable, form paragraph 10.14 set forth below should be used.

The statutory basis for correction of inventorship in a patent under 37 CFR 1.324 is 35 U.S.C. 256. It is important to recognize that 35 U.S.C. 256 is stricter than 35 U.S.C. 116, the statutory basis for corrections of inventorship in applications under 37 CFR 1.48. 35 U.S.C. 256 requires “on application of all the parties and assignees,” while 35 U.S.C. 116 does not have the same requirement. Under 35 U.S.C. 116 and 37 CFR 1.48, waiver requests under 37 CFR 1.183may be submitted (see, e.g., MPEP § 201.03, under the heading “Statement of Lack of Deceptive Intention”). This is not possible under 35 U.S.C. 256 and 37 CFR 1.324. In correction of inventorship in a nonprovisional application under 37 CFR 1.48(a), the requirement for a statement by each originally named inventor may be waived pursuant to 37 CFR 1.183; however, correction of inventorship in a patent under 37 CFR 1.324 requires petition of all the parties, i.e., originally named inventors and assignees, in accordance with statute (35 U.S.C. 256) and thus the requirement cannot be waived.

1481.03 Correction of 35 U.S.C. 119 and 35 U.S.C. 120 Benefits[edit | edit source]

I.CORRECTION TO PERFECT CLAIM FOR 35 U.S.C. 119 (a)-(d) AND (f) BENEFITS

See MPEP § 201.16 for a discussion of when 35 U.S.C. 119 (a)-(d) and (f) benefits can be perfected by certificate of correction.

II.CORRECTION AS TO 35 U.S.C. 120 AND 35 U.S.C. 119(e) BENEFITS

A.For Applications Filed Prior to November 29, 2000

For applications filed prior to November 29, 2000, it is the version of 37 CFR 1.78, which was in effect as of November 29, 2000, that applies. The pre- November 29, 2000 version reads as follows:

37 CFR 1.78. Claiming benefit of earlier filing date andcross-references to other applications.

(a)(1) A nonprovisional application may claim an invention disclosed in one or more prior filed copending nonprovisional applications or copending international applications designating the United States of America. In order for a nonprovisional application to claim the benefit of a prior filed copending nonprovisional application or copending international application designating the United States of America, each prior application must name as an inventor at least one inventor named in the later filed nonprovisional application and disclose the named inventor’s invention claimed in at least one claim of the later filed nonprovisional application in the manner provided by the first paragraph of 35 U.S.C. 112. In addition, each prior application must be:

(i)An international application entitled to a filing date in accordance with PCT Article 11 and designating the United States of America; or

(ii)Complete as set forth in § 1.51(b); or

(iii)Entitled to a filing date as set forth in § 1.53(b) or § 1.53(d) and include the basic filing fee set forth in § 1.16; or

(iv)Entitled to a filing date as set forth in § 1.53(b) and have paid therein the processing and retention fee set forth in § 1.21(l) within the time period set forth in § 1.53(f).

(2)Except for a continued prosecution application filed under §

1.53(d), any nonprovisional application claiming the benefit of one or more prior filed copending nonprovisional applications or international applications designating the United States of America must contain a reference to each such prior application, identifying it by application number (consisting of the series code and serial number) or international application number and international filing date and indicating the relationship of the applications. Unless the reference required by this paragraph is included in an application data sheet (§ 1.76), the specification must contain or be amended to contain such reference in the first sentence following any title. The request for a continued prosecution application under § 1.53(d) is the specific reference required by 35 U.S.C. 120 to the prior application. The identification of an application by application number under this section is the specific reference required by 35 U.S.C. 120 to every application assigned that application number. Cross-references to other related applications may be made when appropriate (see § 1.14(a)).

(3)A nonprovisional application other than for a design patent may claim an invention disclosed in one or more prior filed copending provisional applications. In order for a nonprovisional application to claim the benefit of one or more prior filed copending provisional applications, each prior provisional application must name as an inventor at least one inventor named in the later filed nonprovisional application and disclose the named inventor's invention claimed in at least one claim of the later filed nonprovisional application in the manner provided by the first paragraph of 35 U.S.C. 112. In addition, each prior provisional application must be entitled to a filing date as set forth in § 1.53(c), have any required English-language translation filed therein within the time period set forth in § 1.52(d), and have paid therein the basic filing fee set forth in § 1.16(k) within the time period set forth in § 1.53(g).

(4)Any nonprovisional application claiming the benefit of one or more prior filed copending provisional applications must contain a reference to each such prior provisional application, identifying it as a provisional application, and including the provisional application number (consisting of series code and serial number). Unless the reference required by this paragraph is included in an application data sheet (§ 1.76), the specification must contain or be amended to contain such reference in the first sentence following any title.

Under certain conditions specified below, a Certificate of Correction can be used, with respect to 35 U.S.C. 120 and 119(e) priority, to correct:

(A)the failure to make reference to a prior copending application pursuant to 37 CFR 1.78(a)(2) and (a)(4); or

(B)an incorrect reference to a prior copending application pursuant to 37 CFR 1.78(a)(2) and (a)(4).

For all situations other than where priority is based upon 35 U.S.C. 365(c), the conditions are as follows:

(A)for 35 U.S.C. 120 priority, all requirements set forth in 37 CFR 1.78(a)(1) must have been met in the application which became the patent to be corrected;

(B)for 35 U.S.C. 119(e) priority, all requirements set forth in 37 CFR 1.78(a)(3) must have been met in the application which became the patent to be corrected; and

(C)it must be clear from the record of the patent and the parent application(s) that priority is appropriate. See MPEP § 201.1l for requirements under 35 U.S.C. 119(e) and 120.

Where 35 U.S.C. 120 and 365(c) priority based on an international application is to be asserted or corrected in a patent via a Certificate of Correction, the following conditions must be satisfied:

(A)all requirements set forth in 37 CFR 1.78(a)(1) must have been met in the application which became the patent to be corrected;

(B)it must be clear from the record of the patent and the parent application(s) that priority is appropriate (see MPEP § 201.11); and

(C)the patentee must submit with the request for the certificate copies of documentation showing designation of states and any other information needed to make it clear from the record that the 35 U.S.C. 120priority is appropriate. See MPEP § 201.13(b) as to the requirements for 35 U.S.C. 120 priority based on an international application.

If all the above-stated conditions are satisfied, a Certificate of Correction can be used to amend the patent to make reference to a prior copending application, or to correct an incorrect reference to the prior copending application. Note In re Schuurs, 218 USPQ 443 (Comm’r Pat. 1983) which suggests that a Certificate of Correction is an appropriate remedy for correcting, in a patent, reference to a prior copending application. Also, note In re Lambrech, 202 USPQ 620 (Comm’r Pat. 1976), citing In re Van Esdonk, 187 USPQ 671 (Comm’r Pat. 1975).

If any of the above-stated conditions is not satisfied, the filing of a reissue application (see MPEP § 1401 - § 1460) would be appropriate to pursue the desired correction of the patent.

B.For Applications Filed on or After November 29, 2000

For applications filed on or after November 29, 2000, the version of 37 CFR 1.78 reproduced below applies (note that amendments to 37 CFR 1.78 took effect on November 29, 2000, December 28, 2001, May 1, 2003, January 21, 2004, September 21, 2004, December 8, 2004, July 1, 2005, and November 25, 2005).

37 CFR 1.78. Claiming benefit of earlier filing date and cross-references to other applications.

(a)(1)A nonprovisional application or international application designating the United States of America may claim an invention disclosed in one or more prior-filed copending nonprovisional applications or international applications designating the United States of America. In order for an application to claim the benefit of a prior-filed copending nonprovisional application or international application designating the United States of America, each prior-filed application must name as an inventor at least one inventor named in the later-filed application and disclose the named inventor’s invention claimed in at least one claim of the later-filed application in the manner provided by the first paragraph of 35 U.S.C. 112. In addition, each prior-filed application must be:

(i) An international application entitled to a filing date in accordance with PCT Article 11 and designating the United States of America; or

(ii) Entitled to a filing date as set forth in § 1.53(b) or § 1.53(d) and have paid therein the basic filing fee set forth in § 1.16within the pendency of the application.

(2)(i)Except for a continued prosecution application filed under § 1.53(d), any nonprovisional application or international application designating the United States of America claiming the benefit of one or more prior-filed copending nonprovisional applications or international applications designating the United States of America must contain or be amended to contain a reference to each such prior-filed application, identifying it by application number (consisting of the series code and serial number) or international application number and international filing date and indicating the relationship of the applications. Cross references to other related applications may be made when appropriate (see § 1.14).

(ii)This reference must be submitted during the pendency of the later-filed application. If the later-filed application is an application filed under 35 U.S.C. 111(a), this reference must also be submitted within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior-filed application. If the later-filed application is a nonprovisional application which entered the national stage from an international application after compliance with 35 U.S.C. 371, this reference must also be submitted within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371 (b) or (f) in the later-filed international application or sixteen months from the filing date of the prior-filed application. These time periods are not extendable. Except as provided in paragraph (a)(3) of this section, the failure to timely submit the reference required by 35 U.S.C. 120 and paragraph (a)(2)(i) of this section is considered a waiver of any benefit under 35 U.S.C. 120, 121, or 365(c) to such prior-filed application. The time periods in this paragraph do not apply if the later-filed application is:

(A)An application for a design patent;

(B)An application filed under 35 U.S.C. 111 (a) before November 29, 2000; or

(C)A nonprovisional application which entered the national stage after compliance with 35 U.S.C. 371 from an international application filed under 35 U.S.C. 363 before November 29, 2000.

(iii)If the later-filed application is a nonprovisional application, the reference required by this paragraph must be included in an application data sheet (§ 1.76), or the specification must contain or be amended to contain such reference in the first sentence(s) following the title.

(iv)The request for a continued prosecution application under § 1.53(d) is the specific reference required by 35 U.S.C. 120 to the prior-filed application. The identification of an application by application number under this section is the identification of every application assigned that application number necessary for a specific reference required by 35 U.S.C. 120 to every such application assigned that application number.

(3)If the reference required by 35 U.S.C. 120 and paragraph (a)(2) of this section is presented after the time period provided by paragraph (a)(2)(ii) of this section, the claim under 35 U.S.C. 120, 121, or 365(c) for the benefit of a prior-filed copending nonprovisional application or international application designating the United States of America may be accepted if the reference identifying the prior-filed application by application number or international application number and international filing date was unintentionally delayed. A petition to accept an unintentionally delayed claim under 35 U.S.C. 120, 121, or 365(c) for the benefit of a prior-filed application must be accompanied by:

(i)The reference required by 35 U.S.C. 120 and paragraph (a)(2) of this section to the prior-filed application, unless previously submitted;

(ii)The surcharge set forth in § 1.17(t); and

(iii)A statement that the entire delay between the date the claim was due under paragraph (a)(2)(ii) of this section and the date the claim was filed was unintentional. The Director may require additional information where there is a question whether the delay was unintentional.

(4)A nonprovisional application, other than for a design patent, or an international application designating the United States of America may claim an invention disclosed in one or more prior-filed provisional applications. In order for an application to claim the benefit of one or more prior-filed provisional applications, each prior-filed provisional application must name as an inventor at least one inventor named in the later-filed application and disclose the named inventor’s invention claimed in at least one claim of the later-filed application in the manner provided by the first paragraph of 35 U.S.C. 112. In addition, each prior-filed provisional application must be entitled to a filing date as set forth in § 1.53(c), and the basic filing fee set forth in § 1.16(d) must be paid within the time period set forth in § 1.53(g).

(5)(i) Any nonprovisional application or international application designating the United States of America claiming the benefit of one or more prior-filed provisional applications must contain or be amended to contain a reference to each such prior- filed provisional application, identifying it by the provisional application number (consisting of series code and serial number).

(ii)This reference must be submitted during the pendency of the later-filed application. If the later-filed application is an application filed under 35 U.S.C. 111(a), this reference must also be submitted within the later of four months from the actual filing date of the later-filed application or sixteen months from the filing date of the prior-filed provisional application. If the later- filed application is a nonprovisional application which entered the national stage from an international application after compliance with 35 U.S.C. 371, this reference must also be submitted within the later of four months from the date on which the national stage commenced under 35 U.S.C. 371(b) or (f) in the later-filed international application or sixteen months from the filing date of the prior-filed provisional application. These time periods are not extendable. Except as provided in paragraph(a)(6) of this section, the failure to timely submit the reference is considered a waiver of any benefit under 35 U.S.C. 119(e) to such prior-filed provisional application. The time periods in this paragraph do not apply if the later-filed application is:

(A)An application filed under 35 U.S.C. 111(a) before November 29, 2000; or

(B)A nonprovisional application which entered the national stage after compliance with 35 U.S.C. 371 from an international application filed under 35 U.S.C. 363 before November 29, 2000.

(iii)If the later-filed application is a nonprovisional application, the reference required by this paragraph must be included in an application data sheet (§ 1.76), or the specification must contain or be amended to contain such reference in the first sentence(s) following the title.

(iv)If the prior-filed provisional application was filed in a language other than English and both an English-language translation of the prior-filed provisional application and a statement that the translation is accurate were not previously filed in the prior-filed provisional application, applicant will be notified and given a period of time within which to file, in the prior-filed provisional application, the translation and the statement. If the notice is mailed in a pending nonprovisional application, a timely reply to such a notice must include the filing in the nonprovisional application of either a confirmation that the translation and statement were filed in the provisional application, or an amendment or Supplemental Application Data Sheet withdrawing the benefit claim, or the nonprovisional application will be abandoned. The translation and statement may be filed in the provisional application, even if the provisional application has become abandoned.

(6)If the reference required by 35 U.S.C. 119(e) and paragraph (a)(5) of this section is presented in a nonprovisional application after the time period provided by paragraph (a)(5)(ii) of this section, the claim under 35 U.S.C. 119(e) for the benefit of a prior filed provisional application may be accepted during the pendency of the later-filed application if the reference identifying the prior-filed application by provisional application number was unintentionally delayed. A petition to accept an unintentionally delayed claim under 35 U.S.C. 119(e) for the benefit of a prior filed provisional application must be accompanied by:

(i)The reference required by 35 U.S.C. 119(e) and paragraph (a)(5) of this section to the prior-filed provisional application, unless previously submitted;

(ii)The surcharge set forth in § 1.17(t); and

(iii)A statement that the entire delay between the date the claim was due under paragraph (a)(5)(ii) of this section and the date the claim was filed was unintentional. The Director may require additional information where there is a question whether the delay was unintentional.

(b)Where two or more applications filed by the same applicant contain conflicting claims, elimination of such claims from all but one application may be required in the absence of good and sufficient reason for their retention during pendency in more than one application.

(c)If an application or a patent under reexamination and at least one other application naming different inventors are owned by the same person and contain conflicting claims, and there is no statement of record indicating that the claimed inventions were commonly owned or subject to an obligation of assignment to the same person at the time the later invention was made, the Office may require the assignee to state whether the claimed inventions were commonly owned or subject to an obligation of assignment to the same person at the time the later invention was made, and if not, indicate which named inventor is the prior inventor. Even if the claimed inventions were commonly owned, or subject to an obligation of assignment to the same person, at the time the later invention was made, the conflicting claims may be rejected under the doctrine of double patenting in view of such commonly owned or assigned applications or patents under reexamination.

Under no circumstances can a Certificate of Correction be employed to correct an applicant’s mistake by adding or correcting a priority claim under 35 U.S.C. 119(e) for an application filed on or after November 29, 2000.

Section 4503 of the American Inventors Protection Act of 1999 (AIPA) amended 35 U.S.C. 119(e)(1) to state that:

No application shall be entitled to the benefit of an earlier filed provisional application under this subsection unless an amendment containing the specific reference to the earlier filed provisional application is submitted at such time during the pendency of the application as required by the Director. The Director may consider the failure to submit such an amendment within that time period as a waiver of any benefit under this subsection. The Director may establish procedures, including the payment of a surcharge, to accept an unintentionally delayed submission of an amendment under this section during the pendency of the application. (emphasis added)

A Certificate of Correction is NOT a valid mechanism for adding or correcting a priority claim under 35 U.S.C. 119(e) after a patent has been granted on an application filed on or after November 29, 2000.

Under certain conditions as specified below, however, a Certificate of Correction can still be used, with respect to 35 U.S.C. 120 priority, to correct:

(A)the failure to make reference to a prior copending application pursuant to 37 CFR 1.78(a)(2); or

(B)an incorrect reference to a prior copending application pursuant to 37 CFR 1.78(a)(2).

Where priority is based upon 35 U.S.C. 120 to a national application, the following conditions must be satisfied:

(A)all requirements set forth in 37 CFR 1.78(a)(1) must have been met in the application which became the patent to be corrected;

(B) it must be clear from the record of the patent and the parent application(s) that priority is appropriate (see MPEP § 201.11); and

(C)a grantable petition to accept an unintentionally delayed claim for the benefit of a prior application must be filed, including a surcharge as set forth in 37 CFR 1.17(t), as required by 37 CFR 1.78(a)(3).

Where 35 U.S.C. 120 and 365(c) priority based on an international application is to be asserted or corrected in a patent via a Certificate of Correction, the following conditions must be satisfied:

(A)all requirements set forth in 37 CFR 1.78(a)(1) must have been met in the application which became the patent to be corrected;

(B)it must be clear from the record of the patent and the parent application(s) that priority is appropriate (see MPEP § 201.11);

(C)the patentee must submit together with the request for the certificate, copies of documentation showing designation of states and any other information needed to make it clear from the record that the 35 U.S.C. 120 priority is appropriate (see MPEP § 201.13(b) as to the requirements for 35 U.S.C. 120priority based on an international application; and

(D)a grantable petition to accept an unintentionally delayed claim for the benefit of a prior application must be filed, including a surcharge as set forth in 37 CFR 1.17(t), as required by 37 CFR 1.78(a)(3).

If all the above-stated conditions are satisfied, a Certificate of Correction can be used to amend the patent to make reference to a prior copending application, or to correct an incorrect reference to the prior copending application, for benefit claims under 35 U.S.C. 120 and 365(c).

If any of the above-stated conditions is not satisfied, the filing of a reissue application (see MPEP § 1401 - § 1460) may be appropriate to pursue the desired correction of the patent for benefit claims under 35 U.S.C. 120 and 365(c).

1485 Handling of Request for Certificates of Correction[edit | edit source]

A request for a Certificate of Correction should be addressed to:

Commissioner for Patents

Office of Patent Publication

ATTN: Certificate of Correction Branch

P.O. Box 1450

Alexandria, VA 22313-1450

Requests for Certificates of Correction will be forwarded to the Certificate of Correction Branch of the Office of Patent Publication, where they will be listed in a permanent record book.

If the patent is involved in an interference, a Certificate of Correction under 37 CFR 1.324 will not be issued unless a corresponding motion under 37 CFR 41.121(a)(2) or 41.121(a)(3) has been granted by the administrative patent judge. Otherwise, determination as to whether an error has been made, the responsibility for the error, if any, and whether the error is of such a nature as to justify the issuance of a Certificate of Correction will be made by the Certificate of Correction Branch. If a report is necessary in making such determination, the case will be forwarded to the appropriate group with a request that the report be furnished. If no certificate is to issue, the party making the request is so notified and the request, report, if any, and copy of the communication to the person making the request are placed in the file wrapper (for a paper file) or entered into the file history (for an IFW file), and entered into the “Contents” for the file by the Certificate of Correction Branch. The case is then returned to the patented files. If a certificate is to issue, it will be prepared and forwarded to the person making the request by the Office of Patent Publication. In that case, the request, the report, if any, and a copy of the letter transmitting the Certificate of Correction to the person making the request will be placed in the file wrapper (for a paper file) or entered into the file history (for an IFW file), and entered into the “Contents” for the file.

Applicants, or their attorneys or agents, are urged to submit the text of the correction on a special Certificate of Correction form, PTO/SB/44 (also referred to as Form PTO-1050), which can serve as the camera copy for use in direct offset printing of the Certificate of Correction.

Where only a part of a request can be approved, or where the Office discovers and includes additional corrections, the appropriate alterations are made on the form PTO/SB/44 by the Office. The patentee is notified of the changes on the Notification of Approval-in-part form PTOL-404. The certificate is issued approximately 6 weeks thereafter.

Form PTO/SB/44 should be used exclusively regardless of the length or complexity of the subject matter. Intricate chemical formulas or page of specification or drawings may be reproduced and mounted on a blank copy of PTO/SB/44. Failure to use the form has frequently delayed issuance since the text must be retyped by the Office onto a PTO/SB/44.

The exact page and line number where the errors occur in the application file should be identified on the request. However, on form PTO/SB/44, only the column and line number in the printed patent should be used.

The patent grant should be retained by the patentee. The Office does not attach the Certificate of Correction to patentee’s copy of the patent. The patent grant will be returned to the patentee if submitted.

Below is a sample form illustrating a variety of corrections and the suggested manner of setting out the format. Particular attention is directed to:

(A)Identification of the exact point of error by reference to column and line number of the printed patent for changes in the specification or to claim number and line where a claim is involved.

(B)Conservation of space on the form by typing single space, beginning two lines down from the printed message.

(C)Starting the correction to each separate column as a sentence, and using semicolons to separate corrections within the same column, where possible.

(D)Leaving a two-inch space blank at bottom of the last sheet for the signature of the attesting officer.

(E)Using quotation marks to enclose the exact subject matter to be deleted or corrected; using double hyphens (-- --) to enclose subject matter to be added, except for formulas.

(F)Where a formula is involved, setting out only that portion thereof which is to be corrected or, if necessary, pasting a photocopy onto form PTO/SB/ 44.

ELECTRONIC PUBLICATION OF CERTIFICATES OF CORRECTION WITH LATER LISTING IN THE OFFICIAL GAZETTE

Effective August 2001, the U.S. Patent and Trademark Office (USPTO) publishes on the USPTO web site at http://www.uspto.gov/web/patents/certofcorrect a listing by patent number of the patents for which certificates of correction are being issued.

The USPTO is now automating the publication process for certificates of correction. This new process will result in certificates of correction being published quicker electronically on the USPTO’s web site as compared to their paper publication and the listing of the certificates of correction in the Official Gazette. Under the newly automated process, each issue of certificates of correction will be electronically published on the USPTO web site at http://www.uspto.gov/web/ patents/certofcorrect, and will also subsequently be listed in the Official Gazette (and in the Official Gazette Notices posted at http://www.uspto.gov/web/ offices/com/sol/og) approximately three weeks thereafter. The listing of certificates of correction in the Official Gazette will include the certificate’s date of issuance.

On the date on which the listing of certificates of correction is electronically published on the USPTO web site: (A) the certificate of correction will be entered into the file wrapper of a paper-file patent, or entered into the file history of an IFW-file patent and will be available to the public; (B) a printed copy of the certificate of correction will be mailed to the patentee or the patent’s assignee; and (C) an image of the printed certificate of correction will be added to the image of the patent on the patent database at http:// www.uspto.gov.patft. Dissemination of all other paper copies of the certificate of correction will occur shortly thereafter.

The date on which the USPTO makes the certificate of correction available to the public (e.g., by adding the certificate of correction to the file wrapper/file history) will be regarded as the date of issuance of the certificate of correction, not the date of the certificate of correction appearing in the Official Gazette. (For IFW processing, see IFW Manual.) Certificates of correction published in the above-described manner will provide the public with prompt notice and access, and this is consistent with the legislative intent behind the American Inventors Protection Act of 1999. See

35 U.S.C. 10(a) (authorizing the USPTO to publish in electronic form).

The listing of certificates of correction can be electronically accessed on the day of issuance at http:// www.uspto.gov/web/patents/certofcorrect. The electronic image of the printed certificate of correction can be accessed on the patent database at http:// www.uspto.gov/patft and the listing of the certificates of correction, as published in the Official Gazettethree weeks later, will be electronically accessible at http://www.uspto.gov/web/offices/com/sol/og.

1490 Disclaimers[edit | edit source]

35 U.S.C. 253. Disclaimer.

Whenever, without any deceptive intention, a claim of a patent is invalid the remaining claims shall not thereby be rendered invalid. A patentee, whether of the whole or any sectional interest therein, may, on payment of the fee required by law, make disclaimer of any complete claim, stating therein the extent of his interest in such patent. Such disclaimer shall be in writing, and recorded in the Patent and Trademark Office; and it shall thereafter be considered as part of the original patent to the extent of the interest possessed by the disclaimant and by those claiming under him.

In like manner any patentee or applicant may disclaim or dedicate to the public the entire term, or any terminal part of the term, of the patent granted or to be granted.

37 CFR 1.321. Statutory disclaimers, including terminal disclaimers.

(a)A patentee owning the whole or any sectional interest in a patent may disclaim any complete claim or claims in a patent. In like manner any patentee may disclaim or dedicate to the public the entire term, or any terminal part of the term, of the patent granted. Such disclaimer is binding upon the grantee and its successors or assigns. A notice of the disclaimer is published in the Official Gazette and attached to the printed copies of the specification. The disclaimer, to be recorded in the Patent and Trademark Office, must:

(1)be signed by the patentee, or an attorney or agent of record;

(2)identify the patent and complete claim or claims, or term being disclaimed. A disclaimer which is not a disclaimer of a complete claim or claims, or term, will be refused recordation;

(3)state the present extent of patentee’s ownership interest in the patent; and

(4)be accompanied by the fee set forth in § 1.20(d).

(b)An applicant or assignee may disclaim or dedicate to the public the entire term, or any terminal part of the term, of a patent to be granted. Such terminal disclaimer is binding upon the grantee and its successors or assigns. The terminal disclaimer, to be recorded in the Patent and Trademark Office, must:

(1)be signed:

(i)by the applicant, or

(ii)if there is an assignee of record of an undivided part interest, by the applicant and such assignee, or

(iii)if there is an assignee of record of the entire interest, by such assignee, or

(iv)by an attorney or agent of record;

(2)specify the portion of the term of the patent being disclaimed;


(3)state the present extent of applicant’s or assignee’s ownership interest in the patent to be granted; and

(4)be accompanied by the fee set forth in § 1.20(d).

(c)A terminal disclaimer, when filed to obviate judicially created double patenting in a patent application or in a reexamination proceeding except as provided for in paragraph (d) of this section, must:

(1)Comply with the provisions of paragraphs (b)(2) through (b)(4) of this section;

(2)Be signed in accordance with paragraph (b)(1) of this section if filed in a patent application or in accordance with paragraph (a)(1) of this section if filed in a reexamination proceeding; and

(3)Include a provision that any patent granted on that application or any patent subject to the reexamination proceeding shall be enforceable only for and during such period that said patent is commonly owned with the application or patent which formed the basis for the judicially created double patenting.

(d)A terminal disclaimer, when filed in a patent application or in a reexamination proceeding to obviate double patenting based upon a patent or application that is not commonly owned but was disqualified under 35 U.S.C. 103(c) as resulting from activities undertaken within the scope of a joint research agreement, must:

(1)Comply with the provisions of paragraphs (b)(2) through (b)(4) of this section;

(2)Be signed in accordance with paragraph (b)(1) of this section if filed in a patent application or be signed in accordance with paragraph (a)(1) of this section if filed in a reexamination proceeding;

(3)Include a provision waiving the right to separately enforce any patent granted on that application or any patent subject to the reexamination proceeding and the patent or any patent granted on the application which formed the basis for the double patenting, and that any patent granted on that application or any patent subject to the reexamination proceeding shall be enforceable only for and during such period that said patent and the patent, or any patent granted on the application, which formed the basis for the double patenting are not separately enforced.

A disclaimer is a statement filed by an owner (in part or in entirety) of a patent or of a patent to be granted (i.e., an application), in which said owner relinquishes certain legal rights to the patent. There are two types of disclaimers: a statutory disclaimer and a terminal disclaimer. The owner of a patent or an application is the original inventor(s) or the assignee of the original inventor(s). The patent or application is assigned by one assignment or by multiple assignments which establish a chain of title from the inventor( s) to the assignee(s). The owner of the patent or application can sign a disclaimer, and a person empowered by the owner to sign the disclaimer can also sign it. Per 37 CFR 1.321(b)(1)(iv), an attorney or agent of record is permitted to sign the disclaimer. A registered practitioner acting in a representative capacity under 37 CFR 1.34 is not permitted to sign the disclaimer. For a disclaimer to be accepted, it must be signed by the proper party as follows:

(A)A disclaimer filed in an application must be signed by

(1)the applicant where the application has not been assigned,

(2)the applicant and the assignee where each owns a part interest in the application,

(3)the assignee where assignee owns the entire interest in the application, or

(4)an attorney or agent of record.

(B)A disclaimer filed in a patent or a reexamination proceeding must be signed by either

(1)the patentee (the assignee, the inventor(s) if the patent is not assigned, or the assignee and the inventors if the patent is assigned-in-part), or

(2)an attorney or agent of record.

(C)Where the assignee (of an application or of a patent being reexamined or to be reissued) signs the disclaimer, there is a requirement to comply with 37 CFR 3.73(b) in order to satisfy 37 CFR 1.321, unless an attorney or agent of record signs the disclaimer. In order to comply with 37 CFR 3.73(b), the assignee’s ownership interest must be established by:

(1)filing in the application or patent evidence of a chain of title from the original owner to the assignee and a statement affirming that the documentary evidence of the chain of title from the original owner to the assignee was, or concurrently is being, submitted for recordation pursuant to 37 CFR 3.11, or

(2)specifying in the record of the application or patent where such evidence is recorded in the Office (e.g., reel and frame number, etc.).

The submission with respect to 37 CFR 3.73(b) to establish ownership must be signed by a party authorized to act on behalf of the assignee. See also MPEP § 324 as to compliance with 37 CFR 3.73(b). A copy of the “Statement Under 37 CFR 3.73 (b),” which is reproduced in MPEP § 324, may be sent by the examiner to applicant to provide an acceptable way to comply with the requirements of 37 CFR 3.73(b).

(D)Where the attorney or agent of record signs the disclaimer, there is no need to comply with 37 CFR 3.73(b).

(E)The signature on the disclaimer need not be an original signature. Pursuant to 37 CFR 1.4(d)(1)(ii), the submitted disclaimer can be a copy, such as a photocopy or facsimile transmission of an original disclaimer.

I.STATUTORY DISCLAIMERS

Under 37 CFR 1.321(a) the owner of a patent may disclaim a complete claim or claims of his or her patent. This may result from a lawsuit or because he or she has reason to believe that the claim or claims are too broad or otherwise invalid. If the patent is involved in an interference, see 37 CFR 41.121(a).

As noted above, a statutory disclaimer is a statement in which a patent owner relinquishes legal rights to one or more claims of a patent. A statutory disclaimer is not, however, a vehicle for adding or amending claims, since there is no provision for such in the statute (35 U.S.C. 253) nor the rules (37 CFR 1.321). Thus, claims of a patent cannot be disclaimed in favor of new claims to be added to the patent or an amendment to existing claims.

II.TERMINAL DISCLAIMERS

37 CFR 1.321(a) also provides for the filing by an applicant or patentee of a terminal disclaimer which disclaims or dedicates to the public the entire term or any portion of the term of a patent or patent to be granted.

37 CFR 1.321(c) specifically provides for the filing of a terminal disclaimer in an application or a reexamination proceeding for the purpose of overcoming a nonstatutory double patenting rejection. See MPEP § 804.02.

37 CFR 1.321(d) specifically provides for the filing of a terminal disclaimer in an application or a reexamination proceeding for the purpose of overcoming a nonstatutory double patenting rejection based on a U.S. patent or application that is not commonly owned but was disqualified under 35 U.S.C. 103(c).

III.PROCESSING

Certificate of Correction Branch

The Certificate of Correction Branch is responsible for the handling of all statutory disclaimers filed under the first paragraph of 35 U.S.C. 253, whether the case is pending or patented, and all terminal disclaimers (filed under the second paragraph of 35 U.S.C. 253) except for those filed in an application or reexamination proceeding pending in a Technology Center (TC). This involves:

(A)Determining the compliance of the disclaimer with 35 U.S.C. 253 and 37 CFR 1.321 and 3.73;

(B)Notifying applicant or patentee when the disclaimer is informal and thus not acceptable;

(C)Recording the disclaimers in the record of the application file; and

(D)Providing the disclaimer data for printing in the Official Gazette.

IV.TERMINAL DISCLAIMER IN PENDING APPLICATION PRACTICE IN THE TECHNOLOGY CENTERS

Where a terminal disclaimer is filed in an application pending in a TC, it will be processed by the paralegal of the Office of the Special Program Examiner of the TC having responsibility for the application. The paralegal will:

(A)Determine compliance with 35 U.S.C. 253and 37 CFR 1.321 and 3.73, and ensure that the appropriate terminal disclaimer fee set forth in 37 CFR 1.20(d) is/was applied;

(B)Notify the examiner having charge of the application whether the terminal disclaimer is acceptable or not;

(C)Where the terminal disclaimer is not acceptable, indicate the nature of the informalities so that the examiner can inform applicant in the next Office action. For an IFW application, complete the IFW terminal disclaimer form by checking the “Disapproved” box and have the form scanned into IFW;

(D)Where the terminal disclaimer is acceptable, record the terminal disclaimer in the record of the application as set forth below.

The paralegal will record an acceptable terminal disclaimer as being present in an application by:

For IFW applications:

(A)Completing the IFW terminal disclaimer form by checking the “Approved” box and having the form scanned into IFW; and

(B)Entering the terminal disclaimer into PALM for the application.

For application files that are maintained in paper:

For paper applications with 08/ and earlier series code

(A)Attaching a green label to the file wrapper;

(B)Stamping a notice on the file of the term which has been disclaimed (note that the blanks on the stamped notice for entering information on the patent(s) being disclaimed are no longer filled in);

(C)Endorsing the paper containing the terminal disclaimer submission on the “Contents” flap of the application file; and

(D)Entering the terminal disclaimer into the PALM system records, for the application.

For paper applications with 09/ and later series code

(A)Checking a box on the file wrapper which states that the terminal disclaimer has been filed (Any blanks for entering information on the patent(s) being disclaimed are no longer filled in. Note that applications with 10/ and later series codes no longer have such blanks to complete);

(B)Endorsing the paper containing the terminal disclaimer submission on the “Contents” flap of the application file; and

(C)Entering the terminal disclaimer into the PALM system records, for the application.

The paralegal completes a Terminal Disclaimer Informal Memo to notify the examiner of the nature of any informalities in the terminal disclaimer. The examiner should notify the applicant of the informalities in the next Office action, or by interview with applicant if such will expedite prosecution of the application. Further, the examiner should initial and date the Terminal Disclaimer Informal Memo and return it to the paralegal to indicate that the examiner has appropriately notified applicant about the terminal disclaimer. The paralegal will then discard the Terminal Disclaimer Informal Memo.

V.OTHER MATTERS DIRECTED TO TERMINAL DISCLAIMERS

A.Requirements of Terminal Disclaimers

A proper terminal disclaimer must disclaim the terminal part of the statutory term of any patent granted on the application being examined which would extend beyond the expiration date of the full statutory term, shortened by any terminal disclaimer, of the patent (or of any patent granted on the application) to which the disclaimer is directed. Note the exculpatory language in the second paragraph of the sample terminal disclaimer forms, PTO/SB/25 and PTO/SB/26, provided at the end of this Chapter. That language (“In making the above disclaimer, the owner does not disclaim...”) is permissible in a terminal disclaimer.

A terminal disclaimer filed to obviate a nonstatutory double patenting rejection based on a commonly owned patent or application must comply with the requirements of 37 CFR 1.321(c). The terminal disclaimer must state that any patent granted on the application being examined will be enforceable only for and during the period that it and the patent to which the disclaimer is directed or the patent granted on the application to which the disclaimer is directed are commonly owned. See MPEP § 706.02(1)(2) for examples of common ownership, or lack thereof.

A terminal disclaimer filed to obviate a nonstatutory double patenting rejection based on a non-commonly owned patent or application disqualified under 35 U.S.C. 103(c) as a result of activities undertaken within the scope of a joint research agreement under 35 U.S.C. 103(c)(2) and (3) must comply with 37 CFR 1.321(d), which sets forth signature, waiver rights and enforceability requirements.

The terminal disclaimer must include a provision:

(1)waiving the right to separately enforce (a) any patent granted on that application or the patent being reexamined and (b) the reference patent, or any patent granted on the reference application which formed the basis for the double patenting; and

(2)agreeing that any patent granted on that application or patent being reexamined shall be enforceable only for and during such period that said patent and the reference patent, or any patent granted on the reference application, which formed the basis for the double patenting are not separately enforced.

A terminal disclaimer must state that the agreement is to run with any patent granted on the application being examined and is to be binding upon the grantee, its successors, or assigns.

A statement of assignee interest in a terminal disclaimer that “A and B are the owners of 100% of the instant application...” is sufficient to satisfy the 37 CFR 1.321(b)(3) requirement that a terminal disclaimer “state the present extent of applicant’s or assignee’s ownership interest in the patent to be granted.” Although the quoted statement does not identify what specific percentage is owned by A and what specific percentage is owned by B, the statement does provide consent to the terminal disclaimer by the entirety of the ownership of the application (A and B own all of the invention, regardless of the individual percentages they own).

The appropriate one of form paragraphs 14.27.04to 14.27.08 (reproduced below) may be used to provide 

applicant or patent owner with an example of acceptable terminal disclaimer language. Additionally, copies of forms PTO/SB/25 and PTO/SB/26 (provided at the end of this Chapter) may be attached to the Office action to provide sample terminal disclaimers.

Pursuant to the last sentence of 35 U.S.C. 253, “any patentee or applicant may disclaim or dedicate to the public... any terminal part of the term, of the patent granted or to be granted”. Accordingly, the disclaimer must be of a terminal portion of the term of the entire patent to be granted. A disclaimer of a terminal portion of the term of an individual claim, or individual claims will not be accepted. It is further noted that a disclaimer of the term of individual claims would not be appropriate since the claims of a pending application or proceeding are subject to cancelation, amendment, or renumbering. The statute does not provide for conditional disclaimers and accordingly, a proposed disclaimer which is made contingent on the allowance of certain claims cannot be accepted. The disclaimer should identify the disclaimant and his or her interest in the application and should specify the date when the disclaimer is to become effective.

B.Effect of Disclaimers in Continuing Applications and in Reissues

A terminal disclaimer filed to obviate a double patenting rejection is effective only with respect to the application identified in the disclaimer unless by its terms it extends to continuing applications. For example, a terminal disclaimer filed in a parent application normally has no effect on a continuing application claiming filing date benefits of the parent application under 35 U.S.C. 120. A terminal disclaimer filed in a parent application to obviate a double patenting rejection does, however, carry over to a continued prosecution application (CPA) filed under 37 CFR 1.53(d) (effective July 14, 2003, CPAs are only available in design applications). The terminal disclaimer filed in the parent application carries over because the CPA retains the same application number as the parent application, i.e., the application number to which the previously filed terminal disclaimer is directed. If applicant does not want the terminal disclaimer to carry over to the CPA, applicant must file a petition under 37 CFR 1.182, along with the required petition fee, requesting the terminal disclaimer filed in the parent application not be carried over to the CPA; see below “Withdrawing a Terminal Disclaimer” (paragraph “A. Before Issuance of Patent”). If applicant files a Request for Continued Examination (RCE) of an application under 37 CFR 1.114 (which can be filed on or after May 29, 2000 for an application filed on or after June 8, 1995), any terminal disclaimer present will continue to operate, since a new application has not been filed, but rather prosecution has been continued in the existing application. A petition under 37 CFR 1.182, along with the required petition fee, may be filed, if withdrawal of the terminal disclaimer is to be requested.

Reissue applications: Where a terminal disclaimer was filed in an original application, a copy of that terminal disclaimer is not required be filed by applicant in the reissue.

For reissue application files that are maintained in paper:

The face of the file wrapper of the reissue application should, however, be marked by the examiner in order to indicate that a terminal disclaimer has been filed for the patent (and will be effective for the patent as it will be reissued). Further, a copy of the terminal disclaimer should be placed in the reissue application file by the Technology Center.

For IFW reissue applications:

The “Final SPRE Review” form will be filled in to indicate that a terminal disclaimer has been filed for the patent (and will be effective for the patent as it will be reissued). Further, a copy of the terminal disclaimer should be scanned into the reissue application file history by the Technology Center.

C.Disclaimer Identifies the Wrong Target Application or Patent

In some instances a terminal disclaimer filed to obviate an obviousness type double patenting rejection will identify the wrong target application or patent (i.e., an application or patent which is not the basis for the double patenting rejection). In these instances, a replacement terminal disclaimer identifying the correct target application or patent would be required by the examiner. Once a correct replacement terminal disclaimer is received, the next Office action should make it clear that “the second terminal disclaimer replaces the first terminal disclaimer, and the first terminal disclaimer is thus void.” A second terminal disclaimer fee should not be assessed/charged, since the first fee is applied to the second terminal disclaimer.

D.Two or More Copending Applications

If two (or more) pending applications are filed, in each of which a rejection of one claimed invention over the other on the ground of provisional obviousness- type double patenting (ODP) is proper, the ODP rejection will be made in each application. If the ODP rejection is the only rejection remaining in the earlier filed of the two pending applications, (but the later- filed application is rejectable on other grounds), the examiner should then withdraw that rejection and permit the earlier-filed application to issue as a patent without a terminal disclaimer. If the ODP rejection is the only rejection remaining in the later-filed application, (while the earlier-filed application is rejectable on other grounds), a terminal disclaimer must be required in the later-filed application, before the ODP rejection can be withdrawn.

If the ODP rejections in both applications are the only rejections remaining in those applications, the examiner should then withdraw the ODP rejection in the earlier filed application thereby permitting that application to issue without need of a terminal disclaimer. A terminal disclaimer must be required in the later-filed application before the ODP rejection can be withdrawn and the application be permitted to issue.

If both applications are filed on the same day, the examiner should determine which application claims the base invention and which application claims the improvement (added limitations). The ODP rejection in the base application can be withdrawn without a terminal disclaimer, while the ODP rejection in the improvement application cannot be withdrawn without a terminal disclaimer.

Where there are three applications containing claims that conflict such that an ODP rejection is made in each application based upon the other two, it is not sufficient to file a terminal disclaimer in only one of the applications addressing the other two applications. Rather, an appropriate terminal disclaimer must be filed in at least two of the applications to link all three together. This is because a terminal disclaimer filed to obviate a double patenting rejection is effective only with respect to the application in which the terminal disclaimer is filed; it is not effective to link the other two applications to each other.

VI. WITHDRAWING A RECORDED TERMINAL DISCLAIMER

If timely requested, a recorded terminal disclaimer may be withdrawn before the application in which it is filed issues as a patent, or in a reexamination proceeding, before the reexamination certificate issues. After a patent or reexamination certificate issues, it is unlikely that a recorded terminal disclaimer will be nullified.

A. Before Issuance Of Patent

While the filing and recordation of an unnecessary terminal disclaimer has been characterized as an “unhappy circumstance” in In re Jentoft, 392 F.2d 633, 157 USPQ 363 (CCPA 1968), there is no statutory prohibition against nullifying or otherwise canceling the effect of a recorded terminal disclaimer which was erroneously filed before the patent issues. Since the terminal disclaimer would not take effect until the patent is granted, and the public has not had the opportunity to rely on the terminal disclaimer, relief from this unhappy circumstance may be available by way of petition or by refiling the application (other than by refiling it as a CPA).

Under appropriate circumstances, consistent with the orderly administration of the examination process, the nullification of a recorded terminal disclaimer may be addressed by filing a petition under 37 CFR 1.182 requesting withdrawal of the recorded terminal disclaimer. Petitions seeking to reopen the question of the propriety of the double patenting rejection that prompted the filing of the terminal disclaimer have not been favorably considered. The filing of a continuing application other than a CPA, while abandoning the application in which the terminal disclaimer has been filed, will typically nullify the effect of a terminal disclaimer. The filing of a Request for Continued Examination (RCE) of an application under 37 CFR 1.114 will not nullify the effect of a terminal disclaimer, since a new application has not been filed, but rather prosecution has been continued in the existing application.

B.After Issuance Of Patent

The mechanisms to correct a patent — Certificate of Correction (35 U.S.C. 255), reissue (35 U.S.C. 251), and reexamination (35 U.S.C. 305) — are not available to withdraw or otherwise nullify the effect of a recorded terminal disclaimer. As a general principle, public policy does not favor the restoration to the patent owner of something that has been freely dedicated to the public, particularly where the public interest is not protected in some manner — e.g., intervening rights in the case of a reissue patent. See, e.g., Altoona Publix Theatres v. American Tri-Ergon Corp., 294 U.S. 477, 24 USPQ 308 (1935).

Certificates of Correction (35 U.S.C. 255) are available for the correction of an applicant’s mistake. The scope of this remedial provision is limited in two ways — by the nature of the mistake for which correction is sought and the nature of the proposed correction. In re Arnott, 19 USPQ2d 1049 (Comm’r Pat. 1991). The nature of the mistake for which correction is sought is limited to those mistakes that are:

(A)of a clerical nature,

(B)of a typographical nature, or

(C)of a minor character.

The nature of the proposed correction is limited to those situations where the correction does not involve changes which would:

(A)constitute new matter, or

(B)require reexamination.

A mistake in filing a terminal disclaimer does not fall within any of the categories of mistake for which a certificate of correction of applicant’s mistake is permissible, and any attempt to remove or nullify the effect of the terminal disclaimer would typically require reexamination of the circumstances under which it was filed.

Although the remedial nature of reissue (35 U.S.C. 251) is well recognized, reissue is not available to correct all errors. It has been the Office position that reissue is not available to withdraw or otherwise nullify the effect of a terminal disclaimer recorded in an issued patent. First, the reissue statute only authorizes the Director of the USPTO to reissue a patent “for the unexpired part of the term of the original patent.” Since the granting of a reissue patent without the effect of a recorded terminal disclaimer would result in extending the term of the original patent, reissue under these circumstances would be contrary to the statute. Second, the principle against recapturing something that has been intentionally dedicated to the public dates back to Leggett v. Avery, 101 U.S. 256 (1879). The attempt to restore that portion of the patent term that was dedicated to the public to secure the grant of the original patent would be contrary to this recapture principle. Finally, applicants have the opportunity to challenge the need for a terminal disclaimer during the prosecution of the application that issues as a patent. “Reissue is not a substitute for Patent Office appeal procedures.” Ball Corp. v. United States, 729 F.2d 1429, 1435, 221 USPQ 289, 293 (Fed. Cir. 1984). Where applicants did not challenge the propriety of the examiner’s obvious-type double patenting rejection, but filed a terminal disclaimer to avoid the rejection, the filing of the terminal disclaimer did not constitute error within the meaning of 35 U.S.C. 251. Ex parte Anthony, 230 USPQ 467 (Bd. App. 1982), aff’d, No. 84-1357 (Fed. Cir. June 14, 1985).

Finally, the nullification of a recorded terminal disclaimer would not be appropriate in a reexamination proceeding. There is a prohibition (35 U.S.C. 305) against enlarging the scope of a claim during a reexamination proceeding. As noted by the Board in Anthony, supra, if a terminal disclaimer was nullified, “claims would be able to be sued upon for a longer period than would the claims of the original patent. Therefore, the vertical scope, as opposed to the horizontal scope (where the subject matter is enlarged), would be enlarged.”

← MPEP 1300 ↑ MPEP Table of Contents MPEP 1500 →